id	sid	tid	token	lemma	pos
10_1101-2021_01_08_425864	1	1	Fatty	fatty	NN
10_1101-2021_01_08_425864	1	2	acid	acid	NN
10_1101-2021_01_08_425864	1	3	oxidation	oxidation	NN
10_1101-2021_01_08_425864	1	4	participates	participate	NNS
10_1101-2021_01_08_425864	1	5	of	of	IN
10_1101-2021_01_08_425864	1	6	the	the	DT
10_1101-2021_01_08_425864	1	7	survival	survival	NN
10_1101-2021_01_08_425864	1	8	to	to	IN
10_1101-2021_01_08_425864	1	9	starvation	starvation	NN
10_1101-2021_01_08_425864	1	10	,	,	,
10_1101-2021_01_08_425864	1	11	cell	cell	NN
10_1101-2021_01_08_425864	1	12	cycle	cycle	NN
10_1101-2021_01_08_425864	1	13	progression	progression	NN
10_1101-2021_01_08_425864	1	14	and	and	CC
10_1101-2021_01_08_425864	1	15	differentiation	differentiation	NN
10_1101-2021_01_08_425864	1	16	in	in	IN
10_1101-2021_01_08_425864	1	17	the	the	DT
10_1101-2021_01_08_425864	1	18	insect	insect	JJ
10_1101-2021_01_08_425864	1	19	stages	stage	NNS
10_1101-2021_01_08_425864	1	20	of	of	IN
10_1101-2021_01_08_425864	1	21	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	1	22	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	1	23	1	1	CD
10_1101-2021_01_08_425864	1	24	2	2	CD
10_1101-2021_01_08_425864	1	25	3	3	CD
10_1101-2021_01_08_425864	1	26	4	4	CD
10_1101-2021_01_08_425864	1	27	Fatty	Fatty	NNP
10_1101-2021_01_08_425864	1	28	acid	acid	NN
10_1101-2021_01_08_425864	1	29	oxidation	oxidation	NN
10_1101-2021_01_08_425864	1	30	participates	participate	NNS
10_1101-2021_01_08_425864	1	31	of	of	IN
10_1101-2021_01_08_425864	1	32	the	the	DT
10_1101-2021_01_08_425864	1	33	survival	survival	NN
10_1101-2021_01_08_425864	1	34	to	to	IN
10_1101-2021_01_08_425864	1	35	starvation	starvation	NN
10_1101-2021_01_08_425864	1	36	,	,	,
10_1101-2021_01_08_425864	1	37	cell	cell	NN
10_1101-2021_01_08_425864	1	38	cycle	cycle	NN
10_1101-2021_01_08_425864	1	39	progression	progression	NN
10_1101-2021_01_08_425864	1	40	5	5	CD
10_1101-2021_01_08_425864	1	41	and	and	CC
10_1101-2021_01_08_425864	1	42	differentiation	differentiation	NN
10_1101-2021_01_08_425864	1	43	in	in	IN
10_1101-2021_01_08_425864	1	44	the	the	DT
10_1101-2021_01_08_425864	1	45	insect	insect	JJ
10_1101-2021_01_08_425864	1	46	stages	stage	NNS
10_1101-2021_01_08_425864	1	47	of	of	IN
10_1101-2021_01_08_425864	1	48	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	1	49	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	1	50	6	6	CD
10_1101-2021_01_08_425864	1	51	7	7	CD
10_1101-2021_01_08_425864	1	52	Rodolpho	Rodolpho	NNP
10_1101-2021_01_08_425864	1	53	Ornitz	Ornitz	NNP
10_1101-2021_01_08_425864	1	54	Oliveira	Oliveira	NNP
10_1101-2021_01_08_425864	1	55	Souza¹	Souza¹	NNP
10_1101-2021_01_08_425864	1	56	,	,	,
10_1101-2021_01_08_425864	1	57	Flávia	Flávia	NNP
10_1101-2021_01_08_425864	1	58	Silva	Silva	NNP
10_1101-2021_01_08_425864	1	59	Damasceno¹	Damasceno¹	NNP
10_1101-2021_01_08_425864	1	60	,	,	,
10_1101-2021_01_08_425864	1	61	Sabrina	Sabrina	NNP
10_1101-2021_01_08_425864	1	62	Marsiccobetre1	Marsiccobetre1	NNP
10_1101-2021_01_08_425864	1	63	,	,	,
10_1101-2021_01_08_425864	1	64	Marc	Marc	NNP
10_1101-2021_01_08_425864	1	65	Biran2	Biran2	NNP
10_1101-2021_01_08_425864	1	66	,	,	,
10_1101-2021_01_08_425864	1	67	8	8	CD
10_1101-2021_01_08_425864	1	68	Gilson	Gilson	NNP
10_1101-2021_01_08_425864	1	69	Murata3	Murata3	NNP
10_1101-2021_01_08_425864	1	70	,	,	,
10_1101-2021_01_08_425864	1	71	Rui	Rui	NNP
10_1101-2021_01_08_425864	1	72	Curi4	curi4	CD
10_1101-2021_01_08_425864	1	73	,	,	,
10_1101-2021_01_08_425864	1	74	Frédéric	Frédéric	NNP
10_1101-2021_01_08_425864	1	75	Bringaud5	Bringaud5	NNP
10_1101-2021_01_08_425864	1	76	,	,	,
10_1101-2021_01_08_425864	1	77	Ariel	Ariel	NNP
10_1101-2021_01_08_425864	1	78	Mariano	Mariano	NNP
10_1101-2021_01_08_425864	1	79	Silber¹	Silber¹	NNP
10_1101-2021_01_08_425864	1	80	*	*	NFP
10_1101-2021_01_08_425864	1	81	9	9	CD
10_1101-2021_01_08_425864	1	82	10	10	CD
10_1101-2021_01_08_425864	1	83	11	11	CD
10_1101-2021_01_08_425864	1	84	¹	¹	CD
10_1101-2021_01_08_425864	1	85	University	University	NNP
10_1101-2021_01_08_425864	1	86	of	of	IN
10_1101-2021_01_08_425864	1	87	São	São	NNP
10_1101-2021_01_08_425864	1	88	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	1	89	,	,	,
10_1101-2021_01_08_425864	1	90	Laboratory	Laboratory	NNP
10_1101-2021_01_08_425864	1	91	of	of	IN
10_1101-2021_01_08_425864	1	92	Biochemistry	Biochemistry	NNP
10_1101-2021_01_08_425864	1	93	of	of	IN
10_1101-2021_01_08_425864	1	94	Tryps	Tryps	NNP
10_1101-2021_01_08_425864	1	95	–	–	:
10_1101-2021_01_08_425864	1	96	LaBTryps	LaBTryps	NNP
10_1101-2021_01_08_425864	1	97	,	,	,
10_1101-2021_01_08_425864	1	98	Department	Department	NNP
10_1101-2021_01_08_425864	1	99	of	of	IN
10_1101-2021_01_08_425864	1	100	12	12	CD
10_1101-2021_01_08_425864	1	101	Parasitology	Parasitology	NNP
10_1101-2021_01_08_425864	1	102	,	,	,
10_1101-2021_01_08_425864	1	103	Institute	Institute	NNP
10_1101-2021_01_08_425864	1	104	of	of	IN
10_1101-2021_01_08_425864	1	105	Biomedical	Biomedical	NNP
10_1101-2021_01_08_425864	1	106	Sciences	Sciences	NNPS
10_1101-2021_01_08_425864	1	107	–	–	:
10_1101-2021_01_08_425864	1	108	São	São	NNP
10_1101-2021_01_08_425864	1	109	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	1	110	,	,	,
10_1101-2021_01_08_425864	1	111	SP	SP	NNP
10_1101-2021_01_08_425864	1	112	,	,	,
10_1101-2021_01_08_425864	1	113	Brazil	Brazil	NNP
10_1101-2021_01_08_425864	1	114	13	13	CD
10_1101-2021_01_08_425864	1	115	14	14	CD
10_1101-2021_01_08_425864	1	116	2	2	CD
10_1101-2021_01_08_425864	1	117	Centre	Centre	NNP
10_1101-2021_01_08_425864	1	118	de	de	IN
10_1101-2021_01_08_425864	1	119	Résonance	Résonance	NNP
10_1101-2021_01_08_425864	1	120	Magnétique	Magnétique	NNP
10_1101-2021_01_08_425864	1	121	des	des	NNP
10_1101-2021_01_08_425864	1	122	Systèmes	Systèmes	NNP
10_1101-2021_01_08_425864	1	123	Biologiques	Biologiques	NNP
10_1101-2021_01_08_425864	1	124	(	(	-LRB-
10_1101-2021_01_08_425864	1	125	RMSB	RMSB	NNP
10_1101-2021_01_08_425864	1	126	)	)	-RRB-
10_1101-2021_01_08_425864	1	127	,	,	,
10_1101-2021_01_08_425864	1	128	Université	Université	NNP
10_1101-2021_01_08_425864	1	129	de	de	NNP
10_1101-2021_01_08_425864	1	130	Bordeaux	Bordeaux	NNP
10_1101-2021_01_08_425864	1	131	,	,	,
10_1101-2021_01_08_425864	1	132	15	15	CD
10_1101-2021_01_08_425864	1	133	CNRS	CNRS	NNP
10_1101-2021_01_08_425864	1	134	UMR-5536	UMR-5536	NNP
10_1101-2021_01_08_425864	1	135	,	,	,
10_1101-2021_01_08_425864	1	136	Bordeaux	Bordeaux	NNP
10_1101-2021_01_08_425864	1	137	,	,	,
10_1101-2021_01_08_425864	1	138	France	France	NNP
10_1101-2021_01_08_425864	1	139	16	16	CD
10_1101-2021_01_08_425864	1	140	17	17	CD
10_1101-2021_01_08_425864	1	141	3	3	CD
10_1101-2021_01_08_425864	1	142	University	University	NNP
10_1101-2021_01_08_425864	1	143	of	of	IN
10_1101-2021_01_08_425864	1	144	São	São	NNP
10_1101-2021_01_08_425864	1	145	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	1	146	,	,	,
10_1101-2021_01_08_425864	1	147	Department	Department	NNP
10_1101-2021_01_08_425864	1	148	of	of	IN
10_1101-2021_01_08_425864	1	149	Physiology	Physiology	NNP
10_1101-2021_01_08_425864	1	150	,	,	,
10_1101-2021_01_08_425864	1	151	Institute	Institute	NNP
10_1101-2021_01_08_425864	1	152	of	of	IN
10_1101-2021_01_08_425864	1	153	Biomedical	Biomedical	NNP
10_1101-2021_01_08_425864	1	154	Sciences	Sciences	NNPS
10_1101-2021_01_08_425864	1	155	–	–	:
10_1101-2021_01_08_425864	1	156	São	São	NNP
10_1101-2021_01_08_425864	1	157	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	1	158	,	,	,
10_1101-2021_01_08_425864	1	159	18	18	CD
10_1101-2021_01_08_425864	1	160	SP	SP	NNP
10_1101-2021_01_08_425864	1	161	,	,	,
10_1101-2021_01_08_425864	1	162	Brazil	Brazil	NNP
10_1101-2021_01_08_425864	1	163	19	19	CD
10_1101-2021_01_08_425864	1	164	20	20	CD
10_1101-2021_01_08_425864	1	165	4	4	CD
10_1101-2021_01_08_425864	1	166	Cruzeiro	Cruzeiro	NNP
10_1101-2021_01_08_425864	1	167	do	do	VBP
10_1101-2021_01_08_425864	1	168	Sul	Sul	NNP
10_1101-2021_01_08_425864	1	169	University	University	NNP
10_1101-2021_01_08_425864	1	170	,	,	,
10_1101-2021_01_08_425864	1	171	Interdisciplinary	Interdisciplinary	NNP
10_1101-2021_01_08_425864	1	172	Post	Post	NNP
10_1101-2021_01_08_425864	1	173	-	-	NNP
10_1101-2021_01_08_425864	1	174	Graduate	Graduate	NNP
10_1101-2021_01_08_425864	1	175	Program	Program	NNP
10_1101-2021_01_08_425864	1	176	in	in	IN
10_1101-2021_01_08_425864	1	177	Health	Health	NNP
10_1101-2021_01_08_425864	1	178	Sciences	Sciences	NNPS
10_1101-2021_01_08_425864	1	179	-	-	HYPH
10_1101-2021_01_08_425864	1	180	São	São	NNP
10_1101-2021_01_08_425864	1	181	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	1	182	,	,	,
10_1101-2021_01_08_425864	1	183	21	21	CD
10_1101-2021_01_08_425864	1	184	SP	SP	NNP
10_1101-2021_01_08_425864	1	185	,	,	,
10_1101-2021_01_08_425864	1	186	Brazil	Brazil	NNP
10_1101-2021_01_08_425864	1	187	22	22	CD
10_1101-2021_01_08_425864	1	188	23	23	CD
10_1101-2021_01_08_425864	1	189	5	5	CD
10_1101-2021_01_08_425864	1	190	Laboratoire	Laboratoire	NNP
10_1101-2021_01_08_425864	1	191	de	de	IN
10_1101-2021_01_08_425864	1	192	Microbiologie	Microbiologie	NNP
10_1101-2021_01_08_425864	1	193	Fondamentale	Fondamentale	NNP
10_1101-2021_01_08_425864	1	194	et	et	NNP
10_1101-2021_01_08_425864	1	195	Pathogénicité	Pathogénicité	NNP
10_1101-2021_01_08_425864	1	196	(	(	-LRB-
10_1101-2021_01_08_425864	1	197	MFP	MFP	NNP
10_1101-2021_01_08_425864	1	198	)	)	-RRB-
10_1101-2021_01_08_425864	1	199	,	,	,
10_1101-2021_01_08_425864	1	200	Université	Université	NNP
10_1101-2021_01_08_425864	1	201	de	de	NNP
10_1101-2021_01_08_425864	1	202	Bordeaux	Bordeaux	NNP
10_1101-2021_01_08_425864	1	203	,	,	,
10_1101-2021_01_08_425864	1	204	24	24	CD
10_1101-2021_01_08_425864	1	205	CNRS	cnr	NNS
10_1101-2021_01_08_425864	1	206	UMR-5234	UMR-5234	NNP
10_1101-2021_01_08_425864	1	207	,	,	,
10_1101-2021_01_08_425864	1	208	Bordeaux	Bordeaux	NNP
10_1101-2021_01_08_425864	1	209	,	,	,
10_1101-2021_01_08_425864	1	210	France	France	NNP
10_1101-2021_01_08_425864	1	211	25	25	CD
10_1101-2021_01_08_425864	1	212	26	26	CD
10_1101-2021_01_08_425864	1	213	27	27	CD
10_1101-2021_01_08_425864	1	214	28	28	CD
10_1101-2021_01_08_425864	1	215	*	*	NFP
10_1101-2021_01_08_425864	1	216	Corresponding	correspond	VBG
10_1101-2021_01_08_425864	1	217	author	author	NN
10_1101-2021_01_08_425864	1	218	29	29	CD
10_1101-2021_01_08_425864	1	219	E	e	NN
10_1101-2021_01_08_425864	1	220	-	-	NN
10_1101-2021_01_08_425864	1	221	mail	mail	NN
10_1101-2021_01_08_425864	1	222	:	:	:
10_1101-2021_01_08_425864	1	223	asilber@usp.br	asilber@usp.br	NNP
10_1101-2021_01_08_425864	1	224	(	(	-LRB-
10_1101-2021_01_08_425864	1	225	AMS	AMS	NNP
10_1101-2021_01_08_425864	1	226	)	)	-RRB-
10_1101-2021_01_08_425864	1	227	30	30	CD
10_1101-2021_01_08_425864	1	228	31	31	CD
10_1101-2021_01_08_425864	1	229	32	32	CD
10_1101-2021_01_08_425864	1	230	33	33	CD
10_1101-2021_01_08_425864	1	231	.CC	.cc	CD
10_1101-2021_01_08_425864	1	232	-	-	:
10_1101-2021_01_08_425864	1	233	BY	by	IN
10_1101-2021_01_08_425864	1	234	4.0	4.0	CD
10_1101-2021_01_08_425864	1	235	International	international	JJ
10_1101-2021_01_08_425864	1	236	licensemade	licensemade	NN
10_1101-2021_01_08_425864	1	237	available	available	JJ
10_1101-2021_01_08_425864	1	238	under	under	IN
10_1101-2021_01_08_425864	1	239	a	a	DT
10_1101-2021_01_08_425864	1	240	(	(	-LRB-
10_1101-2021_01_08_425864	1	241	which	which	WDT
10_1101-2021_01_08_425864	1	242	was	be	VBD
10_1101-2021_01_08_425864	1	243	not	not	RB
10_1101-2021_01_08_425864	1	244	certified	certify	VBN
10_1101-2021_01_08_425864	1	245	by	by	IN
10_1101-2021_01_08_425864	1	246	peer	peer	NN
10_1101-2021_01_08_425864	1	247	review	review	NN
10_1101-2021_01_08_425864	1	248	)	)	-RRB-
10_1101-2021_01_08_425864	1	249	is	be	VBZ
10_1101-2021_01_08_425864	1	250	the	the	DT
10_1101-2021_01_08_425864	1	251	author	author	NN
10_1101-2021_01_08_425864	1	252	/	/	SYM
10_1101-2021_01_08_425864	1	253	funder	funder	NN
10_1101-2021_01_08_425864	1	254	,	,	,
10_1101-2021_01_08_425864	1	255	who	who	WP
10_1101-2021_01_08_425864	1	256	has	have	VBZ
10_1101-2021_01_08_425864	1	257	granted	grant	VBN
10_1101-2021_01_08_425864	1	258	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	1	259	a	a	DT
10_1101-2021_01_08_425864	1	260	license	license	NN
10_1101-2021_01_08_425864	1	261	to	to	TO
10_1101-2021_01_08_425864	1	262	display	display	VB
10_1101-2021_01_08_425864	1	263	the	the	DT
10_1101-2021_01_08_425864	1	264	preprint	preprint	NN
10_1101-2021_01_08_425864	1	265	in	in	IN
10_1101-2021_01_08_425864	1	266	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	1	267	.	.	.
10_1101-2021_01_08_425864	2	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	2	2	is	be	VBZ
10_1101-2021_01_08_425864	2	3	The	the	DT
10_1101-2021_01_08_425864	2	4	copyright	copyright	NN
10_1101-2021_01_08_425864	2	5	holder	holder	NN
10_1101-2021_01_08_425864	2	6	for	for	IN
10_1101-2021_01_08_425864	2	7	this	this	DT
10_1101-2021_01_08_425864	2	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	2	9	version	version	NN
10_1101-2021_01_08_425864	2	10	posted	post	VBD
10_1101-2021_01_08_425864	2	11	January	January	NNP
10_1101-2021_01_08_425864	2	12	8	8	CD
10_1101-2021_01_08_425864	2	13	,	,	,
10_1101-2021_01_08_425864	2	14	2021	2021	CD
10_1101-2021_01_08_425864	2	15	.	.	.
10_1101-2021_01_08_425864	2	16	;	;	:
10_1101-2021_01_08_425864	2	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	2	18	:	:	:
10_1101-2021_01_08_425864	2	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	2	20	preprint	preprint	NN
10_1101-2021_01_08_425864	2	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	2	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	2	23	34	34	CD
10_1101-2021_01_08_425864	2	24	Abstract	Abstract	NNP
10_1101-2021_01_08_425864	2	25	35	35	CD
10_1101-2021_01_08_425864	2	26	During	during	IN
10_1101-2021_01_08_425864	2	27	its	-PRON-	PRP$
10_1101-2021_01_08_425864	2	28	complex	complex	JJ
10_1101-2021_01_08_425864	2	29	life	life	NN
10_1101-2021_01_08_425864	2	30	cycle	cycle	NN
10_1101-2021_01_08_425864	2	31	,	,	,
10_1101-2021_01_08_425864	2	32	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	2	33	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	2	34	colonizes	colonize	VBZ
10_1101-2021_01_08_425864	2	35	different	different	JJ
10_1101-2021_01_08_425864	2	36	niches	niche	NNS
10_1101-2021_01_08_425864	2	37	in	in	IN
10_1101-2021_01_08_425864	2	38	its	-PRON-	PRP$
10_1101-2021_01_08_425864	2	39	insect	insect	NN
10_1101-2021_01_08_425864	2	40	and	and	CC
10_1101-2021_01_08_425864	2	41	36	36	CD
10_1101-2021_01_08_425864	2	42	mammalian	mammalian	JJ
10_1101-2021_01_08_425864	2	43	hosts	host	NNS
10_1101-2021_01_08_425864	2	44	.	.	.
10_1101-2021_01_08_425864	3	1	This	this	DT
10_1101-2021_01_08_425864	3	2	characteristic	characteristic	NN
10_1101-2021_01_08_425864	3	3	determined	determine	VBD
10_1101-2021_01_08_425864	3	4	the	the	DT
10_1101-2021_01_08_425864	3	5	types	type	NNS
10_1101-2021_01_08_425864	3	6	of	of	IN
10_1101-2021_01_08_425864	3	7	parasites	parasite	NNS
10_1101-2021_01_08_425864	3	8	that	that	WDT
10_1101-2021_01_08_425864	3	9	adapted	adapt	VBD
10_1101-2021_01_08_425864	3	10	to	to	TO
10_1101-2021_01_08_425864	3	11	face	face	VB
10_1101-2021_01_08_425864	3	12	37	37	CD
10_1101-2021_01_08_425864	3	13	challenging	challenge	VBG
10_1101-2021_01_08_425864	3	14	environmental	environmental	JJ
10_1101-2021_01_08_425864	3	15	cues	cue	NNS
10_1101-2021_01_08_425864	3	16	.	.	.
10_1101-2021_01_08_425864	4	1	The	the	DT
10_1101-2021_01_08_425864	4	2	primary	primary	JJ
10_1101-2021_01_08_425864	4	3	environmental	environmental	JJ
10_1101-2021_01_08_425864	4	4	challenge	challenge	NN
10_1101-2021_01_08_425864	4	5	,	,	,
10_1101-2021_01_08_425864	4	6	particularly	particularly	RB
10_1101-2021_01_08_425864	4	7	in	in	IN
10_1101-2021_01_08_425864	4	8	the	the	DT
10_1101-2021_01_08_425864	4	9	insect	insect	NN
10_1101-2021_01_08_425864	4	10	38	38	CD
10_1101-2021_01_08_425864	4	11	stages	stage	NNS
10_1101-2021_01_08_425864	4	12	,	,	,
10_1101-2021_01_08_425864	4	13	is	be	VBZ
10_1101-2021_01_08_425864	4	14	poor	poor	JJ
10_1101-2021_01_08_425864	4	15	nutrient	nutrient	NN
10_1101-2021_01_08_425864	4	16	availability	availability	NN
10_1101-2021_01_08_425864	4	17	.	.	.
10_1101-2021_01_08_425864	5	1	These	these	DT
10_1101-2021_01_08_425864	5	2	T.	t.	NN
10_1101-2021_01_08_425864	5	3	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	5	4	stages	stage	NNS
10_1101-2021_01_08_425864	5	5	could	could	MD
10_1101-2021_01_08_425864	5	6	be	be	VB
10_1101-2021_01_08_425864	5	7	exposed	expose	VBN
10_1101-2021_01_08_425864	5	8	to	to	IN
10_1101-2021_01_08_425864	5	9	fatty	fatty	NN
10_1101-2021_01_08_425864	5	10	acids	acid	NNS
10_1101-2021_01_08_425864	5	11	originating	originate	VBG
10_1101-2021_01_08_425864	5	12	39	39	CD
10_1101-2021_01_08_425864	5	13	from	from	IN
10_1101-2021_01_08_425864	5	14	the	the	DT
10_1101-2021_01_08_425864	5	15	degradation	degradation	NN
10_1101-2021_01_08_425864	5	16	of	of	IN
10_1101-2021_01_08_425864	5	17	the	the	DT
10_1101-2021_01_08_425864	5	18	perimicrovillar	perimicrovillar	JJ
10_1101-2021_01_08_425864	5	19	membrane	membrane	NN
10_1101-2021_01_08_425864	5	20	.	.	.
10_1101-2021_01_08_425864	6	1	In	in	IN
10_1101-2021_01_08_425864	6	2	this	this	DT
10_1101-2021_01_08_425864	6	3	study	study	NN
10_1101-2021_01_08_425864	6	4	,	,	,
10_1101-2021_01_08_425864	6	5	we	-PRON-	PRP
10_1101-2021_01_08_425864	6	6	revisit	revisit	VBP
10_1101-2021_01_08_425864	6	7	the	the	DT
10_1101-2021_01_08_425864	6	8	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	6	9	fate	fate	NN
10_1101-2021_01_08_425864	6	10	of	of	IN
10_1101-2021_01_08_425864	6	11	40	40	CD
10_1101-2021_01_08_425864	6	12	fatty	fatty	NN
10_1101-2021_01_08_425864	6	13	acid	acid	NN
10_1101-2021_01_08_425864	6	14	breakdown	breakdown	NN
10_1101-2021_01_08_425864	6	15	in	in	IN
10_1101-2021_01_08_425864	6	16	T.	T.	NNP
10_1101-2021_01_08_425864	6	17	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	6	18	.	.	.
10_1101-2021_01_08_425864	7	1	Herein	Herein	NNP
10_1101-2021_01_08_425864	7	2	,	,	,
10_1101-2021_01_08_425864	7	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	7	4	show	show	VBP
10_1101-2021_01_08_425864	7	5	that	that	IN
10_1101-2021_01_08_425864	7	6	during	during	IN
10_1101-2021_01_08_425864	7	7	parasite	parasite	NN
10_1101-2021_01_08_425864	7	8	proliferation	proliferation	NNP
10_1101-2021_01_08_425864	7	9	,	,	,
10_1101-2021_01_08_425864	7	10	the	the	DT
10_1101-2021_01_08_425864	7	11	glucose	glucose	NN
10_1101-2021_01_08_425864	7	12	41	41	CD
10_1101-2021_01_08_425864	7	13	concentration	concentration	NN
10_1101-2021_01_08_425864	7	14	in	in	IN
10_1101-2021_01_08_425864	7	15	the	the	DT
10_1101-2021_01_08_425864	7	16	medium	medium	NN
10_1101-2021_01_08_425864	7	17	can	can	MD
10_1101-2021_01_08_425864	7	18	regulate	regulate	VB
10_1101-2021_01_08_425864	7	19	the	the	DT
10_1101-2021_01_08_425864	7	20	fatty	fatty	NN
10_1101-2021_01_08_425864	7	21	acid	acid	NN
10_1101-2021_01_08_425864	7	22	metabolism	metabolism	NN
10_1101-2021_01_08_425864	7	23	.	.	.
10_1101-2021_01_08_425864	8	1	At	at	IN
10_1101-2021_01_08_425864	8	2	the	the	DT
10_1101-2021_01_08_425864	8	3	stationary	stationary	JJ
10_1101-2021_01_08_425864	8	4	phase	phase	NN
10_1101-2021_01_08_425864	8	5	,	,	,
10_1101-2021_01_08_425864	8	6	the	the	DT
10_1101-2021_01_08_425864	8	7	42	42	CD
10_1101-2021_01_08_425864	8	8	parasites	parasite	NNS
10_1101-2021_01_08_425864	8	9	fully	fully	RB
10_1101-2021_01_08_425864	8	10	oxidize	oxidize	VBP
10_1101-2021_01_08_425864	8	11	fatty	fatty	NN
10_1101-2021_01_08_425864	8	12	acids	acid	NNS
10_1101-2021_01_08_425864	8	13	.	.	.
10_1101-2021_01_08_425864	9	1	[	[	-LRB-
10_1101-2021_01_08_425864	9	2	U-14C]-palmitate	u-14c]-palmitate	CD
10_1101-2021_01_08_425864	9	3	can	can	MD
10_1101-2021_01_08_425864	9	4	be	be	VB
10_1101-2021_01_08_425864	9	5	taken	take	VBN
10_1101-2021_01_08_425864	9	6	up	up	RP
10_1101-2021_01_08_425864	9	7	from	from	IN
10_1101-2021_01_08_425864	9	8	the	the	DT
10_1101-2021_01_08_425864	9	9	medium	medium	NN
10_1101-2021_01_08_425864	9	10	,	,	,
10_1101-2021_01_08_425864	9	11	leading	lead	VBG
10_1101-2021_01_08_425864	9	12	to	to	IN
10_1101-2021_01_08_425864	9	13	43	43	CD
10_1101-2021_01_08_425864	9	14	CO2	CO2	NNP
10_1101-2021_01_08_425864	9	15	production	production	NN
10_1101-2021_01_08_425864	9	16	via	via	IN
10_1101-2021_01_08_425864	9	17	beta	beta	NN
10_1101-2021_01_08_425864	9	18	-	-	HYPH
10_1101-2021_01_08_425864	9	19	oxidation	oxidation	NN
10_1101-2021_01_08_425864	9	20	.	.	.
10_1101-2021_01_08_425864	10	1	Lastly	lastly	RB
10_1101-2021_01_08_425864	10	2	,	,	,
10_1101-2021_01_08_425864	10	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	10	4	also	also	RB
10_1101-2021_01_08_425864	10	5	show	show	VBP
10_1101-2021_01_08_425864	10	6	that	that	IN
10_1101-2021_01_08_425864	10	7	fatty	fatty	NN
10_1101-2021_01_08_425864	10	8	acids	acid	NNS
10_1101-2021_01_08_425864	10	9	are	be	VBP
10_1101-2021_01_08_425864	10	10	degraded	degrade	VBN
10_1101-2021_01_08_425864	10	11	through	through	IN
10_1101-2021_01_08_425864	10	12	beta-	beta-	JJ
10_1101-2021_01_08_425864	10	13	44	44	CD
10_1101-2021_01_08_425864	10	14	oxidation	oxidation	NN
10_1101-2021_01_08_425864	10	15	.	.	.
10_1101-2021_01_08_425864	11	1	Additionally	additionally	RB
10_1101-2021_01_08_425864	11	2	,	,	,
10_1101-2021_01_08_425864	11	3	through	through	IN
10_1101-2021_01_08_425864	11	4	beta	beta	NN
10_1101-2021_01_08_425864	11	5	-	-	HYPH
10_1101-2021_01_08_425864	11	6	oxidation	oxidation	NN
10_1101-2021_01_08_425864	11	7	,	,	,
10_1101-2021_01_08_425864	11	8	electrons	electron	NNS
10_1101-2021_01_08_425864	11	9	are	be	VBP
10_1101-2021_01_08_425864	11	10	fed	feed	VBN
10_1101-2021_01_08_425864	11	11	directly	directly	RB
10_1101-2021_01_08_425864	11	12	to	to	IN
10_1101-2021_01_08_425864	11	13	oxidative	oxidative	CD
10_1101-2021_01_08_425864	11	14	45	45	CD
10_1101-2021_01_08_425864	11	15	phosphorylation	phosphorylation	NN
10_1101-2021_01_08_425864	11	16	,	,	,
10_1101-2021_01_08_425864	11	17	and	and	CC
10_1101-2021_01_08_425864	11	18	acetyl	acetyl	NN
10_1101-2021_01_08_425864	11	19	-	-	HYPH
10_1101-2021_01_08_425864	11	20	CoA	CoA	NNP
10_1101-2021_01_08_425864	11	21	is	be	VBZ
10_1101-2021_01_08_425864	11	22	supplied	supply	VBN
10_1101-2021_01_08_425864	11	23	to	to	IN
10_1101-2021_01_08_425864	11	24	the	the	DT
10_1101-2021_01_08_425864	11	25	tricarboxylic	tricarboxylic	JJ
10_1101-2021_01_08_425864	11	26	acid	acid	NN
10_1101-2021_01_08_425864	11	27	cycle	cycle	NN
10_1101-2021_01_08_425864	11	28	,	,	,
10_1101-2021_01_08_425864	11	29	which	which	WDT
10_1101-2021_01_08_425864	11	30	can	can	MD
10_1101-2021_01_08_425864	11	31	be	be	VB
10_1101-2021_01_08_425864	11	32	used	use	VBN
10_1101-2021_01_08_425864	11	33	to	to	TO
10_1101-2021_01_08_425864	11	34	46	46	CD
10_1101-2021_01_08_425864	11	35	feed	feed	VB
10_1101-2021_01_08_425864	11	36	other	other	JJ
10_1101-2021_01_08_425864	11	37	anabolic	anabolic	JJ
10_1101-2021_01_08_425864	11	38	pathways	pathway	NNS
10_1101-2021_01_08_425864	11	39	such	such	JJ
10_1101-2021_01_08_425864	11	40	as	as	IN
10_1101-2021_01_08_425864	11	41	the	the	DT
10_1101-2021_01_08_425864	11	42	de	de	FW
10_1101-2021_01_08_425864	11	43	novo	novo	NNP
10_1101-2021_01_08_425864	11	44	biosynthesis	biosynthesis	NNP
10_1101-2021_01_08_425864	11	45	of	of	IN
10_1101-2021_01_08_425864	11	46	fatty	fatty	NNP
10_1101-2021_01_08_425864	11	47	acids	acid	NNS
10_1101-2021_01_08_425864	11	48	.	.	.
10_1101-2021_01_08_425864	12	1	47	47	CD
10_1101-2021_01_08_425864	12	2	48	48	CD
10_1101-2021_01_08_425864	12	3	Author	author	NN
10_1101-2021_01_08_425864	12	4	Summary	Summary	NNP
10_1101-2021_01_08_425864	12	5	49	49	CD
10_1101-2021_01_08_425864	12	6	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	12	7	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	12	8	is	be	VBZ
10_1101-2021_01_08_425864	12	9	a	a	DT
10_1101-2021_01_08_425864	12	10	protist	protist	JJ
10_1101-2021_01_08_425864	12	11	parasite	parasite	NN
10_1101-2021_01_08_425864	12	12	with	with	IN
10_1101-2021_01_08_425864	12	13	a	a	DT
10_1101-2021_01_08_425864	12	14	life	life	NN
10_1101-2021_01_08_425864	12	15	cycle	cycle	NN
10_1101-2021_01_08_425864	12	16	involving	involve	VBG
10_1101-2021_01_08_425864	12	17	two	two	CD
10_1101-2021_01_08_425864	12	18	types	type	NNS
10_1101-2021_01_08_425864	12	19	of	of	IN
10_1101-2021_01_08_425864	12	20	hosts	host	NNS
10_1101-2021_01_08_425864	12	21	,	,	,
10_1101-2021_01_08_425864	12	22	a	a	DT
10_1101-2021_01_08_425864	12	23	50	50	CD
10_1101-2021_01_08_425864	12	24	vertebrate	vertebrate	NN
10_1101-2021_01_08_425864	12	25	one	one	CD
10_1101-2021_01_08_425864	12	26	(	(	-LRB-
10_1101-2021_01_08_425864	12	27	which	which	WDT
10_1101-2021_01_08_425864	12	28	includes	include	VBZ
10_1101-2021_01_08_425864	12	29	humans	human	NNS
10_1101-2021_01_08_425864	12	30	,	,	,
10_1101-2021_01_08_425864	12	31	causing	cause	VBG
10_1101-2021_01_08_425864	12	32	Chagas	Chagas	NNP
10_1101-2021_01_08_425864	12	33	disease	disease	NN
10_1101-2021_01_08_425864	12	34	)	)	-RRB-
10_1101-2021_01_08_425864	12	35	and	and	CC
10_1101-2021_01_08_425864	12	36	an	an	DT
10_1101-2021_01_08_425864	12	37	invertebrate	invertebrate	JJ
10_1101-2021_01_08_425864	12	38	one	one	NN
10_1101-2021_01_08_425864	12	39	(	(	-LRB-
10_1101-2021_01_08_425864	12	40	kissing	kiss	VBG
10_1101-2021_01_08_425864	12	41	51	51	CD
10_1101-2021_01_08_425864	12	42	bugs	bug	NNS
10_1101-2021_01_08_425864	12	43	,	,	,
10_1101-2021_01_08_425864	12	44	which	which	WDT
10_1101-2021_01_08_425864	12	45	vectorize	vectorize	VBP
10_1101-2021_01_08_425864	12	46	the	the	DT
10_1101-2021_01_08_425864	12	47	infection	infection	NN
10_1101-2021_01_08_425864	12	48	among	among	IN
10_1101-2021_01_08_425864	12	49	mammals	mammal	NNS
10_1101-2021_01_08_425864	12	50	)	)	-RRB-
10_1101-2021_01_08_425864	12	51	.	.	.
10_1101-2021_01_08_425864	13	1	In	in	IN
10_1101-2021_01_08_425864	13	2	both	both	DT
10_1101-2021_01_08_425864	13	3	hosts	host	NNS
10_1101-2021_01_08_425864	13	4	,	,	,
10_1101-2021_01_08_425864	13	5	the	the	DT
10_1101-2021_01_08_425864	13	6	parasite	parasite	NN
10_1101-2021_01_08_425864	13	7	faces	face	VBZ
10_1101-2021_01_08_425864	13	8	environmental	environmental	JJ
10_1101-2021_01_08_425864	13	9	52	52	CD
10_1101-2021_01_08_425864	13	10	challenges	challenge	NNS
10_1101-2021_01_08_425864	13	11	such	such	JJ
10_1101-2021_01_08_425864	13	12	as	as	IN
10_1101-2021_01_08_425864	13	13	sudden	sudden	JJ
10_1101-2021_01_08_425864	13	14	changes	change	NNS
10_1101-2021_01_08_425864	13	15	in	in	IN
10_1101-2021_01_08_425864	13	16	the	the	DT
10_1101-2021_01_08_425864	13	17	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	13	18	composition	composition	NN
10_1101-2021_01_08_425864	13	19	of	of	IN
10_1101-2021_01_08_425864	13	20	the	the	DT
10_1101-2021_01_08_425864	13	21	medium	medium	NN
10_1101-2021_01_08_425864	13	22	in	in	IN
10_1101-2021_01_08_425864	13	23	which	which	WDT
10_1101-2021_01_08_425864	13	24	they	-PRON-	PRP
10_1101-2021_01_08_425864	13	25	53	53	CD
10_1101-2021_01_08_425864	13	26	develop	develop	VBP
10_1101-2021_01_08_425864	13	27	,	,	,
10_1101-2021_01_08_425864	13	28	severe	severe	JJ
10_1101-2021_01_08_425864	13	29	starvation	starvation	NN
10_1101-2021_01_08_425864	13	30	,	,	,
10_1101-2021_01_08_425864	13	31	osmotic	osmotic	JJ
10_1101-2021_01_08_425864	13	32	stress	stress	NN
10_1101-2021_01_08_425864	13	33	and	and	CC
10_1101-2021_01_08_425864	13	34	redox	redox	NN
10_1101-2021_01_08_425864	13	35	imbalance	imbalance	NN
10_1101-2021_01_08_425864	13	36	,	,	,
10_1101-2021_01_08_425864	13	37	among	among	IN
10_1101-2021_01_08_425864	13	38	others	other	NNS
10_1101-2021_01_08_425864	13	39	.	.	.
10_1101-2021_01_08_425864	14	1	Because	because	IN
10_1101-2021_01_08_425864	14	2	kissing	kiss	VBG
10_1101-2021_01_08_425864	14	3	bugs	bug	NNS
10_1101-2021_01_08_425864	14	4	54	54	CD
10_1101-2021_01_08_425864	14	5	feed	feed	NN
10_1101-2021_01_08_425864	14	6	infrequently	infrequently	RB
10_1101-2021_01_08_425864	14	7	in	in	IN
10_1101-2021_01_08_425864	14	8	nature	nature	NN
10_1101-2021_01_08_425864	14	9	,	,	,
10_1101-2021_01_08_425864	14	10	an	an	DT
10_1101-2021_01_08_425864	14	11	intriguing	intriguing	JJ
10_1101-2021_01_08_425864	14	12	aspect	aspect	NN
10_1101-2021_01_08_425864	14	13	of	of	IN
10_1101-2021_01_08_425864	14	14	T.	T.	NNP
10_1101-2021_01_08_425864	14	15	cruzi	cruzi	NNP
10_1101-2021_01_08_425864	14	16	biology	biology	NN
10_1101-2021_01_08_425864	14	17	(	(	-LRB-
10_1101-2021_01_08_425864	14	18	it	-PRON-	PRP
10_1101-2021_01_08_425864	14	19	exclusively	exclusively	RB
10_1101-2021_01_08_425864	14	20	inhabits	inhabit	VBZ
10_1101-2021_01_08_425864	14	21	the	the	DT
10_1101-2021_01_08_425864	14	22	55	55	CD
10_1101-2021_01_08_425864	14	23	digestive	digestive	JJ
10_1101-2021_01_08_425864	14	24	tube	tube	NN
10_1101-2021_01_08_425864	14	25	of	of	IN
10_1101-2021_01_08_425864	14	26	these	these	DT
10_1101-2021_01_08_425864	14	27	insects	insect	NNS
10_1101-2021_01_08_425864	14	28	)	)	-RRB-
10_1101-2021_01_08_425864	14	29	is	be	VBZ
10_1101-2021_01_08_425864	14	30	how	how	WRB
10_1101-2021_01_08_425864	14	31	they	-PRON-	PRP
10_1101-2021_01_08_425864	14	32	subsist	subsist	VBP
10_1101-2021_01_08_425864	14	33	during	during	IN
10_1101-2021_01_08_425864	14	34	long	long	JJ
10_1101-2021_01_08_425864	14	35	periods	period	NNS
10_1101-2021_01_08_425864	14	36	of	of	IN
10_1101-2021_01_08_425864	14	37	starvation	starvation	NN
10_1101-2021_01_08_425864	14	38	.	.	.
10_1101-2021_01_08_425864	15	1	In	in	IN
10_1101-2021_01_08_425864	15	2	this	this	DT
10_1101-2021_01_08_425864	15	3	work	work	NN
10_1101-2021_01_08_425864	15	4	,	,	,
10_1101-2021_01_08_425864	15	5	we	-PRON-	PRP
10_1101-2021_01_08_425864	15	6	56	56	CD
10_1101-2021_01_08_425864	15	7	show	show	VBP
10_1101-2021_01_08_425864	15	8	that	that	IN
10_1101-2021_01_08_425864	15	9	this	this	DT
10_1101-2021_01_08_425864	15	10	parasite	parasite	NN
10_1101-2021_01_08_425864	15	11	performs	perform	VBZ
10_1101-2021_01_08_425864	15	12	a	a	DT
10_1101-2021_01_08_425864	15	13	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	15	14	switch	switch	NN
10_1101-2021_01_08_425864	15	15	from	from	IN
10_1101-2021_01_08_425864	15	16	glucose	glucose	VB
10_1101-2021_01_08_425864	15	17	consumption	consumption	NN
10_1101-2021_01_08_425864	15	18	to	to	IN
10_1101-2021_01_08_425864	15	19	lipid	lipid	NN
10_1101-2021_01_08_425864	15	20	oxidation	oxidation	NN
10_1101-2021_01_08_425864	15	21	,	,	,
10_1101-2021_01_08_425864	15	22	and	and	CC
10_1101-2021_01_08_425864	15	23	57	57	CD
10_1101-2021_01_08_425864	15	24	it	-PRON-	PRP
10_1101-2021_01_08_425864	15	25	is	be	VBZ
10_1101-2021_01_08_425864	15	26	able	able	JJ
10_1101-2021_01_08_425864	15	27	to	to	TO
10_1101-2021_01_08_425864	15	28	consume	consume	VB
10_1101-2021_01_08_425864	15	29	lipids	lipid	NNS
10_1101-2021_01_08_425864	15	30	and	and	CC
10_1101-2021_01_08_425864	15	31	the	the	DT
10_1101-2021_01_08_425864	15	32	lipid	lipid	NN
10_1101-2021_01_08_425864	15	33	-	-	HYPH
10_1101-2021_01_08_425864	15	34	derived	derive	VBN
10_1101-2021_01_08_425864	15	35	fatty	fatty	NN
10_1101-2021_01_08_425864	15	36	acids	acid	NNS
10_1101-2021_01_08_425864	15	37	from	from	IN
10_1101-2021_01_08_425864	15	38	both	both	DT
10_1101-2021_01_08_425864	15	39	internal	internal	JJ
10_1101-2021_01_08_425864	15	40	origins	origin	NNS
10_1101-2021_01_08_425864	15	41	as	as	RB
10_1101-2021_01_08_425864	15	42	well	well	RB
10_1101-2021_01_08_425864	15	43	as	as	IN
10_1101-2021_01_08_425864	15	44	58	58	CD
10_1101-2021_01_08_425864	15	45	externally	externally	RB
10_1101-2021_01_08_425864	15	46	supplied	supply	VBN
10_1101-2021_01_08_425864	15	47	compounds	compound	NNS
10_1101-2021_01_08_425864	15	48	.	.	.
10_1101-2021_01_08_425864	16	1	When	when	WRB
10_1101-2021_01_08_425864	16	2	fatty	fatty	NN
10_1101-2021_01_08_425864	16	3	acid	acid	NN
10_1101-2021_01_08_425864	16	4	oxidation	oxidation	NN
10_1101-2021_01_08_425864	16	5	is	be	VBZ
10_1101-2021_01_08_425864	16	6	chemically	chemically	RB
10_1101-2021_01_08_425864	16	7	inhibited	inhibit	VBN
10_1101-2021_01_08_425864	16	8	by	by	IN
10_1101-2021_01_08_425864	16	9	etomoxir	etomoxir	NNS
10_1101-2021_01_08_425864	16	10	,	,	,
10_1101-2021_01_08_425864	16	11	a	a	DT
10_1101-2021_01_08_425864	16	12	very	very	RB
10_1101-2021_01_08_425864	16	13	59	59	CD
10_1101-2021_01_08_425864	16	14	well	well	RB
10_1101-2021_01_08_425864	16	15	-	-	HYPH
10_1101-2021_01_08_425864	16	16	known	know	VBN
10_1101-2021_01_08_425864	16	17	drug	drug	NN
10_1101-2021_01_08_425864	16	18	that	that	WDT
10_1101-2021_01_08_425864	16	19	inhibits	inhibit	VBZ
10_1101-2021_01_08_425864	16	20	the	the	DT
10_1101-2021_01_08_425864	16	21	translocation	translocation	NN
10_1101-2021_01_08_425864	16	22	of	of	IN
10_1101-2021_01_08_425864	16	23	fatty	fatty	NN
10_1101-2021_01_08_425864	16	24	acids	acid	NNS
10_1101-2021_01_08_425864	16	25	into	into	IN
10_1101-2021_01_08_425864	16	26	the	the	DT
10_1101-2021_01_08_425864	16	27	mitochondria	mitochondria	NN
10_1101-2021_01_08_425864	16	28	,	,	,
10_1101-2021_01_08_425864	16	29	the	the	DT
10_1101-2021_01_08_425864	16	30	proliferative	proliferative	JJ
10_1101-2021_01_08_425864	16	31	60	60	CD
10_1101-2021_01_08_425864	16	32	insect	insect	JJ
10_1101-2021_01_08_425864	16	33	stage	stage	NN
10_1101-2021_01_08_425864	16	34	of	of	IN
10_1101-2021_01_08_425864	16	35	the	the	DT
10_1101-2021_01_08_425864	16	36	parasites	parasite	NNS
10_1101-2021_01_08_425864	16	37	has	have	VBZ
10_1101-2021_01_08_425864	16	38	dramatically	dramatically	RB
10_1101-2021_01_08_425864	16	39	diminished	diminish	VBN
10_1101-2021_01_08_425864	16	40	survival	survival	NN
10_1101-2021_01_08_425864	16	41	under	under	IN
10_1101-2021_01_08_425864	16	42	severe	severe	JJ
10_1101-2021_01_08_425864	16	43	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	16	44	stress	stress	NN
10_1101-2021_01_08_425864	16	45	and	and	CC
10_1101-2021_01_08_425864	16	46	61	61	CD
10_1101-2021_01_08_425864	16	47	its	-PRON-	PRP$
10_1101-2021_01_08_425864	16	48	differentiation	differentiation	NN
10_1101-2021_01_08_425864	16	49	into	into	IN
10_1101-2021_01_08_425864	16	50	its	-PRON-	PRP$
10_1101-2021_01_08_425864	16	51	infective	infective	JJ
10_1101-2021_01_08_425864	16	52	forms	form	NNS
10_1101-2021_01_08_425864	16	53	is	be	VBZ
10_1101-2021_01_08_425864	16	54	impaired	impair	VBN
10_1101-2021_01_08_425864	16	55	.	.	.
10_1101-2021_01_08_425864	17	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	17	2	findings	finding	NNS
10_1101-2021_01_08_425864	17	3	place	place	VBP
10_1101-2021_01_08_425864	17	4	fatty	fatty	NN
10_1101-2021_01_08_425864	17	5	acids	acid	NNS
10_1101-2021_01_08_425864	17	6	in	in	IN
10_1101-2021_01_08_425864	17	7	the	the	DT
10_1101-2021_01_08_425864	17	8	centre	centre	NN
10_1101-2021_01_08_425864	17	9	of	of	IN
10_1101-2021_01_08_425864	17	10	62	62	CD
10_1101-2021_01_08_425864	17	11	the	the	DT
10_1101-2021_01_08_425864	17	12	scene	scene	NN
10_1101-2021_01_08_425864	17	13	regarding	regard	VBG
10_1101-2021_01_08_425864	17	14	their	-PRON-	PRP$
10_1101-2021_01_08_425864	17	15	extraordinary	extraordinary	JJ
10_1101-2021_01_08_425864	17	16	resistance	resistance	NN
10_1101-2021_01_08_425864	17	17	to	to	IN
10_1101-2021_01_08_425864	17	18	nutrient	nutrient	NN
10_1101-2021_01_08_425864	17	19	-	-	HYPH
10_1101-2021_01_08_425864	17	20	depleted	deplete	VBN
10_1101-2021_01_08_425864	17	21	environments	environment	NNS
10_1101-2021_01_08_425864	17	22	.	.	.
10_1101-2021_01_08_425864	18	1	63	63	CD
10_1101-2021_01_08_425864	18	2	64	64	CD
10_1101-2021_01_08_425864	18	3	65	65	CD
10_1101-2021_01_08_425864	18	4	.CC	.cc	CD
10_1101-2021_01_08_425864	18	5	-	-	:
10_1101-2021_01_08_425864	18	6	BY	by	IN
10_1101-2021_01_08_425864	18	7	4.0	4.0	CD
10_1101-2021_01_08_425864	18	8	International	international	JJ
10_1101-2021_01_08_425864	18	9	licensemade	licensemade	NN
10_1101-2021_01_08_425864	18	10	available	available	JJ
10_1101-2021_01_08_425864	18	11	under	under	IN
10_1101-2021_01_08_425864	18	12	a	a	DT
10_1101-2021_01_08_425864	18	13	(	(	-LRB-
10_1101-2021_01_08_425864	18	14	which	which	WDT
10_1101-2021_01_08_425864	18	15	was	be	VBD
10_1101-2021_01_08_425864	18	16	not	not	RB
10_1101-2021_01_08_425864	18	17	certified	certify	VBN
10_1101-2021_01_08_425864	18	18	by	by	IN
10_1101-2021_01_08_425864	18	19	peer	peer	NN
10_1101-2021_01_08_425864	18	20	review	review	NN
10_1101-2021_01_08_425864	18	21	)	)	-RRB-
10_1101-2021_01_08_425864	18	22	is	be	VBZ
10_1101-2021_01_08_425864	18	23	the	the	DT
10_1101-2021_01_08_425864	18	24	author	author	NN
10_1101-2021_01_08_425864	18	25	/	/	SYM
10_1101-2021_01_08_425864	18	26	funder	funder	NN
10_1101-2021_01_08_425864	18	27	,	,	,
10_1101-2021_01_08_425864	18	28	who	who	WP
10_1101-2021_01_08_425864	18	29	has	have	VBZ
10_1101-2021_01_08_425864	18	30	granted	grant	VBN
10_1101-2021_01_08_425864	18	31	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	18	32	a	a	DT
10_1101-2021_01_08_425864	18	33	license	license	NN
10_1101-2021_01_08_425864	18	34	to	to	TO
10_1101-2021_01_08_425864	18	35	display	display	VB
10_1101-2021_01_08_425864	18	36	the	the	DT
10_1101-2021_01_08_425864	18	37	preprint	preprint	NN
10_1101-2021_01_08_425864	18	38	in	in	IN
10_1101-2021_01_08_425864	18	39	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	18	40	.	.	.
10_1101-2021_01_08_425864	19	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	19	2	is	be	VBZ
10_1101-2021_01_08_425864	19	3	The	the	DT
10_1101-2021_01_08_425864	19	4	copyright	copyright	NN
10_1101-2021_01_08_425864	19	5	holder	holder	NN
10_1101-2021_01_08_425864	19	6	for	for	IN
10_1101-2021_01_08_425864	19	7	this	this	DT
10_1101-2021_01_08_425864	19	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	19	9	version	version	NN
10_1101-2021_01_08_425864	19	10	posted	post	VBD
10_1101-2021_01_08_425864	19	11	January	January	NNP
10_1101-2021_01_08_425864	19	12	8	8	CD
10_1101-2021_01_08_425864	19	13	,	,	,
10_1101-2021_01_08_425864	19	14	2021	2021	CD
10_1101-2021_01_08_425864	19	15	.	.	.
10_1101-2021_01_08_425864	19	16	;	;	:
10_1101-2021_01_08_425864	19	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	19	18	:	:	:
10_1101-2021_01_08_425864	19	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	19	20	preprint	preprint	NN
10_1101-2021_01_08_425864	19	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	19	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	19	23	66	66	CD
10_1101-2021_01_08_425864	19	24	Introduction	introduction	NN
10_1101-2021_01_08_425864	19	25	67	67	CD
10_1101-2021_01_08_425864	19	26	T.	t.	NN
10_1101-2021_01_08_425864	19	27	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	19	28	,	,	,
10_1101-2021_01_08_425864	19	29	a	a	DT
10_1101-2021_01_08_425864	19	30	flagellated	flagellated	JJ
10_1101-2021_01_08_425864	19	31	parasite	parasite	NN
10_1101-2021_01_08_425864	19	32	,	,	,
10_1101-2021_01_08_425864	19	33	is	be	VBZ
10_1101-2021_01_08_425864	19	34	the	the	DT
10_1101-2021_01_08_425864	19	35	causative	causative	JJ
10_1101-2021_01_08_425864	19	36	agent	agent	NN
10_1101-2021_01_08_425864	19	37	of	of	IN
10_1101-2021_01_08_425864	19	38	Chagas	Chagas	NNP
10_1101-2021_01_08_425864	19	39	disease	disease	NN
10_1101-2021_01_08_425864	19	40	,	,	,
10_1101-2021_01_08_425864	19	41	a	a	DT
10_1101-2021_01_08_425864	19	42	neglected	neglect	VBN
10_1101-2021_01_08_425864	19	43	health	health	NN
10_1101-2021_01_08_425864	19	44	68	68	CD
10_1101-2021_01_08_425864	19	45	problem	problem	NN
10_1101-2021_01_08_425864	19	46	endemic	endemic	RB
10_1101-2021_01_08_425864	19	47	to	to	IN
10_1101-2021_01_08_425864	19	48	the	the	DT
10_1101-2021_01_08_425864	19	49	Americas	Americas	NNPS
10_1101-2021_01_08_425864	19	50	[	[	-LRB-
10_1101-2021_01_08_425864	19	51	1	1	CD
10_1101-2021_01_08_425864	19	52	]	]	-RRB-
10_1101-2021_01_08_425864	19	53	.	.	.
10_1101-2021_01_08_425864	20	1	The	the	DT
10_1101-2021_01_08_425864	20	2	parasite	parasite	NN
10_1101-2021_01_08_425864	20	3	life	life	NN
10_1101-2021_01_08_425864	20	4	cycle	cycle	NN
10_1101-2021_01_08_425864	20	5	is	be	VBZ
10_1101-2021_01_08_425864	20	6	complex	complex	JJ
10_1101-2021_01_08_425864	20	7	,	,	,
10_1101-2021_01_08_425864	20	8	alternating	alternate	VBG
10_1101-2021_01_08_425864	20	9	between	between	IN
10_1101-2021_01_08_425864	20	10	69	69	CD
10_1101-2021_01_08_425864	20	11	replicative	replicative	JJ
10_1101-2021_01_08_425864	20	12	and	and	CC
10_1101-2021_01_08_425864	20	13	non	non	JJ
10_1101-2021_01_08_425864	20	14	-	-	JJ
10_1101-2021_01_08_425864	20	15	replicative	replicative	JJ
10_1101-2021_01_08_425864	20	16	forms	form	NNS
10_1101-2021_01_08_425864	20	17	in	in	IN
10_1101-2021_01_08_425864	20	18	two	two	CD
10_1101-2021_01_08_425864	20	19	types	type	NNS
10_1101-2021_01_08_425864	20	20	of	of	IN
10_1101-2021_01_08_425864	20	21	hosts	host	NNS
10_1101-2021_01_08_425864	20	22	,	,	,
10_1101-2021_01_08_425864	20	23	mammalians	mammalian	NNS
10_1101-2021_01_08_425864	20	24	and	and	CC
10_1101-2021_01_08_425864	20	25	triatomine	triatomine	JJ
10_1101-2021_01_08_425864	20	26	insects	insect	NNS
10_1101-2021_01_08_425864	20	27	[	[	-LRB-
10_1101-2021_01_08_425864	20	28	2	2	CD
10_1101-2021_01_08_425864	20	29	]	]	-RRB-
10_1101-2021_01_08_425864	20	30	.	.	.
10_1101-2021_01_08_425864	21	1	70	70	CD
10_1101-2021_01_08_425864	21	2	In	in	IN
10_1101-2021_01_08_425864	21	3	mammalian	mammalian	JJ
10_1101-2021_01_08_425864	21	4	hosts	host	NNS
10_1101-2021_01_08_425864	21	5	,	,	,
10_1101-2021_01_08_425864	21	6	two	two	CD
10_1101-2021_01_08_425864	21	7	primary	primary	JJ
10_1101-2021_01_08_425864	21	8	forms	form	NNS
10_1101-2021_01_08_425864	21	9	are	be	VBP
10_1101-2021_01_08_425864	21	10	recognized	recognize	VBN
10_1101-2021_01_08_425864	21	11	:	:	:
10_1101-2021_01_08_425864	21	12	replicative	replicative	JJ
10_1101-2021_01_08_425864	21	13	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	21	14	amastigotes	amastigote	NNS
10_1101-2021_01_08_425864	21	15	and	and	CC
10_1101-2021_01_08_425864	21	16	71	71	CD
10_1101-2021_01_08_425864	21	17	nondividing	nondividing	JJ
10_1101-2021_01_08_425864	21	18	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	21	19	,	,	,
10_1101-2021_01_08_425864	21	20	which	which	WDT
10_1101-2021_01_08_425864	21	21	are	be	VBP
10_1101-2021_01_08_425864	21	22	released	release	VBN
10_1101-2021_01_08_425864	21	23	from	from	IN
10_1101-2021_01_08_425864	21	24	infected	infected	JJ
10_1101-2021_01_08_425864	21	25	host	host	NN
10_1101-2021_01_08_425864	21	26	cells	cell	NNS
10_1101-2021_01_08_425864	21	27	into	into	IN
10_1101-2021_01_08_425864	21	28	the	the	DT
10_1101-2021_01_08_425864	21	29	extracellular	extracellular	NNP
10_1101-2021_01_08_425864	21	30	72	72	CD
10_1101-2021_01_08_425864	21	31	medium	medium	NN
10_1101-2021_01_08_425864	21	32	.	.	.
10_1101-2021_01_08_425864	22	1	After	after	IN
10_1101-2021_01_08_425864	22	2	being	be	VBG
10_1101-2021_01_08_425864	22	3	released	release	VBN
10_1101-2021_01_08_425864	22	4	from	from	IN
10_1101-2021_01_08_425864	22	5	infected	infected	JJ
10_1101-2021_01_08_425864	22	6	cells	cell	NNS
10_1101-2021_01_08_425864	22	7	,	,	,
10_1101-2021_01_08_425864	22	8	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	22	9	can	can	MD
10_1101-2021_01_08_425864	22	10	spread	spread	VB
10_1101-2021_01_08_425864	22	11	the	the	DT
10_1101-2021_01_08_425864	22	12	infection	infection	NN
10_1101-2021_01_08_425864	22	13	by	by	IN
10_1101-2021_01_08_425864	22	14	73	73	CD
10_1101-2021_01_08_425864	22	15	infecting	infect	VBG
10_1101-2021_01_08_425864	22	16	new	new	JJ
10_1101-2021_01_08_425864	22	17	cells	cell	NNS
10_1101-2021_01_08_425864	22	18	,	,	,
10_1101-2021_01_08_425864	22	19	or	or	CC
10_1101-2021_01_08_425864	22	20	they	-PRON-	PRP
10_1101-2021_01_08_425864	22	21	can	can	MD
10_1101-2021_01_08_425864	22	22	be	be	VB
10_1101-2021_01_08_425864	22	23	ingested	ingest	VBN
10_1101-2021_01_08_425864	22	24	by	by	IN
10_1101-2021_01_08_425864	22	25	a	a	DT
10_1101-2021_01_08_425864	22	26	triatomine	triatomine	JJ
10_1101-2021_01_08_425864	22	27	bug	bug	NN
10_1101-2021_01_08_425864	22	28	during	during	IN
10_1101-2021_01_08_425864	22	29	its	-PRON-	PRP$
10_1101-2021_01_08_425864	22	30	blood	blood	NN
10_1101-2021_01_08_425864	22	31	meal	meal	NN
10_1101-2021_01_08_425864	22	32	.	.	.
10_1101-2021_01_08_425864	23	1	Once	once	RB
10_1101-2021_01_08_425864	23	2	inside	inside	IN
10_1101-2021_01_08_425864	23	3	74	74	CD
10_1101-2021_01_08_425864	23	4	the	the	DT
10_1101-2021_01_08_425864	23	5	invertebrate	invertebrate	JJ
10_1101-2021_01_08_425864	23	6	host	host	NN
10_1101-2021_01_08_425864	23	7	,	,	,
10_1101-2021_01_08_425864	23	8	the	the	DT
10_1101-2021_01_08_425864	23	9	ingested	ingested	JJ
10_1101-2021_01_08_425864	23	10	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	23	11	differentiate	differentiate	JJ
10_1101-2021_01_08_425864	23	12	into	into	IN
10_1101-2021_01_08_425864	23	13	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	23	14	,	,	,
10_1101-2021_01_08_425864	23	15	which	which	WDT
10_1101-2021_01_08_425864	23	16	initiate	initiate	VBP
10_1101-2021_01_08_425864	23	17	75	75	CD
10_1101-2021_01_08_425864	23	18	their	-PRON-	PRP$
10_1101-2021_01_08_425864	23	19	proliferation	proliferation	NN
10_1101-2021_01_08_425864	23	20	and	and	CC
10_1101-2021_01_08_425864	23	21	colonization	colonization	NN
10_1101-2021_01_08_425864	23	22	of	of	IN
10_1101-2021_01_08_425864	23	23	the	the	DT
10_1101-2021_01_08_425864	23	24	insect	insect	JJ
10_1101-2021_01_08_425864	23	25	digestive	digestive	JJ
10_1101-2021_01_08_425864	23	26	tract	tract	NN
10_1101-2021_01_08_425864	23	27	[	[	-LRB-
10_1101-2021_01_08_425864	23	28	3	3	CD
10_1101-2021_01_08_425864	23	29	]	]	-RRB-
10_1101-2021_01_08_425864	23	30	.	.	.
10_1101-2021_01_08_425864	24	1	Once	once	IN
10_1101-2021_01_08_425864	24	2	the	the	DT
10_1101-2021_01_08_425864	24	3	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	24	4	reach	reach	VBP
10_1101-2021_01_08_425864	24	5	the	the	DT
10_1101-2021_01_08_425864	24	6	76	76	CD
10_1101-2021_01_08_425864	24	7	final	final	JJ
10_1101-2021_01_08_425864	24	8	portion	portion	NN
10_1101-2021_01_08_425864	24	9	of	of	IN
10_1101-2021_01_08_425864	24	10	the	the	DT
10_1101-2021_01_08_425864	24	11	digestive	digestive	JJ
10_1101-2021_01_08_425864	24	12	tube	tube	NN
10_1101-2021_01_08_425864	24	13	,	,	,
10_1101-2021_01_08_425864	24	14	they	-PRON-	PRP
10_1101-2021_01_08_425864	24	15	initiate	initiate	VBP
10_1101-2021_01_08_425864	24	16	differentiation	differentiation	NN
10_1101-2021_01_08_425864	24	17	into	into	IN
10_1101-2021_01_08_425864	24	18	non	non	JJ
10_1101-2021_01_08_425864	24	19	-	-	JJ
10_1101-2021_01_08_425864	24	20	proliferative	proliferative	JJ
10_1101-2021_01_08_425864	24	21	,	,	,
10_1101-2021_01_08_425864	24	22	infective	infective	JJ
10_1101-2021_01_08_425864	24	23	77	77	CD
10_1101-2021_01_08_425864	24	24	metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	24	25	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	24	26	.	.	.
10_1101-2021_01_08_425864	25	1	These	these	DT
10_1101-2021_01_08_425864	25	2	forms	form	NNS
10_1101-2021_01_08_425864	25	3	will	will	MD
10_1101-2021_01_08_425864	25	4	be	be	VB
10_1101-2021_01_08_425864	25	5	expelled	expel	VBN
10_1101-2021_01_08_425864	25	6	during	during	IN
10_1101-2021_01_08_425864	25	7	a	a	DT
10_1101-2021_01_08_425864	25	8	new	new	JJ
10_1101-2021_01_08_425864	25	9	blood	blood	NN
10_1101-2021_01_08_425864	25	10	meal	meal	NN
10_1101-2021_01_08_425864	25	11	and	and	CC
10_1101-2021_01_08_425864	25	12	will	will	MD
10_1101-2021_01_08_425864	25	13	be	be	VB
10_1101-2021_01_08_425864	25	14	able	able	JJ
10_1101-2021_01_08_425864	25	15	78	78	CD
10_1101-2021_01_08_425864	25	16	to	to	TO
10_1101-2021_01_08_425864	25	17	infect	infect	VB
10_1101-2021_01_08_425864	25	18	a	a	DT
10_1101-2021_01_08_425864	25	19	new	new	JJ
10_1101-2021_01_08_425864	25	20	vertebrate	vertebrate	NN
10_1101-2021_01_08_425864	25	21	host	host	NN
10_1101-2021_01_08_425864	25	22	[	[	-LRB-
10_1101-2021_01_08_425864	25	23	2,4–6	2,4–6	CD
10_1101-2021_01_08_425864	25	24	]	]	-RRB-
10_1101-2021_01_08_425864	25	25	.	.	.
10_1101-2021_01_08_425864	26	1	79	79	CD
10_1101-2021_01_08_425864	26	2	The	the	DT
10_1101-2021_01_08_425864	26	3	diversity	diversity	NN
10_1101-2021_01_08_425864	26	4	of	of	IN
10_1101-2021_01_08_425864	26	5	environments	environment	NNS
10_1101-2021_01_08_425864	26	6	through	through	IN
10_1101-2021_01_08_425864	26	7	which	which	WDT
10_1101-2021_01_08_425864	26	8	T.	t.	NN
10_1101-2021_01_08_425864	26	9	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	26	10	passes	pass	VBZ
10_1101-2021_01_08_425864	26	11	during	during	IN
10_1101-2021_01_08_425864	26	12	its	-PRON-	PRP$
10_1101-2021_01_08_425864	26	13	life	life	NN
10_1101-2021_01_08_425864	26	14	cycle	cycle	NN
10_1101-2021_01_08_425864	26	15	(	(	-LRB-
10_1101-2021_01_08_425864	26	16	i.e.	i.e.	FW
10_1101-2021_01_08_425864	26	17	,	,	,
10_1101-2021_01_08_425864	26	18	the	the	DT
10_1101-2021_01_08_425864	26	19	80	80	CD
10_1101-2021_01_08_425864	26	20	digestive	digestive	JJ
10_1101-2021_01_08_425864	26	21	tube	tube	NN
10_1101-2021_01_08_425864	26	22	of	of	IN
10_1101-2021_01_08_425864	26	23	the	the	DT
10_1101-2021_01_08_425864	26	24	insect	insect	JJ
10_1101-2021_01_08_425864	26	25	vector	vector	NN
10_1101-2021_01_08_425864	26	26	,	,	,
10_1101-2021_01_08_425864	26	27	the	the	DT
10_1101-2021_01_08_425864	26	28	bloodstream	bloodstream	NN
10_1101-2021_01_08_425864	26	29	and	and	CC
10_1101-2021_01_08_425864	26	30	the	the	DT
10_1101-2021_01_08_425864	26	31	mammalian	mammalian	NNP
10_1101-2021_01_08_425864	26	32	cells	cell	NNS
10_1101-2021_01_08_425864	26	33	cytoplasm	cytoplasm	NNP
10_1101-2021_01_08_425864	26	34	)	)	-RRB-
10_1101-2021_01_08_425864	26	35	subjects	subject	VBZ
10_1101-2021_01_08_425864	26	36	it	-PRON-	PRP
10_1101-2021_01_08_425864	26	37	81	81	CD
10_1101-2021_01_08_425864	26	38	to	to	IN
10_1101-2021_01_08_425864	26	39	different	different	JJ
10_1101-2021_01_08_425864	26	40	levels	level	NNS
10_1101-2021_01_08_425864	26	41	of	of	IN
10_1101-2021_01_08_425864	26	42	nutrient	nutrient	NN
10_1101-2021_01_08_425864	26	43	availability	availability	NN
10_1101-2021_01_08_425864	26	44	[	[	-LRB-
10_1101-2021_01_08_425864	26	45	3,7	3,7	CD
10_1101-2021_01_08_425864	26	46	]	]	-RRB-
10_1101-2021_01_08_425864	26	47	.	.	.
10_1101-2021_01_08_425864	27	1	Therefore	therefore	RB
10_1101-2021_01_08_425864	27	2	,	,	,
10_1101-2021_01_08_425864	27	3	this	this	DT
10_1101-2021_01_08_425864	27	4	organism	organism	NN
10_1101-2021_01_08_425864	27	5	evolved	evolve	VBD
10_1101-2021_01_08_425864	27	6	a	a	DT
10_1101-2021_01_08_425864	27	7	robust	robust	JJ
10_1101-2021_01_08_425864	27	8	,	,	,
10_1101-2021_01_08_425864	27	9	flexible	flexible	JJ
10_1101-2021_01_08_425864	27	10	82	82	CD
10_1101-2021_01_08_425864	27	11	and	and	CC
10_1101-2021_01_08_425864	27	12	efficient	efficient	JJ
10_1101-2021_01_08_425864	27	13	metabolism	metabolism	NN
10_1101-2021_01_08_425864	27	14	[	[	-LRB-
10_1101-2021_01_08_425864	27	15	5,8	5,8	CD
10_1101-2021_01_08_425864	27	16	]	]	-RRB-
10_1101-2021_01_08_425864	27	17	.	.	.
10_1101-2021_01_08_425864	28	1	As	as	IN
10_1101-2021_01_08_425864	28	2	an	an	DT
10_1101-2021_01_08_425864	28	3	example	example	NN
10_1101-2021_01_08_425864	28	4	,	,	,
10_1101-2021_01_08_425864	28	5	it	-PRON-	PRP
10_1101-2021_01_08_425864	28	6	was	be	VBD
10_1101-2021_01_08_425864	28	7	recognized	recognize	VBN
10_1101-2021_01_08_425864	28	8	early	early	RB
10_1101-2021_01_08_425864	28	9	on	on	IN
10_1101-2021_01_08_425864	28	10	that	that	DT
10_1101-2021_01_08_425864	28	11	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	28	12	are	be	VBP
10_1101-2021_01_08_425864	28	13	able	able	JJ
10_1101-2021_01_08_425864	28	14	83	83	CD
10_1101-2021_01_08_425864	28	15	to	to	TO
10_1101-2021_01_08_425864	28	16	rapidly	rapidly	RB
10_1101-2021_01_08_425864	28	17	switch	switch	VB
10_1101-2021_01_08_425864	28	18	their	-PRON-	PRP$
10_1101-2021_01_08_425864	28	19	metabolism	metabolism	NN
10_1101-2021_01_08_425864	28	20	,	,	,
10_1101-2021_01_08_425864	28	21	allowing	allow	VBG
10_1101-2021_01_08_425864	28	22	the	the	DT
10_1101-2021_01_08_425864	28	23	consumption	consumption	NN
10_1101-2021_01_08_425864	28	24	of	of	IN
10_1101-2021_01_08_425864	28	25	carbohydrates	carbohydrate	NNS
10_1101-2021_01_08_425864	28	26	and	and	CC
10_1101-2021_01_08_425864	28	27	different	different	JJ
10_1101-2021_01_08_425864	28	28	amino	amino	NN
10_1101-2021_01_08_425864	28	29	84	84	CD
10_1101-2021_01_08_425864	28	30	acids	acid	NNS
10_1101-2021_01_08_425864	28	31	[	[	-LRB-
10_1101-2021_01_08_425864	28	32	9,10	9,10	NN
10_1101-2021_01_08_425864	28	33	]	]	-RRB-
10_1101-2021_01_08_425864	28	34	.	.	.
10_1101-2021_01_08_425864	29	1	Several	several	JJ
10_1101-2021_01_08_425864	29	2	studies	study	NNS
10_1101-2021_01_08_425864	29	3	identified	identify	VBN
10_1101-2021_01_08_425864	29	4	aspartate	aspartate	NN
10_1101-2021_01_08_425864	29	5	,	,	,
10_1101-2021_01_08_425864	29	6	asparagine	asparagine	JJ
10_1101-2021_01_08_425864	29	7	,	,	,
10_1101-2021_01_08_425864	29	8	glutamate	glutamate	NNP
10_1101-2021_01_08_425864	29	9	[	[	-LRB-
10_1101-2021_01_08_425864	29	10	11	11	CD
10_1101-2021_01_08_425864	29	11	]	]	-RRB-
10_1101-2021_01_08_425864	29	12	,	,	,
10_1101-2021_01_08_425864	29	13	proline	proline	NNP
10_1101-2021_01_08_425864	29	14	[	[	-LRB-
10_1101-2021_01_08_425864	29	15	12–14	12–14	CD
10_1101-2021_01_08_425864	29	16	]	]	-RRB-
10_1101-2021_01_08_425864	29	17	,	,	,
10_1101-2021_01_08_425864	29	18	85	85	CD
10_1101-2021_01_08_425864	29	19	histidine	histidine	NN
10_1101-2021_01_08_425864	29	20	[	[	-LRB-
10_1101-2021_01_08_425864	29	21	15	15	CD
10_1101-2021_01_08_425864	29	22	]	]	-RRB-
10_1101-2021_01_08_425864	29	23	,	,	,
10_1101-2021_01_08_425864	29	24	alanine	alanine	NN
10_1101-2021_01_08_425864	29	25	[	[	-LRB-
10_1101-2021_01_08_425864	29	26	11,16	11,16	CD
10_1101-2021_01_08_425864	29	27	]	]	-RRB-
10_1101-2021_01_08_425864	29	28	and	and	CC
10_1101-2021_01_08_425864	29	29	glutamine	glutamine	NN
10_1101-2021_01_08_425864	29	30	[	[	-LRB-
10_1101-2021_01_08_425864	29	31	11,17	11,17	CD
10_1101-2021_01_08_425864	29	32	]	]	-RRB-
10_1101-2021_01_08_425864	29	33	as	as	IN
10_1101-2021_01_08_425864	29	34	oxidisable	oxidisable	JJ
10_1101-2021_01_08_425864	29	35	energy	energy	NN
10_1101-2021_01_08_425864	29	36	sources	source	NNS
10_1101-2021_01_08_425864	29	37	.	.	.
10_1101-2021_01_08_425864	30	1	Despite	despite	IN
10_1101-2021_01_08_425864	30	2	the	the	DT
10_1101-2021_01_08_425864	30	3	86	86	CD
10_1101-2021_01_08_425864	30	4	quantity	quantity	NN
10_1101-2021_01_08_425864	30	5	of	of	IN
10_1101-2021_01_08_425864	30	6	accumulated	accumulate	VBN
10_1101-2021_01_08_425864	30	7	information	information	NN
10_1101-2021_01_08_425864	30	8	on	on	IN
10_1101-2021_01_08_425864	30	9	amino	amino	JJ
10_1101-2021_01_08_425864	30	10	acid	acid	NN
10_1101-2021_01_08_425864	30	11	and	and	CC
10_1101-2021_01_08_425864	30	12	carbohydrate	carbohydrate	NN
10_1101-2021_01_08_425864	30	13	consumption	consumption	NN
10_1101-2021_01_08_425864	30	14	,	,	,
10_1101-2021_01_08_425864	30	15	little	little	JJ
10_1101-2021_01_08_425864	30	16	is	be	VBZ
10_1101-2021_01_08_425864	30	17	known	know	VBN
10_1101-2021_01_08_425864	30	18	87	87	CD
10_1101-2021_01_08_425864	30	19	about	about	IN
10_1101-2021_01_08_425864	30	20	how	how	WRB
10_1101-2021_01_08_425864	30	21	T.	t.	NN
10_1101-2021_01_08_425864	30	22	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	30	23	uses	use	VBZ
10_1101-2021_01_08_425864	30	24	fatty	fatty	NN
10_1101-2021_01_08_425864	30	25	acids	acid	NNS
10_1101-2021_01_08_425864	30	26	and	and	CC
10_1101-2021_01_08_425864	30	27	how	how	WRB
10_1101-2021_01_08_425864	30	28	these	these	DT
10_1101-2021_01_08_425864	30	29	compounds	compound	NNS
10_1101-2021_01_08_425864	30	30	contribute	contribute	VBP
10_1101-2021_01_08_425864	30	31	to	to	IN
10_1101-2021_01_08_425864	30	32	the	the	DT
10_1101-2021_01_08_425864	30	33	parasite´s	parasite´s	NNP
10_1101-2021_01_08_425864	30	34	metabolism	metabolism	NN
10_1101-2021_01_08_425864	30	35	88	88	CD
10_1101-2021_01_08_425864	30	36	and	and	CC
10_1101-2021_01_08_425864	30	37	survival	survival	NN
10_1101-2021_01_08_425864	30	38	.	.	.
10_1101-2021_01_08_425864	31	1	In	in	IN
10_1101-2021_01_08_425864	31	2	this	this	DT
10_1101-2021_01_08_425864	31	3	study	study	NN
10_1101-2021_01_08_425864	31	4	,	,	,
10_1101-2021_01_08_425864	31	5	we	-PRON-	PRP
10_1101-2021_01_08_425864	31	6	explore	explore	VBP
10_1101-2021_01_08_425864	31	7	fatty	fatty	NN
10_1101-2021_01_08_425864	31	8	acid	acid	NN
10_1101-2021_01_08_425864	31	9	metabolism	metabolism	NN
10_1101-2021_01_08_425864	31	10	in	in	IN
10_1101-2021_01_08_425864	31	11	T.	T.	NNP
10_1101-2021_01_08_425864	31	12	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	31	13	.	.	.
10_1101-2021_01_08_425864	32	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	32	2	also	also	RB
10_1101-2021_01_08_425864	32	3	address	address	VBP
10_1101-2021_01_08_425864	32	4	fatty	fatty	NN
10_1101-2021_01_08_425864	32	5	acid	acid	NN
10_1101-2021_01_08_425864	32	6	89	89	CD
10_1101-2021_01_08_425864	32	7	regulation	regulation	NN
10_1101-2021_01_08_425864	32	8	by	by	IN
10_1101-2021_01_08_425864	32	9	external	external	JJ
10_1101-2021_01_08_425864	32	10	glucose	glucose	NN
10_1101-2021_01_08_425864	32	11	levels	level	NNS
10_1101-2021_01_08_425864	32	12	and	and	CC
10_1101-2021_01_08_425864	32	13	the	the	DT
10_1101-2021_01_08_425864	32	14	involvement	involvement	NN
10_1101-2021_01_08_425864	32	15	of	of	IN
10_1101-2021_01_08_425864	32	16	their	-PRON-	PRP$
10_1101-2021_01_08_425864	32	17	oxidation	oxidation	NN
10_1101-2021_01_08_425864	32	18	in	in	IN
10_1101-2021_01_08_425864	32	19	the	the	DT
10_1101-2021_01_08_425864	32	20	replication	replication	NN
10_1101-2021_01_08_425864	32	21	and	and	CC
10_1101-2021_01_08_425864	32	22	90	90	CD
10_1101-2021_01_08_425864	32	23	differentiation	differentiation	NN
10_1101-2021_01_08_425864	32	24	of	of	IN
10_1101-2021_01_08_425864	32	25	T.	t.	NN
10_1101-2021_01_08_425864	32	26	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	32	27	insect	insect	NN
10_1101-2021_01_08_425864	32	28	stages	stage	NNS
10_1101-2021_01_08_425864	32	29	.	.	.
10_1101-2021_01_08_425864	33	1	91	91	CD
10_1101-2021_01_08_425864	33	2	92	92	CD
10_1101-2021_01_08_425864	33	3	Methods	method	NNS
10_1101-2021_01_08_425864	33	4	93	93	CD
10_1101-2021_01_08_425864	33	5	Parasites	parasite	NNS
10_1101-2021_01_08_425864	33	6	94	94	CD
10_1101-2021_01_08_425864	33	7	Epimastigotes	Epimastigotes	NNPS
10_1101-2021_01_08_425864	33	8	of	of	IN
10_1101-2021_01_08_425864	33	9	T.	t.	NN
10_1101-2021_01_08_425864	33	10	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	33	11	strain	strain	NN
10_1101-2021_01_08_425864	33	12	CL	CL	NNP
10_1101-2021_01_08_425864	33	13	clone	clone	NN
10_1101-2021_01_08_425864	33	14	14	14	CD
10_1101-2021_01_08_425864	33	15	were	be	VBD
10_1101-2021_01_08_425864	33	16	maintained	maintain	VBN
10_1101-2021_01_08_425864	33	17	in	in	IN
10_1101-2021_01_08_425864	33	18	the	the	DT
10_1101-2021_01_08_425864	33	19	exponential	exponential	JJ
10_1101-2021_01_08_425864	33	20	growth	growth	NN
10_1101-2021_01_08_425864	33	21	phase	phase	NN
10_1101-2021_01_08_425864	33	22	95	95	CD
10_1101-2021_01_08_425864	33	23	by	by	IN
10_1101-2021_01_08_425864	33	24	sub	sub	JJ
10_1101-2021_01_08_425864	33	25	-	-	JJ
10_1101-2021_01_08_425864	33	26	culturing	culture	VBG
10_1101-2021_01_08_425864	33	27	them	-PRON-	PRP
10_1101-2021_01_08_425864	33	28	for	for	IN
10_1101-2021_01_08_425864	33	29	48	48	CD
10_1101-2021_01_08_425864	33	30	h	h	NN
10_1101-2021_01_08_425864	33	31	in	in	IN
10_1101-2021_01_08_425864	33	32	Liver	Liver	NNP
10_1101-2021_01_08_425864	33	33	Infusion	Infusion	NNP
10_1101-2021_01_08_425864	33	34	Tryptose	Tryptose	NNP
10_1101-2021_01_08_425864	33	35	(	(	-LRB-
10_1101-2021_01_08_425864	33	36	LIT	LIT	NNP
10_1101-2021_01_08_425864	33	37	)	)	-RRB-
10_1101-2021_01_08_425864	33	38	medium	medium	NN
10_1101-2021_01_08_425864	33	39	at	at	IN
10_1101-2021_01_08_425864	33	40	28	28	CD
10_1101-2021_01_08_425864	33	41	°	°	,
10_1101-2021_01_08_425864	33	42	C	C	NNP
10_1101-2021_01_08_425864	33	43	[	[	-LRB-
10_1101-2021_01_08_425864	33	44	18	18	CD
10_1101-2021_01_08_425864	33	45	]	]	-RRB-
10_1101-2021_01_08_425864	33	46	.	.	.
10_1101-2021_01_08_425864	34	1	Metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	34	2	96	96	CD
10_1101-2021_01_08_425864	34	3	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	34	4	were	be	VBD
10_1101-2021_01_08_425864	34	5	obtained	obtain	VBN
10_1101-2021_01_08_425864	34	6	through	through	IN
10_1101-2021_01_08_425864	34	7	the	the	DT
10_1101-2021_01_08_425864	34	8	differentiation	differentiation	NN
10_1101-2021_01_08_425864	34	9	of	of	IN
10_1101-2021_01_08_425864	34	10	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	34	11	at	at	IN
10_1101-2021_01_08_425864	34	12	the	the	DT
10_1101-2021_01_08_425864	34	13	stationary	stationary	JJ
10_1101-2021_01_08_425864	34	14	growth	growth	NN
10_1101-2021_01_08_425864	34	15	97	97	CD
10_1101-2021_01_08_425864	34	16	phase	phase	NN
10_1101-2021_01_08_425864	34	17	in	in	IN
10_1101-2021_01_08_425864	34	18	TAU-3AAG	TAU-3AAG	NNP
10_1101-2021_01_08_425864	34	19	(	(	-LRB-
10_1101-2021_01_08_425864	34	20	Triatomine	Triatomine	NNP
10_1101-2021_01_08_425864	34	21	Artificial	Artificial	NNP
10_1101-2021_01_08_425864	34	22	Urine	Urine	NNP
10_1101-2021_01_08_425864	34	23	supplemented	supplement	VBN
10_1101-2021_01_08_425864	34	24	with	with	IN
10_1101-2021_01_08_425864	34	25	10	10	CD
10_1101-2021_01_08_425864	34	26	mM	mm	NN
10_1101-2021_01_08_425864	34	27	proline	proline	NN
10_1101-2021_01_08_425864	34	28	,	,	,
10_1101-2021_01_08_425864	34	29	50	50	CD
10_1101-2021_01_08_425864	34	30	mM	mM	NNP
10_1101-2021_01_08_425864	34	31	98	98	CD
10_1101-2021_01_08_425864	34	32	glutamate	glutamate	NN
10_1101-2021_01_08_425864	34	33	,	,	,
10_1101-2021_01_08_425864	34	34	2	2	CD
10_1101-2021_01_08_425864	34	35	mM	mM	NNP
10_1101-2021_01_08_425864	34	36	aspartate	aspartate	NN
10_1101-2021_01_08_425864	34	37	and	and	CC
10_1101-2021_01_08_425864	34	38	10	10	CD
10_1101-2021_01_08_425864	34	39	mM	mm	NN
10_1101-2021_01_08_425864	34	40	glucose	glucose	NN
10_1101-2021_01_08_425864	34	41	)	)	-RRB-
10_1101-2021_01_08_425864	34	42	as	as	IN
10_1101-2021_01_08_425864	34	43	previously	previously	RB
10_1101-2021_01_08_425864	34	44	reported	report	VBN
10_1101-2021_01_08_425864	34	45	[	[	-LRB-
10_1101-2021_01_08_425864	34	46	19	19	CD
10_1101-2021_01_08_425864	34	47	]	]	-RRB-
10_1101-2021_01_08_425864	34	48	.	.	.
10_1101-2021_01_08_425864	35	1	.CC	.CC	NFP
10_1101-2021_01_08_425864	35	2	-	-	:
10_1101-2021_01_08_425864	35	3	BY	by	IN
10_1101-2021_01_08_425864	35	4	4.0	4.0	CD
10_1101-2021_01_08_425864	35	5	International	international	JJ
10_1101-2021_01_08_425864	35	6	licensemade	licensemade	NN
10_1101-2021_01_08_425864	35	7	available	available	JJ
10_1101-2021_01_08_425864	35	8	under	under	IN
10_1101-2021_01_08_425864	35	9	a	a	DT
10_1101-2021_01_08_425864	35	10	(	(	-LRB-
10_1101-2021_01_08_425864	35	11	which	which	WDT
10_1101-2021_01_08_425864	35	12	was	be	VBD
10_1101-2021_01_08_425864	35	13	not	not	RB
10_1101-2021_01_08_425864	35	14	certified	certify	VBN
10_1101-2021_01_08_425864	35	15	by	by	IN
10_1101-2021_01_08_425864	35	16	peer	peer	NN
10_1101-2021_01_08_425864	35	17	review	review	NN
10_1101-2021_01_08_425864	35	18	)	)	-RRB-
10_1101-2021_01_08_425864	35	19	is	be	VBZ
10_1101-2021_01_08_425864	35	20	the	the	DT
10_1101-2021_01_08_425864	35	21	author	author	NN
10_1101-2021_01_08_425864	35	22	/	/	SYM
10_1101-2021_01_08_425864	35	23	funder	funder	NN
10_1101-2021_01_08_425864	35	24	,	,	,
10_1101-2021_01_08_425864	35	25	who	who	WP
10_1101-2021_01_08_425864	35	26	has	have	VBZ
10_1101-2021_01_08_425864	35	27	granted	grant	VBN
10_1101-2021_01_08_425864	35	28	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	35	29	a	a	DT
10_1101-2021_01_08_425864	35	30	license	license	NN
10_1101-2021_01_08_425864	35	31	to	to	TO
10_1101-2021_01_08_425864	35	32	display	display	VB
10_1101-2021_01_08_425864	35	33	the	the	DT
10_1101-2021_01_08_425864	35	34	preprint	preprint	NN
10_1101-2021_01_08_425864	35	35	in	in	IN
10_1101-2021_01_08_425864	35	36	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	35	37	.	.	.
10_1101-2021_01_08_425864	36	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	36	2	is	be	VBZ
10_1101-2021_01_08_425864	36	3	The	the	DT
10_1101-2021_01_08_425864	36	4	copyright	copyright	NN
10_1101-2021_01_08_425864	36	5	holder	holder	NN
10_1101-2021_01_08_425864	36	6	for	for	IN
10_1101-2021_01_08_425864	36	7	this	this	DT
10_1101-2021_01_08_425864	36	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	36	9	version	version	NN
10_1101-2021_01_08_425864	36	10	posted	post	VBD
10_1101-2021_01_08_425864	36	11	January	January	NNP
10_1101-2021_01_08_425864	36	12	8	8	CD
10_1101-2021_01_08_425864	36	13	,	,	,
10_1101-2021_01_08_425864	36	14	2021	2021	CD
10_1101-2021_01_08_425864	36	15	.	.	.
10_1101-2021_01_08_425864	36	16	;	;	:
10_1101-2021_01_08_425864	36	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	36	18	:	:	:
10_1101-2021_01_08_425864	36	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	36	20	preprint	preprint	NN
10_1101-2021_01_08_425864	36	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	36	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	36	23	99	99	CD
10_1101-2021_01_08_425864	36	24	100	100	CD
10_1101-2021_01_08_425864	36	25	Fatty	Fatty	NNP
10_1101-2021_01_08_425864	36	26	acid	acid	JJ
10_1101-2021_01_08_425864	36	27	oxidation	oxidation	NN
10_1101-2021_01_08_425864	36	28	assays	assays	RB
10_1101-2021_01_08_425864	36	29	101	101	CD
10_1101-2021_01_08_425864	36	30	Preparation	Preparation	NNP
10_1101-2021_01_08_425864	36	31	of	of	IN
10_1101-2021_01_08_425864	36	32	palmitate	palmitate	NN
10_1101-2021_01_08_425864	36	33	-	-	HYPH
10_1101-2021_01_08_425864	36	34	BSA	BSA	NNP
10_1101-2021_01_08_425864	36	35	conjugates	conjugate	NNS
10_1101-2021_01_08_425864	36	36	.	.	.
10_1101-2021_01_08_425864	37	1	Sodium	sodium	NN
10_1101-2021_01_08_425864	37	2	palmitate	palmitate	NN
10_1101-2021_01_08_425864	37	3	at	at	IN
10_1101-2021_01_08_425864	37	4	70	70	CD
10_1101-2021_01_08_425864	37	5	mM	mM	NNP
10_1101-2021_01_08_425864	37	6	was	be	VBD
10_1101-2021_01_08_425864	37	7	solubilized	solubilize	VBN
10_1101-2021_01_08_425864	37	8	in	in	IN
10_1101-2021_01_08_425864	37	9	water	water	NN
10_1101-2021_01_08_425864	37	10	by	by	IN
10_1101-2021_01_08_425864	37	11	102	102	CD
10_1101-2021_01_08_425864	37	12	heating	heat	VBG
10_1101-2021_01_08_425864	37	13	it	-PRON-	PRP
10_1101-2021_01_08_425864	37	14	up	up	IN
10_1101-2021_01_08_425864	37	15	to	to	TO
10_1101-2021_01_08_425864	37	16	70	70	CD
10_1101-2021_01_08_425864	37	17	°	°	,
10_1101-2021_01_08_425864	37	18	C	C	NNP
10_1101-2021_01_08_425864	37	19	.	.	.
10_1101-2021_01_08_425864	38	1	BSA	bsa	DT
10_1101-2021_01_08_425864	38	2	free	free	JJ
10_1101-2021_01_08_425864	38	3	fatty	fatty	NN
10_1101-2021_01_08_425864	38	4	acids	acid	NNS
10_1101-2021_01_08_425864	38	5	(	(	-LRB-
10_1101-2021_01_08_425864	38	6	FFA	FFA	NNP
10_1101-2021_01_08_425864	38	7	BSA	BSA	NNP
10_1101-2021_01_08_425864	38	8	)	)	-RRB-
10_1101-2021_01_08_425864	38	9	(	(	-LRB-
10_1101-2021_01_08_425864	38	10	Sigma	Sigma	NNP
10_1101-2021_01_08_425864	38	11	®	®	NNP
10_1101-2021_01_08_425864	38	12	)	)	-RRB-
10_1101-2021_01_08_425864	38	13	was	be	VBD
10_1101-2021_01_08_425864	38	14	dissolved	dissolve	VBN
10_1101-2021_01_08_425864	38	15	in	in	IN
10_1101-2021_01_08_425864	38	16	PBS	PBS	NNP
10_1101-2021_01_08_425864	38	17	and	and	CC
10_1101-2021_01_08_425864	38	18	warmed	warm	VBD
10_1101-2021_01_08_425864	38	19	103	103	CD
10_1101-2021_01_08_425864	38	20	up	up	IN
10_1101-2021_01_08_425864	38	21	to	to	TO
10_1101-2021_01_08_425864	38	22	37	37	CD
10_1101-2021_01_08_425864	38	23	°	°	,
10_1101-2021_01_08_425864	38	24	C	C	NNP
10_1101-2021_01_08_425864	38	25	with	with	IN
10_1101-2021_01_08_425864	38	26	continuous	continuous	JJ
10_1101-2021_01_08_425864	38	27	stirring	stirring	NN
10_1101-2021_01_08_425864	38	28	.	.	.
10_1101-2021_01_08_425864	39	1	Solubilized	solubilized	JJ
10_1101-2021_01_08_425864	39	2	palmitate	palmitate	NN
10_1101-2021_01_08_425864	39	3	was	be	VBD
10_1101-2021_01_08_425864	39	4	added	add	VBN
10_1101-2021_01_08_425864	39	5	to	to	IN
10_1101-2021_01_08_425864	39	6	BSA	BSA	NNP
10_1101-2021_01_08_425864	39	7	at	at	IN
10_1101-2021_01_08_425864	39	8	37	37	CD
10_1101-2021_01_08_425864	39	9	°	°	,
10_1101-2021_01_08_425864	39	10	C	C	NNP
10_1101-2021_01_08_425864	39	11	with	with	IN
10_1101-2021_01_08_425864	39	12	104	104	CD
10_1101-2021_01_08_425864	39	13	continuous	continuous	JJ
10_1101-2021_01_08_425864	39	14	stirring	stirring	NN
10_1101-2021_01_08_425864	39	15	(	(	-LRB-
10_1101-2021_01_08_425864	39	16	for	for	IN
10_1101-2021_01_08_425864	39	17	a	a	DT
10_1101-2021_01_08_425864	39	18	final	final	JJ
10_1101-2021_01_08_425864	39	19	concentration	concentration	NN
10_1101-2021_01_08_425864	39	20	of	of	IN
10_1101-2021_01_08_425864	39	21	5	5	CD
10_1101-2021_01_08_425864	39	22	mM	mM	NNP
10_1101-2021_01_08_425864	39	23	in	in	IN
10_1101-2021_01_08_425864	39	24	7	7	CD
10_1101-2021_01_08_425864	39	25	%	%	NN
10_1101-2021_01_08_425864	39	26	BSA	BSA	NNP
10_1101-2021_01_08_425864	39	27	)	)	-RRB-
10_1101-2021_01_08_425864	39	28	.	.	.
10_1101-2021_01_08_425864	40	1	The	the	DT
10_1101-2021_01_08_425864	40	2	conjugated	conjugate	VBN
10_1101-2021_01_08_425864	40	3	palmitate	palmitate	NN
10_1101-2021_01_08_425864	40	4	-	-	:
10_1101-2021_01_08_425864	40	5	BSA	BSA	NNP
10_1101-2021_01_08_425864	40	6	105	105	CD
10_1101-2021_01_08_425864	40	7	was	be	VBD
10_1101-2021_01_08_425864	40	8	aliquoted	aliquote	VBN
10_1101-2021_01_08_425864	40	9	and	and	CC
10_1101-2021_01_08_425864	40	10	stored	store	VBN
10_1101-2021_01_08_425864	40	11	at	at	IN
10_1101-2021_01_08_425864	40	12	−80	−80	NNP
10_1101-2021_01_08_425864	40	13	°	°	,
10_1101-2021_01_08_425864	40	14	C	C	NNP
10_1101-2021_01_08_425864	40	15	[	[	-LRB-
10_1101-2021_01_08_425864	40	16	20	20	CD
10_1101-2021_01_08_425864	40	17	]	]	-RRB-
10_1101-2021_01_08_425864	40	18	.	.	.
10_1101-2021_01_08_425864	41	1	106	106	CD
10_1101-2021_01_08_425864	41	2	107	107	CD
10_1101-2021_01_08_425864	41	3	CO2	CO2	NNP
10_1101-2021_01_08_425864	41	4	production	production	NN
10_1101-2021_01_08_425864	41	5	from	from	IN
10_1101-2021_01_08_425864	41	6	oxidisable	oxidisable	JJ
10_1101-2021_01_08_425864	41	7	carbon	carbon	NN
10_1101-2021_01_08_425864	41	8	sources	source	NNS
10_1101-2021_01_08_425864	41	9	.	.	.
10_1101-2021_01_08_425864	42	1	To	to	TO
10_1101-2021_01_08_425864	42	2	test	test	VB
10_1101-2021_01_08_425864	42	3	the	the	DT
10_1101-2021_01_08_425864	42	4	production	production	NN
10_1101-2021_01_08_425864	42	5	of	of	IN
10_1101-2021_01_08_425864	42	6	CO2	CO2	NNP
10_1101-2021_01_08_425864	42	7	from	from	IN
10_1101-2021_01_08_425864	42	8	palmitate	palmitate	NN
10_1101-2021_01_08_425864	42	9	,	,	,
10_1101-2021_01_08_425864	42	10	108	108	CD
10_1101-2021_01_08_425864	42	11	glucose	glucose	NN
10_1101-2021_01_08_425864	42	12	or	or	CC
10_1101-2021_01_08_425864	42	13	histidine	histidine	NN
10_1101-2021_01_08_425864	42	14	,	,	,
10_1101-2021_01_08_425864	42	15	exponentially	exponentially	RB
10_1101-2021_01_08_425864	42	16	growing	grow	VBG
10_1101-2021_01_08_425864	42	17	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	42	18	(	(	-LRB-
10_1101-2021_01_08_425864	42	19	5x107	5x107	CD
10_1101-2021_01_08_425864	42	20	mL-1	mL-1	NNP
10_1101-2021_01_08_425864	42	21	)	)	-RRB-
10_1101-2021_01_08_425864	42	22	were	be	VBD
10_1101-2021_01_08_425864	42	23	washed	wash	VBN
10_1101-2021_01_08_425864	42	24	twice	twice	RB
10_1101-2021_01_08_425864	42	25	in	in	IN
10_1101-2021_01_08_425864	42	26	PBS	PBS	NNP
10_1101-2021_01_08_425864	42	27	109	109	CD
10_1101-2021_01_08_425864	42	28	and	and	CC
10_1101-2021_01_08_425864	42	29	incubated	incubate	VBD
10_1101-2021_01_08_425864	42	30	for	for	IN
10_1101-2021_01_08_425864	42	31	different	different	JJ
10_1101-2021_01_08_425864	42	32	times	time	NNS
10_1101-2021_01_08_425864	42	33	(	(	-LRB-
10_1101-2021_01_08_425864	42	34	0	0	CD
10_1101-2021_01_08_425864	42	35	,	,	,
10_1101-2021_01_08_425864	42	36	30	30	CD
10_1101-2021_01_08_425864	42	37	,	,	,
10_1101-2021_01_08_425864	42	38	60	60	CD
10_1101-2021_01_08_425864	42	39	and	and	CC
10_1101-2021_01_08_425864	42	40	120	120	CD
10_1101-2021_01_08_425864	42	41	min	min	NN
10_1101-2021_01_08_425864	42	42	)	)	-RRB-
10_1101-2021_01_08_425864	42	43	in	in	IN
10_1101-2021_01_08_425864	42	44	the	the	DT
10_1101-2021_01_08_425864	42	45	presence	presence	NN
10_1101-2021_01_08_425864	42	46	of	of	IN
10_1101-2021_01_08_425864	42	47	0.1	0.1	CD
10_1101-2021_01_08_425864	42	48	mM	mM	NNP
10_1101-2021_01_08_425864	42	49	of	of	IN
10_1101-2021_01_08_425864	42	50	palmitate	palmitate	NNP
10_1101-2021_01_08_425864	42	51	110	110	CD
10_1101-2021_01_08_425864	42	52	spiked	spike	VBN
10_1101-2021_01_08_425864	42	53	with	with	IN
10_1101-2021_01_08_425864	42	54	0.2	0.2	CD
10_1101-2021_01_08_425864	42	55	µCi	µCi	NNS
10_1101-2021_01_08_425864	42	56	of	of	IN
10_1101-2021_01_08_425864	42	57	14C	14c	CD
10_1101-2021_01_08_425864	42	58	-	-	HYPH
10_1101-2021_01_08_425864	42	59	U	u	NN
10_1101-2021_01_08_425864	42	60	-	-	HYPH
10_1101-2021_01_08_425864	42	61	substrates	substrate	NNS
10_1101-2021_01_08_425864	42	62	.	.	.
10_1101-2021_01_08_425864	43	1	To	to	TO
10_1101-2021_01_08_425864	43	2	trap	trap	VB
10_1101-2021_01_08_425864	43	3	the	the	DT
10_1101-2021_01_08_425864	43	4	produced	produce	VBN
10_1101-2021_01_08_425864	43	5	CO2	CO2	NNP
10_1101-2021_01_08_425864	43	6	,	,	,
10_1101-2021_01_08_425864	43	7	Whatman	Whatman	NNP
10_1101-2021_01_08_425864	43	8	paper	paper	NN
10_1101-2021_01_08_425864	43	9	was	be	VBD
10_1101-2021_01_08_425864	43	10	embedded	embed	VBN
10_1101-2021_01_08_425864	43	11	111	111	CD
10_1101-2021_01_08_425864	43	12	in	in	IN
10_1101-2021_01_08_425864	43	13	2	2	CD
10_1101-2021_01_08_425864	43	14	M	M	NNP
10_1101-2021_01_08_425864	43	15	KOH	KOH	NNP
10_1101-2021_01_08_425864	43	16	solution	solution	NN
10_1101-2021_01_08_425864	43	17	and	and	CC
10_1101-2021_01_08_425864	43	18	was	be	VBD
10_1101-2021_01_08_425864	43	19	placed	place	VBN
10_1101-2021_01_08_425864	43	20	in	in	IN
10_1101-2021_01_08_425864	43	21	the	the	DT
10_1101-2021_01_08_425864	43	22	top	top	NN
10_1101-2021_01_08_425864	43	23	of	of	IN
10_1101-2021_01_08_425864	43	24	the	the	DT
10_1101-2021_01_08_425864	43	25	tube	tube	NN
10_1101-2021_01_08_425864	43	26	.	.	.
10_1101-2021_01_08_425864	44	1	The	the	DT
10_1101-2021_01_08_425864	44	2	14CO2	14co2	CD
10_1101-2021_01_08_425864	44	3	trapped	trap	VBN
10_1101-2021_01_08_425864	44	4	by	by	IN
10_1101-2021_01_08_425864	44	5	this	this	DT
10_1101-2021_01_08_425864	44	6	reaction	reaction	NN
10_1101-2021_01_08_425864	44	7	was	be	VBD
10_1101-2021_01_08_425864	44	8	112	112	CD
10_1101-2021_01_08_425864	44	9	quantified	quantify	VBN
10_1101-2021_01_08_425864	44	10	by	by	IN
10_1101-2021_01_08_425864	44	11	scintillation	scintillation	NN
10_1101-2021_01_08_425864	44	12	[	[	-LRB-
10_1101-2021_01_08_425864	44	13	15,16	15,16	CD
10_1101-2021_01_08_425864	44	14	]	]	-RRB-
10_1101-2021_01_08_425864	44	15	.	.	.
10_1101-2021_01_08_425864	45	1	113	113	CD
10_1101-2021_01_08_425864	45	2	114	114	CD
10_1101-2021_01_08_425864	45	3	1H	1h	CD
10_1101-2021_01_08_425864	45	4	-	-	HYPH
10_1101-2021_01_08_425864	45	5	NMR	nmr	JJ
10_1101-2021_01_08_425864	45	6	analysis	analysis	NN
10_1101-2021_01_08_425864	45	7	of	of	IN
10_1101-2021_01_08_425864	45	8	the	the	DT
10_1101-2021_01_08_425864	45	9	exometabolome	exometabolome	NN
10_1101-2021_01_08_425864	45	10	.	.	.
10_1101-2021_01_08_425864	46	1	Epimastigotes	Epimastigotes	NNP
10_1101-2021_01_08_425864	46	2	(	(	-LRB-
10_1101-2021_01_08_425864	46	3	1x108	1x108	CD
10_1101-2021_01_08_425864	46	4	mL-1	mL-1	NNP
10_1101-2021_01_08_425864	46	5	)	)	-RRB-
10_1101-2021_01_08_425864	46	6	were	be	VBD
10_1101-2021_01_08_425864	46	7	collected	collect	VBN
10_1101-2021_01_08_425864	46	8	by	by	IN
10_1101-2021_01_08_425864	46	9	115	115	CD
10_1101-2021_01_08_425864	46	10	centrifugation	centrifugation	NN
10_1101-2021_01_08_425864	46	11	at	at	IN
10_1101-2021_01_08_425864	46	12	1,400	1,400	CD
10_1101-2021_01_08_425864	46	13	x	x	SYM
10_1101-2021_01_08_425864	46	14	g	g	NNP
10_1101-2021_01_08_425864	46	15	for	for	IN
10_1101-2021_01_08_425864	46	16	10	10	CD
10_1101-2021_01_08_425864	46	17	min	min	NN
10_1101-2021_01_08_425864	46	18	,	,	,
10_1101-2021_01_08_425864	46	19	washed	wash	VBD
10_1101-2021_01_08_425864	46	20	twice	twice	RB
10_1101-2021_01_08_425864	46	21	with	with	IN
10_1101-2021_01_08_425864	46	22	PBS	PBS	NNP
10_1101-2021_01_08_425864	46	23	and	and	CC
10_1101-2021_01_08_425864	46	24	incubated	incubate	VBD
10_1101-2021_01_08_425864	46	25	in	in	IN
10_1101-2021_01_08_425864	46	26	1	1	CD
10_1101-2021_01_08_425864	46	27	mL	mL	NNP
10_1101-2021_01_08_425864	46	28	(	(	-LRB-
10_1101-2021_01_08_425864	46	29	single	single	JJ
10_1101-2021_01_08_425864	46	30	point	point	NN
10_1101-2021_01_08_425864	46	31	116	116	CD
10_1101-2021_01_08_425864	46	32	analysis	analysis	NN
10_1101-2021_01_08_425864	46	33	)	)	-RRB-
10_1101-2021_01_08_425864	46	34	of	of	IN
10_1101-2021_01_08_425864	46	35	PBS	PBS	NNP
10_1101-2021_01_08_425864	46	36	supplemented	supplement	VBD
10_1101-2021_01_08_425864	46	37	with	with	IN
10_1101-2021_01_08_425864	46	38	2	2	CD
10_1101-2021_01_08_425864	46	39	g	g	NNP
10_1101-2021_01_08_425864	46	40	/	/	SYM
10_1101-2021_01_08_425864	46	41	L	L	NNP
10_1101-2021_01_08_425864	46	42	NaHCO3	NaHCO3	NNP
10_1101-2021_01_08_425864	46	43	(	(	-LRB-
10_1101-2021_01_08_425864	46	44	pH	pH	NNP
10_1101-2021_01_08_425864	46	45	7.4	7.4	CD
10_1101-2021_01_08_425864	46	46	)	)	-RRB-
10_1101-2021_01_08_425864	46	47	.	.	.
10_1101-2021_01_08_425864	47	1	The	the	DT
10_1101-2021_01_08_425864	47	2	cells	cell	NNS
10_1101-2021_01_08_425864	47	3	were	be	VBD
10_1101-2021_01_08_425864	47	4	maintained	maintain	VBN
10_1101-2021_01_08_425864	47	5	for	for	IN
10_1101-2021_01_08_425864	47	6	6	6	CD
10_1101-2021_01_08_425864	47	7	h	h	NN
10_1101-2021_01_08_425864	47	8	at	at	IN
10_1101-2021_01_08_425864	47	9	27	27	CD
10_1101-2021_01_08_425864	47	10	117	117	CD
10_1101-2021_01_08_425864	47	11	°	°	NNS
10_1101-2021_01_08_425864	47	12	C	c	NN
10_1101-2021_01_08_425864	47	13	in	in	IN
10_1101-2021_01_08_425864	47	14	incubation	incubation	NN
10_1101-2021_01_08_425864	47	15	buffer	buffer	NN
10_1101-2021_01_08_425864	47	16	containing	contain	VBG
10_1101-2021_01_08_425864	47	17	[	[	-LRB-
10_1101-2021_01_08_425864	47	18	U-13C]-glucose	u-13c]-glucose	IN
10_1101-2021_01_08_425864	47	19	,	,	,
10_1101-2021_01_08_425864	47	20	non	non	JJ
10_1101-2021_01_08_425864	47	21	-	-	JJ
10_1101-2021_01_08_425864	47	22	enriched	enriched	JJ
10_1101-2021_01_08_425864	47	23	palmitate	palmitate	NN
10_1101-2021_01_08_425864	47	24	or	or	CC
10_1101-2021_01_08_425864	47	25	no	no	DT
10_1101-2021_01_08_425864	47	26	carbon	carbon	NN
10_1101-2021_01_08_425864	47	27	sources	source	NNS
10_1101-2021_01_08_425864	47	28	.	.	.
10_1101-2021_01_08_425864	48	1	The	the	DT
10_1101-2021_01_08_425864	48	2	118	118	CD
10_1101-2021_01_08_425864	48	3	integrity	integrity	NN
10_1101-2021_01_08_425864	48	4	of	of	IN
10_1101-2021_01_08_425864	48	5	the	the	DT
10_1101-2021_01_08_425864	48	6	cells	cell	NNS
10_1101-2021_01_08_425864	48	7	during	during	IN
10_1101-2021_01_08_425864	48	8	the	the	DT
10_1101-2021_01_08_425864	48	9	incubation	incubation	NN
10_1101-2021_01_08_425864	48	10	was	be	VBD
10_1101-2021_01_08_425864	48	11	checked	check	VBN
10_1101-2021_01_08_425864	48	12	by	by	IN
10_1101-2021_01_08_425864	48	13	microscopic	microscopic	JJ
10_1101-2021_01_08_425864	48	14	observation	observation	NN
10_1101-2021_01_08_425864	48	15	.	.	.
10_1101-2021_01_08_425864	49	1	The	the	DT
10_1101-2021_01_08_425864	49	2	supernatant	supernatant	JJ
10_1101-2021_01_08_425864	49	3	119	119	CD
10_1101-2021_01_08_425864	49	4	(	(	-LRB-
10_1101-2021_01_08_425864	49	5	1	1	CD
10_1101-2021_01_08_425864	49	6	mL	mL	NNP
10_1101-2021_01_08_425864	49	7	)	)	-RRB-
10_1101-2021_01_08_425864	49	8	was	be	VBD
10_1101-2021_01_08_425864	49	9	collected	collect	VBN
10_1101-2021_01_08_425864	49	10	and	and	CC
10_1101-2021_01_08_425864	49	11	50	50	CD
10_1101-2021_01_08_425864	49	12	µl	µl	NNS
10_1101-2021_01_08_425864	49	13	of	of	IN
10_1101-2021_01_08_425864	49	14	maleate	maleate	NN
10_1101-2021_01_08_425864	49	15	solution	solution	NN
10_1101-2021_01_08_425864	49	16	in	in	IN
10_1101-2021_01_08_425864	49	17	D2O	d2o	NN
10_1101-2021_01_08_425864	49	18	(	(	-LRB-
10_1101-2021_01_08_425864	49	19	10	10	CD
10_1101-2021_01_08_425864	49	20	mM	mM	NNP
10_1101-2021_01_08_425864	49	21	)	)	-RRB-
10_1101-2021_01_08_425864	49	22	was	be	VBD
10_1101-2021_01_08_425864	49	23	added	add	VBN
10_1101-2021_01_08_425864	49	24	as	as	IN
10_1101-2021_01_08_425864	49	25	an	an	DT
10_1101-2021_01_08_425864	49	26	internal	internal	JJ
10_1101-2021_01_08_425864	49	27	120	120	CD
10_1101-2021_01_08_425864	49	28	reference	reference	NN
10_1101-2021_01_08_425864	49	29	.	.	.
10_1101-2021_01_08_425864	50	1	1H	1h	LS
10_1101-2021_01_08_425864	50	2	-	-	:
10_1101-2021_01_08_425864	50	3	NMR	NMR	NNP
10_1101-2021_01_08_425864	50	4	spectra	spectra	NNP
10_1101-2021_01_08_425864	50	5	were	be	VBD
10_1101-2021_01_08_425864	50	6	collected	collect	VBN
10_1101-2021_01_08_425864	50	7	at	at	IN
10_1101-2021_01_08_425864	50	8	500.19	500.19	CD
10_1101-2021_01_08_425864	50	9	MHz	MHz	NNS
10_1101-2021_01_08_425864	50	10	on	on	IN
10_1101-2021_01_08_425864	50	11	a	a	DT
10_1101-2021_01_08_425864	50	12	Bruker	Bruker	NNP
10_1101-2021_01_08_425864	50	13	Avance	Avance	NNP
10_1101-2021_01_08_425864	50	14	III	III	NNP
10_1101-2021_01_08_425864	50	15	500	500	CD
10_1101-2021_01_08_425864	50	16	HD	HD	NNP
10_1101-2021_01_08_425864	50	17	121	121	CD
10_1101-2021_01_08_425864	50	18	spectrometer	spectrometer	VBP
10_1101-2021_01_08_425864	50	19	equipped	equip	VBN
10_1101-2021_01_08_425864	50	20	with	with	IN
10_1101-2021_01_08_425864	50	21	a	a	DT
10_1101-2021_01_08_425864	50	22	5	5	CD
10_1101-2021_01_08_425864	50	23	mm	mm	NN
10_1101-2021_01_08_425864	50	24	Prodigy	Prodigy	NNP
10_1101-2021_01_08_425864	50	25	cryoprobe	cryoprobe	NN
10_1101-2021_01_08_425864	50	26	.	.	.
10_1101-2021_01_08_425864	51	1	The	the	DT
10_1101-2021_01_08_425864	51	2	measurements	measurement	NNS
10_1101-2021_01_08_425864	51	3	were	be	VBD
10_1101-2021_01_08_425864	51	4	recorded	record	VBN
10_1101-2021_01_08_425864	51	5	at	at	IN
10_1101-2021_01_08_425864	51	6	25	25	CD
10_1101-2021_01_08_425864	51	7	°	°	NNS
10_1101-2021_01_08_425864	51	8	C	C	NNP
10_1101-2021_01_08_425864	51	9	.	.	.
10_1101-2021_01_08_425864	52	1	122	122	CD
10_1101-2021_01_08_425864	52	2	The	the	DT
10_1101-2021_01_08_425864	52	3	acquisition	acquisition	NN
10_1101-2021_01_08_425864	52	4	conditions	condition	NNS
10_1101-2021_01_08_425864	52	5	were	be	VBD
10_1101-2021_01_08_425864	52	6	as	as	IN
10_1101-2021_01_08_425864	52	7	follows	follow	VBZ
10_1101-2021_01_08_425864	52	8	:	:	:
10_1101-2021_01_08_425864	52	9	90	90	CD
10_1101-2021_01_08_425864	52	10	°	°	NN
10_1101-2021_01_08_425864	52	11	flip	flip	JJ
10_1101-2021_01_08_425864	52	12	angle	angle	NN
10_1101-2021_01_08_425864	52	13	,	,	,
10_1101-2021_01_08_425864	52	14	5,000	5,000	CD
10_1101-2021_01_08_425864	52	15	Hz	Hz	NNP
10_1101-2021_01_08_425864	52	16	spectral	spectral	JJ
10_1101-2021_01_08_425864	52	17	width	width	NN
10_1101-2021_01_08_425864	52	18	,	,	,
10_1101-2021_01_08_425864	52	19	32	32	CD
10_1101-2021_01_08_425864	52	20	K	k	NN
10_1101-2021_01_08_425864	52	21	memory	memory	NN
10_1101-2021_01_08_425864	52	22	123	123	CD
10_1101-2021_01_08_425864	52	23	size	size	NN
10_1101-2021_01_08_425864	52	24	,	,	,
10_1101-2021_01_08_425864	52	25	and	and	CC
10_1101-2021_01_08_425864	52	26	9.3	9.3	CD
10_1101-2021_01_08_425864	52	27	sec	sec	NNP
10_1101-2021_01_08_425864	52	28	total	total	JJ
10_1101-2021_01_08_425864	52	29	recycling	recycling	NN
10_1101-2021_01_08_425864	52	30	time	time	NN
10_1101-2021_01_08_425864	52	31	.	.	.
10_1101-2021_01_08_425864	53	1	The	the	DT
10_1101-2021_01_08_425864	53	2	measurements	measurement	NNS
10_1101-2021_01_08_425864	53	3	were	be	VBD
10_1101-2021_01_08_425864	53	4	performed	perform	VBN
10_1101-2021_01_08_425864	53	5	with	with	IN
10_1101-2021_01_08_425864	53	6	64	64	CD
10_1101-2021_01_08_425864	53	7	scans	scan	NNS
10_1101-2021_01_08_425864	53	8	for	for	IN
10_1101-2021_01_08_425864	53	9	a	a	DT
10_1101-2021_01_08_425864	53	10	total	total	JJ
10_1101-2021_01_08_425864	53	11	124	124	CD
10_1101-2021_01_08_425864	53	12	time	time	NN
10_1101-2021_01_08_425864	53	13	of	of	IN
10_1101-2021_01_08_425864	53	14	close	close	NN
10_1101-2021_01_08_425864	53	15	to	to	TO
10_1101-2021_01_08_425864	53	16	10	10	CD
10_1101-2021_01_08_425864	53	17	min	min	NN
10_1101-2021_01_08_425864	53	18	and	and	CC
10_1101-2021_01_08_425864	53	19	30	30	CD
10_1101-2021_01_08_425864	53	20	sec	sec	NNP
10_1101-2021_01_08_425864	53	21	.	.	.
10_1101-2021_01_08_425864	54	1	The	the	DT
10_1101-2021_01_08_425864	54	2	resonances	resonance	NNS
10_1101-2021_01_08_425864	54	3	of	of	IN
10_1101-2021_01_08_425864	54	4	the	the	DT
10_1101-2021_01_08_425864	54	5	obtained	obtained	JJ
10_1101-2021_01_08_425864	54	6	spectra	spectra	NNP
10_1101-2021_01_08_425864	54	7	were	be	VBD
10_1101-2021_01_08_425864	54	8	integrated	integrate	VBN
10_1101-2021_01_08_425864	54	9	and	and	CC
10_1101-2021_01_08_425864	54	10	the	the	DT
10_1101-2021_01_08_425864	54	11	125	125	CD
10_1101-2021_01_08_425864	54	12	metabolite	metabolite	JJ
10_1101-2021_01_08_425864	54	13	concentrations	concentration	NNS
10_1101-2021_01_08_425864	54	14	were	be	VBD
10_1101-2021_01_08_425864	54	15	calculated	calculate	VBN
10_1101-2021_01_08_425864	54	16	using	use	VBG
10_1101-2021_01_08_425864	54	17	the	the	DT
10_1101-2021_01_08_425864	54	18	ERETIC2	ERETIC2	``
10_1101-2021_01_08_425864	54	19	NMR	NMR	NNP
10_1101-2021_01_08_425864	54	20	quantification	quantification	NN
10_1101-2021_01_08_425864	54	21	Bruker	Bruker	NNP
10_1101-2021_01_08_425864	54	22	program	program	NN
10_1101-2021_01_08_425864	54	23	.	.	.
10_1101-2021_01_08_425864	55	1	126	126	CD
10_1101-2021_01_08_425864	55	2	127	127	CD
10_1101-2021_01_08_425864	55	3	Oxygen	oxygen	NN
10_1101-2021_01_08_425864	55	4	consumption	consumption	NN
10_1101-2021_01_08_425864	55	5	.	.	.
10_1101-2021_01_08_425864	56	1	To	to	TO
10_1101-2021_01_08_425864	56	2	evaluate	evaluate	VB
10_1101-2021_01_08_425864	56	3	the	the	DT
10_1101-2021_01_08_425864	56	4	importance	importance	NN
10_1101-2021_01_08_425864	56	5	of	of	IN
10_1101-2021_01_08_425864	56	6	internal	internal	JJ
10_1101-2021_01_08_425864	56	7	fatty	fatty	NN
10_1101-2021_01_08_425864	56	8	acid	acid	NN
10_1101-2021_01_08_425864	56	9	sources	source	NNS
10_1101-2021_01_08_425864	56	10	in	in	IN
10_1101-2021_01_08_425864	56	11	O2	o2	CD
10_1101-2021_01_08_425864	56	12	consumption	consumption	NN
10_1101-2021_01_08_425864	56	13	,	,	,
10_1101-2021_01_08_425864	56	14	128	128	CD
10_1101-2021_01_08_425864	56	15	exponentially	exponentially	RB
10_1101-2021_01_08_425864	56	16	growing	grow	VBG
10_1101-2021_01_08_425864	56	17	parasites	parasite	NNS
10_1101-2021_01_08_425864	56	18	were	be	VBD
10_1101-2021_01_08_425864	56	19	treated	treat	VBN
10_1101-2021_01_08_425864	56	20	or	or	CC
10_1101-2021_01_08_425864	56	21	not	not	RB
10_1101-2021_01_08_425864	56	22	treated	treat	VBN
10_1101-2021_01_08_425864	56	23	with	with	IN
10_1101-2021_01_08_425864	56	24	500	500	CD
10_1101-2021_01_08_425864	56	25	µM	µM	NNP
10_1101-2021_01_08_425864	56	26	ETO	ETO	NNP
10_1101-2021_01_08_425864	56	27	(	(	-LRB-
10_1101-2021_01_08_425864	56	28	the	the	DT
10_1101-2021_01_08_425864	56	29	inhibitor	inhibitor	NN
10_1101-2021_01_08_425864	56	30	of	of	IN
10_1101-2021_01_08_425864	56	31	129	129	CD
10_1101-2021_01_08_425864	56	32	carnitine	carnitine	NN
10_1101-2021_01_08_425864	56	33	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	56	34	1	1	CD
10_1101-2021_01_08_425864	56	35	)	)	-RRB-
10_1101-2021_01_08_425864	56	36	,	,	,
10_1101-2021_01_08_425864	56	37	washed	wash	VBD
10_1101-2021_01_08_425864	56	38	twice	twice	RB
10_1101-2021_01_08_425864	56	39	in	in	IN
10_1101-2021_01_08_425864	56	40	PBS	PBS	NNP
10_1101-2021_01_08_425864	56	41	and	and	CC
10_1101-2021_01_08_425864	56	42	resuspended	resuspend	VBD
10_1101-2021_01_08_425864	56	43	in	in	IN
10_1101-2021_01_08_425864	56	44	Mitochondrial	Mitochondrial	NNP
10_1101-2021_01_08_425864	56	45	Cellular	Cellular	NNP
10_1101-2021_01_08_425864	56	46	130	130	CD
10_1101-2021_01_08_425864	56	47	Respiration	Respiration	NNP
10_1101-2021_01_08_425864	56	48	(	(	-LRB-
10_1101-2021_01_08_425864	56	49	MCR	MCR	NNP
10_1101-2021_01_08_425864	56	50	)	)	-RRB-
10_1101-2021_01_08_425864	56	51	buffer	buffer	NN
10_1101-2021_01_08_425864	56	52	.	.	.
10_1101-2021_01_08_425864	57	1	The	the	DT
10_1101-2021_01_08_425864	57	2	rates	rate	NNS
10_1101-2021_01_08_425864	57	3	of	of	IN
10_1101-2021_01_08_425864	57	4	oxygen	oxygen	NN
10_1101-2021_01_08_425864	57	5	consumption	consumption	NN
10_1101-2021_01_08_425864	57	6	were	be	VBD
10_1101-2021_01_08_425864	57	7	measured	measure	VBN
10_1101-2021_01_08_425864	57	8	using	use	VBG
10_1101-2021_01_08_425864	57	9	intact	intact	JJ
10_1101-2021_01_08_425864	57	10	cells	cell	NNS
10_1101-2021_01_08_425864	57	11	in	in	IN
10_1101-2021_01_08_425864	57	12	a	a	DT
10_1101-2021_01_08_425864	57	13	131	131	CD
10_1101-2021_01_08_425864	57	14	high	high	JJ
10_1101-2021_01_08_425864	57	15	-	-	HYPH
10_1101-2021_01_08_425864	57	16	resolution	resolution	NN
10_1101-2021_01_08_425864	57	17	oxygraph	oxygraph	NN
10_1101-2021_01_08_425864	57	18	(	(	-LRB-
10_1101-2021_01_08_425864	57	19	Oxygraph-2k	oxygraph-2k	IN
10_1101-2021_01_08_425864	57	20	;	;	:
10_1101-2021_01_08_425864	57	21	Oroboros	Oroboros	NNP
10_1101-2021_01_08_425864	57	22	Instruments	Instruments	NNP
10_1101-2021_01_08_425864	57	23	,	,	,
10_1101-2021_01_08_425864	57	24	Innsbruck	Innsbruck	NNP
10_1101-2021_01_08_425864	57	25	,	,	,
10_1101-2021_01_08_425864	57	26	Austria	Austria	NNP
10_1101-2021_01_08_425864	57	27	)	)	-RRB-
10_1101-2021_01_08_425864	57	28	.	.	.
10_1101-2021_01_08_425864	58	1	Oligomycin	Oligomycin	NNP
10_1101-2021_01_08_425864	58	2	A	A	NNP
10_1101-2021_01_08_425864	58	3	132	132	CD
10_1101-2021_01_08_425864	58	4	(	(	-LRB-
10_1101-2021_01_08_425864	58	5	0.5	0.5	CD
10_1101-2021_01_08_425864	58	6	µg	µg	IN
10_1101-2021_01_08_425864	58	7	/	/	SYM
10_1101-2021_01_08_425864	58	8	mL	ml	NN
10_1101-2021_01_08_425864	58	9	)	)	-RRB-
10_1101-2021_01_08_425864	58	10	and	and	CC
10_1101-2021_01_08_425864	58	11	FCCP	FCCP	NNP
10_1101-2021_01_08_425864	58	12	(	(	-LRB-
10_1101-2021_01_08_425864	58	13	0.5	0.5	CD
10_1101-2021_01_08_425864	58	14	µM	µM	NNP
10_1101-2021_01_08_425864	58	15	)	)	-RRB-
10_1101-2021_01_08_425864	58	16	were	be	VBD
10_1101-2021_01_08_425864	58	17	sequentially	sequentially	RB
10_1101-2021_01_08_425864	58	18	added	add	VBN
10_1101-2021_01_08_425864	58	19	to	to	TO
10_1101-2021_01_08_425864	58	20	measure	measure	VB
10_1101-2021_01_08_425864	58	21	the	the	DT
10_1101-2021_01_08_425864	58	22	optimal	optimal	JJ
10_1101-2021_01_08_425864	58	23	non	non	JJ
10_1101-2021_01_08_425864	58	24	-	-	JJ
10_1101-2021_01_08_425864	58	25	coupled	coupled	JJ
10_1101-2021_01_08_425864	58	26	.CC	.CC	NFP
10_1101-2021_01_08_425864	58	27	-	-	:
10_1101-2021_01_08_425864	58	28	BY	by	IN
10_1101-2021_01_08_425864	58	29	4.0	4.0	CD
10_1101-2021_01_08_425864	58	30	International	international	JJ
10_1101-2021_01_08_425864	58	31	licensemade	licensemade	NN
10_1101-2021_01_08_425864	58	32	available	available	JJ
10_1101-2021_01_08_425864	58	33	under	under	IN
10_1101-2021_01_08_425864	58	34	a	a	DT
10_1101-2021_01_08_425864	58	35	(	(	-LRB-
10_1101-2021_01_08_425864	58	36	which	which	WDT
10_1101-2021_01_08_425864	58	37	was	be	VBD
10_1101-2021_01_08_425864	58	38	not	not	RB
10_1101-2021_01_08_425864	58	39	certified	certify	VBN
10_1101-2021_01_08_425864	58	40	by	by	IN
10_1101-2021_01_08_425864	58	41	peer	peer	NN
10_1101-2021_01_08_425864	58	42	review	review	NN
10_1101-2021_01_08_425864	58	43	)	)	-RRB-
10_1101-2021_01_08_425864	58	44	is	be	VBZ
10_1101-2021_01_08_425864	58	45	the	the	DT
10_1101-2021_01_08_425864	58	46	author	author	NN
10_1101-2021_01_08_425864	58	47	/	/	SYM
10_1101-2021_01_08_425864	58	48	funder	funder	NN
10_1101-2021_01_08_425864	58	49	,	,	,
10_1101-2021_01_08_425864	58	50	who	who	WP
10_1101-2021_01_08_425864	58	51	has	have	VBZ
10_1101-2021_01_08_425864	58	52	granted	grant	VBN
10_1101-2021_01_08_425864	58	53	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	58	54	a	a	DT
10_1101-2021_01_08_425864	58	55	license	license	NN
10_1101-2021_01_08_425864	58	56	to	to	TO
10_1101-2021_01_08_425864	58	57	display	display	VB
10_1101-2021_01_08_425864	58	58	the	the	DT
10_1101-2021_01_08_425864	58	59	preprint	preprint	NN
10_1101-2021_01_08_425864	58	60	in	in	IN
10_1101-2021_01_08_425864	58	61	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	58	62	.	.	.
10_1101-2021_01_08_425864	59	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	59	2	is	be	VBZ
10_1101-2021_01_08_425864	59	3	The	the	DT
10_1101-2021_01_08_425864	59	4	copyright	copyright	NN
10_1101-2021_01_08_425864	59	5	holder	holder	NN
10_1101-2021_01_08_425864	59	6	for	for	IN
10_1101-2021_01_08_425864	59	7	this	this	DT
10_1101-2021_01_08_425864	59	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	59	9	version	version	NN
10_1101-2021_01_08_425864	59	10	posted	post	VBD
10_1101-2021_01_08_425864	59	11	January	January	NNP
10_1101-2021_01_08_425864	59	12	8	8	CD
10_1101-2021_01_08_425864	59	13	,	,	,
10_1101-2021_01_08_425864	59	14	2021	2021	CD
10_1101-2021_01_08_425864	59	15	.	.	.
10_1101-2021_01_08_425864	59	16	;	;	:
10_1101-2021_01_08_425864	59	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	59	18	:	:	:
10_1101-2021_01_08_425864	59	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	59	20	preprint	preprint	NN
10_1101-2021_01_08_425864	59	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	59	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	59	23	133	133	CD
10_1101-2021_01_08_425864	59	24	respiration	respiration	NN
10_1101-2021_01_08_425864	59	25	and	and	CC
10_1101-2021_01_08_425864	59	26	the	the	DT
10_1101-2021_01_08_425864	59	27	respiration	respiration	NN
10_1101-2021_01_08_425864	59	28	leak	leak	NN
10_1101-2021_01_08_425864	59	29	state	state	NN
10_1101-2021_01_08_425864	59	30	,	,	,
10_1101-2021_01_08_425864	59	31	respectively	respectively	RB
10_1101-2021_01_08_425864	59	32	.	.	.
10_1101-2021_01_08_425864	60	1	The	the	DT
10_1101-2021_01_08_425864	60	2	data	datum	NNS
10_1101-2021_01_08_425864	60	3	were	be	VBD
10_1101-2021_01_08_425864	60	4	recorded	record	VBN
10_1101-2021_01_08_425864	60	5	and	and	CC
10_1101-2021_01_08_425864	60	6	treated	treat	VBN
10_1101-2021_01_08_425864	60	7	using	use	VBG
10_1101-2021_01_08_425864	60	8	134	134	CD
10_1101-2021_01_08_425864	60	9	DatLab	DatLab	NNP
10_1101-2021_01_08_425864	60	10	7	7	CD
10_1101-2021_01_08_425864	60	11	software	software	NN
10_1101-2021_01_08_425864	60	12	[	[	-LRB-
10_1101-2021_01_08_425864	60	13	15,16,21	15,16,21	NNP
10_1101-2021_01_08_425864	60	14	]	]	-RRB-
10_1101-2021_01_08_425864	60	15	.	.	.
10_1101-2021_01_08_425864	61	1	135	135	CD
10_1101-2021_01_08_425864	61	2	136	136	CD
10_1101-2021_01_08_425864	61	3	Mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	61	4	activity	activity	NN
10_1101-2021_01_08_425864	61	5	assays	assays	RB
10_1101-2021_01_08_425864	61	6	137	137	CD
10_1101-2021_01_08_425864	61	7	MTT	MTT	NNP
10_1101-2021_01_08_425864	61	8	and	and	CC
10_1101-2021_01_08_425864	61	9	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	61	10	Blue	Blue	NNP
10_1101-2021_01_08_425864	61	11	.	.	.
10_1101-2021_01_08_425864	62	1	The	the	DT
10_1101-2021_01_08_425864	62	2	parasites	parasite	NNS
10_1101-2021_01_08_425864	62	3	were	be	VBD
10_1101-2021_01_08_425864	62	4	washed	wash	VBN
10_1101-2021_01_08_425864	62	5	twice	twice	RB
10_1101-2021_01_08_425864	62	6	and	and	CC
10_1101-2021_01_08_425864	62	7	incubated	incubate	VBN
10_1101-2021_01_08_425864	62	8	in	in	IN
10_1101-2021_01_08_425864	62	9	PBS	PBS	NNP
10_1101-2021_01_08_425864	62	10	supplemented	supplement	VBD
10_1101-2021_01_08_425864	62	11	with	with	IN
10_1101-2021_01_08_425864	62	12	138	138	CD
10_1101-2021_01_08_425864	62	13	0.1	0.1	CD
10_1101-2021_01_08_425864	62	14	mM	mm	NN
10_1101-2021_01_08_425864	62	15	palmitate	palmitate	NN
10_1101-2021_01_08_425864	62	16	in	in	IN
10_1101-2021_01_08_425864	62	17	0.35	0.35	CD
10_1101-2021_01_08_425864	62	18	%	%	NN
10_1101-2021_01_08_425864	62	19	FFA	FFA	NNP
10_1101-2021_01_08_425864	62	20	BSA	BSA	NNP
10_1101-2021_01_08_425864	62	21	,	,	,
10_1101-2021_01_08_425864	62	22	0.35	0.35	CD
10_1101-2021_01_08_425864	62	23	%	%	NN
10_1101-2021_01_08_425864	62	24	FFA	FFA	NNP
10_1101-2021_01_08_425864	62	25	BSA	bsa	RB
10_1101-2021_01_08_425864	62	26	alone	alone	JJ
10_1101-2021_01_08_425864	62	27	,	,	,
10_1101-2021_01_08_425864	62	28	and	and	CC
10_1101-2021_01_08_425864	62	29	5	5	CD
10_1101-2021_01_08_425864	62	30	mM	mm	NN
10_1101-2021_01_08_425864	62	31	glucose	glucose	NN
10_1101-2021_01_08_425864	62	32	,	,	,
10_1101-2021_01_08_425864	62	33	and	and	CC
10_1101-2021_01_08_425864	62	34	5	5	CD
10_1101-2021_01_08_425864	62	35	mM	mM	NNP
10_1101-2021_01_08_425864	62	36	histidine	histidine	NN
10_1101-2021_01_08_425864	62	37	139	139	CD
10_1101-2021_01_08_425864	62	38	or	or	CC
10_1101-2021_01_08_425864	62	39	not	not	RB
10_1101-2021_01_08_425864	62	40	supplemented	supplement	VBN
10_1101-2021_01_08_425864	62	41	media	medium	NNS
10_1101-2021_01_08_425864	62	42	were	be	VBD
10_1101-2021_01_08_425864	62	43	used	use	VBN
10_1101-2021_01_08_425864	62	44	as	as	IN
10_1101-2021_01_08_425864	62	45	controls	control	NNS
10_1101-2021_01_08_425864	62	46	(	(	-LRB-
10_1101-2021_01_08_425864	62	47	positives	positive	NNS
10_1101-2021_01_08_425864	62	48	and	and	CC
10_1101-2021_01_08_425864	62	49	negative	negative	JJ
10_1101-2021_01_08_425864	62	50	,	,	,
10_1101-2021_01_08_425864	62	51	respectively	respectively	RB
10_1101-2021_01_08_425864	62	52	)	)	-RRB-
10_1101-2021_01_08_425864	62	53	.	.	.
10_1101-2021_01_08_425864	63	1	The	the	DT
10_1101-2021_01_08_425864	63	2	cell	cell	NN
10_1101-2021_01_08_425864	63	3	140	140	CD
10_1101-2021_01_08_425864	63	4	viability	viability	NN
10_1101-2021_01_08_425864	63	5	was	be	VBD
10_1101-2021_01_08_425864	63	6	evaluated	evaluate	VBN
10_1101-2021_01_08_425864	63	7	at	at	IN
10_1101-2021_01_08_425864	63	8	24	24	CD
10_1101-2021_01_08_425864	63	9	h	h	NN
10_1101-2021_01_08_425864	63	10	and	and	CC
10_1101-2021_01_08_425864	63	11	48	48	CD
10_1101-2021_01_08_425864	63	12	h	h	NN
10_1101-2021_01_08_425864	63	13	after	after	IN
10_1101-2021_01_08_425864	63	14	incubation	incubation	NN
10_1101-2021_01_08_425864	63	15	using	use	VBG
10_1101-2021_01_08_425864	63	16	the	the	DT
10_1101-2021_01_08_425864	63	17	MTT	MTT	NNP
10_1101-2021_01_08_425864	63	18	assay	assay	NN
10_1101-2021_01_08_425864	63	19	,	,	,
10_1101-2021_01_08_425864	63	20	as	as	IN
10_1101-2021_01_08_425864	63	21	described	describe	VBN
10_1101-2021_01_08_425864	63	22	in	in	IN
10_1101-2021_01_08_425864	63	23	[	[	-LRB-
10_1101-2021_01_08_425864	63	24	15,16	15,16	CD
10_1101-2021_01_08_425864	63	25	]	]	-RRB-
10_1101-2021_01_08_425864	63	26	.	.	.
10_1101-2021_01_08_425864	64	1	141	141	CD
10_1101-2021_01_08_425864	64	2	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	64	3	Blue	Blue	NNP
10_1101-2021_01_08_425864	64	4	.	.	.
10_1101-2021_01_08_425864	65	1	The	the	DT
10_1101-2021_01_08_425864	65	2	parasites	parasite	NNS
10_1101-2021_01_08_425864	65	3	were	be	VBD
10_1101-2021_01_08_425864	65	4	washed	wash	VBN
10_1101-2021_01_08_425864	65	5	twice	twice	RB
10_1101-2021_01_08_425864	65	6	and	and	CC
10_1101-2021_01_08_425864	65	7	incubated	incubate	VBN
10_1101-2021_01_08_425864	65	8	in	in	IN
10_1101-2021_01_08_425864	65	9	PBS	PBS	NNP
10_1101-2021_01_08_425864	65	10	or	or	CC
10_1101-2021_01_08_425864	65	11	PBS	PBS	NNP
10_1101-2021_01_08_425864	65	12	supplemented	supplement	VBD
10_1101-2021_01_08_425864	65	13	with	with	IN
10_1101-2021_01_08_425864	65	14	500	500	CD
10_1101-2021_01_08_425864	65	15	142	142	CD
10_1101-2021_01_08_425864	65	16	μM	μM	NNP
10_1101-2021_01_08_425864	65	17	ETO	eto	NN
10_1101-2021_01_08_425864	65	18	in	in	IN
10_1101-2021_01_08_425864	65	19	96-well	96-well	CD
10_1101-2021_01_08_425864	65	20	plates	plate	NNS
10_1101-2021_01_08_425864	65	21	.	.	.
10_1101-2021_01_08_425864	66	1	The	the	DT
10_1101-2021_01_08_425864	66	2	plates	plate	NNS
10_1101-2021_01_08_425864	66	3	were	be	VBD
10_1101-2021_01_08_425864	66	4	maintained	maintain	VBN
10_1101-2021_01_08_425864	66	5	at	at	IN
10_1101-2021_01_08_425864	66	6	28	28	CD
10_1101-2021_01_08_425864	66	7	°	°	,
10_1101-2021_01_08_425864	66	8	C	c	NN
10_1101-2021_01_08_425864	66	9	during	during	IN
10_1101-2021_01_08_425864	66	10	all	all	PDT
10_1101-2021_01_08_425864	66	11	the	the	DT
10_1101-2021_01_08_425864	66	12	experiments	experiment	NNS
10_1101-2021_01_08_425864	66	13	.	.	.
10_1101-2021_01_08_425864	67	1	After	after	IN
10_1101-2021_01_08_425864	67	2	143	143	CD
10_1101-2021_01_08_425864	67	3	every	every	DT
10_1101-2021_01_08_425864	67	4	24	24	CD
10_1101-2021_01_08_425864	67	5	h	h	NN
10_1101-2021_01_08_425864	67	6	,	,	,
10_1101-2021_01_08_425864	67	7	the	the	DT
10_1101-2021_01_08_425864	67	8	cells	cell	NNS
10_1101-2021_01_08_425864	67	9	were	be	VBD
10_1101-2021_01_08_425864	67	10	incubated	incubate	VBN
10_1101-2021_01_08_425864	67	11	with	with	IN
10_1101-2021_01_08_425864	67	12	0.125	0.125	CD
10_1101-2021_01_08_425864	67	13	μg.mL-1	μg.mL-1	NNS
10_1101-2021_01_08_425864	67	14	of	of	IN
10_1101-2021_01_08_425864	67	15	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	67	16	Blue	blue	JJ
10_1101-2021_01_08_425864	67	17	reagent	reagent	NN
10_1101-2021_01_08_425864	67	18	and	and	CC
10_1101-2021_01_08_425864	67	19	kept	keep	VBD
10_1101-2021_01_08_425864	67	20	at	at	IN
10_1101-2021_01_08_425864	67	21	28	28	CD
10_1101-2021_01_08_425864	67	22	°	°	,
10_1101-2021_01_08_425864	67	23	C	C	NNP
10_1101-2021_01_08_425864	67	24	for	for	IN
10_1101-2021_01_08_425864	67	25	144	144	CD
10_1101-2021_01_08_425864	67	26	2	2	CD
10_1101-2021_01_08_425864	67	27	h	h	NN
10_1101-2021_01_08_425864	67	28	under	under	IN
10_1101-2021_01_08_425864	67	29	protection	protection	NN
10_1101-2021_01_08_425864	67	30	from	from	IN
10_1101-2021_01_08_425864	67	31	light	light	NN
10_1101-2021_01_08_425864	67	32	.	.	.
10_1101-2021_01_08_425864	68	1	The	the	DT
10_1101-2021_01_08_425864	68	2	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	68	3	was	be	VBD
10_1101-2021_01_08_425864	68	4	accessed	access	VBN
10_1101-2021_01_08_425864	68	5	using	use	VBG
10_1101-2021_01_08_425864	68	6	the	the	DT
10_1101-2021_01_08_425864	68	7	wavelengths	wavelength	NNS
10_1101-2021_01_08_425864	68	8	λexc	λexc	VB
10_1101-2021_01_08_425864	68	9	=	=	SYM
10_1101-2021_01_08_425864	68	10	530	530	CD
10_1101-2021_01_08_425864	68	11	nm	nm	CC
10_1101-2021_01_08_425864	68	12	145	145	CD
10_1101-2021_01_08_425864	68	13	and	and	CC
10_1101-2021_01_08_425864	68	14	λem	λem	NN
10_1101-2021_01_08_425864	68	15	=	=	SYM
10_1101-2021_01_08_425864	68	16	590	590	CD
10_1101-2021_01_08_425864	68	17	nm	nm	UH
10_1101-2021_01_08_425864	68	18	in	in	IN
10_1101-2021_01_08_425864	68	19	the	the	DT
10_1101-2021_01_08_425864	68	20	SpectraMax	SpectraMax	NNP
10_1101-2021_01_08_425864	68	21	®	®	NNPS
10_1101-2021_01_08_425864	68	22	i3	i3	NNP
10_1101-2021_01_08_425864	68	23	(	(	-LRB-
10_1101-2021_01_08_425864	68	24	Molecular	Molecular	NNP
10_1101-2021_01_08_425864	68	25	Devices	Devices	NNPS
10_1101-2021_01_08_425864	68	26	)	)	-RRB-
10_1101-2021_01_08_425864	68	27	plate	plate	VBP
10_1101-2021_01_08_425864	68	28	reader	reader	NN
10_1101-2021_01_08_425864	68	29	.	.	.
10_1101-2021_01_08_425864	69	1	146	146	CD
10_1101-2021_01_08_425864	69	2	147	147	CD
10_1101-2021_01_08_425864	69	3	Measurement	Measurement	NNP
10_1101-2021_01_08_425864	69	4	of	of	IN
10_1101-2021_01_08_425864	69	5	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	69	6	ATP	ATP	NNP
10_1101-2021_01_08_425864	69	7	content	content	NN
10_1101-2021_01_08_425864	69	8	148	148	CD
10_1101-2021_01_08_425864	69	9	The	the	DT
10_1101-2021_01_08_425864	69	10	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	69	11	ATP	atp	NN
10_1101-2021_01_08_425864	69	12	levels	level	NNS
10_1101-2021_01_08_425864	69	13	were	be	VBD
10_1101-2021_01_08_425864	69	14	assessed	assess	VBN
10_1101-2021_01_08_425864	69	15	using	use	VBG
10_1101-2021_01_08_425864	69	16	a	a	DT
10_1101-2021_01_08_425864	69	17	luciferase	luciferase	NN
10_1101-2021_01_08_425864	69	18	assay	assay	NN
10_1101-2021_01_08_425864	69	19	kit	kit	NN
10_1101-2021_01_08_425864	69	20	(	(	-LRB-
10_1101-2021_01_08_425864	69	21	Sigma	Sigma	NNP
10_1101-2021_01_08_425864	69	22	-	-	HYPH
10_1101-2021_01_08_425864	69	23	Aldrich	Aldrich	NNP
10_1101-2021_01_08_425864	69	24	®	®	NNP
10_1101-2021_01_08_425864	69	25	)	)	-RRB-
10_1101-2021_01_08_425864	69	26	,	,	,
10_1101-2021_01_08_425864	69	27	as	as	IN
10_1101-2021_01_08_425864	69	28	149	149	CD
10_1101-2021_01_08_425864	69	29	described	describe	VBN
10_1101-2021_01_08_425864	69	30	in	in	IN
10_1101-2021_01_08_425864	69	31	[	[	-LRB-
10_1101-2021_01_08_425864	69	32	15–17	15–17	CD
10_1101-2021_01_08_425864	69	33	]	]	-RRB-
10_1101-2021_01_08_425864	69	34	.	.	.
10_1101-2021_01_08_425864	70	1	In	in	IN
10_1101-2021_01_08_425864	70	2	brief	brief	NN
10_1101-2021_01_08_425864	70	3	,	,	,
10_1101-2021_01_08_425864	70	4	the	the	DT
10_1101-2021_01_08_425864	70	5	parasites	parasite	NNS
10_1101-2021_01_08_425864	70	6	were	be	VBD
10_1101-2021_01_08_425864	70	7	incubated	incubate	VBN
10_1101-2021_01_08_425864	70	8	in	in	IN
10_1101-2021_01_08_425864	70	9	PBS	PBS	NNP
10_1101-2021_01_08_425864	70	10	supplemented	supplement	VBN
10_1101-2021_01_08_425864	70	11	(	(	-LRB-
10_1101-2021_01_08_425864	70	12	or	or	CC
10_1101-2021_01_08_425864	70	13	not	not	RB
10_1101-2021_01_08_425864	70	14	)	)	-RRB-
10_1101-2021_01_08_425864	70	15	with	with	IN
10_1101-2021_01_08_425864	70	16	0.1	0.1	CD
10_1101-2021_01_08_425864	70	17	150	150	CD
10_1101-2021_01_08_425864	70	18	mM	mm	NN
10_1101-2021_01_08_425864	70	19	palmitate	palmitate	NN
10_1101-2021_01_08_425864	70	20	,	,	,
10_1101-2021_01_08_425864	70	21	0.35	0.35	CD
10_1101-2021_01_08_425864	70	22	%	%	NN
10_1101-2021_01_08_425864	70	23	FFA	FFA	NNP
10_1101-2021_01_08_425864	70	24	BSA	BSA	NNP
10_1101-2021_01_08_425864	70	25	,	,	,
10_1101-2021_01_08_425864	70	26	5	5	CD
10_1101-2021_01_08_425864	70	27	mM	mm	NN
10_1101-2021_01_08_425864	70	28	glucose	glucose	NN
10_1101-2021_01_08_425864	70	29	or	or	CC
10_1101-2021_01_08_425864	70	30	5	5	CD
10_1101-2021_01_08_425864	70	31	mM	mM	NNP
10_1101-2021_01_08_425864	70	32	histidine	histidine	NN
10_1101-2021_01_08_425864	70	33	for	for	IN
10_1101-2021_01_08_425864	70	34	24	24	CD
10_1101-2021_01_08_425864	70	35	h	h	NN
10_1101-2021_01_08_425864	70	36	at	at	IN
10_1101-2021_01_08_425864	70	37	28	28	CD
10_1101-2021_01_08_425864	70	38	°	°	,
10_1101-2021_01_08_425864	70	39	C	C	NNP
10_1101-2021_01_08_425864	70	40	.	.	.
10_1101-2021_01_08_425864	71	1	The	the	DT
10_1101-2021_01_08_425864	71	2	ATP	ATP	NNP
10_1101-2021_01_08_425864	71	3	151	151	CD
10_1101-2021_01_08_425864	71	4	concentrations	concentration	NNS
10_1101-2021_01_08_425864	71	5	were	be	VBD
10_1101-2021_01_08_425864	71	6	determined	determine	VBN
10_1101-2021_01_08_425864	71	7	by	by	IN
10_1101-2021_01_08_425864	71	8	using	use	VBG
10_1101-2021_01_08_425864	71	9	a	a	DT
10_1101-2021_01_08_425864	71	10	calibration	calibration	NN
10_1101-2021_01_08_425864	71	11	curve	curve	NN
10_1101-2021_01_08_425864	71	12	with	with	IN
10_1101-2021_01_08_425864	71	13	ATP	atp	NN
10_1101-2021_01_08_425864	71	14	disodium	disodium	NN
10_1101-2021_01_08_425864	71	15	salt	salt	NN
10_1101-2021_01_08_425864	71	16	(	(	-LRB-
10_1101-2021_01_08_425864	71	17	Sigma	Sigma	NNP
10_1101-2021_01_08_425864	71	18	)	)	-RRB-
10_1101-2021_01_08_425864	71	19	,	,	,
10_1101-2021_01_08_425864	71	20	and	and	CC
10_1101-2021_01_08_425864	71	21	152	152	CD
10_1101-2021_01_08_425864	71	22	the	the	DT
10_1101-2021_01_08_425864	71	23	luminescence	luminescence	NN
10_1101-2021_01_08_425864	71	24	at	at	IN
10_1101-2021_01_08_425864	71	25	570	570	CD
10_1101-2021_01_08_425864	71	26	nm	nm	CD
10_1101-2021_01_08_425864	71	27	was	be	VBD
10_1101-2021_01_08_425864	71	28	measured	measure	VBN
10_1101-2021_01_08_425864	71	29	as	as	IN
10_1101-2021_01_08_425864	71	30	indicated	indicate	VBN
10_1101-2021_01_08_425864	71	31	by	by	IN
10_1101-2021_01_08_425864	71	32	the	the	DT
10_1101-2021_01_08_425864	71	33	manufacturer	manufacturer	NN
10_1101-2021_01_08_425864	71	34	.	.	.
10_1101-2021_01_08_425864	72	1	153	153	CD
10_1101-2021_01_08_425864	72	2	154	154	CD
10_1101-2021_01_08_425864	72	3	Enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	72	4	activities	activity	NNS
10_1101-2021_01_08_425864	72	5	155	155	CD
10_1101-2021_01_08_425864	72	6	Carnitine	Carnitine	NNP
10_1101-2021_01_08_425864	72	7	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	72	8	1	1	CD
10_1101-2021_01_08_425864	72	9	(	(	-LRB-
10_1101-2021_01_08_425864	72	10	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	72	11	)	)	-RRB-
10_1101-2021_01_08_425864	72	12	.	.	.
10_1101-2021_01_08_425864	73	1	The	the	DT
10_1101-2021_01_08_425864	73	2	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	73	3	were	be	VBD
10_1101-2021_01_08_425864	73	4	washed	wash	VBN
10_1101-2021_01_08_425864	73	5	twice	twice	RB
10_1101-2021_01_08_425864	73	6	in	in	IN
10_1101-2021_01_08_425864	73	7	PBS	PBS	NNP
10_1101-2021_01_08_425864	73	8	(	(	-LRB-
10_1101-2021_01_08_425864	73	9	1,000	1,000	CD
10_1101-2021_01_08_425864	73	10	x	x	SYM
10_1101-2021_01_08_425864	73	11	156	156	CD
10_1101-2021_01_08_425864	73	12	g	g	NN
10_1101-2021_01_08_425864	73	13	,	,	,
10_1101-2021_01_08_425864	73	14	5	5	CD
10_1101-2021_01_08_425864	73	15	min	min	NN
10_1101-2021_01_08_425864	73	16	at	at	IN
10_1101-2021_01_08_425864	73	17	4	4	CD
10_1101-2021_01_08_425864	73	18	°	°	,
10_1101-2021_01_08_425864	73	19	C	C	NNP
10_1101-2021_01_08_425864	73	20	)	)	-RRB-
10_1101-2021_01_08_425864	73	21	,	,	,
10_1101-2021_01_08_425864	73	22	resuspended	resuspend	VBN
10_1101-2021_01_08_425864	73	23	in	in	IN
10_1101-2021_01_08_425864	73	24	buffered	buffered	JJ
10_1101-2021_01_08_425864	73	25	Tris	Tris	NNP
10_1101-2021_01_08_425864	73	26	-	-	HYPH
10_1101-2021_01_08_425864	73	27	EDTA	EDTA	NNP
10_1101-2021_01_08_425864	73	28	(	(	-LRB-
10_1101-2021_01_08_425864	73	29	100	100	CD
10_1101-2021_01_08_425864	73	30	mM	mm	NN
10_1101-2021_01_08_425864	73	31	,	,	,
10_1101-2021_01_08_425864	73	32	2.5	2.5	CD
10_1101-2021_01_08_425864	73	33	mM	mM	NNP
10_1101-2021_01_08_425864	73	34	and	and	CC
10_1101-2021_01_08_425864	73	35	0.1	0.1	CD
10_1101-2021_01_08_425864	73	36	%	%	NN
10_1101-2021_01_08_425864	73	37	Triton	Triton	NNP
10_1101-2021_01_08_425864	73	38	X-100	X-100	NNP
10_1101-2021_01_08_425864	73	39	)	)	-RRB-
10_1101-2021_01_08_425864	73	40	157	157	CD
10_1101-2021_01_08_425864	73	41	containing	contain	VBG
10_1101-2021_01_08_425864	73	42	1	1	CD
10_1101-2021_01_08_425864	73	43	µM	µM	NNP
10_1101-2021_01_08_425864	73	44	phenylmethyl	phenylmethyl	NN
10_1101-2021_01_08_425864	73	45	-	-	HYPH
10_1101-2021_01_08_425864	73	46	sulphonyl	sulphonyl	NN
10_1101-2021_01_08_425864	73	47	fluoride	fluoride	NN
10_1101-2021_01_08_425864	73	48	(	(	-LRB-
10_1101-2021_01_08_425864	73	49	PMSF	PMSF	NNP
10_1101-2021_01_08_425864	73	50	)	)	-RRB-
10_1101-2021_01_08_425864	73	51	,	,	,
10_1101-2021_01_08_425864	73	52	0.5	0.5	CD
10_1101-2021_01_08_425864	73	53	mM	mm	NN
10_1101-2021_01_08_425864	73	54	N	n	CD
10_1101-2021_01_08_425864	73	55	-	-	HYPH
10_1101-2021_01_08_425864	73	56	alpha	alpha	NN
10_1101-2021_01_08_425864	73	57	-	-	HYPH
10_1101-2021_01_08_425864	73	58	p	p	NN
10_1101-2021_01_08_425864	73	59	-	-	HYPH
10_1101-2021_01_08_425864	73	60	tosyl	tosyl	NN
10_1101-2021_01_08_425864	73	61	-	-	HYPH
10_1101-2021_01_08_425864	73	62	lysyl-	lysyl-	NN
10_1101-2021_01_08_425864	73	63	158	158	CD
10_1101-2021_01_08_425864	73	64	chloromethyl	chloromethyl	NN
10_1101-2021_01_08_425864	73	65	ketone	ketone	NN
10_1101-2021_01_08_425864	73	66	(	(	-LRB-
10_1101-2021_01_08_425864	73	67	TLCK	TLCK	NNP
10_1101-2021_01_08_425864	73	68	)	)	-RRB-
10_1101-2021_01_08_425864	73	69	,	,	,
10_1101-2021_01_08_425864	73	70	0.01	0.01	CD
10_1101-2021_01_08_425864	73	71	mg	mg	NNP
10_1101-2021_01_08_425864	73	72	aprotinin	aprotinin	NN
10_1101-2021_01_08_425864	73	73	and	and	CC
10_1101-2021_01_08_425864	73	74	0.1	0.1	CD
10_1101-2021_01_08_425864	73	75	mM	mM	NNP
10_1101-2021_01_08_425864	73	76	trans	trans	JJ
10_1101-2021_01_08_425864	73	77	-	-	JJ
10_1101-2021_01_08_425864	73	78	epoxysuccinyl	epoxysuccinyl	JJ
10_1101-2021_01_08_425864	73	79	-	-	HYPH
10_1101-2021_01_08_425864	73	80	L	l	NN
10_1101-2021_01_08_425864	73	81	-	-	HYPH
10_1101-2021_01_08_425864	73	82	leucyl	leucyl	NNP
10_1101-2021_01_08_425864	73	83	amido	amido	NNP
10_1101-2021_01_08_425864	73	84	159	159	CD
10_1101-2021_01_08_425864	73	85	(	(	-LRB-
10_1101-2021_01_08_425864	73	86	4-guanidino	4-guanidino	CD
10_1101-2021_01_08_425864	73	87	)	)	-RRB-
10_1101-2021_01_08_425864	73	88	butane	butane	NN
10_1101-2021_01_08_425864	73	89	(	(	-LRB-
10_1101-2021_01_08_425864	73	90	E-64	e-64	CD
10_1101-2021_01_08_425864	73	91	)	)	-RRB-
10_1101-2021_01_08_425864	73	92	as	as	IN
10_1101-2021_01_08_425864	73	93	a	a	DT
10_1101-2021_01_08_425864	73	94	protease	protease	NN
10_1101-2021_01_08_425864	73	95	inhibitors	inhibitor	NNS
10_1101-2021_01_08_425864	73	96	(	(	-LRB-
10_1101-2021_01_08_425864	73	97	Sigma	Sigma	NNP
10_1101-2021_01_08_425864	73	98	Aldrich	Aldrich	NNP
10_1101-2021_01_08_425864	73	99	®	®	NNP
10_1101-2021_01_08_425864	73	100	)	)	-RRB-
10_1101-2021_01_08_425864	73	101	and	and	CC
10_1101-2021_01_08_425864	73	102	lysed	lyse	VBN
10_1101-2021_01_08_425864	73	103	by	by	IN
10_1101-2021_01_08_425864	73	104	sonication	sonication	NN
10_1101-2021_01_08_425864	73	105	(	(	-LRB-
10_1101-2021_01_08_425864	73	106	5	5	CD
10_1101-2021_01_08_425864	73	107	160	160	CD
10_1101-2021_01_08_425864	73	108	pulses	pulse	NNS
10_1101-2021_01_08_425864	73	109	for	for	IN
10_1101-2021_01_08_425864	73	110	1	1	CD
10_1101-2021_01_08_425864	73	111	min	min	NN
10_1101-2021_01_08_425864	73	112	each	each	DT
10_1101-2021_01_08_425864	73	113	,	,	,
10_1101-2021_01_08_425864	73	114	20	20	CD
10_1101-2021_01_08_425864	73	115	%	%	NN
10_1101-2021_01_08_425864	73	116	)	)	-RRB-
10_1101-2021_01_08_425864	73	117	.	.	.
10_1101-2021_01_08_425864	74	1	The	the	DT
10_1101-2021_01_08_425864	74	2	lysates	lysate	NNS
10_1101-2021_01_08_425864	74	3	were	be	VBD
10_1101-2021_01_08_425864	74	4	clarified	clarify	VBN
10_1101-2021_01_08_425864	74	5	by	by	IN
10_1101-2021_01_08_425864	74	6	centrifugation	centrifugation	NN
10_1101-2021_01_08_425864	74	7	at	at	IN
10_1101-2021_01_08_425864	74	8	10,000	10,000	CD
10_1101-2021_01_08_425864	74	9	x	x	SYM
10_1101-2021_01_08_425864	74	10	g	g	NN
10_1101-2021_01_08_425864	74	11	for	for	IN
10_1101-2021_01_08_425864	74	12	30	30	CD
10_1101-2021_01_08_425864	74	13	min	min	NN
10_1101-2021_01_08_425864	74	14	at	at	IN
10_1101-2021_01_08_425864	74	15	161	161	CD
10_1101-2021_01_08_425864	74	16	4	4	CD
10_1101-2021_01_08_425864	74	17	°	°	,
10_1101-2021_01_08_425864	74	18	C	C	NNP
10_1101-2021_01_08_425864	74	19	.	.	.
10_1101-2021_01_08_425864	75	1	The	the	DT
10_1101-2021_01_08_425864	75	2	soluble	soluble	JJ
10_1101-2021_01_08_425864	75	3	fraction	fraction	NN
10_1101-2021_01_08_425864	75	4	was	be	VBD
10_1101-2021_01_08_425864	75	5	collected	collect	VBN
10_1101-2021_01_08_425864	75	6	and	and	CC
10_1101-2021_01_08_425864	75	7	the	the	DT
10_1101-2021_01_08_425864	75	8	proteins	protein	NNS
10_1101-2021_01_08_425864	75	9	were	be	VBD
10_1101-2021_01_08_425864	75	10	quantified	quantify	VBN
10_1101-2021_01_08_425864	75	11	by	by	IN
10_1101-2021_01_08_425864	75	12	Bradford	Bradford	NNP
10_1101-2021_01_08_425864	75	13	method	method	NN
10_1101-2021_01_08_425864	75	14	[	[	-LRB-
10_1101-2021_01_08_425864	75	15	22	22	CD
10_1101-2021_01_08_425864	75	16	]	]	-RRB-
10_1101-2021_01_08_425864	75	17	162	162	CD
10_1101-2021_01_08_425864	75	18	and	and	CC
10_1101-2021_01_08_425864	75	19	adjusted	adjust	VBN
10_1101-2021_01_08_425864	75	20	to	to	IN
10_1101-2021_01_08_425864	75	21	0.1	0.1	CD
10_1101-2021_01_08_425864	75	22	mg	mg	NNP
10_1101-2021_01_08_425864	75	23	/	/	SYM
10_1101-2021_01_08_425864	75	24	mL	mL	NNP
10_1101-2021_01_08_425864	75	25	protein	protein	NN
10_1101-2021_01_08_425864	75	26	.	.	.
10_1101-2021_01_08_425864	76	1	The	the	DT
10_1101-2021_01_08_425864	76	2	reaction	reaction	NN
10_1101-2021_01_08_425864	76	3	mixture	mixture	NN
10_1101-2021_01_08_425864	76	4	contained	contain	VBD
10_1101-2021_01_08_425864	76	5	0.5	0.5	CD
10_1101-2021_01_08_425864	76	6	mM	mM	NNP
10_1101-2021_01_08_425864	76	7	L	L	NNP
10_1101-2021_01_08_425864	76	8	-	-	HYPH
10_1101-2021_01_08_425864	76	9	carnitine	carnitine	NN
10_1101-2021_01_08_425864	76	10	,	,	,
10_1101-2021_01_08_425864	76	11	0.1	0.1	CD
10_1101-2021_01_08_425864	76	12	mM	mM	NNP
10_1101-2021_01_08_425864	76	13	163	163	CD
10_1101-2021_01_08_425864	76	14	palmitoyl	palmitoyl	NN
10_1101-2021_01_08_425864	76	15	-	-	HYPH
10_1101-2021_01_08_425864	76	16	CoA	coa	NN
10_1101-2021_01_08_425864	76	17	and	and	CC
10_1101-2021_01_08_425864	76	18	2.5	2.5	CD
10_1101-2021_01_08_425864	76	19	mM	mM	NNP
10_1101-2021_01_08_425864	76	20	DTNB	dtnb	NN
10_1101-2021_01_08_425864	76	21	in	in	IN
10_1101-2021_01_08_425864	76	22	Tris	Tris	NNP
10_1101-2021_01_08_425864	76	23	-	-	HYPH
10_1101-2021_01_08_425864	76	24	EDTA	EDTA	NNP
10_1101-2021_01_08_425864	76	25	buffer	buffer	NN
10_1101-2021_01_08_425864	76	26	(	(	-LRB-
10_1101-2021_01_08_425864	76	27	pH	pH	NNP
10_1101-2021_01_08_425864	76	28	=	=	SYM
10_1101-2021_01_08_425864	76	29	8.0	8.0	CD
10_1101-2021_01_08_425864	76	30	)	)	-RRB-
10_1101-2021_01_08_425864	76	31	.	.	.
10_1101-2021_01_08_425864	77	1	The	the	DT
10_1101-2021_01_08_425864	77	2	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	77	3	activity	activity	NN
10_1101-2021_01_08_425864	77	4	was	be	VBD
10_1101-2021_01_08_425864	77	5	measured	measure	VBN
10_1101-2021_01_08_425864	77	6	164	164	CD
10_1101-2021_01_08_425864	77	7	spectrophotometrically	spectrophotometrically	RB
10_1101-2021_01_08_425864	77	8	at	at	IN
10_1101-2021_01_08_425864	77	9	412	412	CD
10_1101-2021_01_08_425864	77	10	nm	nm	NN
10_1101-2021_01_08_425864	77	11	by	by	IN
10_1101-2021_01_08_425864	77	12	DTNB	dtnb	NN
10_1101-2021_01_08_425864	77	13	reaction	reaction	NN
10_1101-2021_01_08_425864	77	14	with	with	IN
10_1101-2021_01_08_425864	77	15	free	free	JJ
10_1101-2021_01_08_425864	77	16	HS	HS	NNP
10_1101-2021_01_08_425864	77	17	-	-	HYPH
10_1101-2021_01_08_425864	77	18	CoA	CoA	NNP
10_1101-2021_01_08_425864	77	19	,	,	,
10_1101-2021_01_08_425864	77	20	forming	form	VBG
10_1101-2021_01_08_425864	77	21	the	the	DT
10_1101-2021_01_08_425864	77	22	TNB-	TNB-	NNP
10_1101-2021_01_08_425864	77	23	ion	ion	NN
10_1101-2021_01_08_425864	77	24	.	.	.
10_1101-2021_01_08_425864	78	1	To	to	IN
10_1101-2021_01_08_425864	78	2	165	165	CD
10_1101-2021_01_08_425864	78	3	calculate	calculate	NN
10_1101-2021_01_08_425864	78	4	the	the	DT
10_1101-2021_01_08_425864	78	5	specific	specific	JJ
10_1101-2021_01_08_425864	78	6	activity	activity	NN
10_1101-2021_01_08_425864	78	7	,	,	,
10_1101-2021_01_08_425864	78	8	the	the	DT
10_1101-2021_01_08_425864	78	9	absorbance	absorbance	NN
10_1101-2021_01_08_425864	78	10	values	value	NNS
10_1101-2021_01_08_425864	78	11	were	be	VBD
10_1101-2021_01_08_425864	78	12	converted	convert	VBN
10_1101-2021_01_08_425864	78	13	into	into	IN
10_1101-2021_01_08_425864	78	14	molarity	molarity	NN
10_1101-2021_01_08_425864	78	15	by	by	IN
10_1101-2021_01_08_425864	78	16	using	use	VBG
10_1101-2021_01_08_425864	78	17	the	the	DT
10_1101-2021_01_08_425864	78	18	TNB-	TNB-	NNP
10_1101-2021_01_08_425864	78	19	166	166	CD
10_1101-2021_01_08_425864	78	20	extinction	extinction	NN
10_1101-2021_01_08_425864	78	21	molar	molar	JJ
10_1101-2021_01_08_425864	78	22	coefficient	coefficient	NN
10_1101-2021_01_08_425864	78	23	of	of	IN
10_1101-2021_01_08_425864	78	24	12,000	12,000	CD
10_1101-2021_01_08_425864	78	25	M-1.s-1	M-1.s-1	NNS
10_1101-2021_01_08_425864	78	26	[	[	-LRB-
10_1101-2021_01_08_425864	78	27	23	23	CD
10_1101-2021_01_08_425864	78	28	]	]	-RRB-
10_1101-2021_01_08_425864	78	29	.	.	.
10_1101-2021_01_08_425864	79	1	As	as	IN
10_1101-2021_01_08_425864	79	2	a	a	DT
10_1101-2021_01_08_425864	79	3	blank	blank	NN
10_1101-2021_01_08_425864	79	4	,	,	,
10_1101-2021_01_08_425864	79	5	we	-PRON-	PRP
10_1101-2021_01_08_425864	79	6	performed	perform	VBD
10_1101-2021_01_08_425864	79	7	the	the	DT
10_1101-2021_01_08_425864	79	8	same	same	JJ
10_1101-2021_01_08_425864	79	9	assay	assay	NN
10_1101-2021_01_08_425864	79	10	without	without	IN
10_1101-2021_01_08_425864	79	11	.CC	.CC	:
10_1101-2021_01_08_425864	79	12	-	-	:
10_1101-2021_01_08_425864	79	13	BY	by	IN
10_1101-2021_01_08_425864	79	14	4.0	4.0	CD
10_1101-2021_01_08_425864	79	15	International	international	JJ
10_1101-2021_01_08_425864	79	16	licensemade	licensemade	NN
10_1101-2021_01_08_425864	79	17	available	available	JJ
10_1101-2021_01_08_425864	79	18	under	under	IN
10_1101-2021_01_08_425864	79	19	a	a	DT
10_1101-2021_01_08_425864	79	20	(	(	-LRB-
10_1101-2021_01_08_425864	79	21	which	which	WDT
10_1101-2021_01_08_425864	79	22	was	be	VBD
10_1101-2021_01_08_425864	79	23	not	not	RB
10_1101-2021_01_08_425864	79	24	certified	certify	VBN
10_1101-2021_01_08_425864	79	25	by	by	IN
10_1101-2021_01_08_425864	79	26	peer	peer	NN
10_1101-2021_01_08_425864	79	27	review	review	NN
10_1101-2021_01_08_425864	79	28	)	)	-RRB-
10_1101-2021_01_08_425864	79	29	is	be	VBZ
10_1101-2021_01_08_425864	79	30	the	the	DT
10_1101-2021_01_08_425864	79	31	author	author	NN
10_1101-2021_01_08_425864	79	32	/	/	SYM
10_1101-2021_01_08_425864	79	33	funder	funder	NN
10_1101-2021_01_08_425864	79	34	,	,	,
10_1101-2021_01_08_425864	79	35	who	who	WP
10_1101-2021_01_08_425864	79	36	has	have	VBZ
10_1101-2021_01_08_425864	79	37	granted	grant	VBN
10_1101-2021_01_08_425864	79	38	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	79	39	a	a	DT
10_1101-2021_01_08_425864	79	40	license	license	NN
10_1101-2021_01_08_425864	79	41	to	to	TO
10_1101-2021_01_08_425864	79	42	display	display	VB
10_1101-2021_01_08_425864	79	43	the	the	DT
10_1101-2021_01_08_425864	79	44	preprint	preprint	NN
10_1101-2021_01_08_425864	79	45	in	in	IN
10_1101-2021_01_08_425864	79	46	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	79	47	.	.	.
10_1101-2021_01_08_425864	80	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	80	2	is	be	VBZ
10_1101-2021_01_08_425864	80	3	The	the	DT
10_1101-2021_01_08_425864	80	4	copyright	copyright	NN
10_1101-2021_01_08_425864	80	5	holder	holder	NN
10_1101-2021_01_08_425864	80	6	for	for	IN
10_1101-2021_01_08_425864	80	7	this	this	DT
10_1101-2021_01_08_425864	80	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	80	9	version	version	NN
10_1101-2021_01_08_425864	80	10	posted	post	VBD
10_1101-2021_01_08_425864	80	11	January	January	NNP
10_1101-2021_01_08_425864	80	12	8	8	CD
10_1101-2021_01_08_425864	80	13	,	,	,
10_1101-2021_01_08_425864	80	14	2021	2021	CD
10_1101-2021_01_08_425864	80	15	.	.	.
10_1101-2021_01_08_425864	80	16	;	;	:
10_1101-2021_01_08_425864	80	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	80	18	:	:	:
10_1101-2021_01_08_425864	80	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	80	20	preprint	preprint	NN
10_1101-2021_01_08_425864	80	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	80	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	80	23	167	167	CD
10_1101-2021_01_08_425864	80	24	adding	add	VBG
10_1101-2021_01_08_425864	80	25	the	the	DT
10_1101-2021_01_08_425864	80	26	substrate	substrate	NN
10_1101-2021_01_08_425864	80	27	.	.	.
10_1101-2021_01_08_425864	81	1	All	all	PDT
10_1101-2021_01_08_425864	81	2	the	the	DT
10_1101-2021_01_08_425864	81	3	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	81	4	assays	assay	NNS
10_1101-2021_01_08_425864	81	5	were	be	VBD
10_1101-2021_01_08_425864	81	6	performed	perform	VBN
10_1101-2021_01_08_425864	81	7	in	in	IN
10_1101-2021_01_08_425864	81	8	96-well	96-well	CD
10_1101-2021_01_08_425864	81	9	plates	plate	NNS
10_1101-2021_01_08_425864	81	10	at	at	IN
10_1101-2021_01_08_425864	81	11	a	a	DT
10_1101-2021_01_08_425864	81	12	final	final	JJ
10_1101-2021_01_08_425864	81	13	volume	volume	NN
10_1101-2021_01_08_425864	81	14	of	of	IN
10_1101-2021_01_08_425864	81	15	168	168	CD
10_1101-2021_01_08_425864	81	16	0.2	0.2	CD
10_1101-2021_01_08_425864	81	17	mL	ml	NN
10_1101-2021_01_08_425864	81	18	in	in	IN
10_1101-2021_01_08_425864	81	19	the	the	DT
10_1101-2021_01_08_425864	81	20	SpectraMax	SpectraMax	NNP
10_1101-2021_01_08_425864	81	21	®	®	NNPS
10_1101-2021_01_08_425864	81	22	i3	i3	NNP
10_1101-2021_01_08_425864	81	23	(	(	-LRB-
10_1101-2021_01_08_425864	81	24	Molecular	Molecular	NNP
10_1101-2021_01_08_425864	81	25	Devices	Devices	NNPS
10_1101-2021_01_08_425864	81	26	)	)	-RRB-
10_1101-2021_01_08_425864	81	27	.	.	.
10_1101-2021_01_08_425864	82	1	169	169	CD
10_1101-2021_01_08_425864	82	2	170	170	CD
10_1101-2021_01_08_425864	82	3	Acetyl	Acetyl	NNP
10_1101-2021_01_08_425864	82	4	-	-	HYPH
10_1101-2021_01_08_425864	82	5	CoA	CoA	NNP
10_1101-2021_01_08_425864	82	6	carboxylase	carboxylase	NN
10_1101-2021_01_08_425864	82	7	(	(	-LRB-
10_1101-2021_01_08_425864	82	8	ACC	ACC	NNP
10_1101-2021_01_08_425864	82	9	)	)	-RRB-
10_1101-2021_01_08_425864	82	10	.	.	.
10_1101-2021_01_08_425864	83	1	The	the	DT
10_1101-2021_01_08_425864	83	2	ACC	ACC	NNP
10_1101-2021_01_08_425864	83	3	activity	activity	NN
10_1101-2021_01_08_425864	83	4	was	be	VBD
10_1101-2021_01_08_425864	83	5	measured	measure	VBN
10_1101-2021_01_08_425864	83	6	spectrophotometrically	spectrophotometrically	RB
10_1101-2021_01_08_425864	83	7	by	by	IN
10_1101-2021_01_08_425864	83	8	171	171	CD
10_1101-2021_01_08_425864	83	9	coupling	couple	VBG
10_1101-2021_01_08_425864	83	10	its	-PRON-	PRP$
10_1101-2021_01_08_425864	83	11	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	83	12	reaction	reaction	NN
10_1101-2021_01_08_425864	83	13	with	with	IN
10_1101-2021_01_08_425864	83	14	that	that	DT
10_1101-2021_01_08_425864	83	15	of	of	IN
10_1101-2021_01_08_425864	83	16	citrate	citrate	NN
10_1101-2021_01_08_425864	83	17	synthase	synthase	NN
10_1101-2021_01_08_425864	83	18	(	(	-LRB-
10_1101-2021_01_08_425864	83	19	CS	CS	NNP
10_1101-2021_01_08_425864	83	20	)	)	-RRB-
10_1101-2021_01_08_425864	83	21	,	,	,
10_1101-2021_01_08_425864	83	22	which	which	WDT
10_1101-2021_01_08_425864	83	23	uses	use	VBZ
10_1101-2021_01_08_425864	83	24	oxaloacetate	oxaloacetate	NN
10_1101-2021_01_08_425864	83	25	and	and	CC
10_1101-2021_01_08_425864	83	26	acetyl-	acetyl-	JJ
10_1101-2021_01_08_425864	83	27	172	172	CD
10_1101-2021_01_08_425864	83	28	CoA	coa	NN
10_1101-2021_01_08_425864	83	29	to	to	TO
10_1101-2021_01_08_425864	83	30	produce	produce	VB
10_1101-2021_01_08_425864	83	31	citrate	citrate	NN
10_1101-2021_01_08_425864	83	32	.	.	.
10_1101-2021_01_08_425864	84	1	Measurements	measurement	NNS
10_1101-2021_01_08_425864	84	2	were	be	VBD
10_1101-2021_01_08_425864	84	3	performed	perform	VBN
10_1101-2021_01_08_425864	84	4	at	at	IN
10_1101-2021_01_08_425864	84	5	the	the	DT
10_1101-2021_01_08_425864	84	6	end	end	NN
10_1101-2021_01_08_425864	84	7	-	-	HYPH
10_1101-2021_01_08_425864	84	8	points	point	NNS
10_1101-2021_01_08_425864	84	9	in	in	IN
10_1101-2021_01_08_425864	84	10	two	two	CD
10_1101-2021_01_08_425864	84	11	steps	step	NNS
10_1101-2021_01_08_425864	84	12	.	.	.
10_1101-2021_01_08_425864	85	1	First	first	RB
10_1101-2021_01_08_425864	85	2	,	,	,
10_1101-2021_01_08_425864	85	3	the	the	DT
10_1101-2021_01_08_425864	85	4	173	173	CD
10_1101-2021_01_08_425864	85	5	reaction	reaction	NN
10_1101-2021_01_08_425864	85	6	mixture	mixture	NN
10_1101-2021_01_08_425864	85	7	contained	contain	VBD
10_1101-2021_01_08_425864	85	8	100	100	CD
10_1101-2021_01_08_425864	85	9	mM	mM	NNP
10_1101-2021_01_08_425864	85	10	potassium	potassium	NN
10_1101-2021_01_08_425864	85	11	phosphate	phosphate	NN
10_1101-2021_01_08_425864	85	12	buffer	buffer	NN
10_1101-2021_01_08_425864	85	13	(	(	-LRB-
10_1101-2021_01_08_425864	85	14	pH	pH	NNP
10_1101-2021_01_08_425864	85	15	=	=	SYM
10_1101-2021_01_08_425864	85	16	8.0	8.0	CD
10_1101-2021_01_08_425864	85	17	)	)	-RRB-
10_1101-2021_01_08_425864	85	18	,	,	,
10_1101-2021_01_08_425864	85	19	15	15	CD
10_1101-2021_01_08_425864	85	20	mM	mm	NN
10_1101-2021_01_08_425864	85	21	KHCO3	KHCO3	NNP
10_1101-2021_01_08_425864	85	22	,	,	,
10_1101-2021_01_08_425864	85	23	5	5	CD
10_1101-2021_01_08_425864	85	24	mM	mM	NNP
10_1101-2021_01_08_425864	85	25	174	174	CD
10_1101-2021_01_08_425864	85	26	MnCl2	mncl2	CD
10_1101-2021_01_08_425864	85	27	,	,	,
10_1101-2021_01_08_425864	85	28	5	5	CD
10_1101-2021_01_08_425864	85	29	mM	mm	NN
10_1101-2021_01_08_425864	85	30	ATP	atp	NN
10_1101-2021_01_08_425864	85	31	,	,	,
10_1101-2021_01_08_425864	85	32	1	1	CD
10_1101-2021_01_08_425864	85	33	mM	mm	NN
10_1101-2021_01_08_425864	85	34	acetyl	acetyl	NN
10_1101-2021_01_08_425864	85	35	-	-	HYPH
10_1101-2021_01_08_425864	85	36	CoA	CoA	NNP
10_1101-2021_01_08_425864	85	37	and	and	CC
10_1101-2021_01_08_425864	85	38	0.1	0.1	CD
10_1101-2021_01_08_425864	85	39	μM	μm	NN
10_1101-2021_01_08_425864	85	40	biotin	biotin	JJ
10_1101-2021_01_08_425864	85	41	.	.	.
10_1101-2021_01_08_425864	86	1	The	the	DT
10_1101-2021_01_08_425864	86	2	reaction	reaction	NN
10_1101-2021_01_08_425864	86	3	was	be	VBD
10_1101-2021_01_08_425864	86	4	initiated	initiate	VBN
10_1101-2021_01_08_425864	86	5	by	by	IN
10_1101-2021_01_08_425864	86	6	adding	add	VBG
10_1101-2021_01_08_425864	86	7	0.1	0.1	CD
10_1101-2021_01_08_425864	86	8	175	175	CD
10_1101-2021_01_08_425864	86	9	mg	mg	NN
10_1101-2021_01_08_425864	86	10	of	of	IN
10_1101-2021_01_08_425864	86	11	cell	cell	NN
10_1101-2021_01_08_425864	86	12	extract	extract	NN
10_1101-2021_01_08_425864	86	13	and	and	CC
10_1101-2021_01_08_425864	86	14	developed	develop	VBD
10_1101-2021_01_08_425864	86	15	using	use	VBG
10_1101-2021_01_08_425864	86	16	15	15	CD
10_1101-2021_01_08_425864	86	17	min	min	NN
10_1101-2021_01_08_425864	86	18	incubations	incubation	NNS
10_1101-2021_01_08_425864	86	19	at	at	IN
10_1101-2021_01_08_425864	86	20	28	28	CD
10_1101-2021_01_08_425864	86	21	°	°	,
10_1101-2021_01_08_425864	86	22	C	C	NNP
10_1101-2021_01_08_425864	86	23	.	.	.
10_1101-2021_01_08_425864	87	1	The	the	DT
10_1101-2021_01_08_425864	87	2	reaction	reaction	NN
10_1101-2021_01_08_425864	87	3	was	be	VBD
10_1101-2021_01_08_425864	87	4	stopped	stop	VBN
10_1101-2021_01_08_425864	87	5	by	by	IN
10_1101-2021_01_08_425864	87	6	176	176	CD
10_1101-2021_01_08_425864	87	7	adding	add	VBG
10_1101-2021_01_08_425864	87	8	perchloric	perchloric	JJ
10_1101-2021_01_08_425864	87	9	acid	acid	NN
10_1101-2021_01_08_425864	87	10	40	40	CD
10_1101-2021_01_08_425864	87	11	%	%	NN
10_1101-2021_01_08_425864	87	12	(	(	-LRB-
10_1101-2021_01_08_425864	87	13	v	v	NN
10_1101-2021_01_08_425864	87	14	/	/	SYM
10_1101-2021_01_08_425864	87	15	v	v	NN
10_1101-2021_01_08_425864	87	16	)	)	-RRB-
10_1101-2021_01_08_425864	87	17	and	and	CC
10_1101-2021_01_08_425864	87	18	centrifuged	centrifuge	VBD
10_1101-2021_01_08_425864	87	19	10,000	10,000	CD
10_1101-2021_01_08_425864	87	20	x	x	SYM
10_1101-2021_01_08_425864	87	21	g	g	NN
10_1101-2021_01_08_425864	87	22	for	for	IN
10_1101-2021_01_08_425864	87	23	15	15	CD
10_1101-2021_01_08_425864	87	24	min	min	NN
10_1101-2021_01_08_425864	87	25	at	at	IN
10_1101-2021_01_08_425864	87	26	4	4	CD
10_1101-2021_01_08_425864	87	27	°	°	NNS
10_1101-2021_01_08_425864	87	28	C	C	NNP
10_1101-2021_01_08_425864	87	29	.	.	.
10_1101-2021_01_08_425864	88	1	The	the	DT
10_1101-2021_01_08_425864	88	2	second	second	JJ
10_1101-2021_01_08_425864	88	3	reaction	reaction	NN
10_1101-2021_01_08_425864	88	4	177	177	CD
10_1101-2021_01_08_425864	88	5	was	be	VBD
10_1101-2021_01_08_425864	88	6	performed	perform	VBN
10_1101-2021_01_08_425864	88	7	by	by	IN
10_1101-2021_01_08_425864	88	8	using	use	VBG
10_1101-2021_01_08_425864	88	9	0.1	0.1	CD
10_1101-2021_01_08_425864	88	10	mL	ml	NN
10_1101-2021_01_08_425864	88	11	of	of	IN
10_1101-2021_01_08_425864	88	12	the	the	DT
10_1101-2021_01_08_425864	88	13	supernatant	supernatant	JJ
10_1101-2021_01_08_425864	88	14	from	from	IN
10_1101-2021_01_08_425864	88	15	the	the	DT
10_1101-2021_01_08_425864	88	16	first	first	JJ
10_1101-2021_01_08_425864	88	17	reaction	reaction	NN
10_1101-2021_01_08_425864	88	18	,	,	,
10_1101-2021_01_08_425864	88	19	20	20	CD
10_1101-2021_01_08_425864	88	20	mM	mm	NN
10_1101-2021_01_08_425864	88	21	oxaloacetate	oxaloacetate	NN
10_1101-2021_01_08_425864	88	22	and	and	CC
10_1101-2021_01_08_425864	88	23	178	178	CD
10_1101-2021_01_08_425864	88	24	0.5	0.5	CD
10_1101-2021_01_08_425864	88	25	mM	mm	NN
10_1101-2021_01_08_425864	88	26	of	of	IN
10_1101-2021_01_08_425864	88	27	DTNB	DTNB	NNP
10_1101-2021_01_08_425864	88	28	in	in	IN
10_1101-2021_01_08_425864	88	29	100	100	CD
10_1101-2021_01_08_425864	88	30	mM	mM	NNP
10_1101-2021_01_08_425864	88	31	potassium	potassium	NN
10_1101-2021_01_08_425864	88	32	phosphate	phosphate	NN
10_1101-2021_01_08_425864	88	33	buffer	buffer	NN
10_1101-2021_01_08_425864	88	34	(	(	-LRB-
10_1101-2021_01_08_425864	88	35	pH	pH	NNP
10_1101-2021_01_08_425864	88	36	=	=	SYM
10_1101-2021_01_08_425864	88	37	8.0	8.0	CD
10_1101-2021_01_08_425864	88	38	)	)	-RRB-
10_1101-2021_01_08_425864	88	39	.	.	.
10_1101-2021_01_08_425864	89	1	The	the	DT
10_1101-2021_01_08_425864	89	2	reaction	reaction	NN
10_1101-2021_01_08_425864	89	3	was	be	VBD
10_1101-2021_01_08_425864	89	4	initiated	initiate	VBN
10_1101-2021_01_08_425864	89	5	by	by	IN
10_1101-2021_01_08_425864	89	6	179	179	CD
10_1101-2021_01_08_425864	89	7	adding	add	VBG
10_1101-2021_01_08_425864	89	8	0.5	0.5	CD
10_1101-2021_01_08_425864	89	9	units	unit	NNS
10_1101-2021_01_08_425864	89	10	of	of	IN
10_1101-2021_01_08_425864	89	11	CS	CS	NNP
10_1101-2021_01_08_425864	89	12	(	(	-LRB-
10_1101-2021_01_08_425864	89	13	Sigma	Sigma	NNP
10_1101-2021_01_08_425864	89	14	Aldrich	Aldrich	NNP
10_1101-2021_01_08_425864	89	15	©	©	NNP
10_1101-2021_01_08_425864	89	16	)	)	-RRB-
10_1101-2021_01_08_425864	89	17	.	.	.
10_1101-2021_01_08_425864	90	1	To	to	TO
10_1101-2021_01_08_425864	90	2	calculate	calculate	VB
10_1101-2021_01_08_425864	90	3	the	the	DT
10_1101-2021_01_08_425864	90	4	specific	specific	JJ
10_1101-2021_01_08_425864	90	5	activity	activity	NN
10_1101-2021_01_08_425864	90	6	of	of	IN
10_1101-2021_01_08_425864	90	7	ACC	ACC	NNP
10_1101-2021_01_08_425864	90	8	,	,	,
10_1101-2021_01_08_425864	90	9	we	-PRON-	PRP
10_1101-2021_01_08_425864	90	10	converted	convert	VBD
10_1101-2021_01_08_425864	90	11	180	180	CD
10_1101-2021_01_08_425864	90	12	the	the	DT
10_1101-2021_01_08_425864	90	13	absorbance	absorbance	NN
10_1101-2021_01_08_425864	90	14	values	value	NNS
10_1101-2021_01_08_425864	90	15	to	to	IN
10_1101-2021_01_08_425864	90	16	molarity	molarity	NN
10_1101-2021_01_08_425864	90	17	by	by	IN
10_1101-2021_01_08_425864	90	18	using	use	VBG
10_1101-2021_01_08_425864	90	19	the	the	DT
10_1101-2021_01_08_425864	90	20	TNB-	tnb-	JJ
10_1101-2021_01_08_425864	90	21	extinction	extinction	NN
10_1101-2021_01_08_425864	90	22	molar	molar	JJ
10_1101-2021_01_08_425864	90	23	coefficient	coefficient	NN
10_1101-2021_01_08_425864	90	24	of	of	IN
10_1101-2021_01_08_425864	90	25	12,000	12,000	CD
10_1101-2021_01_08_425864	90	26	M-1.s-1	M-1.s-1	NNS
10_1101-2021_01_08_425864	90	27	.	.	.
10_1101-2021_01_08_425864	91	1	181	181	CD
10_1101-2021_01_08_425864	91	2	For	for	IN
10_1101-2021_01_08_425864	91	3	the	the	DT
10_1101-2021_01_08_425864	91	4	blank	blank	JJ
10_1101-2021_01_08_425864	91	5	reaction	reaction	NN
10_1101-2021_01_08_425864	91	6	,	,	,
10_1101-2021_01_08_425864	91	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	91	8	performed	perform	VBD
10_1101-2021_01_08_425864	91	9	the	the	DT
10_1101-2021_01_08_425864	91	10	same	same	JJ
10_1101-2021_01_08_425864	91	11	assay	assay	NN
10_1101-2021_01_08_425864	91	12	without	without	IN
10_1101-2021_01_08_425864	91	13	acetyl	acetyl	NN
10_1101-2021_01_08_425864	91	14	-	-	HYPH
10_1101-2021_01_08_425864	91	15	CoA	CoA	NNP
10_1101-2021_01_08_425864	91	16	[	[	-LRB-
10_1101-2021_01_08_425864	91	17	24	24	CD
10_1101-2021_01_08_425864	91	18	]	]	-RRB-
10_1101-2021_01_08_425864	91	19	.	.	.
10_1101-2021_01_08_425864	92	1	182	182	CD
10_1101-2021_01_08_425864	92	2	183	183	CD
10_1101-2021_01_08_425864	92	3	Hexokinase	hexokinase	NN
10_1101-2021_01_08_425864	92	4	(	(	-LRB-
10_1101-2021_01_08_425864	92	5	HK	HK	NNP
10_1101-2021_01_08_425864	92	6	)	)	-RRB-
10_1101-2021_01_08_425864	92	7	.	.	.
10_1101-2021_01_08_425864	93	1	The	the	DT
10_1101-2021_01_08_425864	93	2	HK	HK	NNP
10_1101-2021_01_08_425864	93	3	activity	activity	NN
10_1101-2021_01_08_425864	93	4	was	be	VBD
10_1101-2021_01_08_425864	93	5	measured	measure	VBN
10_1101-2021_01_08_425864	93	6	as	as	IN
10_1101-2021_01_08_425864	93	7	described	describe	VBN
10_1101-2021_01_08_425864	93	8	in	in	IN
10_1101-2021_01_08_425864	93	9	[	[	-LRB-
10_1101-2021_01_08_425864	93	10	25	25	CD
10_1101-2021_01_08_425864	93	11	]	]	-RRB-
10_1101-2021_01_08_425864	93	12	.	.	.
10_1101-2021_01_08_425864	94	1	Briefly	briefly	RB
10_1101-2021_01_08_425864	94	2	,	,	,
10_1101-2021_01_08_425864	94	3	the	the	DT
10_1101-2021_01_08_425864	94	4	activity	activity	NN
10_1101-2021_01_08_425864	94	5	was	be	VBD
10_1101-2021_01_08_425864	94	6	184	184	CD
10_1101-2021_01_08_425864	94	7	measured	measure	VBN
10_1101-2021_01_08_425864	94	8	by	by	IN
10_1101-2021_01_08_425864	94	9	coupling	couple	VBG
10_1101-2021_01_08_425864	94	10	the	the	DT
10_1101-2021_01_08_425864	94	11	hexokinase	hexokinase	NN
10_1101-2021_01_08_425864	94	12	activity	activity	NN
10_1101-2021_01_08_425864	94	13	with	with	IN
10_1101-2021_01_08_425864	94	14	a	a	DT
10_1101-2021_01_08_425864	94	15	commercial	commercial	JJ
10_1101-2021_01_08_425864	94	16	glucose-6-phosphate	glucose-6-phosphate	NNP
10_1101-2021_01_08_425864	94	17	185	185	CD
10_1101-2021_01_08_425864	94	18	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	94	19	,	,	,
10_1101-2021_01_08_425864	94	20	which	which	WDT
10_1101-2021_01_08_425864	94	21	oxidizes	oxidize	VBZ
10_1101-2021_01_08_425864	94	22	the	the	DT
10_1101-2021_01_08_425864	94	23	glucose-6-phosphate	glucose-6-phosphate	NNP
10_1101-2021_01_08_425864	94	24	(	(	-LRB-
10_1101-2021_01_08_425864	94	25	G6PD	G6PD	NNP
10_1101-2021_01_08_425864	94	26	,	,	,
10_1101-2021_01_08_425864	94	27	SIGMA	SIGMA	NNP
10_1101-2021_01_08_425864	94	28	)	)	-RRB-
10_1101-2021_01_08_425864	94	29	resulting	result	VBG
10_1101-2021_01_08_425864	94	30	from	from	IN
10_1101-2021_01_08_425864	94	31	the	the	DT
10_1101-2021_01_08_425864	94	32	HK	HK	NNP
10_1101-2021_01_08_425864	94	33	186	186	CD
10_1101-2021_01_08_425864	94	34	activity	activity	NN
10_1101-2021_01_08_425864	94	35	with	with	IN
10_1101-2021_01_08_425864	94	36	the	the	DT
10_1101-2021_01_08_425864	94	37	concomitant	concomitant	JJ
10_1101-2021_01_08_425864	94	38	reduction	reduction	NN
10_1101-2021_01_08_425864	94	39	of	of	IN
10_1101-2021_01_08_425864	94	40	NADP+	NADP+	NNP
10_1101-2021_01_08_425864	94	41	to	to	IN
10_1101-2021_01_08_425864	94	42	NADPH	NADPH	NNP
10_1101-2021_01_08_425864	94	43	.	.	.
10_1101-2021_01_08_425864	95	1	The	the	DT
10_1101-2021_01_08_425864	95	2	resulting	result	VBG
10_1101-2021_01_08_425864	95	3	NADPH	NADPH	NNP
10_1101-2021_01_08_425864	95	4	was	be	VBD
10_1101-2021_01_08_425864	95	5	187	187	CD
10_1101-2021_01_08_425864	95	6	spectrophotometrically	spectrophotometrically	RB
10_1101-2021_01_08_425864	95	7	monitored	monitor	VBN
10_1101-2021_01_08_425864	95	8	at	at	IN
10_1101-2021_01_08_425864	95	9	340	340	CD
10_1101-2021_01_08_425864	95	10	nm	nm	NN
10_1101-2021_01_08_425864	95	11	.	.	.
10_1101-2021_01_08_425864	96	1	The	the	DT
10_1101-2021_01_08_425864	96	2	reaction	reaction	NN
10_1101-2021_01_08_425864	96	3	mixture	mixture	NN
10_1101-2021_01_08_425864	96	4	contained	contain	VBD
10_1101-2021_01_08_425864	96	5	50	50	CD
10_1101-2021_01_08_425864	96	6	mM	mM	NNP
10_1101-2021_01_08_425864	96	7	Triethanolamine	Triethanolamine	NNP
10_1101-2021_01_08_425864	96	8	188	188	CD
10_1101-2021_01_08_425864	96	9	buffer	buffer	NN
10_1101-2021_01_08_425864	96	10	pH	pH	NNP
10_1101-2021_01_08_425864	96	11	7.5	7.5	CD
10_1101-2021_01_08_425864	96	12	,	,	,
10_1101-2021_01_08_425864	96	13	5	5	CD
10_1101-2021_01_08_425864	96	14	mM	mM	NNP
10_1101-2021_01_08_425864	96	15	MgCl2	mgcl2	NN
10_1101-2021_01_08_425864	96	16	,	,	,
10_1101-2021_01_08_425864	96	17	100	100	CD
10_1101-2021_01_08_425864	96	18	mM	mM	NNP
10_1101-2021_01_08_425864	96	19	KCl	KCl	NNS
10_1101-2021_01_08_425864	96	20	,	,	,
10_1101-2021_01_08_425864	96	21	10	10	CD
10_1101-2021_01_08_425864	96	22	mM	mm	NN
10_1101-2021_01_08_425864	96	23	glucose	glucose	NN
10_1101-2021_01_08_425864	96	24	,	,	,
10_1101-2021_01_08_425864	96	25	5	5	CD
10_1101-2021_01_08_425864	96	26	mM	mm	NN
10_1101-2021_01_08_425864	96	27	ATP	atp	NN
10_1101-2021_01_08_425864	96	28	and	and	CC
10_1101-2021_01_08_425864	96	29	5	5	CD
10_1101-2021_01_08_425864	96	30	U	u	NN
10_1101-2021_01_08_425864	96	31	of	of	IN
10_1101-2021_01_08_425864	96	32	commercial	commercial	JJ
10_1101-2021_01_08_425864	96	33	189	189	CD
10_1101-2021_01_08_425864	96	34	G6PD	G6PD	NNP
10_1101-2021_01_08_425864	96	35	.	.	.
10_1101-2021_01_08_425864	97	1	To	to	TO
10_1101-2021_01_08_425864	97	2	calculate	calculate	VB
10_1101-2021_01_08_425864	97	3	the	the	DT
10_1101-2021_01_08_425864	97	4	specific	specific	JJ
10_1101-2021_01_08_425864	97	5	activity	activity	NN
10_1101-2021_01_08_425864	97	6	,	,	,
10_1101-2021_01_08_425864	97	7	the	the	DT
10_1101-2021_01_08_425864	97	8	absorbance	absorbance	NN
10_1101-2021_01_08_425864	97	9	values	value	NNS
10_1101-2021_01_08_425864	97	10	were	be	VBD
10_1101-2021_01_08_425864	97	11	converted	convert	VBN
10_1101-2021_01_08_425864	97	12	to	to	IN
10_1101-2021_01_08_425864	97	13	molarity	molarity	NN
10_1101-2021_01_08_425864	97	14	using	use	VBG
10_1101-2021_01_08_425864	97	15	the	the	DT
10_1101-2021_01_08_425864	97	16	190	190	CD
10_1101-2021_01_08_425864	97	17	NADP(H	NADP(H	NNP
10_1101-2021_01_08_425864	97	18	)	)	-RRB-
10_1101-2021_01_08_425864	97	19	extinction	extinction	NN
10_1101-2021_01_08_425864	97	20	molar	molar	JJ
10_1101-2021_01_08_425864	97	21	coefficient	coefficient	NN
10_1101-2021_01_08_425864	97	22	of	of	IN
10_1101-2021_01_08_425864	97	23	6,220	6,220	CD
10_1101-2021_01_08_425864	97	24	M-1.s-1	M-1.s-1	NNS
10_1101-2021_01_08_425864	97	25	.	.	.
10_1101-2021_01_08_425864	98	1	191	191	CD
10_1101-2021_01_08_425864	98	2	Serine	Serine	NNP
10_1101-2021_01_08_425864	98	3	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	98	4	(	(	-LRB-
10_1101-2021_01_08_425864	98	5	SPT	SPT	NNP
10_1101-2021_01_08_425864	98	6	)	)	-RRB-
10_1101-2021_01_08_425864	98	7	.	.	.
10_1101-2021_01_08_425864	99	1	The	the	DT
10_1101-2021_01_08_425864	99	2	SPT	SPT	NNP
10_1101-2021_01_08_425864	99	3	activity	activity	NN
10_1101-2021_01_08_425864	99	4	was	be	VBD
10_1101-2021_01_08_425864	99	5	measured	measure	VBN
10_1101-2021_01_08_425864	99	6	through	through	IN
10_1101-2021_01_08_425864	99	7	the	the	DT
10_1101-2021_01_08_425864	99	8	reduction	reduction	NN
10_1101-2021_01_08_425864	99	9	of	of	IN
10_1101-2021_01_08_425864	99	10	the	the	DT
10_1101-2021_01_08_425864	99	11	192	192	CD
10_1101-2021_01_08_425864	99	12	DTNB	dtnb	NN
10_1101-2021_01_08_425864	99	13	reaction	reaction	NN
10_1101-2021_01_08_425864	99	14	by	by	IN
10_1101-2021_01_08_425864	99	15	the	the	DT
10_1101-2021_01_08_425864	99	16	free	free	JJ
10_1101-2021_01_08_425864	99	17	HS	HS	NNP
10_1101-2021_01_08_425864	99	18	-	-	HYPH
10_1101-2021_01_08_425864	99	19	CoA	CoA	NNP
10_1101-2021_01_08_425864	99	20	,	,	,
10_1101-2021_01_08_425864	99	21	forming	form	VBG
10_1101-2021_01_08_425864	99	22	the	the	DT
10_1101-2021_01_08_425864	99	23	TNB-	tnb-	JJ
10_1101-2021_01_08_425864	99	24	ion	ion	NN
10_1101-2021_01_08_425864	99	25	,	,	,
10_1101-2021_01_08_425864	99	26	which	which	WDT
10_1101-2021_01_08_425864	99	27	was	be	VBD
10_1101-2021_01_08_425864	99	28	measured	measure	VBN
10_1101-2021_01_08_425864	99	29	193	193	CD
10_1101-2021_01_08_425864	99	30	spectrophotometrically	spectrophotometrically	RB
10_1101-2021_01_08_425864	99	31	at	at	IN
10_1101-2021_01_08_425864	99	32	412	412	CD
10_1101-2021_01_08_425864	99	33	nm	nm	IN
10_1101-2021_01_08_425864	99	34	as	as	RB
10_1101-2021_01_08_425864	99	35	previously	previously	RB
10_1101-2021_01_08_425864	99	36	described	describe	VBN
10_1101-2021_01_08_425864	99	37	[	[	-LRB-
10_1101-2021_01_08_425864	99	38	23	23	CD
10_1101-2021_01_08_425864	99	39	]	]	-RRB-
10_1101-2021_01_08_425864	99	40	.	.	.
10_1101-2021_01_08_425864	100	1	In	in	IN
10_1101-2021_01_08_425864	100	2	brief	brief	NN
10_1101-2021_01_08_425864	100	3	,	,	,
10_1101-2021_01_08_425864	100	4	the	the	DT
10_1101-2021_01_08_425864	100	5	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	100	6	were	be	VBD
10_1101-2021_01_08_425864	100	7	194	194	CD
10_1101-2021_01_08_425864	100	8	washed	wash	VBN
10_1101-2021_01_08_425864	100	9	twice	twice	RB
10_1101-2021_01_08_425864	100	10	in	in	IN
10_1101-2021_01_08_425864	100	11	PBS	PBS	NNP
10_1101-2021_01_08_425864	100	12	,	,	,
10_1101-2021_01_08_425864	100	13	resuspended	resuspend	VBD
10_1101-2021_01_08_425864	100	14	in	in	IN
10_1101-2021_01_08_425864	100	15	Tris	Tris	NNP
10_1101-2021_01_08_425864	100	16	-	-	HYPH
10_1101-2021_01_08_425864	100	17	EDTA	EDTA	NNP
10_1101-2021_01_08_425864	100	18	buffer	buffer	NN
10_1101-2021_01_08_425864	100	19	(	(	-LRB-
10_1101-2021_01_08_425864	100	20	100	100	CD
10_1101-2021_01_08_425864	100	21	mM/2.5	mM/2.5	NNP
10_1101-2021_01_08_425864	100	22	mM	mM	NNP
10_1101-2021_01_08_425864	100	23	)	)	-RRB-
10_1101-2021_01_08_425864	100	24	containing	contain	VBG
10_1101-2021_01_08_425864	100	25	Triton	Triton	NNP
10_1101-2021_01_08_425864	100	26	X-100	X-100	NNP
10_1101-2021_01_08_425864	100	27	195	195	CD
10_1101-2021_01_08_425864	100	28	0.1	0.1	CD
10_1101-2021_01_08_425864	100	29	%	%	NN
10_1101-2021_01_08_425864	100	30	and	and	CC
10_1101-2021_01_08_425864	100	31	lysed	lyse	VBN
10_1101-2021_01_08_425864	100	32	by	by	IN
10_1101-2021_01_08_425864	100	33	sonication	sonication	NN
10_1101-2021_01_08_425864	100	34	(	(	-LRB-
10_1101-2021_01_08_425864	100	35	20	20	CD
10_1101-2021_01_08_425864	100	36	%	%	NN
10_1101-2021_01_08_425864	100	37	of	of	IN
10_1101-2021_01_08_425864	100	38	potency	potency	NN
10_1101-2021_01_08_425864	100	39	,	,	,
10_1101-2021_01_08_425864	100	40	during	during	IN
10_1101-2021_01_08_425864	100	41	2	2	CD
10_1101-2021_01_08_425864	100	42	min	min	NNP
10_1101-2021_01_08_425864	100	43	)	)	-RRB-
10_1101-2021_01_08_425864	100	44	.	.	.
10_1101-2021_01_08_425864	101	1	The	the	DT
10_1101-2021_01_08_425864	101	2	reaction	reaction	NN
10_1101-2021_01_08_425864	101	3	mixture	mixture	NN
10_1101-2021_01_08_425864	101	4	contained	contain	VBD
10_1101-2021_01_08_425864	101	5	0.1	0.1	CD
10_1101-2021_01_08_425864	101	6	196	196	CD
10_1101-2021_01_08_425864	101	7	mg	mg	CD
10_1101-2021_01_08_425864	101	8	of	of	IN
10_1101-2021_01_08_425864	101	9	protein	protein	NN
10_1101-2021_01_08_425864	101	10	free	free	JJ
10_1101-2021_01_08_425864	101	11	-	-	HYPH
10_1101-2021_01_08_425864	101	12	cell	cell	NN
10_1101-2021_01_08_425864	101	13	extract	extract	NN
10_1101-2021_01_08_425864	101	14	,	,	,
10_1101-2021_01_08_425864	101	15	0.5	0.5	CD
10_1101-2021_01_08_425864	101	16	mM	mM	NNP
10_1101-2021_01_08_425864	101	17	L	L	NNP
10_1101-2021_01_08_425864	101	18	-	-	HYPH
10_1101-2021_01_08_425864	101	19	serine	serine	NNP
10_1101-2021_01_08_425864	101	20	,	,	,
10_1101-2021_01_08_425864	101	21	0.1	0.1	CD
10_1101-2021_01_08_425864	101	22	mM	mm	NN
10_1101-2021_01_08_425864	101	23	palmitoyl	palmitoyl	NN
10_1101-2021_01_08_425864	101	24	-	-	HYPH
10_1101-2021_01_08_425864	101	25	CoA	CoA	NNP
10_1101-2021_01_08_425864	101	26	and	and	CC
10_1101-2021_01_08_425864	101	27	2.5	2.5	CD
10_1101-2021_01_08_425864	101	28	mM	mM	NNP
10_1101-2021_01_08_425864	101	29	DTNB	dtnb	NN
10_1101-2021_01_08_425864	101	30	in	in	IN
10_1101-2021_01_08_425864	101	31	Tris-	Tris-	NNP
10_1101-2021_01_08_425864	101	32	197	197	CD
10_1101-2021_01_08_425864	101	33	EDTA	edta	NN
10_1101-2021_01_08_425864	101	34	buffer	buffer	NN
10_1101-2021_01_08_425864	101	35	(	(	-LRB-
10_1101-2021_01_08_425864	101	36	100	100	CD
10_1101-2021_01_08_425864	101	37	mM/2.5	mM/2.5	NNP
10_1101-2021_01_08_425864	101	38	mM	mM	NNP
10_1101-2021_01_08_425864	101	39	)	)	-RRB-
10_1101-2021_01_08_425864	101	40	pH	ph	NN
10_1101-2021_01_08_425864	101	41	=	=	NFP
10_1101-2021_01_08_425864	101	42	8.0	8.0	CD
10_1101-2021_01_08_425864	101	43	[	[	-LRB-
10_1101-2021_01_08_425864	101	44	26	26	CD
10_1101-2021_01_08_425864	101	45	]	]	-RRB-
10_1101-2021_01_08_425864	101	46	.	.	.
10_1101-2021_01_08_425864	102	1	To	to	TO
10_1101-2021_01_08_425864	102	2	calculate	calculate	VB
10_1101-2021_01_08_425864	102	3	the	the	DT
10_1101-2021_01_08_425864	102	4	specific	specific	JJ
10_1101-2021_01_08_425864	102	5	activity	activity	NN
10_1101-2021_01_08_425864	102	6	,	,	,
10_1101-2021_01_08_425864	102	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	102	8	converted	convert	VBD
10_1101-2021_01_08_425864	102	9	the	the	DT
10_1101-2021_01_08_425864	102	10	198	198	CD
10_1101-2021_01_08_425864	102	11	absorbance	absorbance	NN
10_1101-2021_01_08_425864	102	12	values	value	NNS
10_1101-2021_01_08_425864	102	13	to	to	IN
10_1101-2021_01_08_425864	102	14	molarity	molarity	NN
10_1101-2021_01_08_425864	102	15	using	use	VBG
10_1101-2021_01_08_425864	102	16	the	the	DT
10_1101-2021_01_08_425864	102	17	TNB-	tnb-	JJ
10_1101-2021_01_08_425864	102	18	extinction	extinction	NN
10_1101-2021_01_08_425864	102	19	molar	molar	JJ
10_1101-2021_01_08_425864	102	20	coefficient	coefficient	NN
10_1101-2021_01_08_425864	102	21	of	of	IN
10_1101-2021_01_08_425864	102	22	12,000	12,000	CD
10_1101-2021_01_08_425864	102	23	M-1.s-1	M-1.s-1	NNS
10_1101-2021_01_08_425864	102	24	.	.	.
10_1101-2021_01_08_425864	103	1	For	for	IN
10_1101-2021_01_08_425864	103	2	the	the	DT
10_1101-2021_01_08_425864	103	3	199	199	CD
10_1101-2021_01_08_425864	103	4	blank	blank	JJ
10_1101-2021_01_08_425864	103	5	reaction	reaction	NN
10_1101-2021_01_08_425864	103	6	,	,	,
10_1101-2021_01_08_425864	103	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	103	8	performed	perform	VBD
10_1101-2021_01_08_425864	103	9	the	the	DT
10_1101-2021_01_08_425864	103	10	same	same	JJ
10_1101-2021_01_08_425864	103	11	assay	assay	NN
10_1101-2021_01_08_425864	103	12	without	without	IN
10_1101-2021_01_08_425864	103	13	adding	add	VBG
10_1101-2021_01_08_425864	103	14	palmitoyl	palmitoyl	NN
10_1101-2021_01_08_425864	103	15	-	-	:
10_1101-2021_01_08_425864	103	16	CoA.	coa.	NN
10_1101-2021_01_08_425864	104	1	All	all	PDT
10_1101-2021_01_08_425864	104	2	the	the	DT
10_1101-2021_01_08_425864	104	3	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	104	4	assays	assays	RB
10_1101-2021_01_08_425864	104	5	200	200	CD
10_1101-2021_01_08_425864	104	6	were	be	VBD
10_1101-2021_01_08_425864	104	7	performed	perform	VBN
10_1101-2021_01_08_425864	104	8	in	in	IN
10_1101-2021_01_08_425864	104	9	96-well	96-well	CD
10_1101-2021_01_08_425864	104	10	plates	plate	NNS
10_1101-2021_01_08_425864	104	11	in	in	IN
10_1101-2021_01_08_425864	104	12	a	a	DT
10_1101-2021_01_08_425864	104	13	final	final	JJ
10_1101-2021_01_08_425864	104	14	volume	volume	NN
10_1101-2021_01_08_425864	104	15	of	of	IN
10_1101-2021_01_08_425864	104	16	0.2	0.2	CD
10_1101-2021_01_08_425864	104	17	mL	ml	NN
10_1101-2021_01_08_425864	104	18	in	in	IN
10_1101-2021_01_08_425864	104	19	the	the	DT
10_1101-2021_01_08_425864	104	20	SpectraMax	SpectraMax	NNP
10_1101-2021_01_08_425864	104	21	®	®	NNPS
10_1101-2021_01_08_425864	104	22	i3	i3	NNP
10_1101-2021_01_08_425864	104	23	(	(	-LRB-
10_1101-2021_01_08_425864	104	24	Molecular	Molecular	NNP
10_1101-2021_01_08_425864	104	25	201	201	CD
10_1101-2021_01_08_425864	104	26	Devices	Devices	NNPS
10_1101-2021_01_08_425864	104	27	)	)	-RRB-
10_1101-2021_01_08_425864	104	28	.	.	.
10_1101-2021_01_08_425864	105	1	.CC	.CC	NFP
10_1101-2021_01_08_425864	105	2	-	-	:
10_1101-2021_01_08_425864	105	3	BY	by	IN
10_1101-2021_01_08_425864	105	4	4.0	4.0	CD
10_1101-2021_01_08_425864	105	5	International	international	JJ
10_1101-2021_01_08_425864	105	6	licensemade	licensemade	NN
10_1101-2021_01_08_425864	105	7	available	available	JJ
10_1101-2021_01_08_425864	105	8	under	under	IN
10_1101-2021_01_08_425864	105	9	a	a	DT
10_1101-2021_01_08_425864	105	10	(	(	-LRB-
10_1101-2021_01_08_425864	105	11	which	which	WDT
10_1101-2021_01_08_425864	105	12	was	be	VBD
10_1101-2021_01_08_425864	105	13	not	not	RB
10_1101-2021_01_08_425864	105	14	certified	certify	VBN
10_1101-2021_01_08_425864	105	15	by	by	IN
10_1101-2021_01_08_425864	105	16	peer	peer	NN
10_1101-2021_01_08_425864	105	17	review	review	NN
10_1101-2021_01_08_425864	105	18	)	)	-RRB-
10_1101-2021_01_08_425864	105	19	is	be	VBZ
10_1101-2021_01_08_425864	105	20	the	the	DT
10_1101-2021_01_08_425864	105	21	author	author	NN
10_1101-2021_01_08_425864	105	22	/	/	SYM
10_1101-2021_01_08_425864	105	23	funder	funder	NN
10_1101-2021_01_08_425864	105	24	,	,	,
10_1101-2021_01_08_425864	105	25	who	who	WP
10_1101-2021_01_08_425864	105	26	has	have	VBZ
10_1101-2021_01_08_425864	105	27	granted	grant	VBN
10_1101-2021_01_08_425864	105	28	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	105	29	a	a	DT
10_1101-2021_01_08_425864	105	30	license	license	NN
10_1101-2021_01_08_425864	105	31	to	to	TO
10_1101-2021_01_08_425864	105	32	display	display	VB
10_1101-2021_01_08_425864	105	33	the	the	DT
10_1101-2021_01_08_425864	105	34	preprint	preprint	NN
10_1101-2021_01_08_425864	105	35	in	in	IN
10_1101-2021_01_08_425864	105	36	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	105	37	.	.	.
10_1101-2021_01_08_425864	106	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	106	2	is	be	VBZ
10_1101-2021_01_08_425864	106	3	The	the	DT
10_1101-2021_01_08_425864	106	4	copyright	copyright	NN
10_1101-2021_01_08_425864	106	5	holder	holder	NN
10_1101-2021_01_08_425864	106	6	for	for	IN
10_1101-2021_01_08_425864	106	7	this	this	DT
10_1101-2021_01_08_425864	106	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	106	9	version	version	NN
10_1101-2021_01_08_425864	106	10	posted	post	VBD
10_1101-2021_01_08_425864	106	11	January	January	NNP
10_1101-2021_01_08_425864	106	12	8	8	CD
10_1101-2021_01_08_425864	106	13	,	,	,
10_1101-2021_01_08_425864	106	14	2021	2021	CD
10_1101-2021_01_08_425864	106	15	.	.	.
10_1101-2021_01_08_425864	106	16	;	;	:
10_1101-2021_01_08_425864	106	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	106	18	:	:	:
10_1101-2021_01_08_425864	106	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	106	20	preprint	preprint	NN
10_1101-2021_01_08_425864	106	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	106	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	106	23	202	202	CD
10_1101-2021_01_08_425864	106	24	203	203	CD
10_1101-2021_01_08_425864	106	25	Glucose	Glucose	NNP
10_1101-2021_01_08_425864	106	26	and	and	CC
10_1101-2021_01_08_425864	106	27	triglyceride	triglyceride	NN
10_1101-2021_01_08_425864	106	28	quantification	quantification	NN
10_1101-2021_01_08_425864	106	29	204	204	CD
10_1101-2021_01_08_425864	106	30	Spent	spend	VBN
10_1101-2021_01_08_425864	106	31	LIT	LIT	NNP
10_1101-2021_01_08_425864	106	32	medium	medium	NN
10_1101-2021_01_08_425864	106	33	from	from	IN
10_1101-2021_01_08_425864	106	34	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	106	35	cultures	culture	NNS
10_1101-2021_01_08_425864	106	36	was	be	VBD
10_1101-2021_01_08_425864	106	37	collected	collect	VBN
10_1101-2021_01_08_425864	106	38	by	by	IN
10_1101-2021_01_08_425864	106	39	recovering	recover	VBG
10_1101-2021_01_08_425864	106	40	the	the	DT
10_1101-2021_01_08_425864	106	41	supernatants	supernatant	NNS
10_1101-2021_01_08_425864	106	42	205	205	CD
10_1101-2021_01_08_425864	106	43	from	from	IN
10_1101-2021_01_08_425864	106	44	a	a	DT
10_1101-2021_01_08_425864	106	45	centrifugation	centrifugation	NN
10_1101-2021_01_08_425864	106	46	(	(	-LRB-
10_1101-2021_01_08_425864	106	47	10,000	10,000	CD
10_1101-2021_01_08_425864	106	48	x	x	SYM
10_1101-2021_01_08_425864	106	49	g	g	NN
10_1101-2021_01_08_425864	106	50	for	for	IN
10_1101-2021_01_08_425864	106	51	15	15	CD
10_1101-2021_01_08_425864	106	52	min	min	NN
10_1101-2021_01_08_425864	106	53	at	at	IN
10_1101-2021_01_08_425864	106	54	4	4	CD
10_1101-2021_01_08_425864	106	55	°	°	,
10_1101-2021_01_08_425864	106	56	C	C	NNP
10_1101-2021_01_08_425864	106	57	)	)	-RRB-
10_1101-2021_01_08_425864	106	58	.	.	.
10_1101-2021_01_08_425864	107	1	Each	each	DT
10_1101-2021_01_08_425864	107	2	sample	sample	NN
10_1101-2021_01_08_425864	107	3	of	of	IN
10_1101-2021_01_08_425864	107	4	spent	spend	VBN
10_1101-2021_01_08_425864	107	5	LIT	LIT	NNP
10_1101-2021_01_08_425864	107	6	was	be	VBD
10_1101-2021_01_08_425864	107	7	analysed	analyse	VBN
10_1101-2021_01_08_425864	107	8	for	for	IN
10_1101-2021_01_08_425864	107	9	its	-PRON-	PRP$
10_1101-2021_01_08_425864	107	10	206	206	CD
10_1101-2021_01_08_425864	107	11	glucose	glucose	NN
10_1101-2021_01_08_425864	107	12	and	and	CC
10_1101-2021_01_08_425864	107	13	triglyceride	triglyceride	NN
10_1101-2021_01_08_425864	107	14	contents	content	NNS
10_1101-2021_01_08_425864	107	15	using	use	VBG
10_1101-2021_01_08_425864	107	16	commercial	commercial	JJ
10_1101-2021_01_08_425864	107	17	kits	kit	NNS
10_1101-2021_01_08_425864	107	18	(	(	-LRB-
10_1101-2021_01_08_425864	107	19	triglyceride	triglyceride	NNP
10_1101-2021_01_08_425864	107	20	monoreagent	monoreagent	NNP
10_1101-2021_01_08_425864	107	21	and	and	CC
10_1101-2021_01_08_425864	107	22	glucose	glucose	VB
10_1101-2021_01_08_425864	107	23	207	207	CD
10_1101-2021_01_08_425864	107	24	monoreagent	monoreagent	NN
10_1101-2021_01_08_425864	107	25	by	by	IN
10_1101-2021_01_08_425864	107	26	Bioclin	Bioclin	NNP
10_1101-2021_01_08_425864	107	27	Brazil	Brazil	NNP
10_1101-2021_01_08_425864	107	28	)	)	-RRB-
10_1101-2021_01_08_425864	107	29	according	accord	VBG
10_1101-2021_01_08_425864	107	30	to	to	IN
10_1101-2021_01_08_425864	107	31	the	the	DT
10_1101-2021_01_08_425864	107	32	manufacturer	manufacturer	NN
10_1101-2021_01_08_425864	107	33	’s	’s	POS
10_1101-2021_01_08_425864	107	34	instructions	instruction	NNS
10_1101-2021_01_08_425864	107	35	.	.	.
10_1101-2021_01_08_425864	108	1	These	these	DT
10_1101-2021_01_08_425864	108	2	kits	kit	NNS
10_1101-2021_01_08_425864	108	3	are	be	VBP
10_1101-2021_01_08_425864	108	4	based	base	VBN
10_1101-2021_01_08_425864	108	5	on	on	IN
10_1101-2021_01_08_425864	108	6	208	208	CD
10_1101-2021_01_08_425864	108	7	colorimetric	colorimetric	JJ
10_1101-2021_01_08_425864	108	8	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	108	9	reactions	reaction	NNS
10_1101-2021_01_08_425864	108	10	,	,	,
10_1101-2021_01_08_425864	108	11	and	and	CC
10_1101-2021_01_08_425864	108	12	the	the	DT
10_1101-2021_01_08_425864	108	13	absorbance	absorbance	NN
10_1101-2021_01_08_425864	108	14	of	of	IN
10_1101-2021_01_08_425864	108	15	each	each	DT
10_1101-2021_01_08_425864	108	16	assay	assay	NN
10_1101-2021_01_08_425864	108	17	was	be	VBD
10_1101-2021_01_08_425864	108	18	measured	measure	VBN
10_1101-2021_01_08_425864	108	19	in	in	IN
10_1101-2021_01_08_425864	108	20	96-well	96-well	CD
10_1101-2021_01_08_425864	108	21	plates	plate	NNS
10_1101-2021_01_08_425864	108	22	209	209	CD
10_1101-2021_01_08_425864	108	23	at	at	IN
10_1101-2021_01_08_425864	108	24	a	a	DT
10_1101-2021_01_08_425864	108	25	final	final	JJ
10_1101-2021_01_08_425864	108	26	volume	volume	NN
10_1101-2021_01_08_425864	108	27	of	of	IN
10_1101-2021_01_08_425864	108	28	0.2	0.2	CD
10_1101-2021_01_08_425864	108	29	mL	ml	NN
10_1101-2021_01_08_425864	108	30	in	in	IN
10_1101-2021_01_08_425864	108	31	the	the	DT
10_1101-2021_01_08_425864	108	32	SpectraMax	SpectraMax	NNP
10_1101-2021_01_08_425864	108	33	®	®	NNPS
10_1101-2021_01_08_425864	108	34	i3	i3	NNP
10_1101-2021_01_08_425864	108	35	(	(	-LRB-
10_1101-2021_01_08_425864	108	36	Molecular	Molecular	NNP
10_1101-2021_01_08_425864	108	37	Devices	Devices	NNPS
10_1101-2021_01_08_425864	108	38	)	)	-RRB-
10_1101-2021_01_08_425864	108	39	.	.	.
10_1101-2021_01_08_425864	109	1	210	210	CD
10_1101-2021_01_08_425864	109	2	211	211	CD
10_1101-2021_01_08_425864	109	3	Proliferation	Proliferation	NNP
10_1101-2021_01_08_425864	109	4	assays	assays	RB
10_1101-2021_01_08_425864	109	5	212	212	CD
10_1101-2021_01_08_425864	109	6	Exponentially	exponentially	RB
10_1101-2021_01_08_425864	109	7	growing	grow	VBG
10_1101-2021_01_08_425864	109	8	T.	t.	NN
10_1101-2021_01_08_425864	109	9	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	109	10	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	109	11	(	(	-LRB-
10_1101-2021_01_08_425864	109	12	5x107	5x107	CD
10_1101-2021_01_08_425864	109	13	mL-1	mL-1	NNP
10_1101-2021_01_08_425864	109	14	)	)	-RRB-
10_1101-2021_01_08_425864	109	15	were	be	VBD
10_1101-2021_01_08_425864	109	16	treated	treat	VBN
10_1101-2021_01_08_425864	109	17	with	with	IN
10_1101-2021_01_08_425864	109	18	different	different	JJ
10_1101-2021_01_08_425864	109	19	213	213	CD
10_1101-2021_01_08_425864	109	20	concentrations	concentration	NNS
10_1101-2021_01_08_425864	109	21	of	of	IN
10_1101-2021_01_08_425864	109	22	ETO	ETO	NNP
10_1101-2021_01_08_425864	109	23	or	or	CC
10_1101-2021_01_08_425864	109	24	not	not	RB
10_1101-2021_01_08_425864	109	25	treated	treat	VBN
10_1101-2021_01_08_425864	109	26	(	(	-LRB-
10_1101-2021_01_08_425864	109	27	negative	negative	JJ
10_1101-2021_01_08_425864	109	28	control	control	NN
10_1101-2021_01_08_425864	109	29	)	)	-RRB-
10_1101-2021_01_08_425864	109	30	in	in	IN
10_1101-2021_01_08_425864	109	31	LIT	LIT	NNP
10_1101-2021_01_08_425864	109	32	medium	medium	NN
10_1101-2021_01_08_425864	109	33	.	.	.
10_1101-2021_01_08_425864	110	1	As	as	IN
10_1101-2021_01_08_425864	110	2	a	a	DT
10_1101-2021_01_08_425864	110	3	positive	positive	JJ
10_1101-2021_01_08_425864	110	4	control	control	NN
10_1101-2021_01_08_425864	110	5	for	for	IN
10_1101-2021_01_08_425864	110	6	214	214	CD
10_1101-2021_01_08_425864	110	7	growth	growth	NN
10_1101-2021_01_08_425864	110	8	inhibition	inhibition	NN
10_1101-2021_01_08_425864	110	9	,	,	,
10_1101-2021_01_08_425864	110	10	we	-PRON-	PRP
10_1101-2021_01_08_425864	110	11	used	use	VBD
10_1101-2021_01_08_425864	110	12	a	a	DT
10_1101-2021_01_08_425864	110	13	combination	combination	NN
10_1101-2021_01_08_425864	110	14	of	of	IN
10_1101-2021_01_08_425864	110	15	rotenone	rotenone	NN
10_1101-2021_01_08_425864	110	16	(	(	-LRB-
10_1101-2021_01_08_425864	110	17	60	60	CD
10_1101-2021_01_08_425864	110	18	µM	µM	NNP
10_1101-2021_01_08_425864	110	19	)	)	-RRB-
10_1101-2021_01_08_425864	110	20	and	and	CC
10_1101-2021_01_08_425864	110	21	antimycin	antimycin	NNS
10_1101-2021_01_08_425864	110	22	(	(	-LRB-
10_1101-2021_01_08_425864	110	23	0.5	0.5	CD
10_1101-2021_01_08_425864	110	24	µM	µm	NN
10_1101-2021_01_08_425864	110	25	)	)	-RRB-
10_1101-2021_01_08_425864	110	26	[	[	-LRB-
10_1101-2021_01_08_425864	110	27	27	27	CD
10_1101-2021_01_08_425864	110	28	]	]	-RRB-
10_1101-2021_01_08_425864	110	29	.	.	.
10_1101-2021_01_08_425864	111	1	The	the	DT
10_1101-2021_01_08_425864	111	2	215	215	CD
10_1101-2021_01_08_425864	111	3	parasites	parasite	NNS
10_1101-2021_01_08_425864	111	4	(	(	-LRB-
10_1101-2021_01_08_425864	111	5	2.5x106	2.5x106	NNP
10_1101-2021_01_08_425864	111	6	mL-1	mL-1	NNP
10_1101-2021_01_08_425864	111	7	)	)	-RRB-
10_1101-2021_01_08_425864	111	8	were	be	VBD
10_1101-2021_01_08_425864	111	9	transferred	transfer	VBN
10_1101-2021_01_08_425864	111	10	to	to	IN
10_1101-2021_01_08_425864	111	11	96-well	96-well	CD
10_1101-2021_01_08_425864	111	12	plates	plate	NNS
10_1101-2021_01_08_425864	111	13	and	and	CC
10_1101-2021_01_08_425864	111	14	then	then	RB
10_1101-2021_01_08_425864	111	15	incubated	incubate	VBD
10_1101-2021_01_08_425864	111	16	at	at	IN
10_1101-2021_01_08_425864	111	17	28	28	CD
10_1101-2021_01_08_425864	111	18	°	°	,
10_1101-2021_01_08_425864	111	19	C	C	NNP
10_1101-2021_01_08_425864	111	20	.	.	.
10_1101-2021_01_08_425864	112	1	The	the	DT
10_1101-2021_01_08_425864	112	2	cell	cell	NN
10_1101-2021_01_08_425864	112	3	216	216	CD
10_1101-2021_01_08_425864	112	4	proliferation	proliferation	NN
10_1101-2021_01_08_425864	112	5	was	be	VBD
10_1101-2021_01_08_425864	112	6	quantified	quantify	VBN
10_1101-2021_01_08_425864	112	7	by	by	IN
10_1101-2021_01_08_425864	112	8	reading	read	VBG
10_1101-2021_01_08_425864	112	9	the	the	DT
10_1101-2021_01_08_425864	112	10	optical	optical	JJ
10_1101-2021_01_08_425864	112	11	density	density	NN
10_1101-2021_01_08_425864	112	12	(	(	-LRB-
10_1101-2021_01_08_425864	112	13	OD	OD	NNP
10_1101-2021_01_08_425864	112	14	)	)	-RRB-
10_1101-2021_01_08_425864	112	15	at	at	IN
10_1101-2021_01_08_425864	112	16	620	620	CD
10_1101-2021_01_08_425864	112	17	nm	nm	CD
10_1101-2021_01_08_425864	112	18	for	for	IN
10_1101-2021_01_08_425864	112	19	eight	eight	CD
10_1101-2021_01_08_425864	112	20	days	day	NNS
10_1101-2021_01_08_425864	112	21	.	.	.
10_1101-2021_01_08_425864	113	1	The	the	DT
10_1101-2021_01_08_425864	113	2	OD	OD	NNP
10_1101-2021_01_08_425864	113	3	217	217	CD
10_1101-2021_01_08_425864	113	4	values	value	NNS
10_1101-2021_01_08_425864	113	5	were	be	VBD
10_1101-2021_01_08_425864	113	6	converted	convert	VBN
10_1101-2021_01_08_425864	113	7	to	to	IN
10_1101-2021_01_08_425864	113	8	cell	cell	NN
10_1101-2021_01_08_425864	113	9	numbers	number	NNS
10_1101-2021_01_08_425864	113	10	using	use	VBG
10_1101-2021_01_08_425864	113	11	a	a	DT
10_1101-2021_01_08_425864	113	12	linear	linear	JJ
10_1101-2021_01_08_425864	113	13	regression	regression	NN
10_1101-2021_01_08_425864	113	14	equation	equation	NN
10_1101-2021_01_08_425864	113	15	previously	previously	RB
10_1101-2021_01_08_425864	113	16	obtained	obtain	VBN
10_1101-2021_01_08_425864	113	17	under	under	IN
10_1101-2021_01_08_425864	113	18	218	218	CD
10_1101-2021_01_08_425864	113	19	the	the	DT
10_1101-2021_01_08_425864	113	20	same	same	JJ
10_1101-2021_01_08_425864	113	21	conditions	condition	NNS
10_1101-2021_01_08_425864	113	22	.	.	.
10_1101-2021_01_08_425864	114	1	Each	each	DT
10_1101-2021_01_08_425864	114	2	experiment	experiment	NN
10_1101-2021_01_08_425864	114	3	was	be	VBD
10_1101-2021_01_08_425864	114	4	performed	perform	VBN
10_1101-2021_01_08_425864	114	5	in	in	IN
10_1101-2021_01_08_425864	114	6	quadruplicate	quadruplicate	NN
10_1101-2021_01_08_425864	114	7	[	[	-LRB-
10_1101-2021_01_08_425864	114	8	28	28	CD
10_1101-2021_01_08_425864	114	9	]	]	-RRB-
10_1101-2021_01_08_425864	114	10	.	.	.
10_1101-2021_01_08_425864	115	1	219	219	CD
10_1101-2021_01_08_425864	115	2	220	220	CD
10_1101-2021_01_08_425864	115	3	Flow	flow	NN
10_1101-2021_01_08_425864	115	4	cytometry	cytometry	NN
10_1101-2021_01_08_425864	115	5	analyses	analyse	VBZ
10_1101-2021_01_08_425864	115	6	221	221	CD
10_1101-2021_01_08_425864	115	7	Cell	Cell	NNP
10_1101-2021_01_08_425864	115	8	death	death	NN
10_1101-2021_01_08_425864	115	9	.	.	.
10_1101-2021_01_08_425864	116	1	Epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	116	2	in	in	IN
10_1101-2021_01_08_425864	116	3	the	the	DT
10_1101-2021_01_08_425864	116	4	exponential	exponential	JJ
10_1101-2021_01_08_425864	116	5	phase	phase	NN
10_1101-2021_01_08_425864	116	6	of	of	IN
10_1101-2021_01_08_425864	116	7	growth	growth	NN
10_1101-2021_01_08_425864	116	8	were	be	VBD
10_1101-2021_01_08_425864	116	9	maintained	maintain	VBN
10_1101-2021_01_08_425864	116	10	in	in	IN
10_1101-2021_01_08_425864	116	11	LIT	LIT	NNP
10_1101-2021_01_08_425864	116	12	and	and	CC
10_1101-2021_01_08_425864	116	13	treated	treat	VBD
10_1101-2021_01_08_425864	116	14	222	222	CD
10_1101-2021_01_08_425864	116	15	with	with	IN
10_1101-2021_01_08_425864	116	16	ETO	ETO	NNP
10_1101-2021_01_08_425864	116	17	500	500	CD
10_1101-2021_01_08_425864	116	18	µM	µM	NNP
10_1101-2021_01_08_425864	116	19	for	for	IN
10_1101-2021_01_08_425864	116	20	5	5	CD
10_1101-2021_01_08_425864	116	21	days	day	NNS
10_1101-2021_01_08_425864	116	22	.	.	.
10_1101-2021_01_08_425864	117	1	After	after	IN
10_1101-2021_01_08_425864	117	2	the	the	DT
10_1101-2021_01_08_425864	117	3	incubation	incubation	NN
10_1101-2021_01_08_425864	117	4	time	time	NN
10_1101-2021_01_08_425864	117	5	,	,	,
10_1101-2021_01_08_425864	117	6	the	the	DT
10_1101-2021_01_08_425864	117	7	parasites	parasite	NNS
10_1101-2021_01_08_425864	117	8	were	be	VBD
10_1101-2021_01_08_425864	117	9	analysed	analyse	VBN
10_1101-2021_01_08_425864	117	10	as	as	IN
10_1101-2021_01_08_425864	117	11	described	describe	VBN
10_1101-2021_01_08_425864	117	12	in	in	IN
10_1101-2021_01_08_425864	117	13	223	223	CD
10_1101-2021_01_08_425864	117	14	[	[	-LRB-
10_1101-2021_01_08_425864	117	15	28	28	CD
10_1101-2021_01_08_425864	117	16	]	]	-RRB-
10_1101-2021_01_08_425864	117	17	.	.	.
10_1101-2021_01_08_425864	118	1	The	the	DT
10_1101-2021_01_08_425864	118	2	cells	cell	NNS
10_1101-2021_01_08_425864	118	3	were	be	VBD
10_1101-2021_01_08_425864	118	4	analysed	analyse	VBN
10_1101-2021_01_08_425864	118	5	by	by	IN
10_1101-2021_01_08_425864	118	6	flow	flow	NN
10_1101-2021_01_08_425864	118	7	cytometry	cytometry	NN
10_1101-2021_01_08_425864	118	8	(	(	-LRB-
10_1101-2021_01_08_425864	118	9	FACScalibur	FACScalibur	NNP
10_1101-2021_01_08_425864	118	10	BD	BD	NNP
10_1101-2021_01_08_425864	118	11	Biosciences	Biosciences	NNP
10_1101-2021_01_08_425864	118	12	)	)	-RRB-
10_1101-2021_01_08_425864	118	13	.	.	.
10_1101-2021_01_08_425864	119	1	224	224	CD
10_1101-2021_01_08_425864	119	2	225	225	CD
10_1101-2021_01_08_425864	119	3	Cell	cell	NN
10_1101-2021_01_08_425864	119	4	cycle	cycle	NN
10_1101-2021_01_08_425864	119	5	(	(	-LRB-
10_1101-2021_01_08_425864	119	6	DNA	dna	NN
10_1101-2021_01_08_425864	119	7	content	content	NN
10_1101-2021_01_08_425864	119	8	)	)	-RRB-
10_1101-2021_01_08_425864	119	9	.	.	.
10_1101-2021_01_08_425864	120	1	Epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	120	2	in	in	IN
10_1101-2021_01_08_425864	120	3	the	the	DT
10_1101-2021_01_08_425864	120	4	exponential	exponential	JJ
10_1101-2021_01_08_425864	120	5	phase	phase	NN
10_1101-2021_01_08_425864	120	6	of	of	IN
10_1101-2021_01_08_425864	120	7	growth	growth	NN
10_1101-2021_01_08_425864	120	8	were	be	VBD
10_1101-2021_01_08_425864	120	9	maintained	maintain	VBN
10_1101-2021_01_08_425864	120	10	in	in	IN
10_1101-2021_01_08_425864	120	11	LIT	LIT	NNP
10_1101-2021_01_08_425864	120	12	226	226	CD
10_1101-2021_01_08_425864	120	13	and	and	CC
10_1101-2021_01_08_425864	120	14	treated	treat	VBN
10_1101-2021_01_08_425864	120	15	with	with	IN
10_1101-2021_01_08_425864	120	16	ETO	ETO	NNP
10_1101-2021_01_08_425864	120	17	500	500	CD
10_1101-2021_01_08_425864	120	18	µM	µM	NNP
10_1101-2021_01_08_425864	120	19	over	over	IN
10_1101-2021_01_08_425864	120	20	5	5	CD
10_1101-2021_01_08_425864	120	21	days	day	NNS
10_1101-2021_01_08_425864	120	22	.	.	.
10_1101-2021_01_08_425864	121	1	After	after	IN
10_1101-2021_01_08_425864	121	2	the	the	DT
10_1101-2021_01_08_425864	121	3	incubation	incubation	NN
10_1101-2021_01_08_425864	121	4	time	time	NN
10_1101-2021_01_08_425864	121	5	,	,	,
10_1101-2021_01_08_425864	121	6	the	the	DT
10_1101-2021_01_08_425864	121	7	parasites	parasite	NNS
10_1101-2021_01_08_425864	121	8	were	be	VBD
10_1101-2021_01_08_425864	121	9	washed	wash	VBN
10_1101-2021_01_08_425864	121	10	twice	twice	RB
10_1101-2021_01_08_425864	121	11	227	227	CD
10_1101-2021_01_08_425864	121	12	in	in	IN
10_1101-2021_01_08_425864	121	13	PBS	PBS	NNP
10_1101-2021_01_08_425864	121	14	and	and	CC
10_1101-2021_01_08_425864	121	15	resuspended	resuspend	VBD
10_1101-2021_01_08_425864	121	16	in	in	IN
10_1101-2021_01_08_425864	121	17	lysis	lysis	NN
10_1101-2021_01_08_425864	121	18	buffer	buffer	NNP
10_1101-2021_01_08_425864	121	19	(	(	-LRB-
10_1101-2021_01_08_425864	121	20	phosphate	phosphate	NN
10_1101-2021_01_08_425864	121	21	buffer	buffer	NNP
10_1101-2021_01_08_425864	121	22	Na2HPO4	Na2HPO4	NNP
10_1101-2021_01_08_425864	121	23	7.7	7.7	CD
10_1101-2021_01_08_425864	121	24	mM	mM	NNP
10_1101-2021_01_08_425864	121	25	;	;	:
10_1101-2021_01_08_425864	121	26	KH2PO4	KH2PO4	NNP
10_1101-2021_01_08_425864	121	27	2.3	2.3	CD
10_1101-2021_01_08_425864	121	28	mM	mM	NNP
10_1101-2021_01_08_425864	121	29	;	;	:
10_1101-2021_01_08_425864	121	30	pH	pH	NNP
10_1101-2021_01_08_425864	121	31	=	=	NFP
10_1101-2021_01_08_425864	121	32	228	228	CD
10_1101-2021_01_08_425864	121	33	7.4	7.4	CD
10_1101-2021_01_08_425864	121	34	)	)	-RRB-
10_1101-2021_01_08_425864	121	35	and	and	CC
10_1101-2021_01_08_425864	121	36	digitonin	digitonin	NN
10_1101-2021_01_08_425864	121	37	64	64	CD
10_1101-2021_01_08_425864	121	38	µM.	µM.	NNS
10_1101-2021_01_08_425864	122	1	After	after	IN
10_1101-2021_01_08_425864	122	2	incubating	incubate	VBG
10_1101-2021_01_08_425864	122	3	on	on	IN
10_1101-2021_01_08_425864	122	4	ice	ice	NN
10_1101-2021_01_08_425864	122	5	for	for	IN
10_1101-2021_01_08_425864	122	6	30	30	CD
10_1101-2021_01_08_425864	122	7	min	min	NN
10_1101-2021_01_08_425864	122	8	,	,	,
10_1101-2021_01_08_425864	122	9	propidium	propidium	NN
10_1101-2021_01_08_425864	122	10	iodide	iodide	NNP
10_1101-2021_01_08_425864	122	11	0.2	0.2	CD
10_1101-2021_01_08_425864	122	12	μg	μg	NN
10_1101-2021_01_08_425864	122	13	/	/	SYM
10_1101-2021_01_08_425864	122	14	mL	mL	NNP
10_1101-2021_01_08_425864	122	15	was	be	VBD
10_1101-2021_01_08_425864	122	16	added	add	VBN
10_1101-2021_01_08_425864	122	17	.	.	.
10_1101-2021_01_08_425864	123	1	229	229	CD
10_1101-2021_01_08_425864	123	2	The	the	DT
10_1101-2021_01_08_425864	123	3	samples	sample	NNS
10_1101-2021_01_08_425864	123	4	were	be	VBD
10_1101-2021_01_08_425864	123	5	analysed	analyse	VBN
10_1101-2021_01_08_425864	123	6	by	by	IN
10_1101-2021_01_08_425864	123	7	flow	flow	NN
10_1101-2021_01_08_425864	123	8	cytometry	cytometry	NN
10_1101-2021_01_08_425864	123	9	(	(	-LRB-
10_1101-2021_01_08_425864	123	10	Guava	Guava	NNP
10_1101-2021_01_08_425864	123	11	)	)	-RRB-
10_1101-2021_01_08_425864	123	12	adapted	adapt	VBD
10_1101-2021_01_08_425864	123	13	from	from	IN
10_1101-2021_01_08_425864	123	14	[	[	-LRB-
10_1101-2021_01_08_425864	123	15	29	29	CD
10_1101-2021_01_08_425864	123	16	]	]	-RRB-
10_1101-2021_01_08_425864	123	17	.	.	.
10_1101-2021_01_08_425864	124	1	230	230	CD
10_1101-2021_01_08_425864	124	2	231	231	CD
10_1101-2021_01_08_425864	124	3	Fatty	Fatty	NNP
10_1101-2021_01_08_425864	124	4	acid	acid	NN
10_1101-2021_01_08_425864	124	5	staining	stain	VBG
10_1101-2021_01_08_425864	124	6	using	use	VBG
10_1101-2021_01_08_425864	124	7	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	124	8	®	®	NNPS
10_1101-2021_01_08_425864	124	9	500/510	500/510	NNP
10_1101-2021_01_08_425864	124	10	.	.	.
10_1101-2021_01_08_425864	125	1	Exponentially	exponentially	RB
10_1101-2021_01_08_425864	125	2	growing	grow	VBG
10_1101-2021_01_08_425864	125	3	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	125	4	were	be	VBD
10_1101-2021_01_08_425864	125	5	kept	keep	VBN
10_1101-2021_01_08_425864	125	6	in	in	IN
10_1101-2021_01_08_425864	125	7	232	232	CD
10_1101-2021_01_08_425864	125	8	LIT	LIT	NNP
10_1101-2021_01_08_425864	125	9	medium	medium	NN
10_1101-2021_01_08_425864	125	10	to	to	TO
10_1101-2021_01_08_425864	125	11	reach	reach	VB
10_1101-2021_01_08_425864	125	12	three	three	CD
10_1101-2021_01_08_425864	125	13	different	different	JJ
10_1101-2021_01_08_425864	125	14	cell	cell	NN
10_1101-2021_01_08_425864	125	15	densities	density	NNS
10_1101-2021_01_08_425864	125	16	(	(	-LRB-
10_1101-2021_01_08_425864	125	17	2.5x107	2.5x107	NNP
10_1101-2021_01_08_425864	125	18	mL-1	mL-1	NNP
10_1101-2021_01_08_425864	125	19	,	,	,
10_1101-2021_01_08_425864	125	20	5x107	5x107	CD
10_1101-2021_01_08_425864	125	21	mL-1	ml-1	NN
10_1101-2021_01_08_425864	125	22	and	and	CC
10_1101-2021_01_08_425864	125	23	108	108	CD
10_1101-2021_01_08_425864	125	24	mL-1	ml-1	NN
10_1101-2021_01_08_425864	125	25	)	)	-RRB-
10_1101-2021_01_08_425864	125	26	in	in	IN
10_1101-2021_01_08_425864	125	27	24-	24-	NNP
10_1101-2021_01_08_425864	125	28	233	233	CD
10_1101-2021_01_08_425864	125	29	well	well	NN
10_1101-2021_01_08_425864	125	30	plates	plate	NNS
10_1101-2021_01_08_425864	125	31	at	at	IN
10_1101-2021_01_08_425864	125	32	28	28	CD
10_1101-2021_01_08_425864	125	33	°	°	,
10_1101-2021_01_08_425864	125	34	C	C	NNP
10_1101-2021_01_08_425864	125	35	.	.	.
10_1101-2021_01_08_425864	126	1	Twenty	twenty	CD
10_1101-2021_01_08_425864	126	2	-	-	HYPH
10_1101-2021_01_08_425864	126	3	four	four	CD
10_1101-2021_01_08_425864	126	4	hours	hour	NNS
10_1101-2021_01_08_425864	126	5	before	before	IN
10_1101-2021_01_08_425864	126	6	the	the	DT
10_1101-2021_01_08_425864	126	7	flow	flow	NN
10_1101-2021_01_08_425864	126	8	cytometry	cytometry	NN
10_1101-2021_01_08_425864	126	9	analysis	analysis	NN
10_1101-2021_01_08_425864	126	10	,	,	,
10_1101-2021_01_08_425864	126	11	the	the	DT
10_1101-2021_01_08_425864	126	12	parasites	parasite	NNS
10_1101-2021_01_08_425864	126	13	were	be	VBD
10_1101-2021_01_08_425864	126	14	treated	treat	VBN
10_1101-2021_01_08_425864	126	15	234	234	CD
10_1101-2021_01_08_425864	126	16	with	with	IN
10_1101-2021_01_08_425864	126	17	1	1	CD
10_1101-2021_01_08_425864	126	18	µM	µM	NNP
10_1101-2021_01_08_425864	126	19	C1-BODIPY	C1-BODIPY	NNP
10_1101-2021_01_08_425864	126	20	®	®	NNPS
10_1101-2021_01_08_425864	126	21	500/510-C12	500/510-c12	CD
10_1101-2021_01_08_425864	126	22	.	.	.
10_1101-2021_01_08_425864	127	1	This	this	DT
10_1101-2021_01_08_425864	127	2	fluorophore	fluorophore	NN
10_1101-2021_01_08_425864	127	3	allows	allow	VBZ
10_1101-2021_01_08_425864	127	4	for	for	IN
10_1101-2021_01_08_425864	127	5	measurements	measurement	NNS
10_1101-2021_01_08_425864	127	6	of	of	IN
10_1101-2021_01_08_425864	127	7	the	the	DT
10_1101-2021_01_08_425864	127	8	relationship	relationship	NN
10_1101-2021_01_08_425864	127	9	235	235	CD
10_1101-2021_01_08_425864	127	10	between	between	IN
10_1101-2021_01_08_425864	127	11	fatty	fatty	NN
10_1101-2021_01_08_425864	127	12	acid	acid	NN
10_1101-2021_01_08_425864	127	13	accumulation	accumulation	NN
10_1101-2021_01_08_425864	127	14	and	and	CC
10_1101-2021_01_08_425864	127	15	consumption	consumption	NN
10_1101-2021_01_08_425864	127	16	by	by	IN
10_1101-2021_01_08_425864	127	17	shifting	shift	VBG
10_1101-2021_01_08_425864	127	18	the	the	DT
10_1101-2021_01_08_425864	127	19	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	127	20	filter	filter	NN
10_1101-2021_01_08_425864	127	21	.	.	.
10_1101-2021_01_08_425864	128	1	The	the	DT
10_1101-2021_01_08_425864	128	2	samples	sample	NNS
10_1101-2021_01_08_425864	128	3	236	236	CD
10_1101-2021_01_08_425864	128	4	were	be	VBD
10_1101-2021_01_08_425864	128	5	collected	collect	VBN
10_1101-2021_01_08_425864	128	6	,	,	,
10_1101-2021_01_08_425864	128	7	washed	wash	VBN
10_1101-2021_01_08_425864	128	8	twice	twice	RB
10_1101-2021_01_08_425864	128	9	in	in	IN
10_1101-2021_01_08_425864	128	10	PBS	PBS	NNP
10_1101-2021_01_08_425864	128	11	and	and	CC
10_1101-2021_01_08_425864	128	12	incubated	incubate	VBD
10_1101-2021_01_08_425864	128	13	in	in	IN
10_1101-2021_01_08_425864	128	14	4	4	CD
10_1101-2021_01_08_425864	128	15	%	%	NN
10_1101-2021_01_08_425864	128	16	paraformaldehyde	paraformaldehyde	NN
10_1101-2021_01_08_425864	128	17	for	for	IN
10_1101-2021_01_08_425864	128	18	15	15	CD
10_1101-2021_01_08_425864	128	19	min	min	NN
10_1101-2021_01_08_425864	128	20	.	.	.
10_1101-2021_01_08_425864	129	1	After	after	IN
10_1101-2021_01_08_425864	129	2	.CC	.CC	NFP
10_1101-2021_01_08_425864	129	3	-	-	:
10_1101-2021_01_08_425864	129	4	BY	by	IN
10_1101-2021_01_08_425864	129	5	4.0	4.0	CD
10_1101-2021_01_08_425864	129	6	International	international	JJ
10_1101-2021_01_08_425864	129	7	licensemade	licensemade	NN
10_1101-2021_01_08_425864	129	8	available	available	JJ
10_1101-2021_01_08_425864	129	9	under	under	IN
10_1101-2021_01_08_425864	129	10	a	a	DT
10_1101-2021_01_08_425864	129	11	(	(	-LRB-
10_1101-2021_01_08_425864	129	12	which	which	WDT
10_1101-2021_01_08_425864	129	13	was	be	VBD
10_1101-2021_01_08_425864	129	14	not	not	RB
10_1101-2021_01_08_425864	129	15	certified	certify	VBN
10_1101-2021_01_08_425864	129	16	by	by	IN
10_1101-2021_01_08_425864	129	17	peer	peer	NN
10_1101-2021_01_08_425864	129	18	review	review	NN
10_1101-2021_01_08_425864	129	19	)	)	-RRB-
10_1101-2021_01_08_425864	129	20	is	be	VBZ
10_1101-2021_01_08_425864	129	21	the	the	DT
10_1101-2021_01_08_425864	129	22	author	author	NN
10_1101-2021_01_08_425864	129	23	/	/	SYM
10_1101-2021_01_08_425864	129	24	funder	funder	NN
10_1101-2021_01_08_425864	129	25	,	,	,
10_1101-2021_01_08_425864	129	26	who	who	WP
10_1101-2021_01_08_425864	129	27	has	have	VBZ
10_1101-2021_01_08_425864	129	28	granted	grant	VBN
10_1101-2021_01_08_425864	129	29	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	129	30	a	a	DT
10_1101-2021_01_08_425864	129	31	license	license	NN
10_1101-2021_01_08_425864	129	32	to	to	TO
10_1101-2021_01_08_425864	129	33	display	display	VB
10_1101-2021_01_08_425864	129	34	the	the	DT
10_1101-2021_01_08_425864	129	35	preprint	preprint	NN
10_1101-2021_01_08_425864	129	36	in	in	IN
10_1101-2021_01_08_425864	129	37	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	129	38	.	.	.
10_1101-2021_01_08_425864	130	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	130	2	is	be	VBZ
10_1101-2021_01_08_425864	130	3	The	the	DT
10_1101-2021_01_08_425864	130	4	copyright	copyright	NN
10_1101-2021_01_08_425864	130	5	holder	holder	NN
10_1101-2021_01_08_425864	130	6	for	for	IN
10_1101-2021_01_08_425864	130	7	this	this	DT
10_1101-2021_01_08_425864	130	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	130	9	version	version	NN
10_1101-2021_01_08_425864	130	10	posted	post	VBD
10_1101-2021_01_08_425864	130	11	January	January	NNP
10_1101-2021_01_08_425864	130	12	8	8	CD
10_1101-2021_01_08_425864	130	13	,	,	,
10_1101-2021_01_08_425864	130	14	2021	2021	CD
10_1101-2021_01_08_425864	130	15	.	.	.
10_1101-2021_01_08_425864	130	16	;	;	:
10_1101-2021_01_08_425864	130	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	130	18	:	:	:
10_1101-2021_01_08_425864	130	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	130	20	preprint	preprint	NN
10_1101-2021_01_08_425864	130	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	130	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	VBZ
10_1101-2021_01_08_425864	130	23	237	237	CD
10_1101-2021_01_08_425864	130	24	incubation	incubation	NN
10_1101-2021_01_08_425864	130	25	,	,	,
10_1101-2021_01_08_425864	130	26	the	the	DT
10_1101-2021_01_08_425864	130	27	cells	cell	NNS
10_1101-2021_01_08_425864	130	28	were	be	VBD
10_1101-2021_01_08_425864	130	29	washed	wash	VBN
10_1101-2021_01_08_425864	130	30	twice	twice	RB
10_1101-2021_01_08_425864	130	31	with	with	IN
10_1101-2021_01_08_425864	130	32	PBS	PBS	NNP
10_1101-2021_01_08_425864	130	33	and	and	CC
10_1101-2021_01_08_425864	130	34	suspended	suspend	VBN
10_1101-2021_01_08_425864	130	35	in	in	IN
10_1101-2021_01_08_425864	130	36	the	the	DT
10_1101-2021_01_08_425864	130	37	same	same	JJ
10_1101-2021_01_08_425864	130	38	buffer	buffer	NN
10_1101-2021_01_08_425864	130	39	.	.	.
10_1101-2021_01_08_425864	131	1	Flow	flow	VB
10_1101-2021_01_08_425864	131	2	cytometry	cytometry	NN
10_1101-2021_01_08_425864	131	3	238	238	CD
10_1101-2021_01_08_425864	131	4	analysis	analysis	NN
10_1101-2021_01_08_425864	131	5	was	be	VBD
10_1101-2021_01_08_425864	131	6	performed	perform	VBN
10_1101-2021_01_08_425864	131	7	with	with	IN
10_1101-2021_01_08_425864	131	8	FL-1	FL-1	NNP
10_1101-2021_01_08_425864	131	9	and	and	CC
10_1101-2021_01_08_425864	131	10	FL-2	FL-2	NNP
10_1101-2021_01_08_425864	131	11	filters	filter	NNS
10_1101-2021_01_08_425864	131	12	in	in	IN
10_1101-2021_01_08_425864	131	13	a	a	DT
10_1101-2021_01_08_425864	131	14	FACS	FACS	NNP
10_1101-2021_01_08_425864	131	15	Fortessa	Fortessa	NNP
10_1101-2021_01_08_425864	131	16	DB	DB	NNP
10_1101-2021_01_08_425864	131	17	®	®	NNP
10_1101-2021_01_08_425864	131	18	.	.	.
10_1101-2021_01_08_425864	132	1	The	the	DT
10_1101-2021_01_08_425864	132	2	results	result	NNS
10_1101-2021_01_08_425864	132	3	were	be	VBD
10_1101-2021_01_08_425864	132	4	239	239	CD
10_1101-2021_01_08_425864	132	5	analysed	analyse	VBN
10_1101-2021_01_08_425864	132	6	using	use	VBG
10_1101-2021_01_08_425864	132	7	FloJo	FloJo	NNP
10_1101-2021_01_08_425864	132	8	software	software	NN
10_1101-2021_01_08_425864	132	9	.	.	.
10_1101-2021_01_08_425864	133	1	240	240	CD
10_1101-2021_01_08_425864	133	2	241	241	CD
10_1101-2021_01_08_425864	133	3	Fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	133	4	microscopy	microscopy	NN
10_1101-2021_01_08_425864	133	5	242	242	CD
10_1101-2021_01_08_425864	133	6	The	the	DT
10_1101-2021_01_08_425864	133	7	parasites	parasite	NNS
10_1101-2021_01_08_425864	133	8	were	be	VBD
10_1101-2021_01_08_425864	133	9	maintained	maintain	VBN
10_1101-2021_01_08_425864	133	10	in	in	IN
10_1101-2021_01_08_425864	133	11	LIT	LIT	NNP
10_1101-2021_01_08_425864	133	12	medium	medium	NN
10_1101-2021_01_08_425864	133	13	as	as	IN
10_1101-2021_01_08_425864	133	14	previously	previously	RB
10_1101-2021_01_08_425864	133	15	reported	report	VBN
10_1101-2021_01_08_425864	133	16	for	for	IN
10_1101-2021_01_08_425864	133	17	fatty	fatty	NN
10_1101-2021_01_08_425864	133	18	acid	acid	NN
10_1101-2021_01_08_425864	133	19	staining	stain	VBG
10_1101-2021_01_08_425864	133	20	243	243	CD
10_1101-2021_01_08_425864	133	21	using	use	VBG
10_1101-2021_01_08_425864	133	22	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	133	23	®	®	NNPS
10_1101-2021_01_08_425864	133	24	500/510	500/510	NNP
10_1101-2021_01_08_425864	133	25	.	.	.
10_1101-2021_01_08_425864	134	1	After	after	IN
10_1101-2021_01_08_425864	134	2	incubation	incubation	NN
10_1101-2021_01_08_425864	134	3	,	,	,
10_1101-2021_01_08_425864	134	4	the	the	DT
10_1101-2021_01_08_425864	134	5	cells	cell	NNS
10_1101-2021_01_08_425864	134	6	were	be	VBD
10_1101-2021_01_08_425864	134	7	washed	wash	VBN
10_1101-2021_01_08_425864	134	8	twice	twice	RB
10_1101-2021_01_08_425864	134	9	in	in	IN
10_1101-2021_01_08_425864	134	10	PBS	PBS	NNP
10_1101-2021_01_08_425864	134	11	and	and	CC
10_1101-2021_01_08_425864	134	12	placed	place	VBN
10_1101-2021_01_08_425864	134	13	on	on	IN
10_1101-2021_01_08_425864	134	14	glass	glass	NN
10_1101-2021_01_08_425864	134	15	244	244	CD
10_1101-2021_01_08_425864	134	16	slides	slide	NNS
10_1101-2021_01_08_425864	134	17	.	.	.
10_1101-2021_01_08_425864	135	1	The	the	DT
10_1101-2021_01_08_425864	135	2	images	image	NNS
10_1101-2021_01_08_425864	135	3	were	be	VBD
10_1101-2021_01_08_425864	135	4	acquired	acquire	VBN
10_1101-2021_01_08_425864	135	5	with	with	IN
10_1101-2021_01_08_425864	135	6	a	a	DT
10_1101-2021_01_08_425864	135	7	digital	digital	JJ
10_1101-2021_01_08_425864	135	8	DFC	DFC	NNP
10_1101-2021_01_08_425864	135	9	365	365	CD
10_1101-2021_01_08_425864	135	10	FX	FX	NNP
10_1101-2021_01_08_425864	135	11	camera	camera	NN
10_1101-2021_01_08_425864	135	12	coupled	couple	VBN
10_1101-2021_01_08_425864	135	13	to	to	IN
10_1101-2021_01_08_425864	135	14	a	a	DT
10_1101-2021_01_08_425864	135	15	DMI6000B	dmi6000b	NN
10_1101-2021_01_08_425864	135	16	/	/	SYM
10_1101-2021_01_08_425864	135	17	AF6000	AF6000	NNP
10_1101-2021_01_08_425864	135	18	245	245	CD
10_1101-2021_01_08_425864	135	19	microscope	microscope	NN
10_1101-2021_01_08_425864	135	20	(	(	-LRB-
10_1101-2021_01_08_425864	135	21	Leica	Leica	NNP
10_1101-2021_01_08_425864	135	22	)	)	-RRB-
10_1101-2021_01_08_425864	135	23	.	.	.
10_1101-2021_01_08_425864	136	1	The	the	DT
10_1101-2021_01_08_425864	136	2	images	image	NNS
10_1101-2021_01_08_425864	136	3	were	be	VBD
10_1101-2021_01_08_425864	136	4	analysed	analyse	VBN
10_1101-2021_01_08_425864	136	5	using	use	VBG
10_1101-2021_01_08_425864	136	6	ImageJ	ImageJ	NNPS
10_1101-2021_01_08_425864	136	7	software	software	NN
10_1101-2021_01_08_425864	136	8	.	.	.
10_1101-2021_01_08_425864	137	1	246	246	CD
10_1101-2021_01_08_425864	137	2	247	247	CD
10_1101-2021_01_08_425864	137	3	Results	result	NNS
10_1101-2021_01_08_425864	137	4	248	248	CD
10_1101-2021_01_08_425864	137	5	Palmitate	Palmitate	NNP
10_1101-2021_01_08_425864	137	6	supports	support	VBZ
10_1101-2021_01_08_425864	137	7	ATP	atp	NN
10_1101-2021_01_08_425864	137	8	synthesis	synthesis	NN
10_1101-2021_01_08_425864	137	9	in	in	IN
10_1101-2021_01_08_425864	137	10	T.	t.	NN
10_1101-2021_01_08_425864	137	11	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	137	12	249	249	CD
10_1101-2021_01_08_425864	137	13	We	-PRON-	PRP
10_1101-2021_01_08_425864	137	14	initially	initially	RB
10_1101-2021_01_08_425864	137	15	investigated	investigate	VBD
10_1101-2021_01_08_425864	137	16	the	the	DT
10_1101-2021_01_08_425864	137	17	ability	ability	NN
10_1101-2021_01_08_425864	137	18	of	of	IN
10_1101-2021_01_08_425864	137	19	T.	T.	NNP
10_1101-2021_01_08_425864	137	20	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	137	21	epimastigotes	epimastigote	VBZ
10_1101-2021_01_08_425864	137	22	to	to	TO
10_1101-2021_01_08_425864	137	23	oxidize	oxidize	VB
10_1101-2021_01_08_425864	137	24	fatty	fatty	NN
10_1101-2021_01_08_425864	137	25	acids	acid	NNS
10_1101-2021_01_08_425864	137	26	.	.	.
10_1101-2021_01_08_425864	138	1	To	to	IN
10_1101-2021_01_08_425864	138	2	this	this	DT
10_1101-2021_01_08_425864	138	3	250	250	CD
10_1101-2021_01_08_425864	138	4	end	end	NN
10_1101-2021_01_08_425864	138	5	,	,	,
10_1101-2021_01_08_425864	138	6	we	-PRON-	PRP
10_1101-2021_01_08_425864	138	7	used	use	VBD
10_1101-2021_01_08_425864	138	8	palmitate	palmitate	NN
10_1101-2021_01_08_425864	138	9	as	as	IN
10_1101-2021_01_08_425864	138	10	a	a	DT
10_1101-2021_01_08_425864	138	11	proxy	proxy	NN
10_1101-2021_01_08_425864	138	12	for	for	IN
10_1101-2021_01_08_425864	138	13	fatty	fatty	NN
10_1101-2021_01_08_425864	138	14	acids	acid	NNS
10_1101-2021_01_08_425864	138	15	in	in	IN
10_1101-2021_01_08_425864	138	16	general	general	JJ
10_1101-2021_01_08_425864	138	17	.	.	.
10_1101-2021_01_08_425864	139	1	The	the	DT
10_1101-2021_01_08_425864	139	2	parasites	parasite	NNS
10_1101-2021_01_08_425864	139	3	were	be	VBD
10_1101-2021_01_08_425864	139	4	incubated	incubate	VBN
10_1101-2021_01_08_425864	139	5	with	with	IN
10_1101-2021_01_08_425864	139	6	0.1	0.1	CD
10_1101-2021_01_08_425864	139	7	251	251	CD
10_1101-2021_01_08_425864	139	8	mM	mM	NNP
10_1101-2021_01_08_425864	139	9	14C-[U]-palmitate	14c-[u]-palmitate	NN
10_1101-2021_01_08_425864	139	10	,	,	,
10_1101-2021_01_08_425864	139	11	which	which	WDT
10_1101-2021_01_08_425864	139	12	allowed	allow	VBD
10_1101-2021_01_08_425864	139	13	us	-PRON-	PRP
10_1101-2021_01_08_425864	139	14	to	to	TO
10_1101-2021_01_08_425864	139	15	measure	measure	VB
10_1101-2021_01_08_425864	139	16	the	the	DT
10_1101-2021_01_08_425864	139	17	production	production	NN
10_1101-2021_01_08_425864	139	18	of	of	IN
10_1101-2021_01_08_425864	139	19	1.3	1.3	CD
10_1101-2021_01_08_425864	139	20	nmoles	nmole	NNS
10_1101-2021_01_08_425864	139	21	of	of	IN
10_1101-2021_01_08_425864	139	22	CO2	CO2	NNP
10_1101-2021_01_08_425864	139	23	derived	derive	VBD
10_1101-2021_01_08_425864	139	24	252	252	CD
10_1101-2021_01_08_425864	139	25	from	from	IN
10_1101-2021_01_08_425864	139	26	palmitate	palmitate	NN
10_1101-2021_01_08_425864	139	27	oxidation	oxidation	NN
10_1101-2021_01_08_425864	139	28	during	during	IN
10_1101-2021_01_08_425864	139	29	the	the	DT
10_1101-2021_01_08_425864	139	30	first	first	JJ
10_1101-2021_01_08_425864	139	31	60	60	CD
10_1101-2021_01_08_425864	139	32	min	min	NN
10_1101-2021_01_08_425864	139	33	and	and	CC
10_1101-2021_01_08_425864	139	34	1.5	1.5	CD
10_1101-2021_01_08_425864	139	35	extra	extra	JJ
10_1101-2021_01_08_425864	139	36	nmoles	nmole	NNS
10_1101-2021_01_08_425864	139	37	during	during	IN
10_1101-2021_01_08_425864	139	38	the	the	DT
10_1101-2021_01_08_425864	139	39	following	follow	VBG
10_1101-2021_01_08_425864	139	40	60	60	CD
10_1101-2021_01_08_425864	139	41	min	min	NN
10_1101-2021_01_08_425864	139	42	253	253	CD
10_1101-2021_01_08_425864	139	43	(	(	-LRB-
10_1101-2021_01_08_425864	139	44	Fig	Fig	NNP
10_1101-2021_01_08_425864	139	45	1a	1a	NNP
10_1101-2021_01_08_425864	139	46	)	)	-RRB-
10_1101-2021_01_08_425864	139	47	.	.	.
10_1101-2021_01_08_425864	140	1	This	this	DT
10_1101-2021_01_08_425864	140	2	finding	finding	NN
10_1101-2021_01_08_425864	140	3	indicated	indicate	VBD
10_1101-2021_01_08_425864	140	4	that	that	IN
10_1101-2021_01_08_425864	140	5	beta	beta	NN
10_1101-2021_01_08_425864	140	6	-	-	HYPH
10_1101-2021_01_08_425864	140	7	oxidation	oxidation	NN
10_1101-2021_01_08_425864	140	8	and	and	CC
10_1101-2021_01_08_425864	140	9	the	the	DT
10_1101-2021_01_08_425864	140	10	further	further	RB
10_1101-2021_01_08_425864	140	11	‘	'	``
10_1101-2021_01_08_425864	140	12	burning	burn	VBG
10_1101-2021_01_08_425864	140	13	’	'	''
10_1101-2021_01_08_425864	140	14	of	of	IN
10_1101-2021_01_08_425864	140	15	the	the	DT
10_1101-2021_01_08_425864	140	16	resulting	result	VBG
10_1101-2021_01_08_425864	140	17	acetyl-	acetyl-	JJ
10_1101-2021_01_08_425864	140	18	254	254	CD
10_1101-2021_01_08_425864	140	19	CoA	CoA	NNP
10_1101-2021_01_08_425864	140	20	is	be	VBZ
10_1101-2021_01_08_425864	140	21	operative	operative	JJ
10_1101-2021_01_08_425864	140	22	in	in	IN
10_1101-2021_01_08_425864	140	23	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	140	24	mitochondria	mitochondria	NNP
10_1101-2021_01_08_425864	140	25	.	.	.
10_1101-2021_01_08_425864	141	1	Because	because	IN
10_1101-2021_01_08_425864	141	2	palmitate	palmitate	NN
10_1101-2021_01_08_425864	141	3	is	be	VBZ
10_1101-2021_01_08_425864	141	4	taken	take	VBN
10_1101-2021_01_08_425864	141	5	up	up	RP
10_1101-2021_01_08_425864	141	6	from	from	IN
10_1101-2021_01_08_425864	141	7	extracellular	extracellular	NNP
10_1101-2021_01_08_425864	141	8	255	255	CD
10_1101-2021_01_08_425864	141	9	medium	medium	NN
10_1101-2021_01_08_425864	141	10	and	and	CC
10_1101-2021_01_08_425864	141	11	oxidized	oxidize	VBN
10_1101-2021_01_08_425864	141	12	to	to	IN
10_1101-2021_01_08_425864	141	13	CO2	CO2	NNP
10_1101-2021_01_08_425864	141	14	,	,	,
10_1101-2021_01_08_425864	141	15	it	-PRON-	PRP
10_1101-2021_01_08_425864	141	16	is	be	VBZ
10_1101-2021_01_08_425864	141	17	reasonable	reasonable	JJ
10_1101-2021_01_08_425864	141	18	to	to	TO
10_1101-2021_01_08_425864	141	19	assume	assume	VB
10_1101-2021_01_08_425864	141	20	that	that	IN
10_1101-2021_01_08_425864	141	21	it	-PRON-	PRP
10_1101-2021_01_08_425864	141	22	could	could	MD
10_1101-2021_01_08_425864	141	23	contribute	contribute	VB
10_1101-2021_01_08_425864	141	24	to	to	IN
10_1101-2021_01_08_425864	141	25	resistance	resistance	NN
10_1101-2021_01_08_425864	141	26	to	to	IN
10_1101-2021_01_08_425864	141	27	severe	severe	JJ
10_1101-2021_01_08_425864	141	28	256	256	CD
10_1101-2021_01_08_425864	141	29	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	141	30	stress	stress	NN
10_1101-2021_01_08_425864	141	31	.	.	.
10_1101-2021_01_08_425864	142	1	To	to	TO
10_1101-2021_01_08_425864	142	2	support	support	VB
10_1101-2021_01_08_425864	142	3	this	this	DT
10_1101-2021_01_08_425864	142	4	idea	idea	NN
10_1101-2021_01_08_425864	142	5	,	,	,
10_1101-2021_01_08_425864	142	6	we	-PRON-	PRP
10_1101-2021_01_08_425864	142	7	tested	test	VBD
10_1101-2021_01_08_425864	142	8	the	the	DT
10_1101-2021_01_08_425864	142	9	ability	ability	NN
10_1101-2021_01_08_425864	142	10	of	of	IN
10_1101-2021_01_08_425864	142	11	palmitate	palmitate	NN
10_1101-2021_01_08_425864	142	12	to	to	TO
10_1101-2021_01_08_425864	142	13	extend	extend	VB
10_1101-2021_01_08_425864	142	14	parasite	parasite	NN
10_1101-2021_01_08_425864	142	15	survival	survival	NN
10_1101-2021_01_08_425864	142	16	257	257	CD
10_1101-2021_01_08_425864	142	17	under	under	IN
10_1101-2021_01_08_425864	142	18	extreme	extreme	JJ
10_1101-2021_01_08_425864	142	19	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	142	20	stress	stress	NN
10_1101-2021_01_08_425864	142	21	.	.	.
10_1101-2021_01_08_425864	143	1	Parasites	parasite	NNS
10_1101-2021_01_08_425864	143	2	were	be	VBD
10_1101-2021_01_08_425864	143	3	incubated	incubate	VBN
10_1101-2021_01_08_425864	143	4	for	for	IN
10_1101-2021_01_08_425864	143	5	24	24	CD
10_1101-2021_01_08_425864	143	6	and	and	CC
10_1101-2021_01_08_425864	143	7	48	48	CD
10_1101-2021_01_08_425864	143	8	h	h	NNS
10_1101-2021_01_08_425864	143	9	in	in	IN
10_1101-2021_01_08_425864	143	10	PBS	PBS	NNP
10_1101-2021_01_08_425864	143	11	(	(	-LRB-
10_1101-2021_01_08_425864	143	12	negative	negative	JJ
10_1101-2021_01_08_425864	143	13	control	control	NN
10_1101-2021_01_08_425864	143	14	,	,	,
10_1101-2021_01_08_425864	143	15	258	258	CD
10_1101-2021_01_08_425864	143	16	in	in	IN
10_1101-2021_01_08_425864	143	17	this	this	DT
10_1101-2021_01_08_425864	143	18	condition	condition	NN
10_1101-2021_01_08_425864	143	19	we	-PRON-	PRP
10_1101-2021_01_08_425864	143	20	expected	expect	VBD
10_1101-2021_01_08_425864	143	21	the	the	DT
10_1101-2021_01_08_425864	143	22	lower	low	JJR
10_1101-2021_01_08_425864	143	23	viability	viability	NN
10_1101-2021_01_08_425864	143	24	after	after	IN
10_1101-2021_01_08_425864	143	25	the	the	DT
10_1101-2021_01_08_425864	143	26	incubations	incubation	NNS
10_1101-2021_01_08_425864	143	27	)	)	-RRB-
10_1101-2021_01_08_425864	143	28	,	,	,
10_1101-2021_01_08_425864	143	29	0.1	0.1	CD
10_1101-2021_01_08_425864	143	30	mM	mm	NN
10_1101-2021_01_08_425864	143	31	palmitate	palmitate	NN
10_1101-2021_01_08_425864	143	32	in	in	IN
10_1101-2021_01_08_425864	143	33	PBS	PBS	NNP
10_1101-2021_01_08_425864	143	34	259	259	CD
10_1101-2021_01_08_425864	143	35	supplemented	supplement	VBD
10_1101-2021_01_08_425864	143	36	with	with	IN
10_1101-2021_01_08_425864	143	37	BSA	BSA	NNP
10_1101-2021_01_08_425864	143	38	(	(	-LRB-
10_1101-2021_01_08_425864	143	39	as	as	IN
10_1101-2021_01_08_425864	143	40	a	a	DT
10_1101-2021_01_08_425864	143	41	palmitate	palmitate	NN
10_1101-2021_01_08_425864	143	42	carrier	carrier	NN
10_1101-2021_01_08_425864	143	43	)	)	-RRB-
10_1101-2021_01_08_425864	143	44	,	,	,
10_1101-2021_01_08_425864	143	45	5.0	5.0	CD
10_1101-2021_01_08_425864	143	46	mM	mm	NN
10_1101-2021_01_08_425864	143	47	histidine	histidine	NN
10_1101-2021_01_08_425864	143	48	in	in	IN
10_1101-2021_01_08_425864	143	49	PBS	PBS	NNP
10_1101-2021_01_08_425864	143	50	or	or	CC
10_1101-2021_01_08_425864	143	51	5.0	5.0	CD
10_1101-2021_01_08_425864	143	52	mM	mm	NN
10_1101-2021_01_08_425864	143	53	glucose	glucose	NN
10_1101-2021_01_08_425864	143	54	in	in	IN
10_1101-2021_01_08_425864	143	55	PBS	PBS	NNP
10_1101-2021_01_08_425864	143	56	260	260	CD
10_1101-2021_01_08_425864	143	57	(	(	-LRB-
10_1101-2021_01_08_425864	143	58	both	both	CC
10_1101-2021_01_08_425864	143	59	positive	positive	JJ
10_1101-2021_01_08_425864	143	60	controls	control	NNS
10_1101-2021_01_08_425864	143	61	,	,	,
10_1101-2021_01_08_425864	143	62	since	since	IN
10_1101-2021_01_08_425864	143	63	it	-PRON-	PRP
10_1101-2021_01_08_425864	143	64	is	be	VBZ
10_1101-2021_01_08_425864	143	65	well	well	RB
10_1101-2021_01_08_425864	143	66	knowing	know	VBG
10_1101-2021_01_08_425864	143	67	the	the	DT
10_1101-2021_01_08_425864	143	68	ability	ability	NN
10_1101-2021_01_08_425864	143	69	of	of	IN
10_1101-2021_01_08_425864	143	70	both	both	DT
10_1101-2021_01_08_425864	143	71	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	143	72	to	to	TO
10_1101-2021_01_08_425864	143	73	extend	extend	VB
10_1101-2021_01_08_425864	143	74	the	the	DT
10_1101-2021_01_08_425864	143	75	parasites	parasite	NNS
10_1101-2021_01_08_425864	143	76	´	´	CD
10_1101-2021_01_08_425864	143	77	261	261	CD
10_1101-2021_01_08_425864	143	78	viability	viability	NN
10_1101-2021_01_08_425864	143	79	in	in	IN
10_1101-2021_01_08_425864	143	80	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	143	81	stress	stress	NN
10_1101-2021_01_08_425864	143	82	conditions	condition	NNS
10_1101-2021_01_08_425864	143	83	,	,	,
10_1101-2021_01_08_425864	143	84	see	see	VB
10_1101-2021_01_08_425864	143	85	[	[	-LRB-
10_1101-2021_01_08_425864	143	86	15	15	CD
10_1101-2021_01_08_425864	143	87	]	]	-RRB-
10_1101-2021_01_08_425864	143	88	)	)	-RRB-
10_1101-2021_01_08_425864	143	89	.	.	.
10_1101-2021_01_08_425864	144	1	As	as	IN
10_1101-2021_01_08_425864	144	2	an	an	DT
10_1101-2021_01_08_425864	144	3	additional	additional	JJ
10_1101-2021_01_08_425864	144	4	negative	negative	JJ
10_1101-2021_01_08_425864	144	5	control	control	NN
10_1101-2021_01_08_425864	144	6	,	,	,
10_1101-2021_01_08_425864	144	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	144	8	used	use	VBD
10_1101-2021_01_08_425864	144	9	PBS	PBS	NNP
10_1101-2021_01_08_425864	144	10	262	262	CD
10_1101-2021_01_08_425864	144	11	supplemented	supplement	VBD
10_1101-2021_01_08_425864	144	12	with	with	IN
10_1101-2021_01_08_425864	144	13	BSA	BSA	NNP
10_1101-2021_01_08_425864	144	14	without	without	IN
10_1101-2021_01_08_425864	144	15	added	add	VBN
10_1101-2021_01_08_425864	144	16	palmitate	palmitate	NN
10_1101-2021_01_08_425864	144	17	.	.	.
10_1101-2021_01_08_425864	145	1	The	the	DT
10_1101-2021_01_08_425864	145	2	viability	viability	NN
10_1101-2021_01_08_425864	145	3	of	of	IN
10_1101-2021_01_08_425864	145	4	these	these	DT
10_1101-2021_01_08_425864	145	5	cells	cell	NNS
10_1101-2021_01_08_425864	145	6	was	be	VBD
10_1101-2021_01_08_425864	145	7	assayed	assay	VBN
10_1101-2021_01_08_425864	145	8	by	by	IN
10_1101-2021_01_08_425864	145	9	263	263	CD
10_1101-2021_01_08_425864	145	10	measuring	measure	VBG
10_1101-2021_01_08_425864	145	11	the	the	DT
10_1101-2021_01_08_425864	145	12	total	total	JJ
10_1101-2021_01_08_425864	145	13	reductive	reductive	JJ
10_1101-2021_01_08_425864	145	14	activity	activity	NN
10_1101-2021_01_08_425864	145	15	by	by	IN
10_1101-2021_01_08_425864	145	16	MTT	MTT	NNP
10_1101-2021_01_08_425864	145	17	assay	assay	NNP
10_1101-2021_01_08_425864	145	18	.	.	.
10_1101-2021_01_08_425864	146	1	Additionally	additionally	RB
10_1101-2021_01_08_425864	146	2	,	,	,
10_1101-2021_01_08_425864	146	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	146	4	measured	measure	VBD
10_1101-2021_01_08_425864	146	5	the	the	DT
10_1101-2021_01_08_425864	146	6	total	total	JJ
10_1101-2021_01_08_425864	146	7	ATP	ATP	NNP
10_1101-2021_01_08_425864	146	8	levels	level	NNS
10_1101-2021_01_08_425864	146	9	.	.	.
10_1101-2021_01_08_425864	147	1	264	264	CD
10_1101-2021_01_08_425864	147	2	Cells	cell	NNS
10_1101-2021_01_08_425864	147	3	incubated	incubate	VBD
10_1101-2021_01_08_425864	147	4	in	in	IN
10_1101-2021_01_08_425864	147	5	the	the	DT
10_1101-2021_01_08_425864	147	6	presence	presence	NN
10_1101-2021_01_08_425864	147	7	of	of	IN
10_1101-2021_01_08_425864	147	8	palmitate	palmitate	NN
10_1101-2021_01_08_425864	147	9	showed	show	VBD
10_1101-2021_01_08_425864	147	10	higher	high	JJR
10_1101-2021_01_08_425864	147	11	viability	viability	NN
10_1101-2021_01_08_425864	147	12	than	than	IN
10_1101-2021_01_08_425864	147	13	the	the	DT
10_1101-2021_01_08_425864	147	14	negative	negative	JJ
10_1101-2021_01_08_425864	147	15	controls	control	NNS
10_1101-2021_01_08_425864	147	16	,	,	,
10_1101-2021_01_08_425864	147	17	but	but	CC
10_1101-2021_01_08_425864	147	18	265	265	CD
10_1101-2021_01_08_425864	147	19	not	not	RB
10_1101-2021_01_08_425864	147	20	as	as	RB
10_1101-2021_01_08_425864	147	21	high	high	JJ
10_1101-2021_01_08_425864	147	22	as	as	IN
10_1101-2021_01_08_425864	147	23	that	that	DT
10_1101-2021_01_08_425864	147	24	of	of	IN
10_1101-2021_01_08_425864	147	25	parasites	parasite	NNS
10_1101-2021_01_08_425864	147	26	incubated	incubate	VBN
10_1101-2021_01_08_425864	147	27	with	with	IN
10_1101-2021_01_08_425864	147	28	glucose	glucose	NN
10_1101-2021_01_08_425864	147	29	or	or	CC
10_1101-2021_01_08_425864	147	30	histidine	histidine	NN
10_1101-2021_01_08_425864	147	31	(	(	-LRB-
10_1101-2021_01_08_425864	147	32	Fig	fig	NN
10_1101-2021_01_08_425864	147	33	1b	1b	CD
10_1101-2021_01_08_425864	147	34	)	)	-RRB-
10_1101-2021_01_08_425864	147	35	.	.	.
10_1101-2021_01_08_425864	148	1	Consistently	consistently	RB
10_1101-2021_01_08_425864	148	2	,	,	,
10_1101-2021_01_08_425864	148	3	parasites	parasite	NNS
10_1101-2021_01_08_425864	148	4	266	266	CD
10_1101-2021_01_08_425864	148	5	incubated	incubate	VBD
10_1101-2021_01_08_425864	148	6	in	in	IN
10_1101-2021_01_08_425864	148	7	the	the	DT
10_1101-2021_01_08_425864	148	8	presence	presence	NN
10_1101-2021_01_08_425864	148	9	of	of	IN
10_1101-2021_01_08_425864	148	10	palmitate	palmitate	NN
10_1101-2021_01_08_425864	148	11	showed	show	VBD
10_1101-2021_01_08_425864	148	12	higher	high	JJR
10_1101-2021_01_08_425864	148	13	ATP	atp	NN
10_1101-2021_01_08_425864	148	14	contents	content	NNS
10_1101-2021_01_08_425864	148	15	than	than	IN
10_1101-2021_01_08_425864	148	16	both	both	DT
10_1101-2021_01_08_425864	148	17	negative	negative	JJ
10_1101-2021_01_08_425864	148	18	controls	control	NNS
10_1101-2021_01_08_425864	148	19	.	.	.
10_1101-2021_01_08_425864	149	1	267	267	CD
10_1101-2021_01_08_425864	149	2	However	however	RB
10_1101-2021_01_08_425864	149	3	,	,	,
10_1101-2021_01_08_425864	149	4	the	the	DT
10_1101-2021_01_08_425864	149	5	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	149	6	ATP	ATP	NNP
10_1101-2021_01_08_425864	149	7	levels	level	NNS
10_1101-2021_01_08_425864	149	8	in	in	IN
10_1101-2021_01_08_425864	149	9	the	the	DT
10_1101-2021_01_08_425864	149	10	cells	cell	NNS
10_1101-2021_01_08_425864	149	11	incubated	incubate	VBN
10_1101-2021_01_08_425864	149	12	with	with	IN
10_1101-2021_01_08_425864	149	13	palmitate	palmitate	NN
10_1101-2021_01_08_425864	149	14	were	be	VBD
10_1101-2021_01_08_425864	149	15	diminished	diminish	VBN
10_1101-2021_01_08_425864	149	16	by	by	IN
10_1101-2021_01_08_425864	149	17	half	half	NN
10_1101-2021_01_08_425864	149	18	268	268	CD
10_1101-2021_01_08_425864	149	19	when	when	WRB
10_1101-2021_01_08_425864	149	20	compared	compare	VBN
10_1101-2021_01_08_425864	149	21	to	to	IN
10_1101-2021_01_08_425864	149	22	parasites	parasite	NNS
10_1101-2021_01_08_425864	149	23	incubated	incubate	VBN
10_1101-2021_01_08_425864	149	24	with	with	IN
10_1101-2021_01_08_425864	149	25	histidine	histidine	NN
10_1101-2021_01_08_425864	149	26	.	.	.
10_1101-2021_01_08_425864	150	1	Interestingly	interestingly	RB
10_1101-2021_01_08_425864	150	2	,	,	,
10_1101-2021_01_08_425864	150	3	the	the	DT
10_1101-2021_01_08_425864	150	4	palmitate	palmitate	NN
10_1101-2021_01_08_425864	150	5	kept	keep	VBD
10_1101-2021_01_08_425864	150	6	the	the	DT
10_1101-2021_01_08_425864	150	7	ATP	ATP	NNP
10_1101-2021_01_08_425864	150	8	269	269	CD
10_1101-2021_01_08_425864	150	9	content	content	NN
10_1101-2021_01_08_425864	150	10	at	at	IN
10_1101-2021_01_08_425864	150	11	levels	level	NNS
10_1101-2021_01_08_425864	150	12	comparable	comparable	JJ
10_1101-2021_01_08_425864	150	13	to	to	TO
10_1101-2021_01_08_425864	150	14	glucose	glucose	VB
10_1101-2021_01_08_425864	150	15	(	(	-LRB-
10_1101-2021_01_08_425864	150	16	Fig	fig	NN
10_1101-2021_01_08_425864	150	17	1c	1c	CD
10_1101-2021_01_08_425864	150	18	)	)	-RRB-
10_1101-2021_01_08_425864	150	19	.	.	.
10_1101-2021_01_08_425864	151	1	270	270	CD
10_1101-2021_01_08_425864	151	2	.CC	.CC	:
10_1101-2021_01_08_425864	151	3	-	-	:
10_1101-2021_01_08_425864	151	4	BY	by	IN
10_1101-2021_01_08_425864	151	5	4.0	4.0	CD
10_1101-2021_01_08_425864	151	6	International	international	JJ
10_1101-2021_01_08_425864	151	7	licensemade	licensemade	NN
10_1101-2021_01_08_425864	151	8	available	available	JJ
10_1101-2021_01_08_425864	151	9	under	under	IN
10_1101-2021_01_08_425864	151	10	a	a	DT
10_1101-2021_01_08_425864	151	11	(	(	-LRB-
10_1101-2021_01_08_425864	151	12	which	which	WDT
10_1101-2021_01_08_425864	151	13	was	be	VBD
10_1101-2021_01_08_425864	151	14	not	not	RB
10_1101-2021_01_08_425864	151	15	certified	certify	VBN
10_1101-2021_01_08_425864	151	16	by	by	IN
10_1101-2021_01_08_425864	151	17	peer	peer	NN
10_1101-2021_01_08_425864	151	18	review	review	NN
10_1101-2021_01_08_425864	151	19	)	)	-RRB-
10_1101-2021_01_08_425864	151	20	is	be	VBZ
10_1101-2021_01_08_425864	151	21	the	the	DT
10_1101-2021_01_08_425864	151	22	author	author	NN
10_1101-2021_01_08_425864	151	23	/	/	SYM
10_1101-2021_01_08_425864	151	24	funder	funder	NN
10_1101-2021_01_08_425864	151	25	,	,	,
10_1101-2021_01_08_425864	151	26	who	who	WP
10_1101-2021_01_08_425864	151	27	has	have	VBZ
10_1101-2021_01_08_425864	151	28	granted	grant	VBN
10_1101-2021_01_08_425864	151	29	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	151	30	a	a	DT
10_1101-2021_01_08_425864	151	31	license	license	NN
10_1101-2021_01_08_425864	151	32	to	to	TO
10_1101-2021_01_08_425864	151	33	display	display	VB
10_1101-2021_01_08_425864	151	34	the	the	DT
10_1101-2021_01_08_425864	151	35	preprint	preprint	NN
10_1101-2021_01_08_425864	151	36	in	in	IN
10_1101-2021_01_08_425864	151	37	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	151	38	.	.	.
10_1101-2021_01_08_425864	152	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	152	2	is	be	VBZ
10_1101-2021_01_08_425864	152	3	The	the	DT
10_1101-2021_01_08_425864	152	4	copyright	copyright	NN
10_1101-2021_01_08_425864	152	5	holder	holder	NN
10_1101-2021_01_08_425864	152	6	for	for	IN
10_1101-2021_01_08_425864	152	7	this	this	DT
10_1101-2021_01_08_425864	152	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	152	9	version	version	NN
10_1101-2021_01_08_425864	152	10	posted	post	VBD
10_1101-2021_01_08_425864	152	11	January	January	NNP
10_1101-2021_01_08_425864	152	12	8	8	CD
10_1101-2021_01_08_425864	152	13	,	,	,
10_1101-2021_01_08_425864	152	14	2021	2021	CD
10_1101-2021_01_08_425864	152	15	.	.	.
10_1101-2021_01_08_425864	152	16	;	;	:
10_1101-2021_01_08_425864	152	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	152	18	:	:	:
10_1101-2021_01_08_425864	152	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	152	20	preprint	preprint	NN
10_1101-2021_01_08_425864	152	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	152	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	152	23	271	271	CD
10_1101-2021_01_08_425864	152	24	Figure	figure	NN
10_1101-2021_01_08_425864	152	25	1	1	CD
10_1101-2021_01_08_425864	152	26	.	.	.
10_1101-2021_01_08_425864	153	1	Palmitate	palmitate	NN
10_1101-2021_01_08_425864	153	2	oxidation	oxidation	NN
10_1101-2021_01_08_425864	153	3	promotes	promote	VBZ
10_1101-2021_01_08_425864	153	4	ATP	atp	NN
10_1101-2021_01_08_425864	153	5	production	production	NN
10_1101-2021_01_08_425864	153	6	and	and	CC
10_1101-2021_01_08_425864	153	7	viability	viability	NN
10_1101-2021_01_08_425864	153	8	in	in	IN
10_1101-2021_01_08_425864	153	9	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	153	10	forms	form	NNS
10_1101-2021_01_08_425864	153	11	272	272	CD
10_1101-2021_01_08_425864	153	12	under	under	IN
10_1101-2021_01_08_425864	153	13	starvation	starvation	NN
10_1101-2021_01_08_425864	153	14	.	.	.
10_1101-2021_01_08_425864	154	1	Schematic	schematic	JJ
10_1101-2021_01_08_425864	154	2	representation	representation	NN
10_1101-2021_01_08_425864	154	3	of	of	IN
10_1101-2021_01_08_425864	154	4	14C	14c	CD
10_1101-2021_01_08_425864	154	5	-	-	HYPH
10_1101-2021_01_08_425864	154	6	U	U	NNP
10_1101-2021_01_08_425864	154	7	-	-	HYPH
10_1101-2021_01_08_425864	154	8	palmitate	palmitate	NN
10_1101-2021_01_08_425864	154	9	metabolism	metabolism	NN
10_1101-2021_01_08_425864	154	10	.	.	.
10_1101-2021_01_08_425864	155	1	The	the	DT
10_1101-2021_01_08_425864	155	2	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	155	3	273	273	CD
10_1101-2021_01_08_425864	155	4	corresponding	correspond	VBG
10_1101-2021_01_08_425864	155	5	to	to	IN
10_1101-2021_01_08_425864	155	6	labelled	label	VBN
10_1101-2021_01_08_425864	155	7	palmitate	palmitate	NN
10_1101-2021_01_08_425864	155	8	metabolism	metabolism	NN
10_1101-2021_01_08_425864	155	9	are	be	VBP
10_1101-2021_01_08_425864	155	10	presented	present	VBN
10_1101-2021_01_08_425864	155	11	in	in	IN
10_1101-2021_01_08_425864	155	12	green	green	NN
10_1101-2021_01_08_425864	155	13	.	.	.
10_1101-2021_01_08_425864	156	1	A	a	DT
10_1101-2021_01_08_425864	156	2	)	)	-RRB-
10_1101-2021_01_08_425864	156	3	14CO2	14co2	CD
10_1101-2021_01_08_425864	156	4	production	production	NN
10_1101-2021_01_08_425864	156	5	from	from	IN
10_1101-2021_01_08_425864	156	6	274	274	CD
10_1101-2021_01_08_425864	156	7	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	156	8	incubated	incubate	VBN
10_1101-2021_01_08_425864	156	9	in	in	IN
10_1101-2021_01_08_425864	156	10	PBS	PBS	NNP
10_1101-2021_01_08_425864	156	11	with	with	IN
10_1101-2021_01_08_425864	156	12	14C	14c	CD
10_1101-2021_01_08_425864	156	13	-	-	HYPH
10_1101-2021_01_08_425864	156	14	U	U	NNP
10_1101-2021_01_08_425864	156	15	-	-	HYPH
10_1101-2021_01_08_425864	156	16	palmitate	palmitate	NNP
10_1101-2021_01_08_425864	156	17	100	100	CD
10_1101-2021_01_08_425864	156	18	µM.	µM.	NNS
10_1101-2021_01_08_425864	157	1	The	the	DT
10_1101-2021_01_08_425864	157	2	14CO2	14co2	CD
10_1101-2021_01_08_425864	157	3	was	be	VBD
10_1101-2021_01_08_425864	157	4	captured	capture	VBN
10_1101-2021_01_08_425864	157	5	at	at	IN
10_1101-2021_01_08_425864	157	6	0	0	CD
10_1101-2021_01_08_425864	157	7	,	,	,
10_1101-2021_01_08_425864	157	8	30	30	CD
10_1101-2021_01_08_425864	157	9	,	,	,
10_1101-2021_01_08_425864	157	10	60	60	CD
10_1101-2021_01_08_425864	157	11	275	275	CD
10_1101-2021_01_08_425864	157	12	and	and	CC
10_1101-2021_01_08_425864	157	13	120	120	CD
10_1101-2021_01_08_425864	157	14	min	min	NN
10_1101-2021_01_08_425864	157	15	.	.	.
10_1101-2021_01_08_425864	158	1	B	b	NN
10_1101-2021_01_08_425864	158	2	)	)	-RRB-
10_1101-2021_01_08_425864	158	3	Viability	viability	NN
10_1101-2021_01_08_425864	158	4	of	of	IN
10_1101-2021_01_08_425864	158	5	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	158	6	forms	form	NNS
10_1101-2021_01_08_425864	158	7	after	after	IN
10_1101-2021_01_08_425864	158	8	incubation	incubation	NN
10_1101-2021_01_08_425864	158	9	with	with	IN
10_1101-2021_01_08_425864	158	10	different	different	JJ
10_1101-2021_01_08_425864	158	11	carbon	carbon	NN
10_1101-2021_01_08_425864	158	12	sources	source	NNS
10_1101-2021_01_08_425864	158	13	and	and	CC
10_1101-2021_01_08_425864	158	14	276	276	CD
10_1101-2021_01_08_425864	158	15	palmitate	palmitate	NN
10_1101-2021_01_08_425864	158	16	.	.	.
10_1101-2021_01_08_425864	159	1	The	the	DT
10_1101-2021_01_08_425864	159	2	viability	viability	NN
10_1101-2021_01_08_425864	159	3	was	be	VBD
10_1101-2021_01_08_425864	159	4	assessed	assess	VBN
10_1101-2021_01_08_425864	159	5	after	after	IN
10_1101-2021_01_08_425864	159	6	24	24	CD
10_1101-2021_01_08_425864	159	7	and	and	CC
10_1101-2021_01_08_425864	159	8	48	48	CD
10_1101-2021_01_08_425864	159	9	h	h	NN
10_1101-2021_01_08_425864	159	10	by	by	IN
10_1101-2021_01_08_425864	159	11	MTT	MTT	NNP
10_1101-2021_01_08_425864	159	12	assay	assay	NNP
10_1101-2021_01_08_425864	159	13	.	.	.
10_1101-2021_01_08_425864	160	1	C	C	NNP
10_1101-2021_01_08_425864	160	2	)	)	-RRB-
10_1101-2021_01_08_425864	160	3	The	the	DT
10_1101-2021_01_08_425864	160	4	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	160	5	ATP	atp	NN
10_1101-2021_01_08_425864	160	6	277	277	CD
10_1101-2021_01_08_425864	160	7	content	content	NN
10_1101-2021_01_08_425864	160	8	was	be	VBD
10_1101-2021_01_08_425864	160	9	evaluated	evaluate	VBN
10_1101-2021_01_08_425864	160	10	following	follow	VBG
10_1101-2021_01_08_425864	160	11	incubation	incubation	NN
10_1101-2021_01_08_425864	160	12	with	with	IN
10_1101-2021_01_08_425864	160	13	different	different	JJ
10_1101-2021_01_08_425864	160	14	energy	energy	NN
10_1101-2021_01_08_425864	160	15	substrates	substrate	NNS
10_1101-2021_01_08_425864	160	16	or	or	CC
10_1101-2021_01_08_425864	160	17	not	not	RB
10_1101-2021_01_08_425864	160	18	(	(	-LRB-
10_1101-2021_01_08_425864	160	19	PBS	PBS	NNP
10_1101-2021_01_08_425864	160	20	,	,	,
10_1101-2021_01_08_425864	160	21	negative	negative	JJ
10_1101-2021_01_08_425864	160	22	278	278	CD
10_1101-2021_01_08_425864	160	23	control	control	NN
10_1101-2021_01_08_425864	160	24	)	)	-RRB-
10_1101-2021_01_08_425864	160	25	.	.	.
10_1101-2021_01_08_425864	161	1	The	the	DT
10_1101-2021_01_08_425864	161	2	ATP	ATP	NNP
10_1101-2021_01_08_425864	161	3	concentration	concentration	NN
10_1101-2021_01_08_425864	161	4	was	be	VBD
10_1101-2021_01_08_425864	161	5	determined	determine	VBN
10_1101-2021_01_08_425864	161	6	by	by	IN
10_1101-2021_01_08_425864	161	7	luciferase	luciferase	NN
10_1101-2021_01_08_425864	161	8	assay	assay	NNP
10_1101-2021_01_08_425864	161	9	and	and	CC
10_1101-2021_01_08_425864	161	10	the	the	DT
10_1101-2021_01_08_425864	161	11	data	datum	NNS
10_1101-2021_01_08_425864	161	12	were	be	VBD
10_1101-2021_01_08_425864	161	13	adjusted	adjust	VBN
10_1101-2021_01_08_425864	161	14	by	by	IN
10_1101-2021_01_08_425864	161	15	279	279	CD
10_1101-2021_01_08_425864	161	16	the	the	DT
10_1101-2021_01_08_425864	161	17	number	number	NN
10_1101-2021_01_08_425864	161	18	of	of	IN
10_1101-2021_01_08_425864	161	19	cells	cell	NNS
10_1101-2021_01_08_425864	161	20	.	.	.
10_1101-2021_01_08_425864	162	1	A	a	DT
10_1101-2021_01_08_425864	162	2	statistical	statistical	JJ
10_1101-2021_01_08_425864	162	3	analysis	analysis	NN
10_1101-2021_01_08_425864	162	4	was	be	VBD
10_1101-2021_01_08_425864	162	5	performed	perform	VBN
10_1101-2021_01_08_425864	162	6	with	with	IN
10_1101-2021_01_08_425864	162	7	one	one	CD
10_1101-2021_01_08_425864	162	8	-	-	HYPH
10_1101-2021_01_08_425864	162	9	way	way	NN
10_1101-2021_01_08_425864	162	10	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	162	11	followed	follow	VBN
10_1101-2021_01_08_425864	162	12	by	by	IN
10_1101-2021_01_08_425864	162	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	162	14	's	's	POS
10_1101-2021_01_08_425864	162	15	280	280	CD
10_1101-2021_01_08_425864	162	16	post	post	NN
10_1101-2021_01_08_425864	162	17	-	-	NN
10_1101-2021_01_08_425864	162	18	test	test	NN
10_1101-2021_01_08_425864	162	19	at	at	IN
10_1101-2021_01_08_425864	162	20	p	p	NN
10_1101-2021_01_08_425864	162	21	<	<	XX
10_1101-2021_01_08_425864	162	22	0.05	0.05	XX
10_1101-2021_01_08_425864	162	23	using	use	VBG
10_1101-2021_01_08_425864	162	24	the	the	DT
10_1101-2021_01_08_425864	162	25	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	162	26	Prism	Prism	NNP
10_1101-2021_01_08_425864	162	27	8.0.2	8.0.2	NNP
10_1101-2021_01_08_425864	162	28	software	software	NN
10_1101-2021_01_08_425864	162	29	program	program	NN
10_1101-2021_01_08_425864	162	30	.	.	.
10_1101-2021_01_08_425864	163	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	163	2	represent	represent	VBP
10_1101-2021_01_08_425864	163	3	the	the	DT
10_1101-2021_01_08_425864	163	4	level	level	NN
10_1101-2021_01_08_425864	163	5	of	of	IN
10_1101-2021_01_08_425864	163	6	281	281	CD
10_1101-2021_01_08_425864	163	7	statistical	statistical	JJ
10_1101-2021_01_08_425864	163	8	significance	significance	NN
10_1101-2021_01_08_425864	163	9	in	in	IN
10_1101-2021_01_08_425864	163	10	this	this	DT
10_1101-2021_01_08_425864	163	11	figure	figure	NN
10_1101-2021_01_08_425864	163	12	as	as	IN
10_1101-2021_01_08_425864	163	13	follows	follow	VBZ
10_1101-2021_01_08_425864	163	14	:	:	:
10_1101-2021_01_08_425864	163	15	*	*	NFP
10_1101-2021_01_08_425864	163	16	*	*	NFP
10_1101-2021_01_08_425864	163	17	*	*	NFP
10_1101-2021_01_08_425864	163	18	p	p	NN
10_1101-2021_01_08_425864	163	19	value	value	NN
10_1101-2021_01_08_425864	163	20	<	<	XX
10_1101-2021_01_08_425864	163	21	0.001	0.001	CD
10_1101-2021_01_08_425864	163	22	;	;	:
10_1101-2021_01_08_425864	163	23	*	*	NFP
10_1101-2021_01_08_425864	163	24	*	*	NFP
10_1101-2021_01_08_425864	163	25	p	p	NN
10_1101-2021_01_08_425864	163	26	value	value	NN
10_1101-2021_01_08_425864	163	27	<	<	XX
10_1101-2021_01_08_425864	163	28	0.01	0.01	XX
10_1101-2021_01_08_425864	163	29	;	;	:
10_1101-2021_01_08_425864	163	30	*	*	NFP
10_1101-2021_01_08_425864	163	31	p	p	NN
10_1101-2021_01_08_425864	163	32	value	value	NN
10_1101-2021_01_08_425864	163	33	<	<	XX
10_1101-2021_01_08_425864	163	34	282	282	CD
10_1101-2021_01_08_425864	163	35	0.05	0.05	CD
10_1101-2021_01_08_425864	163	36	.	.	.
10_1101-2021_01_08_425864	164	1	For	for	IN
10_1101-2021_01_08_425864	164	2	a	a	DT
10_1101-2021_01_08_425864	164	3	p	p	NN
10_1101-2021_01_08_425864	164	4	value	value	NN
10_1101-2021_01_08_425864	164	5	>	>	NN
10_1101-2021_01_08_425864	164	6	0.05	0.05	CD
10_1101-2021_01_08_425864	164	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	164	8	consider	consider	VBP
10_1101-2021_01_08_425864	164	9	the	the	DT
10_1101-2021_01_08_425864	164	10	differences	difference	NNS
10_1101-2021_01_08_425864	164	11	to	to	TO
10_1101-2021_01_08_425864	164	12	be	be	VB
10_1101-2021_01_08_425864	164	13	not	not	RB
10_1101-2021_01_08_425864	164	14	significant	significant	JJ
10_1101-2021_01_08_425864	164	15	(	(	-LRB-
10_1101-2021_01_08_425864	164	16	ns	ns	NNP
10_1101-2021_01_08_425864	164	17	)	)	-RRB-
10_1101-2021_01_08_425864	164	18	.	.	.
10_1101-2021_01_08_425864	165	1	283	283	CD
10_1101-2021_01_08_425864	165	2	284	284	CD
10_1101-2021_01_08_425864	165	3	Epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	165	4	forms	form	NNS
10_1101-2021_01_08_425864	165	5	excrete	excrete	VBP
10_1101-2021_01_08_425864	165	6	acetate	acetate	NNP
10_1101-2021_01_08_425864	165	7	as	as	IN
10_1101-2021_01_08_425864	165	8	a	a	DT
10_1101-2021_01_08_425864	165	9	primary	primary	JJ
10_1101-2021_01_08_425864	165	10	end	end	NN
10_1101-2021_01_08_425864	165	11	-	-	HYPH
10_1101-2021_01_08_425864	165	12	product	product	NN
10_1101-2021_01_08_425864	165	13	of	of	IN
10_1101-2021_01_08_425864	165	14	palmitate	palmitate	NN
10_1101-2021_01_08_425864	165	15	oxidation	oxidation	NN
10_1101-2021_01_08_425864	165	16	285	285	CD
10_1101-2021_01_08_425864	165	17	Because	because	IN
10_1101-2021_01_08_425864	165	18	the	the	DT
10_1101-2021_01_08_425864	165	19	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	165	20	were	be	VBD
10_1101-2021_01_08_425864	165	21	able	able	JJ
10_1101-2021_01_08_425864	165	22	to	to	TO
10_1101-2021_01_08_425864	165	23	oxidize	oxidize	VB
10_1101-2021_01_08_425864	165	24	14C	14c	CD
10_1101-2021_01_08_425864	165	25	-	-	HYPH
10_1101-2021_01_08_425864	165	26	U	u	NN
10_1101-2021_01_08_425864	165	27	-	-	HYPH
10_1101-2021_01_08_425864	165	28	palmitate	palmitate	NN
10_1101-2021_01_08_425864	165	29	to	to	IN
10_1101-2021_01_08_425864	165	30	14CO2	14co2	CD
10_1101-2021_01_08_425864	165	31	,	,	,
10_1101-2021_01_08_425864	165	32	we	-PRON-	PRP
10_1101-2021_01_08_425864	165	33	were	be	VBD
10_1101-2021_01_08_425864	165	34	interested	interested	JJ
10_1101-2021_01_08_425864	165	35	286	286	CD
10_1101-2021_01_08_425864	165	36	in	in	IN
10_1101-2021_01_08_425864	165	37	analysing	analyse	VBG
10_1101-2021_01_08_425864	165	38	their	-PRON-	PRP$
10_1101-2021_01_08_425864	165	39	exometabolome	exometabolome	NN
10_1101-2021_01_08_425864	165	40	and	and	CC
10_1101-2021_01_08_425864	165	41	comparing	compare	VBG
10_1101-2021_01_08_425864	165	42	it	-PRON-	PRP
10_1101-2021_01_08_425864	165	43	with	with	IN
10_1101-2021_01_08_425864	165	44	that	that	DT
10_1101-2021_01_08_425864	165	45	of	of	IN
10_1101-2021_01_08_425864	165	46	parasites	parasite	NNS
10_1101-2021_01_08_425864	165	47	exclusively	exclusively	RB
10_1101-2021_01_08_425864	165	48	consuming	consume	VBG
10_1101-2021_01_08_425864	165	49	287	287	CD
10_1101-2021_01_08_425864	165	50	glucose	glucose	NN
10_1101-2021_01_08_425864	165	51	,	,	,
10_1101-2021_01_08_425864	165	52	palmitate	palmitate	VBP
10_1101-2021_01_08_425864	165	53	or	or	CC
10_1101-2021_01_08_425864	165	54	without	without	IN
10_1101-2021_01_08_425864	165	55	any	any	DT
10_1101-2021_01_08_425864	165	56	carbon	carbon	NN
10_1101-2021_01_08_425864	165	57	source	source	NN
10_1101-2021_01_08_425864	165	58	.	.	.
10_1101-2021_01_08_425864	166	1	Thus	thus	RB
10_1101-2021_01_08_425864	166	2	,	,	,
10_1101-2021_01_08_425864	166	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	166	4	subjected	subject	VBD
10_1101-2021_01_08_425864	166	5	exponentially	exponentially	RB
10_1101-2021_01_08_425864	166	6	growing	grow	VBG
10_1101-2021_01_08_425864	166	7	parasites	parasite	NNS
10_1101-2021_01_08_425864	166	8	288	288	CD
10_1101-2021_01_08_425864	166	9	to	to	TO
10_1101-2021_01_08_425864	166	10	16	16	CD
10_1101-2021_01_08_425864	166	11	h	h	NN
10_1101-2021_01_08_425864	166	12	of	of	IN
10_1101-2021_01_08_425864	166	13	starvation	starvation	NN
10_1101-2021_01_08_425864	166	14	and	and	CC
10_1101-2021_01_08_425864	166	15	then	then	RB
10_1101-2021_01_08_425864	166	16	incubated	incubate	VBD
10_1101-2021_01_08_425864	166	17	them	-PRON-	PRP
10_1101-2021_01_08_425864	166	18	for	for	IN
10_1101-2021_01_08_425864	166	19	6	6	CD
10_1101-2021_01_08_425864	166	20	h	h	NN
10_1101-2021_01_08_425864	166	21	in	in	IN
10_1101-2021_01_08_425864	166	22	the	the	DT
10_1101-2021_01_08_425864	166	23	presence	presence	NN
10_1101-2021_01_08_425864	166	24	of	of	IN
10_1101-2021_01_08_425864	166	25	0.3	0.3	CD
10_1101-2021_01_08_425864	166	26	mM	mM	NNP
10_1101-2021_01_08_425864	166	27	palmitate	palmitate	NN
10_1101-2021_01_08_425864	166	28	,	,	,
10_1101-2021_01_08_425864	166	29	10	10	CD
10_1101-2021_01_08_425864	166	30	mM	mm	NN
10_1101-2021_01_08_425864	166	31	289	289	CD
10_1101-2021_01_08_425864	166	32	13C	13c	CD
10_1101-2021_01_08_425864	166	33	-	-	HYPH
10_1101-2021_01_08_425864	166	34	U	u	NN
10_1101-2021_01_08_425864	166	35	-	-	HYPH
10_1101-2021_01_08_425864	166	36	glucose	glucose	NN
10_1101-2021_01_08_425864	166	37	or	or	CC
10_1101-2021_01_08_425864	166	38	without	without	IN
10_1101-2021_01_08_425864	166	39	any	any	DT
10_1101-2021_01_08_425864	166	40	carbon	carbon	NN
10_1101-2021_01_08_425864	166	41	source	source	NN
10_1101-2021_01_08_425864	166	42	.	.	.
10_1101-2021_01_08_425864	167	1	For	for	IN
10_1101-2021_01_08_425864	167	2	the	the	DT
10_1101-2021_01_08_425864	167	3	control	control	NN
10_1101-2021_01_08_425864	167	4	,	,	,
10_1101-2021_01_08_425864	167	5	we	-PRON-	PRP
10_1101-2021_01_08_425864	167	6	analysed	analyse	VBD
10_1101-2021_01_08_425864	167	7	a	a	DT
10_1101-2021_01_08_425864	167	8	sample	sample	NN
10_1101-2021_01_08_425864	167	9	of	of	IN
10_1101-2021_01_08_425864	167	10	non	non	JJ
10_1101-2021_01_08_425864	167	11	-	-	JJ
10_1101-2021_01_08_425864	167	12	starved	starve	VBN
10_1101-2021_01_08_425864	167	13	290	290	CD
10_1101-2021_01_08_425864	167	14	parasites	parasite	NNS
10_1101-2021_01_08_425864	167	15	.	.	.
10_1101-2021_01_08_425864	168	1	After	after	IN
10_1101-2021_01_08_425864	168	2	the	the	DT
10_1101-2021_01_08_425864	168	3	incubations	incubation	NNS
10_1101-2021_01_08_425864	168	4	,	,	,
10_1101-2021_01_08_425864	168	5	the	the	DT
10_1101-2021_01_08_425864	168	6	extracellular	extracellular	JJ
10_1101-2021_01_08_425864	168	7	media	medium	NNS
10_1101-2021_01_08_425864	168	8	were	be	VBD
10_1101-2021_01_08_425864	168	9	collected	collect	VBN
10_1101-2021_01_08_425864	168	10	and	and	CC
10_1101-2021_01_08_425864	168	11	analysed	analyse	VBN
10_1101-2021_01_08_425864	168	12	by	by	IN
10_1101-2021_01_08_425864	168	13	1H	1h	JJ
10_1101-2021_01_08_425864	168	14	-	-	:
10_1101-2021_01_08_425864	168	15	NMR	NMR	NNP
10_1101-2021_01_08_425864	168	16	291	291	CD
10_1101-2021_01_08_425864	168	17	spectrometry	spectrometry	NN
10_1101-2021_01_08_425864	168	18	.	.	.
10_1101-2021_01_08_425864	169	1	As	as	IN
10_1101-2021_01_08_425864	169	2	expected	expect	VBN
10_1101-2021_01_08_425864	169	3	,	,	,
10_1101-2021_01_08_425864	169	4	all	all	PDT
10_1101-2021_01_08_425864	169	5	the	the	DT
10_1101-2021_01_08_425864	169	6	incubation	incubation	NN
10_1101-2021_01_08_425864	169	7	conditions	condition	NNS
10_1101-2021_01_08_425864	169	8	produced	produce	VBD
10_1101-2021_01_08_425864	169	9	different	different	JJ
10_1101-2021_01_08_425864	169	10	flux	flux	JJ
10_1101-2021_01_08_425864	169	11	profiles	profile	NNS
10_1101-2021_01_08_425864	169	12	for	for	IN
10_1101-2021_01_08_425864	169	13	excreted	excreted	JJ
10_1101-2021_01_08_425864	169	14	292	292	CD
10_1101-2021_01_08_425864	169	15	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	169	16	(	(	-LRB-
10_1101-2021_01_08_425864	169	17	Fig	fig	NN
10_1101-2021_01_08_425864	169	18	2	2	CD
10_1101-2021_01_08_425864	169	19	and	and	CC
10_1101-2021_01_08_425864	169	20	S1	S1	NNP
10_1101-2021_01_08_425864	169	21	Fig	Fig	NNP
10_1101-2021_01_08_425864	169	22	)	)	-RRB-
10_1101-2021_01_08_425864	169	23	.	.	.
10_1101-2021_01_08_425864	170	1	Under	under	IN
10_1101-2021_01_08_425864	170	2	our	-PRON-	PRP$
10_1101-2021_01_08_425864	170	3	experimental	experimental	JJ
10_1101-2021_01_08_425864	170	4	conditions	condition	NNS
10_1101-2021_01_08_425864	170	5	,	,	,
10_1101-2021_01_08_425864	170	6	the	the	DT
10_1101-2021_01_08_425864	170	7	non	non	JJ
10_1101-2021_01_08_425864	170	8	-	-	JJ
10_1101-2021_01_08_425864	170	9	starved	starved	JJ
10_1101-2021_01_08_425864	170	10	parasites	parasite	NNS
10_1101-2021_01_08_425864	170	11	293	293	CD
10_1101-2021_01_08_425864	170	12	primarily	primarily	RB
10_1101-2021_01_08_425864	170	13	excreted	excrete	VBN
10_1101-2021_01_08_425864	170	14	succinate	succinate	NN
10_1101-2021_01_08_425864	170	15	and	and	CC
10_1101-2021_01_08_425864	170	16	acetate	acetate	JJ
10_1101-2021_01_08_425864	170	17	in	in	IN
10_1101-2021_01_08_425864	170	18	similar	similar	JJ
10_1101-2021_01_08_425864	170	19	quantities	quantity	NNS
10_1101-2021_01_08_425864	170	20	,	,	,
10_1101-2021_01_08_425864	170	21	and	and	CC
10_1101-2021_01_08_425864	170	22	alanine	alanine	NN
10_1101-2021_01_08_425864	170	23	and	and	CC
10_1101-2021_01_08_425864	170	24	lactate	lactate	VB
10_1101-2021_01_08_425864	170	25	to	to	IN
10_1101-2021_01_08_425864	170	26	a	a	DT
10_1101-2021_01_08_425864	170	27	lesser	less	JJR
10_1101-2021_01_08_425864	170	28	extent	extent	NN
10_1101-2021_01_08_425864	170	29	.	.	.
10_1101-2021_01_08_425864	171	1	294	294	CD
10_1101-2021_01_08_425864	171	2	Parasites	Parasites	NNPS
10_1101-2021_01_08_425864	171	3	starved	starve	VBD
10_1101-2021_01_08_425864	171	4	for	for	IN
10_1101-2021_01_08_425864	171	5	16	16	CD
10_1101-2021_01_08_425864	171	6	h	h	NN
10_1101-2021_01_08_425864	171	7	in	in	IN
10_1101-2021_01_08_425864	171	8	PBS	PBS	NNP
10_1101-2021_01_08_425864	171	9	and	and	CC
10_1101-2021_01_08_425864	171	10	left	leave	VBD
10_1101-2021_01_08_425864	171	11	to	to	TO
10_1101-2021_01_08_425864	171	12	incubate	incubate	VB
10_1101-2021_01_08_425864	171	13	in	in	IN
10_1101-2021_01_08_425864	171	14	the	the	DT
10_1101-2021_01_08_425864	171	15	absence	absence	NN
10_1101-2021_01_08_425864	171	16	of	of	IN
10_1101-2021_01_08_425864	171	17	other	other	JJ
10_1101-2021_01_08_425864	171	18	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	171	19	had	have	VBD
10_1101-2021_01_08_425864	171	20	295	295	CD
10_1101-2021_01_08_425864	171	21	diminished	diminish	VBN
10_1101-2021_01_08_425864	171	22	succinate	succinate	NN
10_1101-2021_01_08_425864	171	23	production	production	NN
10_1101-2021_01_08_425864	171	24	(	(	-LRB-
10_1101-2021_01_08_425864	171	25	~7-fold	~7-fold	NN
10_1101-2021_01_08_425864	171	26	)	)	-RRB-
10_1101-2021_01_08_425864	171	27	but	but	CC
10_1101-2021_01_08_425864	171	28	increased	increase	VBN
10_1101-2021_01_08_425864	171	29	acetate	acetate	JJ
10_1101-2021_01_08_425864	171	30	production	production	NN
10_1101-2021_01_08_425864	171	31	three	three	CD
10_1101-2021_01_08_425864	171	32	-	-	HYPH
10_1101-2021_01_08_425864	171	33	fold	fold	RB
10_1101-2021_01_08_425864	171	34	compared	compare	VBN
10_1101-2021_01_08_425864	171	35	to	to	IN
10_1101-2021_01_08_425864	171	36	296	296	CD
10_1101-2021_01_08_425864	171	37	the	the	DT
10_1101-2021_01_08_425864	171	38	non	non	JJ
10_1101-2021_01_08_425864	171	39	-	-	JJ
10_1101-2021_01_08_425864	171	40	starved	starved	JJ
10_1101-2021_01_08_425864	171	41	parasites	parasite	NNS
10_1101-2021_01_08_425864	171	42	.	.	.
10_1101-2021_01_08_425864	172	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	172	2	is	be	VBZ
10_1101-2021_01_08_425864	172	3	relevant	relevant	JJ
10_1101-2021_01_08_425864	172	4	to	to	TO
10_1101-2021_01_08_425864	172	5	stress	stress	VB
10_1101-2021_01_08_425864	172	6	that	that	IN
10_1101-2021_01_08_425864	172	7	the	the	DT
10_1101-2021_01_08_425864	172	8	only	only	JJ
10_1101-2021_01_08_425864	172	9	possible	possible	JJ
10_1101-2021_01_08_425864	172	10	origin	origin	NN
10_1101-2021_01_08_425864	172	11	for	for	IN
10_1101-2021_01_08_425864	172	12	these	these	DT
10_1101-2021_01_08_425864	172	13	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	172	14	are	be	VBP
10_1101-2021_01_08_425864	172	15	297	297	CD
10_1101-2021_01_08_425864	172	16	internal	internal	JJ
10_1101-2021_01_08_425864	172	17	carbon	carbon	NN
10_1101-2021_01_08_425864	172	18	sources	source	NNS
10_1101-2021_01_08_425864	172	19	(	(	-LRB-
10_1101-2021_01_08_425864	172	20	ICS	ics	NN
10_1101-2021_01_08_425864	172	21	)	)	-RRB-
10_1101-2021_01_08_425864	172	22	.	.	.
10_1101-2021_01_08_425864	173	1	Notably	notably	RB
10_1101-2021_01_08_425864	173	2	,	,	,
10_1101-2021_01_08_425864	173	3	no	no	DT
10_1101-2021_01_08_425864	173	4	other	other	JJ
10_1101-2021_01_08_425864	173	5	excreted	excreted	JJ
10_1101-2021_01_08_425864	173	6	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	173	7	were	be	VBD
10_1101-2021_01_08_425864	173	8	detected	detect	VBN
10_1101-2021_01_08_425864	173	9	under	under	IN
10_1101-2021_01_08_425864	173	10	these	these	DT
10_1101-2021_01_08_425864	173	11	298	298	CD
10_1101-2021_01_08_425864	173	12	conditions	condition	NNS
10_1101-2021_01_08_425864	173	13	,	,	,
10_1101-2021_01_08_425864	173	14	indicating	indicate	VBG
10_1101-2021_01_08_425864	173	15	that	that	IN
10_1101-2021_01_08_425864	173	16	under	under	IN
10_1101-2021_01_08_425864	173	17	starvation	starvation	NN
10_1101-2021_01_08_425864	173	18	,	,	,
10_1101-2021_01_08_425864	173	19	most	most	JJS
10_1101-2021_01_08_425864	173	20	of	of	IN
10_1101-2021_01_08_425864	173	21	the	the	DT
10_1101-2021_01_08_425864	173	22	ICS	ICS	NNP
10_1101-2021_01_08_425864	173	23	are	be	VBP
10_1101-2021_01_08_425864	173	24	transformed	transform	VBN
10_1101-2021_01_08_425864	173	25	into	into	IN
10_1101-2021_01_08_425864	173	26	acetate	acetate	NNP
10_1101-2021_01_08_425864	173	27	as	as	IN
10_1101-2021_01_08_425864	173	28	an	an	DT
10_1101-2021_01_08_425864	173	29	end	end	NN
10_1101-2021_01_08_425864	173	30	299	299	CD
10_1101-2021_01_08_425864	173	31	product	product	NN
10_1101-2021_01_08_425864	173	32	,	,	,
10_1101-2021_01_08_425864	173	33	which	which	WDT
10_1101-2021_01_08_425864	173	34	is	be	VBZ
10_1101-2021_01_08_425864	173	35	compatible	compatible	JJ
10_1101-2021_01_08_425864	173	36	with	with	IN
10_1101-2021_01_08_425864	173	37	the	the	DT
10_1101-2021_01_08_425864	173	38	oxidation	oxidation	NN
10_1101-2021_01_08_425864	173	39	of	of	IN
10_1101-2021_01_08_425864	173	40	internal	internal	JJ
10_1101-2021_01_08_425864	173	41	fatty	fatty	NN
10_1101-2021_01_08_425864	173	42	acids	acid	NNS
10_1101-2021_01_08_425864	173	43	.	.	.
10_1101-2021_01_08_425864	174	1	These	these	DT
10_1101-2021_01_08_425864	174	2	results	result	NNS
10_1101-2021_01_08_425864	174	3	raise	raise	VBP
10_1101-2021_01_08_425864	174	4	the	the	DT
10_1101-2021_01_08_425864	174	5	question	question	NN
10_1101-2021_01_08_425864	174	6	300	300	CD
10_1101-2021_01_08_425864	174	7	about	about	IN
10_1101-2021_01_08_425864	174	8	the	the	DT
10_1101-2021_01_08_425864	174	9	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	174	10	fates	fate	NNS
10_1101-2021_01_08_425864	174	11	of	of	IN
10_1101-2021_01_08_425864	174	12	glucose	glucose	NN
10_1101-2021_01_08_425864	174	13	or	or	CC
10_1101-2021_01_08_425864	174	14	fatty	fatty	NN
10_1101-2021_01_08_425864	174	15	acids	acid	NNS
10_1101-2021_01_08_425864	174	16	in	in	IN
10_1101-2021_01_08_425864	174	17	previously	previously	RB
10_1101-2021_01_08_425864	174	18	starved	starve	VBN
10_1101-2021_01_08_425864	174	19	parasites	parasite	NNS
10_1101-2021_01_08_425864	174	20	.	.	.
10_1101-2021_01_08_425864	175	1	Starved	starve	VBN
10_1101-2021_01_08_425864	175	2	301	301	CD
10_1101-2021_01_08_425864	175	3	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	175	4	that	that	WDT
10_1101-2021_01_08_425864	175	5	recovered	recover	VBD
10_1101-2021_01_08_425864	175	6	in	in	IN
10_1101-2021_01_08_425864	175	7	the	the	DT
10_1101-2021_01_08_425864	175	8	presence	presence	NN
10_1101-2021_01_08_425864	175	9	of	of	IN
10_1101-2021_01_08_425864	175	10	glucose	glucose	NNP
10_1101-2021_01_08_425864	175	11	exhibited	exhibit	VBD
10_1101-2021_01_08_425864	175	12	a	a	DT
10_1101-2021_01_08_425864	175	13	profuse	profuse	NN
10_1101-2021_01_08_425864	175	14	excretion	excretion	NN
10_1101-2021_01_08_425864	175	15	of	of	IN
10_1101-2021_01_08_425864	175	16	succinate	succinate	NNP
10_1101-2021_01_08_425864	175	17	302	302	CD
10_1101-2021_01_08_425864	175	18	(	(	-LRB-
10_1101-2021_01_08_425864	175	19	450-fold	450-fold	CD
10_1101-2021_01_08_425864	175	20	the	the	DT
10_1101-2021_01_08_425864	175	21	quantity	quantity	NN
10_1101-2021_01_08_425864	175	22	excreted	excrete	VBN
10_1101-2021_01_08_425864	175	23	by	by	IN
10_1101-2021_01_08_425864	175	24	the	the	DT
10_1101-2021_01_08_425864	175	25	starved	starve	VBN
10_1101-2021_01_08_425864	175	26	cells	cell	NNS
10_1101-2021_01_08_425864	175	27	)	)	-RRB-
10_1101-2021_01_08_425864	175	28	and	and	CC
10_1101-2021_01_08_425864	175	29	roughly	roughly	RB
10_1101-2021_01_08_425864	175	30	equivalent	equivalent	JJ
10_1101-2021_01_08_425864	175	31	quantities	quantity	NNS
10_1101-2021_01_08_425864	175	32	of	of	IN
10_1101-2021_01_08_425864	175	33	acetate	acetate	JJ
10_1101-2021_01_08_425864	175	34	303	303	CD
10_1101-2021_01_08_425864	175	35	compared	compare	VBN
10_1101-2021_01_08_425864	175	36	with	with	IN
10_1101-2021_01_08_425864	175	37	the	the	DT
10_1101-2021_01_08_425864	175	38	starved	starve	VBN
10_1101-2021_01_08_425864	175	39	cells	cell	NNS
10_1101-2021_01_08_425864	175	40	.	.	.
10_1101-2021_01_08_425864	176	1	Interestingly	interestingly	RB
10_1101-2021_01_08_425864	176	2	,	,	,
10_1101-2021_01_08_425864	176	3	lactate	lactate	JJ
10_1101-2021_01_08_425864	176	4	and	and	CC
10_1101-2021_01_08_425864	176	5	alanine	alanine	NN
10_1101-2021_01_08_425864	176	6	were	be	VBD
10_1101-2021_01_08_425864	176	7	also	also	RB
10_1101-2021_01_08_425864	176	8	excreted	excrete	VBN
10_1101-2021_01_08_425864	176	9	at	at	IN
10_1101-2021_01_08_425864	176	10	similar	similar	JJ
10_1101-2021_01_08_425864	176	11	levels	level	NNS
10_1101-2021_01_08_425864	176	12	.	.	.
10_1101-2021_01_08_425864	177	1	304	304	CD
10_1101-2021_01_08_425864	177	2	As	as	IN
10_1101-2021_01_08_425864	177	3	expected	expect	VBN
10_1101-2021_01_08_425864	177	4	,	,	,
10_1101-2021_01_08_425864	177	5	the	the	DT
10_1101-2021_01_08_425864	177	6	recovery	recovery	NN
10_1101-2021_01_08_425864	177	7	with	with	IN
10_1101-2021_01_08_425864	177	8	glucose	glucose	NNP
10_1101-2021_01_08_425864	177	9	produced	produce	VBD
10_1101-2021_01_08_425864	177	10	an	an	DT
10_1101-2021_01_08_425864	177	11	increase	increase	NN
10_1101-2021_01_08_425864	177	12	in	in	IN
10_1101-2021_01_08_425864	177	13	all	all	PDT
10_1101-2021_01_08_425864	177	14	the	the	DT
10_1101-2021_01_08_425864	177	15	secreted	secrete	VBN
10_1101-2021_01_08_425864	177	16	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	177	17	.	.	.
10_1101-2021_01_08_425864	178	1	However	however	RB
10_1101-2021_01_08_425864	178	2	,	,	,
10_1101-2021_01_08_425864	178	3	305	305	CD
10_1101-2021_01_08_425864	178	4	analysing	analyse	VBG
10_1101-2021_01_08_425864	178	5	their	-PRON-	PRP$
10_1101-2021_01_08_425864	178	6	distribution	distribution	NN
10_1101-2021_01_08_425864	178	7	is	be	VBZ
10_1101-2021_01_08_425864	178	8	a	a	DT
10_1101-2021_01_08_425864	178	9	reconfiguration	reconfiguration	NN
10_1101-2021_01_08_425864	178	10	of	of	IN
10_1101-2021_01_08_425864	178	11	the	the	DT
10_1101-2021_01_08_425864	178	12	metabolism	metabolism	NN
10_1101-2021_01_08_425864	178	13	towards	towards	IN
10_1101-2021_01_08_425864	178	14	a	a	DT
10_1101-2021_01_08_425864	178	15	majority	majority	NN
10_1101-2021_01_08_425864	178	16	production	production	NN
10_1101-2021_01_08_425864	178	17	of	of	IN
10_1101-2021_01_08_425864	178	18	306	306	CD
10_1101-2021_01_08_425864	178	19	succinate	succinate	NN
10_1101-2021_01_08_425864	178	20	.	.	.
10_1101-2021_01_08_425864	179	1	Finally	finally	RB
10_1101-2021_01_08_425864	179	2	,	,	,
10_1101-2021_01_08_425864	179	3	in	in	IN
10_1101-2021_01_08_425864	179	4	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	179	5	incubated	incubate	VBN
10_1101-2021_01_08_425864	179	6	with	with	IN
10_1101-2021_01_08_425864	179	7	palmitate	palmitate	NN
10_1101-2021_01_08_425864	179	8	,	,	,
10_1101-2021_01_08_425864	179	9	we	-PRON-	PRP
10_1101-2021_01_08_425864	179	10	observed	observe	VBD
10_1101-2021_01_08_425864	179	11	an	an	DT
10_1101-2021_01_08_425864	179	12	increase	increase	NN
10_1101-2021_01_08_425864	179	13	in	in	IN
10_1101-2021_01_08_425864	179	14	the	the	DT
10_1101-2021_01_08_425864	179	15	acetate	acetate	JJ
10_1101-2021_01_08_425864	179	16	307	307	CD
10_1101-2021_01_08_425864	179	17	and	and	CC
10_1101-2021_01_08_425864	179	18	alanine	alanine	NN
10_1101-2021_01_08_425864	179	19	production	production	NN
10_1101-2021_01_08_425864	179	20	of	of	IN
10_1101-2021_01_08_425864	179	21	approximately	approximately	RB
10_1101-2021_01_08_425864	179	22	2.5	2.5	CD
10_1101-2021_01_08_425864	179	23	times	time	NNS
10_1101-2021_01_08_425864	179	24	to	to	IN
10_1101-2021_01_08_425864	179	25	the	the	DT
10_1101-2021_01_08_425864	179	26	levels	level	NNS
10_1101-2021_01_08_425864	179	27	in	in	IN
10_1101-2021_01_08_425864	179	28	parasites	parasite	NNS
10_1101-2021_01_08_425864	179	29	that	that	WDT
10_1101-2021_01_08_425864	179	30	recovered	recover	VBD
10_1101-2021_01_08_425864	179	31	in	in	IN
10_1101-2021_01_08_425864	179	32	the	the	DT
10_1101-2021_01_08_425864	179	33	308	308	CD
10_1101-2021_01_08_425864	179	34	presence	presence	NN
10_1101-2021_01_08_425864	179	35	of	of	IN
10_1101-2021_01_08_425864	179	36	glucose	glucose	NN
10_1101-2021_01_08_425864	179	37	.	.	.
10_1101-2021_01_08_425864	180	1	Interestingly	interestingly	RB
10_1101-2021_01_08_425864	180	2	,	,	,
10_1101-2021_01_08_425864	180	3	succinate	succinate	NN
10_1101-2021_01_08_425864	180	4	is	be	VBZ
10_1101-2021_01_08_425864	180	5	excreted	excrete	VBN
10_1101-2021_01_08_425864	180	6	in	in	IN
10_1101-2021_01_08_425864	180	7	a	a	DT
10_1101-2021_01_08_425864	180	8	smaller	small	JJR
10_1101-2021_01_08_425864	180	9	quantity	quantity	NN
10_1101-2021_01_08_425864	180	10	than	than	IN
10_1101-2021_01_08_425864	180	11	acetate	acetate	NN
10_1101-2021_01_08_425864	180	12	and	and	CC
10_1101-2021_01_08_425864	180	13	alanine	alanine	NN
10_1101-2021_01_08_425864	180	14	,	,	,
10_1101-2021_01_08_425864	180	15	309	309	CD
10_1101-2021_01_08_425864	180	16	but	but	CC
10_1101-2021_01_08_425864	180	17	still	still	RB
10_1101-2021_01_08_425864	180	18	at	at	IN
10_1101-2021_01_08_425864	180	19	10-fold	10-fold	CD
10_1101-2021_01_08_425864	180	20	the	the	DT
10_1101-2021_01_08_425864	180	21	rate	rate	NN
10_1101-2021_01_08_425864	180	22	observed	observe	VBN
10_1101-2021_01_08_425864	180	23	in	in	IN
10_1101-2021_01_08_425864	180	24	the	the	DT
10_1101-2021_01_08_425864	180	25	starved	starve	VBN
10_1101-2021_01_08_425864	180	26	non	non	JJ
10_1101-2021_01_08_425864	180	27	-	-	JJ
10_1101-2021_01_08_425864	180	28	recovered	recovered	JJ
10_1101-2021_01_08_425864	180	29	cells	cell	NNS
10_1101-2021_01_08_425864	180	30	.	.	.
10_1101-2021_01_08_425864	181	1	Surprisingly	surprisingly	RB
10_1101-2021_01_08_425864	181	2	,	,	,
10_1101-2021_01_08_425864	181	3	there	there	EX
10_1101-2021_01_08_425864	181	4	was	be	VBD
10_1101-2021_01_08_425864	181	5	also	also	RB
10_1101-2021_01_08_425864	181	6	a	a	DT
10_1101-2021_01_08_425864	181	7	.CC	.CC	NFP
10_1101-2021_01_08_425864	181	8	-	-	:
10_1101-2021_01_08_425864	181	9	BY	by	IN
10_1101-2021_01_08_425864	181	10	4.0	4.0	CD
10_1101-2021_01_08_425864	181	11	International	international	JJ
10_1101-2021_01_08_425864	181	12	licensemade	licensemade	NN
10_1101-2021_01_08_425864	181	13	available	available	JJ
10_1101-2021_01_08_425864	181	14	under	under	IN
10_1101-2021_01_08_425864	181	15	a	a	DT
10_1101-2021_01_08_425864	181	16	(	(	-LRB-
10_1101-2021_01_08_425864	181	17	which	which	WDT
10_1101-2021_01_08_425864	181	18	was	be	VBD
10_1101-2021_01_08_425864	181	19	not	not	RB
10_1101-2021_01_08_425864	181	20	certified	certify	VBN
10_1101-2021_01_08_425864	181	21	by	by	IN
10_1101-2021_01_08_425864	181	22	peer	peer	NN
10_1101-2021_01_08_425864	181	23	review	review	NN
10_1101-2021_01_08_425864	181	24	)	)	-RRB-
10_1101-2021_01_08_425864	181	25	is	be	VBZ
10_1101-2021_01_08_425864	181	26	the	the	DT
10_1101-2021_01_08_425864	181	27	author	author	NN
10_1101-2021_01_08_425864	181	28	/	/	SYM
10_1101-2021_01_08_425864	181	29	funder	funder	NN
10_1101-2021_01_08_425864	181	30	,	,	,
10_1101-2021_01_08_425864	181	31	who	who	WP
10_1101-2021_01_08_425864	181	32	has	have	VBZ
10_1101-2021_01_08_425864	181	33	granted	grant	VBN
10_1101-2021_01_08_425864	181	34	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	181	35	a	a	DT
10_1101-2021_01_08_425864	181	36	license	license	NN
10_1101-2021_01_08_425864	181	37	to	to	TO
10_1101-2021_01_08_425864	181	38	display	display	VB
10_1101-2021_01_08_425864	181	39	the	the	DT
10_1101-2021_01_08_425864	181	40	preprint	preprint	NN
10_1101-2021_01_08_425864	181	41	in	in	IN
10_1101-2021_01_08_425864	181	42	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	181	43	.	.	.
10_1101-2021_01_08_425864	182	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	182	2	is	be	VBZ
10_1101-2021_01_08_425864	182	3	The	the	DT
10_1101-2021_01_08_425864	182	4	copyright	copyright	NN
10_1101-2021_01_08_425864	182	5	holder	holder	NN
10_1101-2021_01_08_425864	182	6	for	for	IN
10_1101-2021_01_08_425864	182	7	this	this	DT
10_1101-2021_01_08_425864	182	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	182	9	version	version	NN
10_1101-2021_01_08_425864	182	10	posted	post	VBD
10_1101-2021_01_08_425864	182	11	January	January	NNP
10_1101-2021_01_08_425864	182	12	8	8	CD
10_1101-2021_01_08_425864	182	13	,	,	,
10_1101-2021_01_08_425864	182	14	2021	2021	CD
10_1101-2021_01_08_425864	182	15	.	.	.
10_1101-2021_01_08_425864	182	16	;	;	:
10_1101-2021_01_08_425864	182	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	182	18	:	:	:
10_1101-2021_01_08_425864	182	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	182	20	preprint	preprint	NN
10_1101-2021_01_08_425864	182	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	182	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	182	23	310	310	CD
10_1101-2021_01_08_425864	182	24	significant	significant	JJ
10_1101-2021_01_08_425864	182	25	production	production	NN
10_1101-2021_01_08_425864	182	26	of	of	IN
10_1101-2021_01_08_425864	182	27	pyruvate	pyruvate	NN
10_1101-2021_01_08_425864	182	28	(	(	-LRB-
10_1101-2021_01_08_425864	182	29	not	not	RB
10_1101-2021_01_08_425864	182	30	previously	previously	RB
10_1101-2021_01_08_425864	182	31	described	describe	VBN
10_1101-2021_01_08_425864	182	32	in	in	IN
10_1101-2021_01_08_425864	182	33	the	the	DT
10_1101-2021_01_08_425864	182	34	literature	literature	NN
10_1101-2021_01_08_425864	182	35	,	,	,
10_1101-2021_01_08_425864	182	36	and	and	CC
10_1101-2021_01_08_425864	182	37	not	not	RB
10_1101-2021_01_08_425864	182	38	observed	observe	VBN
10_1101-2021_01_08_425864	182	39	under	under	IN
10_1101-2021_01_08_425864	182	40	311	311	CD
10_1101-2021_01_08_425864	182	41	any	any	DT
10_1101-2021_01_08_425864	182	42	other	other	JJ
10_1101-2021_01_08_425864	182	43	conditions	condition	NNS
10_1101-2021_01_08_425864	182	44	)	)	-RRB-
10_1101-2021_01_08_425864	182	45	and	and	CC
10_1101-2021_01_08_425864	182	46	a	a	DT
10_1101-2021_01_08_425864	182	47	small	small	JJ
10_1101-2021_01_08_425864	182	48	amount	amount	NN
10_1101-2021_01_08_425864	182	49	of	of	IN
10_1101-2021_01_08_425864	182	50	lactate	lactate	NN
10_1101-2021_01_08_425864	182	51	derived	derive	VBN
10_1101-2021_01_08_425864	182	52	from	from	IN
10_1101-2021_01_08_425864	182	53	palmitate	palmitate	NN
10_1101-2021_01_08_425864	182	54	.	.	.
10_1101-2021_01_08_425864	183	1	312	312	CD
10_1101-2021_01_08_425864	183	2	313	313	CD
10_1101-2021_01_08_425864	183	3	Figure	figure	NN
10_1101-2021_01_08_425864	183	4	2	2	CD
10_1101-2021_01_08_425864	183	5	.	.	.
10_1101-2021_01_08_425864	184	1	Excreted	excreted	JJ
10_1101-2021_01_08_425864	184	2	end	end	NN
10_1101-2021_01_08_425864	184	3	products	product	NNS
10_1101-2021_01_08_425864	184	4	of	of	IN
10_1101-2021_01_08_425864	184	5	glucose	glucose	NN
10_1101-2021_01_08_425864	184	6	and	and	CC
10_1101-2021_01_08_425864	184	7	palmitate	palmitate	VB
10_1101-2021_01_08_425864	184	8	metabolism	metabolism	NN
10_1101-2021_01_08_425864	184	9	in	in	IN
10_1101-2021_01_08_425864	184	10	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	184	11	forms	form	NNS
10_1101-2021_01_08_425864	184	12	of	of	IN
10_1101-2021_01_08_425864	184	13	314	314	CD
10_1101-2021_01_08_425864	184	14	T.	t.	NN
10_1101-2021_01_08_425864	184	15	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	184	16	.	.	.
10_1101-2021_01_08_425864	185	1	A	a	LS
10_1101-2021_01_08_425864	185	2	)	)	-RRB-
10_1101-2021_01_08_425864	185	3	The	the	DT
10_1101-2021_01_08_425864	185	4	extracellular	extracellular	JJ
10_1101-2021_01_08_425864	185	5	medium	medium	NN
10_1101-2021_01_08_425864	185	6	of	of	IN
10_1101-2021_01_08_425864	185	7	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	185	8	forms	form	NNS
10_1101-2021_01_08_425864	185	9	incubated	incubate	VBN
10_1101-2021_01_08_425864	185	10	under	under	IN
10_1101-2021_01_08_425864	185	11	different	different	JJ
10_1101-2021_01_08_425864	185	12	conditions	condition	NNS
10_1101-2021_01_08_425864	185	13	315	315	CD
10_1101-2021_01_08_425864	185	14	was	be	VBD
10_1101-2021_01_08_425864	185	15	analysed	analyse	VBN
10_1101-2021_01_08_425864	185	16	by	by	IN
10_1101-2021_01_08_425864	185	17	1H	1h	JJ
10_1101-2021_01_08_425864	185	18	-	-	HYPH
10_1101-2021_01_08_425864	185	19	NMR	NMR	NNP
10_1101-2021_01_08_425864	185	20	spectrometry	spectrometry	NN
10_1101-2021_01_08_425864	185	21	to	to	TO
10_1101-2021_01_08_425864	185	22	detect	detect	VB
10_1101-2021_01_08_425864	185	23	and	and	CC
10_1101-2021_01_08_425864	185	24	quantify	quantify	VB
10_1101-2021_01_08_425864	185	25	the	the	DT
10_1101-2021_01_08_425864	185	26	end	end	NN
10_1101-2021_01_08_425864	185	27	-	-	HYPH
10_1101-2021_01_08_425864	185	28	products	product	NNS
10_1101-2021_01_08_425864	185	29	.	.	.
10_1101-2021_01_08_425864	186	1	The	the	DT
10_1101-2021_01_08_425864	186	2	resulting	result	VBG
10_1101-2021_01_08_425864	186	3	data	datum	NNS
10_1101-2021_01_08_425864	186	4	316	316	CD
10_1101-2021_01_08_425864	186	5	were	be	VBD
10_1101-2021_01_08_425864	186	6	expressed	express	VBN
10_1101-2021_01_08_425864	186	7	in	in	IN
10_1101-2021_01_08_425864	186	8	nmoles	nmoles	NNP
10_1101-2021_01_08_425864	186	9	/	/	SYM
10_1101-2021_01_08_425864	186	10	h/108	h/108	NNP
10_1101-2021_01_08_425864	186	11	cells	cell	NNS
10_1101-2021_01_08_425864	186	12	.	.	.
10_1101-2021_01_08_425864	187	1	Means	Means	NNPS
10_1101-2021_01_08_425864	187	2	±	±	NNP
10_1101-2021_01_08_425864	187	3	SD	sd	NN
10_1101-2021_01_08_425864	187	4	of	of	IN
10_1101-2021_01_08_425864	187	5	three	three	CD
10_1101-2021_01_08_425864	187	6	independent	independent	JJ
10_1101-2021_01_08_425864	187	7	experiments	experiment	NNS
10_1101-2021_01_08_425864	187	8	.	.	.
10_1101-2021_01_08_425864	188	1	ICS	ics	NN
10_1101-2021_01_08_425864	188	2	is	be	VBZ
10_1101-2021_01_08_425864	188	3	internal	internal	JJ
10_1101-2021_01_08_425864	188	4	317	317	CD
10_1101-2021_01_08_425864	188	5	carbon	carbon	NN
10_1101-2021_01_08_425864	188	6	sources	source	NNS
10_1101-2021_01_08_425864	188	7	;	;	:
10_1101-2021_01_08_425864	188	8	nd	nd	NNP
10_1101-2021_01_08_425864	188	9	is	be	VBZ
10_1101-2021_01_08_425864	188	10	non	non	JJ
10_1101-2021_01_08_425864	188	11	-	-	JJ
10_1101-2021_01_08_425864	188	12	detectable	detectable	JJ
10_1101-2021_01_08_425864	188	13	.	.	.
10_1101-2021_01_08_425864	189	1	B	b	NN
10_1101-2021_01_08_425864	189	2	)	)	-RRB-
10_1101-2021_01_08_425864	189	3	and	and	CC
10_1101-2021_01_08_425864	189	4	C	C	NNP
10_1101-2021_01_08_425864	189	5	)	)	-RRB-
10_1101-2021_01_08_425864	189	6	Schematic	schematic	JJ
10_1101-2021_01_08_425864	189	7	representation	representation	NN
10_1101-2021_01_08_425864	189	8	of	of	IN
10_1101-2021_01_08_425864	189	9	the	the	DT
10_1101-2021_01_08_425864	189	10	contribution	contribution	NN
10_1101-2021_01_08_425864	189	11	of	of	IN
10_1101-2021_01_08_425864	189	12	318	318	CD
10_1101-2021_01_08_425864	189	13	glucose	glucose	NN
10_1101-2021_01_08_425864	189	14	and	and	CC
10_1101-2021_01_08_425864	189	15	palmitate	palmitate	VBP
10_1101-2021_01_08_425864	189	16	to	to	IN
10_1101-2021_01_08_425864	189	17	the	the	DT
10_1101-2021_01_08_425864	189	18	metabolism	metabolism	NN
10_1101-2021_01_08_425864	189	19	of	of	IN
10_1101-2021_01_08_425864	189	20	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	189	21	forms	form	NNS
10_1101-2021_01_08_425864	189	22	of	of	IN
10_1101-2021_01_08_425864	189	23	T.	T.	NNP
10_1101-2021_01_08_425864	189	24	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	189	25	.	.	.
10_1101-2021_01_08_425864	190	1	The	the	DT
10_1101-2021_01_08_425864	190	2	glycosomal	glycosomal	NN
10_1101-2021_01_08_425864	190	3	319	319	CD
10_1101-2021_01_08_425864	190	4	compartment	compartment	NN
10_1101-2021_01_08_425864	190	5	and	and	CC
10_1101-2021_01_08_425864	190	6	TCA	TCA	NNP
10_1101-2021_01_08_425864	190	7	cycle	cycle	NN
10_1101-2021_01_08_425864	190	8	are	be	VBP
10_1101-2021_01_08_425864	190	9	indicated	indicate	VBN
10_1101-2021_01_08_425864	190	10	.	.	.
10_1101-2021_01_08_425864	191	1	The	the	DT
10_1101-2021_01_08_425864	191	2	amount	amount	NN
10_1101-2021_01_08_425864	191	3	of	of	IN
10_1101-2021_01_08_425864	191	4	end	end	NN
10_1101-2021_01_08_425864	191	5	-	-	HYPH
10_1101-2021_01_08_425864	191	6	product	product	NN
10_1101-2021_01_08_425864	191	7	determined	determine	VBN
10_1101-2021_01_08_425864	191	8	by	by	IN
10_1101-2021_01_08_425864	191	9	the	the	DT
10_1101-2021_01_08_425864	191	10	font	font	NN
10_1101-2021_01_08_425864	191	11	size	size	NN
10_1101-2021_01_08_425864	191	12	.	.	.
10_1101-2021_01_08_425864	192	1	320	320	CD
10_1101-2021_01_08_425864	192	2	Numbers	number	NNS
10_1101-2021_01_08_425864	192	3	indicates	indicate	VBZ
10_1101-2021_01_08_425864	192	4	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	192	5	steps	step	NNS
10_1101-2021_01_08_425864	192	6	.	.	.
10_1101-2021_01_08_425864	193	1	1	1	LS
10_1101-2021_01_08_425864	193	2	.	.	.
10_1101-2021_01_08_425864	194	1	Glycolysis	glycolysis	NN
10_1101-2021_01_08_425864	194	2	;	;	:
10_1101-2021_01_08_425864	194	3	2	2	LS
10_1101-2021_01_08_425864	194	4	.	.	.
10_1101-2021_01_08_425864	194	5	pyruvate	pyruvate	VB
10_1101-2021_01_08_425864	194	6	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	194	7	;	;	:
10_1101-2021_01_08_425864	194	8	3	3	CD
10_1101-2021_01_08_425864	194	9	.	.	.
10_1101-2021_01_08_425864	194	10	citrate	citrate	NNP
10_1101-2021_01_08_425864	194	11	synthase	synthase	NN
10_1101-2021_01_08_425864	194	12	;	;	:
10_1101-2021_01_08_425864	194	13	4	4	CD
10_1101-2021_01_08_425864	194	14	.	.	.
10_1101-2021_01_08_425864	195	1	321	321	CD
10_1101-2021_01_08_425864	195	2	aconitase	aconitase	NN
10_1101-2021_01_08_425864	195	3	;	;	:
10_1101-2021_01_08_425864	195	4	5	5	LS
10_1101-2021_01_08_425864	195	5	.	.	.
10_1101-2021_01_08_425864	195	6	isocitrate	isocitrate	VB
10_1101-2021_01_08_425864	195	7	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	195	8	;	;	:
10_1101-2021_01_08_425864	195	9	6	6	CD
10_1101-2021_01_08_425864	195	10	.	.	.
10_1101-2021_01_08_425864	195	11	α	α	LS
10_1101-2021_01_08_425864	195	12	-	-	HYPH
10_1101-2021_01_08_425864	195	13	ketoglutarate	ketoglutarate	NNP
10_1101-2021_01_08_425864	195	14	dehydrogenase	dehydrogenase	NNP
10_1101-2021_01_08_425864	195	15	;	;	:
10_1101-2021_01_08_425864	195	16	7	7	CD
10_1101-2021_01_08_425864	195	17	.	.	.
10_1101-2021_01_08_425864	195	18	succinyl	succinyl	NNP
10_1101-2021_01_08_425864	195	19	-	-	HYPH
10_1101-2021_01_08_425864	195	20	CoA	CoA	NNP
10_1101-2021_01_08_425864	195	21	322	322	CD
10_1101-2021_01_08_425864	195	22	synthetase	synthetase	NN
10_1101-2021_01_08_425864	195	23	;	;	:
10_1101-2021_01_08_425864	195	24	8	8	CD
10_1101-2021_01_08_425864	195	25	.	.	.
10_1101-2021_01_08_425864	196	1	Succinate	succinate	VB
10_1101-2021_01_08_425864	196	2	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	196	3	/	/	SYM
10_1101-2021_01_08_425864	196	4	complex	complex	JJ
10_1101-2021_01_08_425864	196	5	II	ii	CD
10_1101-2021_01_08_425864	196	6	/	/	SYM
10_1101-2021_01_08_425864	196	7	fumarate	fumarate	NN
10_1101-2021_01_08_425864	196	8	reductase	reductase	NN
10_1101-2021_01_08_425864	196	9	NADH	NADH	NNP
10_1101-2021_01_08_425864	196	10	-	-	HYPH
10_1101-2021_01_08_425864	196	11	dependent	dependent	JJ
10_1101-2021_01_08_425864	196	12	;	;	:
10_1101-2021_01_08_425864	196	13	9	9	CD
10_1101-2021_01_08_425864	196	14	.	.	.
10_1101-2021_01_08_425864	197	1	323	323	CD
10_1101-2021_01_08_425864	197	2	fumarate	fumarate	NN
10_1101-2021_01_08_425864	197	3	hydratase	hydratase	NN
10_1101-2021_01_08_425864	197	4	;	;	:
10_1101-2021_01_08_425864	197	5	10	10	CD
10_1101-2021_01_08_425864	197	6	.	.	.
10_1101-2021_01_08_425864	197	7	malate	malate	NNP
10_1101-2021_01_08_425864	197	8	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	197	9	;	;	:
10_1101-2021_01_08_425864	197	10	11	11	CD
10_1101-2021_01_08_425864	197	11	.	.	.
10_1101-2021_01_08_425864	198	1	Malic	malic	JJ
10_1101-2021_01_08_425864	198	2	enzyme	enzyme	NNS
10_1101-2021_01_08_425864	198	3	;	;	:
10_1101-2021_01_08_425864	198	4	12	12	CD
10_1101-2021_01_08_425864	198	5	.	.	.
10_1101-2021_01_08_425864	198	6	alanine	alanine	NNP
10_1101-2021_01_08_425864	198	7	dehydrogenase	dehydrogenase	NNP
10_1101-2021_01_08_425864	198	8	/	/	SYM
10_1101-2021_01_08_425864	198	9	alanine	alanine	NNP
10_1101-2021_01_08_425864	198	10	324	324	CD
10_1101-2021_01_08_425864	198	11	aminotransferase	aminotransferase	NN
10_1101-2021_01_08_425864	198	12	;	;	:
10_1101-2021_01_08_425864	198	13	13	13	CD
10_1101-2021_01_08_425864	198	14	.	.	.
10_1101-2021_01_08_425864	198	15	lactate	lactate	JJ
10_1101-2021_01_08_425864	198	16	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	198	17	;	;	:
10_1101-2021_01_08_425864	198	18	14	14	CD
10_1101-2021_01_08_425864	198	19	.	.	.
10_1101-2021_01_08_425864	198	20	acetate	acetate	NNP
10_1101-2021_01_08_425864	198	21	:	:	:
10_1101-2021_01_08_425864	198	22	succinyl	succinyl	NNP
10_1101-2021_01_08_425864	198	23	-	-	HYPH
10_1101-2021_01_08_425864	198	24	CoA	CoA	NNP
10_1101-2021_01_08_425864	198	25	transferase	transferase	NN
10_1101-2021_01_08_425864	198	26	;	;	:
10_1101-2021_01_08_425864	198	27	15	15	CD
10_1101-2021_01_08_425864	198	28	.	.	.
10_1101-2021_01_08_425864	198	29	acetyl	acetyl	NNP
10_1101-2021_01_08_425864	198	30	-	-	HYPH
10_1101-2021_01_08_425864	198	31	CoA	CoA	NNP
10_1101-2021_01_08_425864	198	32	325	325	CD
10_1101-2021_01_08_425864	198	33	hydrolase	hydrolase	NN
10_1101-2021_01_08_425864	198	34	;	;	:
10_1101-2021_01_08_425864	198	35	16	16	CD
10_1101-2021_01_08_425864	198	36	.	.	.
10_1101-2021_01_08_425864	198	37	succinyl	succinyl	NNP
10_1101-2021_01_08_425864	198	38	-	-	HYPH
10_1101-2021_01_08_425864	198	39	CoA	CoA	NNP
10_1101-2021_01_08_425864	198	40	synthetase	synthetase	NN
10_1101-2021_01_08_425864	198	41	;	;	:
10_1101-2021_01_08_425864	198	42	17	17	CD
10_1101-2021_01_08_425864	198	43	.	.	.
10_1101-2021_01_08_425864	199	1	Glycosomal	glycosomal	JJ
10_1101-2021_01_08_425864	199	2	fumarate	fumarate	NN
10_1101-2021_01_08_425864	199	3	reductase	reductase	NN
10_1101-2021_01_08_425864	199	4	and	and	CC
10_1101-2021_01_08_425864	199	5	18	18	CD
10_1101-2021_01_08_425864	199	6	.	.	.
10_1101-2021_01_08_425864	200	1	Palmitate	palmitate	NN
10_1101-2021_01_08_425864	200	2	326	326	CD
10_1101-2021_01_08_425864	200	3	oxidation	oxidation	NN
10_1101-2021_01_08_425864	200	4	by	by	IN
10_1101-2021_01_08_425864	200	5	beta	beta	NN
10_1101-2021_01_08_425864	200	6	-	-	HYPH
10_1101-2021_01_08_425864	200	7	oxidation	oxidation	NN
10_1101-2021_01_08_425864	200	8	,	,	,
10_1101-2021_01_08_425864	200	9	resulting	result	VBG
10_1101-2021_01_08_425864	200	10	in	in	IN
10_1101-2021_01_08_425864	200	11	FADH2	FADH2	NNP
10_1101-2021_01_08_425864	200	12	,	,	,
10_1101-2021_01_08_425864	200	13	NADH	NADH	NNP
10_1101-2021_01_08_425864	200	14	and	and	CC
10_1101-2021_01_08_425864	200	15	acetyl	acetyl	NNP
10_1101-2021_01_08_425864	200	16	-	-	HYPH
10_1101-2021_01_08_425864	200	17	CoA	CoA	NNP
10_1101-2021_01_08_425864	200	18	;	;	:
10_1101-2021_01_08_425864	200	19	Abbreviations	Abbreviations	NNP
10_1101-2021_01_08_425864	200	20	:	:	:
10_1101-2021_01_08_425864	200	21	Cit	Cit	NNP
10_1101-2021_01_08_425864	200	22	:	:	:
10_1101-2021_01_08_425864	200	23	Citrate	Citrate	NNP
10_1101-2021_01_08_425864	200	24	,	,	,
10_1101-2021_01_08_425864	200	25	327	327	CD
10_1101-2021_01_08_425864	200	26	Aco	aco	JJ
10_1101-2021_01_08_425864	200	27	:	:	:
10_1101-2021_01_08_425864	200	28	Aconitate	Aconitate	NNP
10_1101-2021_01_08_425864	200	29	,	,	,
10_1101-2021_01_08_425864	200	30	IsoC	IsoC	NNP
10_1101-2021_01_08_425864	200	31	:	:	:
10_1101-2021_01_08_425864	200	32	Isocitrate	isocitrate	VB
10_1101-2021_01_08_425864	200	33	,	,	,
10_1101-2021_01_08_425864	200	34	α	α	NNP
10_1101-2021_01_08_425864	200	35	-	-	HYPH
10_1101-2021_01_08_425864	200	36	kg	kg	NNS
10_1101-2021_01_08_425864	200	37	:	:	:
10_1101-2021_01_08_425864	200	38	α	α	LS
10_1101-2021_01_08_425864	200	39	-	-	:
10_1101-2021_01_08_425864	200	40	Ketoglutarate	Ketoglutarate	NNP
10_1101-2021_01_08_425864	200	41	,	,	,
10_1101-2021_01_08_425864	200	42	Suc	Suc	NNP
10_1101-2021_01_08_425864	200	43	-	-	HYPH
10_1101-2021_01_08_425864	200	44	CoA	CoA	NNP
10_1101-2021_01_08_425864	200	45	:	:	:
10_1101-2021_01_08_425864	200	46	Succinyl	Succinyl	NNP
10_1101-2021_01_08_425864	200	47	-	-	HYPH
10_1101-2021_01_08_425864	200	48	CoA	CoA	NNP
10_1101-2021_01_08_425864	200	49	,	,	,
10_1101-2021_01_08_425864	200	50	Suc	Suc	NNP
10_1101-2021_01_08_425864	200	51	:	:	:
10_1101-2021_01_08_425864	200	52	Succinate	Succinate	NNP
10_1101-2021_01_08_425864	200	53	,	,	,
10_1101-2021_01_08_425864	200	54	328	328	CD
10_1101-2021_01_08_425864	200	55	Fum	Fum	NNP
10_1101-2021_01_08_425864	200	56	:	:	:
10_1101-2021_01_08_425864	200	57	Fumarate	Fumarate	NNP
10_1101-2021_01_08_425864	200	58	,	,	,
10_1101-2021_01_08_425864	200	59	Mal	Mal	NNP
10_1101-2021_01_08_425864	200	60	:	:	:
10_1101-2021_01_08_425864	200	61	Malate	Malate	NNP
10_1101-2021_01_08_425864	200	62	,	,	,
10_1101-2021_01_08_425864	200	63	and	and	CC
10_1101-2021_01_08_425864	200	64	Oxa	oxa	NN
10_1101-2021_01_08_425864	200	65	:	:	:
10_1101-2021_01_08_425864	200	66	Oxaloacetate	oxaloacetate	VB
10_1101-2021_01_08_425864	200	67	.	.	.
10_1101-2021_01_08_425864	201	1	329	329	CD
10_1101-2021_01_08_425864	201	2	330	330	CD
10_1101-2021_01_08_425864	201	3	Glucose	Glucose	NNP
10_1101-2021_01_08_425864	201	4	metabolism	metabolism	NN
10_1101-2021_01_08_425864	201	5	represses	repress	VBZ
10_1101-2021_01_08_425864	201	6	the	the	DT
10_1101-2021_01_08_425864	201	7	fatty	fatty	NN
10_1101-2021_01_08_425864	201	8	acid	acid	NN
10_1101-2021_01_08_425864	201	9	oxidation	oxidation	NN
10_1101-2021_01_08_425864	201	10	in	in	IN
10_1101-2021_01_08_425864	201	11	epimastigotes	epimastigote	VBZ
10_1101-2021_01_08_425864	201	12	331	331	CD
10_1101-2021_01_08_425864	201	13	Glucose	Glucose	NNP
10_1101-2021_01_08_425864	201	14	is	be	VBZ
10_1101-2021_01_08_425864	201	15	the	the	DT
10_1101-2021_01_08_425864	201	16	primary	primary	JJ
10_1101-2021_01_08_425864	201	17	carbon	carbon	NN
10_1101-2021_01_08_425864	201	18	source	source	NN
10_1101-2021_01_08_425864	201	19	for	for	IN
10_1101-2021_01_08_425864	201	20	exponentially	exponentially	RB
10_1101-2021_01_08_425864	201	21	proliferating	proliferate	VBG
10_1101-2021_01_08_425864	201	22	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	201	23	,	,	,
10_1101-2021_01_08_425864	201	24	and	and	CC
10_1101-2021_01_08_425864	201	25	after	after	IN
10_1101-2021_01_08_425864	201	26	332	332	CD
10_1101-2021_01_08_425864	201	27	its	-PRON-	PRP$
10_1101-2021_01_08_425864	201	28	exhaustion	exhaustion	NN
10_1101-2021_01_08_425864	201	29	from	from	IN
10_1101-2021_01_08_425864	201	30	the	the	DT
10_1101-2021_01_08_425864	201	31	culture	culture	NN
10_1101-2021_01_08_425864	201	32	medium	medium	NN
10_1101-2021_01_08_425864	201	33	,	,	,
10_1101-2021_01_08_425864	201	34	the	the	DT
10_1101-2021_01_08_425864	201	35	parasites	parasite	NNS
10_1101-2021_01_08_425864	201	36	change	change	VBP
10_1101-2021_01_08_425864	201	37	their	-PRON-	PRP$
10_1101-2021_01_08_425864	201	38	metabolism	metabolism	NN
10_1101-2021_01_08_425864	201	39	to	to	TO
10_1101-2021_01_08_425864	201	40	use	use	VB
10_1101-2021_01_08_425864	201	41	amino	amino	JJ
10_1101-2021_01_08_425864	201	42	acids	acid	NNS
10_1101-2021_01_08_425864	201	43	as	as	IN
10_1101-2021_01_08_425864	201	44	333	333	CD
10_1101-2021_01_08_425864	201	45	carbon	carbon	NN
10_1101-2021_01_08_425864	201	46	sources	source	NNS
10_1101-2021_01_08_425864	201	47	preferentially	preferentially	RB
10_1101-2021_01_08_425864	201	48	[	[	-LRB-
10_1101-2021_01_08_425864	201	49	10	10	CD
10_1101-2021_01_08_425864	201	50	]	]	-RRB-
10_1101-2021_01_08_425864	201	51	.	.	.
10_1101-2021_01_08_425864	202	1	Therefore	therefore	RB
10_1101-2021_01_08_425864	202	2	,	,	,
10_1101-2021_01_08_425864	202	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	202	4	were	be	VBD
10_1101-2021_01_08_425864	202	5	interested	interested	JJ
10_1101-2021_01_08_425864	202	6	in	in	IN
10_1101-2021_01_08_425864	202	7	analysing	analyse	VBG
10_1101-2021_01_08_425864	202	8	if	if	IN
10_1101-2021_01_08_425864	202	9	this	this	DT
10_1101-2021_01_08_425864	202	10	preference	preference	NN
10_1101-2021_01_08_425864	202	11	for	for	IN
10_1101-2021_01_08_425864	202	12	334	334	CD
10_1101-2021_01_08_425864	202	13	glucose	glucose	NN
10_1101-2021_01_08_425864	202	14	is	be	VBZ
10_1101-2021_01_08_425864	202	15	maintained	maintain	VBN
10_1101-2021_01_08_425864	202	16	in	in	IN
10_1101-2021_01_08_425864	202	17	relation	relation	NN
10_1101-2021_01_08_425864	202	18	to	to	IN
10_1101-2021_01_08_425864	202	19	the	the	DT
10_1101-2021_01_08_425864	202	20	consumption	consumption	NN
10_1101-2021_01_08_425864	202	21	of	of	IN
10_1101-2021_01_08_425864	202	22	lipids	lipid	NNS
10_1101-2021_01_08_425864	202	23	.	.	.
10_1101-2021_01_08_425864	203	1	To	to	TO
10_1101-2021_01_08_425864	203	2	determine	determine	VB
10_1101-2021_01_08_425864	203	3	if	if	IN
10_1101-2021_01_08_425864	203	4	glucose	glucose	NN
10_1101-2021_01_08_425864	203	5	metabolism	metabolism	VBG
10_1101-2021_01_08_425864	203	6	335	335	CD
10_1101-2021_01_08_425864	203	7	interferes	interfere	NNS
10_1101-2021_01_08_425864	203	8	with	with	IN
10_1101-2021_01_08_425864	203	9	the	the	DT
10_1101-2021_01_08_425864	203	10	consumption	consumption	NN
10_1101-2021_01_08_425864	203	11	of	of	IN
10_1101-2021_01_08_425864	203	12	fatty	fatty	NN
10_1101-2021_01_08_425864	203	13	acids	acid	NNS
10_1101-2021_01_08_425864	203	14	,	,	,
10_1101-2021_01_08_425864	203	15	we	-PRON-	PRP
10_1101-2021_01_08_425864	203	16	created	create	VBD
10_1101-2021_01_08_425864	203	17	a	a	DT
10_1101-2021_01_08_425864	203	18	48	48	CD
10_1101-2021_01_08_425864	203	19	h	h	NN
10_1101-2021_01_08_425864	203	20	proliferation	proliferation	NN
10_1101-2021_01_08_425864	203	21	curve	curve	NN
10_1101-2021_01_08_425864	203	22	using	use	VBG
10_1101-2021_01_08_425864	203	23	parasites	parasite	NNS
10_1101-2021_01_08_425864	203	24	336	336	CD
10_1101-2021_01_08_425864	203	25	with	with	IN
10_1101-2021_01_08_425864	203	26	an	an	DT
10_1101-2021_01_08_425864	203	27	initial	initial	JJ
10_1101-2021_01_08_425864	203	28	concentration	concentration	NN
10_1101-2021_01_08_425864	203	29	adjusted	adjust	VBN
10_1101-2021_01_08_425864	203	30	to	to	IN
10_1101-2021_01_08_425864	203	31	2.5	2.5	CD
10_1101-2021_01_08_425864	203	32	x	x	SYM
10_1101-2021_01_08_425864	203	33	107	107	CD
10_1101-2021_01_08_425864	203	34	mL-1	ml-1	NN
10_1101-2021_01_08_425864	203	35	and	and	CC
10_1101-2021_01_08_425864	203	36	quantified	quantify	VBD
10_1101-2021_01_08_425864	203	37	them	-PRON-	PRP
10_1101-2021_01_08_425864	203	38	for	for	IN
10_1101-2021_01_08_425864	203	39	24	24	CD
10_1101-2021_01_08_425864	203	40	h	h	NNS
10_1101-2021_01_08_425864	203	41	each	each	DT
10_1101-2021_01_08_425864	203	42	.	.	.
10_1101-2021_01_08_425864	204	1	Under	under	IN
10_1101-2021_01_08_425864	204	2	these	these	DT
10_1101-2021_01_08_425864	204	3	337	337	CD
10_1101-2021_01_08_425864	204	4	conditions	condition	NNS
10_1101-2021_01_08_425864	204	5	,	,	,
10_1101-2021_01_08_425864	204	6	the	the	DT
10_1101-2021_01_08_425864	204	7	parasites	parasite	NNS
10_1101-2021_01_08_425864	204	8	from	from	IN
10_1101-2021_01_08_425864	204	9	the	the	DT
10_1101-2021_01_08_425864	204	10	beginning	beginning	NN
10_1101-2021_01_08_425864	204	11	of	of	IN
10_1101-2021_01_08_425864	204	12	the	the	DT
10_1101-2021_01_08_425864	204	13	experiment	experiment	NN
10_1101-2021_01_08_425864	204	14	,	,	,
10_1101-2021_01_08_425864	204	15	at	at	IN
10_1101-2021_01_08_425864	204	16	0	0	CD
10_1101-2021_01_08_425864	204	17	h	h	NN
10_1101-2021_01_08_425864	204	18	,	,	,
10_1101-2021_01_08_425864	204	19	are	be	VBP
10_1101-2021_01_08_425864	204	20	at	at	IN
10_1101-2021_01_08_425864	204	21	mid	mid	JJ
10_1101-2021_01_08_425864	204	22	-	-	JJ
10_1101-2021_01_08_425864	204	23	exponential	exponential	JJ
10_1101-2021_01_08_425864	204	24	phase	phase	NN
10_1101-2021_01_08_425864	204	25	,	,	,
10_1101-2021_01_08_425864	204	26	338	338	CD
10_1101-2021_01_08_425864	204	27	they	-PRON-	PRP
10_1101-2021_01_08_425864	204	28	are	be	VBP
10_1101-2021_01_08_425864	204	29	at	at	IN
10_1101-2021_01_08_425864	204	30	late	late	JJ
10_1101-2021_01_08_425864	204	31	exponential	exponential	JJ
10_1101-2021_01_08_425864	204	32	phase	phase	NN
10_1101-2021_01_08_425864	204	33	at	at	IN
10_1101-2021_01_08_425864	204	34	24	24	CD
10_1101-2021_01_08_425864	204	35	h	h	NN
10_1101-2021_01_08_425864	204	36	,	,	,
10_1101-2021_01_08_425864	204	37	and	and	CC
10_1101-2021_01_08_425864	204	38	at	at	IN
10_1101-2021_01_08_425864	204	39	48	48	CD
10_1101-2021_01_08_425864	204	40	h	h	NN
10_1101-2021_01_08_425864	204	41	they	-PRON-	PRP
10_1101-2021_01_08_425864	204	42	reached	reach	VBD
10_1101-2021_01_08_425864	204	43	stationary	stationary	JJ
10_1101-2021_01_08_425864	204	44	phase	phase	NN
10_1101-2021_01_08_425864	204	45	at	at	IN
10_1101-2021_01_08_425864	204	46	a	a	DT
10_1101-2021_01_08_425864	204	47	concentration	concentration	NN
10_1101-2021_01_08_425864	204	48	339	339	CD
10_1101-2021_01_08_425864	204	49	of	of	IN
10_1101-2021_01_08_425864	204	50	10	10	CD
10_1101-2021_01_08_425864	204	51	x	x	SYM
10_1101-2021_01_08_425864	204	52	107	107	CD
10_1101-2021_01_08_425864	204	53	mL-1	ml-1	NN
10_1101-2021_01_08_425864	204	54	(	(	-LRB-
10_1101-2021_01_08_425864	204	55	Fig	Fig	NNP
10_1101-2021_01_08_425864	204	56	3A	3A	NNP
10_1101-2021_01_08_425864	204	57	)	)	-RRB-
10_1101-2021_01_08_425864	204	58	.	.	.
10_1101-2021_01_08_425864	205	1	At	at	IN
10_1101-2021_01_08_425864	205	2	0	0	CD
10_1101-2021_01_08_425864	205	3	h	h	NN
10_1101-2021_01_08_425864	205	4	,	,	,
10_1101-2021_01_08_425864	205	5	24	24	CD
10_1101-2021_01_08_425864	205	6	h	h	NN
10_1101-2021_01_08_425864	205	7	and	and	CC
10_1101-2021_01_08_425864	205	8	48	48	CD
10_1101-2021_01_08_425864	205	9	h	h	NNS
10_1101-2021_01_08_425864	205	10	,	,	,
10_1101-2021_01_08_425864	205	11	the	the	DT
10_1101-2021_01_08_425864	205	12	culture	culture	NN
10_1101-2021_01_08_425864	205	13	medium	medium	NN
10_1101-2021_01_08_425864	205	14	was	be	VBD
10_1101-2021_01_08_425864	205	15	collected	collect	VBN
10_1101-2021_01_08_425864	205	16	to	to	TO
10_1101-2021_01_08_425864	205	17	measure	measure	VB
10_1101-2021_01_08_425864	205	18	the	the	DT
10_1101-2021_01_08_425864	205	19	340	340	CD
10_1101-2021_01_08_425864	205	20	remaining	remain	VBG
10_1101-2021_01_08_425864	205	21	glucose	glucose	NN
10_1101-2021_01_08_425864	205	22	and	and	CC
10_1101-2021_01_08_425864	205	23	triacylglycerol	triacylglycerol	NN
10_1101-2021_01_08_425864	205	24	(	(	-LRB-
10_1101-2021_01_08_425864	205	25	TAGs	TAGs	NNP
10_1101-2021_01_08_425864	205	26	)	)	-RRB-
10_1101-2021_01_08_425864	205	27	concentrations	concentration	NNS
10_1101-2021_01_08_425864	205	28	(	(	-LRB-
10_1101-2021_01_08_425864	205	29	Figs	fig	NNS
10_1101-2021_01_08_425864	205	30	3B	3b	NN
10_1101-2021_01_08_425864	205	31	and	and	CC
10_1101-2021_01_08_425864	205	32	3C	3c	NN
10_1101-2021_01_08_425864	205	33	)	)	-RRB-
10_1101-2021_01_08_425864	205	34	.	.	.
10_1101-2021_01_08_425864	206	1	Most	Most	JJS
10_1101-2021_01_08_425864	206	2	of	of	IN
10_1101-2021_01_08_425864	206	3	the	the	DT
10_1101-2021_01_08_425864	206	4	glucose	glucose	NN
10_1101-2021_01_08_425864	206	5	341	341	CD
10_1101-2021_01_08_425864	206	6	was	be	VBD
10_1101-2021_01_08_425864	206	7	consumed	consume	VBN
10_1101-2021_01_08_425864	206	8	during	during	IN
10_1101-2021_01_08_425864	206	9	the	the	DT
10_1101-2021_01_08_425864	206	10	first	first	JJ
10_1101-2021_01_08_425864	206	11	24	24	CD
10_1101-2021_01_08_425864	206	12	h	h	NN
10_1101-2021_01_08_425864	206	13	(	(	-LRB-
10_1101-2021_01_08_425864	206	14	during	during	IN
10_1101-2021_01_08_425864	206	15	proliferation	proliferation	NN
10_1101-2021_01_08_425864	206	16	)	)	-RRB-
10_1101-2021_01_08_425864	206	17	,	,	,
10_1101-2021_01_08_425864	206	18	while	while	IN
10_1101-2021_01_08_425864	206	19	the	the	DT
10_1101-2021_01_08_425864	206	20	concentration	concentration	NN
10_1101-2021_01_08_425864	206	21	of	of	IN
10_1101-2021_01_08_425864	206	22	TAGs	tag	NNS
10_1101-2021_01_08_425864	206	23	remained	remain	VBD
10_1101-2021_01_08_425864	206	24	342	342	CD
10_1101-2021_01_08_425864	206	25	the	the	DT
10_1101-2021_01_08_425864	206	26	same	same	JJ
10_1101-2021_01_08_425864	206	27	.	.	.
10_1101-2021_01_08_425864	207	1	After	after	IN
10_1101-2021_01_08_425864	207	2	48	48	CD
10_1101-2021_01_08_425864	207	3	h	h	NN
10_1101-2021_01_08_425864	207	4	of	of	IN
10_1101-2021_01_08_425864	207	5	proliferation	proliferation	NN
10_1101-2021_01_08_425864	207	6	(	(	-LRB-
10_1101-2021_01_08_425864	207	7	stationary	stationary	JJ
10_1101-2021_01_08_425864	207	8	phase	phase	NN
10_1101-2021_01_08_425864	207	9	)	)	-RRB-
10_1101-2021_01_08_425864	207	10	,	,	,
10_1101-2021_01_08_425864	207	11	the	the	DT
10_1101-2021_01_08_425864	207	12	TAG	TAG	NNP
10_1101-2021_01_08_425864	207	13	levels	level	NNS
10_1101-2021_01_08_425864	207	14	and	and	CC
10_1101-2021_01_08_425864	207	15	lipid	lipid	NN
10_1101-2021_01_08_425864	207	16	contents	content	NNS
10_1101-2021_01_08_425864	207	17	of	of	IN
10_1101-2021_01_08_425864	207	18	the	the	DT
10_1101-2021_01_08_425864	207	19	343	343	CD
10_1101-2021_01_08_425864	207	20	droplets	droplet	NNS
10_1101-2021_01_08_425864	207	21	were	be	VBD
10_1101-2021_01_08_425864	207	22	decreased	decrease	VBN
10_1101-2021_01_08_425864	207	23	by	by	IN
10_1101-2021_01_08_425864	207	24	1.5-fold	1.5-fold	CD
10_1101-2021_01_08_425864	207	25	and	and	CC
10_1101-2021_01_08_425864	207	26	2-fold	2-fold	CD
10_1101-2021_01_08_425864	207	27	,	,	,
10_1101-2021_01_08_425864	207	28	respectively	respectively	RB
10_1101-2021_01_08_425864	207	29	,	,	,
10_1101-2021_01_08_425864	207	30	suggesting	suggest	VBG
10_1101-2021_01_08_425864	207	31	that	that	IN
10_1101-2021_01_08_425864	207	32	glucose	glucose	NN
10_1101-2021_01_08_425864	207	33	is	be	VBZ
10_1101-2021_01_08_425864	207	34	preferentially	preferentially	RB
10_1101-2021_01_08_425864	207	35	344	344	CD
10_1101-2021_01_08_425864	207	36	consumed	consume	VBN
10_1101-2021_01_08_425864	207	37	relative	relative	JJ
10_1101-2021_01_08_425864	207	38	to	to	IN
10_1101-2021_01_08_425864	207	39	fatty	fatty	NN
10_1101-2021_01_08_425864	207	40	acids	acid	NNS
10_1101-2021_01_08_425864	207	41	.	.	.
10_1101-2021_01_08_425864	208	1	These	these	DT
10_1101-2021_01_08_425864	208	2	data	datum	NNS
10_1101-2021_01_08_425864	208	3	show	show	VBP
10_1101-2021_01_08_425864	208	4	a	a	DT
10_1101-2021_01_08_425864	208	5	decrease	decrease	NN
10_1101-2021_01_08_425864	208	6	in	in	IN
10_1101-2021_01_08_425864	208	7	the	the	DT
10_1101-2021_01_08_425864	208	8	extracellular	extracellular	JJ
10_1101-2021_01_08_425864	208	9	TAGs	tag	NNS
10_1101-2021_01_08_425864	208	10	between	between	IN
10_1101-2021_01_08_425864	208	11	24	24	CD
10_1101-2021_01_08_425864	208	12	345	345	CD
10_1101-2021_01_08_425864	208	13	and	and	CC
10_1101-2021_01_08_425864	208	14	48	48	CD
10_1101-2021_01_08_425864	208	15	h	h	NNS
10_1101-2021_01_08_425864	208	16	,	,	,
10_1101-2021_01_08_425864	208	17	while	while	IN
10_1101-2021_01_08_425864	208	18	the	the	DT
10_1101-2021_01_08_425864	208	19	glucose	glucose	NN
10_1101-2021_01_08_425864	208	20	was	be	VBD
10_1101-2021_01_08_425864	208	21	already	already	RB
10_1101-2021_01_08_425864	208	22	almost	almost	RB
10_1101-2021_01_08_425864	208	23	entirely	entirely	RB
10_1101-2021_01_08_425864	208	24	consumed	consume	VBN
10_1101-2021_01_08_425864	208	25	,	,	,
10_1101-2021_01_08_425864	208	26	suggesting	suggest	VBG
10_1101-2021_01_08_425864	208	27	that	that	IN
10_1101-2021_01_08_425864	208	28	glucose	glucose	NN
10_1101-2021_01_08_425864	208	29	is	be	VBZ
10_1101-2021_01_08_425864	208	30	346	346	CD
10_1101-2021_01_08_425864	208	31	negatively	negatively	RB
10_1101-2021_01_08_425864	208	32	regulating	regulate	VBG
10_1101-2021_01_08_425864	208	33	the	the	DT
10_1101-2021_01_08_425864	208	34	fatty	fatty	NN
10_1101-2021_01_08_425864	208	35	acid	acid	NN
10_1101-2021_01_08_425864	208	36	catabolism	catabolism	NN
10_1101-2021_01_08_425864	208	37	.	.	.
10_1101-2021_01_08_425864	209	1	347	347	CD
10_1101-2021_01_08_425864	209	2	348	348	CD
10_1101-2021_01_08_425864	209	3	.CC	.cc	CD
10_1101-2021_01_08_425864	209	4	-	-	:
10_1101-2021_01_08_425864	209	5	BY	by	IN
10_1101-2021_01_08_425864	209	6	4.0	4.0	CD
10_1101-2021_01_08_425864	209	7	International	international	JJ
10_1101-2021_01_08_425864	209	8	licensemade	licensemade	NN
10_1101-2021_01_08_425864	209	9	available	available	JJ
10_1101-2021_01_08_425864	209	10	under	under	IN
10_1101-2021_01_08_425864	209	11	a	a	DT
10_1101-2021_01_08_425864	209	12	(	(	-LRB-
10_1101-2021_01_08_425864	209	13	which	which	WDT
10_1101-2021_01_08_425864	209	14	was	be	VBD
10_1101-2021_01_08_425864	209	15	not	not	RB
10_1101-2021_01_08_425864	209	16	certified	certify	VBN
10_1101-2021_01_08_425864	209	17	by	by	IN
10_1101-2021_01_08_425864	209	18	peer	peer	NN
10_1101-2021_01_08_425864	209	19	review	review	NN
10_1101-2021_01_08_425864	209	20	)	)	-RRB-
10_1101-2021_01_08_425864	209	21	is	be	VBZ
10_1101-2021_01_08_425864	209	22	the	the	DT
10_1101-2021_01_08_425864	209	23	author	author	NN
10_1101-2021_01_08_425864	209	24	/	/	SYM
10_1101-2021_01_08_425864	209	25	funder	funder	NN
10_1101-2021_01_08_425864	209	26	,	,	,
10_1101-2021_01_08_425864	209	27	who	who	WP
10_1101-2021_01_08_425864	209	28	has	have	VBZ
10_1101-2021_01_08_425864	209	29	granted	grant	VBN
10_1101-2021_01_08_425864	209	30	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	209	31	a	a	DT
10_1101-2021_01_08_425864	209	32	license	license	NN
10_1101-2021_01_08_425864	209	33	to	to	TO
10_1101-2021_01_08_425864	209	34	display	display	VB
10_1101-2021_01_08_425864	209	35	the	the	DT
10_1101-2021_01_08_425864	209	36	preprint	preprint	NN
10_1101-2021_01_08_425864	209	37	in	in	IN
10_1101-2021_01_08_425864	209	38	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	209	39	.	.	.
10_1101-2021_01_08_425864	210	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	210	2	is	be	VBZ
10_1101-2021_01_08_425864	210	3	The	the	DT
10_1101-2021_01_08_425864	210	4	copyright	copyright	NN
10_1101-2021_01_08_425864	210	5	holder	holder	NN
10_1101-2021_01_08_425864	210	6	for	for	IN
10_1101-2021_01_08_425864	210	7	this	this	DT
10_1101-2021_01_08_425864	210	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	210	9	version	version	NN
10_1101-2021_01_08_425864	210	10	posted	post	VBD
10_1101-2021_01_08_425864	210	11	January	January	NNP
10_1101-2021_01_08_425864	210	12	8	8	CD
10_1101-2021_01_08_425864	210	13	,	,	,
10_1101-2021_01_08_425864	210	14	2021	2021	CD
10_1101-2021_01_08_425864	210	15	.	.	.
10_1101-2021_01_08_425864	210	16	;	;	:
10_1101-2021_01_08_425864	210	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	210	18	:	:	:
10_1101-2021_01_08_425864	210	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	210	20	preprint	preprint	NN
10_1101-2021_01_08_425864	210	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	210	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	210	23	349	349	CD
10_1101-2021_01_08_425864	210	24	Figure	figure	NN
10_1101-2021_01_08_425864	210	25	3	3	CD
10_1101-2021_01_08_425864	210	26	.	.	.
10_1101-2021_01_08_425864	211	1	Changes	change	NNS
10_1101-2021_01_08_425864	211	2	in	in	IN
10_1101-2021_01_08_425864	211	3	glucose	glucose	NN
10_1101-2021_01_08_425864	211	4	and	and	CC
10_1101-2021_01_08_425864	211	5	triacylglycerol	triacylglycerol	NN
10_1101-2021_01_08_425864	211	6	contents	content	NNS
10_1101-2021_01_08_425864	211	7	in	in	IN
10_1101-2021_01_08_425864	211	8	LIT	LIT	NNP
10_1101-2021_01_08_425864	211	9	medium	medium	NN
10_1101-2021_01_08_425864	211	10	.	.	.
10_1101-2021_01_08_425864	212	1	A	a	LS
10_1101-2021_01_08_425864	212	2	)	)	-RRB-
10_1101-2021_01_08_425864	212	3	Growth	growth	NN
10_1101-2021_01_08_425864	212	4	curve	curve	NN
10_1101-2021_01_08_425864	212	5	of	of	IN
10_1101-2021_01_08_425864	212	6	350	350	CD
10_1101-2021_01_08_425864	212	7	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	212	8	forms	form	NNS
10_1101-2021_01_08_425864	212	9	.	.	.
10_1101-2021_01_08_425864	213	1	B	b	NN
10_1101-2021_01_08_425864	213	2	)	)	-RRB-
10_1101-2021_01_08_425864	213	3	Glucose	Glucose	NNP
10_1101-2021_01_08_425864	213	4	quantification	quantification	NN
10_1101-2021_01_08_425864	213	5	over	over	IN
10_1101-2021_01_08_425864	213	6	48	48	CD
10_1101-2021_01_08_425864	213	7	h.	h.	NN
10_1101-2021_01_08_425864	213	8	C	C	NNP
10_1101-2021_01_08_425864	213	9	)	)	-RRB-
10_1101-2021_01_08_425864	213	10	Triacylglycerol	triacylglycerol	NN
10_1101-2021_01_08_425864	213	11	levels	level	NNS
10_1101-2021_01_08_425864	213	12	over	over	IN
10_1101-2021_01_08_425864	213	13	48	48	CD
10_1101-2021_01_08_425864	213	14	h.	h.	NNS
10_1101-2021_01_08_425864	213	15	In	in	IN
10_1101-2021_01_08_425864	213	16	each	each	DT
10_1101-2021_01_08_425864	213	17	351	351	CD
10_1101-2021_01_08_425864	213	18	experiment	experiment	NN
10_1101-2021_01_08_425864	213	19	,	,	,
10_1101-2021_01_08_425864	213	20	we	-PRON-	PRP
10_1101-2021_01_08_425864	213	21	collected	collect	VBD
10_1101-2021_01_08_425864	213	22	each	each	DT
10_1101-2021_01_08_425864	213	23	medium	medium	NN
10_1101-2021_01_08_425864	213	24	at	at	IN
10_1101-2021_01_08_425864	213	25	different	different	JJ
10_1101-2021_01_08_425864	213	26	times	time	NNS
10_1101-2021_01_08_425864	213	27	and	and	CC
10_1101-2021_01_08_425864	213	28	subjected	subject	VBD
10_1101-2021_01_08_425864	213	29	it	-PRON-	PRP
10_1101-2021_01_08_425864	213	30	to	to	IN
10_1101-2021_01_08_425864	213	31	quantification	quantification	NN
10_1101-2021_01_08_425864	213	32	according	accord	VBG
10_1101-2021_01_08_425864	213	33	352	352	CD
10_1101-2021_01_08_425864	213	34	to	to	IN
10_1101-2021_01_08_425864	213	35	the	the	DT
10_1101-2021_01_08_425864	213	36	manufacturer	manufacturer	NN
10_1101-2021_01_08_425864	213	37	's	's	POS
10_1101-2021_01_08_425864	213	38	instructions	instruction	NNS
10_1101-2021_01_08_425864	213	39	.	.	.
10_1101-2021_01_08_425864	214	1	All	all	PDT
10_1101-2021_01_08_425864	214	2	the	the	DT
10_1101-2021_01_08_425864	214	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	214	4	were	be	VBD
10_1101-2021_01_08_425864	214	5	performed	perform	VBN
10_1101-2021_01_08_425864	214	6	in	in	IN
10_1101-2021_01_08_425864	214	7	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	214	8	.	.	.
10_1101-2021_01_08_425864	215	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	215	2	353	353	CD
10_1101-2021_01_08_425864	215	3	analysis	analysis	NN
10_1101-2021_01_08_425864	215	4	was	be	VBD
10_1101-2021_01_08_425864	215	5	performed	perform	VBN
10_1101-2021_01_08_425864	215	6	with	with	IN
10_1101-2021_01_08_425864	215	7	one	one	CD
10_1101-2021_01_08_425864	215	8	-	-	HYPH
10_1101-2021_01_08_425864	215	9	way	way	NN
10_1101-2021_01_08_425864	215	10	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	215	11	followed	follow	VBN
10_1101-2021_01_08_425864	215	12	by	by	IN
10_1101-2021_01_08_425864	215	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	215	14	's	's	POS
10_1101-2021_01_08_425864	215	15	post	post	JJ
10_1101-2021_01_08_425864	215	16	-	-	JJ
10_1101-2021_01_08_425864	215	17	test	test	JJ
10_1101-2021_01_08_425864	215	18	p	p	NN
10_1101-2021_01_08_425864	215	19	<	<	XX
10_1101-2021_01_08_425864	215	20	0.05	0.05	XX
10_1101-2021_01_08_425864	215	21	using	use	VBG
10_1101-2021_01_08_425864	215	22	the	the	DT
10_1101-2021_01_08_425864	215	23	354	354	CD
10_1101-2021_01_08_425864	215	24	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	215	25	Prism	Prism	NNP
10_1101-2021_01_08_425864	215	26	8.0.2	8.0.2	NNP
10_1101-2021_01_08_425864	215	27	software	software	NN
10_1101-2021_01_08_425864	215	28	program	program	NN
10_1101-2021_01_08_425864	215	29	.	.	.
10_1101-2021_01_08_425864	216	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	216	2	represent	represent	VBP
10_1101-2021_01_08_425864	216	3	the	the	DT
10_1101-2021_01_08_425864	216	4	levels	level	NNS
10_1101-2021_01_08_425864	216	5	of	of	IN
10_1101-2021_01_08_425864	216	6	statistical	statistical	JJ
10_1101-2021_01_08_425864	216	7	significance	significance	NN
10_1101-2021_01_08_425864	216	8	in	in	IN
10_1101-2021_01_08_425864	216	9	this	this	DT
10_1101-2021_01_08_425864	216	10	355	355	CD
10_1101-2021_01_08_425864	216	11	figure	figure	NN
10_1101-2021_01_08_425864	216	12	as	as	IN
10_1101-2021_01_08_425864	216	13	follows	follow	VBZ
10_1101-2021_01_08_425864	216	14	:	:	:
10_1101-2021_01_08_425864	216	15	*	*	NFP
10_1101-2021_01_08_425864	216	16	*	*	NFP
10_1101-2021_01_08_425864	216	17	*	*	NFP
10_1101-2021_01_08_425864	216	18	p	p	NN
10_1101-2021_01_08_425864	216	19	value	value	NN
10_1101-2021_01_08_425864	216	20	<	<	XX
10_1101-2021_01_08_425864	216	21	0.001	0.001	CD
10_1101-2021_01_08_425864	216	22	;	;	:
10_1101-2021_01_08_425864	216	23	*	*	NFP
10_1101-2021_01_08_425864	216	24	*	*	NFP
10_1101-2021_01_08_425864	216	25	p	p	NN
10_1101-2021_01_08_425864	216	26	value	value	NN
10_1101-2021_01_08_425864	216	27	<	<	XX
10_1101-2021_01_08_425864	216	28	0.01	0.01	XX
10_1101-2021_01_08_425864	216	29	;	;	:
10_1101-2021_01_08_425864	216	30	and	and	CC
10_1101-2021_01_08_425864	216	31	*	*	NFP
10_1101-2021_01_08_425864	216	32	p	p	NN
10_1101-2021_01_08_425864	216	33	value	value	NN
10_1101-2021_01_08_425864	216	34	<	<	XX
10_1101-2021_01_08_425864	216	35	0.05	0.05	CD
10_1101-2021_01_08_425864	216	36	.	.	.
10_1101-2021_01_08_425864	217	1	For	for	IN
10_1101-2021_01_08_425864	217	2	p	p	NN
10_1101-2021_01_08_425864	217	3	value	value	NN
10_1101-2021_01_08_425864	217	4	>	>	XX
10_1101-2021_01_08_425864	217	5	0.05	0.05	CD
10_1101-2021_01_08_425864	217	6	,	,	,
10_1101-2021_01_08_425864	217	7	356	356	CD
10_1101-2021_01_08_425864	217	8	we	-PRON-	PRP
10_1101-2021_01_08_425864	217	9	consider	consider	VBP
10_1101-2021_01_08_425864	217	10	the	the	DT
10_1101-2021_01_08_425864	217	11	differences	difference	NNS
10_1101-2021_01_08_425864	217	12	not	not	RB
10_1101-2021_01_08_425864	217	13	significant	significant	JJ
10_1101-2021_01_08_425864	217	14	(	(	-LRB-
10_1101-2021_01_08_425864	217	15	ns	ns	NNP
10_1101-2021_01_08_425864	217	16	)	)	-RRB-
10_1101-2021_01_08_425864	217	17	.	.	.
10_1101-2021_01_08_425864	218	1	357	357	CD
10_1101-2021_01_08_425864	218	2	358	358	CD
10_1101-2021_01_08_425864	218	3	Epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	218	4	forms	form	NNS
10_1101-2021_01_08_425864	218	5	use	use	VBP
10_1101-2021_01_08_425864	218	6	endogenous	endogenous	JJ
10_1101-2021_01_08_425864	218	7	fatty	fatty	NN
10_1101-2021_01_08_425864	218	8	acids	acid	NNS
10_1101-2021_01_08_425864	218	9	to	to	TO
10_1101-2021_01_08_425864	218	10	support	support	VB
10_1101-2021_01_08_425864	218	11	growth	growth	NN
10_1101-2021_01_08_425864	218	12	after	after	IN
10_1101-2021_01_08_425864	218	13	glucose	glucose	NN
10_1101-2021_01_08_425864	218	14	exhaustion	exhaustion	NN
10_1101-2021_01_08_425864	218	15	359	359	CD
10_1101-2021_01_08_425864	218	16	From	from	IN
10_1101-2021_01_08_425864	218	17	the	the	DT
10_1101-2021_01_08_425864	218	18	previous	previous	JJ
10_1101-2021_01_08_425864	218	19	results	result	NNS
10_1101-2021_01_08_425864	218	20	,	,	,
10_1101-2021_01_08_425864	218	21	we	-PRON-	PRP
10_1101-2021_01_08_425864	218	22	learned	learn	VBD
10_1101-2021_01_08_425864	218	23	that	that	IN
10_1101-2021_01_08_425864	218	24	under	under	IN
10_1101-2021_01_08_425864	218	25	glucose	glucose	NN
10_1101-2021_01_08_425864	218	26	deprivation	deprivation	NN
10_1101-2021_01_08_425864	218	27	,	,	,
10_1101-2021_01_08_425864	218	28	TAGs	tag	NNS
10_1101-2021_01_08_425864	218	29	are	be	VBP
10_1101-2021_01_08_425864	218	30	taken	take	VBN
10_1101-2021_01_08_425864	218	31	up	up	RP
10_1101-2021_01_08_425864	218	32	by	by	IN
10_1101-2021_01_08_425864	218	33	360	360	CD
10_1101-2021_01_08_425864	218	34	the	the	DT
10_1101-2021_01_08_425864	218	35	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	218	36	,	,	,
10_1101-2021_01_08_425864	218	37	and	and	CC
10_1101-2021_01_08_425864	218	38	internally	internally	RB
10_1101-2021_01_08_425864	218	39	stored	store	VBD
10_1101-2021_01_08_425864	218	40	fatty	fatty	NN
10_1101-2021_01_08_425864	218	41	acids	acid	NNS
10_1101-2021_01_08_425864	218	42	are	be	VBP
10_1101-2021_01_08_425864	218	43	mobilized	mobilize	VBN
10_1101-2021_01_08_425864	218	44	.	.	.
10_1101-2021_01_08_425864	219	1	However	however	RB
10_1101-2021_01_08_425864	219	2	,	,	,
10_1101-2021_01_08_425864	219	3	to	to	IN
10_1101-2021_01_08_425864	219	4	date	date	NN
10_1101-2021_01_08_425864	219	5	,	,	,
10_1101-2021_01_08_425864	219	6	we	-PRON-	PRP
10_1101-2021_01_08_425864	219	7	did	do	VBD
10_1101-2021_01_08_425864	219	8	not	not	RB
10_1101-2021_01_08_425864	219	9	361	361	CD
10_1101-2021_01_08_425864	219	10	provide	provide	VB
10_1101-2021_01_08_425864	219	11	any	any	DT
10_1101-2021_01_08_425864	219	12	evidence	evidence	NN
10_1101-2021_01_08_425864	219	13	pointing	point	VBG
10_1101-2021_01_08_425864	219	14	to	to	IN
10_1101-2021_01_08_425864	219	15	their	-PRON-	PRP$
10_1101-2021_01_08_425864	219	16	use	use	NN
10_1101-2021_01_08_425864	219	17	as	as	IN
10_1101-2021_01_08_425864	219	18	reduced	reduced	JJ
10_1101-2021_01_08_425864	219	19	carbon	carbon	NN
10_1101-2021_01_08_425864	219	20	sources	source	NNS
10_1101-2021_01_08_425864	219	21	.	.	.
10_1101-2021_01_08_425864	220	1	To	to	TO
10_1101-2021_01_08_425864	220	2	confirm	confirm	VB
10_1101-2021_01_08_425864	220	3	this	this	DT
10_1101-2021_01_08_425864	220	4	idea	idea	NN
10_1101-2021_01_08_425864	220	5	,	,	,
10_1101-2021_01_08_425864	220	6	362	362	CD
10_1101-2021_01_08_425864	220	7	exponentially	exponentially	RB
10_1101-2021_01_08_425864	220	8	proliferating	proliferating	NN
10_1101-2021_01_08_425864	220	9	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	220	10	were	be	VBD
10_1101-2021_01_08_425864	220	11	incubated	incubate	VBN
10_1101-2021_01_08_425864	220	12	in	in	IN
10_1101-2021_01_08_425864	220	13	PBS	PBS	NNP
10_1101-2021_01_08_425864	220	14	supplemented	supplement	VBN
10_1101-2021_01_08_425864	220	15	with	with	IN
10_1101-2021_01_08_425864	220	16	palmitate	palmitate	NN
10_1101-2021_01_08_425864	220	17	and	and	CC
10_1101-2021_01_08_425864	220	18	363	363	CD
10_1101-2021_01_08_425864	220	19	14C	14c	CD
10_1101-2021_01_08_425864	220	20	-	-	HYPH
10_1101-2021_01_08_425864	220	21	U	u	NN
10_1101-2021_01_08_425864	220	22	-	-	HYPH
10_1101-2021_01_08_425864	220	23	glucose	glucose	NN
10_1101-2021_01_08_425864	220	24	,	,	,
10_1101-2021_01_08_425864	220	25	or	or	CC
10_1101-2021_01_08_425864	220	26	reciprocally	reciprocally	RB
10_1101-2021_01_08_425864	220	27	,	,	,
10_1101-2021_01_08_425864	220	28	glucose	glucose	NN
10_1101-2021_01_08_425864	220	29	and	and	CC
10_1101-2021_01_08_425864	220	30	14C	14c	NN
10_1101-2021_01_08_425864	220	31	-	-	HYPH
10_1101-2021_01_08_425864	220	32	U	u	NN
10_1101-2021_01_08_425864	220	33	-	-	HYPH
10_1101-2021_01_08_425864	220	34	palmitate	palmitate	NN
10_1101-2021_01_08_425864	220	35	.	.	.
10_1101-2021_01_08_425864	221	1	In	in	IN
10_1101-2021_01_08_425864	221	2	both	both	DT
10_1101-2021_01_08_425864	221	3	cases	case	NNS
10_1101-2021_01_08_425864	221	4	,	,	,
10_1101-2021_01_08_425864	221	5	the	the	DT
10_1101-2021_01_08_425864	221	6	production	production	NN
10_1101-2021_01_08_425864	221	7	of	of	IN
10_1101-2021_01_08_425864	221	8	14C-	14c-	CD
10_1101-2021_01_08_425864	221	9	364	364	CD
10_1101-2021_01_08_425864	221	10	labelled	label	VBN
10_1101-2021_01_08_425864	221	11	CO2	CO2	NNP
10_1101-2021_01_08_425864	221	12	was	be	VBD
10_1101-2021_01_08_425864	221	13	quantified	quantify	VBN
10_1101-2021_01_08_425864	221	14	.	.	.
10_1101-2021_01_08_425864	222	1	The	the	DT
10_1101-2021_01_08_425864	222	2	presence	presence	NN
10_1101-2021_01_08_425864	222	3	of	of	IN
10_1101-2021_01_08_425864	222	4	5	5	CD
10_1101-2021_01_08_425864	222	5	mM	mM	NNP
10_1101-2021_01_08_425864	222	6	glucose	glucose	NN
10_1101-2021_01_08_425864	222	7	diminished	diminish	VBD
10_1101-2021_01_08_425864	222	8	the	the	DT
10_1101-2021_01_08_425864	222	9	release	release	NN
10_1101-2021_01_08_425864	222	10	of	of	IN
10_1101-2021_01_08_425864	222	11	14CO2	14co2	CD
10_1101-2021_01_08_425864	222	12	from	from	IN
10_1101-2021_01_08_425864	222	13	365	365	CD
10_1101-2021_01_08_425864	222	14	14C	14C	NNP
10_1101-2021_01_08_425864	222	15	-	-	HYPH
10_1101-2021_01_08_425864	222	16	U	u	NN
10_1101-2021_01_08_425864	222	17	-	-	HYPH
10_1101-2021_01_08_425864	222	18	palmitate	palmitate	NN
10_1101-2021_01_08_425864	222	19	by	by	IN
10_1101-2021_01_08_425864	222	20	90	90	CD
10_1101-2021_01_08_425864	222	21	%	%	NN
10_1101-2021_01_08_425864	222	22	while	while	IN
10_1101-2021_01_08_425864	222	23	the	the	DT
10_1101-2021_01_08_425864	222	24	presence	presence	NN
10_1101-2021_01_08_425864	222	25	of	of	IN
10_1101-2021_01_08_425864	222	26	palmitate	palmitate	NN
10_1101-2021_01_08_425864	222	27	did	do	VBD
10_1101-2021_01_08_425864	222	28	not	not	RB
10_1101-2021_01_08_425864	222	29	interfere	interfere	VB
10_1101-2021_01_08_425864	222	30	with	with	IN
10_1101-2021_01_08_425864	222	31	the	the	DT
10_1101-2021_01_08_425864	222	32	production	production	NN
10_1101-2021_01_08_425864	222	33	of	of	IN
10_1101-2021_01_08_425864	222	34	14CO2	14co2	CD
10_1101-2021_01_08_425864	222	35	366	366	CD
10_1101-2021_01_08_425864	222	36	from	from	IN
10_1101-2021_01_08_425864	222	37	14C	14c	CD
10_1101-2021_01_08_425864	222	38	-	-	HYPH
10_1101-2021_01_08_425864	222	39	U	u	NN
10_1101-2021_01_08_425864	222	40	-	-	HYPH
10_1101-2021_01_08_425864	222	41	glucose	glucose	NN
10_1101-2021_01_08_425864	222	42	(	(	-LRB-
10_1101-2021_01_08_425864	222	43	Fig	fig	NN
10_1101-2021_01_08_425864	222	44	4	4	CD
10_1101-2021_01_08_425864	222	45	)	)	-RRB-
10_1101-2021_01_08_425864	222	46	.	.	.
10_1101-2021_01_08_425864	223	1	Taken	take	VBN
10_1101-2021_01_08_425864	223	2	together	together	RB
10_1101-2021_01_08_425864	223	3	,	,	,
10_1101-2021_01_08_425864	223	4	our	-PRON-	PRP$
10_1101-2021_01_08_425864	223	5	results	result	NNS
10_1101-2021_01_08_425864	223	6	show	show	VBP
10_1101-2021_01_08_425864	223	7	that	that	WDT
10_1101-2021_01_08_425864	223	8	glucose	glucose	VBP
10_1101-2021_01_08_425864	223	9	inhibits	inhibit	VBZ
10_1101-2021_01_08_425864	223	10	TAGs	tag	NNS
10_1101-2021_01_08_425864	223	11	and	and	CC
10_1101-2021_01_08_425864	223	12	fatty	fatty	VBP
10_1101-2021_01_08_425864	223	13	367	367	CD
10_1101-2021_01_08_425864	223	14	acid	acid	NN
10_1101-2021_01_08_425864	223	15	consumption	consumption	NN
10_1101-2021_01_08_425864	223	16	,	,	,
10_1101-2021_01_08_425864	223	17	and	and	CC
10_1101-2021_01_08_425864	223	18	after	after	IN
10_1101-2021_01_08_425864	223	19	glucose	glucose	VB
10_1101-2021_01_08_425864	223	20	exhaustion	exhaustion	NN
10_1101-2021_01_08_425864	223	21	,	,	,
10_1101-2021_01_08_425864	223	22	a	a	DT
10_1101-2021_01_08_425864	223	23	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	223	24	switch	switch	NN
10_1101-2021_01_08_425864	223	25	occurs	occur	VBZ
10_1101-2021_01_08_425864	223	26	towards	towards	IN
10_1101-2021_01_08_425864	223	27	the	the	DT
10_1101-2021_01_08_425864	223	28	oxidation	oxidation	NN
10_1101-2021_01_08_425864	223	29	of	of	IN
10_1101-2021_01_08_425864	223	30	368	368	CD
10_1101-2021_01_08_425864	223	31	internally	internally	RB
10_1101-2021_01_08_425864	223	32	stored	store	VBN
10_1101-2021_01_08_425864	223	33	fatty	fatty	NN
10_1101-2021_01_08_425864	223	34	acids	acid	NNS
10_1101-2021_01_08_425864	223	35	.	.	.
10_1101-2021_01_08_425864	224	1	369	369	CD
10_1101-2021_01_08_425864	224	2	370	370	CD
10_1101-2021_01_08_425864	224	3	Figure	figure	NN
10_1101-2021_01_08_425864	224	4	4	4	CD
10_1101-2021_01_08_425864	224	5	.	.	.
10_1101-2021_01_08_425864	225	1	Glucose	Glucose	NNP
10_1101-2021_01_08_425864	225	2	metabolism	metabolism	NN
10_1101-2021_01_08_425864	225	3	inhibits	inhibit	VBZ
10_1101-2021_01_08_425864	225	4	FAO	FAO	NNP
10_1101-2021_01_08_425864	225	5	.	.	.
10_1101-2021_01_08_425864	226	1	Parasites	parasite	NNS
10_1101-2021_01_08_425864	226	2	were	be	VBD
10_1101-2021_01_08_425864	226	3	incubated	incubate	VBN
10_1101-2021_01_08_425864	226	4	in	in	IN
10_1101-2021_01_08_425864	226	5	the	the	DT
10_1101-2021_01_08_425864	226	6	presence	presence	NN
10_1101-2021_01_08_425864	226	7	of	of	IN
10_1101-2021_01_08_425864	226	8	14C	14C	NNP
10_1101-2021_01_08_425864	226	9	-	-	HYPH
10_1101-2021_01_08_425864	226	10	U-	u-	NN
10_1101-2021_01_08_425864	226	11	371	371	CD
10_1101-2021_01_08_425864	226	12	palmitate	palmitate	NN
10_1101-2021_01_08_425864	226	13	+	+	CC
10_1101-2021_01_08_425864	226	14	5	5	CD
10_1101-2021_01_08_425864	226	15	mM	mm	NN
10_1101-2021_01_08_425864	226	16	glucose	glucose	NN
10_1101-2021_01_08_425864	226	17	and	and	CC
10_1101-2021_01_08_425864	226	18	14C	14c	NN
10_1101-2021_01_08_425864	226	19	-	-	HYPH
10_1101-2021_01_08_425864	226	20	U	u	NN
10_1101-2021_01_08_425864	226	21	-	-	HYPH
10_1101-2021_01_08_425864	226	22	glucose	glucose	NN
10_1101-2021_01_08_425864	226	23	+	+	SYM
10_1101-2021_01_08_425864	226	24	0.1	0.1	CD
10_1101-2021_01_08_425864	226	25	mM	mm	NN
10_1101-2021_01_08_425864	226	26	palmitate	palmitate	NN
10_1101-2021_01_08_425864	226	27	in	in	IN
10_1101-2021_01_08_425864	226	28	PBS	PBS	NNP
10_1101-2021_01_08_425864	226	29	.	.	.
10_1101-2021_01_08_425864	227	1	14CO2	14co2	CD
10_1101-2021_01_08_425864	227	2	production	production	NN
10_1101-2021_01_08_425864	227	3	from	from	IN
10_1101-2021_01_08_425864	227	4	372	372	CD
10_1101-2021_01_08_425864	227	5	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	227	6	incubated	incubate	VBN
10_1101-2021_01_08_425864	227	7	in	in	IN
10_1101-2021_01_08_425864	227	8	PBS	PBS	NNP
10_1101-2021_01_08_425864	227	9	.	.	.
10_1101-2021_01_08_425864	228	1	The	the	DT
10_1101-2021_01_08_425864	228	2	14CO2	14co2	CD
10_1101-2021_01_08_425864	228	3	was	be	VBD
10_1101-2021_01_08_425864	228	4	captured	capture	VBN
10_1101-2021_01_08_425864	228	5	after	after	IN
10_1101-2021_01_08_425864	228	6	120	120	CD
10_1101-2021_01_08_425864	228	7	min	min	NN
10_1101-2021_01_08_425864	228	8	of	of	IN
10_1101-2021_01_08_425864	228	9	incubation	incubation	NN
10_1101-2021_01_08_425864	228	10	.	.	.
10_1101-2021_01_08_425864	229	1	The	the	DT
10_1101-2021_01_08_425864	229	2	373	373	CD
10_1101-2021_01_08_425864	229	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	229	4	were	be	VBD
10_1101-2021_01_08_425864	229	5	performed	perform	VBN
10_1101-2021_01_08_425864	229	6	in	in	IN
10_1101-2021_01_08_425864	229	7	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	229	8	.	.	.
10_1101-2021_01_08_425864	230	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	230	2	analysis	analysis	NN
10_1101-2021_01_08_425864	230	3	was	be	VBD
10_1101-2021_01_08_425864	230	4	performed	perform	VBN
10_1101-2021_01_08_425864	230	5	with	with	IN
10_1101-2021_01_08_425864	230	6	one	one	CD
10_1101-2021_01_08_425864	230	7	-	-	HYPH
10_1101-2021_01_08_425864	230	8	way	way	NN
10_1101-2021_01_08_425864	230	9	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	230	10	374	374	CD
10_1101-2021_01_08_425864	230	11	followed	follow	VBN
10_1101-2021_01_08_425864	230	12	by	by	IN
10_1101-2021_01_08_425864	230	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	230	14	's	's	POS
10_1101-2021_01_08_425864	230	15	post	post	JJ
10_1101-2021_01_08_425864	230	16	-	-	JJ
10_1101-2021_01_08_425864	230	17	test	test	JJ
10_1101-2021_01_08_425864	230	18	p	p	NN
10_1101-2021_01_08_425864	230	19	<	<	XX
10_1101-2021_01_08_425864	230	20	0.05	0.05	XX
10_1101-2021_01_08_425864	230	21	using	use	VBG
10_1101-2021_01_08_425864	230	22	the	the	DT
10_1101-2021_01_08_425864	230	23	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	230	24	Prism	Prism	NNP
10_1101-2021_01_08_425864	230	25	8.0.2	8.0.2	NNP
10_1101-2021_01_08_425864	230	26	software	software	NN
10_1101-2021_01_08_425864	230	27	program	program	NN
10_1101-2021_01_08_425864	230	28	.	.	.
10_1101-2021_01_08_425864	231	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	231	2	375	375	CD
10_1101-2021_01_08_425864	231	3	represent	represent	VBP
10_1101-2021_01_08_425864	231	4	the	the	DT
10_1101-2021_01_08_425864	231	5	level	level	NN
10_1101-2021_01_08_425864	231	6	of	of	IN
10_1101-2021_01_08_425864	231	7	statistical	statistical	JJ
10_1101-2021_01_08_425864	231	8	significance	significance	NN
10_1101-2021_01_08_425864	231	9	in	in	IN
10_1101-2021_01_08_425864	231	10	this	this	DT
10_1101-2021_01_08_425864	231	11	figure	figure	NN
10_1101-2021_01_08_425864	231	12	as	as	IN
10_1101-2021_01_08_425864	231	13	follows	follow	VBZ
10_1101-2021_01_08_425864	231	14	:	:	:
10_1101-2021_01_08_425864	231	15	*	*	NFP
10_1101-2021_01_08_425864	231	16	*	*	NFP
10_1101-2021_01_08_425864	231	17	*	*	NFP
10_1101-2021_01_08_425864	231	18	p	p	NN
10_1101-2021_01_08_425864	231	19	value	value	NN
10_1101-2021_01_08_425864	231	20	<	<	XX
10_1101-2021_01_08_425864	231	21	0.001	0.001	CD
10_1101-2021_01_08_425864	231	22	;	;	:
10_1101-2021_01_08_425864	231	23	*	*	NFP
10_1101-2021_01_08_425864	231	24	*	*	NFP
10_1101-2021_01_08_425864	231	25	p	p	NN
10_1101-2021_01_08_425864	231	26	value	value	NN
10_1101-2021_01_08_425864	231	27	376	376	CD
10_1101-2021_01_08_425864	231	28	<	<	XX
10_1101-2021_01_08_425864	231	29	0.01	0.01	CD
10_1101-2021_01_08_425864	231	30	;	;	:
10_1101-2021_01_08_425864	231	31	and	and	CC
10_1101-2021_01_08_425864	231	32	*	*	NFP
10_1101-2021_01_08_425864	231	33	p	p	NN
10_1101-2021_01_08_425864	231	34	value	value	NN
10_1101-2021_01_08_425864	231	35	<	<	XX
10_1101-2021_01_08_425864	231	36	0.05	0.05	CD
10_1101-2021_01_08_425864	231	37	.	.	.
10_1101-2021_01_08_425864	232	1	For	for	IN
10_1101-2021_01_08_425864	232	2	p	p	NN
10_1101-2021_01_08_425864	232	3	value	value	NN
10_1101-2021_01_08_425864	232	4	>	>	XX
10_1101-2021_01_08_425864	232	5	0.05	0.05	CD
10_1101-2021_01_08_425864	232	6	,	,	,
10_1101-2021_01_08_425864	232	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	232	8	consider	consider	VBP
10_1101-2021_01_08_425864	232	9	the	the	DT
10_1101-2021_01_08_425864	232	10	differences	difference	NNS
10_1101-2021_01_08_425864	232	11	not	not	RB
10_1101-2021_01_08_425864	232	12	significant	significant	JJ
10_1101-2021_01_08_425864	232	13	(	(	-LRB-
10_1101-2021_01_08_425864	232	14	ns	ns	NNP
10_1101-2021_01_08_425864	232	15	)	)	-RRB-
10_1101-2021_01_08_425864	232	16	.	.	.
10_1101-2021_01_08_425864	233	1	377	377	CD
10_1101-2021_01_08_425864	233	2	378	378	CD
10_1101-2021_01_08_425864	233	3	To	to	TO
10_1101-2021_01_08_425864	233	4	monitor	monitor	VB
10_1101-2021_01_08_425864	233	5	the	the	DT
10_1101-2021_01_08_425864	233	6	dynamics	dynamic	NNS
10_1101-2021_01_08_425864	233	7	of	of	IN
10_1101-2021_01_08_425864	233	8	use	use	NN
10_1101-2021_01_08_425864	233	9	or	or	CC
10_1101-2021_01_08_425864	233	10	accumulation	accumulation	NN
10_1101-2021_01_08_425864	233	11	of	of	IN
10_1101-2021_01_08_425864	233	12	fatty	fatty	NN
10_1101-2021_01_08_425864	233	13	acids	acid	NNS
10_1101-2021_01_08_425864	233	14	in	in	IN
10_1101-2021_01_08_425864	233	15	lipid	lipid	NN
10_1101-2021_01_08_425864	233	16	droplets	droplet	NNS
10_1101-2021_01_08_425864	233	17	,	,	,
10_1101-2021_01_08_425864	233	18	we	-PRON-	PRP
10_1101-2021_01_08_425864	233	19	used	use	VBD
10_1101-2021_01_08_425864	233	20	as	as	IN
10_1101-2021_01_08_425864	233	21	a	a	DT
10_1101-2021_01_08_425864	233	22	379	379	CD
10_1101-2021_01_08_425864	233	23	probe	probe	NN
10_1101-2021_01_08_425864	233	24	a	a	DT
10_1101-2021_01_08_425864	233	25	fluorescent	fluorescent	NN
10_1101-2021_01_08_425864	233	26	fatty	fatty	NN
10_1101-2021_01_08_425864	233	27	acid	acid	NN
10_1101-2021_01_08_425864	233	28	analogue	analogue	NN
10_1101-2021_01_08_425864	233	29	called	call	VBN
10_1101-2021_01_08_425864	233	30	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	233	31	500/510	500/510	NNP
10_1101-2021_01_08_425864	233	32	C1-C12	C1-C12	NNP
10_1101-2021_01_08_425864	233	33	.	.	.
10_1101-2021_01_08_425864	234	1	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	234	2	shifts	shift	VBZ
10_1101-2021_01_08_425864	234	3	its	-PRON-	PRP$
10_1101-2021_01_08_425864	234	4	380	380	CD
10_1101-2021_01_08_425864	234	5	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	234	6	from	from	IN
10_1101-2021_01_08_425864	234	7	red	red	NN
10_1101-2021_01_08_425864	234	8	to	to	IN
10_1101-2021_01_08_425864	234	9	green	green	NN
10_1101-2021_01_08_425864	234	10	upon	upon	IN
10_1101-2021_01_08_425864	234	11	the	the	DT
10_1101-2021_01_08_425864	234	12	uptake	uptake	NN
10_1101-2021_01_08_425864	234	13	and	and	CC
10_1101-2021_01_08_425864	234	14	catabolism	catabolism	NN
10_1101-2021_01_08_425864	234	15	of	of	IN
10_1101-2021_01_08_425864	234	16	fatty	fatty	NN
10_1101-2021_01_08_425864	234	17	acids	acid	NNS
10_1101-2021_01_08_425864	234	18	,	,	,
10_1101-2021_01_08_425864	234	19	and	and	CC
10_1101-2021_01_08_425864	234	20	from	from	IN
10_1101-2021_01_08_425864	234	21	green	green	NN
10_1101-2021_01_08_425864	234	22	to	to	IN
10_1101-2021_01_08_425864	234	23	red	red	NNP
10_1101-2021_01_08_425864	234	24	381	381	CD
10_1101-2021_01_08_425864	234	25	when	when	WRB
10_1101-2021_01_08_425864	234	26	fatty	fatty	NN
10_1101-2021_01_08_425864	234	27	acids	acid	NNS
10_1101-2021_01_08_425864	234	28	are	be	VBP
10_1101-2021_01_08_425864	234	29	accumulated	accumulate	VBN
10_1101-2021_01_08_425864	234	30	in	in	IN
10_1101-2021_01_08_425864	234	31	the	the	DT
10_1101-2021_01_08_425864	234	32	lipid	lipid	NN
10_1101-2021_01_08_425864	234	33	droplets	droplet	NNS
10_1101-2021_01_08_425864	234	34	.	.	.
10_1101-2021_01_08_425864	235	1	Parasites	parasite	NNS
10_1101-2021_01_08_425864	235	2	collected	collect	VBD
10_1101-2021_01_08_425864	235	3	at	at	IN
10_1101-2021_01_08_425864	235	4	the	the	DT
10_1101-2021_01_08_425864	235	5	mid	mid	JJ
10_1101-2021_01_08_425864	235	6	and	and	CC
10_1101-2021_01_08_425864	235	7	late	late	JJ
10_1101-2021_01_08_425864	235	8	382	382	CD
10_1101-2021_01_08_425864	235	9	exponential	exponential	JJ
10_1101-2021_01_08_425864	235	10	proliferation	proliferation	NN
10_1101-2021_01_08_425864	235	11	phases	phase	NNS
10_1101-2021_01_08_425864	235	12	and	and	CC
10_1101-2021_01_08_425864	235	13	the	the	DT
10_1101-2021_01_08_425864	235	14	stationary	stationary	JJ
10_1101-2021_01_08_425864	235	15	phase	phase	NN
10_1101-2021_01_08_425864	235	16	were	be	VBD
10_1101-2021_01_08_425864	235	17	incubated	incubate	VBN
10_1101-2021_01_08_425864	235	18	with	with	IN
10_1101-2021_01_08_425864	235	19	1	1	CD
10_1101-2021_01_08_425864	235	20	μM	μM	NNP
10_1101-2021_01_08_425864	235	21	BODIPY	bodipy	RB
10_1101-2021_01_08_425864	235	22	383	383	CD
10_1101-2021_01_08_425864	235	23	500/510	500/510	NNP
10_1101-2021_01_08_425864	235	24	C1-C12	C1-C12	NNP
10_1101-2021_01_08_425864	235	25	for	for	IN
10_1101-2021_01_08_425864	235	26	16	16	CD
10_1101-2021_01_08_425864	235	27	h	h	NNS
10_1101-2021_01_08_425864	235	28	,	,	,
10_1101-2021_01_08_425864	235	29	before	before	IN
10_1101-2021_01_08_425864	235	30	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	235	31	determination	determination	NN
10_1101-2021_01_08_425864	235	32	by	by	IN
10_1101-2021_01_08_425864	235	33	flow	flow	NN
10_1101-2021_01_08_425864	235	34	cytometry	cytometry	NN
10_1101-2021_01_08_425864	235	35	(	(	-LRB-
10_1101-2021_01_08_425864	235	36	Figs	fig	NNS
10_1101-2021_01_08_425864	235	37	5A	5a	RB
10_1101-2021_01_08_425864	235	38	,	,	,
10_1101-2021_01_08_425864	235	39	5B	5b	JJ
10_1101-2021_01_08_425864	235	40	and	and	CC
10_1101-2021_01_08_425864	235	41	5C	5c	NN
10_1101-2021_01_08_425864	235	42	)	)	-RRB-
10_1101-2021_01_08_425864	235	43	.	.	.
10_1101-2021_01_08_425864	236	1	384	384	CD
10_1101-2021_01_08_425864	236	2	The	the	DT
10_1101-2021_01_08_425864	236	3	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	236	4	values	value	NNS
10_1101-2021_01_08_425864	236	5	increased	increase	VBD
10_1101-2021_01_08_425864	236	6	with	with	IN
10_1101-2021_01_08_425864	236	7	the	the	DT
10_1101-2021_01_08_425864	236	8	harvesting	harvesting	NN
10_1101-2021_01_08_425864	236	9	time	time	NN
10_1101-2021_01_08_425864	236	10	(	(	-LRB-
10_1101-2021_01_08_425864	236	11	and	and	CC
10_1101-2021_01_08_425864	236	12	therefore	therefore	RB
10_1101-2021_01_08_425864	236	13	,	,	,
10_1101-2021_01_08_425864	236	14	with	with	IN
10_1101-2021_01_08_425864	236	15	the	the	DT
10_1101-2021_01_08_425864	236	16	glucose	glucose	NN
10_1101-2021_01_08_425864	236	17	385	385	CD
10_1101-2021_01_08_425864	236	18	depletion	depletion	NN
10_1101-2021_01_08_425864	236	19	)	)	-RRB-
10_1101-2021_01_08_425864	236	20	,	,	,
10_1101-2021_01_08_425864	236	21	indicating	indicate	VBG
10_1101-2021_01_08_425864	236	22	the	the	DT
10_1101-2021_01_08_425864	236	23	increased	increased	JJ
10_1101-2021_01_08_425864	236	24	uptake	uptake	NN
10_1101-2021_01_08_425864	236	25	and	and	CC
10_1101-2021_01_08_425864	236	26	use	use	NN
10_1101-2021_01_08_425864	236	27	of	of	IN
10_1101-2021_01_08_425864	236	28	fatty	fatty	NN
10_1101-2021_01_08_425864	236	29	acids	acid	NNS
10_1101-2021_01_08_425864	236	30	as	as	IN
10_1101-2021_01_08_425864	236	31	substrates	substrate	NNS
10_1101-2021_01_08_425864	236	32	by	by	IN
10_1101-2021_01_08_425864	236	33	a	a	DT
10_1101-2021_01_08_425864	236	34	fatty	fatty	NN
10_1101-2021_01_08_425864	236	35	acyl	acyl	NN
10_1101-2021_01_08_425864	236	36	-	-	HYPH
10_1101-2021_01_08_425864	236	37	CoA	CoA	NNP
10_1101-2021_01_08_425864	236	38	386	386	CD
10_1101-2021_01_08_425864	236	39	synthetase	synthetase	NN
10_1101-2021_01_08_425864	236	40	.	.	.
10_1101-2021_01_08_425864	237	1	These	these	DT
10_1101-2021_01_08_425864	237	2	data	datum	NNS
10_1101-2021_01_08_425864	237	3	were	be	VBD
10_1101-2021_01_08_425864	237	4	confirmed	confirm	VBN
10_1101-2021_01_08_425864	237	5	by	by	IN
10_1101-2021_01_08_425864	237	6	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	237	7	microscopy	microscopy	JJ
10_1101-2021_01_08_425864	237	8	(	(	-LRB-
10_1101-2021_01_08_425864	237	9	Fig	Fig	NNP
10_1101-2021_01_08_425864	237	10	5D	5d	NN
10_1101-2021_01_08_425864	237	11	)	)	-RRB-
10_1101-2021_01_08_425864	237	12	.	.	.
10_1101-2021_01_08_425864	238	1	Interestingly	interestingly	RB
10_1101-2021_01_08_425864	238	2	,	,	,
10_1101-2021_01_08_425864	238	3	parasites	parasite	VBZ
10_1101-2021_01_08_425864	238	4	387	387	CD
10_1101-2021_01_08_425864	238	5	in	in	IN
10_1101-2021_01_08_425864	238	6	stationary	stationary	JJ
10_1101-2021_01_08_425864	238	7	phase	phase	NN
10_1101-2021_01_08_425864	238	8	showed	show	VBD
10_1101-2021_01_08_425864	238	9	an	an	DT
10_1101-2021_01_08_425864	238	10	accumulation	accumulation	NN
10_1101-2021_01_08_425864	238	11	of	of	IN
10_1101-2021_01_08_425864	238	12	activated	activated	JJ
10_1101-2021_01_08_425864	238	13	fatty	fatty	NN
10_1101-2021_01_08_425864	238	14	acids	acid	NNS
10_1101-2021_01_08_425864	238	15	in	in	IN
10_1101-2021_01_08_425864	238	16	spots	spot	NNS
10_1101-2021_01_08_425864	238	17	along	along	IN
10_1101-2021_01_08_425864	238	18	the	the	DT
10_1101-2021_01_08_425864	238	19	cell	cell	NN
10_1101-2021_01_08_425864	238	20	.	.	.
10_1101-2021_01_08_425864	239	1	However	however	RB
10_1101-2021_01_08_425864	239	2	,	,	,
10_1101-2021_01_08_425864	239	3	388	388	CD
10_1101-2021_01_08_425864	239	4	the	the	DT
10_1101-2021_01_08_425864	239	5	number	number	NN
10_1101-2021_01_08_425864	239	6	of	of	IN
10_1101-2021_01_08_425864	239	7	lipid	lipid	NN
10_1101-2021_01_08_425864	239	8	droplets	droplet	NNS
10_1101-2021_01_08_425864	239	9	increased	increase	VBD
10_1101-2021_01_08_425864	239	10	upon	upon	IN
10_1101-2021_01_08_425864	239	11	parasite	parasite	NN
10_1101-2021_01_08_425864	239	12	proliferation	proliferation	NN
10_1101-2021_01_08_425864	239	13	(	(	-LRB-
10_1101-2021_01_08_425864	239	14	Figs	figs	NN
10_1101-2021_01_08_425864	239	15	6A	6a	NN
10_1101-2021_01_08_425864	239	16	,	,	,
10_1101-2021_01_08_425864	239	17	6B	6b	JJ
10_1101-2021_01_08_425864	239	18	6C	6c	NN
10_1101-2021_01_08_425864	239	19	)	)	-RRB-
10_1101-2021_01_08_425864	239	20	.	.	.
10_1101-2021_01_08_425864	240	1	This	this	DT
10_1101-2021_01_08_425864	240	2	observation	observation	NN
10_1101-2021_01_08_425864	240	3	.CC	.CC	:
10_1101-2021_01_08_425864	240	4	-	-	:
10_1101-2021_01_08_425864	240	5	BY	by	IN
10_1101-2021_01_08_425864	240	6	4.0	4.0	CD
10_1101-2021_01_08_425864	240	7	International	international	JJ
10_1101-2021_01_08_425864	240	8	licensemade	licensemade	NN
10_1101-2021_01_08_425864	240	9	available	available	JJ
10_1101-2021_01_08_425864	240	10	under	under	IN
10_1101-2021_01_08_425864	240	11	a	a	DT
10_1101-2021_01_08_425864	240	12	(	(	-LRB-
10_1101-2021_01_08_425864	240	13	which	which	WDT
10_1101-2021_01_08_425864	240	14	was	be	VBD
10_1101-2021_01_08_425864	240	15	not	not	RB
10_1101-2021_01_08_425864	240	16	certified	certify	VBN
10_1101-2021_01_08_425864	240	17	by	by	IN
10_1101-2021_01_08_425864	240	18	peer	peer	NN
10_1101-2021_01_08_425864	240	19	review	review	NN
10_1101-2021_01_08_425864	240	20	)	)	-RRB-
10_1101-2021_01_08_425864	240	21	is	be	VBZ
10_1101-2021_01_08_425864	240	22	the	the	DT
10_1101-2021_01_08_425864	240	23	author	author	NN
10_1101-2021_01_08_425864	240	24	/	/	SYM
10_1101-2021_01_08_425864	240	25	funder	funder	NN
10_1101-2021_01_08_425864	240	26	,	,	,
10_1101-2021_01_08_425864	240	27	who	who	WP
10_1101-2021_01_08_425864	240	28	has	have	VBZ
10_1101-2021_01_08_425864	240	29	granted	grant	VBN
10_1101-2021_01_08_425864	240	30	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	240	31	a	a	DT
10_1101-2021_01_08_425864	240	32	license	license	NN
10_1101-2021_01_08_425864	240	33	to	to	TO
10_1101-2021_01_08_425864	240	34	display	display	VB
10_1101-2021_01_08_425864	240	35	the	the	DT
10_1101-2021_01_08_425864	240	36	preprint	preprint	NN
10_1101-2021_01_08_425864	240	37	in	in	IN
10_1101-2021_01_08_425864	240	38	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	240	39	.	.	.
10_1101-2021_01_08_425864	241	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	241	2	is	be	VBZ
10_1101-2021_01_08_425864	241	3	The	the	DT
10_1101-2021_01_08_425864	241	4	copyright	copyright	NN
10_1101-2021_01_08_425864	241	5	holder	holder	NN
10_1101-2021_01_08_425864	241	6	for	for	IN
10_1101-2021_01_08_425864	241	7	this	this	DT
10_1101-2021_01_08_425864	241	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	241	9	version	version	NN
10_1101-2021_01_08_425864	241	10	posted	post	VBD
10_1101-2021_01_08_425864	241	11	January	January	NNP
10_1101-2021_01_08_425864	241	12	8	8	CD
10_1101-2021_01_08_425864	241	13	,	,	,
10_1101-2021_01_08_425864	241	14	2021	2021	CD
10_1101-2021_01_08_425864	241	15	.	.	.
10_1101-2021_01_08_425864	241	16	;	;	:
10_1101-2021_01_08_425864	241	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	241	18	:	:	:
10_1101-2021_01_08_425864	241	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	241	20	preprint	preprint	NN
10_1101-2021_01_08_425864	241	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	241	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	241	23	389	389	CD
10_1101-2021_01_08_425864	241	24	indicates	indicate	VBZ
10_1101-2021_01_08_425864	241	25	that	that	IN
10_1101-2021_01_08_425864	241	26	not	not	RB
10_1101-2021_01_08_425864	241	27	only	only	RB
10_1101-2021_01_08_425864	241	28	fatty	fatty	NN
10_1101-2021_01_08_425864	241	29	acids	acid	NNS
10_1101-2021_01_08_425864	241	30	metabolism	metabolism	NN
10_1101-2021_01_08_425864	241	31	is	be	VBZ
10_1101-2021_01_08_425864	241	32	activated	activate	VBN
10_1101-2021_01_08_425864	241	33	after	after	IN
10_1101-2021_01_08_425864	241	34	glucose	glucose	NN
10_1101-2021_01_08_425864	241	35	exhaustion	exhaustion	NN
10_1101-2021_01_08_425864	241	36	,	,	,
10_1101-2021_01_08_425864	241	37	but	but	CC
10_1101-2021_01_08_425864	241	38	also	also	RB
10_1101-2021_01_08_425864	241	39	the	the	DT
10_1101-2021_01_08_425864	241	40	390	390	CD
10_1101-2021_01_08_425864	241	41	parasite	parasite	NN
10_1101-2021_01_08_425864	241	42	storage	storage	NN
10_1101-2021_01_08_425864	241	43	of	of	IN
10_1101-2021_01_08_425864	241	44	fatty	fatty	NN
10_1101-2021_01_08_425864	241	45	acids	acid	NNS
10_1101-2021_01_08_425864	241	46	into	into	IN
10_1101-2021_01_08_425864	241	47	lipid	lipid	NN
10_1101-2021_01_08_425864	241	48	droplets	droplet	NNS
10_1101-2021_01_08_425864	241	49	.	.	.
10_1101-2021_01_08_425864	242	1	391	391	CD
10_1101-2021_01_08_425864	242	2	392	392	CD
10_1101-2021_01_08_425864	242	3	393	393	CD
10_1101-2021_01_08_425864	242	4	Figure	figure	NN
10_1101-2021_01_08_425864	242	5	5	5	CD
10_1101-2021_01_08_425864	242	6	.	.	.
10_1101-2021_01_08_425864	243	1	Flow	flow	VB
10_1101-2021_01_08_425864	243	2	cytometry	cytometry	NN
10_1101-2021_01_08_425864	243	3	reveals	reveal	VBZ
10_1101-2021_01_08_425864	243	4	distinct	distinct	JJ
10_1101-2021_01_08_425864	243	5	patterns	pattern	NNS
10_1101-2021_01_08_425864	243	6	in	in	IN
10_1101-2021_01_08_425864	243	7	fatty	fatty	NN
10_1101-2021_01_08_425864	243	8	acid	acid	NN
10_1101-2021_01_08_425864	243	9	pools	pool	NNS
10_1101-2021_01_08_425864	243	10	during	during	IN
10_1101-2021_01_08_425864	243	11	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	243	12	394	394	CD
10_1101-2021_01_08_425864	243	13	growth	growth	NN
10_1101-2021_01_08_425864	243	14	.	.	.
10_1101-2021_01_08_425864	244	1	The	the	DT
10_1101-2021_01_08_425864	244	2	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	244	3	were	be	VBD
10_1101-2021_01_08_425864	244	4	treated	treat	VBN
10_1101-2021_01_08_425864	244	5	with	with	IN
10_1101-2021_01_08_425864	244	6	1	1	CD
10_1101-2021_01_08_425864	244	7	µM	µM	NNP
10_1101-2021_01_08_425864	244	8	of	of	IN
10_1101-2021_01_08_425864	244	9	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	244	10	C1-C12	C1-C12	NNP
10_1101-2021_01_08_425864	244	11	(	(	-LRB-
10_1101-2021_01_08_425864	244	12	500/510	500/510	NNP
10_1101-2021_01_08_425864	244	13	)	)	-RRB-
10_1101-2021_01_08_425864	244	14	and	and	CC
10_1101-2021_01_08_425864	244	15	analysed	analyse	VBN
10_1101-2021_01_08_425864	244	16	by	by	IN
10_1101-2021_01_08_425864	244	17	395	395	CD
10_1101-2021_01_08_425864	244	18	flow	flow	NN
10_1101-2021_01_08_425864	244	19	cytometry	cytometry	NN
10_1101-2021_01_08_425864	244	20	and	and	CC
10_1101-2021_01_08_425864	244	21	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	244	22	microscopy	microscopy	NN
10_1101-2021_01_08_425864	244	23	.	.	.
10_1101-2021_01_08_425864	245	1	A	a	LS
10_1101-2021_01_08_425864	245	2	)	)	-RRB-
10_1101-2021_01_08_425864	245	3	0	0	CD
10_1101-2021_01_08_425864	245	4	h.	h.	NN
10_1101-2021_01_08_425864	245	5	B	B	NNP
10_1101-2021_01_08_425864	245	6	)	)	-RRB-
10_1101-2021_01_08_425864	245	7	24	24	CD
10_1101-2021_01_08_425864	245	8	h.	h.	NN
10_1101-2021_01_08_425864	245	9	C	C	NNP
10_1101-2021_01_08_425864	245	10	)	)	-RRB-
10_1101-2021_01_08_425864	245	11	48	48	CD
10_1101-2021_01_08_425864	245	12	h.	h.	NN
10_1101-2021_01_08_425864	245	13	In	in	IN
10_1101-2021_01_08_425864	245	14	the	the	DT
10_1101-2021_01_08_425864	245	15	flow	flow	NN
10_1101-2021_01_08_425864	245	16	cytometry	cytometry	NN
10_1101-2021_01_08_425864	245	17	396	396	CD
10_1101-2021_01_08_425864	245	18	histograms	histogram	NNS
10_1101-2021_01_08_425864	245	19	,	,	,
10_1101-2021_01_08_425864	245	20	dashed	dash	VBD
10_1101-2021_01_08_425864	245	21	peaks	peak	NNS
10_1101-2021_01_08_425864	245	22	represent	represent	VBP
10_1101-2021_01_08_425864	245	23	unstained	unstained	JJ
10_1101-2021_01_08_425864	245	24	parasites	parasite	NNS
10_1101-2021_01_08_425864	245	25	.	.	.
10_1101-2021_01_08_425864	246	1	Green	green	JJ
10_1101-2021_01_08_425864	246	2	-	-	HYPH
10_1101-2021_01_08_425864	246	3	filled	fill	VBN
10_1101-2021_01_08_425864	246	4	peaks	peak	NNS
10_1101-2021_01_08_425864	246	5	represent	represent	NN
10_1101-2021_01_08_425864	246	6	stained	stain	VBN
10_1101-2021_01_08_425864	246	7	397	397	CD
10_1101-2021_01_08_425864	246	8	parasites	parasite	NNS
10_1101-2021_01_08_425864	246	9	.	.	.
10_1101-2021_01_08_425864	247	1	D	D	NNP
10_1101-2021_01_08_425864	247	2	)	)	-RRB-
10_1101-2021_01_08_425864	247	3	Mean	Mean	NNP
10_1101-2021_01_08_425864	247	4	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	247	5	per	per	IN
10_1101-2021_01_08_425864	247	6	cell	cell	NN
10_1101-2021_01_08_425864	247	7	.	.	.
10_1101-2021_01_08_425864	248	1	The	the	DT
10_1101-2021_01_08_425864	248	2	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	248	3	for	for	IN
10_1101-2021_01_08_425864	248	4	each	each	DT
10_1101-2021_01_08_425864	248	5	cell	cell	NN
10_1101-2021_01_08_425864	248	6	was	be	VBD
10_1101-2021_01_08_425864	248	7	calculated	calculate	VBN
10_1101-2021_01_08_425864	248	8	using	use	VBG
10_1101-2021_01_08_425864	248	9	ImageJ	ImageJ	NNP
10_1101-2021_01_08_425864	248	10	398	398	CD
10_1101-2021_01_08_425864	248	11	software	software	NN
10_1101-2021_01_08_425864	248	12	.	.	.
10_1101-2021_01_08_425864	249	1	All	all	PDT
10_1101-2021_01_08_425864	249	2	the	the	DT
10_1101-2021_01_08_425864	249	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	249	4	were	be	VBD
10_1101-2021_01_08_425864	249	5	performed	perform	VBN
10_1101-2021_01_08_425864	249	6	in	in	IN
10_1101-2021_01_08_425864	249	7	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	249	8	.	.	.
10_1101-2021_01_08_425864	250	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	250	2	analysis	analysis	NN
10_1101-2021_01_08_425864	250	3	was	be	VBD
10_1101-2021_01_08_425864	250	4	performed	perform	VBN
10_1101-2021_01_08_425864	250	5	with	with	IN
10_1101-2021_01_08_425864	250	6	399	399	CD
10_1101-2021_01_08_425864	250	7	one	one	CD
10_1101-2021_01_08_425864	250	8	-	-	HYPH
10_1101-2021_01_08_425864	250	9	way	way	NN
10_1101-2021_01_08_425864	250	10	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	250	11	followed	follow	VBN
10_1101-2021_01_08_425864	250	12	by	by	IN
10_1101-2021_01_08_425864	250	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	250	14	's	's	POS
10_1101-2021_01_08_425864	250	15	post	post	JJ
10_1101-2021_01_08_425864	250	16	-	-	JJ
10_1101-2021_01_08_425864	250	17	test	test	JJ
10_1101-2021_01_08_425864	250	18	p	p	NN
10_1101-2021_01_08_425864	250	19	<	<	XX
10_1101-2021_01_08_425864	250	20	0.05	0.05	XX
10_1101-2021_01_08_425864	250	21	using	use	VBG
10_1101-2021_01_08_425864	250	22	the	the	DT
10_1101-2021_01_08_425864	250	23	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	250	24	Prism	Prism	NNP
10_1101-2021_01_08_425864	250	25	8.0.2	8.0.2	CD
10_1101-2021_01_08_425864	250	26	software	software	NN
10_1101-2021_01_08_425864	250	27	400	400	CD
10_1101-2021_01_08_425864	250	28	program	program	NN
10_1101-2021_01_08_425864	250	29	.	.	.
10_1101-2021_01_08_425864	251	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	251	2	represent	represent	VBP
10_1101-2021_01_08_425864	251	3	the	the	DT
10_1101-2021_01_08_425864	251	4	level	level	NN
10_1101-2021_01_08_425864	251	5	of	of	IN
10_1101-2021_01_08_425864	251	6	statistical	statistical	JJ
10_1101-2021_01_08_425864	251	7	significance	significance	NN
10_1101-2021_01_08_425864	251	8	in	in	IN
10_1101-2021_01_08_425864	251	9	this	this	DT
10_1101-2021_01_08_425864	251	10	figure	figure	NN
10_1101-2021_01_08_425864	251	11	as	as	IN
10_1101-2021_01_08_425864	251	12	follows	follow	VBZ
10_1101-2021_01_08_425864	251	13	:	:	:
10_1101-2021_01_08_425864	251	14	*	*	NFP
10_1101-2021_01_08_425864	251	15	*	*	NFP
10_1101-2021_01_08_425864	251	16	*	*	NFP
10_1101-2021_01_08_425864	251	17	p	p	NN
10_1101-2021_01_08_425864	251	18	value	value	NN
10_1101-2021_01_08_425864	251	19	<	<	XX
10_1101-2021_01_08_425864	251	20	401	401	CD
10_1101-2021_01_08_425864	251	21	0.001	0.001	CD
10_1101-2021_01_08_425864	251	22	;	;	:
10_1101-2021_01_08_425864	251	23	*	*	NFP
10_1101-2021_01_08_425864	251	24	*	*	NFP
10_1101-2021_01_08_425864	251	25	p	p	NN
10_1101-2021_01_08_425864	251	26	value	value	NN
10_1101-2021_01_08_425864	251	27	<	<	XX
10_1101-2021_01_08_425864	251	28	0.01	0.01	XX
10_1101-2021_01_08_425864	251	29	;	;	:
10_1101-2021_01_08_425864	251	30	and	and	CC
10_1101-2021_01_08_425864	251	31	*	*	NFP
10_1101-2021_01_08_425864	251	32	p	p	NN
10_1101-2021_01_08_425864	251	33	value	value	NN
10_1101-2021_01_08_425864	251	34	<	<	XX
10_1101-2021_01_08_425864	251	35	0.05	0.05	CD
10_1101-2021_01_08_425864	251	36	.	.	.
10_1101-2021_01_08_425864	252	1	For	for	IN
10_1101-2021_01_08_425864	252	2	p	p	NN
10_1101-2021_01_08_425864	252	3	value	value	NN
10_1101-2021_01_08_425864	252	4	>	>	XX
10_1101-2021_01_08_425864	252	5	0.05	0.05	CD
10_1101-2021_01_08_425864	252	6	,	,	,
10_1101-2021_01_08_425864	252	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	252	8	consider	consider	VBP
10_1101-2021_01_08_425864	252	9	the	the	DT
10_1101-2021_01_08_425864	252	10	differences	difference	NNS
10_1101-2021_01_08_425864	252	11	not	not	RB
10_1101-2021_01_08_425864	252	12	402	402	CD
10_1101-2021_01_08_425864	252	13	significant	significant	JJ
10_1101-2021_01_08_425864	252	14	(	(	-LRB-
10_1101-2021_01_08_425864	252	15	ns	ns	NNP
10_1101-2021_01_08_425864	252	16	)	)	-RRB-
10_1101-2021_01_08_425864	252	17	.	.	.
10_1101-2021_01_08_425864	253	1	403	403	CD
10_1101-2021_01_08_425864	253	2	404	404	CD
10_1101-2021_01_08_425864	253	3	405	405	CD
10_1101-2021_01_08_425864	253	4	Figure	figure	NN
10_1101-2021_01_08_425864	253	5	6	6	CD
10_1101-2021_01_08_425864	253	6	.	.	.
10_1101-2021_01_08_425864	254	1	Epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	254	2	forms	form	NNS
10_1101-2021_01_08_425864	254	3	accumulates	accumulate	VBZ
10_1101-2021_01_08_425864	254	4	fatty	fatty	NN
10_1101-2021_01_08_425864	254	5	acids	acid	NNS
10_1101-2021_01_08_425864	254	6	into	into	IN
10_1101-2021_01_08_425864	254	7	lipid	lipid	NN
10_1101-2021_01_08_425864	254	8	droplets	droplet	NNS
10_1101-2021_01_08_425864	254	9	during	during	IN
10_1101-2021_01_08_425864	254	10	growth	growth	NN
10_1101-2021_01_08_425864	254	11	.	.	.
10_1101-2021_01_08_425864	255	1	The	the	DT
10_1101-2021_01_08_425864	255	2	406	406	CD
10_1101-2021_01_08_425864	255	3	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	255	4	were	be	VBD
10_1101-2021_01_08_425864	255	5	treated	treat	VBN
10_1101-2021_01_08_425864	255	6	with	with	IN
10_1101-2021_01_08_425864	255	7	1	1	CD
10_1101-2021_01_08_425864	255	8	µM	µM	NNP
10_1101-2021_01_08_425864	255	9	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	255	10	C1-C12	C1-C12	NNP
10_1101-2021_01_08_425864	255	11	(	(	-LRB-
10_1101-2021_01_08_425864	255	12	500/510	500/510	NNP
10_1101-2021_01_08_425864	255	13	)	)	-RRB-
10_1101-2021_01_08_425864	255	14	and	and	CC
10_1101-2021_01_08_425864	255	15	analysed	analyse	VBN
10_1101-2021_01_08_425864	255	16	by	by	IN
10_1101-2021_01_08_425864	255	17	flow	flow	NN
10_1101-2021_01_08_425864	255	18	cytometry	cytometry	NN
10_1101-2021_01_08_425864	255	19	407	407	CD
10_1101-2021_01_08_425864	255	20	and	and	CC
10_1101-2021_01_08_425864	255	21	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	255	22	microscopy	microscopy	NN
10_1101-2021_01_08_425864	255	23	.	.	.
10_1101-2021_01_08_425864	256	1	A	a	LS
10_1101-2021_01_08_425864	256	2	)	)	-RRB-
10_1101-2021_01_08_425864	256	3	0	0	CD
10_1101-2021_01_08_425864	256	4	h.	h.	NN
10_1101-2021_01_08_425864	256	5	B	B	NNP
10_1101-2021_01_08_425864	256	6	)	)	-RRB-
10_1101-2021_01_08_425864	256	7	24	24	CD
10_1101-2021_01_08_425864	256	8	h.	h.	NN
10_1101-2021_01_08_425864	256	9	C	C	NNP
10_1101-2021_01_08_425864	256	10	)	)	-RRB-
10_1101-2021_01_08_425864	256	11	48	48	CD
10_1101-2021_01_08_425864	256	12	h.	h.	NN
10_1101-2021_01_08_425864	256	13	In	in	IN
10_1101-2021_01_08_425864	256	14	the	the	DT
10_1101-2021_01_08_425864	256	15	flow	flow	NN
10_1101-2021_01_08_425864	256	16	cytometry	cytometry	NN
10_1101-2021_01_08_425864	256	17	histograms	histogram	NNS
10_1101-2021_01_08_425864	256	18	,	,	,
10_1101-2021_01_08_425864	256	19	dashed	dash	VBD
10_1101-2021_01_08_425864	256	20	408	408	CD
10_1101-2021_01_08_425864	256	21	peaks	peak	NNS
10_1101-2021_01_08_425864	256	22	represent	represent	VBP
10_1101-2021_01_08_425864	256	23	unstained	unstained	JJ
10_1101-2021_01_08_425864	256	24	parasites	parasite	NNS
10_1101-2021_01_08_425864	256	25	.	.	.
10_1101-2021_01_08_425864	257	1	Yellow	Yellow	NNP
10_1101-2021_01_08_425864	257	2	filled	fill	VBD
10_1101-2021_01_08_425864	257	3	peaks	peak	NNS
10_1101-2021_01_08_425864	257	4	represent	represent	VBP
10_1101-2021_01_08_425864	257	5	positively	positively	RB
10_1101-2021_01_08_425864	257	6	stained	stain	VBN
10_1101-2021_01_08_425864	257	7	parasites	parasite	NNS
10_1101-2021_01_08_425864	257	8	.	.	.
10_1101-2021_01_08_425864	258	1	The	the	DT
10_1101-2021_01_08_425864	258	2	409	409	CD
10_1101-2021_01_08_425864	258	3	number	number	NN
10_1101-2021_01_08_425864	258	4	of	of	IN
10_1101-2021_01_08_425864	258	5	green	green	JJ
10_1101-2021_01_08_425864	258	6	/	/	SYM
10_1101-2021_01_08_425864	258	7	yellow	yellow	JJ
10_1101-2021_01_08_425864	258	8	spots	spot	NNS
10_1101-2021_01_08_425864	258	9	for	for	IN
10_1101-2021_01_08_425864	258	10	each	each	DT
10_1101-2021_01_08_425864	258	11	cell	cell	NN
10_1101-2021_01_08_425864	258	12	was	be	VBD
10_1101-2021_01_08_425864	258	13	calculated	calculate	VBN
10_1101-2021_01_08_425864	258	14	using	use	VBG
10_1101-2021_01_08_425864	258	15	ImageJ	ImageJ	NNPS
10_1101-2021_01_08_425864	258	16	software	software	NN
10_1101-2021_01_08_425864	258	17	.	.	.
10_1101-2021_01_08_425864	259	1	All	all	PDT
10_1101-2021_01_08_425864	259	2	the	the	DT
10_1101-2021_01_08_425864	259	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	259	4	410	410	CD
10_1101-2021_01_08_425864	259	5	were	be	VBD
10_1101-2021_01_08_425864	259	6	performed	perform	VBN
10_1101-2021_01_08_425864	259	7	in	in	IN
10_1101-2021_01_08_425864	259	8	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	259	9	.	.	.
10_1101-2021_01_08_425864	260	1	411	411	CD
10_1101-2021_01_08_425864	260	2	412	412	CD
10_1101-2021_01_08_425864	260	3	To	to	TO
10_1101-2021_01_08_425864	260	4	find	find	VB
10_1101-2021_01_08_425864	260	5	if	if	IN
10_1101-2021_01_08_425864	260	6	the	the	DT
10_1101-2021_01_08_425864	260	7	increase	increase	NN
10_1101-2021_01_08_425864	260	8	in	in	IN
10_1101-2021_01_08_425864	260	9	fatty	fatty	NN
10_1101-2021_01_08_425864	260	10	acid	acid	NN
10_1101-2021_01_08_425864	260	11	pools	pool	NNS
10_1101-2021_01_08_425864	260	12	is	be	VBZ
10_1101-2021_01_08_425864	260	13	accompanied	accompany	VBN
10_1101-2021_01_08_425864	260	14	by	by	IN
10_1101-2021_01_08_425864	260	15	a	a	DT
10_1101-2021_01_08_425864	260	16	change	change	NN
10_1101-2021_01_08_425864	260	17	in	in	IN
10_1101-2021_01_08_425864	260	18	the	the	DT
10_1101-2021_01_08_425864	260	19	levels	level	NNS
10_1101-2021_01_08_425864	260	20	of	of	IN
10_1101-2021_01_08_425864	260	21	enzymes	enzyme	NNS
10_1101-2021_01_08_425864	260	22	413	413	CD
10_1101-2021_01_08_425864	260	23	related	relate	VBN
10_1101-2021_01_08_425864	260	24	to	to	IN
10_1101-2021_01_08_425864	260	25	fatty	fatty	NN
10_1101-2021_01_08_425864	260	26	acid	acid	NN
10_1101-2021_01_08_425864	260	27	metabolism	metabolism	NN
10_1101-2021_01_08_425864	260	28	,	,	,
10_1101-2021_01_08_425864	260	29	we	-PRON-	PRP
10_1101-2021_01_08_425864	260	30	evaluated	evaluate	VBD
10_1101-2021_01_08_425864	260	31	the	the	DT
10_1101-2021_01_08_425864	260	32	specific	specific	JJ
10_1101-2021_01_08_425864	260	33	activities	activity	NNS
10_1101-2021_01_08_425864	260	34	of	of	IN
10_1101-2021_01_08_425864	260	35	the	the	DT
10_1101-2021_01_08_425864	260	36	enzymes	enzyme	NNS
10_1101-2021_01_08_425864	260	37	hexokinase	hexokinase	VBP
10_1101-2021_01_08_425864	260	38	(	(	-LRB-
10_1101-2021_01_08_425864	260	39	HK	HK	NNP
10_1101-2021_01_08_425864	260	40	)	)	-RRB-
10_1101-2021_01_08_425864	260	41	,	,	,
10_1101-2021_01_08_425864	260	42	414	414	CD
10_1101-2021_01_08_425864	260	43	which	which	WDT
10_1101-2021_01_08_425864	260	44	is	be	VBZ
10_1101-2021_01_08_425864	260	45	responsible	responsible	JJ
10_1101-2021_01_08_425864	260	46	for	for	IN
10_1101-2021_01_08_425864	260	47	the	the	DT
10_1101-2021_01_08_425864	260	48	initial	initial	JJ
10_1101-2021_01_08_425864	260	49	step	step	NN
10_1101-2021_01_08_425864	260	50	of	of	IN
10_1101-2021_01_08_425864	260	51	glycolysis	glycolysis	NN
10_1101-2021_01_08_425864	260	52	and	and	CC
10_1101-2021_01_08_425864	260	53	an	an	DT
10_1101-2021_01_08_425864	260	54	indicator	indicator	NN
10_1101-2021_01_08_425864	260	55	of	of	IN
10_1101-2021_01_08_425864	260	56	active	active	JJ
10_1101-2021_01_08_425864	260	57	glycolysis	glycolysis	NN
10_1101-2021_01_08_425864	260	58	;	;	:
10_1101-2021_01_08_425864	260	59	acetyl	acetyl	NN
10_1101-2021_01_08_425864	260	60	-	-	HYPH
10_1101-2021_01_08_425864	260	61	CoA	CoA	NNP
10_1101-2021_01_08_425864	260	62	415	415	CD
10_1101-2021_01_08_425864	260	63	carboxylase	carboxylase	NN
10_1101-2021_01_08_425864	260	64	(	(	-LRB-
10_1101-2021_01_08_425864	260	65	ACC	ACC	NNP
10_1101-2021_01_08_425864	260	66	)	)	-RRB-
10_1101-2021_01_08_425864	260	67	,	,	,
10_1101-2021_01_08_425864	260	68	which	which	WDT
10_1101-2021_01_08_425864	260	69	produces	produce	VBZ
10_1101-2021_01_08_425864	260	70	malonyl	malonyl	NN
10_1101-2021_01_08_425864	260	71	-	-	HYPH
10_1101-2021_01_08_425864	260	72	CoA	CoA	NNP
10_1101-2021_01_08_425864	260	73	for	for	IN
10_1101-2021_01_08_425864	260	74	fatty	fatty	NN
10_1101-2021_01_08_425864	260	75	acid	acid	NN
10_1101-2021_01_08_425864	260	76	synthesis	synthesis	NN
10_1101-2021_01_08_425864	260	77	and	and	CC
10_1101-2021_01_08_425864	260	78	carnitine	carnitine	NN
10_1101-2021_01_08_425864	260	79	416	416	CD
10_1101-2021_01_08_425864	260	80	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	260	81	1	1	CD
10_1101-2021_01_08_425864	260	82	(	(	-LRB-
10_1101-2021_01_08_425864	260	83	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	260	84	)	)	-RRB-
10_1101-2021_01_08_425864	260	85	,	,	,
10_1101-2021_01_08_425864	260	86	the	the	DT
10_1101-2021_01_08_425864	260	87	complex	complex	NN
10_1101-2021_01_08_425864	260	88	that	that	WDT
10_1101-2021_01_08_425864	260	89	plays	play	VBZ
10_1101-2021_01_08_425864	260	90	a	a	DT
10_1101-2021_01_08_425864	260	91	central	central	JJ
10_1101-2021_01_08_425864	260	92	role	role	NN
10_1101-2021_01_08_425864	260	93	in	in	IN
10_1101-2021_01_08_425864	260	94	fatty	fatty	NN
10_1101-2021_01_08_425864	260	95	acid	acid	NN
10_1101-2021_01_08_425864	260	96	oxidation	oxidation	NN
10_1101-2021_01_08_425864	260	97	(	(	-LRB-
10_1101-2021_01_08_425864	260	98	FAO	FAO	NNP
10_1101-2021_01_08_425864	260	99	)	)	-RRB-
10_1101-2021_01_08_425864	260	100	by	by	IN
10_1101-2021_01_08_425864	260	101	417	417	CD
10_1101-2021_01_08_425864	260	102	controlling	control	VBG
10_1101-2021_01_08_425864	260	103	the	the	DT
10_1101-2021_01_08_425864	260	104	entrance	entrance	NN
10_1101-2021_01_08_425864	260	105	of	of	IN
10_1101-2021_01_08_425864	260	106	long	long	JJ
10_1101-2021_01_08_425864	260	107	-	-	HYPH
10_1101-2021_01_08_425864	260	108	chain	chain	NN
10_1101-2021_01_08_425864	260	109	fatty	fatty	NN
10_1101-2021_01_08_425864	260	110	acids	acid	NNS
10_1101-2021_01_08_425864	260	111	into	into	IN
10_1101-2021_01_08_425864	260	112	the	the	DT
10_1101-2021_01_08_425864	260	113	mitochondria	mitochondria	NN
10_1101-2021_01_08_425864	260	114	[	[	-LRB-
10_1101-2021_01_08_425864	260	115	30	30	CD
10_1101-2021_01_08_425864	260	116	]	]	-RRB-
10_1101-2021_01_08_425864	260	117	.	.	.
10_1101-2021_01_08_425864	261	1	For	for	IN
10_1101-2021_01_08_425864	261	2	the	the	DT
10_1101-2021_01_08_425864	261	3	control	control	NN
10_1101-2021_01_08_425864	261	4	,	,	,
10_1101-2021_01_08_425864	261	5	we	-PRON-	PRP
10_1101-2021_01_08_425864	261	6	418	418	CD
10_1101-2021_01_08_425864	261	7	selected	select	VBD
10_1101-2021_01_08_425864	261	8	the	the	DT
10_1101-2021_01_08_425864	261	9	enzyme	enzyme	NNS
10_1101-2021_01_08_425864	261	10	serine	serine	NNP
10_1101-2021_01_08_425864	261	11	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	261	12	1	1	CD
10_1101-2021_01_08_425864	261	13	(	(	-LRB-
10_1101-2021_01_08_425864	261	14	SPT1	SPT1	NNP
10_1101-2021_01_08_425864	261	15	)	)	-RRB-
10_1101-2021_01_08_425864	261	16	,	,	,
10_1101-2021_01_08_425864	261	17	a	a	DT
10_1101-2021_01_08_425864	261	18	constitutively	constitutively	RB
10_1101-2021_01_08_425864	261	19	expressed	express	VBN
10_1101-2021_01_08_425864	261	20	protein	protein	NN
10_1101-2021_01_08_425864	261	21	in	in	IN
10_1101-2021_01_08_425864	261	22	T.	T.	NNP
10_1101-2021_01_08_425864	261	23	419	419	CD
10_1101-2021_01_08_425864	261	24	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	261	25	[	[	-LRB-
10_1101-2021_01_08_425864	261	26	31	31	CD
10_1101-2021_01_08_425864	261	27	]	]	-RRB-
10_1101-2021_01_08_425864	261	28	(	(	-LRB-
10_1101-2021_01_08_425864	261	29	Fig	fig	NN
10_1101-2021_01_08_425864	261	30	7	7	CD
10_1101-2021_01_08_425864	261	31	)	)	-RRB-
10_1101-2021_01_08_425864	261	32	.	.	.
10_1101-2021_01_08_425864	262	1	The	the	DT
10_1101-2021_01_08_425864	262	2	hexokinase	hexokinase	NN
10_1101-2021_01_08_425864	262	3	activity	activity	NN
10_1101-2021_01_08_425864	262	4	diminished	diminish	VBN
10_1101-2021_01_08_425864	262	5	up	up	IN
10_1101-2021_01_08_425864	262	6	to	to	TO
10_1101-2021_01_08_425864	262	7	30	30	CD
10_1101-2021_01_08_425864	262	8	%	%	NN
10_1101-2021_01_08_425864	262	9	with	with	IN
10_1101-2021_01_08_425864	262	10	the	the	DT
10_1101-2021_01_08_425864	262	11	progression	progression	NN
10_1101-2021_01_08_425864	262	12	of	of	IN
10_1101-2021_01_08_425864	262	13	the	the	DT
10_1101-2021_01_08_425864	262	14	420	420	CD
10_1101-2021_01_08_425864	262	15	proliferation	proliferation	NN
10_1101-2021_01_08_425864	262	16	curve	curve	NN
10_1101-2021_01_08_425864	262	17	and	and	CC
10_1101-2021_01_08_425864	262	18	the	the	DT
10_1101-2021_01_08_425864	262	19	correlated	correlate	VBN
10_1101-2021_01_08_425864	262	20	depletion	depletion	NN
10_1101-2021_01_08_425864	262	21	of	of	IN
10_1101-2021_01_08_425864	262	22	glucose	glucose	NN
10_1101-2021_01_08_425864	262	23	(	(	-LRB-
10_1101-2021_01_08_425864	262	24	Fig	fig	NN
10_1101-2021_01_08_425864	262	25	7A	7a	NN
10_1101-2021_01_08_425864	262	26	)	)	-RRB-
10_1101-2021_01_08_425864	262	27	.	.	.
10_1101-2021_01_08_425864	263	1	In	in	IN
10_1101-2021_01_08_425864	263	2	addition	addition	NN
10_1101-2021_01_08_425864	263	3	,	,	,
10_1101-2021_01_08_425864	263	4	the	the	DT
10_1101-2021_01_08_425864	263	5	ACC	ACC	NNP
10_1101-2021_01_08_425864	263	6	activity	activity	NN
10_1101-2021_01_08_425864	263	7	is	be	VBZ
10_1101-2021_01_08_425864	263	8	421	421	CD
10_1101-2021_01_08_425864	263	9	no	no	DT
10_1101-2021_01_08_425864	263	10	more	more	RBR
10_1101-2021_01_08_425864	263	11	detectable	detectable	JJ
10_1101-2021_01_08_425864	263	12	in	in	IN
10_1101-2021_01_08_425864	263	13	the	the	DT
10_1101-2021_01_08_425864	263	14	stationary	stationary	JJ
10_1101-2021_01_08_425864	263	15	phase	phase	NN
10_1101-2021_01_08_425864	263	16	cells	cell	NNS
10_1101-2021_01_08_425864	263	17	(	(	-LRB-
10_1101-2021_01_08_425864	263	18	Fig	fig	NN
10_1101-2021_01_08_425864	263	19	7B	7b	NN
10_1101-2021_01_08_425864	263	20	)	)	-RRB-
10_1101-2021_01_08_425864	263	21	.	.	.
10_1101-2021_01_08_425864	264	1	By	by	IN
10_1101-2021_01_08_425864	264	2	contrast	contrast	NN
10_1101-2021_01_08_425864	264	3	,	,	,
10_1101-2021_01_08_425864	264	4	the	the	DT
10_1101-2021_01_08_425864	264	5	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	264	6	activity	activity	NN
10_1101-2021_01_08_425864	264	7	is	be	VBZ
10_1101-2021_01_08_425864	264	8	increased	increase	VBN
10_1101-2021_01_08_425864	264	9	422	422	CD
10_1101-2021_01_08_425864	264	10	by	by	IN
10_1101-2021_01_08_425864	264	11	~4-fold	~4-fold	NFP
10_1101-2021_01_08_425864	264	12	when	when	WRB
10_1101-2021_01_08_425864	264	13	the	the	DT
10_1101-2021_01_08_425864	264	14	stationary	stationary	JJ
10_1101-2021_01_08_425864	264	15	phase	phase	NN
10_1101-2021_01_08_425864	264	16	is	be	VBZ
10_1101-2021_01_08_425864	264	17	reached	reach	VBN
10_1101-2021_01_08_425864	264	18	(	(	-LRB-
10_1101-2021_01_08_425864	264	19	Fig	Fig	NNP
10_1101-2021_01_08_425864	264	20	7C	7C	NNP
10_1101-2021_01_08_425864	264	21	)	)	-RRB-
10_1101-2021_01_08_425864	264	22	,	,	,
10_1101-2021_01_08_425864	264	23	which	which	WDT
10_1101-2021_01_08_425864	264	24	confirms	confirm	VBZ
10_1101-2021_01_08_425864	264	25	that	that	IN
10_1101-2021_01_08_425864	264	26	fatty	fatty	NN
10_1101-2021_01_08_425864	264	27	acid	acid	VBP
10_1101-2021_01_08_425864	264	28	degradation	degradation	NN
10_1101-2021_01_08_425864	264	29	423	423	CD
10_1101-2021_01_08_425864	264	30	occurs	occur	NNS
10_1101-2021_01_08_425864	264	31	in	in	IN
10_1101-2021_01_08_425864	264	32	the	the	DT
10_1101-2021_01_08_425864	264	33	absence	absence	NN
10_1101-2021_01_08_425864	264	34	of	of	IN
10_1101-2021_01_08_425864	264	35	glucose	glucose	NN
10_1101-2021_01_08_425864	264	36	.	.	.
10_1101-2021_01_08_425864	265	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	265	2	is	be	VBZ
10_1101-2021_01_08_425864	265	3	noteworthy	noteworthy	JJ
10_1101-2021_01_08_425864	265	4	that	that	IN
10_1101-2021_01_08_425864	265	5	the	the	DT
10_1101-2021_01_08_425864	265	6	high	high	JJ
10_1101-2021_01_08_425864	265	7	levels	level	NNS
10_1101-2021_01_08_425864	265	8	of	of	IN
10_1101-2021_01_08_425864	265	9	ACC	ACC	NNP
10_1101-2021_01_08_425864	265	10	activity	activity	NN
10_1101-2021_01_08_425864	265	11	in	in	IN
10_1101-2021_01_08_425864	265	12	the	the	DT
10_1101-2021_01_08_425864	265	13	presence	presence	NN
10_1101-2021_01_08_425864	265	14	424	424	CD
10_1101-2021_01_08_425864	265	15	of	of	IN
10_1101-2021_01_08_425864	265	16	glucose	glucose	NN
10_1101-2021_01_08_425864	265	17	supports	support	VBZ
10_1101-2021_01_08_425864	265	18	the	the	DT
10_1101-2021_01_08_425864	265	19	idea	idea	NN
10_1101-2021_01_08_425864	265	20	that	that	IN
10_1101-2021_01_08_425864	265	21	under	under	IN
10_1101-2021_01_08_425864	265	22	these	these	DT
10_1101-2021_01_08_425864	265	23	conditions	condition	NNS
10_1101-2021_01_08_425864	265	24	,	,	,
10_1101-2021_01_08_425864	265	25	fatty	fatty	NN
10_1101-2021_01_08_425864	265	26	acids	acid	NNS
10_1101-2021_01_08_425864	265	27	are	be	VBP
10_1101-2021_01_08_425864	265	28	probably	probably	RB
10_1101-2021_01_08_425864	265	29	synthesized	synthesize	VBN
10_1101-2021_01_08_425864	265	30	instead	instead	RB
10_1101-2021_01_08_425864	265	31	425	425	CD
10_1101-2021_01_08_425864	265	32	of	of	IN
10_1101-2021_01_08_425864	265	33	being	be	VBG
10_1101-2021_01_08_425864	265	34	catabolized	catabolize	VBN
10_1101-2021_01_08_425864	265	35	.	.	.
10_1101-2021_01_08_425864	266	1	As	as	IN
10_1101-2021_01_08_425864	266	2	expected	expect	VBN
10_1101-2021_01_08_425864	266	3	,	,	,
10_1101-2021_01_08_425864	266	4	SPT1	SPT1	NNP
10_1101-2021_01_08_425864	266	5	did	do	VBD
10_1101-2021_01_08_425864	266	6	not	not	RB
10_1101-2021_01_08_425864	266	7	change	change	VB
10_1101-2021_01_08_425864	266	8	during	during	IN
10_1101-2021_01_08_425864	266	9	the	the	DT
10_1101-2021_01_08_425864	266	10	analysed	analyse	VBN
10_1101-2021_01_08_425864	266	11	time	time	NN
10_1101-2021_01_08_425864	266	12	frame	frame	NN
10_1101-2021_01_08_425864	266	13	(	(	-LRB-
10_1101-2021_01_08_425864	266	14	Fig	fig	NN
10_1101-2021_01_08_425864	266	15	7D	7D	NNP
10_1101-2021_01_08_425864	266	16	)	)	-RRB-
10_1101-2021_01_08_425864	266	17	.	.	.
10_1101-2021_01_08_425864	267	1	426	426	CD
10_1101-2021_01_08_425864	267	2	427	427	CD
10_1101-2021_01_08_425864	267	3	Figure	figure	NN
10_1101-2021_01_08_425864	267	4	6	6	CD
10_1101-2021_01_08_425864	267	5	.	.	.
10_1101-2021_01_08_425864	268	1	Activities	activity	NNS
10_1101-2021_01_08_425864	268	2	of	of	IN
10_1101-2021_01_08_425864	268	3	enzymes	enzyme	NNS
10_1101-2021_01_08_425864	268	4	related	relate	VBN
10_1101-2021_01_08_425864	268	5	to	to	IN
10_1101-2021_01_08_425864	268	6	lipid	lipid	NN
10_1101-2021_01_08_425864	268	7	and	and	CC
10_1101-2021_01_08_425864	268	8	glucose	glucose	VB
10_1101-2021_01_08_425864	268	9	metabolism	metabolism	NN
10_1101-2021_01_08_425864	268	10	during	during	IN
10_1101-2021_01_08_425864	268	11	T.	t.	NN
10_1101-2021_01_08_425864	268	12	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	268	13	growth	growth	NN
10_1101-2021_01_08_425864	268	14	428	428	CD
10_1101-2021_01_08_425864	268	15	curves	curve	NNS
10_1101-2021_01_08_425864	268	16	.	.	.
10_1101-2021_01_08_425864	269	1	A	a	LS
10_1101-2021_01_08_425864	269	2	)	)	-RRB-
10_1101-2021_01_08_425864	269	3	(	(	-LRB-
10_1101-2021_01_08_425864	269	4	HK	HK	NNP
10_1101-2021_01_08_425864	269	5	)	)	-RRB-
10_1101-2021_01_08_425864	269	6	Hexokinase	Hexokinase	NNP
10_1101-2021_01_08_425864	269	7	B	B	NNP
10_1101-2021_01_08_425864	269	8	)	)	-RRB-
10_1101-2021_01_08_425864	269	9	(	(	-LRB-
10_1101-2021_01_08_425864	269	10	ACC	ACC	NNP
10_1101-2021_01_08_425864	269	11	)	)	-RRB-
10_1101-2021_01_08_425864	269	12	acetyl	acetyl	NN
10_1101-2021_01_08_425864	269	13	-	-	HYPH
10_1101-2021_01_08_425864	269	14	CoA	CoA	NNP
10_1101-2021_01_08_425864	269	15	carboxylase	carboxylase	NN
10_1101-2021_01_08_425864	269	16	,	,	,
10_1101-2021_01_08_425864	269	17	C	C	NNP
10_1101-2021_01_08_425864	269	18	)	)	-RRB-
10_1101-2021_01_08_425864	269	19	(	(	-LRB-
10_1101-2021_01_08_425864	269	20	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	269	21	)	)	-RRB-
10_1101-2021_01_08_425864	269	22	carnitine-	carnitine-	NN
10_1101-2021_01_08_425864	269	23	429	429	CD
10_1101-2021_01_08_425864	269	24	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	269	25	,	,	,
10_1101-2021_01_08_425864	269	26	and	and	CC
10_1101-2021_01_08_425864	269	27	D	d	NN
10_1101-2021_01_08_425864	269	28	)	)	-RRB-
10_1101-2021_01_08_425864	269	29	(	(	-LRB-
10_1101-2021_01_08_425864	269	30	SPT	SPT	NNP
10_1101-2021_01_08_425864	269	31	)	)	-RRB-
10_1101-2021_01_08_425864	269	32	serine	serine	JJ
10_1101-2021_01_08_425864	269	33	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	269	34	.	.	.
10_1101-2021_01_08_425864	270	1	All	all	PDT
10_1101-2021_01_08_425864	270	2	these	these	DT
10_1101-2021_01_08_425864	270	3	activities	activity	NNS
10_1101-2021_01_08_425864	270	4	were	be	VBD
10_1101-2021_01_08_425864	270	5	measured	measure	VBN
10_1101-2021_01_08_425864	270	6	in	in	IN
10_1101-2021_01_08_425864	270	7	.CC	.CC	NFP
10_1101-2021_01_08_425864	270	8	-	-	:
10_1101-2021_01_08_425864	270	9	BY	by	IN
10_1101-2021_01_08_425864	270	10	4.0	4.0	CD
10_1101-2021_01_08_425864	270	11	International	international	JJ
10_1101-2021_01_08_425864	270	12	licensemade	licensemade	NN
10_1101-2021_01_08_425864	270	13	available	available	JJ
10_1101-2021_01_08_425864	270	14	under	under	IN
10_1101-2021_01_08_425864	270	15	a	a	DT
10_1101-2021_01_08_425864	270	16	(	(	-LRB-
10_1101-2021_01_08_425864	270	17	which	which	WDT
10_1101-2021_01_08_425864	270	18	was	be	VBD
10_1101-2021_01_08_425864	270	19	not	not	RB
10_1101-2021_01_08_425864	270	20	certified	certify	VBN
10_1101-2021_01_08_425864	270	21	by	by	IN
10_1101-2021_01_08_425864	270	22	peer	peer	NN
10_1101-2021_01_08_425864	270	23	review	review	NN
10_1101-2021_01_08_425864	270	24	)	)	-RRB-
10_1101-2021_01_08_425864	270	25	is	be	VBZ
10_1101-2021_01_08_425864	270	26	the	the	DT
10_1101-2021_01_08_425864	270	27	author	author	NN
10_1101-2021_01_08_425864	270	28	/	/	SYM
10_1101-2021_01_08_425864	270	29	funder	funder	NN
10_1101-2021_01_08_425864	270	30	,	,	,
10_1101-2021_01_08_425864	270	31	who	who	WP
10_1101-2021_01_08_425864	270	32	has	have	VBZ
10_1101-2021_01_08_425864	270	33	granted	grant	VBN
10_1101-2021_01_08_425864	270	34	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	270	35	a	a	DT
10_1101-2021_01_08_425864	270	36	license	license	NN
10_1101-2021_01_08_425864	270	37	to	to	TO
10_1101-2021_01_08_425864	270	38	display	display	VB
10_1101-2021_01_08_425864	270	39	the	the	DT
10_1101-2021_01_08_425864	270	40	preprint	preprint	NN
10_1101-2021_01_08_425864	270	41	in	in	IN
10_1101-2021_01_08_425864	270	42	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	270	43	.	.	.
10_1101-2021_01_08_425864	271	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	271	2	is	be	VBZ
10_1101-2021_01_08_425864	271	3	The	the	DT
10_1101-2021_01_08_425864	271	4	copyright	copyright	NN
10_1101-2021_01_08_425864	271	5	holder	holder	NN
10_1101-2021_01_08_425864	271	6	for	for	IN
10_1101-2021_01_08_425864	271	7	this	this	DT
10_1101-2021_01_08_425864	271	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	271	9	version	version	NN
10_1101-2021_01_08_425864	271	10	posted	post	VBD
10_1101-2021_01_08_425864	271	11	January	January	NNP
10_1101-2021_01_08_425864	271	12	8	8	CD
10_1101-2021_01_08_425864	271	13	,	,	,
10_1101-2021_01_08_425864	271	14	2021	2021	CD
10_1101-2021_01_08_425864	271	15	.	.	.
10_1101-2021_01_08_425864	271	16	;	;	:
10_1101-2021_01_08_425864	271	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	271	18	:	:	:
10_1101-2021_01_08_425864	271	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	271	20	preprint	preprint	NN
10_1101-2021_01_08_425864	271	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	271	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	VBZ
10_1101-2021_01_08_425864	271	23	430	430	CD
10_1101-2021_01_08_425864	271	24	crude	crude	JJ
10_1101-2021_01_08_425864	271	25	extracts	extract	NNS
10_1101-2021_01_08_425864	271	26	from	from	IN
10_1101-2021_01_08_425864	271	27	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	271	28	forms	form	NNS
10_1101-2021_01_08_425864	271	29	at	at	IN
10_1101-2021_01_08_425864	271	30	different	different	JJ
10_1101-2021_01_08_425864	271	31	moments	moment	NNS
10_1101-2021_01_08_425864	271	32	of	of	IN
10_1101-2021_01_08_425864	271	33	the	the	DT
10_1101-2021_01_08_425864	271	34	growth	growth	NN
10_1101-2021_01_08_425864	271	35	curve	curve	NN
10_1101-2021_01_08_425864	271	36	.	.	.
10_1101-2021_01_08_425864	272	1	All	all	PDT
10_1101-2021_01_08_425864	272	2	the	the	DT
10_1101-2021_01_08_425864	272	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	272	4	431	431	CD
10_1101-2021_01_08_425864	272	5	were	be	VBD
10_1101-2021_01_08_425864	272	6	performed	perform	VBN
10_1101-2021_01_08_425864	272	7	in	in	IN
10_1101-2021_01_08_425864	272	8	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	272	9	.	.	.
10_1101-2021_01_08_425864	273	1	Time	time	NN
10_1101-2021_01_08_425864	273	2	course	course	NN
10_1101-2021_01_08_425864	273	3	activities	activity	NNS
10_1101-2021_01_08_425864	273	4	and	and	CC
10_1101-2021_01_08_425864	273	5	controls	control	NNS
10_1101-2021_01_08_425864	273	6	shown	show	VBN
10_1101-2021_01_08_425864	273	7	in	in	IN
10_1101-2021_01_08_425864	273	8	Fig	Fig	NNP
10_1101-2021_01_08_425864	273	9	S2	S2	NNP
10_1101-2021_01_08_425864	273	10	.	.	.
10_1101-2021_01_08_425864	274	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	274	2	analysis	analysis	NN
10_1101-2021_01_08_425864	274	3	432	432	CD
10_1101-2021_01_08_425864	274	4	was	be	VBD
10_1101-2021_01_08_425864	274	5	performed	perform	VBN
10_1101-2021_01_08_425864	274	6	with	with	IN
10_1101-2021_01_08_425864	274	7	one	one	CD
10_1101-2021_01_08_425864	274	8	-	-	HYPH
10_1101-2021_01_08_425864	274	9	way	way	NN
10_1101-2021_01_08_425864	274	10	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	274	11	followed	follow	VBN
10_1101-2021_01_08_425864	274	12	by	by	IN
10_1101-2021_01_08_425864	274	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	274	14	's	's	POS
10_1101-2021_01_08_425864	274	15	post	post	JJ
10_1101-2021_01_08_425864	274	16	-	-	NN
10_1101-2021_01_08_425864	274	17	test	test	NN
10_1101-2021_01_08_425864	274	18	at	at	IN
10_1101-2021_01_08_425864	274	19	p	p	NN
10_1101-2021_01_08_425864	274	20	<	<	XX
10_1101-2021_01_08_425864	274	21	0.05	0.05	CD
10_1101-2021_01_08_425864	274	22	,	,	,
10_1101-2021_01_08_425864	274	23	using	use	VBG
10_1101-2021_01_08_425864	274	24	the	the	DT
10_1101-2021_01_08_425864	274	25	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	274	26	433	433	CD
10_1101-2021_01_08_425864	274	27	Prism	Prism	NNP
10_1101-2021_01_08_425864	274	28	8.0.2	8.0.2	CD
10_1101-2021_01_08_425864	274	29	software	software	NN
10_1101-2021_01_08_425864	274	30	program	program	NN
10_1101-2021_01_08_425864	274	31	.	.	.
10_1101-2021_01_08_425864	275	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	275	2	represent	represent	VBP
10_1101-2021_01_08_425864	275	3	the	the	DT
10_1101-2021_01_08_425864	275	4	level	level	NN
10_1101-2021_01_08_425864	275	5	of	of	IN
10_1101-2021_01_08_425864	275	6	statistical	statistical	JJ
10_1101-2021_01_08_425864	275	7	significance	significance	NN
10_1101-2021_01_08_425864	275	8	in	in	IN
10_1101-2021_01_08_425864	275	9	this	this	DT
10_1101-2021_01_08_425864	275	10	figure	figure	NN
10_1101-2021_01_08_425864	275	11	as	as	IN
10_1101-2021_01_08_425864	275	12	434	434	CD
10_1101-2021_01_08_425864	275	13	follows	follow	VBZ
10_1101-2021_01_08_425864	275	14	:	:	:
10_1101-2021_01_08_425864	275	15	*	*	NFP
10_1101-2021_01_08_425864	275	16	*	*	NFP
10_1101-2021_01_08_425864	275	17	*	*	NFP
10_1101-2021_01_08_425864	275	18	p	p	NN
10_1101-2021_01_08_425864	275	19	value	value	NN
10_1101-2021_01_08_425864	275	20	<	<	XX
10_1101-2021_01_08_425864	275	21	0.001	0.001	CD
10_1101-2021_01_08_425864	275	22	;	;	:
10_1101-2021_01_08_425864	275	23	*	*	NFP
10_1101-2021_01_08_425864	275	24	*	*	NFP
10_1101-2021_01_08_425864	275	25	p	p	NN
10_1101-2021_01_08_425864	275	26	value	value	NN
10_1101-2021_01_08_425864	275	27	<	<	XX
10_1101-2021_01_08_425864	275	28	0.01	0.01	XX
10_1101-2021_01_08_425864	275	29	;	;	:
10_1101-2021_01_08_425864	275	30	and	and	CC
10_1101-2021_01_08_425864	275	31	*	*	NFP
10_1101-2021_01_08_425864	275	32	p	p	NN
10_1101-2021_01_08_425864	275	33	value	value	NN
10_1101-2021_01_08_425864	275	34	<	<	XX
10_1101-2021_01_08_425864	275	35	0.05	0.05	CD
10_1101-2021_01_08_425864	275	36	.	.	.
10_1101-2021_01_08_425864	276	1	For	for	IN
10_1101-2021_01_08_425864	276	2	p	p	NN
10_1101-2021_01_08_425864	276	3	value	value	NN
10_1101-2021_01_08_425864	276	4	>	>	XX
10_1101-2021_01_08_425864	276	5	0.05	0.05	CD
10_1101-2021_01_08_425864	276	6	we	-PRON-	PRP
10_1101-2021_01_08_425864	276	7	consider	consider	VBP
10_1101-2021_01_08_425864	276	8	435	435	CD
10_1101-2021_01_08_425864	276	9	the	the	DT
10_1101-2021_01_08_425864	276	10	differences	difference	NNS
10_1101-2021_01_08_425864	276	11	not	not	RB
10_1101-2021_01_08_425864	276	12	significant	significant	JJ
10_1101-2021_01_08_425864	276	13	(	(	-LRB-
10_1101-2021_01_08_425864	276	14	ns	ns	NNP
10_1101-2021_01_08_425864	276	15	)	)	-RRB-
10_1101-2021_01_08_425864	276	16	.	.	.
10_1101-2021_01_08_425864	277	1	436	436	CD
10_1101-2021_01_08_425864	277	2	437	437	CD
10_1101-2021_01_08_425864	277	3	438	438	CD
10_1101-2021_01_08_425864	277	4	Etomoxir	Etomoxir	NNPS
10_1101-2021_01_08_425864	277	5	,	,	,
10_1101-2021_01_08_425864	277	6	a	a	DT
10_1101-2021_01_08_425864	277	7	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	277	8	inhibitor	inhibitor	NN
10_1101-2021_01_08_425864	277	9	,	,	,
10_1101-2021_01_08_425864	277	10	affects	affect	VBZ
10_1101-2021_01_08_425864	277	11	T.	T.	NNP
10_1101-2021_01_08_425864	277	12	cruzi	cruzi	NNP
10_1101-2021_01_08_425864	277	13	proliferation	proliferation	NN
10_1101-2021_01_08_425864	277	14	and	and	CC
10_1101-2021_01_08_425864	277	15	mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	277	16	activity	activity	NN
10_1101-2021_01_08_425864	277	17	439	439	CD
10_1101-2021_01_08_425864	277	18	To	to	TO
10_1101-2021_01_08_425864	277	19	investigate	investigate	VB
10_1101-2021_01_08_425864	277	20	the	the	DT
10_1101-2021_01_08_425864	277	21	role	role	NN
10_1101-2021_01_08_425864	277	22	of	of	IN
10_1101-2021_01_08_425864	277	23	FAO	FAO	NNP
10_1101-2021_01_08_425864	277	24	in	in	IN
10_1101-2021_01_08_425864	277	25	T.	T.	NNP
10_1101-2021_01_08_425864	277	26	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	277	27	,	,	,
10_1101-2021_01_08_425864	277	28	we	-PRON-	PRP
10_1101-2021_01_08_425864	277	29	tested	test	VBD
10_1101-2021_01_08_425864	277	30	the	the	DT
10_1101-2021_01_08_425864	277	31	effect	effect	NN
10_1101-2021_01_08_425864	277	32	of	of	IN
10_1101-2021_01_08_425864	277	33	a	a	DT
10_1101-2021_01_08_425864	277	34	well	well	RB
10_1101-2021_01_08_425864	277	35	characterized	characterize	VBN
10_1101-2021_01_08_425864	277	36	inhibitor	inhibitor	NN
10_1101-2021_01_08_425864	277	37	440	440	CD
10_1101-2021_01_08_425864	277	38	of	of	IN
10_1101-2021_01_08_425864	277	39	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	277	40	,	,	,
10_1101-2021_01_08_425864	277	41	etomoxir	etomoxir	NNP
10_1101-2021_01_08_425864	277	42	(	(	-LRB-
10_1101-2021_01_08_425864	277	43	ETO	ETO	NNP
10_1101-2021_01_08_425864	277	44	)	)	-RRB-
10_1101-2021_01_08_425864	277	45	,	,	,
10_1101-2021_01_08_425864	277	46	on	on	IN
10_1101-2021_01_08_425864	277	47	the	the	DT
10_1101-2021_01_08_425864	277	48	proliferation	proliferation	NN
10_1101-2021_01_08_425864	277	49	of	of	IN
10_1101-2021_01_08_425864	277	50	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	277	51	.	.	.
10_1101-2021_01_08_425864	278	1	Among	among	IN
10_1101-2021_01_08_425864	278	2	the	the	DT
10_1101-2021_01_08_425864	278	3	ETO	ETO	NNP
10_1101-2021_01_08_425864	278	4	concentrations	concentration	NNS
10_1101-2021_01_08_425864	278	5	441	441	CD
10_1101-2021_01_08_425864	278	6	tested	test	VBN
10_1101-2021_01_08_425864	278	7	here	here	RB
10_1101-2021_01_08_425864	278	8	(	(	-LRB-
10_1101-2021_01_08_425864	278	9	from	from	IN
10_1101-2021_01_08_425864	278	10	0.1	0.1	CD
10_1101-2021_01_08_425864	278	11	to	to	IN
10_1101-2021_01_08_425864	278	12	500	500	CD
10_1101-2021_01_08_425864	278	13	µM	µM	NNP
10_1101-2021_01_08_425864	278	14	)	)	-RRB-
10_1101-2021_01_08_425864	278	15	,	,	,
10_1101-2021_01_08_425864	278	16	only	only	RB
10_1101-2021_01_08_425864	278	17	the	the	DT
10_1101-2021_01_08_425864	278	18	higher	high	JJR
10_1101-2021_01_08_425864	278	19	concentration	concentration	NN
10_1101-2021_01_08_425864	278	20	arrested	arrest	VBN
10_1101-2021_01_08_425864	278	21	parasite	parasite	NN
10_1101-2021_01_08_425864	278	22	proliferation	proliferation	NN
10_1101-2021_01_08_425864	278	23	(	(	-LRB-
10_1101-2021_01_08_425864	278	24	Fig	fig	NN
10_1101-2021_01_08_425864	278	25	442	442	CD
10_1101-2021_01_08_425864	278	26	8A	8A	NNP
10_1101-2021_01_08_425864	278	27	)	)	-RRB-
10_1101-2021_01_08_425864	278	28	.	.	.
10_1101-2021_01_08_425864	279	1	Importantly	importantly	RB
10_1101-2021_01_08_425864	279	2	,	,	,
10_1101-2021_01_08_425864	279	3	the	the	DT
10_1101-2021_01_08_425864	279	4	ETO	ETO	NNP
10_1101-2021_01_08_425864	279	5	effect	effect	NN
10_1101-2021_01_08_425864	279	6	was	be	VBD
10_1101-2021_01_08_425864	279	7	manifested	manifest	VBN
10_1101-2021_01_08_425864	279	8	when	when	WRB
10_1101-2021_01_08_425864	279	9	the	the	DT
10_1101-2021_01_08_425864	279	10	parasites	parasite	NNS
10_1101-2021_01_08_425864	279	11	reached	reach	VBD
10_1101-2021_01_08_425864	279	12	the	the	DT
10_1101-2021_01_08_425864	279	13	late	late	JJ
10_1101-2021_01_08_425864	279	14	exponential	exponential	JJ
10_1101-2021_01_08_425864	279	15	443	443	CD
10_1101-2021_01_08_425864	279	16	phase	phase	NN
10_1101-2021_01_08_425864	279	17	(	(	-LRB-
10_1101-2021_01_08_425864	279	18	a	a	DT
10_1101-2021_01_08_425864	279	19	cell	cell	NN
10_1101-2021_01_08_425864	279	20	density	density	NN
10_1101-2021_01_08_425864	279	21	of	of	IN
10_1101-2021_01_08_425864	279	22	approximately	approximately	RB
10_1101-2021_01_08_425864	279	23	5x107	5x107	CD
10_1101-2021_01_08_425864	279	24	mL-1	ml-1	NN
10_1101-2021_01_08_425864	279	25	)	)	-RRB-
10_1101-2021_01_08_425864	279	26	.	.	.
10_1101-2021_01_08_425864	280	1	This	this	DT
10_1101-2021_01_08_425864	280	2	result	result	NN
10_1101-2021_01_08_425864	280	3	is	be	VBZ
10_1101-2021_01_08_425864	280	4	consistent	consistent	JJ
10_1101-2021_01_08_425864	280	5	with	with	IN
10_1101-2021_01_08_425864	280	6	our	-PRON-	PRP$
10_1101-2021_01_08_425864	280	7	previous	previous	JJ
10_1101-2021_01_08_425864	280	8	444	444	CD
10_1101-2021_01_08_425864	280	9	findings	finding	NNS
10_1101-2021_01_08_425864	280	10	showing	show	VBG
10_1101-2021_01_08_425864	280	11	that	that	IN
10_1101-2021_01_08_425864	280	12	FAO	FAO	NNP
10_1101-2021_01_08_425864	280	13	(	(	-LRB-
10_1101-2021_01_08_425864	280	14	and	and	CC
10_1101-2021_01_08_425864	280	15	thus	thus	RB
10_1101-2021_01_08_425864	280	16	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	280	17	activity	activity	NN
10_1101-2021_01_08_425864	280	18	)	)	-RRB-
10_1101-2021_01_08_425864	280	19	acquires	acquire	VBZ
10_1101-2021_01_08_425864	280	20	an	an	DT
10_1101-2021_01_08_425864	280	21	important	important	JJ
10_1101-2021_01_08_425864	280	22	role	role	NN
10_1101-2021_01_08_425864	280	23	at	at	IN
10_1101-2021_01_08_425864	280	24	this	this	DT
10_1101-2021_01_08_425864	280	25	point	point	NN
10_1101-2021_01_08_425864	280	26	in	in	IN
10_1101-2021_01_08_425864	280	27	the	the	DT
10_1101-2021_01_08_425864	280	28	445	445	CD
10_1101-2021_01_08_425864	280	29	proliferation	proliferation	NN
10_1101-2021_01_08_425864	280	30	curve	curve	NN
10_1101-2021_01_08_425864	280	31	.	.	.
10_1101-2021_01_08_425864	281	1	To	to	TO
10_1101-2021_01_08_425864	281	2	confirm	confirm	VB
10_1101-2021_01_08_425864	281	3	that	that	IN
10_1101-2021_01_08_425864	281	4	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	281	5	is	be	VBZ
10_1101-2021_01_08_425864	281	6	in	in	IN
10_1101-2021_01_08_425864	281	7	fact	fact	NN
10_1101-2021_01_08_425864	281	8	a	a	DT
10_1101-2021_01_08_425864	281	9	target	target	NN
10_1101-2021_01_08_425864	281	10	of	of	IN
10_1101-2021_01_08_425864	281	11	ETO	eto	NN
10_1101-2021_01_08_425864	281	12	in	in	IN
10_1101-2021_01_08_425864	281	13	T.	T.	NNP
10_1101-2021_01_08_425864	281	14	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	281	15	,	,	,
10_1101-2021_01_08_425864	281	16	we	-PRON-	PRP
10_1101-2021_01_08_425864	281	17	assayed	assay	VBD
10_1101-2021_01_08_425864	281	18	the	the	DT
10_1101-2021_01_08_425864	281	19	drug	drug	NN
10_1101-2021_01_08_425864	281	20	's	's	POS
10_1101-2021_01_08_425864	281	21	446	446	CD
10_1101-2021_01_08_425864	281	22	effect	effect	NN
10_1101-2021_01_08_425864	281	23	on	on	IN
10_1101-2021_01_08_425864	281	24	the	the	DT
10_1101-2021_01_08_425864	281	25	enzyme	enzyme	NNS
10_1101-2021_01_08_425864	281	26	activity	activity	NN
10_1101-2021_01_08_425864	281	27	in	in	IN
10_1101-2021_01_08_425864	281	28	free	free	JJ
10_1101-2021_01_08_425864	281	29	cell	cell	NN
10_1101-2021_01_08_425864	281	30	extracts	extract	NNS
10_1101-2021_01_08_425864	281	31	.	.	.
10_1101-2021_01_08_425864	282	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	282	2	results	result	NNS
10_1101-2021_01_08_425864	282	3	showed	show	VBD
10_1101-2021_01_08_425864	282	4	that	that	IN
10_1101-2021_01_08_425864	282	5	500	500	CD
10_1101-2021_01_08_425864	282	6	µM	µM	NNP
10_1101-2021_01_08_425864	282	7	ETO	ETO	NNP
10_1101-2021_01_08_425864	282	8	diminished	diminish	VBD
10_1101-2021_01_08_425864	282	9	447	447	CD
10_1101-2021_01_08_425864	282	10	the	the	DT
10_1101-2021_01_08_425864	282	11	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	282	12	activity	activity	NN
10_1101-2021_01_08_425864	282	13	by	by	IN
10_1101-2021_01_08_425864	282	14	almost	almost	RB
10_1101-2021_01_08_425864	282	15	80	80	CD
10_1101-2021_01_08_425864	282	16	%	%	NN
10_1101-2021_01_08_425864	282	17	(	(	-LRB-
10_1101-2021_01_08_425864	282	18	Fig	fig	NN
10_1101-2021_01_08_425864	282	19	8B	8b	NN
10_1101-2021_01_08_425864	282	20	)	)	-RRB-
10_1101-2021_01_08_425864	282	21	.	.	.
10_1101-2021_01_08_425864	283	1	To	to	TO
10_1101-2021_01_08_425864	283	2	confirm	confirm	VB
10_1101-2021_01_08_425864	283	3	the	the	DT
10_1101-2021_01_08_425864	283	4	interference	interference	NN
10_1101-2021_01_08_425864	283	5	of	of	IN
10_1101-2021_01_08_425864	283	6	ETO	ETO	NNP
10_1101-2021_01_08_425864	283	7	with	with	IN
10_1101-2021_01_08_425864	283	8	the	the	DT
10_1101-2021_01_08_425864	283	9	beta-	beta-	JJ
10_1101-2021_01_08_425864	283	10	448	448	CD
10_1101-2021_01_08_425864	283	11	oxidation	oxidation	NN
10_1101-2021_01_08_425864	283	12	of	of	IN
10_1101-2021_01_08_425864	283	13	fatty	fatty	NN
10_1101-2021_01_08_425864	283	14	acids	acid	NNS
10_1101-2021_01_08_425864	283	15	,	,	,
10_1101-2021_01_08_425864	283	16	parasites	parasite	NNS
10_1101-2021_01_08_425864	283	17	incubated	incubate	VBD
10_1101-2021_01_08_425864	283	18	in	in	IN
10_1101-2021_01_08_425864	283	19	PBS	PBS	NNP
10_1101-2021_01_08_425864	283	20	containing	contain	VBG
10_1101-2021_01_08_425864	283	21	14C	14c	CD
10_1101-2021_01_08_425864	283	22	-	-	HYPH
10_1101-2021_01_08_425864	283	23	U	u	NN
10_1101-2021_01_08_425864	283	24	-	-	HYPH
10_1101-2021_01_08_425864	283	25	palmitate	palmitate	NN
10_1101-2021_01_08_425864	283	26	were	be	VBD
10_1101-2021_01_08_425864	283	27	treated	treat	VBN
10_1101-2021_01_08_425864	283	28	with	with	IN
10_1101-2021_01_08_425864	283	29	500	500	CD
10_1101-2021_01_08_425864	283	30	449	449	CD
10_1101-2021_01_08_425864	283	31	µM	µM	NNP
10_1101-2021_01_08_425864	283	32	ETO	eto	NN
10_1101-2021_01_08_425864	283	33	to	to	TO
10_1101-2021_01_08_425864	283	34	compare	compare	VB
10_1101-2021_01_08_425864	283	35	their	-PRON-	PRP$
10_1101-2021_01_08_425864	283	36	production	production	NN
10_1101-2021_01_08_425864	283	37	of	of	IN
10_1101-2021_01_08_425864	283	38	14CO2	14co2	CD
10_1101-2021_01_08_425864	283	39	with	with	IN
10_1101-2021_01_08_425864	283	40	that	that	DT
10_1101-2021_01_08_425864	283	41	of	of	IN
10_1101-2021_01_08_425864	283	42	the	the	DT
10_1101-2021_01_08_425864	283	43	untreated	untreated	JJ
10_1101-2021_01_08_425864	283	44	controls	control	NNS
10_1101-2021_01_08_425864	283	45	.	.	.
10_1101-2021_01_08_425864	284	1	Palmitate	Palmitate	NNP
10_1101-2021_01_08_425864	284	2	-	-	HYPH
10_1101-2021_01_08_425864	284	3	derived	derive	VBN
10_1101-2021_01_08_425864	284	4	450	450	CD
10_1101-2021_01_08_425864	284	5	CO2	CO2	NNP
10_1101-2021_01_08_425864	284	6	production	production	NN
10_1101-2021_01_08_425864	284	7	diminished	diminish	VBN
10_1101-2021_01_08_425864	284	8	by	by	IN
10_1101-2021_01_08_425864	284	9	80	80	CD
10_1101-2021_01_08_425864	284	10	%	%	NN
10_1101-2021_01_08_425864	284	11	in	in	IN
10_1101-2021_01_08_425864	284	12	ETO	ETO	NNP
10_1101-2021_01_08_425864	284	13	-	-	HYPH
10_1101-2021_01_08_425864	284	14	treated	treat	VBN
10_1101-2021_01_08_425864	284	15	cells	cell	NNS
10_1101-2021_01_08_425864	284	16	compared	compare	VBN
10_1101-2021_01_08_425864	284	17	to	to	IN
10_1101-2021_01_08_425864	284	18	untreated	untreated	JJ
10_1101-2021_01_08_425864	284	19	parasites	parasite	NNS
10_1101-2021_01_08_425864	284	20	(	(	-LRB-
10_1101-2021_01_08_425864	284	21	Fig	fig	NN
10_1101-2021_01_08_425864	284	22	8C	8c	NN
10_1101-2021_01_08_425864	284	23	)	)	-RRB-
10_1101-2021_01_08_425864	284	24	.	.	.
10_1101-2021_01_08_425864	285	1	451	451	CD
10_1101-2021_01_08_425864	285	2	In	in	IN
10_1101-2021_01_08_425864	285	3	addition	addition	NN
10_1101-2021_01_08_425864	285	4	,	,	,
10_1101-2021_01_08_425864	285	5	ETO	ETO	NNP
10_1101-2021_01_08_425864	285	6	treatment	treatment	NN
10_1101-2021_01_08_425864	285	7	did	do	VBD
10_1101-2021_01_08_425864	285	8	not	not	RB
10_1101-2021_01_08_425864	285	9	affect	affect	VB
10_1101-2021_01_08_425864	285	10	the	the	DT
10_1101-2021_01_08_425864	285	11	metabolism	metabolism	NN
10_1101-2021_01_08_425864	285	12	of	of	IN
10_1101-2021_01_08_425864	285	13	14C	14c	CD
10_1101-2021_01_08_425864	285	14	-	-	HYPH
10_1101-2021_01_08_425864	285	15	U	u	NN
10_1101-2021_01_08_425864	285	16	-	-	HYPH
10_1101-2021_01_08_425864	285	17	glucose	glucose	NN
10_1101-2021_01_08_425864	285	18	or	or	CC
10_1101-2021_01_08_425864	285	19	14C	14c	NN
10_1101-2021_01_08_425864	285	20	-	-	HYPH
10_1101-2021_01_08_425864	285	21	U	u	NN
10_1101-2021_01_08_425864	285	22	-	-	HYPH
10_1101-2021_01_08_425864	285	23	histidine	histidine	NN
10_1101-2021_01_08_425864	285	24	,	,	,
10_1101-2021_01_08_425864	285	25	ruling	rule	VBG
10_1101-2021_01_08_425864	285	26	452	452	CD
10_1101-2021_01_08_425864	285	27	out	out	RP
10_1101-2021_01_08_425864	285	28	a	a	DT
10_1101-2021_01_08_425864	285	29	possible	possible	JJ
10_1101-2021_01_08_425864	285	30	unspecific	unspecific	JJ
10_1101-2021_01_08_425864	285	31	reaction	reaction	NN
10_1101-2021_01_08_425864	285	32	of	of	IN
10_1101-2021_01_08_425864	285	33	this	this	DT
10_1101-2021_01_08_425864	285	34	drug	drug	NN
10_1101-2021_01_08_425864	285	35	with	with	IN
10_1101-2021_01_08_425864	285	36	CoA	CoA	NNP
10_1101-2021_01_08_425864	285	37	-	-	HYPH
10_1101-2021_01_08_425864	285	38	SH	SH	NNP
10_1101-2021_01_08_425864	285	39	as	as	IN
10_1101-2021_01_08_425864	285	40	described	describe	VBN
10_1101-2021_01_08_425864	285	41	by	by	IN
10_1101-2021_01_08_425864	285	42	[	[	-LRB-
10_1101-2021_01_08_425864	285	43	32	32	CD
10_1101-2021_01_08_425864	285	44	]	]	-RRB-
10_1101-2021_01_08_425864	285	45	.	.	.
10_1101-2021_01_08_425864	286	1	Other	other	JJ
10_1101-2021_01_08_425864	286	2	compounds	compound	NNS
10_1101-2021_01_08_425864	286	3	453	453	CD
10_1101-2021_01_08_425864	286	4	described	describe	VBN
10_1101-2021_01_08_425864	286	5	as	as	IN
10_1101-2021_01_08_425864	286	6	FAO	FAO	NNP
10_1101-2021_01_08_425864	286	7	inhibitors	inhibitor	NNS
10_1101-2021_01_08_425864	286	8	were	be	VBD
10_1101-2021_01_08_425864	286	9	also	also	RB
10_1101-2021_01_08_425864	286	10	tested	test	VBN
10_1101-2021_01_08_425864	286	11	,	,	,
10_1101-2021_01_08_425864	286	12	but	but	CC
10_1101-2021_01_08_425864	286	13	none	none	NN
10_1101-2021_01_08_425864	286	14	of	of	IN
10_1101-2021_01_08_425864	286	15	them	-PRON-	PRP
10_1101-2021_01_08_425864	286	16	inhibited	inhibit	VBD
10_1101-2021_01_08_425864	286	17	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	286	18	proliferation	proliferation	NN
10_1101-2021_01_08_425864	286	19	454	454	CD
10_1101-2021_01_08_425864	286	20	or	or	CC
10_1101-2021_01_08_425864	286	21	14CO2	14co2	CD
10_1101-2021_01_08_425864	286	22	production	production	NN
10_1101-2021_01_08_425864	286	23	from	from	IN
10_1101-2021_01_08_425864	286	24	14C	14c	CD
10_1101-2021_01_08_425864	286	25	-	-	HYPH
10_1101-2021_01_08_425864	286	26	U	u	NN
10_1101-2021_01_08_425864	286	27	-	-	HYPH
10_1101-2021_01_08_425864	286	28	palmitate	palmitate	NN
10_1101-2021_01_08_425864	286	29	(	(	-LRB-
10_1101-2021_01_08_425864	286	30	S3	S3	NNP
10_1101-2021_01_08_425864	286	31	Fig	Fig	NNP
10_1101-2021_01_08_425864	286	32	)	)	-RRB-
10_1101-2021_01_08_425864	286	33	.	.	.
10_1101-2021_01_08_425864	287	1	In	in	IN
10_1101-2021_01_08_425864	287	2	addition	addition	NN
10_1101-2021_01_08_425864	287	3	,	,	,
10_1101-2021_01_08_425864	287	4	the	the	DT
10_1101-2021_01_08_425864	287	5	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	287	6	cytometric	cytometric	NN
10_1101-2021_01_08_425864	287	7	analysis	analysis	NN
10_1101-2021_01_08_425864	287	8	of	of	IN
10_1101-2021_01_08_425864	287	9	455	455	CD
10_1101-2021_01_08_425864	287	10	cells	cell	NNS
10_1101-2021_01_08_425864	287	11	treated	treat	VBN
10_1101-2021_01_08_425864	287	12	with	with	IN
10_1101-2021_01_08_425864	287	13	500	500	CD
10_1101-2021_01_08_425864	287	14	µM	µM	NNP
10_1101-2021_01_08_425864	287	15	ETO	ETO	NNP
10_1101-2021_01_08_425864	287	16	showed	show	VBD
10_1101-2021_01_08_425864	287	17	a	a	DT
10_1101-2021_01_08_425864	287	18	strong	strong	JJ
10_1101-2021_01_08_425864	287	19	decrease	decrease	NN
10_1101-2021_01_08_425864	287	20	in	in	IN
10_1101-2021_01_08_425864	287	21	the	the	DT
10_1101-2021_01_08_425864	287	22	CoA	CoA	NNP
10_1101-2021_01_08_425864	287	23	acylation	acylation	NN
10_1101-2021_01_08_425864	287	24	levels	level	NNS
10_1101-2021_01_08_425864	287	25	(	(	-LRB-
10_1101-2021_01_08_425864	287	26	activation	activation	NN
10_1101-2021_01_08_425864	287	27	of	of	IN
10_1101-2021_01_08_425864	287	28	456	456	CD
10_1101-2021_01_08_425864	287	29	fatty	fatty	NN
10_1101-2021_01_08_425864	287	30	acids	acid	NNS
10_1101-2021_01_08_425864	287	31	)	)	-RRB-
10_1101-2021_01_08_425864	287	32	with	with	IN
10_1101-2021_01_08_425864	287	33	respect	respect	NN
10_1101-2021_01_08_425864	287	34	to	to	IN
10_1101-2021_01_08_425864	287	35	the	the	DT
10_1101-2021_01_08_425864	287	36	untreated	untreated	JJ
10_1101-2021_01_08_425864	287	37	controls	control	NNS
10_1101-2021_01_08_425864	287	38	(	(	-LRB-
10_1101-2021_01_08_425864	287	39	Fig	fig	NN
10_1101-2021_01_08_425864	287	40	8D	8d	NN
10_1101-2021_01_08_425864	287	41	)	)	-RRB-
10_1101-2021_01_08_425864	287	42	,	,	,
10_1101-2021_01_08_425864	287	43	as	as	IN
10_1101-2021_01_08_425864	287	44	confirmed	confirm	VBN
10_1101-2021_01_08_425864	287	45	by	by	IN
10_1101-2021_01_08_425864	287	46	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	287	47	microscopy	microscopy	JJ
10_1101-2021_01_08_425864	287	48	457	457	CD
10_1101-2021_01_08_425864	287	49	(	(	-LRB-
10_1101-2021_01_08_425864	287	50	Fig	Fig	NNP
10_1101-2021_01_08_425864	287	51	8D	8d	NN
10_1101-2021_01_08_425864	287	52	)	)	-RRB-
10_1101-2021_01_08_425864	287	53	.	.	.
10_1101-2021_01_08_425864	288	1	To	to	TO
10_1101-2021_01_08_425864	288	2	reinforce	reinforce	VB
10_1101-2021_01_08_425864	288	3	the	the	DT
10_1101-2021_01_08_425864	288	4	validation	validation	NN
10_1101-2021_01_08_425864	288	5	of	of	IN
10_1101-2021_01_08_425864	288	6	ETO	ETO	NNP
10_1101-2021_01_08_425864	288	7	for	for	IN
10_1101-2021_01_08_425864	288	8	further	further	JJ
10_1101-2021_01_08_425864	288	9	experiments	experiment	NNS
10_1101-2021_01_08_425864	288	10	,	,	,
10_1101-2021_01_08_425864	288	11	a	a	DT
10_1101-2021_01_08_425864	288	12	set	set	NN
10_1101-2021_01_08_425864	288	13	of	of	IN
10_1101-2021_01_08_425864	288	14	controls	control	NNS
10_1101-2021_01_08_425864	288	15	are	be	VBP
10_1101-2021_01_08_425864	288	16	offered	offer	VBN
10_1101-2021_01_08_425864	288	17	in	in	IN
10_1101-2021_01_08_425864	288	18	458	458	CD
10_1101-2021_01_08_425864	288	19	S3	S3	NNP
10_1101-2021_01_08_425864	288	20	Fig	Fig	NNP
10_1101-2021_01_08_425864	288	21	.	.	.
10_1101-2021_01_08_425864	289	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	289	2	preliminary	preliminary	JJ
10_1101-2021_01_08_425864	289	3	conclusion	conclusion	NN
10_1101-2021_01_08_425864	289	4	is	be	VBZ
10_1101-2021_01_08_425864	289	5	that	that	IN
10_1101-2021_01_08_425864	289	6	ETO	ETO	NNP
10_1101-2021_01_08_425864	289	7	inhibited	inhibit	VBD
10_1101-2021_01_08_425864	289	8	beta	beta	NN
10_1101-2021_01_08_425864	289	9	-	-	HYPH
10_1101-2021_01_08_425864	289	10	oxidation	oxidation	NN
10_1101-2021_01_08_425864	289	11	by	by	IN
10_1101-2021_01_08_425864	289	12	inhibiting	inhibit	VBG
10_1101-2021_01_08_425864	289	13	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	289	14	,	,	,
10_1101-2021_01_08_425864	289	15	459	459	CD
10_1101-2021_01_08_425864	289	16	confirming	confirm	VBG
10_1101-2021_01_08_425864	289	17	that	that	IN
10_1101-2021_01_08_425864	289	18	the	the	DT
10_1101-2021_01_08_425864	289	19	breakdown	breakdown	NN
10_1101-2021_01_08_425864	289	20	of	of	IN
10_1101-2021_01_08_425864	289	21	fatty	fatty	NN
10_1101-2021_01_08_425864	289	22	acids	acid	NNS
10_1101-2021_01_08_425864	289	23	is	be	VBZ
10_1101-2021_01_08_425864	289	24	important	important	JJ
10_1101-2021_01_08_425864	289	25	to	to	IN
10_1101-2021_01_08_425864	289	26	proliferation	proliferation	NN
10_1101-2021_01_08_425864	289	27	progression	progression	NN
10_1101-2021_01_08_425864	289	28	in	in	IN
10_1101-2021_01_08_425864	289	29	the	the	DT
10_1101-2021_01_08_425864	289	30	absence	absence	NN
10_1101-2021_01_08_425864	289	31	460	460	CD
10_1101-2021_01_08_425864	289	32	of	of	IN
10_1101-2021_01_08_425864	289	33	glucose	glucose	NN
10_1101-2021_01_08_425864	289	34	.	.	.
10_1101-2021_01_08_425864	290	1	461	461	CD
10_1101-2021_01_08_425864	290	2	462	462	CD
10_1101-2021_01_08_425864	290	3	Figure	figure	NN
10_1101-2021_01_08_425864	290	4	8	8	CD
10_1101-2021_01_08_425864	290	5	.	.	.
10_1101-2021_01_08_425864	291	1	ETO	ETO	NNP
10_1101-2021_01_08_425864	291	2	inhibits	inhibit	VBZ
10_1101-2021_01_08_425864	291	3	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	291	4	and	and	CC
10_1101-2021_01_08_425864	291	5	interferes	interfere	VBZ
10_1101-2021_01_08_425864	291	6	with	with	IN
10_1101-2021_01_08_425864	291	7	cell	cell	NN
10_1101-2021_01_08_425864	291	8	proliferation	proliferation	NN
10_1101-2021_01_08_425864	291	9	in	in	IN
10_1101-2021_01_08_425864	291	10	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	291	11	forms	form	NNS
10_1101-2021_01_08_425864	291	12	.	.	.
10_1101-2021_01_08_425864	292	1	(	(	-LRB-
10_1101-2021_01_08_425864	292	2	A	a	NN
10_1101-2021_01_08_425864	292	3	)	)	-RRB-
10_1101-2021_01_08_425864	292	4	463	463	CD
10_1101-2021_01_08_425864	292	5	Proliferation	proliferation	NN
10_1101-2021_01_08_425864	292	6	of	of	IN
10_1101-2021_01_08_425864	292	7	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	292	8	forms	form	NNS
10_1101-2021_01_08_425864	292	9	in	in	IN
10_1101-2021_01_08_425864	292	10	the	the	DT
10_1101-2021_01_08_425864	292	11	presence	presence	NN
10_1101-2021_01_08_425864	292	12	of	of	IN
10_1101-2021_01_08_425864	292	13	0.1	0.1	CD
10_1101-2021_01_08_425864	292	14	to	to	TO
10_1101-2021_01_08_425864	292	15	500	500	CD
10_1101-2021_01_08_425864	292	16	µM	µM	NNP
10_1101-2021_01_08_425864	292	17	ETO	ETO	NNP
10_1101-2021_01_08_425864	292	18	.	.	.
10_1101-2021_01_08_425864	293	1	For	for	IN
10_1101-2021_01_08_425864	293	2	the	the	DT
10_1101-2021_01_08_425864	293	3	positive	positive	JJ
10_1101-2021_01_08_425864	293	4	control	control	NN
10_1101-2021_01_08_425864	293	5	464	464	CD
10_1101-2021_01_08_425864	293	6	of	of	IN
10_1101-2021_01_08_425864	293	7	dead	dead	JJ
10_1101-2021_01_08_425864	293	8	cells	cell	NNS
10_1101-2021_01_08_425864	293	9	,	,	,
10_1101-2021_01_08_425864	293	10	a	a	DT
10_1101-2021_01_08_425864	293	11	combination	combination	NN
10_1101-2021_01_08_425864	293	12	of	of	IN
10_1101-2021_01_08_425864	293	13	antimycin	antimycin	NNS
10_1101-2021_01_08_425864	293	14	(	(	-LRB-
10_1101-2021_01_08_425864	293	15	0.5	0.5	CD
10_1101-2021_01_08_425864	293	16	µM	µM	NNP
10_1101-2021_01_08_425864	293	17	)	)	-RRB-
10_1101-2021_01_08_425864	293	18	and	and	CC
10_1101-2021_01_08_425864	293	19	rotenone	rotenone	NN
10_1101-2021_01_08_425864	293	20	(	(	-LRB-
10_1101-2021_01_08_425864	293	21	60	60	CD
10_1101-2021_01_08_425864	293	22	µM	µM	NNP
10_1101-2021_01_08_425864	293	23	)	)	-RRB-
10_1101-2021_01_08_425864	293	24	was	be	VBD
10_1101-2021_01_08_425864	293	25	used	use	VBN
10_1101-2021_01_08_425864	293	26	.	.	.
10_1101-2021_01_08_425864	294	1	(	(	-LRB-
10_1101-2021_01_08_425864	294	2	B	b	NN
10_1101-2021_01_08_425864	294	3	)	)	-RRB-
10_1101-2021_01_08_425864	294	4	Inhibition	inhibition	NN
10_1101-2021_01_08_425864	294	5	of	of	IN
10_1101-2021_01_08_425864	294	6	465	465	CD
10_1101-2021_01_08_425864	294	7	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	294	8	activity	activity	NN
10_1101-2021_01_08_425864	294	9	in	in	IN
10_1101-2021_01_08_425864	294	10	crude	crude	JJ
10_1101-2021_01_08_425864	294	11	extracts	extract	NNS
10_1101-2021_01_08_425864	294	12	using	use	VBG
10_1101-2021_01_08_425864	294	13	250	250	CD
10_1101-2021_01_08_425864	294	14	and	and	CC
10_1101-2021_01_08_425864	294	15	500	500	CD
10_1101-2021_01_08_425864	294	16	µM	µM	NNP
10_1101-2021_01_08_425864	294	17	of	of	IN
10_1101-2021_01_08_425864	294	18	ETO	ETO	NNP
10_1101-2021_01_08_425864	294	19	.	.	.
10_1101-2021_01_08_425864	295	1	C	C	NNP
10_1101-2021_01_08_425864	295	2	)	)	-RRB-
10_1101-2021_01_08_425864	295	3	14CO2	14co2	CD
10_1101-2021_01_08_425864	295	4	capture	capture	NN
10_1101-2021_01_08_425864	295	5	from	from	IN
10_1101-2021_01_08_425864	295	6	14C	14c	CD
10_1101-2021_01_08_425864	295	7	-	-	HYPH
10_1101-2021_01_08_425864	295	8	U-	u-	NN
10_1101-2021_01_08_425864	295	9	466	466	CD
10_1101-2021_01_08_425864	295	10	palmitate	palmitate	NN
10_1101-2021_01_08_425864	295	11	oxidation	oxidation	NN
10_1101-2021_01_08_425864	295	12	.	.	.
10_1101-2021_01_08_425864	296	1	D	D	NNP
10_1101-2021_01_08_425864	296	2	)	)	-RRB-
10_1101-2021_01_08_425864	296	3	Flow	flow	NN
10_1101-2021_01_08_425864	296	4	cytometry	cytometry	NN
10_1101-2021_01_08_425864	296	5	analysis	analysis	NN
10_1101-2021_01_08_425864	296	6	and	and	CC
10_1101-2021_01_08_425864	296	7	fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	296	8	microscopy	microscopy	JJ
10_1101-2021_01_08_425864	296	9	of	of	IN
10_1101-2021_01_08_425864	296	10	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	296	11	forms	form	NNS
10_1101-2021_01_08_425864	296	12	467	467	CD
10_1101-2021_01_08_425864	296	13	treated	treat	VBN
10_1101-2021_01_08_425864	296	14	(	(	-LRB-
10_1101-2021_01_08_425864	296	15	or	or	CC
10_1101-2021_01_08_425864	296	16	not	not	RB
10_1101-2021_01_08_425864	296	17	)	)	-RRB-
10_1101-2021_01_08_425864	296	18	with	with	IN
10_1101-2021_01_08_425864	296	19	ETO	ETO	NNP
10_1101-2021_01_08_425864	296	20	.	.	.
10_1101-2021_01_08_425864	297	1	In	in	IN
10_1101-2021_01_08_425864	297	2	the	the	DT
10_1101-2021_01_08_425864	297	3	histograms	histogram	NNS
10_1101-2021_01_08_425864	297	4	,	,	,
10_1101-2021_01_08_425864	297	5	dashed	dash	VBD
10_1101-2021_01_08_425864	297	6	peaks	peak	NNS
10_1101-2021_01_08_425864	297	7	represent	represent	VBP
10_1101-2021_01_08_425864	297	8	unstained	unstained	JJ
10_1101-2021_01_08_425864	297	9	parasites	parasite	NNS
10_1101-2021_01_08_425864	297	10	and	and	CC
10_1101-2021_01_08_425864	297	11	green-	green-	XX
10_1101-2021_01_08_425864	297	12	468	468	CD
10_1101-2021_01_08_425864	297	13	filled	fill	VBD
10_1101-2021_01_08_425864	297	14	peaks	peak	NNS
10_1101-2021_01_08_425864	297	15	represent	represent	VBP
10_1101-2021_01_08_425864	297	16	parasites	parasite	NNS
10_1101-2021_01_08_425864	297	17	stained	stain	VBN
10_1101-2021_01_08_425864	297	18	with	with	IN
10_1101-2021_01_08_425864	297	19	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	297	20	C1-C12	C1-C12	NNP
10_1101-2021_01_08_425864	297	21	.	.	.
10_1101-2021_01_08_425864	298	1	All	all	PDT
10_1101-2021_01_08_425864	298	2	the	the	DT
10_1101-2021_01_08_425864	298	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	298	4	were	be	VBD
10_1101-2021_01_08_425864	298	5	performed	perform	VBN
10_1101-2021_01_08_425864	298	6	in	in	IN
10_1101-2021_01_08_425864	298	7	.CC	.CC	NFP
10_1101-2021_01_08_425864	298	8	-	-	:
10_1101-2021_01_08_425864	298	9	BY	by	IN
10_1101-2021_01_08_425864	298	10	4.0	4.0	CD
10_1101-2021_01_08_425864	298	11	International	international	JJ
10_1101-2021_01_08_425864	298	12	licensemade	licensemade	NN
10_1101-2021_01_08_425864	298	13	available	available	JJ
10_1101-2021_01_08_425864	298	14	under	under	IN
10_1101-2021_01_08_425864	298	15	a	a	DT
10_1101-2021_01_08_425864	298	16	(	(	-LRB-
10_1101-2021_01_08_425864	298	17	which	which	WDT
10_1101-2021_01_08_425864	298	18	was	be	VBD
10_1101-2021_01_08_425864	298	19	not	not	RB
10_1101-2021_01_08_425864	298	20	certified	certify	VBN
10_1101-2021_01_08_425864	298	21	by	by	IN
10_1101-2021_01_08_425864	298	22	peer	peer	NN
10_1101-2021_01_08_425864	298	23	review	review	NN
10_1101-2021_01_08_425864	298	24	)	)	-RRB-
10_1101-2021_01_08_425864	298	25	is	be	VBZ
10_1101-2021_01_08_425864	298	26	the	the	DT
10_1101-2021_01_08_425864	298	27	author	author	NN
10_1101-2021_01_08_425864	298	28	/	/	SYM
10_1101-2021_01_08_425864	298	29	funder	funder	NN
10_1101-2021_01_08_425864	298	30	,	,	,
10_1101-2021_01_08_425864	298	31	who	who	WP
10_1101-2021_01_08_425864	298	32	has	have	VBZ
10_1101-2021_01_08_425864	298	33	granted	grant	VBN
10_1101-2021_01_08_425864	298	34	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	298	35	a	a	DT
10_1101-2021_01_08_425864	298	36	license	license	NN
10_1101-2021_01_08_425864	298	37	to	to	TO
10_1101-2021_01_08_425864	298	38	display	display	VB
10_1101-2021_01_08_425864	298	39	the	the	DT
10_1101-2021_01_08_425864	298	40	preprint	preprint	NN
10_1101-2021_01_08_425864	298	41	in	in	IN
10_1101-2021_01_08_425864	298	42	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	298	43	.	.	.
10_1101-2021_01_08_425864	299	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	299	2	is	be	VBZ
10_1101-2021_01_08_425864	299	3	The	the	DT
10_1101-2021_01_08_425864	299	4	copyright	copyright	NN
10_1101-2021_01_08_425864	299	5	holder	holder	NN
10_1101-2021_01_08_425864	299	6	for	for	IN
10_1101-2021_01_08_425864	299	7	this	this	DT
10_1101-2021_01_08_425864	299	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	299	9	version	version	NN
10_1101-2021_01_08_425864	299	10	posted	post	VBD
10_1101-2021_01_08_425864	299	11	January	January	NNP
10_1101-2021_01_08_425864	299	12	8	8	CD
10_1101-2021_01_08_425864	299	13	,	,	,
10_1101-2021_01_08_425864	299	14	2021	2021	CD
10_1101-2021_01_08_425864	299	15	.	.	.
10_1101-2021_01_08_425864	299	16	;	;	:
10_1101-2021_01_08_425864	299	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	299	18	:	:	:
10_1101-2021_01_08_425864	299	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	299	20	preprint	preprint	NN
10_1101-2021_01_08_425864	299	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	299	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	299	23	469	469	CD
10_1101-2021_01_08_425864	299	24	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	299	25	.	.	.
10_1101-2021_01_08_425864	300	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	300	2	analysis	analysis	NN
10_1101-2021_01_08_425864	300	3	was	be	VBD
10_1101-2021_01_08_425864	300	4	performed	perform	VBN
10_1101-2021_01_08_425864	300	5	with	with	IN
10_1101-2021_01_08_425864	300	6	one	one	CD
10_1101-2021_01_08_425864	300	7	-	-	HYPH
10_1101-2021_01_08_425864	300	8	way	way	NN
10_1101-2021_01_08_425864	300	9	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	300	10	followed	follow	VBN
10_1101-2021_01_08_425864	300	11	by	by	IN
10_1101-2021_01_08_425864	300	12	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	300	13	's	's	POS
10_1101-2021_01_08_425864	300	14	post	post	JJ
10_1101-2021_01_08_425864	300	15	-	-	JJ
10_1101-2021_01_08_425864	300	16	test	test	NN
10_1101-2021_01_08_425864	300	17	470	470	CD
10_1101-2021_01_08_425864	300	18	at	at	IN
10_1101-2021_01_08_425864	300	19	p	p	NN
10_1101-2021_01_08_425864	300	20	<	<	XX
10_1101-2021_01_08_425864	300	21	0.05	0.05	XX
10_1101-2021_01_08_425864	300	22	using	use	VBG
10_1101-2021_01_08_425864	300	23	the	the	DT
10_1101-2021_01_08_425864	300	24	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	300	25	Prism	Prism	NNP
10_1101-2021_01_08_425864	300	26	8.0.2	8.0.2	NNP
10_1101-2021_01_08_425864	300	27	software	software	NN
10_1101-2021_01_08_425864	300	28	program	program	NN
10_1101-2021_01_08_425864	300	29	.	.	.
10_1101-2021_01_08_425864	301	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	301	2	represent	represent	VBP
10_1101-2021_01_08_425864	301	3	the	the	DT
10_1101-2021_01_08_425864	301	4	level	level	NN
10_1101-2021_01_08_425864	301	5	of	of	IN
10_1101-2021_01_08_425864	301	6	statistical	statistical	JJ
10_1101-2021_01_08_425864	301	7	471	471	CD
10_1101-2021_01_08_425864	301	8	significance	significance	NN
10_1101-2021_01_08_425864	301	9	in	in	IN
10_1101-2021_01_08_425864	301	10	this	this	DT
10_1101-2021_01_08_425864	301	11	figure	figure	NN
10_1101-2021_01_08_425864	301	12	as	as	IN
10_1101-2021_01_08_425864	301	13	follows	follow	VBZ
10_1101-2021_01_08_425864	301	14	:	:	:
10_1101-2021_01_08_425864	301	15	*	*	NFP
10_1101-2021_01_08_425864	301	16	*	*	NFP
10_1101-2021_01_08_425864	301	17	*	*	NFP
10_1101-2021_01_08_425864	301	18	p	p	NN
10_1101-2021_01_08_425864	301	19	value	value	NN
10_1101-2021_01_08_425864	301	20	<	<	XX
10_1101-2021_01_08_425864	301	21	0.001	0.001	CD
10_1101-2021_01_08_425864	301	22	;	;	:
10_1101-2021_01_08_425864	301	23	*	*	NFP
10_1101-2021_01_08_425864	301	24	*	*	NFP
10_1101-2021_01_08_425864	301	25	p	p	NN
10_1101-2021_01_08_425864	301	26	value	value	NN
10_1101-2021_01_08_425864	301	27	<	<	XX
10_1101-2021_01_08_425864	301	28	0.01	0.01	XX
10_1101-2021_01_08_425864	301	29	;	;	:
10_1101-2021_01_08_425864	301	30	and	and	CC
10_1101-2021_01_08_425864	301	31	*	*	NFP
10_1101-2021_01_08_425864	301	32	p	p	NN
10_1101-2021_01_08_425864	301	33	value	value	NN
10_1101-2021_01_08_425864	301	34	<	<	XX
10_1101-2021_01_08_425864	301	35	0.05	0.05	CD
10_1101-2021_01_08_425864	301	36	.	.	.
10_1101-2021_01_08_425864	302	1	472	472	CD
10_1101-2021_01_08_425864	302	2	For	for	IN
10_1101-2021_01_08_425864	302	3	p	p	NN
10_1101-2021_01_08_425864	302	4	values	value	NNS
10_1101-2021_01_08_425864	302	5	>	>	XX
10_1101-2021_01_08_425864	302	6	0.05	0.05	CD
10_1101-2021_01_08_425864	302	7	,	,	,
10_1101-2021_01_08_425864	302	8	we	-PRON-	PRP
10_1101-2021_01_08_425864	302	9	consider	consider	VBP
10_1101-2021_01_08_425864	302	10	the	the	DT
10_1101-2021_01_08_425864	302	11	differences	difference	NNS
10_1101-2021_01_08_425864	302	12	not	not	RB
10_1101-2021_01_08_425864	302	13	significant	significant	JJ
10_1101-2021_01_08_425864	302	14	(	(	-LRB-
10_1101-2021_01_08_425864	302	15	ns	ns	NNP
10_1101-2021_01_08_425864	302	16	)	)	-RRB-
10_1101-2021_01_08_425864	302	17	.	.	.
10_1101-2021_01_08_425864	303	1	473	473	CD
10_1101-2021_01_08_425864	303	2	474	474	CD
10_1101-2021_01_08_425864	303	3	Etomoxir	Etomoxir	NNP
10_1101-2021_01_08_425864	303	4	treatment	treatment	NN
10_1101-2021_01_08_425864	303	5	affects	affect	VBZ
10_1101-2021_01_08_425864	303	6	cell	cell	NN
10_1101-2021_01_08_425864	303	7	cycle	cycle	NN
10_1101-2021_01_08_425864	303	8	progression	progression	NN
10_1101-2021_01_08_425864	303	9	475	475	CD
10_1101-2021_01_08_425864	303	10	The	the	DT
10_1101-2021_01_08_425864	303	11	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	303	12	interference	interference	NN
10_1101-2021_01_08_425864	303	13	of	of	IN
10_1101-2021_01_08_425864	303	14	ETO	ETO	NNP
10_1101-2021_01_08_425864	303	15	diminished	diminish	VBD
10_1101-2021_01_08_425864	303	16	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	303	17	proliferation	proliferation	NN
10_1101-2021_01_08_425864	303	18	;	;	:
10_1101-2021_01_08_425864	303	19	however	however	RB
10_1101-2021_01_08_425864	303	20	,	,	,
10_1101-2021_01_08_425864	303	21	this	this	DT
10_1101-2021_01_08_425864	303	22	476	476	CD
10_1101-2021_01_08_425864	303	23	finding	finding	NN
10_1101-2021_01_08_425864	303	24	could	could	MD
10_1101-2021_01_08_425864	303	25	be	be	VB
10_1101-2021_01_08_425864	303	26	due	due	IN
10_1101-2021_01_08_425864	303	27	to	to	IN
10_1101-2021_01_08_425864	303	28	a	a	DT
10_1101-2021_01_08_425864	303	29	decrease	decrease	NN
10_1101-2021_01_08_425864	303	30	in	in	IN
10_1101-2021_01_08_425864	303	31	the	the	DT
10_1101-2021_01_08_425864	303	32	parasite	parasite	NN
10_1101-2021_01_08_425864	303	33	proliferation	proliferation	NN
10_1101-2021_01_08_425864	303	34	rate	rate	NN
10_1101-2021_01_08_425864	303	35	or	or	CC
10_1101-2021_01_08_425864	303	36	an	an	DT
10_1101-2021_01_08_425864	303	37	increase	increase	NN
10_1101-2021_01_08_425864	303	38	in	in	IN
10_1101-2021_01_08_425864	303	39	the	the	DT
10_1101-2021_01_08_425864	303	40	death	death	NN
10_1101-2021_01_08_425864	303	41	rate	rate	NN
10_1101-2021_01_08_425864	303	42	.	.	.
10_1101-2021_01_08_425864	304	1	477	477	CD
10_1101-2021_01_08_425864	304	2	Therefore	therefore	RB
10_1101-2021_01_08_425864	304	3	,	,	,
10_1101-2021_01_08_425864	304	4	we	-PRON-	PRP
10_1101-2021_01_08_425864	304	5	checked	check	VBD
10_1101-2021_01_08_425864	304	6	if	if	IN
10_1101-2021_01_08_425864	304	7	this	this	DT
10_1101-2021_01_08_425864	304	8	compound	compound	NN
10_1101-2021_01_08_425864	304	9	could	could	MD
10_1101-2021_01_08_425864	304	10	induce	induce	VB
10_1101-2021_01_08_425864	304	11	cell	cell	NN
10_1101-2021_01_08_425864	304	12	death	death	NN
10_1101-2021_01_08_425864	304	13	through	through	IN
10_1101-2021_01_08_425864	304	14	programmed	program	VBN
10_1101-2021_01_08_425864	304	15	cell	cell	NN
10_1101-2021_01_08_425864	304	16	death	death	NN
10_1101-2021_01_08_425864	304	17	478	478	CD
10_1101-2021_01_08_425864	304	18	(	(	-LRB-
10_1101-2021_01_08_425864	304	19	PCD	PCD	NNP
10_1101-2021_01_08_425864	304	20	)	)	-RRB-
10_1101-2021_01_08_425864	304	21	or	or	CC
10_1101-2021_01_08_425864	304	22	necrosis	necrosis	NN
10_1101-2021_01_08_425864	304	23	.	.	.
10_1101-2021_01_08_425864	305	1	PCD	PCD	NNP
10_1101-2021_01_08_425864	305	2	is	be	VBZ
10_1101-2021_01_08_425864	305	3	characterized	characterize	VBN
10_1101-2021_01_08_425864	305	4	by	by	IN
10_1101-2021_01_08_425864	305	5	biochemical	biochemical	JJ
10_1101-2021_01_08_425864	305	6	and	and	CC
10_1101-2021_01_08_425864	305	7	morphological	morphological	JJ
10_1101-2021_01_08_425864	305	8	events	event	NNS
10_1101-2021_01_08_425864	305	9	such	such	JJ
10_1101-2021_01_08_425864	305	10	as	as	IN
10_1101-2021_01_08_425864	305	11	exposure	exposure	NN
10_1101-2021_01_08_425864	305	12	479	479	CD
10_1101-2021_01_08_425864	305	13	to	to	TO
10_1101-2021_01_08_425864	305	14	phosphatidylserine	phosphatidylserine	VB
10_1101-2021_01_08_425864	305	15	,	,	,
10_1101-2021_01_08_425864	305	16	DNA	dna	NN
10_1101-2021_01_08_425864	305	17	fragmentation	fragmentation	NN
10_1101-2021_01_08_425864	305	18	,	,	,
10_1101-2021_01_08_425864	305	19	decreases	decrease	VBZ
10_1101-2021_01_08_425864	305	20	(	(	-LRB-
10_1101-2021_01_08_425864	305	21	or	or	CC
10_1101-2021_01_08_425864	305	22	increases	increase	NNS
10_1101-2021_01_08_425864	305	23	)	)	-RRB-
10_1101-2021_01_08_425864	305	24	in	in	IN
10_1101-2021_01_08_425864	305	25	the	the	DT
10_1101-2021_01_08_425864	305	26	ATP	ATP	NNP
10_1101-2021_01_08_425864	305	27	levels	level	NNS
10_1101-2021_01_08_425864	305	28	,	,	,
10_1101-2021_01_08_425864	305	29	and	and	CC
10_1101-2021_01_08_425864	305	30	increases	increase	VBZ
10_1101-2021_01_08_425864	305	31	480	480	CD
10_1101-2021_01_08_425864	305	32	in	in	IN
10_1101-2021_01_08_425864	305	33	reactive	reactive	JJ
10_1101-2021_01_08_425864	305	34	oxygen	oxygen	NN
10_1101-2021_01_08_425864	305	35	species	specie	NNS
10_1101-2021_01_08_425864	305	36	(	(	-LRB-
10_1101-2021_01_08_425864	305	37	ROS	ROS	NNP
10_1101-2021_01_08_425864	305	38	)	)	-RRB-
10_1101-2021_01_08_425864	305	39	,	,	,
10_1101-2021_01_08_425864	305	40	among	among	IN
10_1101-2021_01_08_425864	305	41	others	other	NNS
10_1101-2021_01_08_425864	305	42	[	[	-LRB-
10_1101-2021_01_08_425864	305	43	33	33	CD
10_1101-2021_01_08_425864	305	44	]	]	-RRB-
10_1101-2021_01_08_425864	305	45	.	.	.
10_1101-2021_01_08_425864	306	1	The	the	DT
10_1101-2021_01_08_425864	306	2	parasites	parasite	NNS
10_1101-2021_01_08_425864	306	3	were	be	VBD
10_1101-2021_01_08_425864	306	4	treated	treat	VBN
10_1101-2021_01_08_425864	306	5	with	with	IN
10_1101-2021_01_08_425864	306	6	500	500	CD
10_1101-2021_01_08_425864	306	7	µM	µM	NNP
10_1101-2021_01_08_425864	306	8	of	of	IN
10_1101-2021_01_08_425864	306	9	481	481	CD
10_1101-2021_01_08_425864	306	10	ETO	ETO	NNS
10_1101-2021_01_08_425864	306	11	for	for	IN
10_1101-2021_01_08_425864	306	12	5	5	CD
10_1101-2021_01_08_425864	306	13	days	day	NNS
10_1101-2021_01_08_425864	306	14	,	,	,
10_1101-2021_01_08_425864	306	15	followed	follow	VBN
10_1101-2021_01_08_425864	306	16	by	by	IN
10_1101-2021_01_08_425864	306	17	incubation	incubation	NN
10_1101-2021_01_08_425864	306	18	with	with	IN
10_1101-2021_01_08_425864	306	19	propidium	propidium	NN
10_1101-2021_01_08_425864	306	20	iodide	iodide	NN
10_1101-2021_01_08_425864	306	21	(	(	-LRB-
10_1101-2021_01_08_425864	306	22	PI	PI	NNP
10_1101-2021_01_08_425864	306	23	)	)	-RRB-
10_1101-2021_01_08_425864	306	24	for	for	IN
10_1101-2021_01_08_425864	306	25	cell	cell	NN
10_1101-2021_01_08_425864	306	26	membrane	membrane	NN
10_1101-2021_01_08_425864	306	27	integrity	integrity	NN
10_1101-2021_01_08_425864	306	28	482	482	CD
10_1101-2021_01_08_425864	306	29	analysis	analysis	NN
10_1101-2021_01_08_425864	306	30	and	and	CC
10_1101-2021_01_08_425864	306	31	annexin	annexin	NN
10_1101-2021_01_08_425864	306	32	-	-	HYPH
10_1101-2021_01_08_425864	306	33	V	v	NN
10_1101-2021_01_08_425864	306	34	FITC	FITC	NNP
10_1101-2021_01_08_425864	306	35	to	to	TO
10_1101-2021_01_08_425864	306	36	evaluate	evaluate	VB
10_1101-2021_01_08_425864	306	37	the	the	DT
10_1101-2021_01_08_425864	306	38	phosphatidylserine	phosphatidylserine	NN
10_1101-2021_01_08_425864	306	39	exposure	exposure	NN
10_1101-2021_01_08_425864	306	40	.	.	.
10_1101-2021_01_08_425864	307	1	Parasites	parasite	NNS
10_1101-2021_01_08_425864	307	2	treated	treat	VBD
10_1101-2021_01_08_425864	307	3	with	with	IN
10_1101-2021_01_08_425864	307	4	ETO	ETO	NNP
10_1101-2021_01_08_425864	307	5	483	483	CD
10_1101-2021_01_08_425864	307	6	showed	show	VBD
10_1101-2021_01_08_425864	307	7	negative	negative	JJ
10_1101-2021_01_08_425864	307	8	results	result	NNS
10_1101-2021_01_08_425864	307	9	for	for	IN
10_1101-2021_01_08_425864	307	10	necrosis	necrosis	NN
10_1101-2021_01_08_425864	307	11	or	or	CC
10_1101-2021_01_08_425864	307	12	programmed	program	VBN
10_1101-2021_01_08_425864	307	13	cell	cell	NN
10_1101-2021_01_08_425864	307	14	death	death	NN
10_1101-2021_01_08_425864	307	15	markers	marker	NNS
10_1101-2021_01_08_425864	307	16	(	(	-LRB-
10_1101-2021_01_08_425864	307	17	Fig	fig	NN
10_1101-2021_01_08_425864	307	18	9A	9a	NN
10_1101-2021_01_08_425864	307	19	)	)	-RRB-
10_1101-2021_01_08_425864	307	20	,	,	,
10_1101-2021_01_08_425864	307	21	indicating	indicate	VBG
10_1101-2021_01_08_425864	307	22	that	that	IN
10_1101-2021_01_08_425864	307	23	the	the	DT
10_1101-2021_01_08_425864	307	24	484	484	CD
10_1101-2021_01_08_425864	307	25	cell	cell	NN
10_1101-2021_01_08_425864	307	26	proliferation	proliferation	NN
10_1101-2021_01_08_425864	307	27	was	be	VBD
10_1101-2021_01_08_425864	307	28	arrested	arrest	VBN
10_1101-2021_01_08_425864	307	29	but	but	CC
10_1101-2021_01_08_425864	307	30	cell	cell	NN
10_1101-2021_01_08_425864	307	31	viability	viability	NN
10_1101-2021_01_08_425864	307	32	was	be	VBD
10_1101-2021_01_08_425864	307	33	maintained	maintain	VBN
10_1101-2021_01_08_425864	307	34	.	.	.
10_1101-2021_01_08_425864	308	1	Because	because	IN
10_1101-2021_01_08_425864	308	2	the	the	DT
10_1101-2021_01_08_425864	308	3	multiplication	multiplication	NN
10_1101-2021_01_08_425864	308	4	rates	rate	NNS
10_1101-2021_01_08_425864	308	5	485	485	CD
10_1101-2021_01_08_425864	308	6	seemed	seem	VBD
10_1101-2021_01_08_425864	308	7	to	to	TO
10_1101-2021_01_08_425864	308	8	be	be	VB
10_1101-2021_01_08_425864	308	9	diminished	diminish	VBN
10_1101-2021_01_08_425864	308	10	,	,	,
10_1101-2021_01_08_425864	308	11	we	-PRON-	PRP
10_1101-2021_01_08_425864	308	12	performed	perform	VBD
10_1101-2021_01_08_425864	308	13	a	a	DT
10_1101-2021_01_08_425864	308	14	cell	cell	NN
10_1101-2021_01_08_425864	308	15	cycle	cycle	NN
10_1101-2021_01_08_425864	308	16	analysis	analysis	NN
10_1101-2021_01_08_425864	308	17	.	.	.
10_1101-2021_01_08_425864	309	1	Noticeably	noticeably	RB
10_1101-2021_01_08_425864	309	2	,	,	,
10_1101-2021_01_08_425864	309	3	the	the	DT
10_1101-2021_01_08_425864	309	4	treated	treat	VBN
10_1101-2021_01_08_425864	309	5	parasites	parasite	NNS
10_1101-2021_01_08_425864	309	6	were	be	VBD
10_1101-2021_01_08_425864	309	7	486	486	CD
10_1101-2021_01_08_425864	309	8	enriched	enrich	VBN
10_1101-2021_01_08_425864	309	9	in	in	IN
10_1101-2021_01_08_425864	309	10	G1	G1	NNP
10_1101-2021_01_08_425864	309	11	(	(	-LRB-
10_1101-2021_01_08_425864	309	12	85.9	85.9	CD
10_1101-2021_01_08_425864	309	13	%	%	NN
10_1101-2021_01_08_425864	309	14	)	)	-RRB-
10_1101-2021_01_08_425864	309	15	with	with	IN
10_1101-2021_01_08_425864	309	16	respect	respect	NN
10_1101-2021_01_08_425864	309	17	to	to	IN
10_1101-2021_01_08_425864	309	18	non	non	JJ
10_1101-2021_01_08_425864	309	19	-	-	JJ
10_1101-2021_01_08_425864	309	20	treated	treated	JJ
10_1101-2021_01_08_425864	309	21	cells	cell	NNS
10_1101-2021_01_08_425864	309	22	(	(	-LRB-
10_1101-2021_01_08_425864	309	23	43.6	43.6	CD
10_1101-2021_01_08_425864	309	24	%	%	NN
10_1101-2021_01_08_425864	309	25	)	)	-RRB-
10_1101-2021_01_08_425864	309	26	,	,	,
10_1101-2021_01_08_425864	309	27	suggesting	suggest	VBG
10_1101-2021_01_08_425864	309	28	that	that	IN
10_1101-2021_01_08_425864	309	29	ETO	ETO	NNP
10_1101-2021_01_08_425864	309	30	prevented	prevent	VBD
10_1101-2021_01_08_425864	309	31	the	the	DT
10_1101-2021_01_08_425864	309	32	487	487	CD
10_1101-2021_01_08_425864	309	33	entry	entry	NN
10_1101-2021_01_08_425864	309	34	of	of	IN
10_1101-2021_01_08_425864	309	35	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	309	36	into	into	IN
10_1101-2021_01_08_425864	309	37	the	the	DT
10_1101-2021_01_08_425864	309	38	S	S	NNP
10_1101-2021_01_08_425864	309	39	phase	phase	NN
10_1101-2021_01_08_425864	309	40	of	of	IN
10_1101-2021_01_08_425864	309	41	the	the	DT
10_1101-2021_01_08_425864	309	42	cell	cell	NN
10_1101-2021_01_08_425864	309	43	cycle	cycle	NN
10_1101-2021_01_08_425864	309	44	(	(	-LRB-
10_1101-2021_01_08_425864	309	45	Fig	Fig	NNP
10_1101-2021_01_08_425864	309	46	9B	9b	NN
10_1101-2021_01_08_425864	309	47	)	)	-RRB-
10_1101-2021_01_08_425864	309	48	.	.	.
10_1101-2021_01_08_425864	310	1	Last	last	JJ
10_1101-2021_01_08_425864	310	2	,	,	,
10_1101-2021_01_08_425864	310	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	310	4	noticed	notice	VBD
10_1101-2021_01_08_425864	310	5	that	that	IN
10_1101-2021_01_08_425864	310	6	after	after	IN
10_1101-2021_01_08_425864	310	7	washing	wash	VBG
10_1101-2021_01_08_425864	310	8	488	488	CD
10_1101-2021_01_08_425864	310	9	out	out	IN
10_1101-2021_01_08_425864	310	10	the	the	DT
10_1101-2021_01_08_425864	310	11	ETO	ETO	NNP
10_1101-2021_01_08_425864	310	12	,	,	,
10_1101-2021_01_08_425864	310	13	the	the	DT
10_1101-2021_01_08_425864	310	14	parasites	parasite	NNS
10_1101-2021_01_08_425864	310	15	recovered	recover	VBD
10_1101-2021_01_08_425864	310	16	their	-PRON-	PRP$
10_1101-2021_01_08_425864	310	17	proliferation	proliferation	NN
10_1101-2021_01_08_425864	310	18	at	at	IN
10_1101-2021_01_08_425864	310	19	rates	rate	NNS
10_1101-2021_01_08_425864	310	20	comparable	comparable	JJ
10_1101-2021_01_08_425864	310	21	to	to	IN
10_1101-2021_01_08_425864	310	22	our	-PRON-	PRP$
10_1101-2021_01_08_425864	310	23	untreated	untreated	JJ
10_1101-2021_01_08_425864	310	24	controls	control	NNS
10_1101-2021_01_08_425864	310	25	489	489	CD
10_1101-2021_01_08_425864	310	26	(	(	-LRB-
10_1101-2021_01_08_425864	310	27	Figs	fig	NNS
10_1101-2021_01_08_425864	310	28	9C	9c	NN
10_1101-2021_01_08_425864	310	29	)	)	-RRB-
10_1101-2021_01_08_425864	310	30	.	.	.
10_1101-2021_01_08_425864	311	1	490	490	CD
10_1101-2021_01_08_425864	311	2	491	491	CD
10_1101-2021_01_08_425864	311	3	Figure	figure	NN
10_1101-2021_01_08_425864	311	4	9	9	CD
10_1101-2021_01_08_425864	311	5	.	.	.
10_1101-2021_01_08_425864	312	1	Analysis	Analysis	NNP
10_1101-2021_01_08_425864	312	2	of	of	IN
10_1101-2021_01_08_425864	312	3	extracellular	extracellular	NNP
10_1101-2021_01_08_425864	312	4	phosphatidylserine	phosphatidylserine	NN
10_1101-2021_01_08_425864	312	5	exposure	exposure	NN
10_1101-2021_01_08_425864	312	6	,	,	,
10_1101-2021_01_08_425864	312	7	membrane	membrane	NN
10_1101-2021_01_08_425864	312	8	integrity	integrity	NN
10_1101-2021_01_08_425864	312	9	and	and	CC
10_1101-2021_01_08_425864	312	10	cell	cell	NN
10_1101-2021_01_08_425864	312	11	492	492	CD
10_1101-2021_01_08_425864	312	12	cycle	cycle	NN
10_1101-2021_01_08_425864	312	13	after	after	IN
10_1101-2021_01_08_425864	312	14	ETO	ETO	NNP
10_1101-2021_01_08_425864	312	15	treatment	treatment	NN
10_1101-2021_01_08_425864	312	16	.	.	.
10_1101-2021_01_08_425864	313	1	Parasites	parasite	NNS
10_1101-2021_01_08_425864	313	2	in	in	IN
10_1101-2021_01_08_425864	313	3	the	the	DT
10_1101-2021_01_08_425864	313	4	exponential	exponential	JJ
10_1101-2021_01_08_425864	313	5	growth	growth	NN
10_1101-2021_01_08_425864	313	6	phase	phase	NN
10_1101-2021_01_08_425864	313	7	were	be	VBD
10_1101-2021_01_08_425864	313	8	treated	treat	VBN
10_1101-2021_01_08_425864	313	9	with	with	IN
10_1101-2021_01_08_425864	313	10	500	500	CD
10_1101-2021_01_08_425864	313	11	µM	µM	NNP
10_1101-2021_01_08_425864	313	12	of	of	IN
10_1101-2021_01_08_425864	313	13	493	493	CD
10_1101-2021_01_08_425864	313	14	ETO	eto	NN
10_1101-2021_01_08_425864	313	15	for	for	IN
10_1101-2021_01_08_425864	313	16	5	5	CD
10_1101-2021_01_08_425864	313	17	days	day	NNS
10_1101-2021_01_08_425864	313	18	.	.	.
10_1101-2021_01_08_425864	314	1	(	(	-LRB-
10_1101-2021_01_08_425864	314	2	A	a	NN
10_1101-2021_01_08_425864	314	3	)	)	-RRB-
10_1101-2021_01_08_425864	314	4	Following	follow	VBG
10_1101-2021_01_08_425864	314	5	the	the	DT
10_1101-2021_01_08_425864	314	6	incubation	incubation	NN
10_1101-2021_01_08_425864	314	7	period	period	NN
10_1101-2021_01_08_425864	314	8	,	,	,
10_1101-2021_01_08_425864	314	9	the	the	DT
10_1101-2021_01_08_425864	314	10	parasites	parasite	NNS
10_1101-2021_01_08_425864	314	11	were	be	VBD
10_1101-2021_01_08_425864	314	12	labelled	label	VBN
10_1101-2021_01_08_425864	314	13	with	with	IN
10_1101-2021_01_08_425864	314	14	propidium	propidium	NN
10_1101-2021_01_08_425864	314	15	494	494	CD
10_1101-2021_01_08_425864	314	16	iodide	iodide	NN
10_1101-2021_01_08_425864	314	17	(	(	-LRB-
10_1101-2021_01_08_425864	314	18	PI	PI	NNP
10_1101-2021_01_08_425864	314	19	)	)	-RRB-
10_1101-2021_01_08_425864	314	20	and	and	CC
10_1101-2021_01_08_425864	314	21	annexin	annexin	VB
10_1101-2021_01_08_425864	314	22	V	V	NNP
10_1101-2021_01_08_425864	314	23	-	-	HYPH
10_1101-2021_01_08_425864	314	24	FITC	FITC	NNP
10_1101-2021_01_08_425864	314	25	(	(	-LRB-
10_1101-2021_01_08_425864	314	26	ANX	ANX	NNP
10_1101-2021_01_08_425864	314	27	)	)	-RRB-
10_1101-2021_01_08_425864	314	28	and	and	CC
10_1101-2021_01_08_425864	314	29	analysed	analyse	VBN
10_1101-2021_01_08_425864	314	30	by	by	IN
10_1101-2021_01_08_425864	314	31	flow	flow	NN
10_1101-2021_01_08_425864	314	32	cytometry	cytometry	NN
10_1101-2021_01_08_425864	314	33	.	.	.
10_1101-2021_01_08_425864	315	1	(	(	-LRB-
10_1101-2021_01_08_425864	315	2	B	b	NN
10_1101-2021_01_08_425864	315	3	)	)	-RRB-
10_1101-2021_01_08_425864	315	4	The	the	DT
10_1101-2021_01_08_425864	315	5	cell	cell	NN
10_1101-2021_01_08_425864	315	6	cycle	cycle	NN
10_1101-2021_01_08_425864	315	7	was	be	VBD
10_1101-2021_01_08_425864	315	8	495	495	CD
10_1101-2021_01_08_425864	315	9	assessed	assess	VBD
10_1101-2021_01_08_425864	315	10	using	use	VBG
10_1101-2021_01_08_425864	315	11	PI	PI	NNP
10_1101-2021_01_08_425864	315	12	staining	staining	NN
10_1101-2021_01_08_425864	315	13	.	.	.
10_1101-2021_01_08_425864	316	1	(	(	-LRB-
10_1101-2021_01_08_425864	316	2	C	c	NN
10_1101-2021_01_08_425864	316	3	)	)	-RRB-
10_1101-2021_01_08_425864	316	4	Growth	growth	NN
10_1101-2021_01_08_425864	316	5	curves	curve	NNS
10_1101-2021_01_08_425864	316	6	of	of	IN
10_1101-2021_01_08_425864	316	7	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	316	8	forms	form	NNS
10_1101-2021_01_08_425864	316	9	before	before	RB
10_1101-2021_01_08_425864	316	10	and	and	CC
10_1101-2021_01_08_425864	316	11	after	after	IN
10_1101-2021_01_08_425864	316	12	removing	remove	VBG
10_1101-2021_01_08_425864	316	13	the	the	DT
10_1101-2021_01_08_425864	316	14	496	496	CD
10_1101-2021_01_08_425864	316	15	treatment	treatment	NN
10_1101-2021_01_08_425864	316	16	.	.	.
10_1101-2021_01_08_425864	317	1	All	all	PDT
10_1101-2021_01_08_425864	317	2	the	the	DT
10_1101-2021_01_08_425864	317	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	317	4	were	be	VBD
10_1101-2021_01_08_425864	317	5	performed	perform	VBN
10_1101-2021_01_08_425864	317	6	in	in	IN
10_1101-2021_01_08_425864	317	7	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	317	8	.	.	.
10_1101-2021_01_08_425864	318	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	318	2	analysis	analysis	NN
10_1101-2021_01_08_425864	318	3	was	be	VBD
10_1101-2021_01_08_425864	318	4	performed	perform	VBN
10_1101-2021_01_08_425864	318	5	with	with	IN
10_1101-2021_01_08_425864	318	6	497	497	CD
10_1101-2021_01_08_425864	318	7	one	one	CD
10_1101-2021_01_08_425864	318	8	-	-	HYPH
10_1101-2021_01_08_425864	318	9	way	way	NN
10_1101-2021_01_08_425864	318	10	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	318	11	followed	follow	VBN
10_1101-2021_01_08_425864	318	12	by	by	IN
10_1101-2021_01_08_425864	318	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	318	14	's	's	POS
10_1101-2021_01_08_425864	318	15	post	post	JJ
10_1101-2021_01_08_425864	318	16	-	-	JJ
10_1101-2021_01_08_425864	318	17	test	test	JJ
10_1101-2021_01_08_425864	318	18	p	p	NN
10_1101-2021_01_08_425864	318	19	<	<	XX
10_1101-2021_01_08_425864	318	20	0.05	0.05	CD
10_1101-2021_01_08_425864	318	21	,	,	,
10_1101-2021_01_08_425864	318	22	using	use	VBG
10_1101-2021_01_08_425864	318	23	the	the	DT
10_1101-2021_01_08_425864	318	24	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	318	25	Prism	Prism	NNP
10_1101-2021_01_08_425864	318	26	8.0.2	8.0.2	CD
10_1101-2021_01_08_425864	318	27	software	software	NN
10_1101-2021_01_08_425864	318	28	498	498	CD
10_1101-2021_01_08_425864	318	29	program	program	NN
10_1101-2021_01_08_425864	318	30	.	.	.
10_1101-2021_01_08_425864	319	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	319	2	represent	represent	VBP
10_1101-2021_01_08_425864	319	3	the	the	DT
10_1101-2021_01_08_425864	319	4	level	level	NN
10_1101-2021_01_08_425864	319	5	of	of	IN
10_1101-2021_01_08_425864	319	6	statistical	statistical	JJ
10_1101-2021_01_08_425864	319	7	significance	significance	NN
10_1101-2021_01_08_425864	319	8	in	in	IN
10_1101-2021_01_08_425864	319	9	this	this	DT
10_1101-2021_01_08_425864	319	10	figure	figure	NN
10_1101-2021_01_08_425864	319	11	as	as	IN
10_1101-2021_01_08_425864	319	12	follows	follow	VBZ
10_1101-2021_01_08_425864	319	13	:	:	:
10_1101-2021_01_08_425864	319	14	*	*	NFP
10_1101-2021_01_08_425864	319	15	*	*	NFP
10_1101-2021_01_08_425864	319	16	*	*	NFP
10_1101-2021_01_08_425864	319	17	p	p	NN
10_1101-2021_01_08_425864	319	18	value	value	NN
10_1101-2021_01_08_425864	319	19	<	<	XX
10_1101-2021_01_08_425864	319	20	499	499	CD
10_1101-2021_01_08_425864	319	21	0.001	0.001	CD
10_1101-2021_01_08_425864	319	22	;	;	:
10_1101-2021_01_08_425864	319	23	*	*	NFP
10_1101-2021_01_08_425864	319	24	*	*	NFP
10_1101-2021_01_08_425864	319	25	p	p	NN
10_1101-2021_01_08_425864	319	26	value	value	NN
10_1101-2021_01_08_425864	319	27	<	<	XX
10_1101-2021_01_08_425864	319	28	0.01	0.01	XX
10_1101-2021_01_08_425864	319	29	;	;	:
10_1101-2021_01_08_425864	319	30	and	and	CC
10_1101-2021_01_08_425864	319	31	*	*	NFP
10_1101-2021_01_08_425864	319	32	p	p	NN
10_1101-2021_01_08_425864	319	33	value	value	NN
10_1101-2021_01_08_425864	319	34	<	<	XX
10_1101-2021_01_08_425864	319	35	0.05	0.05	CD
10_1101-2021_01_08_425864	319	36	.	.	.
10_1101-2021_01_08_425864	320	1	For	for	IN
10_1101-2021_01_08_425864	320	2	p	p	NN
10_1101-2021_01_08_425864	320	3	values	value	NNS
10_1101-2021_01_08_425864	320	4	>	>	XX
10_1101-2021_01_08_425864	320	5	0.05	0.05	CD
10_1101-2021_01_08_425864	320	6	,	,	,
10_1101-2021_01_08_425864	320	7	we	-PRON-	PRP
10_1101-2021_01_08_425864	320	8	consider	consider	VBP
10_1101-2021_01_08_425864	320	9	the	the	DT
10_1101-2021_01_08_425864	320	10	differences	difference	NNS
10_1101-2021_01_08_425864	320	11	not	not	RB
10_1101-2021_01_08_425864	320	12	500	500	CD
10_1101-2021_01_08_425864	320	13	significant	significant	JJ
10_1101-2021_01_08_425864	320	14	(	(	-LRB-
10_1101-2021_01_08_425864	320	15	ns	ns	NNP
10_1101-2021_01_08_425864	320	16	)	)	-RRB-
10_1101-2021_01_08_425864	320	17	.	.	.
10_1101-2021_01_08_425864	321	1	501	501	CD
10_1101-2021_01_08_425864	321	2	502	502	CD
10_1101-2021_01_08_425864	321	3	Inhibition	inhibition	NN
10_1101-2021_01_08_425864	321	4	of	of	IN
10_1101-2021_01_08_425864	321	5	FAO	FAO	NNP
10_1101-2021_01_08_425864	321	6	by	by	IN
10_1101-2021_01_08_425864	321	7	ETO	ETO	NNP
10_1101-2021_01_08_425864	321	8	affects	affect	VBZ
10_1101-2021_01_08_425864	321	9	energy	energy	NN
10_1101-2021_01_08_425864	321	10	metabolism	metabolism	NN
10_1101-2021_01_08_425864	321	11	,	,	,
10_1101-2021_01_08_425864	321	12	impairing	impair	VBG
10_1101-2021_01_08_425864	321	13	the	the	DT
10_1101-2021_01_08_425864	321	14	consumption	consumption	NN
10_1101-2021_01_08_425864	321	15	of	of	IN
10_1101-2021_01_08_425864	321	16	503	503	CD
10_1101-2021_01_08_425864	321	17	endogenous	endogenous	JJ
10_1101-2021_01_08_425864	321	18	fatty	fatty	NN
10_1101-2021_01_08_425864	321	19	acids	acid	NNS
10_1101-2021_01_08_425864	321	20	504	504	CD
10_1101-2021_01_08_425864	321	21	The	the	DT
10_1101-2021_01_08_425864	321	22	evidence	evidence	NN
10_1101-2021_01_08_425864	321	23	obtained	obtain	VBN
10_1101-2021_01_08_425864	321	24	to	to	IN
10_1101-2021_01_08_425864	321	25	date	date	NN
10_1101-2021_01_08_425864	321	26	suggests	suggest	VBZ
10_1101-2021_01_08_425864	321	27	that	that	IN
10_1101-2021_01_08_425864	321	28	parasites	parasite	NNS
10_1101-2021_01_08_425864	321	29	resist	resist	VBP
10_1101-2021_01_08_425864	321	30	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	321	31	stress	stress	NN
10_1101-2021_01_08_425864	321	32	by	by	IN
10_1101-2021_01_08_425864	321	33	mobilizing	mobilize	VBG
10_1101-2021_01_08_425864	321	34	and	and	CC
10_1101-2021_01_08_425864	321	35	505	505	CD
10_1101-2021_01_08_425864	321	36	consuming	consume	VBG
10_1101-2021_01_08_425864	321	37	stored	store	VBN
10_1101-2021_01_08_425864	321	38	fatty	fatty	NN
10_1101-2021_01_08_425864	321	39	acids	acid	NNS
10_1101-2021_01_08_425864	321	40	.	.	.
10_1101-2021_01_08_425864	322	1	Therefore	therefore	RB
10_1101-2021_01_08_425864	322	2	,	,	,
10_1101-2021_01_08_425864	322	3	it	-PRON-	PRP
10_1101-2021_01_08_425864	322	4	is	be	VBZ
10_1101-2021_01_08_425864	322	5	reasonable	reasonable	JJ
10_1101-2021_01_08_425864	322	6	to	to	TO
10_1101-2021_01_08_425864	322	7	hypothesize	hypothesize	VB
10_1101-2021_01_08_425864	322	8	that	that	DT
10_1101-2021_01_08_425864	322	9	ETO	ETO	NNP
10_1101-2021_01_08_425864	322	10	,	,	,
10_1101-2021_01_08_425864	322	11	which	which	WDT
10_1101-2021_01_08_425864	322	12	blocks	block	VBZ
10_1101-2021_01_08_425864	322	13	the	the	DT
10_1101-2021_01_08_425864	322	14	506	506	CD
10_1101-2021_01_08_425864	322	15	mobilization	mobilization	NN
10_1101-2021_01_08_425864	322	16	of	of	IN
10_1101-2021_01_08_425864	322	17	fatty	fatty	NN
10_1101-2021_01_08_425864	322	18	acids	acid	NNS
10_1101-2021_01_08_425864	322	19	into	into	IN
10_1101-2021_01_08_425864	322	20	the	the	DT
10_1101-2021_01_08_425864	322	21	mitochondria	mitochondria	NN
10_1101-2021_01_08_425864	322	22	for	for	IN
10_1101-2021_01_08_425864	322	23	oxidation	oxidation	NN
10_1101-2021_01_08_425864	322	24	,	,	,
10_1101-2021_01_08_425864	322	25	probably	probably	RB
10_1101-2021_01_08_425864	322	26	perturbs	perturb	VBZ
10_1101-2021_01_08_425864	322	27	the	the	DT
10_1101-2021_01_08_425864	322	28	ATP	ATP	NNP
10_1101-2021_01_08_425864	322	29	levels	level	NNS
10_1101-2021_01_08_425864	322	30	in	in	IN
10_1101-2021_01_08_425864	322	31	.CC	.CC	NFP
10_1101-2021_01_08_425864	322	32	-	-	:
10_1101-2021_01_08_425864	322	33	BY	by	IN
10_1101-2021_01_08_425864	322	34	4.0	4.0	CD
10_1101-2021_01_08_425864	322	35	International	international	JJ
10_1101-2021_01_08_425864	322	36	licensemade	licensemade	NN
10_1101-2021_01_08_425864	322	37	available	available	JJ
10_1101-2021_01_08_425864	322	38	under	under	IN
10_1101-2021_01_08_425864	322	39	a	a	DT
10_1101-2021_01_08_425864	322	40	(	(	-LRB-
10_1101-2021_01_08_425864	322	41	which	which	WDT
10_1101-2021_01_08_425864	322	42	was	be	VBD
10_1101-2021_01_08_425864	322	43	not	not	RB
10_1101-2021_01_08_425864	322	44	certified	certify	VBN
10_1101-2021_01_08_425864	322	45	by	by	IN
10_1101-2021_01_08_425864	322	46	peer	peer	NN
10_1101-2021_01_08_425864	322	47	review	review	NN
10_1101-2021_01_08_425864	322	48	)	)	-RRB-
10_1101-2021_01_08_425864	322	49	is	be	VBZ
10_1101-2021_01_08_425864	322	50	the	the	DT
10_1101-2021_01_08_425864	322	51	author	author	NN
10_1101-2021_01_08_425864	322	52	/	/	SYM
10_1101-2021_01_08_425864	322	53	funder	funder	NN
10_1101-2021_01_08_425864	322	54	,	,	,
10_1101-2021_01_08_425864	322	55	who	who	WP
10_1101-2021_01_08_425864	322	56	has	have	VBZ
10_1101-2021_01_08_425864	322	57	granted	grant	VBN
10_1101-2021_01_08_425864	322	58	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	322	59	a	a	DT
10_1101-2021_01_08_425864	322	60	license	license	NN
10_1101-2021_01_08_425864	322	61	to	to	TO
10_1101-2021_01_08_425864	322	62	display	display	VB
10_1101-2021_01_08_425864	322	63	the	the	DT
10_1101-2021_01_08_425864	322	64	preprint	preprint	NN
10_1101-2021_01_08_425864	322	65	in	in	IN
10_1101-2021_01_08_425864	322	66	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	322	67	.	.	.
10_1101-2021_01_08_425864	323	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	323	2	is	be	VBZ
10_1101-2021_01_08_425864	323	3	The	the	DT
10_1101-2021_01_08_425864	323	4	copyright	copyright	NN
10_1101-2021_01_08_425864	323	5	holder	holder	NN
10_1101-2021_01_08_425864	323	6	for	for	IN
10_1101-2021_01_08_425864	323	7	this	this	DT
10_1101-2021_01_08_425864	323	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	323	9	version	version	NN
10_1101-2021_01_08_425864	323	10	posted	post	VBD
10_1101-2021_01_08_425864	323	11	January	January	NNP
10_1101-2021_01_08_425864	323	12	8	8	CD
10_1101-2021_01_08_425864	323	13	,	,	,
10_1101-2021_01_08_425864	323	14	2021	2021	CD
10_1101-2021_01_08_425864	323	15	.	.	.
10_1101-2021_01_08_425864	323	16	;	;	:
10_1101-2021_01_08_425864	323	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	323	18	:	:	:
10_1101-2021_01_08_425864	323	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	323	20	preprint	preprint	NN
10_1101-2021_01_08_425864	323	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	323	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	323	23	507	507	CD
10_1101-2021_01_08_425864	323	24	late	late	JJ
10_1101-2021_01_08_425864	323	25	-	-	HYPH
10_1101-2021_01_08_425864	323	26	exponential	exponential	JJ
10_1101-2021_01_08_425864	323	27	or	or	CC
10_1101-2021_01_08_425864	323	28	stationary	stationary	JJ
10_1101-2021_01_08_425864	323	29	phase	phase	NN
10_1101-2021_01_08_425864	323	30	cells	cell	NNS
10_1101-2021_01_08_425864	323	31	.	.	.
10_1101-2021_01_08_425864	324	1	Parasites	parasite	NNS
10_1101-2021_01_08_425864	324	2	growing	grow	VBG
10_1101-2021_01_08_425864	324	3	for	for	IN
10_1101-2021_01_08_425864	324	4	5	5	CD
10_1101-2021_01_08_425864	324	5	days	day	NNS
10_1101-2021_01_08_425864	324	6	under	under	IN
10_1101-2021_01_08_425864	324	7	500	500	CD
10_1101-2021_01_08_425864	324	8	µM	µM	NNP
10_1101-2021_01_08_425864	324	9	ETO	eto	NN
10_1101-2021_01_08_425864	324	10	treatment	treatment	NN
10_1101-2021_01_08_425864	324	11	508	508	CD
10_1101-2021_01_08_425864	324	12	or	or	CC
10_1101-2021_01_08_425864	324	13	no	no	DT
10_1101-2021_01_08_425864	324	14	treatment	treatment	NN
10_1101-2021_01_08_425864	324	15	were	be	VBD
10_1101-2021_01_08_425864	324	16	collected	collect	VBN
10_1101-2021_01_08_425864	324	17	to	to	TO
10_1101-2021_01_08_425864	324	18	evaluate	evaluate	VB
10_1101-2021_01_08_425864	324	19	the	the	DT
10_1101-2021_01_08_425864	324	20	ability	ability	NN
10_1101-2021_01_08_425864	324	21	of	of	IN
10_1101-2021_01_08_425864	324	22	parasites	parasite	NNS
10_1101-2021_01_08_425864	324	23	that	that	WDT
10_1101-2021_01_08_425864	324	24	were	be	VBD
10_1101-2021_01_08_425864	324	25	treated	treat	VBN
10_1101-2021_01_08_425864	324	26	or	or	CC
10_1101-2021_01_08_425864	324	27	not	not	RB
10_1101-2021_01_08_425864	324	28	with	with	IN
10_1101-2021_01_08_425864	324	29	ETO	ETO	NNP
10_1101-2021_01_08_425864	324	30	509	509	CD
10_1101-2021_01_08_425864	324	31	to	to	TO
10_1101-2021_01_08_425864	324	32	trigger	trigger	VB
10_1101-2021_01_08_425864	324	33	oxygen	oxygen	NN
10_1101-2021_01_08_425864	324	34	consumption	consumption	NN
10_1101-2021_01_08_425864	324	35	.	.	.
10_1101-2021_01_08_425864	325	1	The	the	DT
10_1101-2021_01_08_425864	325	2	rates	rate	NNS
10_1101-2021_01_08_425864	325	3	of	of	IN
10_1101-2021_01_08_425864	325	4	O2	o2	NN
10_1101-2021_01_08_425864	325	5	consumption	consumption	NN
10_1101-2021_01_08_425864	325	6	corresponding	correspond	VBG
10_1101-2021_01_08_425864	325	7	to	to	IN
10_1101-2021_01_08_425864	325	8	basal	basal	NN
10_1101-2021_01_08_425864	325	9	respiration	respiration	NN
10_1101-2021_01_08_425864	325	10	were	be	VBD
10_1101-2021_01_08_425864	325	11	510	510	CD
10_1101-2021_01_08_425864	325	12	measured	measure	VBN
10_1101-2021_01_08_425864	325	13	in	in	IN
10_1101-2021_01_08_425864	325	14	cells	cell	NNS
10_1101-2021_01_08_425864	325	15	resuspended	resuspend	VBN
10_1101-2021_01_08_425864	325	16	in	in	IN
10_1101-2021_01_08_425864	325	17	MCR	MCR	NNP
10_1101-2021_01_08_425864	325	18	respiration	respiration	NN
10_1101-2021_01_08_425864	325	19	buffer	buffer	NN
10_1101-2021_01_08_425864	325	20	.	.	.
10_1101-2021_01_08_425864	326	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	326	2	then	then	RB
10_1101-2021_01_08_425864	326	3	measured	measure	VBD
10_1101-2021_01_08_425864	326	4	the	the	DT
10_1101-2021_01_08_425864	326	5	leak	leak	NN
10_1101-2021_01_08_425864	326	6	respiration	respiration	NN
10_1101-2021_01_08_425864	326	7	by	by	IN
10_1101-2021_01_08_425864	326	8	511	511	CD
10_1101-2021_01_08_425864	326	9	inhibiting	inhibit	VBG
10_1101-2021_01_08_425864	326	10	the	the	DT
10_1101-2021_01_08_425864	326	11	ATP	ATP	NNP
10_1101-2021_01_08_425864	326	12	synthase	synthase	NN
10_1101-2021_01_08_425864	326	13	with	with	IN
10_1101-2021_01_08_425864	326	14	oligomycin	oligomycin	NNP
10_1101-2021_01_08_425864	326	15	A.	a.	NN
10_1101-2021_01_08_425864	327	1	Finally	finally	RB
10_1101-2021_01_08_425864	327	2	,	,	,
10_1101-2021_01_08_425864	327	3	to	to	TO
10_1101-2021_01_08_425864	327	4	measure	measure	VB
10_1101-2021_01_08_425864	327	5	the	the	DT
10_1101-2021_01_08_425864	327	6	maximum	maximum	JJ
10_1101-2021_01_08_425864	327	7	capacity	capacity	NN
10_1101-2021_01_08_425864	327	8	of	of	IN
10_1101-2021_01_08_425864	327	9	the	the	DT
10_1101-2021_01_08_425864	327	10	512	512	CD
10_1101-2021_01_08_425864	327	11	electron	electron	NN
10_1101-2021_01_08_425864	327	12	transport	transport	NN
10_1101-2021_01_08_425864	327	13	system	system	NN
10_1101-2021_01_08_425864	327	14	(	(	-LRB-
10_1101-2021_01_08_425864	327	15	ETS	ETS	NNP
10_1101-2021_01_08_425864	327	16	)	)	-RRB-
10_1101-2021_01_08_425864	327	17	,	,	,
10_1101-2021_01_08_425864	327	18	we	-PRON-	PRP
10_1101-2021_01_08_425864	327	19	used	use	VBD
10_1101-2021_01_08_425864	327	20	the	the	DT
10_1101-2021_01_08_425864	327	21	uncoupler	uncoupler	NN
10_1101-2021_01_08_425864	327	22	FCCP	FCCP	NNP
10_1101-2021_01_08_425864	327	23	[	[	-LRB-
10_1101-2021_01_08_425864	327	24	21	21	CD
10_1101-2021_01_08_425864	327	25	]	]	-RRB-
10_1101-2021_01_08_425864	327	26	.	.	.
10_1101-2021_01_08_425864	328	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	328	2	results	result	NNS
10_1101-2021_01_08_425864	328	3	demonstrate	demonstrate	VBP
10_1101-2021_01_08_425864	328	4	that	that	IN
10_1101-2021_01_08_425864	328	5	513	513	CD
10_1101-2021_01_08_425864	328	6	compared	compare	VBN
10_1101-2021_01_08_425864	328	7	to	to	IN
10_1101-2021_01_08_425864	328	8	no	no	DT
10_1101-2021_01_08_425864	328	9	treatment	treatment	NN
10_1101-2021_01_08_425864	328	10	,	,	,
10_1101-2021_01_08_425864	328	11	ETO	eto	NN
10_1101-2021_01_08_425864	328	12	treatment	treatment	NN
10_1101-2021_01_08_425864	328	13	diminishes	diminish	VBZ
10_1101-2021_01_08_425864	328	14	the	the	DT
10_1101-2021_01_08_425864	328	15	rate	rate	NN
10_1101-2021_01_08_425864	328	16	of	of	IN
10_1101-2021_01_08_425864	328	17	basal	basal	NNP
10_1101-2021_01_08_425864	328	18	oxygen	oxygen	NNP
10_1101-2021_01_08_425864	328	19	consumption	consumption	NN
10_1101-2021_01_08_425864	328	20	,	,	,
10_1101-2021_01_08_425864	328	21	the	the	DT
10_1101-2021_01_08_425864	328	22	leak	leak	NN
10_1101-2021_01_08_425864	328	23	514	514	CD
10_1101-2021_01_08_425864	328	24	respiration	respiration	NN
10_1101-2021_01_08_425864	328	25	and	and	CC
10_1101-2021_01_08_425864	328	26	the	the	DT
10_1101-2021_01_08_425864	328	27	ETS	ETS	NNP
10_1101-2021_01_08_425864	328	28	capacity	capacity	NN
10_1101-2021_01_08_425864	328	29	.	.	.
10_1101-2021_01_08_425864	329	1	In	in	IN
10_1101-2021_01_08_425864	329	2	general	general	JJ
10_1101-2021_01_08_425864	329	3	,	,	,
10_1101-2021_01_08_425864	329	4	respiratory	respiratory	JJ
10_1101-2021_01_08_425864	329	5	rates	rate	NNS
10_1101-2021_01_08_425864	329	6	diminished	diminish	VBN
10_1101-2021_01_08_425864	329	7	in	in	IN
10_1101-2021_01_08_425864	329	8	parasites	parasite	NNS
10_1101-2021_01_08_425864	329	9	treated	treat	VBN
10_1101-2021_01_08_425864	329	10	with	with	IN
10_1101-2021_01_08_425864	329	11	515	515	CD
10_1101-2021_01_08_425864	329	12	ETO	eto	NN
10_1101-2021_01_08_425864	329	13	when	when	WRB
10_1101-2021_01_08_425864	329	14	compared	compare	VBN
10_1101-2021_01_08_425864	329	15	to	to	IN
10_1101-2021_01_08_425864	329	16	the	the	DT
10_1101-2021_01_08_425864	329	17	untreated	untreated	JJ
10_1101-2021_01_08_425864	329	18	ones	one	NNS
10_1101-2021_01_08_425864	329	19	.	.	.
10_1101-2021_01_08_425864	330	1	As	as	IN
10_1101-2021_01_08_425864	330	2	expected	expect	VBN
10_1101-2021_01_08_425864	330	3	,	,	,
10_1101-2021_01_08_425864	330	4	ETO	ETO	NNP
10_1101-2021_01_08_425864	330	5	treatment	treatment	NN
10_1101-2021_01_08_425864	330	6	led	lead	VBD
10_1101-2021_01_08_425864	330	7	to	to	IN
10_1101-2021_01_08_425864	330	8	a	a	DT
10_1101-2021_01_08_425864	330	9	75	75	CD
10_1101-2021_01_08_425864	330	10	%	%	NN
10_1101-2021_01_08_425864	330	11	decrease	decrease	NN
10_1101-2021_01_08_425864	330	12	in	in	IN
10_1101-2021_01_08_425864	330	13	the	the	DT
10_1101-2021_01_08_425864	330	14	516	516	CD
10_1101-2021_01_08_425864	330	15	levels	level	NNS
10_1101-2021_01_08_425864	330	16	of	of	IN
10_1101-2021_01_08_425864	330	17	total	total	JJ
10_1101-2021_01_08_425864	330	18	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	330	19	ATP	ATP	NNP
10_1101-2021_01_08_425864	330	20	compared	compare	VBN
10_1101-2021_01_08_425864	330	21	to	to	IN
10_1101-2021_01_08_425864	330	22	untreated	untreated	JJ
10_1101-2021_01_08_425864	330	23	parasites	parasite	NNS
10_1101-2021_01_08_425864	330	24	(	(	-LRB-
10_1101-2021_01_08_425864	330	25	Fig	Fig	NNP
10_1101-2021_01_08_425864	330	26	10A	10A	NNP
10_1101-2021_01_08_425864	330	27	)	)	-RRB-
10_1101-2021_01_08_425864	330	28	.	.	.
10_1101-2021_01_08_425864	331	1	To	to	TO
10_1101-2021_01_08_425864	331	2	complement	complement	VB
10_1101-2021_01_08_425864	331	3	this	this	DT
10_1101-2021_01_08_425864	331	4	517	517	CD
10_1101-2021_01_08_425864	331	5	result	result	NN
10_1101-2021_01_08_425864	331	6	,	,	,
10_1101-2021_01_08_425864	331	7	because	because	IN
10_1101-2021_01_08_425864	331	8	all	all	PDT
10_1101-2021_01_08_425864	331	9	these	these	DT
10_1101-2021_01_08_425864	331	10	experiments	experiment	NNS
10_1101-2021_01_08_425864	331	11	were	be	VBD
10_1101-2021_01_08_425864	331	12	conducted	conduct	VBN
10_1101-2021_01_08_425864	331	13	in	in	IN
10_1101-2021_01_08_425864	331	14	the	the	DT
10_1101-2021_01_08_425864	331	15	complete	complete	JJ
10_1101-2021_01_08_425864	331	16	absence	absence	NN
10_1101-2021_01_08_425864	331	17	of	of	IN
10_1101-2021_01_08_425864	331	18	an	an	DT
10_1101-2021_01_08_425864	331	19	oxidizable	oxidizable	JJ
10_1101-2021_01_08_425864	331	20	518	518	CD
10_1101-2021_01_08_425864	331	21	external	external	JJ
10_1101-2021_01_08_425864	331	22	metabolite	metabolite	NN
10_1101-2021_01_08_425864	331	23	,	,	,
10_1101-2021_01_08_425864	331	24	our	-PRON-	PRP$
10_1101-2021_01_08_425864	331	25	results	result	NNS
10_1101-2021_01_08_425864	331	26	show	show	VBP
10_1101-2021_01_08_425864	331	27	that	that	IN
10_1101-2021_01_08_425864	331	28	the	the	DT
10_1101-2021_01_08_425864	331	29	parasite	parasite	NN
10_1101-2021_01_08_425864	331	30	is	be	VBZ
10_1101-2021_01_08_425864	331	31	able	able	JJ
10_1101-2021_01_08_425864	331	32	to	to	TO
10_1101-2021_01_08_425864	331	33	oxidize	oxidize	VB
10_1101-2021_01_08_425864	331	34	internal	internal	JJ
10_1101-2021_01_08_425864	331	35	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	331	36	(	(	-LRB-
10_1101-2021_01_08_425864	331	37	Figs	fig	NNS
10_1101-2021_01_08_425864	331	38	10B	10B	NNP
10_1101-2021_01_08_425864	331	39	519	519	CD
10_1101-2021_01_08_425864	331	40	and	and	CC
10_1101-2021_01_08_425864	331	41	10C	10c	CD
10_1101-2021_01_08_425864	331	42	)	)	-RRB-
10_1101-2021_01_08_425864	331	43	.	.	.
10_1101-2021_01_08_425864	332	1	Taking	take	VBG
10_1101-2021_01_08_425864	332	2	into	into	IN
10_1101-2021_01_08_425864	332	3	account	account	NN
10_1101-2021_01_08_425864	332	4	that	that	IN
10_1101-2021_01_08_425864	332	5	treating	treat	VBG
10_1101-2021_01_08_425864	332	6	parasites	parasite	NNS
10_1101-2021_01_08_425864	332	7	with	with	IN
10_1101-2021_01_08_425864	332	8	ETO	ETO	NNP
10_1101-2021_01_08_425864	332	9	diminished	diminish	VBD
10_1101-2021_01_08_425864	332	10	the	the	DT
10_1101-2021_01_08_425864	332	11	basal	basal	NN
10_1101-2021_01_08_425864	332	12	respiration	respiration	NN
10_1101-2021_01_08_425864	332	13	rates	rate	NNS
10_1101-2021_01_08_425864	332	14	520	520	CD
10_1101-2021_01_08_425864	332	15	of	of	IN
10_1101-2021_01_08_425864	332	16	these	these	DT
10_1101-2021_01_08_425864	332	17	parasites	parasite	NNS
10_1101-2021_01_08_425864	332	18	by	by	IN
10_1101-2021_01_08_425864	332	19	approximately	approximately	RB
10_1101-2021_01_08_425864	332	20	one	one	CD
10_1101-2021_01_08_425864	332	21	-	-	HYPH
10_1101-2021_01_08_425864	332	22	half	half	NN
10_1101-2021_01_08_425864	332	23	(	(	-LRB-
10_1101-2021_01_08_425864	332	24	Figs	fig	NNS
10_1101-2021_01_08_425864	332	25	10B	10B	NNP
10_1101-2021_01_08_425864	332	26	and	and	CC
10_1101-2021_01_08_425864	332	27	10C	10c	CD
10_1101-2021_01_08_425864	332	28	)	)	-RRB-
10_1101-2021_01_08_425864	332	29	,	,	,
10_1101-2021_01_08_425864	332	30	it	-PRON-	PRP
10_1101-2021_01_08_425864	332	31	is	be	VBZ
10_1101-2021_01_08_425864	332	32	reasonable	reasonable	JJ
10_1101-2021_01_08_425864	332	33	to	to	TO
10_1101-2021_01_08_425864	332	34	conclude	conclude	VB
10_1101-2021_01_08_425864	332	35	that	that	IN
10_1101-2021_01_08_425864	332	36	a	a	DT
10_1101-2021_01_08_425864	332	37	521	521	CD
10_1101-2021_01_08_425864	332	38	relevant	relevant	JJ
10_1101-2021_01_08_425864	332	39	part	part	NN
10_1101-2021_01_08_425864	332	40	of	of	IN
10_1101-2021_01_08_425864	332	41	the	the	DT
10_1101-2021_01_08_425864	332	42	respiration	respiration	NN
10_1101-2021_01_08_425864	332	43	in	in	IN
10_1101-2021_01_08_425864	332	44	the	the	DT
10_1101-2021_01_08_425864	332	45	absence	absence	NN
10_1101-2021_01_08_425864	332	46	of	of	IN
10_1101-2021_01_08_425864	332	47	external	external	JJ
10_1101-2021_01_08_425864	332	48	oxidisable	oxidisable	JJ
10_1101-2021_01_08_425864	332	49	metabolites	metabolite	NNS
10_1101-2021_01_08_425864	332	50	is	be	VBZ
10_1101-2021_01_08_425864	332	51	based	base	VBN
10_1101-2021_01_08_425864	332	52	on	on	IN
10_1101-2021_01_08_425864	332	53	the	the	DT
10_1101-2021_01_08_425864	332	54	522	522	CD
10_1101-2021_01_08_425864	332	55	consumption	consumption	NN
10_1101-2021_01_08_425864	332	56	of	of	IN
10_1101-2021_01_08_425864	332	57	internal	internal	JJ
10_1101-2021_01_08_425864	332	58	lipids	lipid	NNS
10_1101-2021_01_08_425864	332	59	.	.	.
10_1101-2021_01_08_425864	333	1	This	this	DT
10_1101-2021_01_08_425864	333	2	is	be	VBZ
10_1101-2021_01_08_425864	333	3	consistent	consistent	JJ
10_1101-2021_01_08_425864	333	4	with	with	IN
10_1101-2021_01_08_425864	333	5	the	the	DT
10_1101-2021_01_08_425864	333	6	confirmation	confirmation	NN
10_1101-2021_01_08_425864	333	7	that	that	WDT
10_1101-2021_01_08_425864	333	8	epimastigotes	epimastigote	VBZ
10_1101-2021_01_08_425864	333	9	maintain	maintain	VBP
10_1101-2021_01_08_425864	333	10	523	523	CD
10_1101-2021_01_08_425864	333	11	their	-PRON-	PRP$
10_1101-2021_01_08_425864	333	12	viability	viability	NN
10_1101-2021_01_08_425864	333	13	in	in	IN
10_1101-2021_01_08_425864	333	14	the	the	DT
10_1101-2021_01_08_425864	333	15	presence	presence	NN
10_1101-2021_01_08_425864	333	16	of	of	IN
10_1101-2021_01_08_425864	333	17	non	non	JJ
10_1101-2021_01_08_425864	333	18	-	-	JJ
10_1101-2021_01_08_425864	333	19	fatty	fatty	JJ
10_1101-2021_01_08_425864	333	20	acid	acid	NN
10_1101-2021_01_08_425864	333	21	carbon	carbon	NN
10_1101-2021_01_08_425864	333	22	sources	source	NNS
10_1101-2021_01_08_425864	333	23	in	in	IN
10_1101-2021_01_08_425864	333	24	the	the	DT
10_1101-2021_01_08_425864	333	25	presence	presence	NN
10_1101-2021_01_08_425864	333	26	of	of	IN
10_1101-2021_01_08_425864	333	27	ETO	ETO	NNP
10_1101-2021_01_08_425864	333	28	(	(	-LRB-
10_1101-2021_01_08_425864	333	29	S4	S4	NNP
10_1101-2021_01_08_425864	333	30	Fig	Fig	NNP
10_1101-2021_01_08_425864	333	31	)	)	-RRB-
10_1101-2021_01_08_425864	333	32	.	.	.
10_1101-2021_01_08_425864	334	1	In	in	IN
10_1101-2021_01_08_425864	334	2	524	524	CD
10_1101-2021_01_08_425864	334	3	summary	summary	NN
10_1101-2021_01_08_425864	334	4	,	,	,
10_1101-2021_01_08_425864	334	5	these	these	DT
10_1101-2021_01_08_425864	334	6	results	result	NNS
10_1101-2021_01_08_425864	334	7	confirm	confirm	VBP
10_1101-2021_01_08_425864	334	8	that	that	IN
10_1101-2021_01_08_425864	334	9	ETO	ETO	NNP
10_1101-2021_01_08_425864	334	10	is	be	VBZ
10_1101-2021_01_08_425864	334	11	interfering	interfere	VBG
10_1101-2021_01_08_425864	334	12	with	with	IN
10_1101-2021_01_08_425864	334	13	ATP	ATP	NNP
10_1101-2021_01_08_425864	334	14	synthesis	synthesis	NN
10_1101-2021_01_08_425864	334	15	through	through	IN
10_1101-2021_01_08_425864	334	16	oxidative	oxidative	JJ
10_1101-2021_01_08_425864	334	17	525	525	CD
10_1101-2021_01_08_425864	334	18	phosphorylation	phosphorylation	NN
10_1101-2021_01_08_425864	334	19	in	in	IN
10_1101-2021_01_08_425864	334	20	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	334	21	forms	form	NNS
10_1101-2021_01_08_425864	334	22	.	.	.
10_1101-2021_01_08_425864	335	1	526	526	CD
10_1101-2021_01_08_425864	335	2	527	527	CD
10_1101-2021_01_08_425864	335	3	Figure	figure	NN
10_1101-2021_01_08_425864	335	4	10	10	CD
10_1101-2021_01_08_425864	335	5	.	.	.
10_1101-2021_01_08_425864	336	1	Effects	effect	NNS
10_1101-2021_01_08_425864	336	2	of	of	IN
10_1101-2021_01_08_425864	336	3	ETO	eto	NN
10_1101-2021_01_08_425864	336	4	on	on	IN
10_1101-2021_01_08_425864	336	5	respiration	respiration	NN
10_1101-2021_01_08_425864	336	6	and	and	CC
10_1101-2021_01_08_425864	336	7	ATP	atp	NN
10_1101-2021_01_08_425864	336	8	production	production	NN
10_1101-2021_01_08_425864	336	9	in	in	IN
10_1101-2021_01_08_425864	336	10	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	336	11	forms	form	NNS
10_1101-2021_01_08_425864	336	12	of	of	IN
10_1101-2021_01_08_425864	336	13	T.	T.	NNP
10_1101-2021_01_08_425864	336	14	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	336	15	.	.	.
10_1101-2021_01_08_425864	337	1	528	528	CD
10_1101-2021_01_08_425864	337	2	(	(	-LRB-
10_1101-2021_01_08_425864	337	3	A	a	DT
10_1101-2021_01_08_425864	337	4	)	)	-RRB-
10_1101-2021_01_08_425864	337	5	Oxygen	oxygen	NN
10_1101-2021_01_08_425864	337	6	consumption	consumption	NN
10_1101-2021_01_08_425864	337	7	of	of	IN
10_1101-2021_01_08_425864	337	8	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	337	9	forms	form	NNS
10_1101-2021_01_08_425864	337	10	after	after	IN
10_1101-2021_01_08_425864	337	11	normal	normal	JJ
10_1101-2021_01_08_425864	337	12	growth	growth	NN
10_1101-2021_01_08_425864	337	13	in	in	IN
10_1101-2021_01_08_425864	337	14	LIT	LIT	NNP
10_1101-2021_01_08_425864	337	15	medium	medium	NN
10_1101-2021_01_08_425864	337	16	.	.	.
10_1101-2021_01_08_425864	338	1	(	(	-LRB-
10_1101-2021_01_08_425864	338	2	B	b	NN
10_1101-2021_01_08_425864	338	3	)	)	-RRB-
10_1101-2021_01_08_425864	338	4	Oxygen	Oxygen	NNP
10_1101-2021_01_08_425864	338	5	529	529	CD
10_1101-2021_01_08_425864	338	6	consumption	consumption	NN
10_1101-2021_01_08_425864	338	7	after	after	IN
10_1101-2021_01_08_425864	338	8	ETO	ETO	NNP
10_1101-2021_01_08_425864	338	9	500	500	CD
10_1101-2021_01_08_425864	338	10	μM	μM	NNP
10_1101-2021_01_08_425864	338	11	treatment	treatment	NN
10_1101-2021_01_08_425864	338	12	.	.	.
10_1101-2021_01_08_425864	339	1	Parasite	parasite	VB
10_1101-2021_01_08_425864	339	2	growth	growth	NN
10_1101-2021_01_08_425864	339	3	in	in	IN
10_1101-2021_01_08_425864	339	4	LIT	LIT	NNP
10_1101-2021_01_08_425864	339	5	medium	medium	NN
10_1101-2021_01_08_425864	339	6	with	with	IN
10_1101-2021_01_08_425864	339	7	the	the	DT
10_1101-2021_01_08_425864	339	8	compound	compound	NN
10_1101-2021_01_08_425864	339	9	until	until	IN
10_1101-2021_01_08_425864	339	10	530	530	CD
10_1101-2021_01_08_425864	339	11	the	the	DT
10_1101-2021_01_08_425864	339	12	5th	5th	JJ
10_1101-2021_01_08_425864	339	13	day	day	NN
10_1101-2021_01_08_425864	339	14	.	.	.
10_1101-2021_01_08_425864	340	1	In	in	IN
10_1101-2021_01_08_425864	340	2	black	black	JJ
10_1101-2021_01_08_425864	340	3	,	,	,
10_1101-2021_01_08_425864	340	4	a	a	DT
10_1101-2021_01_08_425864	340	5	time	time	NN
10_1101-2021_01_08_425864	340	6	-	-	HYPH
10_1101-2021_01_08_425864	340	7	course	course	NN
10_1101-2021_01_08_425864	340	8	register	register	NN
10_1101-2021_01_08_425864	340	9	of	of	IN
10_1101-2021_01_08_425864	340	10	the	the	DT
10_1101-2021_01_08_425864	340	11	concentration	concentration	NN
10_1101-2021_01_08_425864	340	12	(	(	-LRB-
10_1101-2021_01_08_425864	340	13	pmols	pmols	NNP
10_1101-2021_01_08_425864	340	14	)	)	-RRB-
10_1101-2021_01_08_425864	340	15	of	of	IN
10_1101-2021_01_08_425864	340	16	O2	o2	NN
10_1101-2021_01_08_425864	340	17	in	in	IN
10_1101-2021_01_08_425864	340	18	the	the	DT
10_1101-2021_01_08_425864	340	19	respiration	respiration	NN
10_1101-2021_01_08_425864	340	20	531	531	CD
10_1101-2021_01_08_425864	340	21	chamber	chamber	NN
10_1101-2021_01_08_425864	340	22	.	.	.
10_1101-2021_01_08_425864	341	1	In	in	IN
10_1101-2021_01_08_425864	341	2	blue	blue	JJ
10_1101-2021_01_08_425864	341	3	,	,	,
10_1101-2021_01_08_425864	341	4	negative	negative	JJ
10_1101-2021_01_08_425864	341	5	of	of	IN
10_1101-2021_01_08_425864	341	6	the	the	DT
10_1101-2021_01_08_425864	341	7	concentration	concentration	NN
10_1101-2021_01_08_425864	341	8	derivative	derivative	JJ
10_1101-2021_01_08_425864	341	9	(	(	-LRB-
10_1101-2021_01_08_425864	341	10	pmols	pmols	NNP
10_1101-2021_01_08_425864	341	11	)	)	-RRB-
10_1101-2021_01_08_425864	341	12	of	of	IN
10_1101-2021_01_08_425864	341	13	O2	o2	NN
10_1101-2021_01_08_425864	341	14	with	with	IN
10_1101-2021_01_08_425864	341	15	respect	respect	NN
10_1101-2021_01_08_425864	341	16	to	to	IN
10_1101-2021_01_08_425864	341	17	time	time	NN
10_1101-2021_01_08_425864	341	18	(	(	-LRB-
10_1101-2021_01_08_425864	341	19	velocity	velocity	NN
10_1101-2021_01_08_425864	341	20	532	532	CD
10_1101-2021_01_08_425864	341	21	of	of	IN
10_1101-2021_01_08_425864	341	22	O2	O2	NNP
10_1101-2021_01_08_425864	341	23	consumption	consumption	NN
10_1101-2021_01_08_425864	341	24	in	in	IN
10_1101-2021_01_08_425864	341	25	pmoles	pmole	NNS
10_1101-2021_01_08_425864	341	26	per	per	IN
10_1101-2021_01_08_425864	341	27	second	second	NN
10_1101-2021_01_08_425864	341	28	)	)	-RRB-
10_1101-2021_01_08_425864	341	29	.	.	.
10_1101-2021_01_08_425864	342	1	The	the	DT
10_1101-2021_01_08_425864	342	2	parasites	parasite	NNS
10_1101-2021_01_08_425864	342	3	were	be	VBD
10_1101-2021_01_08_425864	342	4	washed	wash	VBN
10_1101-2021_01_08_425864	342	5	twice	twice	RB
10_1101-2021_01_08_425864	342	6	in	in	IN
10_1101-2021_01_08_425864	342	7	PBS	PBS	NNP
10_1101-2021_01_08_425864	342	8	and	and	CC
10_1101-2021_01_08_425864	342	9	kept	keep	VBD
10_1101-2021_01_08_425864	342	10	in	in	IN
10_1101-2021_01_08_425864	342	11	MRC	MRC	NNP
10_1101-2021_01_08_425864	342	12	533	533	CD
10_1101-2021_01_08_425864	342	13	buffer	buffer	NN
10_1101-2021_01_08_425864	342	14	at	at	IN
10_1101-2021_01_08_425864	342	15	28	28	CD
10_1101-2021_01_08_425864	342	16	°	°	,
10_1101-2021_01_08_425864	342	17	C	C	NNP
10_1101-2021_01_08_425864	342	18	during	during	IN
10_1101-2021_01_08_425864	342	19	the	the	DT
10_1101-2021_01_08_425864	342	20	assays	assay	NNS
10_1101-2021_01_08_425864	342	21	(	(	-LRB-
10_1101-2021_01_08_425864	342	22	see	see	VB
10_1101-2021_01_08_425864	342	23	Materials	material	NNS
10_1101-2021_01_08_425864	342	24	and	and	CC
10_1101-2021_01_08_425864	342	25	Methods	Methods	NNPS
10_1101-2021_01_08_425864	342	26	for	for	IN
10_1101-2021_01_08_425864	342	27	more	more	JJR
10_1101-2021_01_08_425864	342	28	details	detail	NNS
10_1101-2021_01_08_425864	342	29	)	)	-RRB-
10_1101-2021_01_08_425864	342	30	.	.	.
10_1101-2021_01_08_425864	343	1	(	(	-LRB-
10_1101-2021_01_08_425864	343	2	C	C	NNP
10_1101-2021_01_08_425864	343	3	)	)	-RRB-
10_1101-2021_01_08_425864	343	4	The	the	DT
10_1101-2021_01_08_425864	343	5	basal	basal	NN
10_1101-2021_01_08_425864	343	6	534	534	CD
10_1101-2021_01_08_425864	343	7	respiration	respiration	NN
10_1101-2021_01_08_425864	343	8	(	(	-LRB-
10_1101-2021_01_08_425864	343	9	initial	initial	JJ
10_1101-2021_01_08_425864	343	10	oxygen	oxygen	NN
10_1101-2021_01_08_425864	343	11	flux	flux	NN
10_1101-2021_01_08_425864	343	12	values	value	NNS
10_1101-2021_01_08_425864	343	13	,	,	,
10_1101-2021_01_08_425864	343	14	MRC	MRC	NNP
10_1101-2021_01_08_425864	343	15	)	)	-RRB-
10_1101-2021_01_08_425864	343	16	,	,	,
10_1101-2021_01_08_425864	343	17	respiration	respiration	NN
10_1101-2021_01_08_425864	343	18	leak	leak	NN
10_1101-2021_01_08_425864	343	19	after	after	IN
10_1101-2021_01_08_425864	343	20	the	the	DT
10_1101-2021_01_08_425864	343	21	sequential	sequential	JJ
10_1101-2021_01_08_425864	343	22	addition	addition	NN
10_1101-2021_01_08_425864	343	23	of	of	IN
10_1101-2021_01_08_425864	343	24	0.5	0.5	CD
10_1101-2021_01_08_425864	343	25	535	535	CD
10_1101-2021_01_08_425864	343	26	µg	µg	IN
10_1101-2021_01_08_425864	343	27	/	/	SYM
10_1101-2021_01_08_425864	343	28	mL	ml	NN
10_1101-2021_01_08_425864	343	29	of	of	IN
10_1101-2021_01_08_425864	343	30	oligomycin	oligomycin	NNP
10_1101-2021_01_08_425864	343	31	A	a	NN
10_1101-2021_01_08_425864	343	32	(	(	-LRB-
10_1101-2021_01_08_425864	343	33	2	2	CD
10_1101-2021_01_08_425864	343	34	µg	µg	NN
10_1101-2021_01_08_425864	343	35	/	/	SYM
10_1101-2021_01_08_425864	343	36	mL	ml	NN
10_1101-2021_01_08_425864	343	37	)	)	-RRB-
10_1101-2021_01_08_425864	343	38	,	,	,
10_1101-2021_01_08_425864	343	39	and	and	CC
10_1101-2021_01_08_425864	343	40	electron	electron	NN
10_1101-2021_01_08_425864	343	41	transfer	transfer	NN
10_1101-2021_01_08_425864	343	42	system	system	NN
10_1101-2021_01_08_425864	343	43	(	(	-LRB-
10_1101-2021_01_08_425864	343	44	ETS	ETS	NNP
10_1101-2021_01_08_425864	343	45	)	)	-RRB-
10_1101-2021_01_08_425864	343	46	capacity	capacity	NN
10_1101-2021_01_08_425864	343	47	after	after	IN
10_1101-2021_01_08_425864	343	48	the	the	DT
10_1101-2021_01_08_425864	343	49	sequential	sequential	JJ
10_1101-2021_01_08_425864	343	50	536	536	CD
10_1101-2021_01_08_425864	343	51	addition	addition	NN
10_1101-2021_01_08_425864	343	52	of	of	IN
10_1101-2021_01_08_425864	343	53	0.5	0.5	CD
10_1101-2021_01_08_425864	343	54	µM	µM	NNP
10_1101-2021_01_08_425864	343	55	FCCP	FCCP	NNP
10_1101-2021_01_08_425864	343	56	(	(	-LRB-
10_1101-2021_01_08_425864	343	57	2	2	CD
10_1101-2021_01_08_425864	343	58	µM	µM	NNP
10_1101-2021_01_08_425864	343	59	)	)	-RRB-
10_1101-2021_01_08_425864	343	60	were	be	VBD
10_1101-2021_01_08_425864	343	61	measured	measure	VBN
10_1101-2021_01_08_425864	343	62	for	for	IN
10_1101-2021_01_08_425864	343	63	each	each	DT
10_1101-2021_01_08_425864	343	64	condition	condition	NN
10_1101-2021_01_08_425864	343	65	.	.	.
10_1101-2021_01_08_425864	344	1	(	(	-LRB-
10_1101-2021_01_08_425864	344	2	D	d	NN
10_1101-2021_01_08_425864	344	3	)	)	-RRB-
10_1101-2021_01_08_425864	344	4	Intracellular	intracellular	JJ
10_1101-2021_01_08_425864	344	5	levels	level	NNS
10_1101-2021_01_08_425864	344	6	of	of	IN
10_1101-2021_01_08_425864	344	7	ATP	ATP	NNP
10_1101-2021_01_08_425864	344	8	537	537	CD
10_1101-2021_01_08_425864	344	9	after	after	IN
10_1101-2021_01_08_425864	344	10	treating	treat	VBG
10_1101-2021_01_08_425864	344	11	with	with	IN
10_1101-2021_01_08_425864	344	12	500	500	CD
10_1101-2021_01_08_425864	344	13	µM	µM	NNP
10_1101-2021_01_08_425864	344	14	ETO	ETO	NNP
10_1101-2021_01_08_425864	344	15	.	.	.
10_1101-2021_01_08_425864	345	1	The	the	DT
10_1101-2021_01_08_425864	345	2	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	345	3	ATP	atp	NN
10_1101-2021_01_08_425864	345	4	content	content	NN
10_1101-2021_01_08_425864	345	5	was	be	VBD
10_1101-2021_01_08_425864	345	6	assessed	assess	VBN
10_1101-2021_01_08_425864	345	7	following	follow	VBG
10_1101-2021_01_08_425864	345	8	incubation	incubation	NN
10_1101-2021_01_08_425864	345	9	538	538	CD
10_1101-2021_01_08_425864	345	10	with	with	IN
10_1101-2021_01_08_425864	345	11	different	different	JJ
10_1101-2021_01_08_425864	345	12	energy	energy	NN
10_1101-2021_01_08_425864	345	13	substrates	substrate	NNS
10_1101-2021_01_08_425864	345	14	or	or	CC
10_1101-2021_01_08_425864	345	15	not	not	RB
10_1101-2021_01_08_425864	345	16	(	(	-LRB-
10_1101-2021_01_08_425864	345	17	PBS	PBS	NNP
10_1101-2021_01_08_425864	345	18	,	,	,
10_1101-2021_01_08_425864	345	19	negative	negative	JJ
10_1101-2021_01_08_425864	345	20	control	control	NN
10_1101-2021_01_08_425864	345	21	)	)	-RRB-
10_1101-2021_01_08_425864	345	22	.	.	.
10_1101-2021_01_08_425864	346	1	The	the	DT
10_1101-2021_01_08_425864	346	2	ATP	ATP	NNP
10_1101-2021_01_08_425864	346	3	concentration	concentration	NN
10_1101-2021_01_08_425864	346	4	was	be	VBD
10_1101-2021_01_08_425864	346	5	539	539	CD
10_1101-2021_01_08_425864	346	6	determined	determine	VBN
10_1101-2021_01_08_425864	346	7	by	by	IN
10_1101-2021_01_08_425864	346	8	luciferase	luciferase	NN
10_1101-2021_01_08_425864	346	9	assay	assay	NNP
10_1101-2021_01_08_425864	346	10	and	and	CC
10_1101-2021_01_08_425864	346	11	the	the	DT
10_1101-2021_01_08_425864	346	12	data	datum	NNS
10_1101-2021_01_08_425864	346	13	were	be	VBD
10_1101-2021_01_08_425864	346	14	adjusted	adjust	VBN
10_1101-2021_01_08_425864	346	15	by	by	IN
10_1101-2021_01_08_425864	346	16	the	the	DT
10_1101-2021_01_08_425864	346	17	number	number	NN
10_1101-2021_01_08_425864	346	18	of	of	IN
10_1101-2021_01_08_425864	346	19	cells	cell	NNS
10_1101-2021_01_08_425864	346	20	.	.	.
10_1101-2021_01_08_425864	347	1	All	all	PDT
10_1101-2021_01_08_425864	347	2	the	the	DT
10_1101-2021_01_08_425864	347	3	experiments	experiment	NNS
10_1101-2021_01_08_425864	347	4	540	540	CD
10_1101-2021_01_08_425864	347	5	were	be	VBD
10_1101-2021_01_08_425864	347	6	performed	perform	VBN
10_1101-2021_01_08_425864	347	7	in	in	IN
10_1101-2021_01_08_425864	347	8	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	347	9	.	.	.
10_1101-2021_01_08_425864	348	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	348	2	analysis	analysis	NN
10_1101-2021_01_08_425864	348	3	was	be	VBD
10_1101-2021_01_08_425864	348	4	performed	perform	VBN
10_1101-2021_01_08_425864	348	5	with	with	IN
10_1101-2021_01_08_425864	348	6	one	one	CD
10_1101-2021_01_08_425864	348	7	-	-	HYPH
10_1101-2021_01_08_425864	348	8	way	way	NN
10_1101-2021_01_08_425864	348	9	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	348	10	followed	follow	VBN
10_1101-2021_01_08_425864	348	11	by	by	IN
10_1101-2021_01_08_425864	348	12	541	541	CD
10_1101-2021_01_08_425864	348	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	348	14	's	's	POS
10_1101-2021_01_08_425864	348	15	post	post	JJ
10_1101-2021_01_08_425864	348	16	-	-	NN
10_1101-2021_01_08_425864	348	17	test	test	NN
10_1101-2021_01_08_425864	348	18	at	at	IN
10_1101-2021_01_08_425864	348	19	p	p	NN
10_1101-2021_01_08_425864	348	20	<	<	XX
10_1101-2021_01_08_425864	348	21	0.05	0.05	XX
10_1101-2021_01_08_425864	348	22	using	use	VBG
10_1101-2021_01_08_425864	348	23	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	348	24	Prism	Prism	NNP
10_1101-2021_01_08_425864	348	25	8.0.2	8.0.2	CD
10_1101-2021_01_08_425864	348	26	software	software	NN
10_1101-2021_01_08_425864	348	27	.	.	.
10_1101-2021_01_08_425864	349	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	349	2	represent	represent	VBP
10_1101-2021_01_08_425864	349	3	the	the	DT
10_1101-2021_01_08_425864	349	4	level	level	NN
10_1101-2021_01_08_425864	349	5	of	of	IN
10_1101-2021_01_08_425864	349	6	statistical	statistical	JJ
10_1101-2021_01_08_425864	349	7	542	542	CD
10_1101-2021_01_08_425864	349	8	significance	significance	NN
10_1101-2021_01_08_425864	349	9	as	as	IN
10_1101-2021_01_08_425864	349	10	follows	follow	VBZ
10_1101-2021_01_08_425864	349	11	:	:	:
10_1101-2021_01_08_425864	349	12	*	*	NFP
10_1101-2021_01_08_425864	349	13	*	*	NFP
10_1101-2021_01_08_425864	349	14	*	*	NFP
10_1101-2021_01_08_425864	349	15	p	p	NN
10_1101-2021_01_08_425864	349	16	value	value	NN
10_1101-2021_01_08_425864	349	17	<	<	XX
10_1101-2021_01_08_425864	349	18	0.001	0.001	CD
10_1101-2021_01_08_425864	349	19	;	;	:
10_1101-2021_01_08_425864	349	20	*	*	NFP
10_1101-2021_01_08_425864	349	21	*	*	NFP
10_1101-2021_01_08_425864	349	22	p	p	NN
10_1101-2021_01_08_425864	349	23	value	value	NN
10_1101-2021_01_08_425864	349	24	<	<	XX
10_1101-2021_01_08_425864	349	25	0.01	0.01	XX
10_1101-2021_01_08_425864	349	26	;	;	:
10_1101-2021_01_08_425864	349	27	and	and	CC
10_1101-2021_01_08_425864	349	28	*	*	NFP
10_1101-2021_01_08_425864	349	29	p	p	NN
10_1101-2021_01_08_425864	349	30	value	value	NN
10_1101-2021_01_08_425864	349	31	<	<	XX
10_1101-2021_01_08_425864	349	32	0.05	0.05	CD
10_1101-2021_01_08_425864	349	33	.	.	.
10_1101-2021_01_08_425864	350	1	For	for	IN
10_1101-2021_01_08_425864	350	2	p	p	NN
10_1101-2021_01_08_425864	350	3	values	value	NNS
10_1101-2021_01_08_425864	350	4	>	>	XX
10_1101-2021_01_08_425864	350	5	543	543	CD
10_1101-2021_01_08_425864	350	6	0.05	0.05	CD
10_1101-2021_01_08_425864	350	7	,	,	,
10_1101-2021_01_08_425864	350	8	we	-PRON-	PRP
10_1101-2021_01_08_425864	350	9	consider	consider	VBP
10_1101-2021_01_08_425864	350	10	the	the	DT
10_1101-2021_01_08_425864	350	11	differences	difference	NNS
10_1101-2021_01_08_425864	350	12	not	not	RB
10_1101-2021_01_08_425864	350	13	significant	significant	JJ
10_1101-2021_01_08_425864	350	14	(	(	-LRB-
10_1101-2021_01_08_425864	350	15	ns	ns	NNP
10_1101-2021_01_08_425864	350	16	)	)	-RRB-
10_1101-2021_01_08_425864	350	17	.	.	.
10_1101-2021_01_08_425864	351	1	544	544	CD
10_1101-2021_01_08_425864	351	2	545	545	CD
10_1101-2021_01_08_425864	351	3	Endogenous	endogenous	JJ
10_1101-2021_01_08_425864	351	4	fatty	fatty	NN
10_1101-2021_01_08_425864	351	5	acids	acid	NNS
10_1101-2021_01_08_425864	351	6	contribute	contribute	VBP
10_1101-2021_01_08_425864	351	7	to	to	IN
10_1101-2021_01_08_425864	351	8	long	long	JJ
10_1101-2021_01_08_425864	351	9	-	-	HYPH
10_1101-2021_01_08_425864	351	10	term	term	NN
10_1101-2021_01_08_425864	351	11	starvation	starvation	NN
10_1101-2021_01_08_425864	351	12	resistance	resistance	NN
10_1101-2021_01_08_425864	351	13	in	in	IN
10_1101-2021_01_08_425864	351	14	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	351	15	forms	form	NNS
10_1101-2021_01_08_425864	351	16	.CC	.CC	:
10_1101-2021_01_08_425864	351	17	-	-	:
10_1101-2021_01_08_425864	351	18	BY	by	IN
10_1101-2021_01_08_425864	351	19	4.0	4.0	CD
10_1101-2021_01_08_425864	351	20	International	international	JJ
10_1101-2021_01_08_425864	351	21	licensemade	licensemade	NN
10_1101-2021_01_08_425864	351	22	available	available	JJ
10_1101-2021_01_08_425864	351	23	under	under	IN
10_1101-2021_01_08_425864	351	24	a	a	DT
10_1101-2021_01_08_425864	351	25	(	(	-LRB-
10_1101-2021_01_08_425864	351	26	which	which	WDT
10_1101-2021_01_08_425864	351	27	was	be	VBD
10_1101-2021_01_08_425864	351	28	not	not	RB
10_1101-2021_01_08_425864	351	29	certified	certify	VBN
10_1101-2021_01_08_425864	351	30	by	by	IN
10_1101-2021_01_08_425864	351	31	peer	peer	NN
10_1101-2021_01_08_425864	351	32	review	review	NN
10_1101-2021_01_08_425864	351	33	)	)	-RRB-
10_1101-2021_01_08_425864	351	34	is	be	VBZ
10_1101-2021_01_08_425864	351	35	the	the	DT
10_1101-2021_01_08_425864	351	36	author	author	NN
10_1101-2021_01_08_425864	351	37	/	/	SYM
10_1101-2021_01_08_425864	351	38	funder	funder	NN
10_1101-2021_01_08_425864	351	39	,	,	,
10_1101-2021_01_08_425864	351	40	who	who	WP
10_1101-2021_01_08_425864	351	41	has	have	VBZ
10_1101-2021_01_08_425864	351	42	granted	grant	VBN
10_1101-2021_01_08_425864	351	43	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	351	44	a	a	DT
10_1101-2021_01_08_425864	351	45	license	license	NN
10_1101-2021_01_08_425864	351	46	to	to	TO
10_1101-2021_01_08_425864	351	47	display	display	VB
10_1101-2021_01_08_425864	351	48	the	the	DT
10_1101-2021_01_08_425864	351	49	preprint	preprint	NN
10_1101-2021_01_08_425864	351	50	in	in	IN
10_1101-2021_01_08_425864	351	51	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	351	52	.	.	.
10_1101-2021_01_08_425864	352	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	352	2	is	be	VBZ
10_1101-2021_01_08_425864	352	3	The	the	DT
10_1101-2021_01_08_425864	352	4	copyright	copyright	NN
10_1101-2021_01_08_425864	352	5	holder	holder	NN
10_1101-2021_01_08_425864	352	6	for	for	IN
10_1101-2021_01_08_425864	352	7	this	this	DT
10_1101-2021_01_08_425864	352	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	352	9	version	version	NN
10_1101-2021_01_08_425864	352	10	posted	post	VBD
10_1101-2021_01_08_425864	352	11	January	January	NNP
10_1101-2021_01_08_425864	352	12	8	8	CD
10_1101-2021_01_08_425864	352	13	,	,	,
10_1101-2021_01_08_425864	352	14	2021	2021	CD
10_1101-2021_01_08_425864	352	15	.	.	.
10_1101-2021_01_08_425864	352	16	;	;	:
10_1101-2021_01_08_425864	352	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	352	18	:	:	:
10_1101-2021_01_08_425864	352	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	352	20	preprint	preprint	NN
10_1101-2021_01_08_425864	352	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	352	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	352	23	546	546	CD
10_1101-2021_01_08_425864	352	24	As	as	RB
10_1101-2021_01_08_425864	352	25	previously	previously	RB
10_1101-2021_01_08_425864	352	26	demonstrated	demonstrate	VBN
10_1101-2021_01_08_425864	352	27	,	,	,
10_1101-2021_01_08_425864	352	28	ETO	ETO	NNP
10_1101-2021_01_08_425864	352	29	interferes	interfere	VBZ
10_1101-2021_01_08_425864	352	30	with	with	IN
10_1101-2021_01_08_425864	352	31	the	the	DT
10_1101-2021_01_08_425864	352	32	consumption	consumption	NN
10_1101-2021_01_08_425864	352	33	of	of	IN
10_1101-2021_01_08_425864	352	34	endogenous	endogenous	JJ
10_1101-2021_01_08_425864	352	35	fatty	fatty	NN
10_1101-2021_01_08_425864	352	36	acids	acid	NNS
10_1101-2021_01_08_425864	352	37	,	,	,
10_1101-2021_01_08_425864	352	38	547	547	CD
10_1101-2021_01_08_425864	352	39	and	and	CC
10_1101-2021_01_08_425864	352	40	this	this	DT
10_1101-2021_01_08_425864	352	41	impairment	impairment	NN
10_1101-2021_01_08_425864	352	42	causes	cause	VBZ
10_1101-2021_01_08_425864	352	43	ATP	atp	NN
10_1101-2021_01_08_425864	352	44	depletion	depletion	NN
10_1101-2021_01_08_425864	352	45	and	and	CC
10_1101-2021_01_08_425864	352	46	cell	cell	NN
10_1101-2021_01_08_425864	352	47	cycle	cycle	NN
10_1101-2021_01_08_425864	352	48	arrest	arrest	NN
10_1101-2021_01_08_425864	352	49	.	.	.
10_1101-2021_01_08_425864	353	1	One	one	CD
10_1101-2021_01_08_425864	353	2	intriguing	intriguing	JJ
10_1101-2021_01_08_425864	353	3	characteristic	characteristic	NN
10_1101-2021_01_08_425864	353	4	of	of	IN
10_1101-2021_01_08_425864	353	5	the	the	DT
10_1101-2021_01_08_425864	353	6	548	548	CD
10_1101-2021_01_08_425864	353	7	insect	insect	NN
10_1101-2021_01_08_425864	353	8	stages	stage	NNS
10_1101-2021_01_08_425864	353	9	of	of	IN
10_1101-2021_01_08_425864	353	10	T.	T.	NNP
10_1101-2021_01_08_425864	353	11	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	353	12	is	be	VBZ
10_1101-2021_01_08_425864	353	13	their	-PRON-	PRP$
10_1101-2021_01_08_425864	353	14	resistance	resistance	NN
10_1101-2021_01_08_425864	353	15	to	to	IN
10_1101-2021_01_08_425864	353	16	starvation	starvation	NN
10_1101-2021_01_08_425864	353	17	.	.	.
10_1101-2021_01_08_425864	354	1	To	to	TO
10_1101-2021_01_08_425864	354	2	observe	observe	VB
10_1101-2021_01_08_425864	354	3	the	the	DT
10_1101-2021_01_08_425864	354	4	importance	importance	NN
10_1101-2021_01_08_425864	354	5	of	of	IN
10_1101-2021_01_08_425864	354	6	internal	internal	JJ
10_1101-2021_01_08_425864	354	7	fatty	fatty	NN
10_1101-2021_01_08_425864	354	8	549	549	CD
10_1101-2021_01_08_425864	354	9	acids	acid	NNS
10_1101-2021_01_08_425864	354	10	in	in	IN
10_1101-2021_01_08_425864	354	11	this	this	DT
10_1101-2021_01_08_425864	354	12	process	process	NN
10_1101-2021_01_08_425864	354	13	,	,	,
10_1101-2021_01_08_425864	354	14	we	-PRON-	PRP
10_1101-2021_01_08_425864	354	15	incubated	incubate	VBD
10_1101-2021_01_08_425864	354	16	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	354	17	in	in	IN
10_1101-2021_01_08_425864	354	18	PBS	PBS	NNP
10_1101-2021_01_08_425864	354	19	in	in	IN
10_1101-2021_01_08_425864	354	20	the	the	DT
10_1101-2021_01_08_425864	354	21	presence	presence	NN
10_1101-2021_01_08_425864	354	22	(	(	-LRB-
10_1101-2021_01_08_425864	354	23	or	or	CC
10_1101-2021_01_08_425864	354	24	absence	absence	VB
10_1101-2021_01_08_425864	354	25	)	)	-RRB-
10_1101-2021_01_08_425864	354	26	of	of	IN
10_1101-2021_01_08_425864	354	27	500	500	CD
10_1101-2021_01_08_425864	354	28	μM	μM	NNP
10_1101-2021_01_08_425864	354	29	ETO	ETO	NNP
10_1101-2021_01_08_425864	354	30	.	.	.
10_1101-2021_01_08_425864	355	1	550	550	CD
10_1101-2021_01_08_425864	355	2	The	the	DT
10_1101-2021_01_08_425864	355	3	mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	355	4	activity	activity	NN
10_1101-2021_01_08_425864	355	5	of	of	IN
10_1101-2021_01_08_425864	355	6	these	these	DT
10_1101-2021_01_08_425864	355	7	cells	cell	NNS
10_1101-2021_01_08_425864	355	8	was	be	VBD
10_1101-2021_01_08_425864	355	9	followed	follow	VBN
10_1101-2021_01_08_425864	355	10	for	for	IN
10_1101-2021_01_08_425864	355	11	24	24	CD
10_1101-2021_01_08_425864	355	12	h	h	NN
10_1101-2021_01_08_425864	355	13	with	with	IN
10_1101-2021_01_08_425864	355	14	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	355	15	blue	blue	JJ
10_1101-2021_01_08_425864	355	16	®	®	NNPS
10_1101-2021_01_08_425864	355	17	.	.	.
10_1101-2021_01_08_425864	356	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	356	2	results	result	NNS
10_1101-2021_01_08_425864	356	3	551	551	CD
10_1101-2021_01_08_425864	356	4	showed	show	VBD
10_1101-2021_01_08_425864	356	5	that	that	IN
10_1101-2021_01_08_425864	356	6	the	the	DT
10_1101-2021_01_08_425864	356	7	mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	356	8	activity	activity	NN
10_1101-2021_01_08_425864	356	9	of	of	IN
10_1101-2021_01_08_425864	356	10	the	the	DT
10_1101-2021_01_08_425864	356	11	parasites	parasite	NNS
10_1101-2021_01_08_425864	356	12	in	in	IN
10_1101-2021_01_08_425864	356	13	the	the	DT
10_1101-2021_01_08_425864	356	14	presence	presence	NN
10_1101-2021_01_08_425864	356	15	of	of	IN
10_1101-2021_01_08_425864	356	16	ETO	ETO	NNP
10_1101-2021_01_08_425864	356	17	was	be	VBD
10_1101-2021_01_08_425864	356	18	reduced	reduce	VBN
10_1101-2021_01_08_425864	356	19	by	by	IN
10_1101-2021_01_08_425864	356	20	31	31	CD
10_1101-2021_01_08_425864	356	21	%	%	NN
10_1101-2021_01_08_425864	356	22	552	552	CD
10_1101-2021_01_08_425864	356	23	after	after	IN
10_1101-2021_01_08_425864	356	24	48	48	CD
10_1101-2021_01_08_425864	356	25	h	h	NN
10_1101-2021_01_08_425864	356	26	of	of	IN
10_1101-2021_01_08_425864	356	27	starvation	starvation	NN
10_1101-2021_01_08_425864	356	28	,	,	,
10_1101-2021_01_08_425864	356	29	and	and	CC
10_1101-2021_01_08_425864	356	30	65	65	CD
10_1101-2021_01_08_425864	356	31	%	%	NN
10_1101-2021_01_08_425864	356	32	after	after	IN
10_1101-2021_01_08_425864	356	33	72	72	CD
10_1101-2021_01_08_425864	356	34	h	h	NN
10_1101-2021_01_08_425864	356	35	of	of	IN
10_1101-2021_01_08_425864	356	36	starvation	starvation	NN
10_1101-2021_01_08_425864	356	37	(	(	-LRB-
10_1101-2021_01_08_425864	356	38	Fig	fig	NN
10_1101-2021_01_08_425864	356	39	.	.	.
10_1101-2021_01_08_425864	357	1	11	11	CD
10_1101-2021_01_08_425864	357	2	)	)	-RRB-
10_1101-2021_01_08_425864	357	3	compared	compare	VBN
10_1101-2021_01_08_425864	357	4	to	to	IN
10_1101-2021_01_08_425864	357	5	the	the	DT
10_1101-2021_01_08_425864	357	6	controls	control	NNS
10_1101-2021_01_08_425864	357	7	(	(	-LRB-
10_1101-2021_01_08_425864	357	8	untreated	untreated	JJ
10_1101-2021_01_08_425864	357	9	553	553	CD
10_1101-2021_01_08_425864	357	10	parasites	parasite	NNS
10_1101-2021_01_08_425864	357	11	)	)	-RRB-
10_1101-2021_01_08_425864	357	12	.	.	.
10_1101-2021_01_08_425864	358	1	These	these	DT
10_1101-2021_01_08_425864	358	2	data	datum	NNS
10_1101-2021_01_08_425864	358	3	confirmed	confirm	VBD
10_1101-2021_01_08_425864	358	4	our	-PRON-	PRP$
10_1101-2021_01_08_425864	358	5	hypothesis	hypothesis	NN
10_1101-2021_01_08_425864	358	6	that	that	IN
10_1101-2021_01_08_425864	358	7	the	the	DT
10_1101-2021_01_08_425864	358	8	breakdown	breakdown	NN
10_1101-2021_01_08_425864	358	9	of	of	IN
10_1101-2021_01_08_425864	358	10	accumulated	accumulated	JJ
10_1101-2021_01_08_425864	358	11	fatty	fatty	NN
10_1101-2021_01_08_425864	358	12	acids	acid	NNS
10_1101-2021_01_08_425864	358	13	554	554	CD
10_1101-2021_01_08_425864	358	14	partially	partially	RB
10_1101-2021_01_08_425864	358	15	contributes	contribute	VBZ
10_1101-2021_01_08_425864	358	16	to	to	IN
10_1101-2021_01_08_425864	358	17	the	the	DT
10_1101-2021_01_08_425864	358	18	resistance	resistance	NN
10_1101-2021_01_08_425864	358	19	of	of	IN
10_1101-2021_01_08_425864	358	20	the	the	DT
10_1101-2021_01_08_425864	358	21	parasite	parasite	NN
10_1101-2021_01_08_425864	358	22	under	under	IN
10_1101-2021_01_08_425864	358	23	severe	severe	JJ
10_1101-2021_01_08_425864	358	24	starvation	starvation	NN
10_1101-2021_01_08_425864	358	25	.	.	.
10_1101-2021_01_08_425864	359	1	555	555	CD
10_1101-2021_01_08_425864	359	2	556	556	CD
10_1101-2021_01_08_425864	359	3	Figure	figure	NN
10_1101-2021_01_08_425864	359	4	11	11	CD
10_1101-2021_01_08_425864	359	5	.	.	.
10_1101-2021_01_08_425864	360	1	Internal	internal	JJ
10_1101-2021_01_08_425864	360	2	fatty	fatty	NN
10_1101-2021_01_08_425864	360	3	acid	acid	NN
10_1101-2021_01_08_425864	360	4	consumption	consumption	NN
10_1101-2021_01_08_425864	360	5	contributes	contribute	VBZ
10_1101-2021_01_08_425864	360	6	to	to	TO
10_1101-2021_01_08_425864	360	7	parasite	parasite	VB
10_1101-2021_01_08_425864	360	8	viability	viability	NN
10_1101-2021_01_08_425864	360	9	under	under	IN
10_1101-2021_01_08_425864	360	10	severe	severe	JJ
10_1101-2021_01_08_425864	360	11	557	557	CD
10_1101-2021_01_08_425864	360	12	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	360	13	starvation	starvation	NN
10_1101-2021_01_08_425864	360	14	.	.	.
10_1101-2021_01_08_425864	361	1	Viability	viability	NN
10_1101-2021_01_08_425864	361	2	of	of	IN
10_1101-2021_01_08_425864	361	3	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	361	4	forms	form	NNS
10_1101-2021_01_08_425864	361	5	after	after	IN
10_1101-2021_01_08_425864	361	6	incubation	incubation	NN
10_1101-2021_01_08_425864	361	7	in	in	IN
10_1101-2021_01_08_425864	361	8	PBS	PBS	NNP
10_1101-2021_01_08_425864	361	9	with	with	IN
10_1101-2021_01_08_425864	361	10	or	or	CC
10_1101-2021_01_08_425864	361	11	without	without	IN
10_1101-2021_01_08_425864	361	12	ETO	ETO	NNP
10_1101-2021_01_08_425864	361	13	.	.	.
10_1101-2021_01_08_425864	362	1	558	558	CD
10_1101-2021_01_08_425864	362	2	The	the	DT
10_1101-2021_01_08_425864	362	3	viability	viability	NN
10_1101-2021_01_08_425864	362	4	was	be	VBD
10_1101-2021_01_08_425864	362	5	assessed	assess	VBN
10_1101-2021_01_08_425864	362	6	every	every	DT
10_1101-2021_01_08_425864	362	7	24	24	CD
10_1101-2021_01_08_425864	362	8	h	h	NN
10_1101-2021_01_08_425864	362	9	using	use	VBG
10_1101-2021_01_08_425864	362	10	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	362	11	Blue	Blue	NNP
10_1101-2021_01_08_425864	362	12	®	®	NNP
10_1101-2021_01_08_425864	362	13	.	.	.
10_1101-2021_01_08_425864	363	1	Statistical	statistical	JJ
10_1101-2021_01_08_425864	363	2	analysis	analysis	NN
10_1101-2021_01_08_425864	363	3	was	be	VBD
10_1101-2021_01_08_425864	363	4	performed	perform	VBN
10_1101-2021_01_08_425864	363	5	with	with	IN
10_1101-2021_01_08_425864	363	6	559	559	CD
10_1101-2021_01_08_425864	363	7	one	one	CD
10_1101-2021_01_08_425864	363	8	-	-	HYPH
10_1101-2021_01_08_425864	363	9	way	way	NN
10_1101-2021_01_08_425864	363	10	ANOVA	ANOVA	NNP
10_1101-2021_01_08_425864	363	11	followed	follow	VBN
10_1101-2021_01_08_425864	363	12	by	by	IN
10_1101-2021_01_08_425864	363	13	Tukey	Tukey	NNP
10_1101-2021_01_08_425864	363	14	's	's	POS
10_1101-2021_01_08_425864	363	15	post	post	JJ
10_1101-2021_01_08_425864	363	16	-	-	JJ
10_1101-2021_01_08_425864	363	17	test	test	JJ
10_1101-2021_01_08_425864	363	18	p	p	NN
10_1101-2021_01_08_425864	363	19	<	<	XX
10_1101-2021_01_08_425864	363	20	0.05	0.05	XX
10_1101-2021_01_08_425864	363	21	using	use	VBG
10_1101-2021_01_08_425864	363	22	GraphPad	GraphPad	NNP
10_1101-2021_01_08_425864	363	23	Prism	Prism	NNP
10_1101-2021_01_08_425864	363	24	8.0.2	8.0.2	CD
10_1101-2021_01_08_425864	363	25	software	software	NN
10_1101-2021_01_08_425864	363	26	.	.	.
10_1101-2021_01_08_425864	364	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	364	2	560	560	CD
10_1101-2021_01_08_425864	364	3	represent	represent	VBP
10_1101-2021_01_08_425864	364	4	the	the	DT
10_1101-2021_01_08_425864	364	5	levels	level	NNS
10_1101-2021_01_08_425864	364	6	of	of	IN
10_1101-2021_01_08_425864	364	7	statistical	statistical	JJ
10_1101-2021_01_08_425864	364	8	significance	significance	NN
10_1101-2021_01_08_425864	364	9	as	as	IN
10_1101-2021_01_08_425864	364	10	follow	follow	NN
10_1101-2021_01_08_425864	364	11	:	:	:
10_1101-2021_01_08_425864	364	12	*	*	NFP
10_1101-2021_01_08_425864	364	13	*	*	NFP
10_1101-2021_01_08_425864	364	14	*	*	NFP
10_1101-2021_01_08_425864	364	15	p	p	NN
10_1101-2021_01_08_425864	364	16	value	value	NN
10_1101-2021_01_08_425864	364	17	<	<	XX
10_1101-2021_01_08_425864	364	18	0.001	0.001	CD
10_1101-2021_01_08_425864	364	19	,	,	,
10_1101-2021_01_08_425864	364	20	and	and	CC
10_1101-2021_01_08_425864	364	21	for	for	IN
10_1101-2021_01_08_425864	364	22	p	p	NN
10_1101-2021_01_08_425864	364	23	values	value	NNS
10_1101-2021_01_08_425864	364	24	>	>	XX
10_1101-2021_01_08_425864	364	25	0.05	0.05	CD
10_1101-2021_01_08_425864	364	26	,	,	,
10_1101-2021_01_08_425864	364	27	561	561	CD
10_1101-2021_01_08_425864	364	28	we	-PRON-	PRP
10_1101-2021_01_08_425864	364	29	consider	consider	VBP
10_1101-2021_01_08_425864	364	30	the	the	DT
10_1101-2021_01_08_425864	364	31	differences	difference	NNS
10_1101-2021_01_08_425864	364	32	not	not	RB
10_1101-2021_01_08_425864	364	33	significant	significant	JJ
10_1101-2021_01_08_425864	364	34	(	(	-LRB-
10_1101-2021_01_08_425864	364	35	ns	ns	NNP
10_1101-2021_01_08_425864	364	36	)	)	-RRB-
10_1101-2021_01_08_425864	364	37	.	.	.
10_1101-2021_01_08_425864	365	1	562	562	CD
10_1101-2021_01_08_425864	365	2	563	563	CD
10_1101-2021_01_08_425864	365	3	Inhibition	Inhibition	NNP
10_1101-2021_01_08_425864	365	4	of	of	IN
10_1101-2021_01_08_425864	365	5	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	365	6	impairs	impairs	NNP
10_1101-2021_01_08_425864	365	7	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	365	8	564	564	CD
10_1101-2021_01_08_425864	365	9	Considering	consider	VBG
10_1101-2021_01_08_425864	365	10	that	that	IN
10_1101-2021_01_08_425864	365	11	the	the	DT
10_1101-2021_01_08_425864	365	12	FAO	FAO	NNP
10_1101-2021_01_08_425864	365	13	increases	increase	VBZ
10_1101-2021_01_08_425864	365	14	in	in	IN
10_1101-2021_01_08_425864	365	15	the	the	DT
10_1101-2021_01_08_425864	365	16	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	365	17	during	during	IN
10_1101-2021_01_08_425864	365	18	the	the	DT
10_1101-2021_01_08_425864	365	19	stationary	stationary	JJ
10_1101-2021_01_08_425864	365	20	phase	phase	NN
10_1101-2021_01_08_425864	365	21	,	,	,
10_1101-2021_01_08_425864	365	22	and	and	CC
10_1101-2021_01_08_425864	365	23	that	that	IN
10_1101-2021_01_08_425864	365	24	565	565	CD
10_1101-2021_01_08_425864	365	25	differentiation	differentiation	NN
10_1101-2021_01_08_425864	365	26	into	into	IN
10_1101-2021_01_08_425864	365	27	infective	infective	JJ
10_1101-2021_01_08_425864	365	28	metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	365	29	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	365	30	(	(	-LRB-
10_1101-2021_01_08_425864	365	31	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	365	32	)	)	-RRB-
10_1101-2021_01_08_425864	365	33	is	be	VBZ
10_1101-2021_01_08_425864	365	34	triggered	trigger	VBN
10_1101-2021_01_08_425864	365	35	in	in	IN
10_1101-2021_01_08_425864	365	36	the	the	DT
10_1101-2021_01_08_425864	365	37	566	566	CD
10_1101-2021_01_08_425864	365	38	stationary	stationary	JJ
10_1101-2021_01_08_425864	365	39	phase	phase	NN
10_1101-2021_01_08_425864	365	40	of	of	IN
10_1101-2021_01_08_425864	365	41	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	365	42	parasites	parasite	NNS
10_1101-2021_01_08_425864	365	43	,	,	,
10_1101-2021_01_08_425864	365	44	one	one	PRP
10_1101-2021_01_08_425864	365	45	might	may	MD
10_1101-2021_01_08_425864	365	46	expect	expect	VB
10_1101-2021_01_08_425864	365	47	a	a	DT
10_1101-2021_01_08_425864	365	48	possible	possible	JJ
10_1101-2021_01_08_425864	365	49	relationship	relationship	NN
10_1101-2021_01_08_425864	365	50	between	between	IN
10_1101-2021_01_08_425864	365	51	the	the	DT
10_1101-2021_01_08_425864	365	52	567	567	CD
10_1101-2021_01_08_425864	365	53	consumption	consumption	NN
10_1101-2021_01_08_425864	365	54	of	of	IN
10_1101-2021_01_08_425864	365	55	fatty	fatty	NN
10_1101-2021_01_08_425864	365	56	acids	acid	NNS
10_1101-2021_01_08_425864	365	57	and	and	CC
10_1101-2021_01_08_425864	365	58	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	365	59	.	.	.
10_1101-2021_01_08_425864	366	1	To	to	TO
10_1101-2021_01_08_425864	366	2	approach	approach	VB
10_1101-2021_01_08_425864	366	3	this	this	DT
10_1101-2021_01_08_425864	366	4	possibility	possibility	NN
10_1101-2021_01_08_425864	366	5	,	,	,
10_1101-2021_01_08_425864	366	6	we	-PRON-	PRP
10_1101-2021_01_08_425864	366	7	initially	initially	RB
10_1101-2021_01_08_425864	366	8	compared	compare	VBD
10_1101-2021_01_08_425864	366	9	568	568	CD
10_1101-2021_01_08_425864	366	10	the	the	DT
10_1101-2021_01_08_425864	366	11	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	366	12	activity	activity	NN
10_1101-2021_01_08_425864	366	13	of	of	IN
10_1101-2021_01_08_425864	366	14	stationary	stationary	JJ
10_1101-2021_01_08_425864	366	15	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	366	16	forms	form	NNS
10_1101-2021_01_08_425864	366	17	before	before	IN
10_1101-2021_01_08_425864	366	18	and	and	CC
10_1101-2021_01_08_425864	366	19	after	after	IN
10_1101-2021_01_08_425864	366	20	a	a	DT
10_1101-2021_01_08_425864	366	21	24	24	CD
10_1101-2021_01_08_425864	366	22	h	h	NN
10_1101-2021_01_08_425864	366	23	incubation	incubation	NN
10_1101-2021_01_08_425864	366	24	in	in	IN
10_1101-2021_01_08_425864	366	25	the	the	DT
10_1101-2021_01_08_425864	366	26	569	569	CD
10_1101-2021_01_08_425864	366	27	differentiation	differentiation	NN
10_1101-2021_01_08_425864	366	28	medium	medium	NN
10_1101-2021_01_08_425864	366	29	TAU-3AAG	TAU-3AAG	NNP
10_1101-2021_01_08_425864	366	30	.	.	.
10_1101-2021_01_08_425864	367	1	As	as	IN
10_1101-2021_01_08_425864	367	2	observed	observe	VBN
10_1101-2021_01_08_425864	367	3	,	,	,
10_1101-2021_01_08_425864	367	4	there	there	EX
10_1101-2021_01_08_425864	367	5	is	be	VBZ
10_1101-2021_01_08_425864	367	6	an	an	DT
10_1101-2021_01_08_425864	367	7	increase	increase	NN
10_1101-2021_01_08_425864	367	8	in	in	IN
10_1101-2021_01_08_425864	367	9	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	367	10	activity	activity	NN
10_1101-2021_01_08_425864	367	11	after	after	IN
10_1101-2021_01_08_425864	367	12	570	570	CD
10_1101-2021_01_08_425864	367	13	submitting	submit	VBG
10_1101-2021_01_08_425864	367	14	the	the	DT
10_1101-2021_01_08_425864	367	15	parasites	parasite	NNS
10_1101-2021_01_08_425864	367	16	to	to	IN
10_1101-2021_01_08_425864	367	17	the	the	DT
10_1101-2021_01_08_425864	367	18	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	367	19	in	in	IN
10_1101-2021_01_08_425864	367	20	vitro	vitro	FW
10_1101-2021_01_08_425864	367	21	(	(	-LRB-
10_1101-2021_01_08_425864	367	22	Fig	fig	NN
10_1101-2021_01_08_425864	367	23	.	.	.
10_1101-2021_01_08_425864	368	1	12A	12a	LS
10_1101-2021_01_08_425864	368	2	)	)	-RRB-
10_1101-2021_01_08_425864	368	3	.	.	.
10_1101-2021_01_08_425864	369	1	Parasites	parasite	NNS
10_1101-2021_01_08_425864	369	2	were	be	VBD
10_1101-2021_01_08_425864	369	3	then	then	RB
10_1101-2021_01_08_425864	369	4	submitted	submit	VBN
10_1101-2021_01_08_425864	369	5	to	to	IN
10_1101-2021_01_08_425864	369	6	571	571	CD
10_1101-2021_01_08_425864	369	7	differentiation	differentiation	NN
10_1101-2021_01_08_425864	369	8	with	with	IN
10_1101-2021_01_08_425864	369	9	TAU-3AAG	TAU-3AAG	NNP
10_1101-2021_01_08_425864	369	10	medium	medium	NNP
10_1101-2021_01_08_425864	369	11	in	in	IN
10_1101-2021_01_08_425864	369	12	the	the	DT
10_1101-2021_01_08_425864	369	13	presence	presence	NN
10_1101-2021_01_08_425864	369	14	of	of	IN
10_1101-2021_01_08_425864	369	15	the	the	DT
10_1101-2021_01_08_425864	369	16	probe	probe	NN
10_1101-2021_01_08_425864	369	17	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	369	18	.	.	.
10_1101-2021_01_08_425864	370	1	The	the	DT
10_1101-2021_01_08_425864	370	2	probe	probe	NN
10_1101-2021_01_08_425864	370	3	was	be	VBD
10_1101-2021_01_08_425864	370	4	572	572	CD
10_1101-2021_01_08_425864	370	5	incorporated	incorporate	VBN
10_1101-2021_01_08_425864	370	6	into	into	IN
10_1101-2021_01_08_425864	370	7	lipid	lipid	NN
10_1101-2021_01_08_425864	370	8	droplets	droplet	NNS
10_1101-2021_01_08_425864	370	9	,	,	,
10_1101-2021_01_08_425864	370	10	confirming	confirm	VBG
10_1101-2021_01_08_425864	370	11	that	that	IN
10_1101-2021_01_08_425864	370	12	fatty	fatty	NN
10_1101-2021_01_08_425864	370	13	acids	acid	NNS
10_1101-2021_01_08_425864	370	14	metabolism	metabolism	NN
10_1101-2021_01_08_425864	370	15	was	be	VBD
10_1101-2021_01_08_425864	370	16	active	active	JJ
10_1101-2021_01_08_425864	370	17	during	during	IN
10_1101-2021_01_08_425864	370	18	the	the	DT
10_1101-2021_01_08_425864	370	19	573	573	CD
10_1101-2021_01_08_425864	370	20	beginning	beginning	NN
10_1101-2021_01_08_425864	370	21	of	of	IN
10_1101-2021_01_08_425864	370	22	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	370	23	(	(	-LRB-
10_1101-2021_01_08_425864	370	24	Fig	Fig	NNP
10_1101-2021_01_08_425864	370	25	12B	12B	NNP
10_1101-2021_01_08_425864	370	26	)	)	-RRB-
10_1101-2021_01_08_425864	370	27	.	.	.
10_1101-2021_01_08_425864	371	1	To	to	TO
10_1101-2021_01_08_425864	371	2	address	address	VB
10_1101-2021_01_08_425864	371	3	the	the	DT
10_1101-2021_01_08_425864	371	4	importance	importance	NN
10_1101-2021_01_08_425864	371	5	of	of	IN
10_1101-2021_01_08_425864	371	6	FAO	FAO	NNP
10_1101-2021_01_08_425864	371	7	during	during	IN
10_1101-2021_01_08_425864	371	8	differentiation	differentiation	NN
10_1101-2021_01_08_425864	371	9	,	,	,
10_1101-2021_01_08_425864	371	10	574	574	CD
10_1101-2021_01_08_425864	371	11	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	371	12	was	be	VBD
10_1101-2021_01_08_425864	371	13	induced	induce	VBN
10_1101-2021_01_08_425864	371	14	in	in	IN
10_1101-2021_01_08_425864	371	15	vitro	vitro	FW
10_1101-2021_01_08_425864	371	16	on	on	IN
10_1101-2021_01_08_425864	371	17	ETO	ETO	NNP
10_1101-2021_01_08_425864	371	18	-	-	HYPH
10_1101-2021_01_08_425864	371	19	treated	treat	VBN
10_1101-2021_01_08_425864	371	20	or	or	CC
10_1101-2021_01_08_425864	371	21	untreated	untreated	JJ
10_1101-2021_01_08_425864	371	22	(	(	-LRB-
10_1101-2021_01_08_425864	371	23	control	control	NN
10_1101-2021_01_08_425864	371	24	)	)	-RRB-
10_1101-2021_01_08_425864	371	25	parasites	parasite	NNS
10_1101-2021_01_08_425864	371	26	.	.	.
10_1101-2021_01_08_425864	372	1	ETO	ETO	NNP
10_1101-2021_01_08_425864	372	2	575	575	CD
10_1101-2021_01_08_425864	372	3	treatment	treatment	NN
10_1101-2021_01_08_425864	372	4	interfered	interfere	VBN
10_1101-2021_01_08_425864	372	5	with	with	IN
10_1101-2021_01_08_425864	372	6	differentiation	differentiation	NN
10_1101-2021_01_08_425864	372	7	,	,	,
10_1101-2021_01_08_425864	372	8	diminishing	diminish	VBG
10_1101-2021_01_08_425864	372	9	the	the	DT
10_1101-2021_01_08_425864	372	10	number	number	NN
10_1101-2021_01_08_425864	372	11	of	of	IN
10_1101-2021_01_08_425864	372	12	metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	372	13	forms	form	NNS
10_1101-2021_01_08_425864	372	14	present	present	JJ
10_1101-2021_01_08_425864	372	15	in	in	IN
10_1101-2021_01_08_425864	372	16	the	the	DT
10_1101-2021_01_08_425864	372	17	576	576	CD
10_1101-2021_01_08_425864	372	18	culture	culture	NN
10_1101-2021_01_08_425864	372	19	(	(	-LRB-
10_1101-2021_01_08_425864	372	20	Fig	Fig	NNP
10_1101-2021_01_08_425864	372	21	12C	12C	NNP
10_1101-2021_01_08_425864	372	22	)	)	-RRB-
10_1101-2021_01_08_425864	372	23	.	.	.
10_1101-2021_01_08_425864	373	1	In	in	IN
10_1101-2021_01_08_425864	373	2	addition	addition	NN
10_1101-2021_01_08_425864	373	3	,	,	,
10_1101-2021_01_08_425864	373	4	this	this	DT
10_1101-2021_01_08_425864	373	5	inhibition	inhibition	NN
10_1101-2021_01_08_425864	373	6	was	be	VBD
10_1101-2021_01_08_425864	373	7	dose	dose	RB
10_1101-2021_01_08_425864	373	8	-	-	HYPH
10_1101-2021_01_08_425864	373	9	dependent	dependent	JJ
10_1101-2021_01_08_425864	373	10	,	,	,
10_1101-2021_01_08_425864	373	11	with	with	IN
10_1101-2021_01_08_425864	373	12	an	an	DT
10_1101-2021_01_08_425864	373	13	IC50	IC50	NNP
10_1101-2021_01_08_425864	373	14	=	=	SYM
10_1101-2021_01_08_425864	373	15	+	+	CC
10_1101-2021_01_08_425864	373	16	32.96	32.96	CD
10_1101-2021_01_08_425864	373	17	µM	µM	NNP
10_1101-2021_01_08_425864	373	18	(	(	-LRB-
10_1101-2021_01_08_425864	373	19	Fig	fig	NN
10_1101-2021_01_08_425864	373	20	577	577	CD
10_1101-2021_01_08_425864	373	21	12D	12d	CD
10_1101-2021_01_08_425864	373	22	)	)	-RRB-
10_1101-2021_01_08_425864	373	23	.	.	.
10_1101-2021_01_08_425864	374	1	Importantly	importantly	RB
10_1101-2021_01_08_425864	374	2	,	,	,
10_1101-2021_01_08_425864	374	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	374	4	ruled	rule	VBD
10_1101-2021_01_08_425864	374	5	out	out	RP
10_1101-2021_01_08_425864	374	6	that	that	IN
10_1101-2021_01_08_425864	374	7	the	the	DT
10_1101-2021_01_08_425864	374	8	variation	variation	NN
10_1101-2021_01_08_425864	374	9	found	find	VBN
10_1101-2021_01_08_425864	374	10	in	in	IN
10_1101-2021_01_08_425864	374	11	the	the	DT
10_1101-2021_01_08_425864	374	12	differentiation	differentiation	NN
10_1101-2021_01_08_425864	374	13	rates	rate	NNS
10_1101-2021_01_08_425864	374	14	was	be	VBD
10_1101-2021_01_08_425864	374	15	due	due	JJ
10_1101-2021_01_08_425864	374	16	to	to	IN
10_1101-2021_01_08_425864	374	17	a	a	DT
10_1101-2021_01_08_425864	374	18	578	578	CD
10_1101-2021_01_08_425864	374	19	selective	selective	JJ
10_1101-2021_01_08_425864	374	20	death	death	NN
10_1101-2021_01_08_425864	374	21	of	of	IN
10_1101-2021_01_08_425864	374	22	treated	treat	VBN
10_1101-2021_01_08_425864	374	23	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	374	24	,	,	,
10_1101-2021_01_08_425864	374	25	since	since	IN
10_1101-2021_01_08_425864	374	26	their	-PRON-	PRP$
10_1101-2021_01_08_425864	374	27	survival	survival	NN
10_1101-2021_01_08_425864	374	28	during	during	IN
10_1101-2021_01_08_425864	374	29	this	this	DT
10_1101-2021_01_08_425864	374	30	experiment	experiment	NN
10_1101-2021_01_08_425864	374	31	in	in	IN
10_1101-2021_01_08_425864	374	32	the	the	DT
10_1101-2021_01_08_425864	374	33	presence	presence	NN
10_1101-2021_01_08_425864	374	34	or	or	CC
10_1101-2021_01_08_425864	374	35	579	579	CD
10_1101-2021_01_08_425864	374	36	absence	absence	NN
10_1101-2021_01_08_425864	374	37	of	of	IN
10_1101-2021_01_08_425864	374	38	ETO	ETO	NNP
10_1101-2021_01_08_425864	374	39	(	(	-LRB-
10_1101-2021_01_08_425864	374	40	from	from	IN
10_1101-2021_01_08_425864	374	41	5	5	CD
10_1101-2021_01_08_425864	374	42	to	to	IN
10_1101-2021_01_08_425864	374	43	500	500	CD
10_1101-2021_01_08_425864	374	44	µM	µM	NNP
10_1101-2021_01_08_425864	374	45	)	)	-RRB-
10_1101-2021_01_08_425864	374	46	was	be	VBD
10_1101-2021_01_08_425864	374	47	not	not	RB
10_1101-2021_01_08_425864	374	48	significantly	significantly	RB
10_1101-2021_01_08_425864	374	49	different	different	JJ
10_1101-2021_01_08_425864	374	50	(	(	-LRB-
10_1101-2021_01_08_425864	374	51	S5	s5	NN
10_1101-2021_01_08_425864	374	52	Fig	Fig	NNP
10_1101-2021_01_08_425864	374	53	)	)	-RRB-
10_1101-2021_01_08_425864	374	54	.	.	.
10_1101-2021_01_08_425864	375	1	Based	base	VBN
10_1101-2021_01_08_425864	375	2	on	on	IN
10_1101-2021_01_08_425864	375	3	these	these	DT
10_1101-2021_01_08_425864	375	4	data	datum	NNS
10_1101-2021_01_08_425864	375	5	,	,	,
10_1101-2021_01_08_425864	375	6	we	-PRON-	PRP
10_1101-2021_01_08_425864	375	7	580	580	CD
10_1101-2021_01_08_425864	375	8	could	could	MD
10_1101-2021_01_08_425864	375	9	conclude	conclude	VB
10_1101-2021_01_08_425864	375	10	that	that	IN
10_1101-2021_01_08_425864	375	11	fatty	fatty	NN
10_1101-2021_01_08_425864	375	12	acid	acid	NN
10_1101-2021_01_08_425864	375	13	oxidation	oxidation	NN
10_1101-2021_01_08_425864	375	14	,	,	,
10_1101-2021_01_08_425864	375	15	at	at	IN
10_1101-2021_01_08_425864	375	16	the	the	DT
10_1101-2021_01_08_425864	375	17	level	level	NN
10_1101-2021_01_08_425864	375	18	of	of	IN
10_1101-2021_01_08_425864	375	19	the	the	DT
10_1101-2021_01_08_425864	375	20	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	375	21	,	,	,
10_1101-2021_01_08_425864	375	22	was	be	VBD
10_1101-2021_01_08_425864	375	23	also	also	RB
10_1101-2021_01_08_425864	375	24	participating	participate	VBG
10_1101-2021_01_08_425864	375	25	in	in	IN
10_1101-2021_01_08_425864	375	26	the	the	DT
10_1101-2021_01_08_425864	375	27	581	581	CD
10_1101-2021_01_08_425864	375	28	regulation	regulation	NN
10_1101-2021_01_08_425864	375	29	of	of	IN
10_1101-2021_01_08_425864	375	30	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	375	31	.	.	.
10_1101-2021_01_08_425864	376	1	582	582	CD
10_1101-2021_01_08_425864	376	2	.CC	.CC	NFP
10_1101-2021_01_08_425864	376	3	-	-	:
10_1101-2021_01_08_425864	376	4	BY	by	IN
10_1101-2021_01_08_425864	376	5	4.0	4.0	CD
10_1101-2021_01_08_425864	376	6	International	international	JJ
10_1101-2021_01_08_425864	376	7	licensemade	licensemade	NN
10_1101-2021_01_08_425864	376	8	available	available	JJ
10_1101-2021_01_08_425864	376	9	under	under	IN
10_1101-2021_01_08_425864	376	10	a	a	DT
10_1101-2021_01_08_425864	376	11	(	(	-LRB-
10_1101-2021_01_08_425864	376	12	which	which	WDT
10_1101-2021_01_08_425864	376	13	was	be	VBD
10_1101-2021_01_08_425864	376	14	not	not	RB
10_1101-2021_01_08_425864	376	15	certified	certify	VBN
10_1101-2021_01_08_425864	376	16	by	by	IN
10_1101-2021_01_08_425864	376	17	peer	peer	NN
10_1101-2021_01_08_425864	376	18	review	review	NN
10_1101-2021_01_08_425864	376	19	)	)	-RRB-
10_1101-2021_01_08_425864	376	20	is	be	VBZ
10_1101-2021_01_08_425864	376	21	the	the	DT
10_1101-2021_01_08_425864	376	22	author	author	NN
10_1101-2021_01_08_425864	376	23	/	/	SYM
10_1101-2021_01_08_425864	376	24	funder	funder	NN
10_1101-2021_01_08_425864	376	25	,	,	,
10_1101-2021_01_08_425864	376	26	who	who	WP
10_1101-2021_01_08_425864	376	27	has	have	VBZ
10_1101-2021_01_08_425864	376	28	granted	grant	VBN
10_1101-2021_01_08_425864	376	29	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	376	30	a	a	DT
10_1101-2021_01_08_425864	376	31	license	license	NN
10_1101-2021_01_08_425864	376	32	to	to	TO
10_1101-2021_01_08_425864	376	33	display	display	VB
10_1101-2021_01_08_425864	376	34	the	the	DT
10_1101-2021_01_08_425864	376	35	preprint	preprint	NN
10_1101-2021_01_08_425864	376	36	in	in	IN
10_1101-2021_01_08_425864	376	37	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	376	38	.	.	.
10_1101-2021_01_08_425864	377	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	377	2	is	be	VBZ
10_1101-2021_01_08_425864	377	3	The	the	DT
10_1101-2021_01_08_425864	377	4	copyright	copyright	NN
10_1101-2021_01_08_425864	377	5	holder	holder	NN
10_1101-2021_01_08_425864	377	6	for	for	IN
10_1101-2021_01_08_425864	377	7	this	this	DT
10_1101-2021_01_08_425864	377	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	377	9	version	version	NN
10_1101-2021_01_08_425864	377	10	posted	post	VBD
10_1101-2021_01_08_425864	377	11	January	January	NNP
10_1101-2021_01_08_425864	377	12	8	8	CD
10_1101-2021_01_08_425864	377	13	,	,	,
10_1101-2021_01_08_425864	377	14	2021	2021	CD
10_1101-2021_01_08_425864	377	15	.	.	.
10_1101-2021_01_08_425864	377	16	;	;	:
10_1101-2021_01_08_425864	377	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	377	18	:	:	:
10_1101-2021_01_08_425864	377	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	377	20	preprint	preprint	NN
10_1101-2021_01_08_425864	377	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	377	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	377	23	583	583	CD
10_1101-2021_01_08_425864	377	24	Figure	Figure	NNP
10_1101-2021_01_08_425864	377	25	12	12	CD
10_1101-2021_01_08_425864	377	26	.	.	.
10_1101-2021_01_08_425864	378	1	ETO	ETO	NNP
10_1101-2021_01_08_425864	378	2	inhibits	inhibit	VBZ
10_1101-2021_01_08_425864	378	3	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	378	4	.	.	.
10_1101-2021_01_08_425864	379	1	A	a	LS
10_1101-2021_01_08_425864	379	2	)	)	-RRB-
10_1101-2021_01_08_425864	379	3	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	379	4	activity	activity	NN
10_1101-2021_01_08_425864	379	5	of	of	IN
10_1101-2021_01_08_425864	379	6	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	379	7	forms	form	NNS
10_1101-2021_01_08_425864	379	8	in	in	IN
10_1101-2021_01_08_425864	379	9	stationary	stationary	JJ
10_1101-2021_01_08_425864	379	10	584	584	CD
10_1101-2021_01_08_425864	379	11	phase	phase	NN
10_1101-2021_01_08_425864	379	12	and	and	CC
10_1101-2021_01_08_425864	379	13	24h	24h	NNS
10_1101-2021_01_08_425864	379	14	after	after	IN
10_1101-2021_01_08_425864	379	15	incubated	incubate	VBD
10_1101-2021_01_08_425864	379	16	in	in	IN
10_1101-2021_01_08_425864	379	17	TAU-3AAG	TAU-3AAG	NNP
10_1101-2021_01_08_425864	379	18	medium	medium	NNP
10_1101-2021_01_08_425864	379	19	(	(	-LRB-
10_1101-2021_01_08_425864	379	20	for	for	IN
10_1101-2021_01_08_425864	379	21	triggering	trigger	VBG
10_1101-2021_01_08_425864	379	22	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	379	23	)	)	-RRB-
10_1101-2021_01_08_425864	379	24	.	.	.
10_1101-2021_01_08_425864	380	1	B	b	NN
10_1101-2021_01_08_425864	380	2	)	)	-RRB-
10_1101-2021_01_08_425864	380	3	585	585	CD
10_1101-2021_01_08_425864	380	4	Fluorescence	fluorescence	NN
10_1101-2021_01_08_425864	380	5	microscopy	microscopy	NN
10_1101-2021_01_08_425864	380	6	of	of	IN
10_1101-2021_01_08_425864	380	7	cells	cell	NNS
10_1101-2021_01_08_425864	380	8	incubated	incubate	VBN
10_1101-2021_01_08_425864	380	9	in	in	IN
10_1101-2021_01_08_425864	380	10	TAU-3AAG	TAU-3AAG	NNP
10_1101-2021_01_08_425864	380	11	in	in	IN
10_1101-2021_01_08_425864	380	12	the	the	DT
10_1101-2021_01_08_425864	380	13	presence	presence	NN
10_1101-2021_01_08_425864	380	14	of	of	IN
10_1101-2021_01_08_425864	380	15	BODIPY	BODIPY	NNP
10_1101-2021_01_08_425864	380	16	®	®	NNP
10_1101-2021_01_08_425864	380	17	500	500	CD
10_1101-2021_01_08_425864	380	18	-	-	SYM
10_1101-2021_01_08_425864	380	19	510	510	CD
10_1101-2021_01_08_425864	380	20	586	586	CD
10_1101-2021_01_08_425864	380	21	C1-C12	C1-C12	NNP
10_1101-2021_01_08_425864	380	22	.	.	.
10_1101-2021_01_08_425864	381	1	C	C	NNP
10_1101-2021_01_08_425864	381	2	)	)	-RRB-
10_1101-2021_01_08_425864	381	3	Effects	effect	NNS
10_1101-2021_01_08_425864	381	4	of	of	IN
10_1101-2021_01_08_425864	381	5	different	different	JJ
10_1101-2021_01_08_425864	381	6	ETO	eto	NN
10_1101-2021_01_08_425864	381	7	concentrations	concentration	NNS
10_1101-2021_01_08_425864	381	8	on	on	IN
10_1101-2021_01_08_425864	381	9	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	381	10	.	.	.
10_1101-2021_01_08_425864	382	1	The	the	DT
10_1101-2021_01_08_425864	382	2	differentiation	differentiation	NN
10_1101-2021_01_08_425864	382	3	was	be	VBD
10_1101-2021_01_08_425864	382	4	587	587	CD
10_1101-2021_01_08_425864	382	5	evaluated	evaluate	VBN
10_1101-2021_01_08_425864	382	6	by	by	IN
10_1101-2021_01_08_425864	382	7	counting	count	VBG
10_1101-2021_01_08_425864	382	8	the	the	DT
10_1101-2021_01_08_425864	382	9	cells	cell	NNS
10_1101-2021_01_08_425864	382	10	in	in	IN
10_1101-2021_01_08_425864	382	11	a	a	DT
10_1101-2021_01_08_425864	382	12	Neubauer	Neubauer	NNP
10_1101-2021_01_08_425864	382	13	chamber	chamber	NN
10_1101-2021_01_08_425864	382	14	each	each	DT
10_1101-2021_01_08_425864	382	15	day	day	NN
10_1101-2021_01_08_425864	382	16	for	for	IN
10_1101-2021_01_08_425864	382	17	6	6	CD
10_1101-2021_01_08_425864	382	18	days	day	NNS
10_1101-2021_01_08_425864	382	19	.	.	.
10_1101-2021_01_08_425864	383	1	This	this	DT
10_1101-2021_01_08_425864	383	2	experiment	experiment	NN
10_1101-2021_01_08_425864	383	3	was	be	VBD
10_1101-2021_01_08_425864	383	4	588	588	CD
10_1101-2021_01_08_425864	383	5	performed	perform	VBN
10_1101-2021_01_08_425864	383	6	in	in	IN
10_1101-2021_01_08_425864	383	7	triplicate	triplicate	NN
10_1101-2021_01_08_425864	383	8	.	.	.
10_1101-2021_01_08_425864	384	1	D	d	LS
10_1101-2021_01_08_425864	384	2	)	)	-RRB-
10_1101-2021_01_08_425864	384	3	Percentage	percentage	NN
10_1101-2021_01_08_425864	384	4	of	of	IN
10_1101-2021_01_08_425864	384	5	differentiation	differentiation	NN
10_1101-2021_01_08_425864	384	6	at	at	IN
10_1101-2021_01_08_425864	384	7	the	the	DT
10_1101-2021_01_08_425864	384	8	5th	5th	JJ
10_1101-2021_01_08_425864	384	9	day	day	NN
10_1101-2021_01_08_425864	384	10	of	of	IN
10_1101-2021_01_08_425864	384	11	differentiation	differentiation	NN
10_1101-2021_01_08_425864	384	12	.	.	.
10_1101-2021_01_08_425864	385	1	Inset	inset	NN
10_1101-2021_01_08_425864	385	2	:	:	:
10_1101-2021_01_08_425864	385	3	IC50	IC50	NNP
10_1101-2021_01_08_425864	385	4	of	of	IN
10_1101-2021_01_08_425864	385	5	589	589	CD
10_1101-2021_01_08_425864	385	6	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	385	7	inhibition	inhibition	NN
10_1101-2021_01_08_425864	385	8	by	by	IN
10_1101-2021_01_08_425864	385	9	ETO	ETO	NNP
10_1101-2021_01_08_425864	385	10	.	.	.
10_1101-2021_01_08_425864	386	1	The	the	DT
10_1101-2021_01_08_425864	386	2	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	386	3	activities	activity	NNS
10_1101-2021_01_08_425864	386	4	were	be	VBD
10_1101-2021_01_08_425864	386	5	measured	measure	VBN
10_1101-2021_01_08_425864	386	6	in	in	IN
10_1101-2021_01_08_425864	386	7	duplicate	duplicate	NN
10_1101-2021_01_08_425864	386	8	.	.	.
10_1101-2021_01_08_425864	387	1	All	all	PDT
10_1101-2021_01_08_425864	387	2	the	the	DT
10_1101-2021_01_08_425864	387	3	590	590	CD
10_1101-2021_01_08_425864	387	4	other	other	JJ
10_1101-2021_01_08_425864	387	5	experiments	experiment	NNS
10_1101-2021_01_08_425864	387	6	were	be	VBD
10_1101-2021_01_08_425864	387	7	performed	perform	VBN
10_1101-2021_01_08_425864	387	8	in	in	IN
10_1101-2021_01_08_425864	387	9	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	387	10	.	.	.
10_1101-2021_01_08_425864	388	1	591	591	CD
10_1101-2021_01_08_425864	388	2	592	592	CD
10_1101-2021_01_08_425864	388	3	593	593	CD
10_1101-2021_01_08_425864	388	4	Discussion	discussion	NN
10_1101-2021_01_08_425864	388	5	594	594	CD
10_1101-2021_01_08_425864	388	6	During	during	IN
10_1101-2021_01_08_425864	388	7	the	the	DT
10_1101-2021_01_08_425864	388	8	journey	journey	NN
10_1101-2021_01_08_425864	388	9	of	of	IN
10_1101-2021_01_08_425864	388	10	T.	T.	NNP
10_1101-2021_01_08_425864	388	11	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	388	12	inside	inside	IN
10_1101-2021_01_08_425864	388	13	the	the	DT
10_1101-2021_01_08_425864	388	14	insect	insect	JJ
10_1101-2021_01_08_425864	388	15	vector	vector	NN
10_1101-2021_01_08_425864	388	16	,	,	,
10_1101-2021_01_08_425864	388	17	the	the	DT
10_1101-2021_01_08_425864	388	18	glucose	glucose	NN
10_1101-2021_01_08_425864	388	19	levels	level	NNS
10_1101-2021_01_08_425864	388	20	decrease	decrease	VBP
10_1101-2021_01_08_425864	388	21	rapidly	rapidly	RB
10_1101-2021_01_08_425864	388	22	after	after	IN
10_1101-2021_01_08_425864	388	23	595	595	CD
10_1101-2021_01_08_425864	388	24	each	each	DT
10_1101-2021_01_08_425864	388	25	blood	blood	NN
10_1101-2021_01_08_425864	388	26	meal	meal	NN
10_1101-2021_01_08_425864	388	27	[	[	-LRB-
10_1101-2021_01_08_425864	388	28	34	34	CD
10_1101-2021_01_08_425864	388	29	]	]	-RRB-
10_1101-2021_01_08_425864	388	30	,	,	,
10_1101-2021_01_08_425864	388	31	leaving	leave	VBG
10_1101-2021_01_08_425864	388	32	the	the	DT
10_1101-2021_01_08_425864	388	33	parasite	parasite	NN
10_1101-2021_01_08_425864	388	34	exposed	expose	VBN
10_1101-2021_01_08_425864	388	35	to	to	IN
10_1101-2021_01_08_425864	388	36	an	an	DT
10_1101-2021_01_08_425864	388	37	environment	environment	NN
10_1101-2021_01_08_425864	388	38	rich	rich	JJ
10_1101-2021_01_08_425864	388	39	in	in	IN
10_1101-2021_01_08_425864	388	40	amino	amino	NN
10_1101-2021_01_08_425864	388	41	and	and	CC
10_1101-2021_01_08_425864	388	42	fatty	fatty	NN
10_1101-2021_01_08_425864	388	43	acids	acid	NNS
10_1101-2021_01_08_425864	388	44	in	in	IN
10_1101-2021_01_08_425864	388	45	596	596	CD
10_1101-2021_01_08_425864	388	46	the	the	DT
10_1101-2021_01_08_425864	388	47	digestive	digestive	JJ
10_1101-2021_01_08_425864	388	48	tube	tube	NN
10_1101-2021_01_08_425864	388	49	of	of	IN
10_1101-2021_01_08_425864	388	50	Rhodnius	Rhodnius	NNP
10_1101-2021_01_08_425864	388	51	prolixus	prolixus	NN
10_1101-2021_01_08_425864	388	52	[	[	-LRB-
10_1101-2021_01_08_425864	388	53	35,36	35,36	CD
10_1101-2021_01_08_425864	388	54	]	]	-RRB-
10_1101-2021_01_08_425864	388	55	.	.	.
10_1101-2021_01_08_425864	389	1	Because	because	IN
10_1101-2021_01_08_425864	389	2	the	the	DT
10_1101-2021_01_08_425864	389	3	digestive	digestive	JJ
10_1101-2021_01_08_425864	389	4	tract	tract	NN
10_1101-2021_01_08_425864	389	5	of	of	IN
10_1101-2021_01_08_425864	389	6	triatomine	triatomine	JJ
10_1101-2021_01_08_425864	389	7	insects	insect	NNS
10_1101-2021_01_08_425864	389	8	597	597	CD
10_1101-2021_01_08_425864	389	9	possesses	possesse	NNS
10_1101-2021_01_08_425864	389	10	a	a	DT
10_1101-2021_01_08_425864	389	11	perimicrovillar	perimicrovillar	JJ
10_1101-2021_01_08_425864	389	12	membrane	membrane	NN
10_1101-2021_01_08_425864	389	13	,	,	,
10_1101-2021_01_08_425864	389	14	which	which	WDT
10_1101-2021_01_08_425864	389	15	is	be	VBZ
10_1101-2021_01_08_425864	389	16	composed	compose	VBN
10_1101-2021_01_08_425864	389	17	primarily	primarily	RB
10_1101-2021_01_08_425864	389	18	of	of	IN
10_1101-2021_01_08_425864	389	19	lipids	lipid	NNS
10_1101-2021_01_08_425864	389	20	and	and	CC
10_1101-2021_01_08_425864	389	21	is	be	VBZ
10_1101-2021_01_08_425864	389	22	enriched	enrich	VBN
10_1101-2021_01_08_425864	389	23	by	by	IN
10_1101-2021_01_08_425864	389	24	598	598	CD
10_1101-2021_01_08_425864	389	25	glycoproteins	glycoprotein	NNS
10_1101-2021_01_08_425864	389	26	[	[	-LRB-
10_1101-2021_01_08_425864	389	27	37	37	CD
10_1101-2021_01_08_425864	389	28	]	]	-RRB-
10_1101-2021_01_08_425864	389	29	,	,	,
10_1101-2021_01_08_425864	389	30	it	-PRON-	PRP
10_1101-2021_01_08_425864	389	31	has	have	VBZ
10_1101-2021_01_08_425864	389	32	been	be	VBN
10_1101-2021_01_08_425864	389	33	speculated	speculate	VBN
10_1101-2021_01_08_425864	389	34	that	that	IN
10_1101-2021_01_08_425864	389	35	its	-PRON-	PRP$
10_1101-2021_01_08_425864	389	36	degradation	degradation	NN
10_1101-2021_01_08_425864	389	37	could	could	MD
10_1101-2021_01_08_425864	389	38	provide	provide	VB
10_1101-2021_01_08_425864	389	39	lipids	lipid	NNS
10_1101-2021_01_08_425864	389	40	for	for	IN
10_1101-2021_01_08_425864	389	41	parasite	parasite	NN
10_1101-2021_01_08_425864	389	42	599	599	CD
10_1101-2021_01_08_425864	389	43	metabolism	metabolism	NN
10_1101-2021_01_08_425864	389	44	[	[	-LRB-
10_1101-2021_01_08_425864	389	45	38	38	CD
10_1101-2021_01_08_425864	389	46	]	]	-RRB-
10_1101-2021_01_08_425864	389	47	.	.	.
10_1101-2021_01_08_425864	390	1	In	in	IN
10_1101-2021_01_08_425864	390	2	this	this	DT
10_1101-2021_01_08_425864	390	3	study	study	NN
10_1101-2021_01_08_425864	390	4	,	,	,
10_1101-2021_01_08_425864	390	5	we	-PRON-	PRP
10_1101-2021_01_08_425864	390	6	showed	show	VBD
10_1101-2021_01_08_425864	390	7	that	that	IN
10_1101-2021_01_08_425864	390	8	the	the	DT
10_1101-2021_01_08_425864	390	9	insect	insect	NN
10_1101-2021_01_08_425864	390	10	stages	stage	NNS
10_1101-2021_01_08_425864	390	11	of	of	IN
10_1101-2021_01_08_425864	390	12	T.	t.	NN
10_1101-2021_01_08_425864	390	13	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	390	14	coordinate	coordinate	VBP
10_1101-2021_01_08_425864	390	15	the	the	DT
10_1101-2021_01_08_425864	390	16	activation	activation	NN
10_1101-2021_01_08_425864	390	17	600	600	CD
10_1101-2021_01_08_425864	390	18	of	of	IN
10_1101-2021_01_08_425864	390	19	fatty	fatty	NN
10_1101-2021_01_08_425864	390	20	acid	acid	NN
10_1101-2021_01_08_425864	390	21	consumption	consumption	NN
10_1101-2021_01_08_425864	390	22	with	with	IN
10_1101-2021_01_08_425864	390	23	the	the	DT
10_1101-2021_01_08_425864	390	24	metabolism	metabolism	NN
10_1101-2021_01_08_425864	390	25	of	of	IN
10_1101-2021_01_08_425864	390	26	glucose	glucose	NN
10_1101-2021_01_08_425864	390	27	.	.	.
10_1101-2021_01_08_425864	391	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	391	2	experiments	experiment	NNS
10_1101-2021_01_08_425864	391	3	corroborate	corroborate	VBP
10_1101-2021_01_08_425864	391	4	early	early	JJ
10_1101-2021_01_08_425864	391	5	studies	study	NNS
10_1101-2021_01_08_425864	391	6	601	601	CD
10_1101-2021_01_08_425864	391	7	about	about	IN
10_1101-2021_01_08_425864	391	8	the	the	DT
10_1101-2021_01_08_425864	391	9	relatively	relatively	RB
10_1101-2021_01_08_425864	391	10	slow	slow	JJ
10_1101-2021_01_08_425864	391	11	use	use	NN
10_1101-2021_01_08_425864	391	12	of	of	IN
10_1101-2021_01_08_425864	391	13	palmitate	palmitate	NN
10_1101-2021_01_08_425864	391	14	as	as	IN
10_1101-2021_01_08_425864	391	15	an	an	DT
10_1101-2021_01_08_425864	391	16	energy	energy	NN
10_1101-2021_01_08_425864	391	17	source	source	NN
10_1101-2021_01_08_425864	391	18	by	by	IN
10_1101-2021_01_08_425864	391	19	proliferating	proliferate	VBG
10_1101-2021_01_08_425864	391	20	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	391	21	[	[	-LRB-
10_1101-2021_01_08_425864	391	22	39,40	39,40	CD
10_1101-2021_01_08_425864	391	23	]	]	-RRB-
10_1101-2021_01_08_425864	391	24	.	.	.
10_1101-2021_01_08_425864	392	1	602	602	CD
10_1101-2021_01_08_425864	392	2	In	in	IN
10_1101-2021_01_08_425864	392	3	addition	addition	NN
10_1101-2021_01_08_425864	392	4	,	,	,
10_1101-2021_01_08_425864	392	5	our	-PRON-	PRP$
10_1101-2021_01_08_425864	392	6	results	result	NNS
10_1101-2021_01_08_425864	392	7	shed	shed	VBP
10_1101-2021_01_08_425864	392	8	light	light	NN
10_1101-2021_01_08_425864	392	9	on	on	IN
10_1101-2021_01_08_425864	392	10	the	the	DT
10_1101-2021_01_08_425864	392	11	end	end	NN
10_1101-2021_01_08_425864	392	12	product	product	NN
10_1101-2021_01_08_425864	392	13	excretion	excretion	NN
10_1101-2021_01_08_425864	392	14	by	by	IN
10_1101-2021_01_08_425864	392	15	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	392	16	forms	form	NNS
10_1101-2021_01_08_425864	392	17	during	during	IN
10_1101-2021_01_08_425864	392	18	603	603	CD
10_1101-2021_01_08_425864	392	19	incubation	incubation	NN
10_1101-2021_01_08_425864	392	20	under	under	IN
10_1101-2021_01_08_425864	392	21	starvation	starvation	NN
10_1101-2021_01_08_425864	392	22	conditions	condition	NNS
10_1101-2021_01_08_425864	392	23	,	,	,
10_1101-2021_01_08_425864	392	24	and	and	CC
10_1101-2021_01_08_425864	392	25	during	during	IN
10_1101-2021_01_08_425864	392	26	their	-PRON-	PRP$
10_1101-2021_01_08_425864	392	27	recovery	recovery	NN
10_1101-2021_01_08_425864	392	28	from	from	IN
10_1101-2021_01_08_425864	392	29	starvation	starvation	NN
10_1101-2021_01_08_425864	392	30	using	use	VBG
10_1101-2021_01_08_425864	392	31	glucose	glucose	NN
10_1101-2021_01_08_425864	392	32	or	or	CC
10_1101-2021_01_08_425864	392	33	604	604	CD
10_1101-2021_01_08_425864	392	34	palmitate	palmitate	NN
10_1101-2021_01_08_425864	392	35	.	.	.
10_1101-2021_01_08_425864	393	1	First	first	RB
10_1101-2021_01_08_425864	393	2	,	,	,
10_1101-2021_01_08_425864	393	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	393	4	showed	show	VBD
10_1101-2021_01_08_425864	393	5	that	that	IN
10_1101-2021_01_08_425864	393	6	non	non	JJ
10_1101-2021_01_08_425864	393	7	-	-	JJ
10_1101-2021_01_08_425864	393	8	starved	starved	JJ
10_1101-2021_01_08_425864	393	9	and	and	CC
10_1101-2021_01_08_425864	393	10	starved	starved	JJ
10_1101-2021_01_08_425864	393	11	parasites	parasite	NNS
10_1101-2021_01_08_425864	393	12	recovered	recover	VBN
10_1101-2021_01_08_425864	393	13	in	in	IN
10_1101-2021_01_08_425864	393	14	the	the	DT
10_1101-2021_01_08_425864	393	15	presence	presence	NN
10_1101-2021_01_08_425864	393	16	of	of	IN
10_1101-2021_01_08_425864	393	17	605	605	CD
10_1101-2021_01_08_425864	393	18	glucose	glucose	NN
10_1101-2021_01_08_425864	393	19	,	,	,
10_1101-2021_01_08_425864	393	20	excreting	excrete	VBG
10_1101-2021_01_08_425864	393	21	succinate	succinate	NN
10_1101-2021_01_08_425864	393	22	as	as	IN
10_1101-2021_01_08_425864	393	23	their	-PRON-	PRP$
10_1101-2021_01_08_425864	393	24	primary	primary	JJ
10_1101-2021_01_08_425864	393	25	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	393	26	waste	waste	NN
10_1101-2021_01_08_425864	393	27	,	,	,
10_1101-2021_01_08_425864	393	28	as	as	IN
10_1101-2021_01_08_425864	393	29	expected	expect	VBN
10_1101-2021_01_08_425864	393	30	[	[	-LRB-
10_1101-2021_01_08_425864	393	31	41–43	41–43	CD
10_1101-2021_01_08_425864	393	32	]	]	-RRB-
10_1101-2021_01_08_425864	393	33	.	.	.
10_1101-2021_01_08_425864	394	1	After	after	IN
10_1101-2021_01_08_425864	394	2	16	16	CD
10_1101-2021_01_08_425864	394	3	h	h	NN
10_1101-2021_01_08_425864	394	4	of	of	IN
10_1101-2021_01_08_425864	394	5	606	606	CD
10_1101-2021_01_08_425864	394	6	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	394	7	starvation	starvation	NN
10_1101-2021_01_08_425864	394	8	,	,	,
10_1101-2021_01_08_425864	394	9	the	the	DT
10_1101-2021_01_08_425864	394	10	consumption	consumption	NN
10_1101-2021_01_08_425864	394	11	of	of	IN
10_1101-2021_01_08_425864	394	12	internal	internal	JJ
10_1101-2021_01_08_425864	394	13	carbon	carbon	NN
10_1101-2021_01_08_425864	394	14	sources	source	NNS
10_1101-2021_01_08_425864	394	15	produces	produce	VBZ
10_1101-2021_01_08_425864	394	16	acetate	acetate	RB
10_1101-2021_01_08_425864	394	17	as	as	IN
10_1101-2021_01_08_425864	394	18	the	the	DT
10_1101-2021_01_08_425864	394	19	primary	primary	JJ
10_1101-2021_01_08_425864	394	20	607	607	CD
10_1101-2021_01_08_425864	394	21	end	end	NN
10_1101-2021_01_08_425864	394	22	-	-	HYPH
10_1101-2021_01_08_425864	394	23	product	product	NN
10_1101-2021_01_08_425864	394	24	.	.	.
10_1101-2021_01_08_425864	395	1	In	in	IN
10_1101-2021_01_08_425864	395	2	the	the	DT
10_1101-2021_01_08_425864	395	3	presence	presence	NN
10_1101-2021_01_08_425864	395	4	of	of	IN
10_1101-2021_01_08_425864	395	5	glucose	glucose	NN
10_1101-2021_01_08_425864	395	6	after	after	IN
10_1101-2021_01_08_425864	395	7	16	16	CD
10_1101-2021_01_08_425864	395	8	h	h	NN
10_1101-2021_01_08_425864	395	9	of	of	IN
10_1101-2021_01_08_425864	395	10	starvation	starvation	NN
10_1101-2021_01_08_425864	395	11	,	,	,
10_1101-2021_01_08_425864	395	12	we	-PRON-	PRP
10_1101-2021_01_08_425864	395	13	found	find	VBD
10_1101-2021_01_08_425864	395	14	that	that	IN
10_1101-2021_01_08_425864	395	15	glucose	glucose	NN
10_1101-2021_01_08_425864	395	16	-	-	HYPH
10_1101-2021_01_08_425864	395	17	derived	derive	VBN
10_1101-2021_01_08_425864	395	18	608	608	CD
10_1101-2021_01_08_425864	395	19	carbons	carbon	NNS
10_1101-2021_01_08_425864	395	20	contribute	contribute	VBP
10_1101-2021_01_08_425864	395	21	to	to	IN
10_1101-2021_01_08_425864	395	22	the	the	DT
10_1101-2021_01_08_425864	395	23	excreted	excreted	JJ
10_1101-2021_01_08_425864	395	24	pools	pool	NNS
10_1101-2021_01_08_425864	395	25	of	of	IN
10_1101-2021_01_08_425864	395	26	acetate	acetate	NNP
10_1101-2021_01_08_425864	395	27	and	and	CC
10_1101-2021_01_08_425864	395	28	lactate	lactate	JJ
10_1101-2021_01_08_425864	395	29	.	.	.
10_1101-2021_01_08_425864	396	1	Interestingly	interestingly	RB
10_1101-2021_01_08_425864	396	2	,	,	,
10_1101-2021_01_08_425864	396	3	palmitate	palmitate	NN
10_1101-2021_01_08_425864	396	4	metabolism	metabolism	NN
10_1101-2021_01_08_425864	396	5	609	609	CD
10_1101-2021_01_08_425864	396	6	contributed	contribute	VBD
10_1101-2021_01_08_425864	396	7	to	to	IN
10_1101-2021_01_08_425864	396	8	the	the	DT
10_1101-2021_01_08_425864	396	9	increase	increase	NN
10_1101-2021_01_08_425864	396	10	in	in	IN
10_1101-2021_01_08_425864	396	11	acetate	acetate	JJ
10_1101-2021_01_08_425864	396	12	production	production	NN
10_1101-2021_01_08_425864	396	13	,	,	,
10_1101-2021_01_08_425864	396	14	followed	follow	VBN
10_1101-2021_01_08_425864	396	15	by	by	IN
10_1101-2021_01_08_425864	396	16	the	the	DT
10_1101-2021_01_08_425864	396	17	production	production	NN
10_1101-2021_01_08_425864	396	18	of	of	IN
10_1101-2021_01_08_425864	396	19	alanine	alanine	NN
10_1101-2021_01_08_425864	396	20	,	,	,
10_1101-2021_01_08_425864	396	21	pyruvate	pyruvate	NNP
10_1101-2021_01_08_425864	396	22	,	,	,
10_1101-2021_01_08_425864	396	23	610	610	CD
10_1101-2021_01_08_425864	396	24	succinate	succinate	NN
10_1101-2021_01_08_425864	396	25	and	and	CC
10_1101-2021_01_08_425864	396	26	lactate	lactate	VBP
10_1101-2021_01_08_425864	396	27	.	.	.
10_1101-2021_01_08_425864	397	1	The	the	DT
10_1101-2021_01_08_425864	397	2	unexpected	unexpected	JJ
10_1101-2021_01_08_425864	397	3	production	production	NN
10_1101-2021_01_08_425864	397	4	of	of	IN
10_1101-2021_01_08_425864	397	5	alanine	alanine	NN
10_1101-2021_01_08_425864	397	6	,	,	,
10_1101-2021_01_08_425864	397	7	pyruvate	pyruvate	VB
10_1101-2021_01_08_425864	397	8	and	and	CC
10_1101-2021_01_08_425864	397	9	lactate	lactate	JJ
10_1101-2021_01_08_425864	397	10	can	can	MD
10_1101-2021_01_08_425864	397	11	be	be	VB
10_1101-2021_01_08_425864	397	12	explained	explain	VBN
10_1101-2021_01_08_425864	397	13	611	611	CD
10_1101-2021_01_08_425864	397	14	by	by	IN
10_1101-2021_01_08_425864	397	15	an	an	DT
10_1101-2021_01_08_425864	397	16	increase	increase	NN
10_1101-2021_01_08_425864	397	17	in	in	IN
10_1101-2021_01_08_425864	397	18	the	the	DT
10_1101-2021_01_08_425864	397	19	TCA	TCA	NNP
10_1101-2021_01_08_425864	397	20	cycle	cycle	NN
10_1101-2021_01_08_425864	397	21	activity	activity	NN
10_1101-2021_01_08_425864	397	22	,	,	,
10_1101-2021_01_08_425864	397	23	producing	produce	VBG
10_1101-2021_01_08_425864	397	24	malate	malate	NN
10_1101-2021_01_08_425864	397	25	,	,	,
10_1101-2021_01_08_425864	397	26	which	which	WDT
10_1101-2021_01_08_425864	397	27	can	can	MD
10_1101-2021_01_08_425864	397	28	be	be	VB
10_1101-2021_01_08_425864	397	29	converted	convert	VBN
10_1101-2021_01_08_425864	397	30	into	into	IN
10_1101-2021_01_08_425864	397	31	pyruvate	pyruvate	NN
10_1101-2021_01_08_425864	397	32	by	by	IN
10_1101-2021_01_08_425864	397	33	612	612	CD
10_1101-2021_01_08_425864	397	34	the	the	DT
10_1101-2021_01_08_425864	397	35	decarboxylative	decarboxylative	JJ
10_1101-2021_01_08_425864	397	36	reaction	reaction	NN
10_1101-2021_01_08_425864	397	37	of	of	IN
10_1101-2021_01_08_425864	397	38	the	the	DT
10_1101-2021_01_08_425864	397	39	malic	malic	JJ
10_1101-2021_01_08_425864	397	40	enzyme	enzyme	NNS
10_1101-2021_01_08_425864	397	41	(	(	-LRB-
10_1101-2021_01_08_425864	397	42	ME	me	NN
10_1101-2021_01_08_425864	397	43	)	)	-RRB-
10_1101-2021_01_08_425864	397	44	[	[	-LRB-
10_1101-2021_01_08_425864	397	45	44	44	CD
10_1101-2021_01_08_425864	397	46	]	]	-RRB-
10_1101-2021_01_08_425864	397	47	.	.	.
10_1101-2021_01_08_425864	398	1	Pyruvate	Pyruvate	NNP
10_1101-2021_01_08_425864	398	2	can	can	MD
10_1101-2021_01_08_425864	398	3	be	be	VB
10_1101-2021_01_08_425864	398	4	converted	convert	VBN
10_1101-2021_01_08_425864	398	5	into	into	IN
10_1101-2021_01_08_425864	398	6	alanine	alanine	NN
10_1101-2021_01_08_425864	398	7	613	613	CD
10_1101-2021_01_08_425864	398	8	through	through	IN
10_1101-2021_01_08_425864	398	9	a	a	DT
10_1101-2021_01_08_425864	398	10	transamination	transamination	NN
10_1101-2021_01_08_425864	398	11	reaction	reaction	NN
10_1101-2021_01_08_425864	398	12	by	by	IN
10_1101-2021_01_08_425864	398	13	an	an	DT
10_1101-2021_01_08_425864	398	14	alanine-	alanine-	JJ
10_1101-2021_01_08_425864	398	15	[	[	-LRB-
10_1101-2021_01_08_425864	398	16	45	45	CD
10_1101-2021_01_08_425864	398	17	]	]	-RRB-
10_1101-2021_01_08_425864	398	18	,	,	,
10_1101-2021_01_08_425864	398	19	a	a	DT
10_1101-2021_01_08_425864	398	20	tyrosine-	tyrosine-	JJ
10_1101-2021_01_08_425864	398	21	[	[	-LRB-
10_1101-2021_01_08_425864	398	22	46	46	CD
10_1101-2021_01_08_425864	398	23	]	]	-RRB-
10_1101-2021_01_08_425864	398	24	an	an	DT
10_1101-2021_01_08_425864	398	25	aspartate	aspartate	NN
10_1101-2021_01_08_425864	398	26	aminotransferase	aminotransferase	NN
10_1101-2021_01_08_425864	398	27	614	614	CD
10_1101-2021_01_08_425864	398	28	[	[	-LRB-
10_1101-2021_01_08_425864	398	29	47	47	CD
10_1101-2021_01_08_425864	398	30	]	]	-RRB-
10_1101-2021_01_08_425864	398	31	,	,	,
10_1101-2021_01_08_425864	398	32	or	or	CC
10_1101-2021_01_08_425864	398	33	a	a	DT
10_1101-2021_01_08_425864	398	34	reductive	reductive	JJ
10_1101-2021_01_08_425864	398	35	amination	amination	NN
10_1101-2021_01_08_425864	398	36	by	by	IN
10_1101-2021_01_08_425864	398	37	an	an	DT
10_1101-2021_01_08_425864	398	38	alanine	alanine	NN
10_1101-2021_01_08_425864	398	39	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	398	40	[	[	-LRB-
10_1101-2021_01_08_425864	398	41	48	48	CD
10_1101-2021_01_08_425864	398	42	]	]	-RRB-
10_1101-2021_01_08_425864	398	43	.	.	.
10_1101-2021_01_08_425864	399	1	The	the	DT
10_1101-2021_01_08_425864	399	2	excretion	excretion	NN
10_1101-2021_01_08_425864	399	3	of	of	IN
10_1101-2021_01_08_425864	399	4	lactate	lactate	NN
10_1101-2021_01_08_425864	399	5	could	could	MD
10_1101-2021_01_08_425864	399	6	be	be	VB
10_1101-2021_01_08_425864	399	7	a	a	DT
10_1101-2021_01_08_425864	399	8	615	615	CD
10_1101-2021_01_08_425864	399	9	consequence	consequence	NN
10_1101-2021_01_08_425864	399	10	of	of	IN
10_1101-2021_01_08_425864	399	11	lactate	lactate	JJ
10_1101-2021_01_08_425864	399	12	dehydrogenase	dehydrogenase	JJ
10_1101-2021_01_08_425864	399	13	activity	activity	NN
10_1101-2021_01_08_425864	399	14	.	.	.
10_1101-2021_01_08_425864	400	1	However	however	RB
10_1101-2021_01_08_425864	400	2	,	,	,
10_1101-2021_01_08_425864	400	3	it	-PRON-	PRP
10_1101-2021_01_08_425864	400	4	should	should	MD
10_1101-2021_01_08_425864	400	5	be	be	VB
10_1101-2021_01_08_425864	400	6	noted	note	VBN
10_1101-2021_01_08_425864	400	7	that	that	IN
10_1101-2021_01_08_425864	400	8	this	this	DT
10_1101-2021_01_08_425864	400	9	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	400	10	616	616	CD
10_1101-2021_01_08_425864	400	11	activity	activity	NN
10_1101-2021_01_08_425864	400	12	has	have	VBZ
10_1101-2021_01_08_425864	400	13	not	not	RB
10_1101-2021_01_08_425864	400	14	been	be	VBN
10_1101-2021_01_08_425864	400	15	observed	observe	VBN
10_1101-2021_01_08_425864	400	16	to	to	IN
10_1101-2021_01_08_425864	400	17	date	date	NN
10_1101-2021_01_08_425864	400	18	.	.	.
10_1101-2021_01_08_425864	401	1	In	in	IN
10_1101-2021_01_08_425864	401	2	relation	relation	NN
10_1101-2021_01_08_425864	401	3	to	to	IN
10_1101-2021_01_08_425864	401	4	the	the	DT
10_1101-2021_01_08_425864	401	5	succinate	succinate	NN
10_1101-2021_01_08_425864	401	6	production	production	NN
10_1101-2021_01_08_425864	401	7	,	,	,
10_1101-2021_01_08_425864	401	8	a	a	DT
10_1101-2021_01_08_425864	401	9	relevant	relevant	JJ
10_1101-2021_01_08_425864	401	10	factor	factor	NN
10_1101-2021_01_08_425864	401	11	617	617	CD
10_1101-2021_01_08_425864	401	12	favouring	favour	VBG
10_1101-2021_01_08_425864	401	13	this	this	DT
10_1101-2021_01_08_425864	401	14	process	process	NN
10_1101-2021_01_08_425864	401	15	is	be	VBZ
10_1101-2021_01_08_425864	401	16	the	the	DT
10_1101-2021_01_08_425864	401	17	production	production	NN
10_1101-2021_01_08_425864	401	18	of	of	IN
10_1101-2021_01_08_425864	401	19	NADH	NADH	NNP
10_1101-2021_01_08_425864	401	20	by	by	IN
10_1101-2021_01_08_425864	401	21	the	the	DT
10_1101-2021_01_08_425864	401	22	third	third	JJ
10_1101-2021_01_08_425864	401	23	step	step	NN
10_1101-2021_01_08_425864	401	24	of	of	IN
10_1101-2021_01_08_425864	401	25	the	the	DT
10_1101-2021_01_08_425864	401	26	beta	beta	NN
10_1101-2021_01_08_425864	401	27	-	-	HYPH
10_1101-2021_01_08_425864	401	28	oxidation	oxidation	NN
10_1101-2021_01_08_425864	401	29	(	(	-LRB-
10_1101-2021_01_08_425864	401	30	3-	3-	NN
10_1101-2021_01_08_425864	401	31	618	618	CD
10_1101-2021_01_08_425864	401	32	hydroxyacyl	hydroxyacyl	NN
10_1101-2021_01_08_425864	401	33	-	-	HYPH
10_1101-2021_01_08_425864	401	34	CoA	CoA	NNP
10_1101-2021_01_08_425864	401	35	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	401	36	)	)	-RRB-
10_1101-2021_01_08_425864	401	37	.	.	.
10_1101-2021_01_08_425864	402	1	This	this	DT
10_1101-2021_01_08_425864	402	2	NADH	NADH	NNP
10_1101-2021_01_08_425864	402	3	can	can	MD
10_1101-2021_01_08_425864	402	4	be	be	VB
10_1101-2021_01_08_425864	402	5	oxidized	oxidize	VBN
10_1101-2021_01_08_425864	402	6	through	through	IN
10_1101-2021_01_08_425864	402	7	the	the	DT
10_1101-2021_01_08_425864	402	8	activity	activity	NN
10_1101-2021_01_08_425864	402	9	of	of	IN
10_1101-2021_01_08_425864	402	10	NADH-	NADH-	NNP
10_1101-2021_01_08_425864	402	11	.CC	.CC	NFP
10_1101-2021_01_08_425864	402	12	-	-	:
10_1101-2021_01_08_425864	402	13	BY	by	IN
10_1101-2021_01_08_425864	402	14	4.0	4.0	CD
10_1101-2021_01_08_425864	402	15	International	international	JJ
10_1101-2021_01_08_425864	402	16	licensemade	licensemade	NN
10_1101-2021_01_08_425864	402	17	available	available	JJ
10_1101-2021_01_08_425864	402	18	under	under	IN
10_1101-2021_01_08_425864	402	19	a	a	DT
10_1101-2021_01_08_425864	402	20	(	(	-LRB-
10_1101-2021_01_08_425864	402	21	which	which	WDT
10_1101-2021_01_08_425864	402	22	was	be	VBD
10_1101-2021_01_08_425864	402	23	not	not	RB
10_1101-2021_01_08_425864	402	24	certified	certify	VBN
10_1101-2021_01_08_425864	402	25	by	by	IN
10_1101-2021_01_08_425864	402	26	peer	peer	NN
10_1101-2021_01_08_425864	402	27	review	review	NN
10_1101-2021_01_08_425864	402	28	)	)	-RRB-
10_1101-2021_01_08_425864	402	29	is	be	VBZ
10_1101-2021_01_08_425864	402	30	the	the	DT
10_1101-2021_01_08_425864	402	31	author	author	NN
10_1101-2021_01_08_425864	402	32	/	/	SYM
10_1101-2021_01_08_425864	402	33	funder	funder	NN
10_1101-2021_01_08_425864	402	34	,	,	,
10_1101-2021_01_08_425864	402	35	who	who	WP
10_1101-2021_01_08_425864	402	36	has	have	VBZ
10_1101-2021_01_08_425864	402	37	granted	grant	VBN
10_1101-2021_01_08_425864	402	38	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	402	39	a	a	DT
10_1101-2021_01_08_425864	402	40	license	license	NN
10_1101-2021_01_08_425864	402	41	to	to	TO
10_1101-2021_01_08_425864	402	42	display	display	VB
10_1101-2021_01_08_425864	402	43	the	the	DT
10_1101-2021_01_08_425864	402	44	preprint	preprint	NN
10_1101-2021_01_08_425864	402	45	in	in	IN
10_1101-2021_01_08_425864	402	46	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	402	47	.	.	.
10_1101-2021_01_08_425864	403	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	403	2	is	be	VBZ
10_1101-2021_01_08_425864	403	3	The	the	DT
10_1101-2021_01_08_425864	403	4	copyright	copyright	NN
10_1101-2021_01_08_425864	403	5	holder	holder	NN
10_1101-2021_01_08_425864	403	6	for	for	IN
10_1101-2021_01_08_425864	403	7	this	this	DT
10_1101-2021_01_08_425864	403	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	403	9	version	version	NN
10_1101-2021_01_08_425864	403	10	posted	post	VBD
10_1101-2021_01_08_425864	403	11	January	January	NNP
10_1101-2021_01_08_425864	403	12	8	8	CD
10_1101-2021_01_08_425864	403	13	,	,	,
10_1101-2021_01_08_425864	403	14	2021	2021	CD
10_1101-2021_01_08_425864	403	15	.	.	.
10_1101-2021_01_08_425864	403	16	;	;	:
10_1101-2021_01_08_425864	403	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	403	18	:	:	:
10_1101-2021_01_08_425864	403	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	403	20	preprint	preprint	NN
10_1101-2021_01_08_425864	403	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	403	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	VBZ
10_1101-2021_01_08_425864	403	23	619	619	CD
10_1101-2021_01_08_425864	403	24	dependent	dependent	JJ
10_1101-2021_01_08_425864	403	25	mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	403	26	fumarate	fumarate	NN
10_1101-2021_01_08_425864	403	27	reductase	reductase	NN
10_1101-2021_01_08_425864	403	28	[	[	-LRB-
10_1101-2021_01_08_425864	403	29	49	49	CD
10_1101-2021_01_08_425864	403	30	]	]	-RRB-
10_1101-2021_01_08_425864	403	31	,	,	,
10_1101-2021_01_08_425864	403	32	which	which	WDT
10_1101-2021_01_08_425864	403	33	concomitantly	concomitantly	RB
10_1101-2021_01_08_425864	403	34	converts	convert	VBZ
10_1101-2021_01_08_425864	403	35	NADH	NADH	NNP
10_1101-2021_01_08_425864	403	36	into	into	IN
10_1101-2021_01_08_425864	403	37	NAD+	NAD+	NNP
10_1101-2021_01_08_425864	403	38	620	620	CD
10_1101-2021_01_08_425864	403	39	and	and	CC
10_1101-2021_01_08_425864	403	40	fumarate	fumarate	VBP
10_1101-2021_01_08_425864	403	41	into	into	IN
10_1101-2021_01_08_425864	403	42	succinate	succinate	NN
10_1101-2021_01_08_425864	403	43	.	.	.
10_1101-2021_01_08_425864	404	1	This	this	DT
10_1101-2021_01_08_425864	404	2	succinate	succinate	NN
10_1101-2021_01_08_425864	404	3	can	can	MD
10_1101-2021_01_08_425864	404	4	be	be	VB
10_1101-2021_01_08_425864	404	5	excreted	excrete	VBN
10_1101-2021_01_08_425864	404	6	or	or	CC
10_1101-2021_01_08_425864	404	7	re	re	VBN
10_1101-2021_01_08_425864	404	8	-	-	VBN
10_1101-2021_01_08_425864	404	9	used	use	VBN
10_1101-2021_01_08_425864	404	10	by	by	IN
10_1101-2021_01_08_425864	404	11	the	the	DT
10_1101-2021_01_08_425864	404	12	TCA	TCA	NNP
10_1101-2021_01_08_425864	404	13	cycle	cycle	NN
10_1101-2021_01_08_425864	404	14	,	,	,
10_1101-2021_01_08_425864	404	15	and	and	CC
10_1101-2021_01_08_425864	404	16	the	the	DT
10_1101-2021_01_08_425864	404	17	621	621	CD
10_1101-2021_01_08_425864	404	18	resulting	result	VBG
10_1101-2021_01_08_425864	404	19	NAD+	NAD+	NNP
10_1101-2021_01_08_425864	404	20	can	can	MD
10_1101-2021_01_08_425864	404	21	be	be	VB
10_1101-2021_01_08_425864	404	22	used	use	VBN
10_1101-2021_01_08_425864	404	23	as	as	IN
10_1101-2021_01_08_425864	404	24	a	a	DT
10_1101-2021_01_08_425864	404	25	cofactor	cofactor	NN
10_1101-2021_01_08_425864	404	26	for	for	IN
10_1101-2021_01_08_425864	404	27	other	other	JJ
10_1101-2021_01_08_425864	404	28	enzymes	enzyme	NNS
10_1101-2021_01_08_425864	404	29	.	.	.
10_1101-2021_01_08_425864	405	1	622	622	CD
10_1101-2021_01_08_425864	405	2	As	as	IN
10_1101-2021_01_08_425864	405	3	previously	previously	RB
10_1101-2021_01_08_425864	405	4	mentioned	mention	VBN
10_1101-2021_01_08_425864	405	5	,	,	,
10_1101-2021_01_08_425864	405	6	it	-PRON-	PRP
10_1101-2021_01_08_425864	405	7	is	be	VBZ
10_1101-2021_01_08_425864	405	8	well	well	RB
10_1101-2021_01_08_425864	405	9	known	know	VBN
10_1101-2021_01_08_425864	405	10	that	that	IN
10_1101-2021_01_08_425864	405	11	during	during	IN
10_1101-2021_01_08_425864	405	12	the	the	DT
10_1101-2021_01_08_425864	405	13	initial	initial	JJ
10_1101-2021_01_08_425864	405	14	phase	phase	NN
10_1101-2021_01_08_425864	405	15	of	of	IN
10_1101-2021_01_08_425864	405	16	proliferation	proliferation	NN
10_1101-2021_01_08_425864	405	17	,	,	,
10_1101-2021_01_08_425864	405	18	623	623	CD
10_1101-2021_01_08_425864	405	19	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	405	20	preferentially	preferentially	RB
10_1101-2021_01_08_425864	405	21	consume	consume	VBP
10_1101-2021_01_08_425864	405	22	glucose	glucose	NN
10_1101-2021_01_08_425864	405	23	,	,	,
10_1101-2021_01_08_425864	405	24	and	and	CC
10_1101-2021_01_08_425864	405	25	during	during	IN
10_1101-2021_01_08_425864	405	26	the	the	DT
10_1101-2021_01_08_425864	405	27	stationary	stationary	JJ
10_1101-2021_01_08_425864	405	28	phase	phase	NN
10_1101-2021_01_08_425864	405	29	,	,	,
10_1101-2021_01_08_425864	405	30	a	a	DT
10_1101-2021_01_08_425864	405	31	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	405	32	switch	switch	NN
10_1101-2021_01_08_425864	405	33	624	624	CD
10_1101-2021_01_08_425864	405	34	occurs	occur	VBZ
10_1101-2021_01_08_425864	405	35	towards	towards	IN
10_1101-2021_01_08_425864	405	36	the	the	DT
10_1101-2021_01_08_425864	405	37	consumption	consumption	NN
10_1101-2021_01_08_425864	405	38	of	of	IN
10_1101-2021_01_08_425864	405	39	amino	amino	JJ
10_1101-2021_01_08_425864	405	40	acids	acid	NNS
10_1101-2021_01_08_425864	405	41	[	[	-LRB-
10_1101-2021_01_08_425864	405	42	8,10,42	8,10,42	CD
10_1101-2021_01_08_425864	405	43	]	]	-RRB-
10_1101-2021_01_08_425864	405	44	.	.	.
10_1101-2021_01_08_425864	406	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	406	2	results	result	NNS
10_1101-2021_01_08_425864	406	3	show	show	VBP
10_1101-2021_01_08_425864	406	4	that	that	IN
10_1101-2021_01_08_425864	406	5	this	this	DT
10_1101-2021_01_08_425864	406	6	switch	switch	NN
10_1101-2021_01_08_425864	406	7	625	625	CD
10_1101-2021_01_08_425864	406	8	constitutes	constitute	VBZ
10_1101-2021_01_08_425864	406	9	a	a	DT
10_1101-2021_01_08_425864	406	10	broader	broad	JJR
10_1101-2021_01_08_425864	406	11	and	and	CC
10_1101-2021_01_08_425864	406	12	more	more	JJR
10_1101-2021_01_08_425864	406	13	systemic	systemic	JJ
10_1101-2021_01_08_425864	406	14	metabolic	metabolic	NN
10_1101-2021_01_08_425864	406	15	reprogramming	reprogramming	NN
10_1101-2021_01_08_425864	406	16	,	,	,
10_1101-2021_01_08_425864	406	17	which	which	WDT
10_1101-2021_01_08_425864	406	18	also	also	RB
10_1101-2021_01_08_425864	406	19	includes	include	VBZ
10_1101-2021_01_08_425864	406	20	FAO	FAO	NNP
10_1101-2021_01_08_425864	406	21	.	.	.
10_1101-2021_01_08_425864	407	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	407	2	626	626	CD
10_1101-2021_01_08_425864	407	3	detected	detect	VBD
10_1101-2021_01_08_425864	407	4	this	this	DT
10_1101-2021_01_08_425864	407	5	switch	switch	NN
10_1101-2021_01_08_425864	407	6	through	through	IN
10_1101-2021_01_08_425864	407	7	changes	change	NNS
10_1101-2021_01_08_425864	407	8	in	in	IN
10_1101-2021_01_08_425864	407	9	the	the	DT
10_1101-2021_01_08_425864	407	10	enzymatic	enzymatic	JJ
10_1101-2021_01_08_425864	407	11	activities	activity	NNS
10_1101-2021_01_08_425864	407	12	of	of	IN
10_1101-2021_01_08_425864	407	13	key	key	JJ
10_1101-2021_01_08_425864	407	14	enzymes	enzyme	NNS
10_1101-2021_01_08_425864	407	15	responsible	responsible	JJ
10_1101-2021_01_08_425864	407	16	for	for	IN
10_1101-2021_01_08_425864	407	17	the	the	DT
10_1101-2021_01_08_425864	407	18	627	627	CD
10_1101-2021_01_08_425864	407	19	regulation	regulation	NN
10_1101-2021_01_08_425864	407	20	of	of	IN
10_1101-2021_01_08_425864	407	21	FAO	FAO	NNP
10_1101-2021_01_08_425864	407	22	,	,	,
10_1101-2021_01_08_425864	407	23	such	such	JJ
10_1101-2021_01_08_425864	407	24	as	as	IN
10_1101-2021_01_08_425864	407	25	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	407	26	and	and	CC
10_1101-2021_01_08_425864	407	27	ACC	ACC	NNP
10_1101-2021_01_08_425864	407	28	,	,	,
10_1101-2021_01_08_425864	407	29	which	which	WDT
10_1101-2021_01_08_425864	407	30	have	have	VBP
10_1101-2021_01_08_425864	407	31	increased	increase	VBN
10_1101-2021_01_08_425864	407	32	and	and	CC
10_1101-2021_01_08_425864	407	33	decreased	decrease	VBN
10_1101-2021_01_08_425864	407	34	activities	activity	NNS
10_1101-2021_01_08_425864	407	35	,	,	,
10_1101-2021_01_08_425864	407	36	628	628	CD
10_1101-2021_01_08_425864	407	37	respectively	respectively	RB
10_1101-2021_01_08_425864	407	38	,	,	,
10_1101-2021_01_08_425864	407	39	in	in	IN
10_1101-2021_01_08_425864	407	40	the	the	DT
10_1101-2021_01_08_425864	407	41	presence	presence	NN
10_1101-2021_01_08_425864	407	42	of	of	IN
10_1101-2021_01_08_425864	407	43	glucose	glucose	NN
10_1101-2021_01_08_425864	407	44	.	.	.
10_1101-2021_01_08_425864	408	1	Our	-PRON-	PRP$
10_1101-2021_01_08_425864	408	2	findings	finding	NNS
10_1101-2021_01_08_425864	408	3	showed	show	VBD
10_1101-2021_01_08_425864	408	4	that	that	IN
10_1101-2021_01_08_425864	408	5	the	the	DT
10_1101-2021_01_08_425864	408	6	inhibition	inhibition	NN
10_1101-2021_01_08_425864	408	7	of	of	IN
10_1101-2021_01_08_425864	408	8	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	408	9	affects	affect	VBZ
10_1101-2021_01_08_425864	408	10	the	the	DT
10_1101-2021_01_08_425864	408	11	629	629	CD
10_1101-2021_01_08_425864	408	12	late	late	JJ
10_1101-2021_01_08_425864	408	13	phase	phase	NN
10_1101-2021_01_08_425864	408	14	of	of	IN
10_1101-2021_01_08_425864	408	15	proliferation	proliferation	NN
10_1101-2021_01_08_425864	408	16	of	of	IN
10_1101-2021_01_08_425864	408	17	epimastigotes	epimastigotes	NNPS
10_1101-2021_01_08_425864	408	18	when	when	WRB
10_1101-2021_01_08_425864	408	19	the	the	DT
10_1101-2021_01_08_425864	408	20	switch	switch	NN
10_1101-2021_01_08_425864	408	21	to	to	IN
10_1101-2021_01_08_425864	408	22	FAO	FAO	NNP
10_1101-2021_01_08_425864	408	23	has	have	VBZ
10_1101-2021_01_08_425864	408	24	already	already	RB
10_1101-2021_01_08_425864	408	25	occurred	occur	VBN
10_1101-2021_01_08_425864	408	26	.	.	.
10_1101-2021_01_08_425864	409	1	630	630	CD
10_1101-2021_01_08_425864	409	2	An	an	DT
10_1101-2021_01_08_425864	409	3	interesting	interesting	JJ
10_1101-2021_01_08_425864	409	4	question	question	NN
10_1101-2021_01_08_425864	409	5	about	about	RB
10_1101-2021_01_08_425864	409	6	T.	t.	NN
10_1101-2021_01_08_425864	409	7	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	409	8	epimastigotes	epimastigote	VBZ
10_1101-2021_01_08_425864	409	9	is	be	VBZ
10_1101-2021_01_08_425864	409	10	how	how	WRB
10_1101-2021_01_08_425864	409	11	they	-PRON-	PRP
10_1101-2021_01_08_425864	409	12	survive	survive	VBP
10_1101-2021_01_08_425864	409	13	long	long	JJ
10_1101-2021_01_08_425864	409	14	periods	period	NNS
10_1101-2021_01_08_425864	409	15	of	of	IN
10_1101-2021_01_08_425864	409	16	631	631	CD
10_1101-2021_01_08_425864	409	17	starvation	starvation	NN
10_1101-2021_01_08_425864	409	18	.	.	.
10_1101-2021_01_08_425864	410	1	Early	early	JJ
10_1101-2021_01_08_425864	410	2	data	datum	NNS
10_1101-2021_01_08_425864	410	3	showed	show	VBD
10_1101-2021_01_08_425864	410	4	high	high	JJ
10_1101-2021_01_08_425864	410	5	respiration	respiration	NN
10_1101-2021_01_08_425864	410	6	levels	level	NNS
10_1101-2021_01_08_425864	410	7	in	in	IN
10_1101-2021_01_08_425864	410	8	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	410	9	incubated	incubate	VBN
10_1101-2021_01_08_425864	410	10	in	in	IN
10_1101-2021_01_08_425864	410	11	the	the	DT
10_1101-2021_01_08_425864	410	12	absence	absence	NN
10_1101-2021_01_08_425864	410	13	of	of	IN
10_1101-2021_01_08_425864	410	14	632	632	CD
10_1101-2021_01_08_425864	410	15	external	external	JJ
10_1101-2021_01_08_425864	410	16	oxidisable	oxidisable	JJ
10_1101-2021_01_08_425864	410	17	carbon	carbon	NN
10_1101-2021_01_08_425864	410	18	sources	source	NNS
10_1101-2021_01_08_425864	410	19	.	.	.
10_1101-2021_01_08_425864	411	1	This	this	DT
10_1101-2021_01_08_425864	411	2	oxygen	oxygen	NN
10_1101-2021_01_08_425864	411	3	consumption	consumption	NN
10_1101-2021_01_08_425864	411	4	was	be	VBD
10_1101-2021_01_08_425864	411	5	attributed	attribute	VBN
10_1101-2021_01_08_425864	411	6	to	to	IN
10_1101-2021_01_08_425864	411	7	the	the	DT
10_1101-2021_01_08_425864	411	8	breakdown	breakdown	NN
10_1101-2021_01_08_425864	411	9	of	of	IN
10_1101-2021_01_08_425864	411	10	633	633	CD
10_1101-2021_01_08_425864	411	11	TAGs	tag	NNS
10_1101-2021_01_08_425864	411	12	into	into	IN
10_1101-2021_01_08_425864	411	13	free	free	JJ
10_1101-2021_01_08_425864	411	14	fatty	fatty	NN
10_1101-2021_01_08_425864	411	15	acids	acid	NNS
10_1101-2021_01_08_425864	411	16	and	and	CC
10_1101-2021_01_08_425864	411	17	their	-PRON-	PRP$
10_1101-2021_01_08_425864	411	18	further	further	JJ
10_1101-2021_01_08_425864	411	19	oxidation	oxidation	NN
10_1101-2021_01_08_425864	411	20	[	[	-LRB-
10_1101-2021_01_08_425864	411	21	50	50	CD
10_1101-2021_01_08_425864	411	22	]	]	-RRB-
10_1101-2021_01_08_425864	411	23	.	.	.
10_1101-2021_01_08_425864	412	1	Here	here	RB
10_1101-2021_01_08_425864	412	2	,	,	,
10_1101-2021_01_08_425864	412	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	412	4	confirmed	confirm	VBD
10_1101-2021_01_08_425864	412	5	this	this	DT
10_1101-2021_01_08_425864	412	6	finding	finding	NN
10_1101-2021_01_08_425864	412	7	by	by	IN
10_1101-2021_01_08_425864	412	8	634	634	CD
10_1101-2021_01_08_425864	412	9	inhibiting	inhibit	VBG
10_1101-2021_01_08_425864	412	10	the	the	DT
10_1101-2021_01_08_425864	412	11	internal	internal	JJ
10_1101-2021_01_08_425864	412	12	fatty	fatty	NN
10_1101-2021_01_08_425864	412	13	acid	acid	NNP
10_1101-2021_01_08_425864	412	14	consumption	consumption	NN
10_1101-2021_01_08_425864	412	15	,	,	,
10_1101-2021_01_08_425864	412	16	which	which	WDT
10_1101-2021_01_08_425864	412	17	in	in	IN
10_1101-2021_01_08_425864	412	18	turn	turn	NN
10_1101-2021_01_08_425864	412	19	diminished	diminish	VBD
10_1101-2021_01_08_425864	412	20	the	the	DT
10_1101-2021_01_08_425864	412	21	oxidative	oxidative	JJ
10_1101-2021_01_08_425864	412	22	phosphorylation	phosphorylation	NN
10_1101-2021_01_08_425864	412	23	635	635	CD
10_1101-2021_01_08_425864	412	24	activity	activity	NN
10_1101-2021_01_08_425864	412	25	,	,	,
10_1101-2021_01_08_425864	412	26	internal	internal	JJ
10_1101-2021_01_08_425864	412	27	ATP	atp	NN
10_1101-2021_01_08_425864	412	28	levels	level	NNS
10_1101-2021_01_08_425864	412	29	and	and	CC
10_1101-2021_01_08_425864	412	30	the	the	DT
10_1101-2021_01_08_425864	412	31	total	total	JJ
10_1101-2021_01_08_425864	412	32	reductive	reductive	JJ
10_1101-2021_01_08_425864	412	33	activity	activity	NN
10_1101-2021_01_08_425864	412	34	of	of	IN
10_1101-2021_01_08_425864	412	35	parasites	parasite	NNS
10_1101-2021_01_08_425864	412	36	under	under	IN
10_1101-2021_01_08_425864	412	37	severe	severe	JJ
10_1101-2021_01_08_425864	412	38	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	412	39	stress	stress	NN
10_1101-2021_01_08_425864	412	40	.	.	.
10_1101-2021_01_08_425864	413	1	636	636	CD
10_1101-2021_01_08_425864	413	2	Even	even	RB
10_1101-2021_01_08_425864	413	3	more	more	RBR
10_1101-2021_01_08_425864	413	4	notably	notably	RB
10_1101-2021_01_08_425864	413	5	,	,	,
10_1101-2021_01_08_425864	413	6	we	-PRON-	PRP
10_1101-2021_01_08_425864	413	7	showed	show	VBD
10_1101-2021_01_08_425864	413	8	that	that	IN
10_1101-2021_01_08_425864	413	9	under	under	IN
10_1101-2021_01_08_425864	413	10	these	these	DT
10_1101-2021_01_08_425864	413	11	conditions	condition	NNS
10_1101-2021_01_08_425864	413	12	,	,	,
10_1101-2021_01_08_425864	413	13	the	the	DT
10_1101-2021_01_08_425864	413	14	lipids	lipid	NNS
10_1101-2021_01_08_425864	413	15	stored	store	VBN
10_1101-2021_01_08_425864	413	16	in	in	IN
10_1101-2021_01_08_425864	413	17	lipid	lipid	NN
10_1101-2021_01_08_425864	413	18	droplets	droplet	NNS
10_1101-2021_01_08_425864	413	19	[	[	-LRB-
10_1101-2021_01_08_425864	413	20	51,52	51,52	CD
10_1101-2021_01_08_425864	413	21	]	]	-RRB-
10_1101-2021_01_08_425864	413	22	637	637	CD
10_1101-2021_01_08_425864	413	23	are	be	VBP
10_1101-2021_01_08_425864	413	24	consumed	consume	VBN
10_1101-2021_01_08_425864	413	25	.	.	.
10_1101-2021_01_08_425864	414	1	Unlike	unlike	IN
10_1101-2021_01_08_425864	414	2	what	what	WP
10_1101-2021_01_08_425864	414	3	has	have	VBZ
10_1101-2021_01_08_425864	414	4	been	be	VBN
10_1101-2021_01_08_425864	414	5	observed	observe	VBN
10_1101-2021_01_08_425864	414	6	in	in	IN
10_1101-2021_01_08_425864	414	7	procyclic	procyclic	JJ
10_1101-2021_01_08_425864	414	8	forms	form	NNS
10_1101-2021_01_08_425864	414	9	of	of	IN
10_1101-2021_01_08_425864	414	10	T.	t.	NN
10_1101-2021_01_08_425864	414	11	brucei	brucei	NN
10_1101-2021_01_08_425864	414	12	,	,	,
10_1101-2021_01_08_425864	414	13	in	in	IN
10_1101-2021_01_08_425864	414	14	which	which	WDT
10_1101-2021_01_08_425864	414	15	the	the	DT
10_1101-2021_01_08_425864	414	16	function	function	NN
10_1101-2021_01_08_425864	414	17	638	638	CD
10_1101-2021_01_08_425864	414	18	of	of	IN
10_1101-2021_01_08_425864	414	19	lipid	lipid	NN
10_1101-2021_01_08_425864	414	20	droplets	droplet	NNS
10_1101-2021_01_08_425864	414	21	is	be	VBZ
10_1101-2021_01_08_425864	414	22	not	not	RB
10_1101-2021_01_08_425864	414	23	clear	clear	JJ
10_1101-2021_01_08_425864	414	24	[	[	-LRB-
10_1101-2021_01_08_425864	414	25	53	53	CD
10_1101-2021_01_08_425864	414	26	]	]	-RRB-
10_1101-2021_01_08_425864	414	27	,	,	,
10_1101-2021_01_08_425864	414	28	our	-PRON-	PRP$
10_1101-2021_01_08_425864	414	29	results	result	NNS
10_1101-2021_01_08_425864	414	30	show	show	VBP
10_1101-2021_01_08_425864	414	31	that	that	IN
10_1101-2021_01_08_425864	414	32	in	in	IN
10_1101-2021_01_08_425864	414	33	T.	t.	NN
10_1101-2021_01_08_425864	414	34	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	414	35	,	,	,
10_1101-2021_01_08_425864	414	36	they	-PRON-	PRP
10_1101-2021_01_08_425864	414	37	are	be	VBP
10_1101-2021_01_08_425864	414	38	committed	commit	VBN
10_1101-2021_01_08_425864	414	39	to	to	TO
10_1101-2021_01_08_425864	414	40	epimastigote	epimastigote	VB
10_1101-2021_01_08_425864	414	41	639	639	CD
10_1101-2021_01_08_425864	414	42	survival	survival	NN
10_1101-2021_01_08_425864	414	43	under	under	IN
10_1101-2021_01_08_425864	414	44	extreme	extreme	JJ
10_1101-2021_01_08_425864	414	45	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	414	46	stress	stress	NN
10_1101-2021_01_08_425864	414	47	.	.	.
10_1101-2021_01_08_425864	415	1	Of	of	RB
10_1101-2021_01_08_425864	415	2	course	course	RB
10_1101-2021_01_08_425864	415	3	,	,	,
10_1101-2021_01_08_425864	415	4	the	the	DT
10_1101-2021_01_08_425864	415	5	contribution	contribution	NN
10_1101-2021_01_08_425864	415	6	of	of	IN
10_1101-2021_01_08_425864	415	7	other	other	JJ
10_1101-2021_01_08_425864	415	8	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	415	9	sources	source	NNS
10_1101-2021_01_08_425864	415	10	and	and	CC
10_1101-2021_01_08_425864	415	11	640	640	CD
10_1101-2021_01_08_425864	415	12	processes	process	NNS
10_1101-2021_01_08_425864	415	13	such	such	JJ
10_1101-2021_01_08_425864	415	14	as	as	IN
10_1101-2021_01_08_425864	415	15	autophagy	autophagy	NNP
10_1101-2021_01_08_425864	415	16	in	in	IN
10_1101-2021_01_08_425864	415	17	coping	cope	VBG
10_1101-2021_01_08_425864	415	18	with	with	IN
10_1101-2021_01_08_425864	415	19	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	415	20	stress	stress	NN
10_1101-2021_01_08_425864	415	21	can	can	MD
10_1101-2021_01_08_425864	415	22	not	not	RB
10_1101-2021_01_08_425864	415	23	be	be	VB
10_1101-2021_01_08_425864	415	24	ruled	rule	VBN
10_1101-2021_01_08_425864	415	25	out	out	RP
10_1101-2021_01_08_425864	415	26	[	[	-LRB-
10_1101-2021_01_08_425864	415	27	54	54	CD
10_1101-2021_01_08_425864	415	28	]	]	-RRB-
10_1101-2021_01_08_425864	415	29	.	.	.
10_1101-2021_01_08_425864	416	1	641	641	CD
10_1101-2021_01_08_425864	416	2	Multiple	multiple	JJ
10_1101-2021_01_08_425864	416	3	metabolic	metabolic	NN
10_1101-2021_01_08_425864	416	4	factors	factor	NNS
10_1101-2021_01_08_425864	416	5	has	have	VBZ
10_1101-2021_01_08_425864	416	6	been	be	VBN
10_1101-2021_01_08_425864	416	7	involved	involve	VBN
10_1101-2021_01_08_425864	416	8	in	in	IN
10_1101-2021_01_08_425864	416	9	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	416	10	,	,	,
10_1101-2021_01_08_425864	416	11	such	such	JJ
10_1101-2021_01_08_425864	416	12	as	as	IN
10_1101-2021_01_08_425864	416	13	the	the	DT
10_1101-2021_01_08_425864	416	14	proline	proline	NN
10_1101-2021_01_08_425864	416	15	,	,	,
10_1101-2021_01_08_425864	416	16	aspartate	aspartate	NN
10_1101-2021_01_08_425864	416	17	,	,	,
10_1101-2021_01_08_425864	416	18	642	642	CD
10_1101-2021_01_08_425864	416	19	glutamate	glutamate	NN
10_1101-2021_01_08_425864	416	20	[	[	-LRB-
10_1101-2021_01_08_425864	416	21	55	55	CD
10_1101-2021_01_08_425864	416	22	]	]	-RRB-
10_1101-2021_01_08_425864	416	23	,	,	,
10_1101-2021_01_08_425864	416	24	glutamine	glutamine	NN
10_1101-2021_01_08_425864	416	25	[	[	-LRB-
10_1101-2021_01_08_425864	416	26	17	17	CD
10_1101-2021_01_08_425864	416	27	]	]	-RRB-
10_1101-2021_01_08_425864	416	28	and	and	CC
10_1101-2021_01_08_425864	416	29	lipids	lipid	NNS
10_1101-2021_01_08_425864	416	30	present	present	JJ
10_1101-2021_01_08_425864	416	31	in	in	IN
10_1101-2021_01_08_425864	416	32	the	the	DT
10_1101-2021_01_08_425864	416	33	triatomine	triatomine	JJ
10_1101-2021_01_08_425864	416	34	digestive	digestive	JJ
10_1101-2021_01_08_425864	416	35	tract	tract	NN
10_1101-2021_01_08_425864	416	36	[	[	-LRB-
10_1101-2021_01_08_425864	416	37	56	56	CD
10_1101-2021_01_08_425864	416	38	]	]	-RRB-
10_1101-2021_01_08_425864	416	39	.	.	.
10_1101-2021_01_08_425864	417	1	Interestingly	interestingly	RB
10_1101-2021_01_08_425864	417	2	,	,	,
10_1101-2021_01_08_425864	417	3	643	643	CD
10_1101-2021_01_08_425864	417	4	the	the	DT
10_1101-2021_01_08_425864	417	5	occurrence	occurrence	NN
10_1101-2021_01_08_425864	417	6	of	of	IN
10_1101-2021_01_08_425864	417	7	metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	417	8	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	417	9	in	in	IN
10_1101-2021_01_08_425864	417	10	culture	culture	NN
10_1101-2021_01_08_425864	417	11	leads	lead	VBZ
10_1101-2021_01_08_425864	417	12	to	to	IN
10_1101-2021_01_08_425864	417	13	an	an	DT
10_1101-2021_01_08_425864	417	14	increase	increase	NN
10_1101-2021_01_08_425864	417	15	in	in	IN
10_1101-2021_01_08_425864	417	16	CO2	CO2	NNP
10_1101-2021_01_08_425864	417	17	production	production	NN
10_1101-2021_01_08_425864	417	18	from	from	IN
10_1101-2021_01_08_425864	417	19	644	644	CD
10_1101-2021_01_08_425864	417	20	labelled	label	VBN
10_1101-2021_01_08_425864	417	21	palmitate	palmitate	NN
10_1101-2021_01_08_425864	417	22	[	[	-LRB-
10_1101-2021_01_08_425864	417	23	39	39	CD
10_1101-2021_01_08_425864	417	24	]	]	-RRB-
10_1101-2021_01_08_425864	417	25	.	.	.
10_1101-2021_01_08_425864	418	1	The	the	DT
10_1101-2021_01_08_425864	418	2	ETO	ETO	NNP
10_1101-2021_01_08_425864	418	3	treatment	treatment	NN
10_1101-2021_01_08_425864	418	4	inhibited	inhibit	VBD
10_1101-2021_01_08_425864	418	5	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	418	6	in	in	IN
10_1101-2021_01_08_425864	418	7	vitro	vitro	FW
10_1101-2021_01_08_425864	418	8	,	,	,
10_1101-2021_01_08_425864	418	9	showing	show	VBG
10_1101-2021_01_08_425864	418	10	that	that	IN
10_1101-2021_01_08_425864	418	11	the	the	DT
10_1101-2021_01_08_425864	418	12	645	645	CD
10_1101-2021_01_08_425864	418	13	consumption	consumption	NN
10_1101-2021_01_08_425864	418	14	of	of	IN
10_1101-2021_01_08_425864	418	15	internal	internal	JJ
10_1101-2021_01_08_425864	418	16	fatty	fatty	NN
10_1101-2021_01_08_425864	418	17	acids	acid	NNS
10_1101-2021_01_08_425864	418	18	is	be	VBZ
10_1101-2021_01_08_425864	418	19	important	important	JJ
10_1101-2021_01_08_425864	418	20	for	for	IN
10_1101-2021_01_08_425864	418	21	cell	cell	NN
10_1101-2021_01_08_425864	418	22	differentiation	differentiation	NN
10_1101-2021_01_08_425864	418	23	.	.	.
10_1101-2021_01_08_425864	419	1	Consequently	consequently	RB
10_1101-2021_01_08_425864	419	2	,	,	,
10_1101-2021_01_08_425864	419	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	419	4	propose	propose	VBP
10_1101-2021_01_08_425864	419	5	646	646	CD
10_1101-2021_01_08_425864	419	6	that	that	IN
10_1101-2021_01_08_425864	419	7	lipids	lipid	NNS
10_1101-2021_01_08_425864	419	8	are	be	VBP
10_1101-2021_01_08_425864	419	9	not	not	RB
10_1101-2021_01_08_425864	419	10	only	only	RB
10_1101-2021_01_08_425864	419	11	external	external	JJ
10_1101-2021_01_08_425864	419	12	signals	signal	NNS
10_1101-2021_01_08_425864	419	13	of	of	IN
10_1101-2021_01_08_425864	419	14	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	419	15	,	,	,
10_1101-2021_01_08_425864	419	16	as	as	IN
10_1101-2021_01_08_425864	419	17	previously	previously	RB
10_1101-2021_01_08_425864	419	18	suggested	suggest	VBN
10_1101-2021_01_08_425864	419	19	[	[	-LRB-
10_1101-2021_01_08_425864	419	20	56	56	CD
10_1101-2021_01_08_425864	419	21	]	]	-RRB-
10_1101-2021_01_08_425864	419	22	,	,	,
10_1101-2021_01_08_425864	419	23	but	but	CC
10_1101-2021_01_08_425864	419	24	they	-PRON-	PRP
10_1101-2021_01_08_425864	419	25	647	647	CD
10_1101-2021_01_08_425864	419	26	also	also	RB
10_1101-2021_01_08_425864	419	27	have	have	VBP
10_1101-2021_01_08_425864	419	28	a	a	DT
10_1101-2021_01_08_425864	419	29	central	central	JJ
10_1101-2021_01_08_425864	419	30	role	role	NN
10_1101-2021_01_08_425864	419	31	in	in	IN
10_1101-2021_01_08_425864	419	32	the	the	DT
10_1101-2021_01_08_425864	419	33	bioenergetics	bioenergetic	NNS
10_1101-2021_01_08_425864	419	34	of	of	IN
10_1101-2021_01_08_425864	419	35	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	419	36	.	.	.
10_1101-2021_01_08_425864	420	1	As	as	IN
10_1101-2021_01_08_425864	420	2	in	in	IN
10_1101-2021_01_08_425864	420	3	the	the	DT
10_1101-2021_01_08_425864	420	4	oxidation	oxidation	NN
10_1101-2021_01_08_425864	420	5	of	of	IN
10_1101-2021_01_08_425864	420	6	several	several	JJ
10_1101-2021_01_08_425864	420	7	amino	amino	JJ
10_1101-2021_01_08_425864	420	8	648	648	CD
10_1101-2021_01_08_425864	420	9	acids	acid	NNS
10_1101-2021_01_08_425864	420	10	,	,	,
10_1101-2021_01_08_425864	420	11	the	the	DT
10_1101-2021_01_08_425864	420	12	acetyl	acetyl	NNP
10_1101-2021_01_08_425864	420	13	-	-	HYPH
10_1101-2021_01_08_425864	420	14	CoA	CoA	NNP
10_1101-2021_01_08_425864	420	15	produced	produce	VBN
10_1101-2021_01_08_425864	420	16	from	from	IN
10_1101-2021_01_08_425864	420	17	beta	beta	NN
10_1101-2021_01_08_425864	420	18	-	-	HYPH
10_1101-2021_01_08_425864	420	19	oxidation	oxidation	NN
10_1101-2021_01_08_425864	420	20	and	and	CC
10_1101-2021_01_08_425864	420	21	probably	probably	RB
10_1101-2021_01_08_425864	420	22	the	the	DT
10_1101-2021_01_08_425864	420	23	reduced	reduce	VBN
10_1101-2021_01_08_425864	420	24	cofactors	cofactor	NNS
10_1101-2021_01_08_425864	420	25	resulting	result	VBG
10_1101-2021_01_08_425864	420	26	649	649	CD
10_1101-2021_01_08_425864	420	27	from	from	IN
10_1101-2021_01_08_425864	420	28	these	these	DT
10_1101-2021_01_08_425864	420	29	processes	process	NNS
10_1101-2021_01_08_425864	420	30	are	be	VBP
10_1101-2021_01_08_425864	420	31	contributing	contribute	VBG
10_1101-2021_01_08_425864	420	32	to	to	IN
10_1101-2021_01_08_425864	420	33	the	the	DT
10_1101-2021_01_08_425864	420	34	mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	420	35	ATP	atp	NN
10_1101-2021_01_08_425864	420	36	production	production	NN
10_1101-2021_01_08_425864	420	37	necessary	necessary	JJ
10_1101-2021_01_08_425864	420	38	to	to	TO
10_1101-2021_01_08_425864	420	39	support	support	VB
10_1101-2021_01_08_425864	420	40	this	this	DT
10_1101-2021_01_08_425864	420	41	650	650	CD
10_1101-2021_01_08_425864	420	42	differentiation	differentiation	NN
10_1101-2021_01_08_425864	420	43	step	step	NN
10_1101-2021_01_08_425864	420	44	.	.	.
10_1101-2021_01_08_425864	421	1	651	651	CD
10_1101-2021_01_08_425864	421	2	In	in	IN
10_1101-2021_01_08_425864	421	3	conclusion	conclusion	NN
10_1101-2021_01_08_425864	421	4	,	,	,
10_1101-2021_01_08_425864	421	5	fatty	fatty	NN
10_1101-2021_01_08_425864	421	6	acids	acid	NNS
10_1101-2021_01_08_425864	421	7	are	be	VBP
10_1101-2021_01_08_425864	421	8	important	important	JJ
10_1101-2021_01_08_425864	421	9	carbon	carbon	NN
10_1101-2021_01_08_425864	421	10	sources	source	NNS
10_1101-2021_01_08_425864	421	11	for	for	IN
10_1101-2021_01_08_425864	421	12	T.	T.	NNP
10_1101-2021_01_08_425864	421	13	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	421	14	epimastigotes	epimastigote	VBZ
10_1101-2021_01_08_425864	421	15	in	in	IN
10_1101-2021_01_08_425864	421	16	the	the	DT
10_1101-2021_01_08_425864	421	17	652	652	CD
10_1101-2021_01_08_425864	421	18	absence	absence	NN
10_1101-2021_01_08_425864	421	19	of	of	IN
10_1101-2021_01_08_425864	421	20	glucose	glucose	NN
10_1101-2021_01_08_425864	421	21	.	.	.
10_1101-2021_01_08_425864	422	1	Palmitate	palmitate	NN
10_1101-2021_01_08_425864	422	2	can	can	MD
10_1101-2021_01_08_425864	422	3	be	be	VB
10_1101-2021_01_08_425864	422	4	taken	take	VBN
10_1101-2021_01_08_425864	422	5	up	up	RP
10_1101-2021_01_08_425864	422	6	by	by	IN
10_1101-2021_01_08_425864	422	7	the	the	DT
10_1101-2021_01_08_425864	422	8	cells	cell	NNS
10_1101-2021_01_08_425864	422	9	and	and	CC
10_1101-2021_01_08_425864	422	10	fuel	fuel	VB
10_1101-2021_01_08_425864	422	11	the	the	DT
10_1101-2021_01_08_425864	422	12	TCA	TCA	NNP
10_1101-2021_01_08_425864	422	13	cycle	cycle	NN
10_1101-2021_01_08_425864	422	14	by	by	IN
10_1101-2021_01_08_425864	422	15	producing	produce	VBG
10_1101-2021_01_08_425864	422	16	653	653	CD
10_1101-2021_01_08_425864	422	17	acetyl	acetyl	NN
10_1101-2021_01_08_425864	422	18	-	-	HYPH
10_1101-2021_01_08_425864	422	19	CoA	CoA	NNP
10_1101-2021_01_08_425864	422	20	,	,	,
10_1101-2021_01_08_425864	422	21	the	the	DT
10_1101-2021_01_08_425864	422	22	oxidation	oxidation	NN
10_1101-2021_01_08_425864	422	23	of	of	IN
10_1101-2021_01_08_425864	422	24	which	which	WDT
10_1101-2021_01_08_425864	422	25	generates	generate	VBZ
10_1101-2021_01_08_425864	422	26	CO2	CO2	NNP
10_1101-2021_01_08_425864	422	27	.	.	.
10_1101-2021_01_08_425864	423	1	However	however	RB
10_1101-2021_01_08_425864	423	2	,	,	,
10_1101-2021_01_08_425864	423	3	in	in	IN
10_1101-2021_01_08_425864	423	4	the	the	DT
10_1101-2021_01_08_425864	423	5	absence	absence	NN
10_1101-2021_01_08_425864	423	6	of	of	IN
10_1101-2021_01_08_425864	423	7	external	external	JJ
10_1101-2021_01_08_425864	423	8	carbon	carbon	NN
10_1101-2021_01_08_425864	423	9	.CC	.CC	.
10_1101-2021_01_08_425864	423	10	-	-	:
10_1101-2021_01_08_425864	423	11	BY	by	IN
10_1101-2021_01_08_425864	423	12	4.0	4.0	CD
10_1101-2021_01_08_425864	423	13	International	international	JJ
10_1101-2021_01_08_425864	423	14	licensemade	licensemade	NN
10_1101-2021_01_08_425864	423	15	available	available	JJ
10_1101-2021_01_08_425864	423	16	under	under	IN
10_1101-2021_01_08_425864	423	17	a	a	DT
10_1101-2021_01_08_425864	423	18	(	(	-LRB-
10_1101-2021_01_08_425864	423	19	which	which	WDT
10_1101-2021_01_08_425864	423	20	was	be	VBD
10_1101-2021_01_08_425864	423	21	not	not	RB
10_1101-2021_01_08_425864	423	22	certified	certify	VBN
10_1101-2021_01_08_425864	423	23	by	by	IN
10_1101-2021_01_08_425864	423	24	peer	peer	NN
10_1101-2021_01_08_425864	423	25	review	review	NN
10_1101-2021_01_08_425864	423	26	)	)	-RRB-
10_1101-2021_01_08_425864	423	27	is	be	VBZ
10_1101-2021_01_08_425864	423	28	the	the	DT
10_1101-2021_01_08_425864	423	29	author	author	NN
10_1101-2021_01_08_425864	423	30	/	/	SYM
10_1101-2021_01_08_425864	423	31	funder	funder	NN
10_1101-2021_01_08_425864	423	32	,	,	,
10_1101-2021_01_08_425864	423	33	who	who	WP
10_1101-2021_01_08_425864	423	34	has	have	VBZ
10_1101-2021_01_08_425864	423	35	granted	grant	VBN
10_1101-2021_01_08_425864	423	36	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	423	37	a	a	DT
10_1101-2021_01_08_425864	423	38	license	license	NN
10_1101-2021_01_08_425864	423	39	to	to	TO
10_1101-2021_01_08_425864	423	40	display	display	VB
10_1101-2021_01_08_425864	423	41	the	the	DT
10_1101-2021_01_08_425864	423	42	preprint	preprint	NN
10_1101-2021_01_08_425864	423	43	in	in	IN
10_1101-2021_01_08_425864	423	44	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	423	45	.	.	.
10_1101-2021_01_08_425864	424	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	424	2	is	be	VBZ
10_1101-2021_01_08_425864	424	3	The	the	DT
10_1101-2021_01_08_425864	424	4	copyright	copyright	NN
10_1101-2021_01_08_425864	424	5	holder	holder	NN
10_1101-2021_01_08_425864	424	6	for	for	IN
10_1101-2021_01_08_425864	424	7	this	this	DT
10_1101-2021_01_08_425864	424	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	424	9	version	version	NN
10_1101-2021_01_08_425864	424	10	posted	post	VBD
10_1101-2021_01_08_425864	424	11	January	January	NNP
10_1101-2021_01_08_425864	424	12	8	8	CD
10_1101-2021_01_08_425864	424	13	,	,	,
10_1101-2021_01_08_425864	424	14	2021	2021	CD
10_1101-2021_01_08_425864	424	15	.	.	.
10_1101-2021_01_08_425864	424	16	;	;	:
10_1101-2021_01_08_425864	424	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	424	18	:	:	:
10_1101-2021_01_08_425864	424	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	424	20	preprint	preprint	NN
10_1101-2021_01_08_425864	424	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	424	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	424	23	654	654	CD
10_1101-2021_01_08_425864	424	24	sources	source	NNS
10_1101-2021_01_08_425864	424	25	,	,	,
10_1101-2021_01_08_425864	424	26	lipid	lipid	NN
10_1101-2021_01_08_425864	424	27	droplets	droplet	NNS
10_1101-2021_01_08_425864	424	28	become	become	VBP
10_1101-2021_01_08_425864	424	29	the	the	DT
10_1101-2021_01_08_425864	424	30	primary	primary	JJ
10_1101-2021_01_08_425864	424	31	sources	source	NNS
10_1101-2021_01_08_425864	424	32	of	of	IN
10_1101-2021_01_08_425864	424	33	fatty	fatty	NN
10_1101-2021_01_08_425864	424	34	acids	acid	NNS
10_1101-2021_01_08_425864	424	35	,	,	,
10_1101-2021_01_08_425864	424	36	helping	help	VBG
10_1101-2021_01_08_425864	424	37	the	the	DT
10_1101-2021_01_08_425864	424	38	organism	organism	NN
10_1101-2021_01_08_425864	424	39	to	to	TO
10_1101-2021_01_08_425864	424	40	survive	survive	VB
10_1101-2021_01_08_425864	424	41	655	655	CD
10_1101-2021_01_08_425864	424	42	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	424	43	stress	stress	NN
10_1101-2021_01_08_425864	424	44	.	.	.
10_1101-2021_01_08_425864	425	1	Importantly	importantly	RB
10_1101-2021_01_08_425864	425	2	,	,	,
10_1101-2021_01_08_425864	425	3	FAO	FAO	NNP
10_1101-2021_01_08_425864	425	4	supports	support	VBZ
10_1101-2021_01_08_425864	425	5	endogenous	endogenous	JJ
10_1101-2021_01_08_425864	425	6	respiration	respiration	NN
10_1101-2021_01_08_425864	425	7	rates	rate	NNS
10_1101-2021_01_08_425864	425	8	and	and	CC
10_1101-2021_01_08_425864	425	9	ATP	atp	NN
10_1101-2021_01_08_425864	425	10	production	production	NN
10_1101-2021_01_08_425864	425	11	and	and	CC
10_1101-2021_01_08_425864	425	12	656	656	CD
10_1101-2021_01_08_425864	425	13	powers	power	NNS
10_1101-2021_01_08_425864	425	14	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	425	15	.	.	.
10_1101-2021_01_08_425864	426	1	657	657	CD
10_1101-2021_01_08_425864	426	2	658	658	CD
10_1101-2021_01_08_425864	426	3	659	659	CD
10_1101-2021_01_08_425864	426	4	Acknowledgements	acknowledgement	NNS
10_1101-2021_01_08_425864	426	5	660	660	CD
10_1101-2021_01_08_425864	426	6	We	-PRON-	PRP
10_1101-2021_01_08_425864	426	7	thank	thank	VBP
10_1101-2021_01_08_425864	426	8	the	the	DT
10_1101-2021_01_08_425864	426	9	Core	Core	NNP
10_1101-2021_01_08_425864	426	10	Facility	Facility	NNP
10_1101-2021_01_08_425864	426	11	for	for	IN
10_1101-2021_01_08_425864	426	12	Scientific	Scientific	NNP
10_1101-2021_01_08_425864	426	13	Research	Research	NNP
10_1101-2021_01_08_425864	426	14	at	at	IN
10_1101-2021_01_08_425864	426	15	the	the	DT
10_1101-2021_01_08_425864	426	16	University	University	NNP
10_1101-2021_01_08_425864	426	17	of	of	IN
10_1101-2021_01_08_425864	426	18	Sao	Sao	NNP
10_1101-2021_01_08_425864	426	19	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	426	20	(	(	-LRB-
10_1101-2021_01_08_425864	426	21	CEFAP-	CEFAP-	NNP
10_1101-2021_01_08_425864	426	22	661	661	CD
10_1101-2021_01_08_425864	426	23	USP	USP	NNP
10_1101-2021_01_08_425864	426	24	/	/	SYM
10_1101-2021_01_08_425864	426	25	FLUIR	FLUIR	NNP
10_1101-2021_01_08_425864	426	26	)	)	-RRB-
10_1101-2021_01_08_425864	426	27	for	for	IN
10_1101-2021_01_08_425864	426	28	the	the	DT
10_1101-2021_01_08_425864	426	29	flow	flow	NN
10_1101-2021_01_08_425864	426	30	cytometry	cytometry	NN
10_1101-2021_01_08_425864	426	31	analysis	analysis	NN
10_1101-2021_01_08_425864	426	32	and	and	CC
10_1101-2021_01_08_425864	426	33	Dr.	Dr.	NNP
10_1101-2021_01_08_425864	426	34	Mauro	Mauro	NNP
10_1101-2021_01_08_425864	426	35	Javier	Javier	NNP
10_1101-2021_01_08_425864	426	36	Veliz	Veliz	NNP
10_1101-2021_01_08_425864	426	37	Cortez	Cortez	NNP
10_1101-2021_01_08_425864	426	38	(	(	-LRB-
10_1101-2021_01_08_425864	426	39	Department	Department	NNP
10_1101-2021_01_08_425864	426	40	of	of	IN
10_1101-2021_01_08_425864	426	41	662	662	CD
10_1101-2021_01_08_425864	426	42	Parasitology	Parasitology	NNP
10_1101-2021_01_08_425864	426	43	,	,	,
10_1101-2021_01_08_425864	426	44	ICB	ICB	NNP
10_1101-2021_01_08_425864	426	45	-	-	HYPH
10_1101-2021_01_08_425864	426	46	USP	USP	NNP
10_1101-2021_01_08_425864	426	47	)	)	-RRB-
10_1101-2021_01_08_425864	426	48	for	for	IN
10_1101-2021_01_08_425864	426	49	the	the	DT
10_1101-2021_01_08_425864	426	50	microscopy	microscopy	JJ
10_1101-2021_01_08_425864	426	51	work	work	NN
10_1101-2021_01_08_425864	426	52	.	.	.
10_1101-2021_01_08_425864	427	1	We	-PRON-	PRP
10_1101-2021_01_08_425864	427	2	thank	thank	VBP
10_1101-2021_01_08_425864	427	3	the	the	DT
10_1101-2021_01_08_425864	427	4	Core	Core	NNP
10_1101-2021_01_08_425864	427	5	Facility	Facility	NNP
10_1101-2021_01_08_425864	427	6	for	for	IN
10_1101-2021_01_08_425864	427	7	Scientific	Scientific	NNP
10_1101-2021_01_08_425864	427	8	Research	Research	NNP
10_1101-2021_01_08_425864	427	9	663	663	CD
10_1101-2021_01_08_425864	427	10	at	at	IN
10_1101-2021_01_08_425864	427	11	the	the	DT
10_1101-2021_01_08_425864	427	12	University	University	NNP
10_1101-2021_01_08_425864	427	13	of	of	IN
10_1101-2021_01_08_425864	427	14	Sao	Sao	NNP
10_1101-2021_01_08_425864	427	15	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	427	16	(	(	-LRB-
10_1101-2021_01_08_425864	427	17	CEFAP	CEFAP	NNP
10_1101-2021_01_08_425864	427	18	-	-	HYPH
10_1101-2021_01_08_425864	427	19	USP	USP	NNP
10_1101-2021_01_08_425864	427	20	/	/	SYM
10_1101-2021_01_08_425864	427	21	FLUIR	FLUIR	NNP
10_1101-2021_01_08_425864	427	22	)	)	-RRB-
10_1101-2021_01_08_425864	427	23	for	for	IN
10_1101-2021_01_08_425864	427	24	the	the	DT
10_1101-2021_01_08_425864	427	25	flow	flow	NN
10_1101-2021_01_08_425864	427	26	cytometry	cytometry	NN
10_1101-2021_01_08_425864	427	27	analysis	analysis	NN
10_1101-2021_01_08_425864	427	28	and	and	CC
10_1101-2021_01_08_425864	427	29	Dr.	Dr.	NNP
10_1101-2021_01_08_425864	427	30	Mauro	Mauro	NNP
10_1101-2021_01_08_425864	427	31	664	664	CD
10_1101-2021_01_08_425864	427	32	Javier	Javier	NNP
10_1101-2021_01_08_425864	427	33	Veliz	Veliz	NNP
10_1101-2021_01_08_425864	427	34	Cortez	Cortez	NNP
10_1101-2021_01_08_425864	427	35	(	(	-LRB-
10_1101-2021_01_08_425864	427	36	Department	Department	NNP
10_1101-2021_01_08_425864	427	37	of	of	IN
10_1101-2021_01_08_425864	427	38	Parasitology	Parasitology	NNP
10_1101-2021_01_08_425864	427	39	,	,	,
10_1101-2021_01_08_425864	427	40	ICB	ICB	NNP
10_1101-2021_01_08_425864	427	41	-	-	HYPH
10_1101-2021_01_08_425864	427	42	USP	USP	NNP
10_1101-2021_01_08_425864	427	43	)	)	-RRB-
10_1101-2021_01_08_425864	427	44	for	for	IN
10_1101-2021_01_08_425864	427	45	the	the	DT
10_1101-2021_01_08_425864	427	46	microscopy	microscopy	JJ
10_1101-2021_01_08_425864	427	47	support	support	NN
10_1101-2021_01_08_425864	427	48	.	.	.
10_1101-2021_01_08_425864	428	1	665	665	CD
10_1101-2021_01_08_425864	428	2	666	666	CD
10_1101-2021_01_08_425864	428	3	References	reference	NNS
10_1101-2021_01_08_425864	428	4	667	667	CD
10_1101-2021_01_08_425864	428	5	[	[	-LRB-
10_1101-2021_01_08_425864	428	6	1	1	CD
10_1101-2021_01_08_425864	428	7	]	]	-RRB-
10_1101-2021_01_08_425864	428	8	WHO	who	WP
10_1101-2021_01_08_425864	428	9	|	|	NNP
10_1101-2021_01_08_425864	428	10	Chagas	Chagas	NNP
10_1101-2021_01_08_425864	428	11	disease	disease	NN
10_1101-2021_01_08_425864	428	12	(	(	-LRB-
10_1101-2021_01_08_425864	428	13	American	american	JJ
10_1101-2021_01_08_425864	428	14	trypanosomiasis	trypanosomiasis	NN
10_1101-2021_01_08_425864	428	15	)	)	-RRB-
10_1101-2021_01_08_425864	428	16	,	,	,
10_1101-2021_01_08_425864	428	17	WHO	who	WP
10_1101-2021_01_08_425864	428	18	.	.	.
10_1101-2021_01_08_425864	429	1	(	(	-LRB-
10_1101-2021_01_08_425864	429	2	2018	2018	CD
10_1101-2021_01_08_425864	429	3	)	)	-RRB-
10_1101-2021_01_08_425864	429	4	.	.	.
10_1101-2021_01_08_425864	430	1	668	668	CD
10_1101-2021_01_08_425864	430	2	https://www.who.int/chagas/en/	https://www.who.int/chagas/en/	NNP
10_1101-2021_01_08_425864	430	3	(	(	-LRB-
10_1101-2021_01_08_425864	430	4	accessed	access	VBN
10_1101-2021_01_08_425864	430	5	January	January	NNP
10_1101-2021_01_08_425864	430	6	29	29	CD
10_1101-2021_01_08_425864	430	7	,	,	,
10_1101-2021_01_08_425864	430	8	2019	2019	CD
10_1101-2021_01_08_425864	430	9	)	)	-RRB-
10_1101-2021_01_08_425864	430	10	.	.	.
10_1101-2021_01_08_425864	431	1	669	669	CD
10_1101-2021_01_08_425864	431	2	[	[	-LRB-
10_1101-2021_01_08_425864	431	3	2	2	CD
10_1101-2021_01_08_425864	431	4	]	]	-RRB-
10_1101-2021_01_08_425864	431	5	J.A.	J.A.	NNP
10_1101-2021_01_08_425864	432	1	Perez	Perez	NNP
10_1101-2021_01_08_425864	432	2	-	-	HYPH
10_1101-2021_01_08_425864	432	3	Molina	Molina	NNP
10_1101-2021_01_08_425864	432	4	,	,	,
10_1101-2021_01_08_425864	432	5	I.	I.	NNP
10_1101-2021_01_08_425864	432	6	Molina	Molina	NNP
10_1101-2021_01_08_425864	432	7	,	,	,
10_1101-2021_01_08_425864	432	8	Chagas	Chagas	NNP
10_1101-2021_01_08_425864	432	9	disease	disease	NN
10_1101-2021_01_08_425864	432	10	,	,	,
10_1101-2021_01_08_425864	432	11	Lancet	Lancet	NNP
10_1101-2021_01_08_425864	432	12	.	.	.
10_1101-2021_01_08_425864	433	1	391	391	CD
10_1101-2021_01_08_425864	433	2	(	(	-LRB-
10_1101-2021_01_08_425864	433	3	2018	2018	CD
10_1101-2021_01_08_425864	433	4	)	)	-RRB-
10_1101-2021_01_08_425864	433	5	82–94	82–94	CD
10_1101-2021_01_08_425864	433	6	.	.	.
10_1101-2021_01_08_425864	434	1	670	670	CD
10_1101-2021_01_08_425864	434	2	https://doi.org/10.1016/S0140-6736(17)31612-4	https://doi.org/10.1016/S0140-6736(17)31612-4	NNP
10_1101-2021_01_08_425864	434	3	.	.	.
10_1101-2021_01_08_425864	435	1	671	671	CD
10_1101-2021_01_08_425864	435	2	[	[	-LRB-
10_1101-2021_01_08_425864	435	3	3	3	CD
10_1101-2021_01_08_425864	435	4	]	]	-RRB-
10_1101-2021_01_08_425864	435	5	R.	R.	NNP
10_1101-2021_01_08_425864	435	6	de	de	NNP
10_1101-2021_01_08_425864	435	7	F.P.	F.P.	NNP
10_1101-2021_01_08_425864	436	1	Melo	Melo	NNP
10_1101-2021_01_08_425864	436	2	,	,	,
10_1101-2021_01_08_425864	436	3	A.A.	A.A.	NNP
10_1101-2021_01_08_425864	436	4	Guarneri	Guarneri	NNP
10_1101-2021_01_08_425864	436	5	,	,	,
10_1101-2021_01_08_425864	436	6	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	436	7	Silber	Silber	NNP
10_1101-2021_01_08_425864	436	8	,	,	,
10_1101-2021_01_08_425864	436	9	The	the	DT
10_1101-2021_01_08_425864	436	10	influence	influence	NN
10_1101-2021_01_08_425864	436	11	of	of	IN
10_1101-2021_01_08_425864	436	12	environmental	environmental	JJ
10_1101-2021_01_08_425864	436	13	cues	cue	NNS
10_1101-2021_01_08_425864	436	14	on	on	IN
10_1101-2021_01_08_425864	436	15	the	the	DT
10_1101-2021_01_08_425864	436	16	672	672	CD
10_1101-2021_01_08_425864	436	17	development	development	NN
10_1101-2021_01_08_425864	436	18	of	of	IN
10_1101-2021_01_08_425864	436	19	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	436	20	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	436	21	in	in	IN
10_1101-2021_01_08_425864	436	22	triatominae	triatominae	NN
10_1101-2021_01_08_425864	436	23	vector	vector	NN
10_1101-2021_01_08_425864	436	24	,	,	,
10_1101-2021_01_08_425864	436	25	Front	Front	NNP
10_1101-2021_01_08_425864	436	26	.	.	.
10_1101-2021_01_08_425864	437	1	Cell	cell	NN
10_1101-2021_01_08_425864	437	2	.	.	.
10_1101-2021_01_08_425864	438	1	Infect	infect	VB
10_1101-2021_01_08_425864	438	2	.	.	.
10_1101-2021_01_08_425864	439	1	Microbiol	Microbiol	NNP
10_1101-2021_01_08_425864	439	2	.	.	.
10_1101-2021_01_08_425864	440	1	10	10	CD
10_1101-2021_01_08_425864	440	2	673	673	CD
10_1101-2021_01_08_425864	440	3	(	(	-LRB-
10_1101-2021_01_08_425864	440	4	2020	2020	CD
10_1101-2021_01_08_425864	440	5	)	)	-RRB-
10_1101-2021_01_08_425864	440	6	27	27	CD
10_1101-2021_01_08_425864	440	7	.	.	.
10_1101-2021_01_08_425864	440	8	https://doi.org/10.3389/fcimb.2020.00027	https://doi.org/10.3389/fcimb.2020.00027	NNP
10_1101-2021_01_08_425864	440	9	.	.	.
10_1101-2021_01_08_425864	441	1	674	674	CD
10_1101-2021_01_08_425864	441	2	[	[	-LRB-
10_1101-2021_01_08_425864	441	3	4	4	CD
10_1101-2021_01_08_425864	441	4	]	]	-RRB-
10_1101-2021_01_08_425864	441	5	W.	W.	NNP
10_1101-2021_01_08_425864	441	6	De	De	NNP
10_1101-2021_01_08_425864	441	7	Souza	Souza	NNP
10_1101-2021_01_08_425864	441	8	,	,	,
10_1101-2021_01_08_425864	441	9	Basic	basic	JJ
10_1101-2021_01_08_425864	441	10	cell	cell	NN
10_1101-2021_01_08_425864	441	11	biology	biology	NN
10_1101-2021_01_08_425864	441	12	of	of	IN
10_1101-2021_01_08_425864	441	13	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	441	14	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	441	15	.	.	.
10_1101-2021_01_08_425864	442	1	Curr	curr	UH
10_1101-2021_01_08_425864	442	2	.	.	.
10_1101-2021_01_08_425864	443	1	Pharm	Pharm	NNP
10_1101-2021_01_08_425864	443	2	.	.	.
10_1101-2021_01_08_425864	444	1	Des	Des	NNP
10_1101-2021_01_08_425864	444	2	.	.	.
10_1101-2021_01_08_425864	445	1	8	8	CD
10_1101-2021_01_08_425864	445	2	(	(	-LRB-
10_1101-2021_01_08_425864	445	3	2002	2002	CD
10_1101-2021_01_08_425864	445	4	)	)	-RRB-
10_1101-2021_01_08_425864	445	5	269–85	269–85	CD
10_1101-2021_01_08_425864	445	6	.	.	.
10_1101-2021_01_08_425864	446	1	675	675	CD
10_1101-2021_01_08_425864	446	2	http://www.ncbi.nlm.nih.gov/pubmed/11860366	http://www.ncbi.nlm.nih.gov/pubmed/11860366	NNS
10_1101-2021_01_08_425864	446	3	.	.	.
10_1101-2021_01_08_425864	447	1	676	676	CD
10_1101-2021_01_08_425864	447	2	[	[	-LRB-
10_1101-2021_01_08_425864	447	3	5	5	CD
10_1101-2021_01_08_425864	447	4	]	]	-RRB-
10_1101-2021_01_08_425864	447	5	P.	P.	NNP
10_1101-2021_01_08_425864	447	6	Lisvane	Lisvane	NNP
10_1101-2021_01_08_425864	447	7	Silva	Silva	NNP
10_1101-2021_01_08_425864	447	8	,	,	,
10_1101-2021_01_08_425864	447	9	B.S.	B.S.	NNP
10_1101-2021_01_08_425864	448	1	Mantilla	Mantilla	NNP
10_1101-2021_01_08_425864	448	2	,	,	,
10_1101-2021_01_08_425864	448	3	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	448	4	Barison	Barison	NNP
10_1101-2021_01_08_425864	448	5	,	,	,
10_1101-2021_01_08_425864	448	6	C.	C.	NNP
10_1101-2021_01_08_425864	448	7	Wrenger	Wrenger	NNP
10_1101-2021_01_08_425864	448	8	,	,	,
10_1101-2021_01_08_425864	448	9	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	448	10	Silber	Silber	NNP
10_1101-2021_01_08_425864	448	11	,	,	,
10_1101-2021_01_08_425864	448	12	The	the	DT
10_1101-2021_01_08_425864	448	13	uniqueness	uniqueness	NN
10_1101-2021_01_08_425864	448	14	of	of	IN
10_1101-2021_01_08_425864	448	15	677	677	CD
10_1101-2021_01_08_425864	448	16	the	the	DT
10_1101-2021_01_08_425864	448	17	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	448	18	cruzi	cruzi	NN
10_1101-2021_01_08_425864	448	19	mitochondrion	mitochondrion	NN
10_1101-2021_01_08_425864	448	20	:	:	:
10_1101-2021_01_08_425864	448	21	opportunities	opportunity	NNS
10_1101-2021_01_08_425864	448	22	to	to	TO
10_1101-2021_01_08_425864	448	23	identify	identify	VB
10_1101-2021_01_08_425864	448	24	new	new	JJ
10_1101-2021_01_08_425864	448	25	drug	drug	NN
10_1101-2021_01_08_425864	448	26	target	target	NN
10_1101-2021_01_08_425864	448	27	for	for	IN
10_1101-2021_01_08_425864	448	28	the	the	DT
10_1101-2021_01_08_425864	448	29	678	678	CD
10_1101-2021_01_08_425864	448	30	treatment	treatment	NN
10_1101-2021_01_08_425864	448	31	of	of	IN
10_1101-2021_01_08_425864	448	32	Chagas	Chagas	NNP
10_1101-2021_01_08_425864	448	33	disease	disease	NN
10_1101-2021_01_08_425864	448	34	,	,	,
10_1101-2021_01_08_425864	448	35	Curr	Curr	NNP
10_1101-2021_01_08_425864	448	36	Pharm	Pharm	NNP
10_1101-2021_01_08_425864	448	37	Des	Des	NNP
10_1101-2021_01_08_425864	448	38	.	.	.
10_1101-2021_01_08_425864	449	1	17	17	CD
10_1101-2021_01_08_425864	449	2	(	(	-LRB-
10_1101-2021_01_08_425864	449	3	2011	2011	CD
10_1101-2021_01_08_425864	449	4	)	)	-RRB-
10_1101-2021_01_08_425864	449	5	2074–2099	2074–2099	CD
10_1101-2021_01_08_425864	449	6	.	.	.
10_1101-2021_01_08_425864	450	1	679	679	CD
10_1101-2021_01_08_425864	450	2	https://www.ncbi.nlm.nih.gov/pubmed/21718252	https://www.ncbi.nlm.nih.gov/pubmed/21718252	NN
10_1101-2021_01_08_425864	450	3	.	.	.
10_1101-2021_01_08_425864	451	1	680	680	CD
10_1101-2021_01_08_425864	451	2	[	[	-LRB-
10_1101-2021_01_08_425864	451	3	6	6	CD
10_1101-2021_01_08_425864	451	4	]	]	-RRB-
10_1101-2021_01_08_425864	451	5	C.	C.	NNP
10_1101-2021_01_08_425864	451	6	Bern	Bern	NNP
10_1101-2021_01_08_425864	451	7	,	,	,
10_1101-2021_01_08_425864	451	8	Chagas	Chagas	NNP
10_1101-2021_01_08_425864	451	9	’	'	''
10_1101-2021_01_08_425864	451	10	Disease	Disease	NNP
10_1101-2021_01_08_425864	451	11	,	,	,
10_1101-2021_01_08_425864	451	12	N	N	NNP
10_1101-2021_01_08_425864	451	13	Engl	Engl	NNP
10_1101-2021_01_08_425864	451	14	J	J	NNP
10_1101-2021_01_08_425864	451	15	Med	Med	NNP
10_1101-2021_01_08_425864	451	16	.	.	.
10_1101-2021_01_08_425864	452	1	373	373	CD
10_1101-2021_01_08_425864	452	2	(	(	-LRB-
10_1101-2021_01_08_425864	452	3	2015	2015	CD
10_1101-2021_01_08_425864	452	4	)	)	-RRB-
10_1101-2021_01_08_425864	452	5	1882	1882	CD
10_1101-2021_01_08_425864	452	6	.	.	.
10_1101-2021_01_08_425864	453	1	681	681	CD
10_1101-2021_01_08_425864	453	2	https://doi.org/10.1056/NEJMc1510996	https://doi.org/10.1056/nejmc1510996	JJ
10_1101-2021_01_08_425864	453	3	.CC	.CC	,
10_1101-2021_01_08_425864	453	4	-	-	:
10_1101-2021_01_08_425864	453	5	BY	by	IN
10_1101-2021_01_08_425864	453	6	4.0	4.0	CD
10_1101-2021_01_08_425864	453	7	International	international	JJ
10_1101-2021_01_08_425864	453	8	licensemade	licensemade	NN
10_1101-2021_01_08_425864	453	9	available	available	JJ
10_1101-2021_01_08_425864	453	10	under	under	IN
10_1101-2021_01_08_425864	453	11	a	a	DT
10_1101-2021_01_08_425864	453	12	(	(	-LRB-
10_1101-2021_01_08_425864	453	13	which	which	WDT
10_1101-2021_01_08_425864	453	14	was	be	VBD
10_1101-2021_01_08_425864	453	15	not	not	RB
10_1101-2021_01_08_425864	453	16	certified	certify	VBN
10_1101-2021_01_08_425864	453	17	by	by	IN
10_1101-2021_01_08_425864	453	18	peer	peer	NN
10_1101-2021_01_08_425864	453	19	review	review	NN
10_1101-2021_01_08_425864	453	20	)	)	-RRB-
10_1101-2021_01_08_425864	453	21	is	be	VBZ
10_1101-2021_01_08_425864	453	22	the	the	DT
10_1101-2021_01_08_425864	453	23	author	author	NN
10_1101-2021_01_08_425864	453	24	/	/	SYM
10_1101-2021_01_08_425864	453	25	funder	funder	NN
10_1101-2021_01_08_425864	453	26	,	,	,
10_1101-2021_01_08_425864	453	27	who	who	WP
10_1101-2021_01_08_425864	453	28	has	have	VBZ
10_1101-2021_01_08_425864	453	29	granted	grant	VBN
10_1101-2021_01_08_425864	453	30	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	453	31	a	a	DT
10_1101-2021_01_08_425864	453	32	license	license	NN
10_1101-2021_01_08_425864	453	33	to	to	TO
10_1101-2021_01_08_425864	453	34	display	display	VB
10_1101-2021_01_08_425864	453	35	the	the	DT
10_1101-2021_01_08_425864	453	36	preprint	preprint	NN
10_1101-2021_01_08_425864	453	37	in	in	IN
10_1101-2021_01_08_425864	453	38	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	453	39	.	.	.
10_1101-2021_01_08_425864	454	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	454	2	is	be	VBZ
10_1101-2021_01_08_425864	454	3	The	the	DT
10_1101-2021_01_08_425864	454	4	copyright	copyright	NN
10_1101-2021_01_08_425864	454	5	holder	holder	NN
10_1101-2021_01_08_425864	454	6	for	for	IN
10_1101-2021_01_08_425864	454	7	this	this	DT
10_1101-2021_01_08_425864	454	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	454	9	version	version	NN
10_1101-2021_01_08_425864	454	10	posted	post	VBD
10_1101-2021_01_08_425864	454	11	January	January	NNP
10_1101-2021_01_08_425864	454	12	8	8	CD
10_1101-2021_01_08_425864	454	13	,	,	,
10_1101-2021_01_08_425864	454	14	2021	2021	CD
10_1101-2021_01_08_425864	454	15	.	.	.
10_1101-2021_01_08_425864	454	16	;	;	:
10_1101-2021_01_08_425864	454	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	454	18	:	:	:
10_1101-2021_01_08_425864	454	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	454	20	preprint	preprint	NN
10_1101-2021_01_08_425864	454	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	454	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	454	23	682	682	CD
10_1101-2021_01_08_425864	454	24	[	[	-LRB-
10_1101-2021_01_08_425864	454	25	7	7	CD
10_1101-2021_01_08_425864	454	26	]	]	-RRB-
10_1101-2021_01_08_425864	454	27	Y.	Y.	NNP
10_1101-2021_01_08_425864	454	28	Li	Li	NNP
10_1101-2021_01_08_425864	454	29	,	,	,
10_1101-2021_01_08_425864	454	30	S.	S.	NNP
10_1101-2021_01_08_425864	454	31	Shah	Shah	NNP
10_1101-2021_01_08_425864	454	32	-	-	HYPH
10_1101-2021_01_08_425864	454	33	Simpson	Simpson	NNP
10_1101-2021_01_08_425864	454	34	,	,	,
10_1101-2021_01_08_425864	454	35	K.	K.	NNP
10_1101-2021_01_08_425864	454	36	Okrah	Okrah	NNP
10_1101-2021_01_08_425864	454	37	,	,	,
10_1101-2021_01_08_425864	454	38	A.T.	A.T.	NNP
10_1101-2021_01_08_425864	454	39	Belew	Belew	NNP
10_1101-2021_01_08_425864	454	40	,	,	,
10_1101-2021_01_08_425864	454	41	J.	J.	NNP
10_1101-2021_01_08_425864	454	42	Choi	Choi	NNP
10_1101-2021_01_08_425864	454	43	,	,	,
10_1101-2021_01_08_425864	454	44	K.L.	K.L.	NNP
10_1101-2021_01_08_425864	455	1	Caradonna	Caradonna	NNP
10_1101-2021_01_08_425864	455	2	,	,	,
10_1101-2021_01_08_425864	455	3	P.	P.	NNP
10_1101-2021_01_08_425864	455	4	Padmanabhan	Padmanabhan	NNP
10_1101-2021_01_08_425864	455	5	,	,	,
10_1101-2021_01_08_425864	455	6	683	683	CD
10_1101-2021_01_08_425864	455	7	D.M.	D.M.	NNP
10_1101-2021_01_08_425864	456	1	Ndegwa	Ndegwa	NNP
10_1101-2021_01_08_425864	456	2	,	,	,
10_1101-2021_01_08_425864	456	3	M.R.	M.R.	NNP
10_1101-2021_01_08_425864	457	1	Temanni	Temanni	NNP
10_1101-2021_01_08_425864	457	2	,	,	,
10_1101-2021_01_08_425864	457	3	H.	H.	NNP
10_1101-2021_01_08_425864	457	4	Corrada	Corrada	NNP
10_1101-2021_01_08_425864	457	5	Bravo	Bravo	NNP
10_1101-2021_01_08_425864	457	6	,	,	,
10_1101-2021_01_08_425864	457	7	N.M.	New Mexico	NNP
10_1101-2021_01_08_425864	458	1	El	El	NNP
10_1101-2021_01_08_425864	458	2	-	-	HYPH
10_1101-2021_01_08_425864	458	3	Sayed	Sayed	NNP
10_1101-2021_01_08_425864	458	4	,	,	,
10_1101-2021_01_08_425864	458	5	B.A.	B.A.	NNP
10_1101-2021_01_08_425864	459	1	Burleigh	Burleigh	NNP
10_1101-2021_01_08_425864	459	2	,	,	,
10_1101-2021_01_08_425864	459	3	684	684	CD
10_1101-2021_01_08_425864	459	4	Transcriptome	Transcriptome	NNP
10_1101-2021_01_08_425864	459	5	remodeling	remodeling	NN
10_1101-2021_01_08_425864	459	6	in	in	IN
10_1101-2021_01_08_425864	459	7	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	459	8	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	459	9	and	and	CC
10_1101-2021_01_08_425864	459	10	human	human	JJ
10_1101-2021_01_08_425864	459	11	cells	cell	NNS
10_1101-2021_01_08_425864	459	12	during	during	IN
10_1101-2021_01_08_425864	459	13	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	459	14	685	685	CD
10_1101-2021_01_08_425864	459	15	infection	infection	NN
10_1101-2021_01_08_425864	459	16	,	,	,
10_1101-2021_01_08_425864	459	17	PLOS	PLOS	NNP
10_1101-2021_01_08_425864	459	18	Pathog	Pathog	NNP
10_1101-2021_01_08_425864	459	19	.	.	.
10_1101-2021_01_08_425864	460	1	12	12	CD
10_1101-2021_01_08_425864	460	2	(	(	-LRB-
10_1101-2021_01_08_425864	460	3	2016	2016	CD
10_1101-2021_01_08_425864	460	4	)	)	-RRB-
10_1101-2021_01_08_425864	460	5	e1005511	e1005511	NNP
10_1101-2021_01_08_425864	460	6	.	.	.
10_1101-2021_01_08_425864	461	1	https://doi.org/10.1371/journal.ppat.1005511	https://doi.org/10.1371/journal.ppat.1005511	NNP
10_1101-2021_01_08_425864	461	2	.	.	.
10_1101-2021_01_08_425864	462	1	686	686	CD
10_1101-2021_01_08_425864	462	2	[	[	-LRB-
10_1101-2021_01_08_425864	462	3	8	8	CD
10_1101-2021_01_08_425864	462	4	]	]	-RRB-
10_1101-2021_01_08_425864	462	5	L.	L.	NNP
10_1101-2021_01_08_425864	462	6	Marchese	Marchese	NNP
10_1101-2021_01_08_425864	462	7	,	,	,
10_1101-2021_01_08_425864	462	8	J.	J.	NNP
10_1101-2021_01_08_425864	462	9	Nascimento	Nascimento	NNP
10_1101-2021_01_08_425864	462	10	,	,	,
10_1101-2021_01_08_425864	462	11	F.	F.	NNP
10_1101-2021_01_08_425864	462	12	Damasceno	Damasceno	NNP
10_1101-2021_01_08_425864	462	13	,	,	,
10_1101-2021_01_08_425864	462	14	F.	F.	NNP
10_1101-2021_01_08_425864	462	15	Bringaud	Bringaud	NNP
10_1101-2021_01_08_425864	462	16	,	,	,
10_1101-2021_01_08_425864	462	17	P.	P.	NNP
10_1101-2021_01_08_425864	462	18	Michels	Michels	NNP
10_1101-2021_01_08_425864	462	19	,	,	,
10_1101-2021_01_08_425864	462	20	A.	A.	NNP
10_1101-2021_01_08_425864	462	21	Silber	Silber	NNP
10_1101-2021_01_08_425864	462	22	,	,	,
10_1101-2021_01_08_425864	462	23	The	the	DT
10_1101-2021_01_08_425864	462	24	uptake	uptake	JJ
10_1101-2021_01_08_425864	462	25	687	687	CD
10_1101-2021_01_08_425864	462	26	and	and	CC
10_1101-2021_01_08_425864	462	27	metabolism	metabolism	NN
10_1101-2021_01_08_425864	462	28	of	of	IN
10_1101-2021_01_08_425864	462	29	amino	amino	JJ
10_1101-2021_01_08_425864	462	30	acids	acid	NNS
10_1101-2021_01_08_425864	462	31	,	,	,
10_1101-2021_01_08_425864	462	32	and	and	CC
10_1101-2021_01_08_425864	462	33	their	-PRON-	PRP$
10_1101-2021_01_08_425864	462	34	unique	unique	JJ
10_1101-2021_01_08_425864	462	35	role	role	NN
10_1101-2021_01_08_425864	462	36	in	in	IN
10_1101-2021_01_08_425864	462	37	the	the	DT
10_1101-2021_01_08_425864	462	38	biology	biology	NN
10_1101-2021_01_08_425864	462	39	of	of	IN
10_1101-2021_01_08_425864	462	40	pathogenic	pathogenic	JJ
10_1101-2021_01_08_425864	462	41	688	688	CD
10_1101-2021_01_08_425864	462	42	trypanosomatids	trypanosomatid	NNS
10_1101-2021_01_08_425864	462	43	,	,	,
10_1101-2021_01_08_425864	462	44	Pathogens	Pathogens	NNP
10_1101-2021_01_08_425864	462	45	.	.	.
10_1101-2021_01_08_425864	463	1	7	7	CD
10_1101-2021_01_08_425864	463	2	(	(	-LRB-
10_1101-2021_01_08_425864	463	3	2018	2018	CD
10_1101-2021_01_08_425864	463	4	)	)	-RRB-
10_1101-2021_01_08_425864	463	5	36	36	CD
10_1101-2021_01_08_425864	463	6	.	.	.
10_1101-2021_01_08_425864	463	7	https://doi.org/10.3390/pathogens7020036	https://doi.org/10.3390/pathogens7020036	ADD
10_1101-2021_01_08_425864	463	8	.	.	.
10_1101-2021_01_08_425864	464	1	689	689	CD
10_1101-2021_01_08_425864	464	2	[	[	-LRB-
10_1101-2021_01_08_425864	464	3	9	9	CD
10_1101-2021_01_08_425864	464	4	]	]	-RRB-
10_1101-2021_01_08_425864	464	5	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	464	6	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	464	7	,	,	,
10_1101-2021_01_08_425864	464	8	Energy	Energy	NNP
10_1101-2021_01_08_425864	464	9	metabolism	metabolism	NN
10_1101-2021_01_08_425864	464	10	in	in	IN
10_1101-2021_01_08_425864	464	11	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	464	12	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	464	13	,	,	,
10_1101-2021_01_08_425864	464	14	Subcell	Subcell	NNP
10_1101-2021_01_08_425864	464	15	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	464	16	.	.	.
10_1101-2021_01_08_425864	465	1	18	18	CD
10_1101-2021_01_08_425864	465	2	(	(	-LRB-
10_1101-2021_01_08_425864	465	3	1992	1992	CD
10_1101-2021_01_08_425864	465	4	)	)	-RRB-
10_1101-2021_01_08_425864	465	5	235	235	CD
10_1101-2021_01_08_425864	465	6	–	–	:
10_1101-2021_01_08_425864	465	7	690	690	CD
10_1101-2021_01_08_425864	465	8	257	257	CD
10_1101-2021_01_08_425864	465	9	.	.	.
10_1101-2021_01_08_425864	465	10	https://www.ncbi.nlm.nih.gov/pubmed/1485353	https://www.ncbi.nlm.nih.gov/pubmed/1485353	ADD
10_1101-2021_01_08_425864	465	11	.	.	.
10_1101-2021_01_08_425864	466	1	691	691	CD
10_1101-2021_01_08_425864	466	2	[	[	-LRB-
10_1101-2021_01_08_425864	466	3	10	10	CD
10_1101-2021_01_08_425864	466	4	]	]	-RRB-
10_1101-2021_01_08_425864	466	5	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	466	6	Barison	Barison	NNP
10_1101-2021_01_08_425864	466	7	,	,	,
10_1101-2021_01_08_425864	466	8	L.N.	L.N.	NNP
10_1101-2021_01_08_425864	467	1	Rapado	Rapado	NNP
10_1101-2021_01_08_425864	467	2	,	,	,
10_1101-2021_01_08_425864	467	3	E.F.	E.F.	NNP
10_1101-2021_01_08_425864	467	4	Merino	Merino	NNP
10_1101-2021_01_08_425864	467	5	,	,	,
10_1101-2021_01_08_425864	467	6	E.M.	E.M.	NNP
10_1101-2021_01_08_425864	467	7	Furusho	Furusho	NNP
10_1101-2021_01_08_425864	467	8	Pral	Pral	NNP
10_1101-2021_01_08_425864	467	9	,	,	,
10_1101-2021_01_08_425864	467	10	B.S.	B.S.	NNP
10_1101-2021_01_08_425864	468	1	Mantilla	Mantilla	NNP
10_1101-2021_01_08_425864	468	2	,	,	,
10_1101-2021_01_08_425864	468	3	L.	L.	NNP
10_1101-2021_01_08_425864	468	4	Marchese	Marchese	NNP
10_1101-2021_01_08_425864	468	5	,	,	,
10_1101-2021_01_08_425864	468	6	C.	C.	NNP
10_1101-2021_01_08_425864	468	7	692	692	CD
10_1101-2021_01_08_425864	468	8	Nowicki	Nowicki	NNP
10_1101-2021_01_08_425864	468	9	,	,	,
10_1101-2021_01_08_425864	468	10	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	468	11	Silber	Silber	NNP
10_1101-2021_01_08_425864	468	12	,	,	,
10_1101-2021_01_08_425864	468	13	M.B.	M.B.	NNP
10_1101-2021_01_08_425864	469	1	Cassera	Cassera	NNP
10_1101-2021_01_08_425864	469	2	,	,	,
10_1101-2021_01_08_425864	469	3	Metabolomic	metabolomic	JJ
10_1101-2021_01_08_425864	469	4	profiling	profiling	NN
10_1101-2021_01_08_425864	469	5	reveals	reveal	VBZ
10_1101-2021_01_08_425864	469	6	a	a	DT
10_1101-2021_01_08_425864	469	7	finely	finely	RB
10_1101-2021_01_08_425864	469	8	tuned	tune	VBN
10_1101-2021_01_08_425864	469	9	,	,	,
10_1101-2021_01_08_425864	469	10	693	693	CD
10_1101-2021_01_08_425864	469	11	starvation	starvation	NN
10_1101-2021_01_08_425864	469	12	-	-	HYPH
10_1101-2021_01_08_425864	469	13	induced	induce	VBN
10_1101-2021_01_08_425864	469	14	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	469	15	switch	switch	NN
10_1101-2021_01_08_425864	469	16	in	in	IN
10_1101-2021_01_08_425864	469	17	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	469	18	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	469	19	epimastigotes	epimastigote	VBZ
10_1101-2021_01_08_425864	469	20	,	,	,
10_1101-2021_01_08_425864	469	21	J	J	NNP
10_1101-2021_01_08_425864	469	22	Biol	Biol	NNP
10_1101-2021_01_08_425864	469	23	Chem	Chem	NNP
10_1101-2021_01_08_425864	469	24	.	.	.
10_1101-2021_01_08_425864	470	1	292	292	CD
10_1101-2021_01_08_425864	470	2	694	694	CD
10_1101-2021_01_08_425864	470	3	(	(	-LRB-
10_1101-2021_01_08_425864	470	4	2017	2017	CD
10_1101-2021_01_08_425864	470	5	)	)	-RRB-
10_1101-2021_01_08_425864	470	6	8964–8977	8964–8977	CD
10_1101-2021_01_08_425864	470	7	.	.	.
10_1101-2021_01_08_425864	471	1	https://doi.org/10.1074/jbc.M117.778522	https://doi.org/10.1074/jbc.M117.778522	NNP
10_1101-2021_01_08_425864	471	2	.	.	.
10_1101-2021_01_08_425864	472	1	695	695	CD
10_1101-2021_01_08_425864	472	2	[	[	-LRB-
10_1101-2021_01_08_425864	472	3	11	11	CD
10_1101-2021_01_08_425864	472	4	]	]	-RRB-
10_1101-2021_01_08_425864	472	5	R.	R.	NNP
10_1101-2021_01_08_425864	472	6	Zeledon	Zeledon	NNP
10_1101-2021_01_08_425864	472	7	,	,	,
10_1101-2021_01_08_425864	472	8	Comparative	comparative	JJ
10_1101-2021_01_08_425864	472	9	physiological	physiological	JJ
10_1101-2021_01_08_425864	472	10	studies	study	NNS
10_1101-2021_01_08_425864	472	11	on	on	IN
10_1101-2021_01_08_425864	472	12	four	four	CD
10_1101-2021_01_08_425864	472	13	species	specie	NNS
10_1101-2021_01_08_425864	472	14	of	of	IN
10_1101-2021_01_08_425864	472	15	hemoflagellates	hemoflagellate	NNS
10_1101-2021_01_08_425864	472	16	in	in	IN
10_1101-2021_01_08_425864	472	17	culture	culture	NN
10_1101-2021_01_08_425864	472	18	.	.	.
10_1101-2021_01_08_425864	473	1	696	696	CD
10_1101-2021_01_08_425864	473	2	II	ii	CD
10_1101-2021_01_08_425864	473	3	.	.	.
10_1101-2021_01_08_425864	474	1	Effect	effect	NN
10_1101-2021_01_08_425864	474	2	of	of	IN
10_1101-2021_01_08_425864	474	3	carbohydrates	carbohydrate	NNS
10_1101-2021_01_08_425864	474	4	and	and	CC
10_1101-2021_01_08_425864	474	5	related	related	JJ
10_1101-2021_01_08_425864	474	6	substances	substance	NNS
10_1101-2021_01_08_425864	474	7	and	and	CC
10_1101-2021_01_08_425864	474	8	some	some	DT
10_1101-2021_01_08_425864	474	9	amino	amino	JJ
10_1101-2021_01_08_425864	474	10	compounds	compound	NNS
10_1101-2021_01_08_425864	474	11	on	on	IN
10_1101-2021_01_08_425864	474	12	the	the	DT
10_1101-2021_01_08_425864	474	13	697	697	CD
10_1101-2021_01_08_425864	474	14	respiration	respiration	NN
10_1101-2021_01_08_425864	474	15	,	,	,
10_1101-2021_01_08_425864	474	16	J.	J.	NNP
10_1101-2021_01_08_425864	474	17	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	474	18	.	.	.
10_1101-2021_01_08_425864	475	1	46	46	CD
10_1101-2021_01_08_425864	475	2	(	(	-LRB-
10_1101-2021_01_08_425864	475	3	1960	1960	CD
10_1101-2021_01_08_425864	475	4	)	)	-RRB-
10_1101-2021_01_08_425864	475	5	541	541	CD
10_1101-2021_01_08_425864	475	6	.	.	.
10_1101-2021_01_08_425864	475	7	https://doi.org/10.2307/3274935	https://doi.org/10.2307/3274935	NNP
10_1101-2021_01_08_425864	475	8	.	.	.
10_1101-2021_01_08_425864	476	1	698	698	CD
10_1101-2021_01_08_425864	476	2	[	[	-LRB-
10_1101-2021_01_08_425864	476	3	12	12	CD
10_1101-2021_01_08_425864	476	4	]	]	-RRB-
10_1101-2021_01_08_425864	476	5	D.	D.	NNP
10_1101-2021_01_08_425864	476	6	Sylvester	Sylvester	NNP
10_1101-2021_01_08_425864	476	7	,	,	,
10_1101-2021_01_08_425864	476	8	S.M.	S.M.	NNP
10_1101-2021_01_08_425864	477	1	Krassner	Krassner	NNP
10_1101-2021_01_08_425864	477	2	,	,	,
10_1101-2021_01_08_425864	477	3	Proline	Proline	NNP
10_1101-2021_01_08_425864	477	4	metabolism	metabolism	NN
10_1101-2021_01_08_425864	477	5	in	in	IN
10_1101-2021_01_08_425864	477	6	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	477	7	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	477	8	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	477	9	,	,	,
10_1101-2021_01_08_425864	477	10	Comp	Comp	NNP
10_1101-2021_01_08_425864	477	11	699	699	CD
10_1101-2021_01_08_425864	477	12	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	477	13	Physiol	Physiol	NNP
10_1101-2021_01_08_425864	477	14	B.	B.	NNP
10_1101-2021_01_08_425864	478	1	55	55	CD
10_1101-2021_01_08_425864	478	2	(	(	-LRB-
10_1101-2021_01_08_425864	478	3	1976	1976	CD
10_1101-2021_01_08_425864	478	4	)	)	-RRB-
10_1101-2021_01_08_425864	478	5	443–447	443–447	CD
10_1101-2021_01_08_425864	478	6	.	.	.
10_1101-2021_01_08_425864	479	1	https://www.ncbi.nlm.nih.gov/pubmed/789007	https://www.ncbi.nlm.nih.gov/pubmed/789007	ADD
10_1101-2021_01_08_425864	479	2	.	.	.
10_1101-2021_01_08_425864	480	1	700	700	CD
10_1101-2021_01_08_425864	480	2	[	[	-LRB-
10_1101-2021_01_08_425864	480	3	13	13	CD
10_1101-2021_01_08_425864	480	4	]	]	-RRB-
10_1101-2021_01_08_425864	480	5	L.S.	L.S.	NNP
10_1101-2021_01_08_425864	481	1	Paes	Paes	NNP
10_1101-2021_01_08_425864	481	2	,	,	,
10_1101-2021_01_08_425864	481	3	B.	B.	NNP
10_1101-2021_01_08_425864	481	4	Suarez	Suarez	NNP
10_1101-2021_01_08_425864	481	5	Mantilla	Mantilla	NNP
10_1101-2021_01_08_425864	481	6	,	,	,
10_1101-2021_01_08_425864	481	7	F.M.	F.M.	NNP
10_1101-2021_01_08_425864	482	1	Zimbres	Zimbres	NNP
10_1101-2021_01_08_425864	482	2	,	,	,
10_1101-2021_01_08_425864	482	3	E.M.	E.M.	NNP
10_1101-2021_01_08_425864	482	4	Pral	Pral	NNP
10_1101-2021_01_08_425864	482	5	,	,	,
10_1101-2021_01_08_425864	482	6	P.	P.	NNP
10_1101-2021_01_08_425864	482	7	Diogo	Diogo	NNP
10_1101-2021_01_08_425864	482	8	de	de	NNP
10_1101-2021_01_08_425864	482	9	Melo	Melo	NNP
10_1101-2021_01_08_425864	482	10	,	,	,
10_1101-2021_01_08_425864	482	11	E.B.	E.B.	NNP
10_1101-2021_01_08_425864	483	1	Tahara	Tahara	NNP
10_1101-2021_01_08_425864	483	2	,	,	,
10_1101-2021_01_08_425864	483	3	A.J.	A.J.	NNP
10_1101-2021_01_08_425864	484	1	701	701	CD
10_1101-2021_01_08_425864	484	2	Kowaltowski	Kowaltowski	NNPS
10_1101-2021_01_08_425864	484	3	,	,	,
10_1101-2021_01_08_425864	484	4	M.C.	M.C.	NNP
10_1101-2021_01_08_425864	485	1	Elias	elias	RB
10_1101-2021_01_08_425864	485	2	,	,	,
10_1101-2021_01_08_425864	485	3	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	485	4	Silber	Silber	NNP
10_1101-2021_01_08_425864	485	5	,	,	,
10_1101-2021_01_08_425864	485	6	Proline	Proline	NNP
10_1101-2021_01_08_425864	485	7	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	485	8	regulates	regulate	VBZ
10_1101-2021_01_08_425864	485	9	redox	redox	JJ
10_1101-2021_01_08_425864	485	10	state	state	NN
10_1101-2021_01_08_425864	485	11	and	and	CC
10_1101-2021_01_08_425864	485	12	702	702	CD
10_1101-2021_01_08_425864	485	13	respiratory	respiratory	JJ
10_1101-2021_01_08_425864	485	14	metabolism	metabolism	NN
10_1101-2021_01_08_425864	485	15	in	in	IN
10_1101-2021_01_08_425864	485	16	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	485	17	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	485	18	,	,	,
10_1101-2021_01_08_425864	485	19	PLoS	PLoS	NNP
10_1101-2021_01_08_425864	485	20	One	one	CD
10_1101-2021_01_08_425864	485	21	.	.	.
10_1101-2021_01_08_425864	486	1	8	8	CD
10_1101-2021_01_08_425864	486	2	(	(	-LRB-
10_1101-2021_01_08_425864	486	3	2013	2013	CD
10_1101-2021_01_08_425864	486	4	)	)	-RRB-
10_1101-2021_01_08_425864	486	5	e69419	e69419	NNP
10_1101-2021_01_08_425864	486	6	.	.	.
10_1101-2021_01_08_425864	487	1	703	703	CD
10_1101-2021_01_08_425864	487	2	https://doi.org/10.1371/journal.pone.0069419	https://doi.org/10.1371/journal.pone.0069419	NN
10_1101-2021_01_08_425864	487	3	.	.	.
10_1101-2021_01_08_425864	488	1	704	704	CD
10_1101-2021_01_08_425864	488	2	[	[	-LRB-
10_1101-2021_01_08_425864	488	3	14	14	CD
10_1101-2021_01_08_425864	488	4	]	]	-RRB-
10_1101-2021_01_08_425864	488	5	B.S.	B.S.	NNP
10_1101-2021_01_08_425864	489	1	Mantilla	Mantilla	NNP
10_1101-2021_01_08_425864	489	2	,	,	,
10_1101-2021_01_08_425864	489	3	L.S.	L.S.	NNP
10_1101-2021_01_08_425864	490	1	Paes	Paes	NNP
10_1101-2021_01_08_425864	490	2	,	,	,
10_1101-2021_01_08_425864	490	3	E.M.F.	E.M.F.	NNP
10_1101-2021_01_08_425864	491	1	Pral	pral	JJ
10_1101-2021_01_08_425864	491	2	,	,	,
10_1101-2021_01_08_425864	491	3	D.E.	D.E.	NNP
10_1101-2021_01_08_425864	492	1	Martil	Martil	NNP
10_1101-2021_01_08_425864	492	2	,	,	,
10_1101-2021_01_08_425864	492	3	O.H.	O.H.	NNP
10_1101-2021_01_08_425864	493	1	Thiemann	Thiemann	NNP
10_1101-2021_01_08_425864	493	2	,	,	,
10_1101-2021_01_08_425864	493	3	P.	P.	NNP
10_1101-2021_01_08_425864	493	4	Fernández	Fernández	NNP
10_1101-2021_01_08_425864	493	5	-	-	HYPH
10_1101-2021_01_08_425864	493	6	Silva	Silva	NNP
10_1101-2021_01_08_425864	493	7	,	,	,
10_1101-2021_01_08_425864	493	8	E.L.	E.L.	NNP
10_1101-2021_01_08_425864	493	9	705	705	CD
10_1101-2021_01_08_425864	493	10	Bastos	Bastos	NNP
10_1101-2021_01_08_425864	493	11	,	,	,
10_1101-2021_01_08_425864	493	12	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	493	13	Silber	Silber	NNP
10_1101-2021_01_08_425864	493	14	,	,	,
10_1101-2021_01_08_425864	493	15	Role	Role	NNP
10_1101-2021_01_08_425864	493	16	of	of	IN
10_1101-2021_01_08_425864	493	17	Δ1-pyrroline-5-carboxylate	δ1-pyrroline-5-carboxylate	JJ
10_1101-2021_01_08_425864	493	18	dehydrogenase	dehydrogenase	NN
10_1101-2021_01_08_425864	493	19	supports	support	VBZ
10_1101-2021_01_08_425864	493	20	706	706	CD
10_1101-2021_01_08_425864	493	21	mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	493	22	metabolism	metabolism	NN
10_1101-2021_01_08_425864	493	23	and	and	CC
10_1101-2021_01_08_425864	493	24	host	host	NN
10_1101-2021_01_08_425864	493	25	-	-	HYPH
10_1101-2021_01_08_425864	493	26	cell	cell	NN
10_1101-2021_01_08_425864	493	27	invasion	invasion	NN
10_1101-2021_01_08_425864	493	28	of	of	IN
10_1101-2021_01_08_425864	493	29	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	493	30	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	493	31	.	.	.
10_1101-2021_01_08_425864	493	32	,	,	,
10_1101-2021_01_08_425864	493	33	J.	J.	NNP
10_1101-2021_01_08_425864	493	34	Biol	Biol	NNP
10_1101-2021_01_08_425864	493	35	.	.	.
10_1101-2021_01_08_425864	494	1	Chem	Chem	NNP
10_1101-2021_01_08_425864	494	2	.	.	.
10_1101-2021_01_08_425864	495	1	290	290	CD
10_1101-2021_01_08_425864	495	2	707	707	CD
10_1101-2021_01_08_425864	495	3	(	(	-LRB-
10_1101-2021_01_08_425864	495	4	2015	2015	CD
10_1101-2021_01_08_425864	495	5	)	)	-RRB-
10_1101-2021_01_08_425864	495	6	.	.	.
10_1101-2021_01_08_425864	496	1	https://doi.org/10.1074/jbc.M114.574525	https://doi.org/10.1074/jbc.M114.574525	NNP
10_1101-2021_01_08_425864	496	2	.	.	.
10_1101-2021_01_08_425864	497	1	.CC	.CC	NFP
10_1101-2021_01_08_425864	497	2	-	-	:
10_1101-2021_01_08_425864	497	3	BY	by	IN
10_1101-2021_01_08_425864	497	4	4.0	4.0	CD
10_1101-2021_01_08_425864	497	5	International	international	JJ
10_1101-2021_01_08_425864	497	6	licensemade	licensemade	NN
10_1101-2021_01_08_425864	497	7	available	available	JJ
10_1101-2021_01_08_425864	497	8	under	under	IN
10_1101-2021_01_08_425864	497	9	a	a	DT
10_1101-2021_01_08_425864	497	10	(	(	-LRB-
10_1101-2021_01_08_425864	497	11	which	which	WDT
10_1101-2021_01_08_425864	497	12	was	be	VBD
10_1101-2021_01_08_425864	497	13	not	not	RB
10_1101-2021_01_08_425864	497	14	certified	certify	VBN
10_1101-2021_01_08_425864	497	15	by	by	IN
10_1101-2021_01_08_425864	497	16	peer	peer	NN
10_1101-2021_01_08_425864	497	17	review	review	NN
10_1101-2021_01_08_425864	497	18	)	)	-RRB-
10_1101-2021_01_08_425864	497	19	is	be	VBZ
10_1101-2021_01_08_425864	497	20	the	the	DT
10_1101-2021_01_08_425864	497	21	author	author	NN
10_1101-2021_01_08_425864	497	22	/	/	SYM
10_1101-2021_01_08_425864	497	23	funder	funder	NN
10_1101-2021_01_08_425864	497	24	,	,	,
10_1101-2021_01_08_425864	497	25	who	who	WP
10_1101-2021_01_08_425864	497	26	has	have	VBZ
10_1101-2021_01_08_425864	497	27	granted	grant	VBN
10_1101-2021_01_08_425864	497	28	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	497	29	a	a	DT
10_1101-2021_01_08_425864	497	30	license	license	NN
10_1101-2021_01_08_425864	497	31	to	to	TO
10_1101-2021_01_08_425864	497	32	display	display	VB
10_1101-2021_01_08_425864	497	33	the	the	DT
10_1101-2021_01_08_425864	497	34	preprint	preprint	NN
10_1101-2021_01_08_425864	497	35	in	in	IN
10_1101-2021_01_08_425864	497	36	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	497	37	.	.	.
10_1101-2021_01_08_425864	498	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	498	2	is	be	VBZ
10_1101-2021_01_08_425864	498	3	The	the	DT
10_1101-2021_01_08_425864	498	4	copyright	copyright	NN
10_1101-2021_01_08_425864	498	5	holder	holder	NN
10_1101-2021_01_08_425864	498	6	for	for	IN
10_1101-2021_01_08_425864	498	7	this	this	DT
10_1101-2021_01_08_425864	498	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	498	9	version	version	NN
10_1101-2021_01_08_425864	498	10	posted	post	VBD
10_1101-2021_01_08_425864	498	11	January	January	NNP
10_1101-2021_01_08_425864	498	12	8	8	CD
10_1101-2021_01_08_425864	498	13	,	,	,
10_1101-2021_01_08_425864	498	14	2021	2021	CD
10_1101-2021_01_08_425864	498	15	.	.	.
10_1101-2021_01_08_425864	498	16	;	;	:
10_1101-2021_01_08_425864	498	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	498	18	:	:	:
10_1101-2021_01_08_425864	498	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	498	20	preprint	preprint	NN
10_1101-2021_01_08_425864	498	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	498	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	498	23	708	708	CD
10_1101-2021_01_08_425864	498	24	[	[	-LRB-
10_1101-2021_01_08_425864	498	25	15	15	CD
10_1101-2021_01_08_425864	498	26	]	]	-RRB-
10_1101-2021_01_08_425864	498	27	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	498	28	Barisón	Barisón	NNP
10_1101-2021_01_08_425864	498	29	,	,	,
10_1101-2021_01_08_425864	498	30	F.S.	F.S.	NNP
10_1101-2021_01_08_425864	499	1	Damasceno	Damasceno	NNP
10_1101-2021_01_08_425864	499	2	,	,	,
10_1101-2021_01_08_425864	499	3	B.S.	B.S.	NNP
10_1101-2021_01_08_425864	500	1	Mantilla	Mantilla	NNP
10_1101-2021_01_08_425864	500	2	,	,	,
10_1101-2021_01_08_425864	500	3	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	500	4	Silber	Silber	NNP
10_1101-2021_01_08_425864	500	5	,	,	,
10_1101-2021_01_08_425864	500	6	The	the	DT
10_1101-2021_01_08_425864	500	7	active	active	JJ
10_1101-2021_01_08_425864	500	8	transport	transport	NN
10_1101-2021_01_08_425864	500	9	of	of	IN
10_1101-2021_01_08_425864	500	10	histidine	histidine	NNP
10_1101-2021_01_08_425864	500	11	709	709	CD
10_1101-2021_01_08_425864	500	12	and	and	CC
10_1101-2021_01_08_425864	500	13	its	-PRON-	PRP$
10_1101-2021_01_08_425864	500	14	role	role	NN
10_1101-2021_01_08_425864	500	15	in	in	IN
10_1101-2021_01_08_425864	500	16	ATP	atp	NN
10_1101-2021_01_08_425864	500	17	production	production	NN
10_1101-2021_01_08_425864	500	18	in	in	IN
10_1101-2021_01_08_425864	500	19	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	500	20	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	500	21	.	.	.
10_1101-2021_01_08_425864	500	22	,	,	,
10_1101-2021_01_08_425864	500	23	J.	J.	NNP
10_1101-2021_01_08_425864	500	24	Bioenerg	Bioenerg	NNP
10_1101-2021_01_08_425864	500	25	.	.	.
10_1101-2021_01_08_425864	501	1	Biomembr	Biomembr	NNP
10_1101-2021_01_08_425864	501	2	.	.	.
10_1101-2021_01_08_425864	502	1	48	48	CD
10_1101-2021_01_08_425864	502	2	(	(	-LRB-
10_1101-2021_01_08_425864	502	3	2016	2016	CD
10_1101-2021_01_08_425864	502	4	)	)	-RRB-
10_1101-2021_01_08_425864	502	5	710	710	CD
10_1101-2021_01_08_425864	502	6	437–49	437–49	CD
10_1101-2021_01_08_425864	502	7	.	.	.
10_1101-2021_01_08_425864	503	1	https://doi.org/10.1007/s10863-016-9665-9	https://doi.org/10.1007/s10863-016-9665-9	ADD
10_1101-2021_01_08_425864	503	2	.	.	.
10_1101-2021_01_08_425864	504	1	711	711	CD
10_1101-2021_01_08_425864	504	2	[	[	-LRB-
10_1101-2021_01_08_425864	504	3	16	16	CD
10_1101-2021_01_08_425864	504	4	]	]	-RRB-
10_1101-2021_01_08_425864	504	5	R.M.B.M.	R.M.B.M.	NNP
10_1101-2021_01_08_425864	505	1	Girard	Girard	NNP
10_1101-2021_01_08_425864	505	2	,	,	,
10_1101-2021_01_08_425864	505	3	M.	M.	NNP
10_1101-2021_01_08_425864	505	4	Crispim	Crispim	NNP
10_1101-2021_01_08_425864	505	5	,	,	,
10_1101-2021_01_08_425864	505	6	M.B.	M.B.	NNP
10_1101-2021_01_08_425864	506	1	Alencar	Alencar	NNP
10_1101-2021_01_08_425864	506	2	,	,	,
10_1101-2021_01_08_425864	506	3	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	506	4	Silber	Silber	NNP
10_1101-2021_01_08_425864	506	5	,	,	,
10_1101-2021_01_08_425864	506	6	Uptake	Uptake	NNP
10_1101-2021_01_08_425864	506	7	of	of	IN
10_1101-2021_01_08_425864	506	8	L	L	NNP
10_1101-2021_01_08_425864	506	9	-	-	HYPH
10_1101-2021_01_08_425864	506	10	alanine	alanine	NNP
10_1101-2021_01_08_425864	506	11	and	and	CC
10_1101-2021_01_08_425864	506	12	its	-PRON-	PRP$
10_1101-2021_01_08_425864	506	13	712	712	CD
10_1101-2021_01_08_425864	506	14	distinct	distinct	JJ
10_1101-2021_01_08_425864	506	15	roles	role	NNS
10_1101-2021_01_08_425864	506	16	in	in	IN
10_1101-2021_01_08_425864	506	17	the	the	DT
10_1101-2021_01_08_425864	506	18	bioenergetics	bioenergetic	NNS
10_1101-2021_01_08_425864	506	19	of	of	IN
10_1101-2021_01_08_425864	506	20	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	506	21	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	506	22	,	,	,
10_1101-2021_01_08_425864	506	23	MSphere	msphere	RB
10_1101-2021_01_08_425864	506	24	.	.	.
10_1101-2021_01_08_425864	507	1	3	3	CD
10_1101-2021_01_08_425864	507	2	(	(	-LRB-
10_1101-2021_01_08_425864	507	3	2018	2018	CD
10_1101-2021_01_08_425864	507	4	)	)	-RRB-
10_1101-2021_01_08_425864	507	5	.	.	.
10_1101-2021_01_08_425864	508	1	713	713	CD
10_1101-2021_01_08_425864	508	2	https://doi.org/10.1128/mSphereDirect.00338-18	https://doi.org/10.1128/mSphereDirect.00338-18	NNS
10_1101-2021_01_08_425864	508	3	.	.	.
10_1101-2021_01_08_425864	509	1	714	714	CD
10_1101-2021_01_08_425864	509	2	[	[	-LRB-
10_1101-2021_01_08_425864	509	3	17	17	CD
10_1101-2021_01_08_425864	509	4	]	]	-RRB-
10_1101-2021_01_08_425864	509	5	F.S.	F.S.	NNP
10_1101-2021_01_08_425864	510	1	Damasceno	Damasceno	NNP
10_1101-2021_01_08_425864	510	2	,	,	,
10_1101-2021_01_08_425864	510	3	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	510	4	Barisón	Barisón	NNP
10_1101-2021_01_08_425864	510	5	,	,	,
10_1101-2021_01_08_425864	510	6	M.	M.	NNP
10_1101-2021_01_08_425864	510	7	Crispim	Crispim	NNP
10_1101-2021_01_08_425864	510	8	,	,	,
10_1101-2021_01_08_425864	510	9	R.O.O.	R.O.O.	NNP
10_1101-2021_01_08_425864	511	1	Souza	Souza	NNP
10_1101-2021_01_08_425864	511	2	,	,	,
10_1101-2021_01_08_425864	511	3	L.	L.	NNP
10_1101-2021_01_08_425864	511	4	Marchese	Marchese	NNP
10_1101-2021_01_08_425864	511	5	,	,	,
10_1101-2021_01_08_425864	511	6	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	511	7	Silber	Silber	NNP
10_1101-2021_01_08_425864	511	8	,	,	,
10_1101-2021_01_08_425864	511	9	L-	L-	NNP
10_1101-2021_01_08_425864	511	10	715	715	CD
10_1101-2021_01_08_425864	511	11	Glutamine	Glutamine	NNP
10_1101-2021_01_08_425864	511	12	uptake	uptake	NN
10_1101-2021_01_08_425864	511	13	is	be	VBZ
10_1101-2021_01_08_425864	511	14	developmentally	developmentally	RB
10_1101-2021_01_08_425864	511	15	regulated	regulate	VBN
10_1101-2021_01_08_425864	511	16	and	and	CC
10_1101-2021_01_08_425864	511	17	is	be	VBZ
10_1101-2021_01_08_425864	511	18	involved	involve	VBN
10_1101-2021_01_08_425864	511	19	in	in	IN
10_1101-2021_01_08_425864	511	20	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	511	21	in	in	IN
10_1101-2021_01_08_425864	511	22	716	716	CD
10_1101-2021_01_08_425864	511	23	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	511	24	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	511	25	,	,	,
10_1101-2021_01_08_425864	511	26	Mol	Mol	NNP
10_1101-2021_01_08_425864	511	27	.	.	.
10_1101-2021_01_08_425864	512	1	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	512	2	.	.	.
10_1101-2021_01_08_425864	513	1	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	513	2	.	.	.
10_1101-2021_01_08_425864	514	1	224	224	CD
10_1101-2021_01_08_425864	514	2	(	(	-LRB-
10_1101-2021_01_08_425864	514	3	2018	2018	CD
10_1101-2021_01_08_425864	514	4	)	)	-RRB-
10_1101-2021_01_08_425864	514	5	.	.	.
10_1101-2021_01_08_425864	515	1	717	717	CD
10_1101-2021_01_08_425864	515	2	https://doi.org/10.1016/j.molbiopara.2018.07.007	https://doi.org/10.1016/j.molbiopara.2018.07.007	CD
10_1101-2021_01_08_425864	515	3	.	.	.
10_1101-2021_01_08_425864	516	1	718	718	CD
10_1101-2021_01_08_425864	516	2	[	[	-LRB-
10_1101-2021_01_08_425864	516	3	18	18	CD
10_1101-2021_01_08_425864	516	4	]	]	-RRB-
10_1101-2021_01_08_425864	516	5	E.P.	E.P.	NNP
10_1101-2021_01_08_425864	517	1	Camargo	camargo	NN
10_1101-2021_01_08_425864	517	2	,	,	,
10_1101-2021_01_08_425864	517	3	Growth	growth	NN
10_1101-2021_01_08_425864	517	4	and	and	CC
10_1101-2021_01_08_425864	517	5	differentiation	differentiation	NN
10_1101-2021_01_08_425864	517	6	in	in	IN
10_1101-2021_01_08_425864	517	7	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	517	8	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	517	9	.	.	.
10_1101-2021_01_08_425864	518	1	I.	I.	NNP
10_1101-2021_01_08_425864	519	1	Origin	origin	NN
10_1101-2021_01_08_425864	519	2	of	of	IN
10_1101-2021_01_08_425864	519	3	metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	519	4	719	719	CD
10_1101-2021_01_08_425864	519	5	trypanosomes	trypanosome	NNS
10_1101-2021_01_08_425864	519	6	in	in	IN
10_1101-2021_01_08_425864	519	7	liquid	liquid	JJ
10_1101-2021_01_08_425864	519	8	media	medium	NNS
10_1101-2021_01_08_425864	519	9	,	,	,
10_1101-2021_01_08_425864	519	10	Rev.	Rev.	NNP
10_1101-2021_01_08_425864	520	1	Inst	inst	RB
10_1101-2021_01_08_425864	520	2	.	.	.
10_1101-2021_01_08_425864	521	1	Med	Med	NNP
10_1101-2021_01_08_425864	521	2	.	.	.
10_1101-2021_01_08_425864	522	1	Trop	Trop	NNP
10_1101-2021_01_08_425864	522	2	.	.	.
10_1101-2021_01_08_425864	523	1	Sao	Sao	NNP
10_1101-2021_01_08_425864	523	2	Paulo	Paulo	NNP
10_1101-2021_01_08_425864	523	3	.	.	.
10_1101-2021_01_08_425864	524	1	6	6	CD
10_1101-2021_01_08_425864	524	2	(	(	-LRB-
10_1101-2021_01_08_425864	524	3	1964	1964	CD
10_1101-2021_01_08_425864	524	4	)	)	-RRB-
10_1101-2021_01_08_425864	524	5	93–100	93–100	CD
10_1101-2021_01_08_425864	524	6	.	.	.
10_1101-2021_01_08_425864	525	1	720	720	CD
10_1101-2021_01_08_425864	525	2	http://www.ncbi.nlm.nih.gov/pubmed/14177814	http://www.ncbi.nlm.nih.gov/pubmed/14177814	NNS
10_1101-2021_01_08_425864	525	3	(	(	-LRB-
10_1101-2021_01_08_425864	525	4	accessed	access	VBN
10_1101-2021_01_08_425864	525	5	January	January	NNP
10_1101-2021_01_08_425864	525	6	29	29	CD
10_1101-2021_01_08_425864	525	7	,	,	,
10_1101-2021_01_08_425864	525	8	2019	2019	CD
10_1101-2021_01_08_425864	525	9	)	)	-RRB-
10_1101-2021_01_08_425864	525	10	.	.	.
10_1101-2021_01_08_425864	526	1	721	721	CD
10_1101-2021_01_08_425864	526	2	[	[	-LRB-
10_1101-2021_01_08_425864	526	3	19	19	CD
10_1101-2021_01_08_425864	526	4	]	]	-RRB-
10_1101-2021_01_08_425864	526	5	F.S.	F.S.	NNP
10_1101-2021_01_08_425864	527	1	Damasceno	Damasceno	NNP
10_1101-2021_01_08_425864	527	2	,	,	,
10_1101-2021_01_08_425864	527	3	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	527	4	Barison	Barison	NNP
10_1101-2021_01_08_425864	527	5	,	,	,
10_1101-2021_01_08_425864	527	6	M.	M.	NNP
10_1101-2021_01_08_425864	527	7	Crispim	Crispim	NNP
10_1101-2021_01_08_425864	527	8	,	,	,
10_1101-2021_01_08_425864	527	9	R.O.O.	R.O.O.	NNP
10_1101-2021_01_08_425864	528	1	Souza	Souza	NNP
10_1101-2021_01_08_425864	528	2	,	,	,
10_1101-2021_01_08_425864	528	3	L.	L.	NNP
10_1101-2021_01_08_425864	528	4	Marchese	Marchese	NNP
10_1101-2021_01_08_425864	528	5	,	,	,
10_1101-2021_01_08_425864	528	6	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	528	7	Silber	Silber	NNP
10_1101-2021_01_08_425864	528	8	,	,	,
10_1101-2021_01_08_425864	528	9	L-	L-	NNP
10_1101-2021_01_08_425864	528	10	722	722	CD
10_1101-2021_01_08_425864	528	11	Glutamine	Glutamine	NNP
10_1101-2021_01_08_425864	528	12	uptake	uptake	NN
10_1101-2021_01_08_425864	528	13	is	be	VBZ
10_1101-2021_01_08_425864	528	14	developmentally	developmentally	RB
10_1101-2021_01_08_425864	528	15	regulated	regulate	VBN
10_1101-2021_01_08_425864	528	16	and	and	CC
10_1101-2021_01_08_425864	528	17	is	be	VBZ
10_1101-2021_01_08_425864	528	18	involved	involve	VBN
10_1101-2021_01_08_425864	528	19	in	in	IN
10_1101-2021_01_08_425864	528	20	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	528	21	in	in	IN
10_1101-2021_01_08_425864	528	22	723	723	CD
10_1101-2021_01_08_425864	528	23	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	528	24	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	528	25	,	,	,
10_1101-2021_01_08_425864	528	26	Mol	Mol	NNP
10_1101-2021_01_08_425864	528	27	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	528	28	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	528	29	.	.	.
10_1101-2021_01_08_425864	529	1	224	224	CD
10_1101-2021_01_08_425864	529	2	(	(	-LRB-
10_1101-2021_01_08_425864	529	3	2018	2018	CD
10_1101-2021_01_08_425864	529	4	)	)	-RRB-
10_1101-2021_01_08_425864	529	5	17–25	17–25	CD
10_1101-2021_01_08_425864	529	6	.	.	.
10_1101-2021_01_08_425864	530	1	724	724	CD
10_1101-2021_01_08_425864	530	2	https://doi.org/10.1016/j.molbiopara.2018.07.007	https://doi.org/10.1016/j.molbiopara.2018.07.007	NN
10_1101-2021_01_08_425864	530	3	.	.	.
10_1101-2021_01_08_425864	531	1	725	725	CD
10_1101-2021_01_08_425864	531	2	[	[	-LRB-
10_1101-2021_01_08_425864	531	3	20	20	CD
10_1101-2021_01_08_425864	531	4	]	]	-RRB-
10_1101-2021_01_08_425864	531	5	F.K.	F.K.	NNP
10_1101-2021_01_08_425864	532	1	Huynh	Huynh	NNP
10_1101-2021_01_08_425864	532	2	,	,	,
10_1101-2021_01_08_425864	532	3	M.F.	M.F.	NNP
10_1101-2021_01_08_425864	533	1	Green	green	JJ
10_1101-2021_01_08_425864	533	2	,	,	,
10_1101-2021_01_08_425864	533	3	T.R.	T.R.	NNP
10_1101-2021_01_08_425864	534	1	Koves	kove	NNS
10_1101-2021_01_08_425864	534	2	,	,	,
10_1101-2021_01_08_425864	534	3	M.D.	M.D.	NNP
10_1101-2021_01_08_425864	535	1	Hirschey	Hirschey	NNP
10_1101-2021_01_08_425864	535	2	,	,	,
10_1101-2021_01_08_425864	535	3	Measurement	Measurement	NNP
10_1101-2021_01_08_425864	535	4	of	of	IN
10_1101-2021_01_08_425864	535	5	fatty	fatty	NN
10_1101-2021_01_08_425864	535	6	acid	acid	NN
10_1101-2021_01_08_425864	535	7	oxidation	oxidation	NN
10_1101-2021_01_08_425864	535	8	726	726	CD
10_1101-2021_01_08_425864	535	9	rates	rate	NNS
10_1101-2021_01_08_425864	535	10	in	in	IN
10_1101-2021_01_08_425864	535	11	animal	animal	NN
10_1101-2021_01_08_425864	535	12	tissues	tissue	NNS
10_1101-2021_01_08_425864	535	13	and	and	CC
10_1101-2021_01_08_425864	535	14	cell	cell	NN
10_1101-2021_01_08_425864	535	15	lines	line	NNS
10_1101-2021_01_08_425864	535	16	.	.	.
10_1101-2021_01_08_425864	536	1	Methods	Methods	NNP
10_1101-2021_01_08_425864	536	2	Enzymol	Enzymol	NNP
10_1101-2021_01_08_425864	536	3	.	.	.
10_1101-2021_01_08_425864	537	1	542	542	CD
10_1101-2021_01_08_425864	537	2	(	(	-LRB-
10_1101-2021_01_08_425864	537	3	2014	2014	CD
10_1101-2021_01_08_425864	537	4	)	)	-RRB-
10_1101-2021_01_08_425864	537	5	391–405	391–405	CD
10_1101-2021_01_08_425864	537	6	.	.	.
10_1101-2021_01_08_425864	538	1	727	727	CD
10_1101-2021_01_08_425864	538	2	https://doi.org/10.1016/B978-0-12-416618-9.00020-0	https://doi.org/10.1016/B978-0-12-416618-9.00020-0	NNP
10_1101-2021_01_08_425864	538	3	.	.	.
10_1101-2021_01_08_425864	539	1	728	728	CD
10_1101-2021_01_08_425864	539	2	[	[	-LRB-
10_1101-2021_01_08_425864	539	3	21	21	CD
10_1101-2021_01_08_425864	539	4	]	]	-RRB-
10_1101-2021_01_08_425864	539	5	M.B.	M.B.	NNP
10_1101-2021_01_08_425864	540	1	Alencar	Alencar	NNP
10_1101-2021_01_08_425864	540	2	,	,	,
10_1101-2021_01_08_425864	540	3	R.B.M.M.	R.B.M.M.	NNP
10_1101-2021_01_08_425864	541	1	Girard	Girard	NNP
10_1101-2021_01_08_425864	541	2	,	,	,
10_1101-2021_01_08_425864	541	3	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	541	4	Silber	Silber	NNP
10_1101-2021_01_08_425864	541	5	,	,	,
10_1101-2021_01_08_425864	541	6	Measurement	Measurement	NNP
10_1101-2021_01_08_425864	541	7	of	of	IN
10_1101-2021_01_08_425864	541	8	energy	energy	NN
10_1101-2021_01_08_425864	541	9	states	state	NNS
10_1101-2021_01_08_425864	541	10	of	of	IN
10_1101-2021_01_08_425864	541	11	the	the	DT
10_1101-2021_01_08_425864	541	12	729	729	CD
10_1101-2021_01_08_425864	541	13	trypanosomatid	trypanosomatid	NN
10_1101-2021_01_08_425864	541	14	mitochondrion	mitochondrion	NN
10_1101-2021_01_08_425864	541	15	.	.	.
10_1101-2021_01_08_425864	542	1	Methods	Methods	NNPS
10_1101-2021_01_08_425864	542	2	Mol	Mol	NNP
10_1101-2021_01_08_425864	542	3	.	.	.
10_1101-2021_01_08_425864	543	1	Biol	Biol	NNP
10_1101-2021_01_08_425864	543	2	.	.	.
10_1101-2021_01_08_425864	544	1	2116	2116	CD
10_1101-2021_01_08_425864	544	2	(	(	-LRB-
10_1101-2021_01_08_425864	544	3	2020	2020	CD
10_1101-2021_01_08_425864	544	4	)	)	-RRB-
10_1101-2021_01_08_425864	544	5	655–671	655–671	CD
10_1101-2021_01_08_425864	544	6	.	.	.
10_1101-2021_01_08_425864	545	1	730	730	CD
10_1101-2021_01_08_425864	545	2	https://doi.org/10.1007/978-1-0716-0294-2_39	https://doi.org/10.1007/978-1-0716-0294-2_39	NNS
10_1101-2021_01_08_425864	545	3	.	.	.
10_1101-2021_01_08_425864	546	1	731	731	CD
10_1101-2021_01_08_425864	546	2	[	[	-LRB-
10_1101-2021_01_08_425864	546	3	22	22	CD
10_1101-2021_01_08_425864	546	4	]	]	-RRB-
10_1101-2021_01_08_425864	546	5	M.M.	M.M.	NNP
10_1101-2021_01_08_425864	547	1	Bradford	Bradford	NNP
10_1101-2021_01_08_425864	547	2	,	,	,
10_1101-2021_01_08_425864	547	3	A	a	DT
10_1101-2021_01_08_425864	547	4	rapid	rapid	JJ
10_1101-2021_01_08_425864	547	5	and	and	CC
10_1101-2021_01_08_425864	547	6	sensitive	sensitive	JJ
10_1101-2021_01_08_425864	547	7	method	method	NN
10_1101-2021_01_08_425864	547	8	for	for	IN
10_1101-2021_01_08_425864	547	9	the	the	DT
10_1101-2021_01_08_425864	547	10	quantitation	quantitation	NN
10_1101-2021_01_08_425864	547	11	of	of	IN
10_1101-2021_01_08_425864	547	12	microgram	microgram	NN
10_1101-2021_01_08_425864	547	13	quantities	quantity	NNS
10_1101-2021_01_08_425864	547	14	of	of	IN
10_1101-2021_01_08_425864	547	15	732	732	CD
10_1101-2021_01_08_425864	547	16	protein	protein	NN
10_1101-2021_01_08_425864	547	17	utilizing	utilize	VBG
10_1101-2021_01_08_425864	547	18	the	the	DT
10_1101-2021_01_08_425864	547	19	principle	principle	NN
10_1101-2021_01_08_425864	547	20	of	of	IN
10_1101-2021_01_08_425864	547	21	protein	protein	NN
10_1101-2021_01_08_425864	547	22	-	-	HYPH
10_1101-2021_01_08_425864	547	23	dye	dye	NN
10_1101-2021_01_08_425864	547	24	binding	binding	NN
10_1101-2021_01_08_425864	547	25	.	.	.
10_1101-2021_01_08_425864	548	1	Anal	anal	JJ
10_1101-2021_01_08_425864	548	2	.	.	.
10_1101-2021_01_08_425864	549	1	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	549	2	.	.	.
10_1101-2021_01_08_425864	550	1	72	72	CD
10_1101-2021_01_08_425864	550	2	(	(	-LRB-
10_1101-2021_01_08_425864	550	3	1976	1976	CD
10_1101-2021_01_08_425864	550	4	)	)	-RRB-
10_1101-2021_01_08_425864	550	5	248–54	248–54	CD
10_1101-2021_01_08_425864	550	6	.	.	.
10_1101-2021_01_08_425864	551	1	733	733	CD
10_1101-2021_01_08_425864	551	2	https://doi.org/10.1006/abio.1976.9999	https://doi.org/10.1006/abio.1976.9999	JJ
10_1101-2021_01_08_425864	551	3	.	.	.
10_1101-2021_01_08_425864	552	1	.CC	.CC	NFP
10_1101-2021_01_08_425864	552	2	-	-	:
10_1101-2021_01_08_425864	552	3	BY	by	IN
10_1101-2021_01_08_425864	552	4	4.0	4.0	CD
10_1101-2021_01_08_425864	552	5	International	international	JJ
10_1101-2021_01_08_425864	552	6	licensemade	licensemade	NN
10_1101-2021_01_08_425864	552	7	available	available	JJ
10_1101-2021_01_08_425864	552	8	under	under	IN
10_1101-2021_01_08_425864	552	9	a	a	DT
10_1101-2021_01_08_425864	552	10	(	(	-LRB-
10_1101-2021_01_08_425864	552	11	which	which	WDT
10_1101-2021_01_08_425864	552	12	was	be	VBD
10_1101-2021_01_08_425864	552	13	not	not	RB
10_1101-2021_01_08_425864	552	14	certified	certify	VBN
10_1101-2021_01_08_425864	552	15	by	by	IN
10_1101-2021_01_08_425864	552	16	peer	peer	NN
10_1101-2021_01_08_425864	552	17	review	review	NN
10_1101-2021_01_08_425864	552	18	)	)	-RRB-
10_1101-2021_01_08_425864	552	19	is	be	VBZ
10_1101-2021_01_08_425864	552	20	the	the	DT
10_1101-2021_01_08_425864	552	21	author	author	NN
10_1101-2021_01_08_425864	552	22	/	/	SYM
10_1101-2021_01_08_425864	552	23	funder	funder	NN
10_1101-2021_01_08_425864	552	24	,	,	,
10_1101-2021_01_08_425864	552	25	who	who	WP
10_1101-2021_01_08_425864	552	26	has	have	VBZ
10_1101-2021_01_08_425864	552	27	granted	grant	VBN
10_1101-2021_01_08_425864	552	28	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	552	29	a	a	DT
10_1101-2021_01_08_425864	552	30	license	license	NN
10_1101-2021_01_08_425864	552	31	to	to	TO
10_1101-2021_01_08_425864	552	32	display	display	VB
10_1101-2021_01_08_425864	552	33	the	the	DT
10_1101-2021_01_08_425864	552	34	preprint	preprint	NN
10_1101-2021_01_08_425864	552	35	in	in	IN
10_1101-2021_01_08_425864	552	36	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	552	37	.	.	.
10_1101-2021_01_08_425864	553	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	553	2	is	be	VBZ
10_1101-2021_01_08_425864	553	3	The	the	DT
10_1101-2021_01_08_425864	553	4	copyright	copyright	NN
10_1101-2021_01_08_425864	553	5	holder	holder	NN
10_1101-2021_01_08_425864	553	6	for	for	IN
10_1101-2021_01_08_425864	553	7	this	this	DT
10_1101-2021_01_08_425864	553	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	553	9	version	version	NN
10_1101-2021_01_08_425864	553	10	posted	post	VBD
10_1101-2021_01_08_425864	553	11	January	January	NNP
10_1101-2021_01_08_425864	553	12	8	8	CD
10_1101-2021_01_08_425864	553	13	,	,	,
10_1101-2021_01_08_425864	553	14	2021	2021	CD
10_1101-2021_01_08_425864	553	15	.	.	.
10_1101-2021_01_08_425864	553	16	;	;	:
10_1101-2021_01_08_425864	553	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	553	18	:	:	:
10_1101-2021_01_08_425864	553	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	553	20	preprint	preprint	NN
10_1101-2021_01_08_425864	553	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	553	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	553	23	734	734	CD
10_1101-2021_01_08_425864	553	24	[	[	-LRB-
10_1101-2021_01_08_425864	553	25	23	23	CD
10_1101-2021_01_08_425864	553	26	]	]	-RRB-
10_1101-2021_01_08_425864	553	27	P.L.L.	P.L.L.	NNP
10_1101-2021_01_08_425864	554	1	Bieber	Bieber	NNP
10_1101-2021_01_08_425864	554	2	,	,	,
10_1101-2021_01_08_425864	554	3	T.	T.	NNP
10_1101-2021_01_08_425864	554	4	Abraham	Abraham	NNP
10_1101-2021_01_08_425864	554	5	,	,	,
10_1101-2021_01_08_425864	554	6	T.	T.	NNP
10_1101-2021_01_08_425864	554	7	Helmrath	Helmrath	NNP
10_1101-2021_01_08_425864	554	8	,	,	,
10_1101-2021_01_08_425864	554	9	Y.	Y.	NNP
10_1101-2021_01_08_425864	554	10	Kim	Kim	NNP
10_1101-2021_01_08_425864	554	11	,	,	,
10_1101-2021_01_08_425864	554	12	R.	R.	NNP
10_1101-2021_01_08_425864	554	13	Dehlin	Dehlin	NNP
10_1101-2021_01_08_425864	554	14	,	,	,
10_1101-2021_01_08_425864	554	15	A	A	NNP
10_1101-2021_01_08_425864	554	16	Rapid	Rapid	NNP
10_1101-2021_01_08_425864	554	17	Spectrophotometric	Spectrophotometric	NNP
10_1101-2021_01_08_425864	554	18	735	735	CD
10_1101-2021_01_08_425864	554	19	assay	assay	NN
10_1101-2021_01_08_425864	554	20	for	for	IN
10_1101-2021_01_08_425864	554	21	carnitine	carnitine	NN
10_1101-2021_01_08_425864	554	22	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	554	23	,	,	,
10_1101-2021_01_08_425864	554	24	1972	1972	CD
10_1101-2021_01_08_425864	554	25	.	.	.
10_1101-2021_01_08_425864	554	26	https://ac.els-cdn.com/0003269772900619/1-	https://ac.els-cdn.com/0003269772900619/1-	UH
10_1101-2021_01_08_425864	554	27	736	736	CD
10_1101-2021_01_08_425864	554	28	s2.0-0003269772900619-main.pdf?_tid=d5130378-0890-4a27-8e0e-	s2.0-0003269772900619-main.pdf?_tid=d5130378-0890-4a27-8e0e-	NNP
10_1101-2021_01_08_425864	554	29	737	737	CD
10_1101-2021_01_08_425864	554	30	63a5c3921132&acdnat=1549722154_d3bdaa5775a2a24b64ccf923a6b8ba4d	63a5c3921132&acdnat=1549722154_d3bdaa5775a2a24b64ccf923a6b8ba4d	CD
10_1101-2021_01_08_425864	554	31	(	(	-LRB-
10_1101-2021_01_08_425864	554	32	accessed	access	VBN
10_1101-2021_01_08_425864	554	33	738	738	CD
10_1101-2021_01_08_425864	554	34	February	February	NNP
10_1101-2021_01_08_425864	554	35	9	9	CD
10_1101-2021_01_08_425864	554	36	,	,	,
10_1101-2021_01_08_425864	554	37	2019	2019	CD
10_1101-2021_01_08_425864	554	38	)	)	-RRB-
10_1101-2021_01_08_425864	554	39	.	.	.
10_1101-2021_01_08_425864	555	1	739	739	CD
10_1101-2021_01_08_425864	555	2	[	[	-LRB-
10_1101-2021_01_08_425864	555	3	24	24	CD
10_1101-2021_01_08_425864	555	4	]	]	-RRB-
10_1101-2021_01_08_425864	555	5	L.B.	L.B.	NNP
10_1101-2021_01_08_425864	556	1	Willis	Willis	NNP
10_1101-2021_01_08_425864	556	2	,	,	,
10_1101-2021_01_08_425864	556	3	W.	W.	NNP
10_1101-2021_01_08_425864	556	4	Saridah	Saridah	NNP
10_1101-2021_01_08_425864	556	5	,	,	,
10_1101-2021_01_08_425864	556	6	W.	W.	NNP
10_1101-2021_01_08_425864	556	7	Omar	Omar	NNP
10_1101-2021_01_08_425864	556	8	,	,	,
10_1101-2021_01_08_425864	556	9	;	;	:
10_1101-2021_01_08_425864	556	10	Ravigadevi	Ravigadevi	NNP
10_1101-2021_01_08_425864	556	11	Sambanthamurthi	Sambanthamurthi	NNP
10_1101-2021_01_08_425864	556	12	,	,	,
10_1101-2021_01_08_425864	556	13	A.J.	A.J.	NNP
10_1101-2021_01_08_425864	557	1	Sinskey	Sinskey	NNP
10_1101-2021_01_08_425864	557	2	,	,	,
10_1101-2021_01_08_425864	557	3	Non-	Non-	NNP
10_1101-2021_01_08_425864	557	4	740	740	CD
10_1101-2021_01_08_425864	557	5	radioactive	radioactive	JJ
10_1101-2021_01_08_425864	557	6	assay	assay	NN
10_1101-2021_01_08_425864	557	7	for	for	IN
10_1101-2021_01_08_425864	557	8	Acetyl	Acetyl	NNP
10_1101-2021_01_08_425864	557	9	-	-	HYPH
10_1101-2021_01_08_425864	557	10	CoA	CoA	NNP
10_1101-2021_01_08_425864	557	11	carboxylase	carboxylase	NN
10_1101-2021_01_08_425864	557	12	activity	activity	NN
10_1101-2021_01_08_425864	557	13	,	,	,
10_1101-2021_01_08_425864	557	14	2008	2008	CD
10_1101-2021_01_08_425864	557	15	.	.	.
10_1101-2021_01_08_425864	558	1	741	741	CD
10_1101-2021_01_08_425864	558	2	http://palmoilis.mpob.gov.my/publications/jopr2008sp2-laura.pdf	http://palmoilis.mpob.gov.my/publications/jopr2008sp2-laura.pdf	NNS
10_1101-2021_01_08_425864	558	3	(	(	-LRB-
10_1101-2021_01_08_425864	558	4	accessed	access	VBN
10_1101-2021_01_08_425864	558	5	February	February	NNP
10_1101-2021_01_08_425864	558	6	9	9	CD
10_1101-2021_01_08_425864	558	7	,	,	,
10_1101-2021_01_08_425864	558	8	742	742	CD
10_1101-2021_01_08_425864	558	9	2019	2019	CD
10_1101-2021_01_08_425864	558	10	)	)	-RRB-
10_1101-2021_01_08_425864	558	11	.	.	.
10_1101-2021_01_08_425864	559	1	743	743	CD
10_1101-2021_01_08_425864	559	2	[	[	-LRB-
10_1101-2021_01_08_425864	559	3	25	25	CD
10_1101-2021_01_08_425864	559	4	]	]	-RRB-
10_1101-2021_01_08_425864	559	5	G.E.	G.E.	NNP
10_1101-2021_01_08_425864	560	1	Racagni	Racagni	NNP
10_1101-2021_01_08_425864	560	2	,	,	,
10_1101-2021_01_08_425864	560	3	E.E.	E.E.	NNP
10_1101-2021_01_08_425864	561	1	Machado	Machado	NNP
10_1101-2021_01_08_425864	561	2	de	de	FW
10_1101-2021_01_08_425864	561	3	Domenech	Domenech	NNP
10_1101-2021_01_08_425864	561	4	,	,	,
10_1101-2021_01_08_425864	561	5	Characterization	Characterization	NNP
10_1101-2021_01_08_425864	561	6	of	of	IN
10_1101-2021_01_08_425864	561	7	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	561	8	cruzi	cruzi	NNP
10_1101-2021_01_08_425864	561	9	744	744	CD
10_1101-2021_01_08_425864	561	10	hexokinase	hexokinase	NN
10_1101-2021_01_08_425864	561	11	,	,	,
10_1101-2021_01_08_425864	561	12	Mol	Mol	NNP
10_1101-2021_01_08_425864	561	13	.	.	.
10_1101-2021_01_08_425864	562	1	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	562	2	.	.	.
10_1101-2021_01_08_425864	563	1	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	563	2	.	.	.
10_1101-2021_01_08_425864	564	1	9	9	CD
10_1101-2021_01_08_425864	564	2	(	(	-LRB-
10_1101-2021_01_08_425864	564	3	1983	1983	CD
10_1101-2021_01_08_425864	564	4	)	)	-RRB-
10_1101-2021_01_08_425864	564	5	181–188	181–188	CD
10_1101-2021_01_08_425864	564	6	.	.	.
10_1101-2021_01_08_425864	565	1	https://doi.org/10.1016/0166-	https://doi.org/10.1016/0166-	NNP
10_1101-2021_01_08_425864	565	2	745	745	CD
10_1101-2021_01_08_425864	565	3	6851(83)90108	6851(83)90108	NNP
10_1101-2021_01_08_425864	565	4	-	-	HYPH
10_1101-2021_01_08_425864	565	5	1	1	CD
10_1101-2021_01_08_425864	565	6	.	.	.
10_1101-2021_01_08_425864	566	1	746	746	CD
10_1101-2021_01_08_425864	566	2	[	[	-LRB-
10_1101-2021_01_08_425864	566	3	26	26	CD
10_1101-2021_01_08_425864	566	4	]	]	-RRB-
10_1101-2021_01_08_425864	566	5	M.F.	M.F.	NNP
10_1101-2021_01_08_425864	567	1	Rütti	Rütti	NNP
10_1101-2021_01_08_425864	567	2	,	,	,
10_1101-2021_01_08_425864	567	3	S.	S.	NNP
10_1101-2021_01_08_425864	567	4	Richard	Richard	NNP
10_1101-2021_01_08_425864	567	5	,	,	,
10_1101-2021_01_08_425864	567	6	A.	A.	NNP
10_1101-2021_01_08_425864	567	7	Penno	Penno	NNP
10_1101-2021_01_08_425864	567	8	,	,	,
10_1101-2021_01_08_425864	567	9	A.	A.	NNP
10_1101-2021_01_08_425864	567	10	von	von	NNP
10_1101-2021_01_08_425864	567	11	Eckardstein	Eckardstein	NNP
10_1101-2021_01_08_425864	567	12	,	,	,
10_1101-2021_01_08_425864	567	13	T.	T.	NNP
10_1101-2021_01_08_425864	567	14	Hornemann	Hornemann	NNP
10_1101-2021_01_08_425864	567	15	,	,	,
10_1101-2021_01_08_425864	567	16	An	an	DT
10_1101-2021_01_08_425864	567	17	improved	improved	JJ
10_1101-2021_01_08_425864	567	18	method	method	NN
10_1101-2021_01_08_425864	567	19	747	747	CD
10_1101-2021_01_08_425864	567	20	to	to	TO
10_1101-2021_01_08_425864	567	21	determine	determine	VB
10_1101-2021_01_08_425864	567	22	serine	serine	JJ
10_1101-2021_01_08_425864	567	23	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	567	24	activity	activity	NN
10_1101-2021_01_08_425864	567	25	,	,	,
10_1101-2021_01_08_425864	567	26	J.	J.	NNP
10_1101-2021_01_08_425864	567	27	Lipid	Lipid	NNP
10_1101-2021_01_08_425864	567	28	Res	Res	NNP
10_1101-2021_01_08_425864	567	29	.	.	.
10_1101-2021_01_08_425864	568	1	50	50	CD
10_1101-2021_01_08_425864	568	2	(	(	-LRB-
10_1101-2021_01_08_425864	568	3	2009	2009	CD
10_1101-2021_01_08_425864	568	4	)	)	-RRB-
10_1101-2021_01_08_425864	568	5	1237–44	1237–44	ADD
10_1101-2021_01_08_425864	568	6	.	.	.
10_1101-2021_01_08_425864	569	1	748	748	CD
10_1101-2021_01_08_425864	569	2	https://doi.org/10.1194/jlr.D900001-JLR200	https://doi.org/10.1194/jlr.D900001-JLR200	NNP
10_1101-2021_01_08_425864	569	3	.	.	.
10_1101-2021_01_08_425864	570	1	749	749	CD
10_1101-2021_01_08_425864	570	2	[	[	-LRB-
10_1101-2021_01_08_425864	570	3	27	27	CD
10_1101-2021_01_08_425864	570	4	]	]	-RRB-
10_1101-2021_01_08_425864	570	5	A.	a.	NN
10_1101-2021_01_08_425864	570	6	Magdaleno	Magdaleno	NNP
10_1101-2021_01_08_425864	570	7	,	,	,
10_1101-2021_01_08_425864	570	8	I.Y.	I.Y.	NNP
10_1101-2021_01_08_425864	571	1	Ahn	Ahn	NNP
10_1101-2021_01_08_425864	571	2	,	,	,
10_1101-2021_01_08_425864	571	3	L.S.	L.S.	NNP
10_1101-2021_01_08_425864	572	1	Paes	Paes	NNP
10_1101-2021_01_08_425864	572	2	,	,	,
10_1101-2021_01_08_425864	572	3	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	572	4	Silber	Silber	NNP
10_1101-2021_01_08_425864	572	5	,	,	,
10_1101-2021_01_08_425864	572	6	Actions	Actions	NNPS
10_1101-2021_01_08_425864	572	7	of	of	IN
10_1101-2021_01_08_425864	572	8	a	a	DT
10_1101-2021_01_08_425864	572	9	proline	proline	JJ
10_1101-2021_01_08_425864	572	10	analogue	analogue	NN
10_1101-2021_01_08_425864	572	11	,	,	,
10_1101-2021_01_08_425864	572	12	L-	L-	NNP
10_1101-2021_01_08_425864	572	13	750	750	CD
10_1101-2021_01_08_425864	572	14	thiazolidine-4-carboxylic	thiazolidine-4-carboxylic	JJ
10_1101-2021_01_08_425864	572	15	acid	acid	NN
10_1101-2021_01_08_425864	572	16	(	(	-LRB-
10_1101-2021_01_08_425864	572	17	T4C	t4c	NN
10_1101-2021_01_08_425864	572	18	)	)	-RRB-
10_1101-2021_01_08_425864	572	19	,	,	,
10_1101-2021_01_08_425864	572	20	on	on	IN
10_1101-2021_01_08_425864	572	21	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	572	22	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	572	23	,	,	,
10_1101-2021_01_08_425864	572	24	PLoS	PLoS	NNP
10_1101-2021_01_08_425864	572	25	One	one	CD
10_1101-2021_01_08_425864	572	26	.	.	.
10_1101-2021_01_08_425864	573	1	4	4	CD
10_1101-2021_01_08_425864	573	2	(	(	-LRB-
10_1101-2021_01_08_425864	573	3	2009	2009	CD
10_1101-2021_01_08_425864	573	4	)	)	-RRB-
10_1101-2021_01_08_425864	573	5	e4534	e4534	NNP
10_1101-2021_01_08_425864	573	6	.	.	.
10_1101-2021_01_08_425864	574	1	751	751	CD
10_1101-2021_01_08_425864	574	2	https://doi.org/10.1371/journal.pone.0004534	https://doi.org/10.1371/journal.pone.0004534	NN
10_1101-2021_01_08_425864	574	3	.	.	.
10_1101-2021_01_08_425864	575	1	752	752	CD
10_1101-2021_01_08_425864	575	2	[	[	-LRB-
10_1101-2021_01_08_425864	575	3	28	28	CD
10_1101-2021_01_08_425864	575	4	]	]	-RRB-
10_1101-2021_01_08_425864	575	5	F.S.	F.S.	NNP
10_1101-2021_01_08_425864	576	1	Damasceno	Damasceno	NNP
10_1101-2021_01_08_425864	576	2	,	,	,
10_1101-2021_01_08_425864	576	3	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	576	4	Barison	Barison	NNP
10_1101-2021_01_08_425864	576	5	,	,	,
10_1101-2021_01_08_425864	576	6	E.M.	E.M.	NNP
10_1101-2021_01_08_425864	576	7	Pral	Pral	NNP
10_1101-2021_01_08_425864	576	8	,	,	,
10_1101-2021_01_08_425864	576	9	L.S.	L.S.	NNP
10_1101-2021_01_08_425864	577	1	Paes	Paes	NNP
10_1101-2021_01_08_425864	577	2	,	,	,
10_1101-2021_01_08_425864	577	3	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	577	4	Silber	Silber	NNP
10_1101-2021_01_08_425864	577	5	,	,	,
10_1101-2021_01_08_425864	577	6	Memantine	Memantine	NNP
10_1101-2021_01_08_425864	577	7	,	,	,
10_1101-2021_01_08_425864	577	8	an	an	DT
10_1101-2021_01_08_425864	577	9	antagonist	antagonist	NN
10_1101-2021_01_08_425864	577	10	753	753	CD
10_1101-2021_01_08_425864	577	11	of	of	IN
10_1101-2021_01_08_425864	577	12	the	the	DT
10_1101-2021_01_08_425864	577	13	NMDA	NMDA	NNP
10_1101-2021_01_08_425864	577	14	glutamate	glutamate	NN
10_1101-2021_01_08_425864	577	15	receptor	receptor	NN
10_1101-2021_01_08_425864	577	16	,	,	,
10_1101-2021_01_08_425864	577	17	affects	affect	VBZ
10_1101-2021_01_08_425864	577	18	cell	cell	NN
10_1101-2021_01_08_425864	577	19	proliferation	proliferation	NN
10_1101-2021_01_08_425864	577	20	,	,	,
10_1101-2021_01_08_425864	577	21	differentiation	differentiation	NN
10_1101-2021_01_08_425864	577	22	and	and	CC
10_1101-2021_01_08_425864	577	23	the	the	DT
10_1101-2021_01_08_425864	577	24	754	754	CD
10_1101-2021_01_08_425864	577	25	intracellular	intracellular	JJ
10_1101-2021_01_08_425864	577	26	cycle	cycle	NN
10_1101-2021_01_08_425864	577	27	and	and	CC
10_1101-2021_01_08_425864	577	28	induces	induce	VBZ
10_1101-2021_01_08_425864	577	29	apoptosis	apoptosis	NN
10_1101-2021_01_08_425864	577	30	in	in	IN
10_1101-2021_01_08_425864	577	31	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	577	32	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	577	33	,	,	,
10_1101-2021_01_08_425864	577	34	PLoS	PLoS	NNP
10_1101-2021_01_08_425864	577	35	Negl	Negl	NNP
10_1101-2021_01_08_425864	577	36	Trop	Trop	NNP
10_1101-2021_01_08_425864	577	37	Dis	Dis	NNP
10_1101-2021_01_08_425864	577	38	.	.	.
10_1101-2021_01_08_425864	578	1	8	8	CD
10_1101-2021_01_08_425864	578	2	755	755	CD
10_1101-2021_01_08_425864	578	3	(	(	-LRB-
10_1101-2021_01_08_425864	578	4	2014	2014	CD
10_1101-2021_01_08_425864	578	5	)	)	-RRB-
10_1101-2021_01_08_425864	578	6	e2717	e2717	NN
10_1101-2021_01_08_425864	578	7	.	.	.
10_1101-2021_01_08_425864	579	1	https://doi.org/10.1371/journal.pntd.0002717	https://doi.org/10.1371/journal.pntd.0002717	NNP
10_1101-2021_01_08_425864	579	2	.	.	.
10_1101-2021_01_08_425864	580	1	756	756	CD
10_1101-2021_01_08_425864	580	2	[	[	-LRB-
10_1101-2021_01_08_425864	580	3	29	29	CD
10_1101-2021_01_08_425864	580	4	]	]	-RRB-
10_1101-2021_01_08_425864	580	5	K.	K.	NNP
10_1101-2021_01_08_425864	580	6	Figarella	Figarella	NNP
10_1101-2021_01_08_425864	580	7	,	,	,
10_1101-2021_01_08_425864	580	8	M.	M.	NNP
10_1101-2021_01_08_425864	580	9	Rawer	Rawer	NNP
10_1101-2021_01_08_425864	580	10	,	,	,
10_1101-2021_01_08_425864	580	11	N.L.	N.L.	NNP
10_1101-2021_01_08_425864	581	1	Uzcategui	Uzcategui	NNP
10_1101-2021_01_08_425864	581	2	,	,	,
10_1101-2021_01_08_425864	581	3	B.K.	B.K.	NNP
10_1101-2021_01_08_425864	582	1	Kubata	Kubata	NNP
10_1101-2021_01_08_425864	582	2	,	,	,
10_1101-2021_01_08_425864	582	3	K.	K.	NNP
10_1101-2021_01_08_425864	582	4	Lauber	Lauber	NNP
10_1101-2021_01_08_425864	582	5	,	,	,
10_1101-2021_01_08_425864	582	6	F.	F.	NNP
10_1101-2021_01_08_425864	582	7	Madeo	Madeo	NNP
10_1101-2021_01_08_425864	582	8	,	,	,
10_1101-2021_01_08_425864	582	9	S.	S.	NNP
10_1101-2021_01_08_425864	582	10	Wesselborg	Wesselborg	NNP
10_1101-2021_01_08_425864	582	11	,	,	,
10_1101-2021_01_08_425864	582	12	757	757	CD
10_1101-2021_01_08_425864	582	13	M.	M.	NNP
10_1101-2021_01_08_425864	582	14	Duszenko	Duszenko	NNP
10_1101-2021_01_08_425864	582	15	,	,	,
10_1101-2021_01_08_425864	582	16	Prostaglandin	Prostaglandin	NNP
10_1101-2021_01_08_425864	582	17	D2	D2	NNP
10_1101-2021_01_08_425864	582	18	induces	induce	VBZ
10_1101-2021_01_08_425864	582	19	programmed	program	VBD
10_1101-2021_01_08_425864	582	20	cell	cell	NN
10_1101-2021_01_08_425864	582	21	death	death	NN
10_1101-2021_01_08_425864	582	22	in	in	IN
10_1101-2021_01_08_425864	582	23	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	582	24	brucei	brucei	NN
10_1101-2021_01_08_425864	582	25	758	758	CD
10_1101-2021_01_08_425864	582	26	bloodstream	bloodstream	NN
10_1101-2021_01_08_425864	582	27	form	form	NN
10_1101-2021_01_08_425864	582	28	,	,	,
10_1101-2021_01_08_425864	582	29	Cell	Cell	NNP
10_1101-2021_01_08_425864	582	30	Death	Death	NNP
10_1101-2021_01_08_425864	582	31	Differ	Differ	NNP
10_1101-2021_01_08_425864	582	32	.	.	.
10_1101-2021_01_08_425864	583	1	12	12	CD
10_1101-2021_01_08_425864	583	2	(	(	-LRB-
10_1101-2021_01_08_425864	583	3	2005	2005	CD
10_1101-2021_01_08_425864	583	4	)	)	-RRB-
10_1101-2021_01_08_425864	583	5	335–346	335–346	CD
10_1101-2021_01_08_425864	583	6	.	.	.
10_1101-2021_01_08_425864	584	1	759	759	CD
10_1101-2021_01_08_425864	584	2	https://doi.org/10.1038/sj.cdd.4401564	https://doi.org/10.1038/sj.cdd.4401564	NNP
10_1101-2021_01_08_425864	584	3	.	.	.
10_1101-2021_01_08_425864	585	1	.CC	.CC	NFP
10_1101-2021_01_08_425864	585	2	-	-	:
10_1101-2021_01_08_425864	585	3	BY	by	IN
10_1101-2021_01_08_425864	585	4	4.0	4.0	CD
10_1101-2021_01_08_425864	585	5	International	international	JJ
10_1101-2021_01_08_425864	585	6	licensemade	licensemade	NN
10_1101-2021_01_08_425864	585	7	available	available	JJ
10_1101-2021_01_08_425864	585	8	under	under	IN
10_1101-2021_01_08_425864	585	9	a	a	DT
10_1101-2021_01_08_425864	585	10	(	(	-LRB-
10_1101-2021_01_08_425864	585	11	which	which	WDT
10_1101-2021_01_08_425864	585	12	was	be	VBD
10_1101-2021_01_08_425864	585	13	not	not	RB
10_1101-2021_01_08_425864	585	14	certified	certify	VBN
10_1101-2021_01_08_425864	585	15	by	by	IN
10_1101-2021_01_08_425864	585	16	peer	peer	NN
10_1101-2021_01_08_425864	585	17	review	review	NN
10_1101-2021_01_08_425864	585	18	)	)	-RRB-
10_1101-2021_01_08_425864	585	19	is	be	VBZ
10_1101-2021_01_08_425864	585	20	the	the	DT
10_1101-2021_01_08_425864	585	21	author	author	NN
10_1101-2021_01_08_425864	585	22	/	/	SYM
10_1101-2021_01_08_425864	585	23	funder	funder	NN
10_1101-2021_01_08_425864	585	24	,	,	,
10_1101-2021_01_08_425864	585	25	who	who	WP
10_1101-2021_01_08_425864	585	26	has	have	VBZ
10_1101-2021_01_08_425864	585	27	granted	grant	VBN
10_1101-2021_01_08_425864	585	28	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	585	29	a	a	DT
10_1101-2021_01_08_425864	585	30	license	license	NN
10_1101-2021_01_08_425864	585	31	to	to	TO
10_1101-2021_01_08_425864	585	32	display	display	VB
10_1101-2021_01_08_425864	585	33	the	the	DT
10_1101-2021_01_08_425864	585	34	preprint	preprint	NN
10_1101-2021_01_08_425864	585	35	in	in	IN
10_1101-2021_01_08_425864	585	36	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	585	37	.	.	.
10_1101-2021_01_08_425864	586	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	586	2	is	be	VBZ
10_1101-2021_01_08_425864	586	3	The	the	DT
10_1101-2021_01_08_425864	586	4	copyright	copyright	NN
10_1101-2021_01_08_425864	586	5	holder	holder	NN
10_1101-2021_01_08_425864	586	6	for	for	IN
10_1101-2021_01_08_425864	586	7	this	this	DT
10_1101-2021_01_08_425864	586	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	586	9	version	version	NN
10_1101-2021_01_08_425864	586	10	posted	post	VBD
10_1101-2021_01_08_425864	586	11	January	January	NNP
10_1101-2021_01_08_425864	586	12	8	8	CD
10_1101-2021_01_08_425864	586	13	,	,	,
10_1101-2021_01_08_425864	586	14	2021	2021	CD
10_1101-2021_01_08_425864	586	15	.	.	.
10_1101-2021_01_08_425864	586	16	;	;	:
10_1101-2021_01_08_425864	586	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	586	18	:	:	:
10_1101-2021_01_08_425864	586	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	586	20	preprint	preprint	NN
10_1101-2021_01_08_425864	586	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	586	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	586	23	760	760	CD
10_1101-2021_01_08_425864	586	24	[	[	-LRB-
10_1101-2021_01_08_425864	586	25	30	30	CD
10_1101-2021_01_08_425864	586	26	]	]	-RRB-
10_1101-2021_01_08_425864	586	27	G.D.	G.D.	NNP
10_1101-2021_01_08_425864	586	28	Lopaschuk	Lopaschuk	NNP
10_1101-2021_01_08_425864	586	29	,	,	,
10_1101-2021_01_08_425864	586	30	S.R.	S.R.	NNP
10_1101-2021_01_08_425864	587	1	Wall	Wall	NNP
10_1101-2021_01_08_425864	587	2	,	,	,
10_1101-2021_01_08_425864	587	3	P.M.	P.M.	NNP
10_1101-2021_01_08_425864	587	4	Olley	Olley	NNP
10_1101-2021_01_08_425864	587	5	,	,	,
10_1101-2021_01_08_425864	587	6	N.J.	New Jersey	NNP
10_1101-2021_01_08_425864	587	7	Davies	Davies	NNP
10_1101-2021_01_08_425864	587	8	,	,	,
10_1101-2021_01_08_425864	587	9	Etomoxir	Etomoxir	NNPS
10_1101-2021_01_08_425864	587	10	,	,	,
10_1101-2021_01_08_425864	587	11	a	a	DT
10_1101-2021_01_08_425864	587	12	carnitine	carnitine	NN
10_1101-2021_01_08_425864	587	13	761	761	CD
10_1101-2021_01_08_425864	587	14	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	587	15	I	-PRON-	PRP
10_1101-2021_01_08_425864	587	16	inhibitor	inhibitor	VBP
10_1101-2021_01_08_425864	587	17	,	,	,
10_1101-2021_01_08_425864	587	18	protects	protect	VBZ
10_1101-2021_01_08_425864	587	19	hearts	heart	NNS
10_1101-2021_01_08_425864	587	20	from	from	IN
10_1101-2021_01_08_425864	587	21	fatty	fatty	NN
10_1101-2021_01_08_425864	587	22	acid	acid	NN
10_1101-2021_01_08_425864	587	23	-	-	HYPH
10_1101-2021_01_08_425864	587	24	induced	induce	VBN
10_1101-2021_01_08_425864	587	25	ischemic	ischemic	JJ
10_1101-2021_01_08_425864	587	26	injury	injury	NN
10_1101-2021_01_08_425864	587	27	762	762	CD
10_1101-2021_01_08_425864	587	28	independent	independent	JJ
10_1101-2021_01_08_425864	587	29	of	of	IN
10_1101-2021_01_08_425864	587	30	changes	change	NNS
10_1101-2021_01_08_425864	587	31	in	in	IN
10_1101-2021_01_08_425864	587	32	long	long	JJ
10_1101-2021_01_08_425864	587	33	chain	chain	NN
10_1101-2021_01_08_425864	587	34	acylcarnitine	acylcarnitine	NN
10_1101-2021_01_08_425864	587	35	.	.	.
10_1101-2021_01_08_425864	588	1	Circ	Circ	NNP
10_1101-2021_01_08_425864	588	2	.	.	.
10_1101-2021_01_08_425864	589	1	Res	Res	NNP
10_1101-2021_01_08_425864	589	2	.	.	.
10_1101-2021_01_08_425864	590	1	63	63	CD
10_1101-2021_01_08_425864	590	2	(	(	-LRB-
10_1101-2021_01_08_425864	590	3	1988	1988	CD
10_1101-2021_01_08_425864	590	4	)	)	-RRB-
10_1101-2021_01_08_425864	590	5	1036–1043	1036–1043	CD
10_1101-2021_01_08_425864	590	6	.	.	.
10_1101-2021_01_08_425864	591	1	763	763	CD
10_1101-2021_01_08_425864	591	2	https://doi.org/10.1161/01.RES.63.8.0.2036	https://doi.org/10.1161/01.RES.63.8.0.2036	NNP
10_1101-2021_01_08_425864	591	3	.	.	.
10_1101-2021_01_08_425864	592	1	764	764	CD
10_1101-2021_01_08_425864	592	2	[	[	-LRB-
10_1101-2021_01_08_425864	592	3	31	31	CD
10_1101-2021_01_08_425864	592	4	]	]	-RRB-
10_1101-2021_01_08_425864	592	5	C.M.	C.M.	NNP
10_1101-2021_01_08_425864	593	1	Koeller	Koeller	NNP
10_1101-2021_01_08_425864	593	2	,	,	,
10_1101-2021_01_08_425864	593	3	N.	N.	NNP
10_1101-2021_01_08_425864	593	4	Heise	Heise	NNP
10_1101-2021_01_08_425864	593	5	,	,	,
10_1101-2021_01_08_425864	593	6	The	the	DT
10_1101-2021_01_08_425864	593	7	sphingolipid	sphingolipid	JJ
10_1101-2021_01_08_425864	593	8	biosynthetic	biosynthetic	JJ
10_1101-2021_01_08_425864	593	9	pathway	pathway	NN
10_1101-2021_01_08_425864	593	10	is	be	VBZ
10_1101-2021_01_08_425864	593	11	a	a	DT
10_1101-2021_01_08_425864	593	12	potential	potential	JJ
10_1101-2021_01_08_425864	593	13	target	target	NN
10_1101-2021_01_08_425864	593	14	for	for	IN
10_1101-2021_01_08_425864	593	15	765	765	CD
10_1101-2021_01_08_425864	593	16	chemotherapy	chemotherapy	NN
10_1101-2021_01_08_425864	593	17	against	against	IN
10_1101-2021_01_08_425864	593	18	Chagas	Chagas	NNP
10_1101-2021_01_08_425864	593	19	disease	disease	NN
10_1101-2021_01_08_425864	593	20	,	,	,
10_1101-2021_01_08_425864	593	21	Enzyme	Enzyme	NNP
10_1101-2021_01_08_425864	593	22	Res	Res	NNP
10_1101-2021_01_08_425864	593	23	.	.	.
10_1101-2021_01_08_425864	594	1	2011	2011	CD
10_1101-2021_01_08_425864	594	2	(	(	-LRB-
10_1101-2021_01_08_425864	594	3	2011	2011	CD
10_1101-2021_01_08_425864	594	4	)	)	-RRB-
10_1101-2021_01_08_425864	594	5	1–13	1–13	CD
10_1101-2021_01_08_425864	594	6	.	.	.
10_1101-2021_01_08_425864	595	1	766	766	CD
10_1101-2021_01_08_425864	595	2	https://doi.org/10.4061/2011/648159	https://doi.org/10.4061/2011/648159	NNP
10_1101-2021_01_08_425864	595	3	.	.	.
10_1101-2021_01_08_425864	596	1	767	767	CD
10_1101-2021_01_08_425864	596	2	[	[	-LRB-
10_1101-2021_01_08_425864	596	3	32	32	CD
10_1101-2021_01_08_425864	596	4	]	]	-RRB-
10_1101-2021_01_08_425864	596	5	A.S.	A.S.	NNP
10_1101-2021_01_08_425864	596	6	Divakaruni	Divakaruni	NNP
10_1101-2021_01_08_425864	596	7	,	,	,
10_1101-2021_01_08_425864	596	8	W.Y.	W.Y.	NNP
10_1101-2021_01_08_425864	597	1	Hsieh	Hsieh	NNP
10_1101-2021_01_08_425864	597	2	,	,	,
10_1101-2021_01_08_425864	597	3	L.	L.	NNP
10_1101-2021_01_08_425864	597	4	Minarrieta	Minarrieta	NNP
10_1101-2021_01_08_425864	597	5	,	,	,
10_1101-2021_01_08_425864	597	6	T.N.	T.N.	NNP
10_1101-2021_01_08_425864	598	1	Duong	Duong	NNP
10_1101-2021_01_08_425864	598	2	,	,	,
10_1101-2021_01_08_425864	598	3	K.K.O.	K.K.O.	NNP
10_1101-2021_01_08_425864	599	1	Kim	Kim	NNP
10_1101-2021_01_08_425864	599	2	,	,	,
10_1101-2021_01_08_425864	599	3	B.R.	B.R.	NNP
10_1101-2021_01_08_425864	600	1	Desousa	Desousa	NNP
10_1101-2021_01_08_425864	600	2	,	,	,
10_1101-2021_01_08_425864	600	3	A.Y.	A.Y.	NNP
10_1101-2021_01_08_425864	601	1	768	768	CD
10_1101-2021_01_08_425864	601	2	Andreyev	Andreyev	NNP
10_1101-2021_01_08_425864	601	3	,	,	,
10_1101-2021_01_08_425864	601	4	C.E.	C.E.	NNP
10_1101-2021_01_08_425864	602	1	Bowman	Bowman	NNP
10_1101-2021_01_08_425864	602	2	,	,	,
10_1101-2021_01_08_425864	602	3	K.	K.	NNP
10_1101-2021_01_08_425864	602	4	Caradonna	Caradonna	NNP
10_1101-2021_01_08_425864	602	5	,	,	,
10_1101-2021_01_08_425864	602	6	B.P.	B.P.	NNP
10_1101-2021_01_08_425864	603	1	Dranka	Dranka	NNP
10_1101-2021_01_08_425864	603	2	,	,	,
10_1101-2021_01_08_425864	603	3	D.A.	D.A.	NNP
10_1101-2021_01_08_425864	604	1	Ferrick	Ferrick	NNP
10_1101-2021_01_08_425864	604	2	,	,	,
10_1101-2021_01_08_425864	604	3	M.	M.	NNP
10_1101-2021_01_08_425864	604	4	Liesa	Liesa	NNP
10_1101-2021_01_08_425864	604	5	,	,	,
10_1101-2021_01_08_425864	604	6	L.	L.	NNP
10_1101-2021_01_08_425864	604	7	Stiles	Stiles	NNP
10_1101-2021_01_08_425864	604	8	,	,	,
10_1101-2021_01_08_425864	604	9	769	769	CD
10_1101-2021_01_08_425864	604	10	G.W.	G.W.	NNP
10_1101-2021_01_08_425864	605	1	Rogers	Rogers	NNP
10_1101-2021_01_08_425864	605	2	,	,	,
10_1101-2021_01_08_425864	605	3	D.	D.	NNP
10_1101-2021_01_08_425864	605	4	Braas	Braas	NNP
10_1101-2021_01_08_425864	605	5	,	,	,
10_1101-2021_01_08_425864	605	6	T.P.	T.P.	NNP
10_1101-2021_01_08_425864	606	1	Ciaraldi	Ciaraldi	NNP
10_1101-2021_01_08_425864	606	2	,	,	,
10_1101-2021_01_08_425864	606	3	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	606	4	Wolfgang	Wolfgang	NNP
10_1101-2021_01_08_425864	606	5	,	,	,
10_1101-2021_01_08_425864	606	6	T.	T.	NNP
10_1101-2021_01_08_425864	606	7	Sparwasser	Sparwasser	NNP
10_1101-2021_01_08_425864	606	8	,	,	,
10_1101-2021_01_08_425864	606	9	L.	L.	NNP
10_1101-2021_01_08_425864	606	10	Berod	Berod	NNP
10_1101-2021_01_08_425864	606	11	,	,	,
10_1101-2021_01_08_425864	606	12	S.J.	S.J.	NNP
10_1101-2021_01_08_425864	607	1	770	770	CD
10_1101-2021_01_08_425864	607	2	Bensinger	Bensinger	NNP
10_1101-2021_01_08_425864	607	3	,	,	,
10_1101-2021_01_08_425864	607	4	A.N.	A.N.	NNP
10_1101-2021_01_08_425864	608	1	Murphy	Murphy	NNP
10_1101-2021_01_08_425864	608	2	,	,	,
10_1101-2021_01_08_425864	608	3	Etomoxir	Etomoxir	NNP
10_1101-2021_01_08_425864	608	4	inhibits	inhibit	VBZ
10_1101-2021_01_08_425864	608	5	macrophage	macrophage	NN
10_1101-2021_01_08_425864	608	6	polarization	polarization	NN
10_1101-2021_01_08_425864	608	7	by	by	IN
10_1101-2021_01_08_425864	608	8	disrupting	disrupt	VBG
10_1101-2021_01_08_425864	608	9	CoA	CoA	NNP
10_1101-2021_01_08_425864	608	10	771	771	CD
10_1101-2021_01_08_425864	608	11	homeostasis	homeostasis	NN
10_1101-2021_01_08_425864	608	12	.	.	.
10_1101-2021_01_08_425864	608	13	,	,	,
10_1101-2021_01_08_425864	608	14	Cell	Cell	NNP
10_1101-2021_01_08_425864	608	15	Metab	Metab	NNP
10_1101-2021_01_08_425864	608	16	.	.	.
10_1101-2021_01_08_425864	609	1	28	28	CD
10_1101-2021_01_08_425864	609	2	(	(	-LRB-
10_1101-2021_01_08_425864	609	3	2018	2018	CD
10_1101-2021_01_08_425864	609	4	)	)	-RRB-
10_1101-2021_01_08_425864	609	5	490	490	CD
10_1101-2021_01_08_425864	609	6	-	-	SYM
10_1101-2021_01_08_425864	609	7	503.e7	503.e7	CD
10_1101-2021_01_08_425864	609	8	.	.	.
10_1101-2021_01_08_425864	610	1	https://doi.org/10.1016/j.cmet.2018.06.001	https://doi.org/10.1016/j.cmet.2018.06.001	ADD
10_1101-2021_01_08_425864	610	2	.	.	.
10_1101-2021_01_08_425864	611	1	772	772	CD
10_1101-2021_01_08_425864	611	2	[	[	-LRB-
10_1101-2021_01_08_425864	611	3	33	33	CD
10_1101-2021_01_08_425864	611	4	]	]	-RRB-
10_1101-2021_01_08_425864	611	5	M.	M.	NNP
10_1101-2021_01_08_425864	611	6	Duszenko	Duszenko	NNP
10_1101-2021_01_08_425864	611	7	,	,	,
10_1101-2021_01_08_425864	611	8	K.	K.	NNP
10_1101-2021_01_08_425864	611	9	Figarella	Figarella	NNP
10_1101-2021_01_08_425864	611	10	,	,	,
10_1101-2021_01_08_425864	611	11	E.T.	E.T.	NNP
10_1101-2021_01_08_425864	612	1	Macleod	Macleod	NNP
10_1101-2021_01_08_425864	612	2	,	,	,
10_1101-2021_01_08_425864	612	3	S.C.	South Carolina	NNP
10_1101-2021_01_08_425864	612	4	Welburn	Welburn	NNP
10_1101-2021_01_08_425864	612	5	,	,	,
10_1101-2021_01_08_425864	612	6	Death	death	NN
10_1101-2021_01_08_425864	612	7	of	of	IN
10_1101-2021_01_08_425864	612	8	a	a	DT
10_1101-2021_01_08_425864	612	9	trypanosome	trypanosome	NN
10_1101-2021_01_08_425864	612	10	:	:	:
10_1101-2021_01_08_425864	612	11	a	a	DT
10_1101-2021_01_08_425864	612	12	selfish	selfish	JJ
10_1101-2021_01_08_425864	612	13	773	773	CD
10_1101-2021_01_08_425864	612	14	altruism	altruism	NN
10_1101-2021_01_08_425864	612	15	,	,	,
10_1101-2021_01_08_425864	612	16	Trends	Trends	NNP
10_1101-2021_01_08_425864	612	17	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	612	18	.	.	.
10_1101-2021_01_08_425864	613	1	22	22	CD
10_1101-2021_01_08_425864	613	2	(	(	-LRB-
10_1101-2021_01_08_425864	613	3	2006	2006	CD
10_1101-2021_01_08_425864	613	4	)	)	-RRB-
10_1101-2021_01_08_425864	613	5	536–542	536–542	CD
10_1101-2021_01_08_425864	613	6	.	.	.
10_1101-2021_01_08_425864	614	1	https://doi.org/10.1016/j.pt.2006.08.010	https://doi.org/10.1016/j.pt.2006.08.010	NNP
10_1101-2021_01_08_425864	614	2	.	.	.
10_1101-2021_01_08_425864	615	1	774	774	CD
10_1101-2021_01_08_425864	615	2	[	[	-LRB-
10_1101-2021_01_08_425864	615	3	34	34	CD
10_1101-2021_01_08_425864	615	4	]	]	-RRB-
10_1101-2021_01_08_425864	615	5	A.C.	A.C.	NNP
10_1101-2021_01_08_425864	615	6	Mariano	Mariano	NNP
10_1101-2021_01_08_425864	615	7	,	,	,
10_1101-2021_01_08_425864	615	8	R.	R.	NNP
10_1101-2021_01_08_425864	615	9	Santos	Santos	NNP
10_1101-2021_01_08_425864	615	10	,	,	,
10_1101-2021_01_08_425864	615	11	M.S.	M.S.	NNP
10_1101-2021_01_08_425864	616	1	Gonzalez	Gonzalez	NNP
10_1101-2021_01_08_425864	616	2	,	,	,
10_1101-2021_01_08_425864	616	3	D.	D.	NNP
10_1101-2021_01_08_425864	616	4	Feder	Feder	NNP
10_1101-2021_01_08_425864	616	5	,	,	,
10_1101-2021_01_08_425864	616	6	E.A.	E.A.	NNP
10_1101-2021_01_08_425864	617	1	Machado	Machado	NNP
10_1101-2021_01_08_425864	617	2	,	,	,
10_1101-2021_01_08_425864	617	3	B.	B.	NNP
10_1101-2021_01_08_425864	617	4	Pascarelli	Pascarelli	NNP
10_1101-2021_01_08_425864	617	5	,	,	,
10_1101-2021_01_08_425864	617	6	K.C.	K.C.	NNP
10_1101-2021_01_08_425864	618	1	775	775	CD
10_1101-2021_01_08_425864	618	2	Gondim	Gondim	NNP
10_1101-2021_01_08_425864	618	3	,	,	,
10_1101-2021_01_08_425864	618	4	J.R.	J.R.	NNP
10_1101-2021_01_08_425864	618	5	Meyer	Meyer	NNP
10_1101-2021_01_08_425864	618	6	-	-	HYPH
10_1101-2021_01_08_425864	618	7	Fernandes	Fernandes	NNP
10_1101-2021_01_08_425864	618	8	,	,	,
10_1101-2021_01_08_425864	618	9	Synthesis	Synthesis	NNP
10_1101-2021_01_08_425864	618	10	and	and	CC
10_1101-2021_01_08_425864	618	11	mobilization	mobilization	NN
10_1101-2021_01_08_425864	618	12	of	of	IN
10_1101-2021_01_08_425864	618	13	glycogen	glycogen	NNP
10_1101-2021_01_08_425864	618	14	and	and	CC
10_1101-2021_01_08_425864	618	15	trehalose	trehalose	DT
10_1101-2021_01_08_425864	618	16	in	in	IN
10_1101-2021_01_08_425864	618	17	776	776	CD
10_1101-2021_01_08_425864	618	18	adult	adult	NN
10_1101-2021_01_08_425864	618	19	male	male	JJ
10_1101-2021_01_08_425864	618	20	Rhodnius	Rhodnius	NNP
10_1101-2021_01_08_425864	618	21	prolixus	prolixus	NN
10_1101-2021_01_08_425864	618	22	,	,	,
10_1101-2021_01_08_425864	618	23	Arch	Arch	NNP
10_1101-2021_01_08_425864	618	24	.	.	.
10_1101-2021_01_08_425864	619	1	Insect	Insect	NNP
10_1101-2021_01_08_425864	619	2	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	619	3	.	.	.
10_1101-2021_01_08_425864	620	1	Physiol	Physiol	NNP
10_1101-2021_01_08_425864	620	2	.	.	.
10_1101-2021_01_08_425864	621	1	72	72	CD
10_1101-2021_01_08_425864	621	2	(	(	-LRB-
10_1101-2021_01_08_425864	621	3	2009	2009	CD
10_1101-2021_01_08_425864	621	4	)	)	-RRB-
10_1101-2021_01_08_425864	621	5	1–15	1–15	ADD
10_1101-2021_01_08_425864	621	6	.	.	.
10_1101-2021_01_08_425864	622	1	777	777	CD
10_1101-2021_01_08_425864	622	2	https://doi.org/10.1002/arch.20319	https://doi.org/10.1002/arch.20319	ADD
10_1101-2021_01_08_425864	622	3	.	.	.
10_1101-2021_01_08_425864	623	1	778	778	CD
10_1101-2021_01_08_425864	623	2	[	[	-LRB-
10_1101-2021_01_08_425864	623	3	35	35	CD
10_1101-2021_01_08_425864	623	4	]	]	-RRB-
10_1101-2021_01_08_425864	623	5	J.M.C.	J.M.C.	NNP
10_1101-2021_01_08_425864	624	1	Ribeiro	Ribeiro	NNP
10_1101-2021_01_08_425864	624	2	,	,	,
10_1101-2021_01_08_425864	624	3	F.A.	F.A.	NNP
10_1101-2021_01_08_425864	625	1	Genta	Genta	NNP
10_1101-2021_01_08_425864	625	2	,	,	,
10_1101-2021_01_08_425864	625	3	M.H.F.	M.H.F.	NNP
10_1101-2021_01_08_425864	626	1	Sorgine	Sorgine	NNP
10_1101-2021_01_08_425864	626	2	,	,	,
10_1101-2021_01_08_425864	626	3	R.	R.	NNP
10_1101-2021_01_08_425864	626	4	Logullo	Logullo	NNP
10_1101-2021_01_08_425864	626	5	,	,	,
10_1101-2021_01_08_425864	626	6	R.D.	R.D.	NNP
10_1101-2021_01_08_425864	627	1	Mesquita	Mesquita	NNP
10_1101-2021_01_08_425864	627	2	,	,	,
10_1101-2021_01_08_425864	627	3	G.O.	G.O.	NNP
10_1101-2021_01_08_425864	628	1	Paiva	Paiva	NNP
10_1101-2021_01_08_425864	628	2	-	-	HYPH
10_1101-2021_01_08_425864	628	3	Silva	Silva	NNP
10_1101-2021_01_08_425864	628	4	,	,	,
10_1101-2021_01_08_425864	628	5	779	779	CD
10_1101-2021_01_08_425864	628	6	D.	D.	NNP
10_1101-2021_01_08_425864	628	7	Majerowicz	Majerowicz	NNP
10_1101-2021_01_08_425864	628	8	,	,	,
10_1101-2021_01_08_425864	628	9	M.	M.	NNP
10_1101-2021_01_08_425864	628	10	Medeiros	Medeiros	NNP
10_1101-2021_01_08_425864	628	11	,	,	,
10_1101-2021_01_08_425864	628	12	L.	L.	NNP
10_1101-2021_01_08_425864	628	13	Koerich	Koerich	NNP
10_1101-2021_01_08_425864	628	14	,	,	,
10_1101-2021_01_08_425864	628	15	W.R.	W.R.	NNP
10_1101-2021_01_08_425864	628	16	Terra	Terra	NNP
10_1101-2021_01_08_425864	628	17	,	,	,
10_1101-2021_01_08_425864	628	18	C.	C.	NNP
10_1101-2021_01_08_425864	628	19	Ferreira	Ferreira	NNP
10_1101-2021_01_08_425864	628	20	,	,	,
10_1101-2021_01_08_425864	628	21	A.C.	A.C.	NNP
10_1101-2021_01_08_425864	628	22	Pimentel	Pimentel	NNP
10_1101-2021_01_08_425864	628	23	,	,	,
10_1101-2021_01_08_425864	628	24	P.M.	P.M.	NNP
10_1101-2021_01_08_425864	628	25	780	780	CD
10_1101-2021_01_08_425864	628	26	Bisch	Bisch	NNP
10_1101-2021_01_08_425864	628	27	,	,	,
10_1101-2021_01_08_425864	628	28	D.C.	D.C.	NNP
10_1101-2021_01_08_425864	628	29	Leite	Leite	NNP
10_1101-2021_01_08_425864	628	30	,	,	,
10_1101-2021_01_08_425864	628	31	M.M.P.	M.M.P.	NNP
10_1101-2021_01_08_425864	629	1	Diniz	Diniz	NNP
10_1101-2021_01_08_425864	629	2	,	,	,
10_1101-2021_01_08_425864	629	3	J.L.	J.L.	NNP
10_1101-2021_01_08_425864	630	1	da	da	NNP
10_1101-2021_01_08_425864	630	2	S.G.	S.G.	NNP
10_1101-2021_01_08_425864	630	3	V.	V.	NNP
10_1101-2021_01_08_425864	630	4	Junior	Junior	NNP
10_1101-2021_01_08_425864	630	5	,	,	,
10_1101-2021_01_08_425864	630	6	M.L.	M.L.	NNP
10_1101-2021_01_08_425864	631	1	Da	Da	NNP
10_1101-2021_01_08_425864	631	2	Silva	Silva	NNP
10_1101-2021_01_08_425864	631	3	,	,	,
10_1101-2021_01_08_425864	631	4	R.N.	R.N.	NNP
10_1101-2021_01_08_425864	632	1	Araujo	Araujo	NNP
10_1101-2021_01_08_425864	632	2	,	,	,
10_1101-2021_01_08_425864	632	3	A.C.P.	A.C.P.	NNP
10_1101-2021_01_08_425864	633	1	781	781	CD
10_1101-2021_01_08_425864	633	2	Gandara	Gandara	NNP
10_1101-2021_01_08_425864	633	3	,	,	,
10_1101-2021_01_08_425864	633	4	S.	S.	NNP
10_1101-2021_01_08_425864	633	5	Brosson	Brosson	NNP
10_1101-2021_01_08_425864	633	6	,	,	,
10_1101-2021_01_08_425864	633	7	D.	D.	NNP
10_1101-2021_01_08_425864	633	8	Salmon	Salmon	NNP
10_1101-2021_01_08_425864	633	9	,	,	,
10_1101-2021_01_08_425864	633	10	S.	S.	NNP
10_1101-2021_01_08_425864	633	11	Bousbata	Bousbata	NNP
10_1101-2021_01_08_425864	633	12	,	,	,
10_1101-2021_01_08_425864	633	13	N.	N.	NNP
10_1101-2021_01_08_425864	633	14	González	González	NNP
10_1101-2021_01_08_425864	633	15	-	-	HYPH
10_1101-2021_01_08_425864	633	16	Caballero	Caballero	NNP
10_1101-2021_01_08_425864	633	17	,	,	,
10_1101-2021_01_08_425864	633	18	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	633	19	Silber	Silber	NNP
10_1101-2021_01_08_425864	633	20	,	,	,
10_1101-2021_01_08_425864	633	21	M.	M.	NNP
10_1101-2021_01_08_425864	633	22	782	782	NNP
10_1101-2021_01_08_425864	633	23	Alves	Alves	NNP
10_1101-2021_01_08_425864	633	24	-	-	HYPH
10_1101-2021_01_08_425864	633	25	Bezerra	Bezerra	NNP
10_1101-2021_01_08_425864	633	26	,	,	,
10_1101-2021_01_08_425864	633	27	K.C.	K.C.	NNP
10_1101-2021_01_08_425864	634	1	Gondim	Gondim	NNP
10_1101-2021_01_08_425864	634	2	,	,	,
10_1101-2021_01_08_425864	634	3	M.A.C.	M.A.C.	NNP
10_1101-2021_01_08_425864	635	1	Silva	Silva	NNP
10_1101-2021_01_08_425864	635	2	-	-	HYPH
10_1101-2021_01_08_425864	635	3	Neto	Neto	NNP
10_1101-2021_01_08_425864	635	4	,	,	,
10_1101-2021_01_08_425864	635	5	G.C.	G.C.	NNP
10_1101-2021_01_08_425864	636	1	Atella	Atella	NNP
10_1101-2021_01_08_425864	636	2	,	,	,
10_1101-2021_01_08_425864	636	3	H.	H.	NNP
10_1101-2021_01_08_425864	636	4	Araujo	Araujo	NNP
10_1101-2021_01_08_425864	636	5	,	,	,
10_1101-2021_01_08_425864	636	6	F.A.	F.A.	NNP
10_1101-2021_01_08_425864	637	1	Dias	Dias	NNP
10_1101-2021_01_08_425864	637	2	,	,	,
10_1101-2021_01_08_425864	637	3	C.	C.	NNP
10_1101-2021_01_08_425864	637	4	783	783	CD
10_1101-2021_01_08_425864	637	5	Polycarpo	Polycarpo	NNP
10_1101-2021_01_08_425864	637	6	,	,	,
10_1101-2021_01_08_425864	637	7	R.J.	R.J.	NNP
10_1101-2021_01_08_425864	637	8	Vionette	Vionette	NNP
10_1101-2021_01_08_425864	637	9	-	-	HYPH
10_1101-2021_01_08_425864	637	10	Amaral	Amaral	NNP
10_1101-2021_01_08_425864	637	11	,	,	,
10_1101-2021_01_08_425864	637	12	P.	P.	NNP
10_1101-2021_01_08_425864	637	13	Fampa	Fampa	NNP
10_1101-2021_01_08_425864	637	14	,	,	,
10_1101-2021_01_08_425864	637	15	A.C.A.	A.C.A.	NNP
10_1101-2021_01_08_425864	638	1	Melo	Melo	NNP
10_1101-2021_01_08_425864	638	2	,	,	,
10_1101-2021_01_08_425864	638	3	A.S.	A.S.	NNP
10_1101-2021_01_08_425864	638	4	Tanaka	Tanaka	NNP
10_1101-2021_01_08_425864	638	5	,	,	,
10_1101-2021_01_08_425864	638	6	C.	C.	NNP
10_1101-2021_01_08_425864	638	7	Balczun	Balczun	NNP
10_1101-2021_01_08_425864	638	8	,	,	,
10_1101-2021_01_08_425864	638	9	J.H.M.	J.H.M.	NNP
10_1101-2021_01_08_425864	639	1	784	784	CD
10_1101-2021_01_08_425864	639	2	Oliveira	Oliveira	NNP
10_1101-2021_01_08_425864	639	3	,	,	,
10_1101-2021_01_08_425864	639	4	R.L.S.	R.L.S.	NNP
10_1101-2021_01_08_425864	640	1	Gonçalves	gonçalve	NNS
10_1101-2021_01_08_425864	640	2	,	,	,
10_1101-2021_01_08_425864	640	3	C.	C.	NNP
10_1101-2021_01_08_425864	640	4	Lazoski	Lazoski	NNP
10_1101-2021_01_08_425864	640	5	,	,	,
10_1101-2021_01_08_425864	640	6	R.	R.	NNP
10_1101-2021_01_08_425864	640	7	Rivera	Rivera	NNP
10_1101-2021_01_08_425864	640	8	-	-	HYPH
10_1101-2021_01_08_425864	640	9	Pomar	Pomar	NNP
10_1101-2021_01_08_425864	640	10	,	,	,
10_1101-2021_01_08_425864	640	11	L.	L.	NNP
10_1101-2021_01_08_425864	640	12	Diambra	Diambra	NNP
10_1101-2021_01_08_425864	640	13	,	,	,
10_1101-2021_01_08_425864	640	14	G.A.	G.A.	NNP
10_1101-2021_01_08_425864	641	1	Schaub	Schaub	NNP
10_1101-2021_01_08_425864	641	2	,	,	,
10_1101-2021_01_08_425864	641	3	E.S.	E.S.	NNP
10_1101-2021_01_08_425864	642	1	785	785	CD
10_1101-2021_01_08_425864	642	2	Garcia	Garcia	NNP
10_1101-2021_01_08_425864	642	3	,	,	,
10_1101-2021_01_08_425864	642	4	P.	P.	NNP
10_1101-2021_01_08_425864	642	5	Azambuja	Azambuja	NNP
10_1101-2021_01_08_425864	642	6	,	,	,
10_1101-2021_01_08_425864	642	7	G.R.C.	G.R.C.	NNP
10_1101-2021_01_08_425864	643	1	Braz	braz	NN
10_1101-2021_01_08_425864	643	2	,	,	,
10_1101-2021_01_08_425864	643	3	P.L.	P.L.	NNP
10_1101-2021_01_08_425864	644	1	Oliveira	Oliveira	NNP
10_1101-2021_01_08_425864	644	2	,	,	,
10_1101-2021_01_08_425864	644	3	An	an	DT
10_1101-2021_01_08_425864	644	4	insight	insight	NN
10_1101-2021_01_08_425864	644	5	into	into	IN
10_1101-2021_01_08_425864	644	6	the	the	DT
10_1101-2021_01_08_425864	644	7	transcriptome	transcriptome	NN
10_1101-2021_01_08_425864	644	8	of	of	IN
10_1101-2021_01_08_425864	644	9	the	the	DT
10_1101-2021_01_08_425864	644	10	.CC	.CC	:
10_1101-2021_01_08_425864	644	11	-	-	:
10_1101-2021_01_08_425864	644	12	BY	by	IN
10_1101-2021_01_08_425864	644	13	4.0	4.0	CD
10_1101-2021_01_08_425864	644	14	International	international	JJ
10_1101-2021_01_08_425864	644	15	licensemade	licensemade	NN
10_1101-2021_01_08_425864	644	16	available	available	JJ
10_1101-2021_01_08_425864	644	17	under	under	IN
10_1101-2021_01_08_425864	644	18	a	a	DT
10_1101-2021_01_08_425864	644	19	(	(	-LRB-
10_1101-2021_01_08_425864	644	20	which	which	WDT
10_1101-2021_01_08_425864	644	21	was	be	VBD
10_1101-2021_01_08_425864	644	22	not	not	RB
10_1101-2021_01_08_425864	644	23	certified	certify	VBN
10_1101-2021_01_08_425864	644	24	by	by	IN
10_1101-2021_01_08_425864	644	25	peer	peer	NN
10_1101-2021_01_08_425864	644	26	review	review	NN
10_1101-2021_01_08_425864	644	27	)	)	-RRB-
10_1101-2021_01_08_425864	644	28	is	be	VBZ
10_1101-2021_01_08_425864	644	29	the	the	DT
10_1101-2021_01_08_425864	644	30	author	author	NN
10_1101-2021_01_08_425864	644	31	/	/	SYM
10_1101-2021_01_08_425864	644	32	funder	funder	NN
10_1101-2021_01_08_425864	644	33	,	,	,
10_1101-2021_01_08_425864	644	34	who	who	WP
10_1101-2021_01_08_425864	644	35	has	have	VBZ
10_1101-2021_01_08_425864	644	36	granted	grant	VBN
10_1101-2021_01_08_425864	644	37	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	644	38	a	a	DT
10_1101-2021_01_08_425864	644	39	license	license	NN
10_1101-2021_01_08_425864	644	40	to	to	TO
10_1101-2021_01_08_425864	644	41	display	display	VB
10_1101-2021_01_08_425864	644	42	the	the	DT
10_1101-2021_01_08_425864	644	43	preprint	preprint	NN
10_1101-2021_01_08_425864	644	44	in	in	IN
10_1101-2021_01_08_425864	644	45	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	644	46	.	.	.
10_1101-2021_01_08_425864	645	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	645	2	is	be	VBZ
10_1101-2021_01_08_425864	645	3	The	the	DT
10_1101-2021_01_08_425864	645	4	copyright	copyright	NN
10_1101-2021_01_08_425864	645	5	holder	holder	NN
10_1101-2021_01_08_425864	645	6	for	for	IN
10_1101-2021_01_08_425864	645	7	this	this	DT
10_1101-2021_01_08_425864	645	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	645	9	version	version	NN
10_1101-2021_01_08_425864	645	10	posted	post	VBD
10_1101-2021_01_08_425864	645	11	January	January	NNP
10_1101-2021_01_08_425864	645	12	8	8	CD
10_1101-2021_01_08_425864	645	13	,	,	,
10_1101-2021_01_08_425864	645	14	2021	2021	CD
10_1101-2021_01_08_425864	645	15	.	.	.
10_1101-2021_01_08_425864	645	16	;	;	:
10_1101-2021_01_08_425864	645	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	645	18	:	:	:
10_1101-2021_01_08_425864	645	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	645	20	preprint	preprint	NN
10_1101-2021_01_08_425864	645	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	645	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	645	23	786	786	CD
10_1101-2021_01_08_425864	645	24	digestive	digestive	JJ
10_1101-2021_01_08_425864	645	25	tract	tract	NN
10_1101-2021_01_08_425864	645	26	of	of	IN
10_1101-2021_01_08_425864	645	27	the	the	DT
10_1101-2021_01_08_425864	645	28	bloodsucking	bloodsucking	NN
10_1101-2021_01_08_425864	645	29	bug	bug	NN
10_1101-2021_01_08_425864	645	30	,	,	,
10_1101-2021_01_08_425864	645	31	Rhodnius	Rhodnius	NNP
10_1101-2021_01_08_425864	645	32	prolixus	prolixus	NN
10_1101-2021_01_08_425864	645	33	,	,	,
10_1101-2021_01_08_425864	645	34	PLoS	PLoS	NNP
10_1101-2021_01_08_425864	645	35	Negl	Negl	NNP
10_1101-2021_01_08_425864	645	36	.	.	.
10_1101-2021_01_08_425864	646	1	Trop	Trop	NNP
10_1101-2021_01_08_425864	646	2	.	.	.
10_1101-2021_01_08_425864	647	1	Dis	Dis	NNP
10_1101-2021_01_08_425864	647	2	.	.	.
10_1101-2021_01_08_425864	648	1	8	8	CD
10_1101-2021_01_08_425864	648	2	(	(	-LRB-
10_1101-2021_01_08_425864	648	3	2014	2014	CD
10_1101-2021_01_08_425864	648	4	)	)	-RRB-
10_1101-2021_01_08_425864	648	5	787	787	CD
10_1101-2021_01_08_425864	648	6	e2594	e2594	JJ
10_1101-2021_01_08_425864	648	7	.	.	.
10_1101-2021_01_08_425864	649	1	https://doi.org/10.1371/journal.pntd.0002594	https://doi.org/10.1371/journal.pntd.0002594	NNP
10_1101-2021_01_08_425864	649	2	.	.	.
10_1101-2021_01_08_425864	650	1	788	788	CD
10_1101-2021_01_08_425864	650	2	[	[	-LRB-
10_1101-2021_01_08_425864	650	3	36	36	CD
10_1101-2021_01_08_425864	650	4	]	]	-RRB-
10_1101-2021_01_08_425864	650	5	L.	L.	NNP
10_1101-2021_01_08_425864	650	6	Antunes	Antunes	NNP
10_1101-2021_01_08_425864	650	7	,	,	,
10_1101-2021_01_08_425864	650	8	J.	J.	NNP
10_1101-2021_01_08_425864	650	9	Han	Han	NNP
10_1101-2021_01_08_425864	650	10	,	,	,
10_1101-2021_01_08_425864	650	11	J.	J.	NNP
10_1101-2021_01_08_425864	650	12	Pan	Pan	NNP
10_1101-2021_01_08_425864	650	13	,	,	,
10_1101-2021_01_08_425864	650	14	C.J.C.	C.J.C.	NNP
10_1101-2021_01_08_425864	651	1	Moreira	Moreira	NNP
10_1101-2021_01_08_425864	651	2	,	,	,
10_1101-2021_01_08_425864	651	3	P.	P.	NNP
10_1101-2021_01_08_425864	651	4	Azambuja	Azambuja	NNP
10_1101-2021_01_08_425864	651	5	,	,	,
10_1101-2021_01_08_425864	651	6	Metabolic	metabolic	JJ
10_1101-2021_01_08_425864	651	7	signatures	signature	NNS
10_1101-2021_01_08_425864	651	8	of	of	IN
10_1101-2021_01_08_425864	651	9	triatomine	triatomine	JJ
10_1101-2021_01_08_425864	651	10	789	789	CD
10_1101-2021_01_08_425864	651	11	vectors	vector	NNS
10_1101-2021_01_08_425864	651	12	of	of	IN
10_1101-2021_01_08_425864	651	13	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	651	14	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	651	15	unveiled	unveil	VBN
10_1101-2021_01_08_425864	651	16	by	by	IN
10_1101-2021_01_08_425864	651	17	metabolomics	metabolomic	NNS
10_1101-2021_01_08_425864	651	18	,	,	,
10_1101-2021_01_08_425864	651	19	PLoS	PLoS	NNP
10_1101-2021_01_08_425864	651	20	One	one	CD
10_1101-2021_01_08_425864	651	21	.	.	.
10_1101-2021_01_08_425864	652	1	8	8	CD
10_1101-2021_01_08_425864	652	2	(	(	-LRB-
10_1101-2021_01_08_425864	652	3	2013	2013	CD
10_1101-2021_01_08_425864	652	4	)	)	-RRB-
10_1101-2021_01_08_425864	652	5	77283	77283	CD
10_1101-2021_01_08_425864	652	6	.	.	.
10_1101-2021_01_08_425864	653	1	790	790	CD
10_1101-2021_01_08_425864	653	2	https://doi.org/10.1371/journal.pone.0077283	https://doi.org/10.1371/journal.pone.0077283	NN
10_1101-2021_01_08_425864	653	3	.	.	.
10_1101-2021_01_08_425864	654	1	791	791	CD
10_1101-2021_01_08_425864	654	2	[	[	-LRB-
10_1101-2021_01_08_425864	654	3	37	37	CD
10_1101-2021_01_08_425864	654	4	]	]	-RRB-
10_1101-2021_01_08_425864	654	5	K.C.	K.C.	NNP
10_1101-2021_01_08_425864	655	1	Gondim	Gondim	NNP
10_1101-2021_01_08_425864	655	2	,	,	,
10_1101-2021_01_08_425864	655	3	G.C.	G.C.	NNP
10_1101-2021_01_08_425864	656	1	Atella	Atella	NNP
10_1101-2021_01_08_425864	656	2	,	,	,
10_1101-2021_01_08_425864	656	3	E.G.	E.G.	NNP
10_1101-2021_01_08_425864	657	1	Pontes	Pontes	NNPS
10_1101-2021_01_08_425864	657	2	,	,	,
10_1101-2021_01_08_425864	657	3	D.	D.	NNP
10_1101-2021_01_08_425864	657	4	Majerowicz	Majerowicz	NNP
10_1101-2021_01_08_425864	657	5	,	,	,
10_1101-2021_01_08_425864	657	6	Lipid	Lipid	NNP
10_1101-2021_01_08_425864	657	7	metabolism	metabolism	NN
10_1101-2021_01_08_425864	657	8	in	in	IN
10_1101-2021_01_08_425864	657	9	insect	insect	JJ
10_1101-2021_01_08_425864	657	10	disease	disease	NN
10_1101-2021_01_08_425864	657	11	792	792	CD
10_1101-2021_01_08_425864	657	12	vectors	vector	NNS
10_1101-2021_01_08_425864	657	13	,	,	,
10_1101-2021_01_08_425864	657	14	Insect	Insect	NNP
10_1101-2021_01_08_425864	657	15	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	657	16	.	.	.
10_1101-2021_01_08_425864	658	1	Mol	Mol	NNP
10_1101-2021_01_08_425864	658	2	.	.	.
10_1101-2021_01_08_425864	659	1	Biol	Biol	NNP
10_1101-2021_01_08_425864	659	2	.	.	.
10_1101-2021_01_08_425864	660	1	101	101	CD
10_1101-2021_01_08_425864	660	2	(	(	-LRB-
10_1101-2021_01_08_425864	660	3	2018	2018	CD
10_1101-2021_01_08_425864	660	4	)	)	-RRB-
10_1101-2021_01_08_425864	660	5	108–123	108–123	CD
10_1101-2021_01_08_425864	660	6	.	.	.
10_1101-2021_01_08_425864	661	1	793	793	CD
10_1101-2021_01_08_425864	661	2	https://doi.org/10.1016/j.ibmb.2018.08.005	https://doi.org/10.1016/j.ibmb.2018.08.005	CD
10_1101-2021_01_08_425864	661	3	.	.	.
10_1101-2021_01_08_425864	662	1	794	794	CD
10_1101-2021_01_08_425864	662	2	[	[	-LRB-
10_1101-2021_01_08_425864	662	3	38	38	CD
10_1101-2021_01_08_425864	662	4	]	]	-RRB-
10_1101-2021_01_08_425864	662	5	P.R.	P.R.	NNP
10_1101-2021_01_08_425864	663	1	Bittencourt	Bittencourt	NNP
10_1101-2021_01_08_425864	663	2	-	-	HYPH
10_1101-2021_01_08_425864	663	3	Cunha	Cunha	NNP
10_1101-2021_01_08_425864	663	4	,	,	,
10_1101-2021_01_08_425864	663	5	L.	L.	NNP
10_1101-2021_01_08_425864	663	6	Silva	Silva	NNP
10_1101-2021_01_08_425864	663	7	-	-	HYPH
10_1101-2021_01_08_425864	663	8	Cardoso	Cardoso	NNP
10_1101-2021_01_08_425864	663	9	,	,	,
10_1101-2021_01_08_425864	663	10	G.A.	G.A.	NNP
10_1101-2021_01_08_425864	664	1	de	de	NNP
10_1101-2021_01_08_425864	664	2	Oliveira	Oliveira	NNP
10_1101-2021_01_08_425864	664	3	,	,	,
10_1101-2021_01_08_425864	664	4	J.R.	J.R.	NNP
10_1101-2021_01_08_425864	664	5	da	da	NNP
10_1101-2021_01_08_425864	664	6	Silva	Silva	NNP
10_1101-2021_01_08_425864	664	7	,	,	,
10_1101-2021_01_08_425864	664	8	A.B.	A.B.	NNP
10_1101-2021_01_08_425864	665	1	da	da	NNP
10_1101-2021_01_08_425864	665	2	Silveira	Silveira	NNP
10_1101-2021_01_08_425864	665	3	,	,	,
10_1101-2021_01_08_425864	665	4	795	795	CD
10_1101-2021_01_08_425864	665	5	G.E.G.	G.E.G.	NNS
10_1101-2021_01_08_425864	666	1	Kluck	Kluck	NNP
10_1101-2021_01_08_425864	666	2	,	,	,
10_1101-2021_01_08_425864	666	3	M.	M.	NNP
10_1101-2021_01_08_425864	666	4	Souza	Souza	NNP
10_1101-2021_01_08_425864	666	5	-	-	HYPH
10_1101-2021_01_08_425864	666	6	Lima	Lima	NNP
10_1101-2021_01_08_425864	666	7	,	,	,
10_1101-2021_01_08_425864	666	8	K.C.	K.C.	NNP
10_1101-2021_01_08_425864	667	1	Gondim	Gondim	NNP
10_1101-2021_01_08_425864	667	2	,	,	,
10_1101-2021_01_08_425864	667	3	M.	M.	NNP
10_1101-2021_01_08_425864	667	4	Dansa	Dansa	NNP
10_1101-2021_01_08_425864	667	5	-	-	HYPH
10_1101-2021_01_08_425864	667	6	Petretsky	Petretsky	NNP
10_1101-2021_01_08_425864	667	7	,	,	,
10_1101-2021_01_08_425864	667	8	C.P.	C.P.	NNP
10_1101-2021_01_08_425864	668	1	Silva	silva	NN
10_1101-2021_01_08_425864	668	2	,	,	,
10_1101-2021_01_08_425864	668	3	H.	H.	NNP
10_1101-2021_01_08_425864	668	4	Masuda	Masuda	NNP
10_1101-2021_01_08_425864	668	5	,	,	,
10_1101-2021_01_08_425864	668	6	796	796	CD
10_1101-2021_01_08_425864	668	7	M.A.C.	M.A.C.	NNP
10_1101-2021_01_08_425864	669	1	da	da	NNP
10_1101-2021_01_08_425864	669	2	Silva	Silva	NNP
10_1101-2021_01_08_425864	669	3	Neto	Neto	NNP
10_1101-2021_01_08_425864	669	4	,	,	,
10_1101-2021_01_08_425864	669	5	G.C.	G.C.	NNP
10_1101-2021_01_08_425864	670	1	Atella	Atella	NNP
10_1101-2021_01_08_425864	670	2	,	,	,
10_1101-2021_01_08_425864	670	3	P.R.	P.R.	NNP
10_1101-2021_01_08_425864	671	1	Bittencourt	Bittencourt	NNP
10_1101-2021_01_08_425864	671	2	-	-	HYPH
10_1101-2021_01_08_425864	671	3	Cunha	Cunha	NNP
10_1101-2021_01_08_425864	671	4	,	,	,
10_1101-2021_01_08_425864	671	5	L.	L.	NNP
10_1101-2021_01_08_425864	671	6	Silva	Silva	NNP
10_1101-2021_01_08_425864	671	7	-	-	HYPH
10_1101-2021_01_08_425864	671	8	Cardoso	Cardoso	NNP
10_1101-2021_01_08_425864	671	9	,	,	,
10_1101-2021_01_08_425864	671	10	G.A.	G.A.	NNP
10_1101-2021_01_08_425864	672	1	de	de	NNP
10_1101-2021_01_08_425864	672	2	797	797	CD
10_1101-2021_01_08_425864	672	3	Oliveira	Oliveira	NNP
10_1101-2021_01_08_425864	672	4	,	,	,
10_1101-2021_01_08_425864	672	5	J.R.	J.R.	NNP
10_1101-2021_01_08_425864	672	6	da	da	NNP
10_1101-2021_01_08_425864	672	7	Silva	Silva	NNP
10_1101-2021_01_08_425864	672	8	,	,	,
10_1101-2021_01_08_425864	672	9	A.B.	A.B.	NNP
10_1101-2021_01_08_425864	673	1	da	da	NNP
10_1101-2021_01_08_425864	673	2	Silveira	Silveira	NNP
10_1101-2021_01_08_425864	673	3	,	,	,
10_1101-2021_01_08_425864	673	4	G.E.G.	G.E.G.	NNP
10_1101-2021_01_08_425864	674	1	Kluck	Kluck	NNP
10_1101-2021_01_08_425864	674	2	,	,	,
10_1101-2021_01_08_425864	674	3	M.	M.	NNP
10_1101-2021_01_08_425864	674	4	Souza	Souza	NNP
10_1101-2021_01_08_425864	674	5	-	-	HYPH
10_1101-2021_01_08_425864	674	6	Lima	Lima	NNP
10_1101-2021_01_08_425864	674	7	,	,	,
10_1101-2021_01_08_425864	674	8	K.C.	K.C.	NNP
10_1101-2021_01_08_425864	675	1	Gondim	Gondim	NNP
10_1101-2021_01_08_425864	675	2	,	,	,
10_1101-2021_01_08_425864	675	3	M.	M.	NNP
10_1101-2021_01_08_425864	675	4	798	798	CD
10_1101-2021_01_08_425864	675	5	Dansa	Dansa	NNP
10_1101-2021_01_08_425864	675	6	-	-	HYPH
10_1101-2021_01_08_425864	675	7	Petretsky	Petretsky	NNP
10_1101-2021_01_08_425864	675	8	,	,	,
10_1101-2021_01_08_425864	675	9	C.P.	C.P.	NNP
10_1101-2021_01_08_425864	676	1	Silva	silva	NN
10_1101-2021_01_08_425864	676	2	,	,	,
10_1101-2021_01_08_425864	676	3	H.	H.	NNP
10_1101-2021_01_08_425864	676	4	Masuda	Masuda	NNP
10_1101-2021_01_08_425864	676	5	,	,	,
10_1101-2021_01_08_425864	676	6	M.A.C.	M.A.C.	NNP
10_1101-2021_01_08_425864	677	1	da	da	NNP
10_1101-2021_01_08_425864	677	2	Silva	Silva	NNP
10_1101-2021_01_08_425864	677	3	Neto	Neto	NNP
10_1101-2021_01_08_425864	677	4	,	,	,
10_1101-2021_01_08_425864	677	5	G.C.	G.C.	NNP
10_1101-2021_01_08_425864	678	1	Atella	Atella	NNP
10_1101-2021_01_08_425864	678	2	,	,	,
10_1101-2021_01_08_425864	678	3	Perimicrovillar	Perimicrovillar	NNP
10_1101-2021_01_08_425864	678	4	799	799	CD
10_1101-2021_01_08_425864	678	5	membrane	membrane	NN
10_1101-2021_01_08_425864	678	6	assembly	assembly	NN
10_1101-2021_01_08_425864	678	7	:	:	:
10_1101-2021_01_08_425864	678	8	the	the	DT
10_1101-2021_01_08_425864	678	9	fate	fate	NN
10_1101-2021_01_08_425864	678	10	of	of	IN
10_1101-2021_01_08_425864	678	11	phospholipids	phospholipid	NNS
10_1101-2021_01_08_425864	678	12	synthesised	synthesise	VBN
10_1101-2021_01_08_425864	678	13	by	by	IN
10_1101-2021_01_08_425864	678	14	the	the	DT
10_1101-2021_01_08_425864	678	15	midgut	midgut	NN
10_1101-2021_01_08_425864	678	16	of	of	IN
10_1101-2021_01_08_425864	678	17	Rhodnius	Rhodnius	NNP
10_1101-2021_01_08_425864	678	18	800	800	CD
10_1101-2021_01_08_425864	678	19	prolixus	prolixus	NN
10_1101-2021_01_08_425864	678	20	,	,	,
10_1101-2021_01_08_425864	678	21	Mem	Mem	NNP
10_1101-2021_01_08_425864	678	22	.	.	.
10_1101-2021_01_08_425864	679	1	Inst	inst	RB
10_1101-2021_01_08_425864	679	2	.	.	.
10_1101-2021_01_08_425864	680	1	Oswaldo	Oswaldo	NNP
10_1101-2021_01_08_425864	680	2	Cruz	Cruz	NNP
10_1101-2021_01_08_425864	680	3	.	.	.
10_1101-2021_01_08_425864	681	1	108	108	CD
10_1101-2021_01_08_425864	681	2	(	(	-LRB-
10_1101-2021_01_08_425864	681	3	2013	2013	CD
10_1101-2021_01_08_425864	681	4	)	)	-RRB-
10_1101-2021_01_08_425864	681	5	494–500	494–500	CD
10_1101-2021_01_08_425864	681	6	.	.	.
10_1101-2021_01_08_425864	682	1	https://doi.org/10.1590/S0074-	https://doi.org/10.1590/s0074-	UH
10_1101-2021_01_08_425864	682	2	801	801	CD
10_1101-2021_01_08_425864	682	3	0276108042013016	0276108042013016	CD
10_1101-2021_01_08_425864	682	4	.	.	.
10_1101-2021_01_08_425864	683	1	802	802	CD
10_1101-2021_01_08_425864	683	2	[	[	-LRB-
10_1101-2021_01_08_425864	683	3	39	39	CD
10_1101-2021_01_08_425864	683	4	]	]	-RRB-
10_1101-2021_01_08_425864	683	5	D.E.	D.E.	NNP
10_1101-2021_01_08_425864	684	1	Wood	wood	NN
10_1101-2021_01_08_425864	684	2	,	,	,
10_1101-2021_01_08_425864	684	3	E.L.	E.L.	NNP
10_1101-2021_01_08_425864	684	4	Schiller	Schiller	NNP
10_1101-2021_01_08_425864	684	5	,	,	,
10_1101-2021_01_08_425864	684	6	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	684	7	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	684	8	:	:	:
10_1101-2021_01_08_425864	684	9	comparative	comparative	JJ
10_1101-2021_01_08_425864	684	10	fatty	fatty	NN
10_1101-2021_01_08_425864	684	11	acid	acid	NN
10_1101-2021_01_08_425864	684	12	metabolism	metabolism	NN
10_1101-2021_01_08_425864	684	13	of	of	IN
10_1101-2021_01_08_425864	684	14	the	the	DT
10_1101-2021_01_08_425864	684	15	803	803	CD
10_1101-2021_01_08_425864	684	16	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	684	17	and	and	CC
10_1101-2021_01_08_425864	684	18	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	684	19	in	in	IN
10_1101-2021_01_08_425864	684	20	vitro	vitro	FW
10_1101-2021_01_08_425864	684	21	.	.	.
10_1101-2021_01_08_425864	685	1	Exp	Exp	NNP
10_1101-2021_01_08_425864	685	2	.	.	.
10_1101-2021_01_08_425864	686	1	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	686	2	.	.	.
10_1101-2021_01_08_425864	687	1	38	38	CD
10_1101-2021_01_08_425864	687	2	(	(	-LRB-
10_1101-2021_01_08_425864	687	3	1975	1975	CD
10_1101-2021_01_08_425864	687	4	)	)	-RRB-
10_1101-2021_01_08_425864	687	5	202–7	202–7	CD
10_1101-2021_01_08_425864	687	6	.	.	.
10_1101-2021_01_08_425864	688	1	804	804	CD
10_1101-2021_01_08_425864	688	2	http://www.ncbi.nlm.nih.gov/pubmed/1100424	http://www.ncbi.nlm.nih.gov/pubmed/1100424	NN
10_1101-2021_01_08_425864	688	3	.	.	.
10_1101-2021_01_08_425864	689	1	805	805	CD
10_1101-2021_01_08_425864	689	2	[	[	-LRB-
10_1101-2021_01_08_425864	689	3	40	40	CD
10_1101-2021_01_08_425864	689	4	]	]	-RRB-
10_1101-2021_01_08_425864	689	5	D.E.	D.E.	NNP
10_1101-2021_01_08_425864	690	1	Wood	wood	NN
10_1101-2021_01_08_425864	690	2	,	,	,
10_1101-2021_01_08_425864	690	3	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	690	4	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	690	5	:	:	:
10_1101-2021_01_08_425864	690	6	fatty	fatty	NNP
10_1101-2021_01_08_425864	690	7	acid	acid	NNP
10_1101-2021_01_08_425864	690	8	metabolism	metabolism	NN
10_1101-2021_01_08_425864	690	9	in	in	IN
10_1101-2021_01_08_425864	690	10	vitro	vitro	FW
10_1101-2021_01_08_425864	690	11	,	,	,
10_1101-2021_01_08_425864	690	12	Exp	Exp	NNP
10_1101-2021_01_08_425864	690	13	.	.	.
10_1101-2021_01_08_425864	691	1	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	691	2	.	.	.
10_1101-2021_01_08_425864	692	1	37	37	CD
10_1101-2021_01_08_425864	692	2	(	(	-LRB-
10_1101-2021_01_08_425864	692	3	1975	1975	CD
10_1101-2021_01_08_425864	692	4	)	)	-RRB-
10_1101-2021_01_08_425864	692	5	60	60	CD
10_1101-2021_01_08_425864	692	6	–	–	:
10_1101-2021_01_08_425864	692	7	806	806	CD
10_1101-2021_01_08_425864	692	8	6	6	CD
10_1101-2021_01_08_425864	692	9	.	.	.
10_1101-2021_01_08_425864	692	10	http://www.ncbi.nlm.nih.gov/pubmed/1090440	http://www.ncbi.nlm.nih.gov/pubmed/1090440	NNS
10_1101-2021_01_08_425864	692	11	.	.	.
10_1101-2021_01_08_425864	693	1	807	807	CD
10_1101-2021_01_08_425864	693	2	[	[	-LRB-
10_1101-2021_01_08_425864	693	3	41	41	CD
10_1101-2021_01_08_425864	693	4	]	]	-RRB-
10_1101-2021_01_08_425864	693	5	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	693	6	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	693	7	,	,	,
10_1101-2021_01_08_425864	693	8	Aerobic	aerobic	JJ
10_1101-2021_01_08_425864	693	9	fermentation	fermentation	NN
10_1101-2021_01_08_425864	693	10	of	of	IN
10_1101-2021_01_08_425864	693	11	glucose	glucose	NN
10_1101-2021_01_08_425864	693	12	by	by	IN
10_1101-2021_01_08_425864	693	13	trypanosomatids	trypanosomatid	NNS
10_1101-2021_01_08_425864	693	14	,	,	,
10_1101-2021_01_08_425864	693	15	FASEB	FASEB	NNP
10_1101-2021_01_08_425864	693	16	J.	J.	NNP
10_1101-2021_01_08_425864	694	1	6	6	CD
10_1101-2021_01_08_425864	694	2	(	(	-LRB-
10_1101-2021_01_08_425864	694	3	1992	1992	CD
10_1101-2021_01_08_425864	694	4	)	)	-RRB-
10_1101-2021_01_08_425864	694	5	3153	3153	CD
10_1101-2021_01_08_425864	694	6	–	–	:
10_1101-2021_01_08_425864	694	7	808	808	CD
10_1101-2021_01_08_425864	694	8	61	61	CD
10_1101-2021_01_08_425864	694	9	.	.	.
10_1101-2021_01_08_425864	694	10	https://doi.org/10.1096/FASEBJ.8.0.23.1397837	https://doi.org/10.1096/fasebj.8.0.23.1397837	ADD
10_1101-2021_01_08_425864	694	11	.	.	.
10_1101-2021_01_08_425864	695	1	809	809	CD
10_1101-2021_01_08_425864	695	2	[	[	-LRB-
10_1101-2021_01_08_425864	695	3	42	42	CD
10_1101-2021_01_08_425864	695	4	]	]	-RRB-
10_1101-2021_01_08_425864	695	5	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	695	6	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	695	7	,	,	,
10_1101-2021_01_08_425864	695	8	Intermediate	Intermediate	NNP
10_1101-2021_01_08_425864	695	9	metabolism	metabolism	NN
10_1101-2021_01_08_425864	695	10	in	in	IN
10_1101-2021_01_08_425864	695	11	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	695	12	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	695	13	,	,	,
10_1101-2021_01_08_425864	695	14	J.	J.	NNP
10_1101-2021_01_08_425864	695	15	Bioenerg	Bioenerg	NNP
10_1101-2021_01_08_425864	695	16	.	.	.
10_1101-2021_01_08_425864	696	1	Biomembr	Biomembr	NNP
10_1101-2021_01_08_425864	696	2	.	.	.
10_1101-2021_01_08_425864	697	1	26	26	CD
10_1101-2021_01_08_425864	697	2	810	810	CD
10_1101-2021_01_08_425864	697	3	(	(	-LRB-
10_1101-2021_01_08_425864	697	4	1994	1994	CD
10_1101-2021_01_08_425864	697	5	)	)	-RRB-
10_1101-2021_01_08_425864	697	6	157–65	157–65	CD
10_1101-2021_01_08_425864	697	7	.	.	.
10_1101-2021_01_08_425864	698	1	http://www.ncbi.nlm.nih.gov/pubmed/8056782	http://www.ncbi.nlm.nih.gov/pubmed/8056782	NN
10_1101-2021_01_08_425864	698	2	(	(	-LRB-
10_1101-2021_01_08_425864	698	3	accessed	access	VBN
10_1101-2021_01_08_425864	698	4	June	June	NNP
10_1101-2021_01_08_425864	698	5	6	6	CD
10_1101-2021_01_08_425864	698	6	,	,	,
10_1101-2021_01_08_425864	698	7	2019	2019	CD
10_1101-2021_01_08_425864	698	8	)	)	-RRB-
10_1101-2021_01_08_425864	698	9	.	.	.
10_1101-2021_01_08_425864	699	1	811	811	CD
10_1101-2021_01_08_425864	699	2	[	[	-LRB-
10_1101-2021_01_08_425864	699	3	43	43	CD
10_1101-2021_01_08_425864	699	4	]	]	-RRB-
10_1101-2021_01_08_425864	699	5	B.	B.	NNP
10_1101-2021_01_08_425864	699	6	Frydman	Frydman	NNP
10_1101-2021_01_08_425864	699	7	,	,	,
10_1101-2021_01_08_425864	699	8	C.	C.	NNP
10_1101-2021_01_08_425864	699	9	Santos	Santos	NNP
10_1101-2021_01_08_425864	699	10	,	,	,
10_1101-2021_01_08_425864	699	11	J.J.B.	J.J.B.	NNP
10_1101-2021_01_08_425864	700	1	Cannata	Cannata	NNP
10_1101-2021_01_08_425864	700	2	,	,	,
10_1101-2021_01_08_425864	700	3	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	700	4	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	700	5	,	,	,
10_1101-2021_01_08_425864	700	6	Carbon-13	Carbon-13	NNP
10_1101-2021_01_08_425864	700	7	nuclear	nuclear	JJ
10_1101-2021_01_08_425864	700	8	magnetic	magnetic	JJ
10_1101-2021_01_08_425864	700	9	resonance	resonance	NN
10_1101-2021_01_08_425864	700	10	.CC	.CC	NFP
10_1101-2021_01_08_425864	700	11	-	-	:
10_1101-2021_01_08_425864	700	12	BY	by	IN
10_1101-2021_01_08_425864	700	13	4.0	4.0	CD
10_1101-2021_01_08_425864	700	14	International	international	JJ
10_1101-2021_01_08_425864	700	15	licensemade	licensemade	NN
10_1101-2021_01_08_425864	700	16	available	available	JJ
10_1101-2021_01_08_425864	700	17	under	under	IN
10_1101-2021_01_08_425864	700	18	a	a	DT
10_1101-2021_01_08_425864	700	19	(	(	-LRB-
10_1101-2021_01_08_425864	700	20	which	which	WDT
10_1101-2021_01_08_425864	700	21	was	be	VBD
10_1101-2021_01_08_425864	700	22	not	not	RB
10_1101-2021_01_08_425864	700	23	certified	certify	VBN
10_1101-2021_01_08_425864	700	24	by	by	IN
10_1101-2021_01_08_425864	700	25	peer	peer	NN
10_1101-2021_01_08_425864	700	26	review	review	NN
10_1101-2021_01_08_425864	700	27	)	)	-RRB-
10_1101-2021_01_08_425864	700	28	is	be	VBZ
10_1101-2021_01_08_425864	700	29	the	the	DT
10_1101-2021_01_08_425864	700	30	author	author	NN
10_1101-2021_01_08_425864	700	31	/	/	SYM
10_1101-2021_01_08_425864	700	32	funder	funder	NN
10_1101-2021_01_08_425864	700	33	,	,	,
10_1101-2021_01_08_425864	700	34	who	who	WP
10_1101-2021_01_08_425864	700	35	has	have	VBZ
10_1101-2021_01_08_425864	700	36	granted	grant	VBN
10_1101-2021_01_08_425864	700	37	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	700	38	a	a	DT
10_1101-2021_01_08_425864	700	39	license	license	NN
10_1101-2021_01_08_425864	700	40	to	to	TO
10_1101-2021_01_08_425864	700	41	display	display	VB
10_1101-2021_01_08_425864	700	42	the	the	DT
10_1101-2021_01_08_425864	700	43	preprint	preprint	NN
10_1101-2021_01_08_425864	700	44	in	in	IN
10_1101-2021_01_08_425864	700	45	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	700	46	.	.	.
10_1101-2021_01_08_425864	701	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	701	2	is	be	VBZ
10_1101-2021_01_08_425864	701	3	The	the	DT
10_1101-2021_01_08_425864	701	4	copyright	copyright	NN
10_1101-2021_01_08_425864	701	5	holder	holder	NN
10_1101-2021_01_08_425864	701	6	for	for	IN
10_1101-2021_01_08_425864	701	7	this	this	DT
10_1101-2021_01_08_425864	701	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	701	9	version	version	NN
10_1101-2021_01_08_425864	701	10	posted	post	VBD
10_1101-2021_01_08_425864	701	11	January	January	NNP
10_1101-2021_01_08_425864	701	12	8	8	CD
10_1101-2021_01_08_425864	701	13	,	,	,
10_1101-2021_01_08_425864	701	14	2021	2021	CD
10_1101-2021_01_08_425864	701	15	.	.	.
10_1101-2021_01_08_425864	701	16	;	;	:
10_1101-2021_01_08_425864	701	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	701	18	:	:	:
10_1101-2021_01_08_425864	701	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	701	20	preprint	preprint	NN
10_1101-2021_01_08_425864	701	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	701	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	701	23	812	812	CD
10_1101-2021_01_08_425864	701	24	analysis	analysis	NN
10_1101-2021_01_08_425864	701	25	of	of	IN
10_1101-2021_01_08_425864	701	26	[	[	-LRB-
10_1101-2021_01_08_425864	701	27	1	1	CD
10_1101-2021_01_08_425864	701	28	-	-	SYM
10_1101-2021_01_08_425864	701	29	13C]-glucose	13c]-glucose	CD
10_1101-2021_01_08_425864	701	30	metabolism	metabolism	NN
10_1101-2021_01_08_425864	701	31	in	in	IN
10_1101-2021_01_08_425864	701	32	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	701	33	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	701	34	.	.	.
10_1101-2021_01_08_425864	702	1	Evidence	evidence	NN
10_1101-2021_01_08_425864	702	2	of	of	IN
10_1101-2021_01_08_425864	702	3	the	the	DT
10_1101-2021_01_08_425864	702	4	presence	presence	NN
10_1101-2021_01_08_425864	702	5	of	of	IN
10_1101-2021_01_08_425864	702	6	813	813	CD
10_1101-2021_01_08_425864	702	7	two	two	CD
10_1101-2021_01_08_425864	702	8	alanine	alanine	NN
10_1101-2021_01_08_425864	702	9	pools	pool	NNS
10_1101-2021_01_08_425864	702	10	and	and	CC
10_1101-2021_01_08_425864	702	11	of	of	IN
10_1101-2021_01_08_425864	702	12	two	two	CD
10_1101-2021_01_08_425864	702	13	CO2	CO2	NNP
10_1101-2021_01_08_425864	702	14	fixation	fixation	NN
10_1101-2021_01_08_425864	702	15	reactions	reaction	NNS
10_1101-2021_01_08_425864	702	16	,	,	,
10_1101-2021_01_08_425864	702	17	Eur	Eur	NNP
10_1101-2021_01_08_425864	702	18	.	.	.
10_1101-2021_01_08_425864	703	1	J.	J.	NNP
10_1101-2021_01_08_425864	703	2	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	703	3	.	.	.
10_1101-2021_01_08_425864	704	1	192	192	CD
10_1101-2021_01_08_425864	704	2	(	(	-LRB-
10_1101-2021_01_08_425864	704	3	1990	1990	CD
10_1101-2021_01_08_425864	704	4	)	)	-RRB-
10_1101-2021_01_08_425864	704	5	363–368	363–368	CD
10_1101-2021_01_08_425864	704	6	.	.	.
10_1101-2021_01_08_425864	705	1	814	814	CD
10_1101-2021_01_08_425864	705	2	https://doi.org/10.1111/j.1432-1033.1990.tb19235.x	https://doi.org/10.1111/j.1432-1033.1990.tb19235.x	NNP
10_1101-2021_01_08_425864	705	3	.	.	.
10_1101-2021_01_08_425864	706	1	815	815	CD
10_1101-2021_01_08_425864	706	2	[	[	-LRB-
10_1101-2021_01_08_425864	706	3	44	44	CD
10_1101-2021_01_08_425864	706	4	]	]	-RRB-
10_1101-2021_01_08_425864	706	5	A.E.	A.E.	NNP
10_1101-2021_01_08_425864	707	1	Leroux	Leroux	NNP
10_1101-2021_01_08_425864	707	2	,	,	,
10_1101-2021_01_08_425864	707	3	D.A.	D.A.	NNP
10_1101-2021_01_08_425864	708	1	Maugeri	Maugeri	NNP
10_1101-2021_01_08_425864	708	2	,	,	,
10_1101-2021_01_08_425864	708	3	F.R.	F.R.	NNP
10_1101-2021_01_08_425864	709	1	Opperdoes	opperdoe	NNS
10_1101-2021_01_08_425864	709	2	,	,	,
10_1101-2021_01_08_425864	709	3	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	709	4	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	709	5	,	,	,
10_1101-2021_01_08_425864	709	6	C.	C.	NNP
10_1101-2021_01_08_425864	709	7	Nowicki	Nowicki	NNP
10_1101-2021_01_08_425864	709	8	,	,	,
10_1101-2021_01_08_425864	709	9	Comparative	comparative	JJ
10_1101-2021_01_08_425864	709	10	studies	study	NNS
10_1101-2021_01_08_425864	709	11	816	816	CD
10_1101-2021_01_08_425864	709	12	on	on	IN
10_1101-2021_01_08_425864	709	13	the	the	DT
10_1101-2021_01_08_425864	709	14	biochemical	biochemical	JJ
10_1101-2021_01_08_425864	709	15	properties	property	NNS
10_1101-2021_01_08_425864	709	16	of	of	IN
10_1101-2021_01_08_425864	709	17	the	the	DT
10_1101-2021_01_08_425864	709	18	malic	malic	JJ
10_1101-2021_01_08_425864	709	19	enzymes	enzyme	NNS
10_1101-2021_01_08_425864	709	20	from	from	IN
10_1101-2021_01_08_425864	709	21	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	709	22	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	709	23	 	 	_SP
10_1101-2021_01_08_425864	709	24	and	and	CC
10_1101-2021_01_08_425864	709	25	817	817	CD
10_1101-2021_01_08_425864	709	26	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	709	27	brucei	brucei	NN
10_1101-2021_01_08_425864	709	28	,	,	,
10_1101-2021_01_08_425864	709	29	FEMS	FEMS	NNP
10_1101-2021_01_08_425864	709	30	Microbiol	Microbiol	NNP
10_1101-2021_01_08_425864	709	31	.	.	.
10_1101-2021_01_08_425864	710	1	Lett	Lett	NNP
10_1101-2021_01_08_425864	710	2	.	.	.
10_1101-2021_01_08_425864	711	1	314	314	CD
10_1101-2021_01_08_425864	711	2	(	(	-LRB-
10_1101-2021_01_08_425864	711	3	2011	2011	CD
10_1101-2021_01_08_425864	711	4	)	)	-RRB-
10_1101-2021_01_08_425864	711	5	25–33	25–33	CD
10_1101-2021_01_08_425864	711	6	.	.	.
10_1101-2021_01_08_425864	712	1	818	818	CD
10_1101-2021_01_08_425864	712	2	https://doi.org/10.1111/j.1574-6968.2010.02142.x	https://doi.org/10.1111/j.1574-6968.2010.02142.x	NN
10_1101-2021_01_08_425864	712	3	.	.	.
10_1101-2021_01_08_425864	713	1	819	819	CD
10_1101-2021_01_08_425864	713	2	[	[	-LRB-
10_1101-2021_01_08_425864	713	3	45	45	CD
10_1101-2021_01_08_425864	713	4	]	]	-RRB-
10_1101-2021_01_08_425864	713	5	C.	C.	NNP
10_1101-2021_01_08_425864	713	6	Zelada	Zelada	NNP
10_1101-2021_01_08_425864	713	7	,	,	,
10_1101-2021_01_08_425864	713	8	M.	M.	NNP
10_1101-2021_01_08_425864	713	9	Montemartini	Montemartini	NNP
10_1101-2021_01_08_425864	713	10	,	,	,
10_1101-2021_01_08_425864	713	11	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	713	12	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	713	13	,	,	,
10_1101-2021_01_08_425864	713	14	C.	C.	NNP
10_1101-2021_01_08_425864	713	15	Nowicki	Nowicki	NNP
10_1101-2021_01_08_425864	713	16	,	,	,
10_1101-2021_01_08_425864	713	17	Purification	Purification	NNP
10_1101-2021_01_08_425864	713	18	and	and	CC
10_1101-2021_01_08_425864	713	19	partial	partial	JJ
10_1101-2021_01_08_425864	713	20	structural	structural	NN
10_1101-2021_01_08_425864	713	21	and	and	CC
10_1101-2021_01_08_425864	713	22	820	820	CD
10_1101-2021_01_08_425864	713	23	kinetic	kinetic	JJ
10_1101-2021_01_08_425864	713	24	characterization	characterization	NN
10_1101-2021_01_08_425864	713	25	of	of	IN
10_1101-2021_01_08_425864	713	26	an	an	DT
10_1101-2021_01_08_425864	713	27	alanine	alanine	NN
10_1101-2021_01_08_425864	713	28	aminotransferase	aminotransferase	NN
10_1101-2021_01_08_425864	713	29	from	from	IN
10_1101-2021_01_08_425864	713	30	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	713	31	of	of	IN
10_1101-2021_01_08_425864	713	32	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	713	33	821	821	CD
10_1101-2021_01_08_425864	713	34	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	713	35	,	,	,
10_1101-2021_01_08_425864	713	36	Mol	Mol	NNP
10_1101-2021_01_08_425864	713	37	.	.	.
10_1101-2021_01_08_425864	714	1	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	714	2	.	.	.
10_1101-2021_01_08_425864	715	1	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	715	2	.	.	.
10_1101-2021_01_08_425864	716	1	79	79	CD
10_1101-2021_01_08_425864	716	2	(	(	-LRB-
10_1101-2021_01_08_425864	716	3	1996	1996	CD
10_1101-2021_01_08_425864	716	4	)	)	-RRB-
10_1101-2021_01_08_425864	716	5	225–228	225–228	CD
10_1101-2021_01_08_425864	716	6	.	.	.
10_1101-2021_01_08_425864	717	1	https://doi.org/10.1016/0166-	https://doi.org/10.1016/0166-	NNP
10_1101-2021_01_08_425864	717	2	822	822	CD
10_1101-2021_01_08_425864	717	3	6851(96)02652	6851(96)02652	CD
10_1101-2021_01_08_425864	717	4	-	-	HYPH
10_1101-2021_01_08_425864	717	5	7	7	CD
10_1101-2021_01_08_425864	717	6	.	.	.
10_1101-2021_01_08_425864	718	1	823	823	CD
10_1101-2021_01_08_425864	718	2	[	[	-LRB-
10_1101-2021_01_08_425864	718	3	46	46	CD
10_1101-2021_01_08_425864	718	4	]	]	-RRB-
10_1101-2021_01_08_425864	718	5	M.	M.	NNP
10_1101-2021_01_08_425864	718	6	Montemartini	Montemartini	NNP
10_1101-2021_01_08_425864	718	7	,	,	,
10_1101-2021_01_08_425864	718	8	J.	J.	NNP
10_1101-2021_01_08_425864	718	9	Buá	Buá	NNP
10_1101-2021_01_08_425864	718	10	,	,	,
10_1101-2021_01_08_425864	718	11	E.	E.	NNP
10_1101-2021_01_08_425864	718	12	Bontempi	Bontempi	NNP
10_1101-2021_01_08_425864	718	13	,	,	,
10_1101-2021_01_08_425864	718	14	C.	C.	NNP
10_1101-2021_01_08_425864	718	15	Zelada	Zelada	NNP
10_1101-2021_01_08_425864	718	16	,	,	,
10_1101-2021_01_08_425864	718	17	A.M.	A.M.	NNP
10_1101-2021_01_08_425864	718	18	Ruiz	Ruiz	NNP
10_1101-2021_01_08_425864	718	19	,	,	,
10_1101-2021_01_08_425864	718	20	J.	J.	NNP
10_1101-2021_01_08_425864	718	21	Santomé	Santomé	NNP
10_1101-2021_01_08_425864	718	22	,	,	,
10_1101-2021_01_08_425864	718	23	J.	J.	NNP
10_1101-2021_01_08_425864	718	24	José	José	NNP
10_1101-2021_01_08_425864	718	25	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	718	26	,	,	,
10_1101-2021_01_08_425864	718	27	824	824	CD
10_1101-2021_01_08_425864	718	28	C.	C.	NNP
10_1101-2021_01_08_425864	718	29	Nowicki	Nowicki	NNP
10_1101-2021_01_08_425864	718	30	,	,	,
10_1101-2021_01_08_425864	718	31	A	a	DT
10_1101-2021_01_08_425864	718	32	recombinant	recombinant	JJ
10_1101-2021_01_08_425864	718	33	tyrosine	tyrosine	JJ
10_1101-2021_01_08_425864	718	34	aminotransferase	aminotransferase	NN
10_1101-2021_01_08_425864	718	35	from	from	IN
10_1101-2021_01_08_425864	718	36	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	718	37	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	718	38	has	have	VBZ
10_1101-2021_01_08_425864	718	39	both	both	CC
10_1101-2021_01_08_425864	718	40	825	825	CD
10_1101-2021_01_08_425864	718	41	tyrosine	tyrosine	NN
10_1101-2021_01_08_425864	718	42	aminotransferase	aminotransferase	NN
10_1101-2021_01_08_425864	718	43	and	and	CC
10_1101-2021_01_08_425864	718	44	alanine	alanine	NN
10_1101-2021_01_08_425864	718	45	aminotransferase	aminotransferase	NN
10_1101-2021_01_08_425864	718	46	activities	activity	NNS
10_1101-2021_01_08_425864	718	47	,	,	,
10_1101-2021_01_08_425864	718	48	FEMS	FEMS	NNP
10_1101-2021_01_08_425864	718	49	Microbiol	Microbiol	NNP
10_1101-2021_01_08_425864	718	50	.	.	.
10_1101-2021_01_08_425864	719	1	Lett	Lett	NNP
10_1101-2021_01_08_425864	719	2	.	.	.
10_1101-2021_01_08_425864	720	1	826	826	CD
10_1101-2021_01_08_425864	720	2	133	133	CD
10_1101-2021_01_08_425864	720	3	(	(	-LRB-
10_1101-2021_01_08_425864	720	4	1995	1995	CD
10_1101-2021_01_08_425864	720	5	)	)	-RRB-
10_1101-2021_01_08_425864	720	6	17–20	17–20	CD
10_1101-2021_01_08_425864	720	7	.	.	.
10_1101-2021_01_08_425864	721	1	https://doi.org/10.1111/j.1574-6968.1995.tb07854.x	https://doi.org/10.1111/j.1574-6968.1995.tb07854.x	NNP
10_1101-2021_01_08_425864	721	2	.	.	.
10_1101-2021_01_08_425864	722	1	827	827	CD
10_1101-2021_01_08_425864	722	2	[	[	-LRB-
10_1101-2021_01_08_425864	722	3	47	47	CD
10_1101-2021_01_08_425864	722	4	]	]	-RRB-
10_1101-2021_01_08_425864	722	5	D.	D.	NNP
10_1101-2021_01_08_425864	722	6	Marciano	Marciano	NNP
10_1101-2021_01_08_425864	722	7	,	,	,
10_1101-2021_01_08_425864	722	8	C.	C.	NNP
10_1101-2021_01_08_425864	722	9	Llorente	Llorente	NNP
10_1101-2021_01_08_425864	722	10	,	,	,
10_1101-2021_01_08_425864	722	11	D.A.	D.A.	NNP
10_1101-2021_01_08_425864	723	1	Maugeri	Maugeri	NNP
10_1101-2021_01_08_425864	723	2	,	,	,
10_1101-2021_01_08_425864	723	3	C.	C.	NNP
10_1101-2021_01_08_425864	723	4	de	de	NNP
10_1101-2021_01_08_425864	723	5	la	la	NNP
10_1101-2021_01_08_425864	723	6	Fuente	Fuente	NNP
10_1101-2021_01_08_425864	723	7	,	,	,
10_1101-2021_01_08_425864	723	8	F.	F.	NNP
10_1101-2021_01_08_425864	723	9	Opperdoes	Opperdoes	NNP
10_1101-2021_01_08_425864	723	10	,	,	,
10_1101-2021_01_08_425864	723	11	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	723	12	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	723	13	,	,	,
10_1101-2021_01_08_425864	723	14	C.	C.	NNP
10_1101-2021_01_08_425864	723	15	828	828	CD
10_1101-2021_01_08_425864	723	16	Nowicki	Nowicki	NNP
10_1101-2021_01_08_425864	723	17	,	,	,
10_1101-2021_01_08_425864	723	18	Biochemical	biochemical	JJ
10_1101-2021_01_08_425864	723	19	characterization	characterization	NN
10_1101-2021_01_08_425864	723	20	of	of	IN
10_1101-2021_01_08_425864	723	21	stage	stage	NN
10_1101-2021_01_08_425864	723	22	-	-	HYPH
10_1101-2021_01_08_425864	723	23	specific	specific	JJ
10_1101-2021_01_08_425864	723	24	isoforms	isoform	NNS
10_1101-2021_01_08_425864	723	25	of	of	IN
10_1101-2021_01_08_425864	723	26	aspartate	aspartate	NN
10_1101-2021_01_08_425864	723	27	829	829	CD
10_1101-2021_01_08_425864	723	28	aminotransferases	aminotransferase	NNS
10_1101-2021_01_08_425864	723	29	from	from	IN
10_1101-2021_01_08_425864	723	30	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	723	31	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	723	32	and	and	CC
10_1101-2021_01_08_425864	723	33	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	723	34	brucei	brucei	NN
10_1101-2021_01_08_425864	723	35	,	,	,
10_1101-2021_01_08_425864	723	36	Mol	Mol	NNP
10_1101-2021_01_08_425864	723	37	.	.	.
10_1101-2021_01_08_425864	724	1	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	724	2	.	.	.
10_1101-2021_01_08_425864	725	1	830	830	CD
10_1101-2021_01_08_425864	725	2	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	725	3	.	.	.
10_1101-2021_01_08_425864	726	1	161	161	CD
10_1101-2021_01_08_425864	726	2	(	(	-LRB-
10_1101-2021_01_08_425864	726	3	2008	2008	CD
10_1101-2021_01_08_425864	726	4	)	)	-RRB-
10_1101-2021_01_08_425864	726	5	12–20	12–20	CD
10_1101-2021_01_08_425864	726	6	.	.	.
10_1101-2021_01_08_425864	727	1	https://doi.org/10.1016/j.molbiopara.2008.05.005	https://doi.org/10.1016/j.molbiopara.2008.05.005	XX
10_1101-2021_01_08_425864	727	2	.	.	.
10_1101-2021_01_08_425864	728	1	831	831	CD
10_1101-2021_01_08_425864	728	2	[	[	-LRB-
10_1101-2021_01_08_425864	728	3	48	48	CD
10_1101-2021_01_08_425864	728	4	]	]	-RRB-
10_1101-2021_01_08_425864	728	5	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	728	6	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	728	7	,	,	,
10_1101-2021_01_08_425864	728	8	S.	S.	NNP
10_1101-2021_01_08_425864	728	9	Arauzo	Arauzo	NNP
10_1101-2021_01_08_425864	728	10	,	,	,
10_1101-2021_01_08_425864	728	11	B.M.	B.M.	NNP
10_1101-2021_01_08_425864	729	1	Franke	Franke	NNP
10_1101-2021_01_08_425864	729	2	de	de	NNP
10_1101-2021_01_08_425864	729	3	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	729	4	,	,	,
10_1101-2021_01_08_425864	729	5	J.J.B.	J.J.B.	NNP
10_1101-2021_01_08_425864	730	1	Cannata	Cannata	NNP
10_1101-2021_01_08_425864	730	2	,	,	,
10_1101-2021_01_08_425864	730	3	On	on	IN
10_1101-2021_01_08_425864	730	4	the	the	DT
10_1101-2021_01_08_425864	730	5	production	production	NN
10_1101-2021_01_08_425864	730	6	of	of	IN
10_1101-2021_01_08_425864	730	7	832	832	CD
10_1101-2021_01_08_425864	730	8	glycerol	glycerol	NN
10_1101-2021_01_08_425864	730	9	and	and	CC
10_1101-2021_01_08_425864	730	10	l	l	NN
10_1101-2021_01_08_425864	730	11	-	-	HYPH
10_1101-2021_01_08_425864	730	12	alanine	alanine	NN
10_1101-2021_01_08_425864	730	13	during	during	IN
10_1101-2021_01_08_425864	730	14	the	the	DT
10_1101-2021_01_08_425864	730	15	aerobic	aerobic	JJ
10_1101-2021_01_08_425864	730	16	fermentation	fermentation	NN
10_1101-2021_01_08_425864	730	17	of	of	IN
10_1101-2021_01_08_425864	730	18	glucose	glucose	NN
10_1101-2021_01_08_425864	730	19	by	by	IN
10_1101-2021_01_08_425864	730	20	trypanosomatids	trypanosomatid	NNS
10_1101-2021_01_08_425864	730	21	,	,	,
10_1101-2021_01_08_425864	730	22	FEMS	FEMS	NNP
10_1101-2021_01_08_425864	730	23	833	833	CD
10_1101-2021_01_08_425864	730	24	Microbiol	Microbiol	NNP
10_1101-2021_01_08_425864	730	25	.	.	.
10_1101-2021_01_08_425864	731	1	Lett	Lett	NNP
10_1101-2021_01_08_425864	731	2	.	.	.
10_1101-2021_01_08_425864	732	1	51	51	CD
10_1101-2021_01_08_425864	732	2	(	(	-LRB-
10_1101-2021_01_08_425864	732	3	1988	1988	CD
10_1101-2021_01_08_425864	732	4	)	)	-RRB-
10_1101-2021_01_08_425864	732	5	187–191	187–191	CD
10_1101-2021_01_08_425864	732	6	.	.	.
10_1101-2021_01_08_425864	733	1	https://doi.org/10.1111/j.1574-6968.1988.tb02995.x	https://doi.org/10.1111/j.1574-6968.1988.tb02995.x	NNP
10_1101-2021_01_08_425864	733	2	.	.	.
10_1101-2021_01_08_425864	734	1	834	834	CD
10_1101-2021_01_08_425864	734	2	[	[	-LRB-
10_1101-2021_01_08_425864	734	3	49	49	CD
10_1101-2021_01_08_425864	734	4	]	]	-RRB-
10_1101-2021_01_08_425864	734	5	A.	a.	NN
10_1101-2021_01_08_425864	734	6	Boveris	Boveris	NNP
10_1101-2021_01_08_425864	734	7	,	,	,
10_1101-2021_01_08_425864	734	8	C.M.	C.M.	NNP
10_1101-2021_01_08_425864	735	1	Hertig	Hertig	NNP
10_1101-2021_01_08_425864	735	2	,	,	,
10_1101-2021_01_08_425864	735	3	J.F.	J.F.	NNP
10_1101-2021_01_08_425864	736	1	Turrens	Turrens	NNP
10_1101-2021_01_08_425864	736	2	,	,	,
10_1101-2021_01_08_425864	736	3	Fumarate	Fumarate	NNP
10_1101-2021_01_08_425864	736	4	reductase	reductase	NN
10_1101-2021_01_08_425864	736	5	and	and	CC
10_1101-2021_01_08_425864	736	6	other	other	JJ
10_1101-2021_01_08_425864	736	7	mitochondrial	mitochondrial	NN
10_1101-2021_01_08_425864	736	8	activities	activity	NNS
10_1101-2021_01_08_425864	736	9	835	835	CD
10_1101-2021_01_08_425864	736	10	in	in	IN
10_1101-2021_01_08_425864	736	11	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	736	12	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	736	13	,	,	,
10_1101-2021_01_08_425864	736	14	Mol	Mol	NNP
10_1101-2021_01_08_425864	736	15	.	.	.
10_1101-2021_01_08_425864	737	1	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	737	2	.	.	.
10_1101-2021_01_08_425864	738	1	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	738	2	.	.	.
10_1101-2021_01_08_425864	739	1	19	19	CD
10_1101-2021_01_08_425864	739	2	(	(	-LRB-
10_1101-2021_01_08_425864	739	3	1986	1986	CD
10_1101-2021_01_08_425864	739	4	)	)	-RRB-
10_1101-2021_01_08_425864	739	5	163–169	163–169	CD
10_1101-2021_01_08_425864	739	6	.	.	.
10_1101-2021_01_08_425864	740	1	836	836	CD
10_1101-2021_01_08_425864	740	2	https://doi.org/10.1016/0166-6851(86)90121-0	https://doi.org/10.1016/0166-6851(86)90121-0	NNPS
10_1101-2021_01_08_425864	740	3	.	.	.
10_1101-2021_01_08_425864	741	1	837	837	CD
10_1101-2021_01_08_425864	741	2	[	[	-LRB-
10_1101-2021_01_08_425864	741	3	50	50	CD
10_1101-2021_01_08_425864	741	4	]	]	-RRB-
10_1101-2021_01_08_425864	741	5	G.W.	G.W.	NNP
10_1101-2021_01_08_425864	742	1	Rogerson	Rogerson	NNP
10_1101-2021_01_08_425864	742	2	,	,	,
10_1101-2021_01_08_425864	742	3	W.E.	W.E.	NNP
10_1101-2021_01_08_425864	743	1	Gutteridge	Gutteridge	NNP
10_1101-2021_01_08_425864	743	2	,	,	,
10_1101-2021_01_08_425864	743	3	Catabolic	catabolic	JJ
10_1101-2021_01_08_425864	743	4	metabolism	metabolism	NN
10_1101-2021_01_08_425864	743	5	in	in	IN
10_1101-2021_01_08_425864	743	6	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	743	7	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	743	8	,	,	,
10_1101-2021_01_08_425864	743	9	Int	Int	NNP
10_1101-2021_01_08_425864	743	10	.	.	.
10_1101-2021_01_08_425864	744	1	J.	J.	NNP
10_1101-2021_01_08_425864	745	1	.CC	.CC	NFP
10_1101-2021_01_08_425864	745	2	-	-	:
10_1101-2021_01_08_425864	745	3	BY	by	IN
10_1101-2021_01_08_425864	745	4	4.0	4.0	CD
10_1101-2021_01_08_425864	745	5	International	international	JJ
10_1101-2021_01_08_425864	745	6	licensemade	licensemade	NN
10_1101-2021_01_08_425864	745	7	available	available	JJ
10_1101-2021_01_08_425864	745	8	under	under	IN
10_1101-2021_01_08_425864	745	9	a	a	DT
10_1101-2021_01_08_425864	745	10	(	(	-LRB-
10_1101-2021_01_08_425864	745	11	which	which	WDT
10_1101-2021_01_08_425864	745	12	was	be	VBD
10_1101-2021_01_08_425864	745	13	not	not	RB
10_1101-2021_01_08_425864	745	14	certified	certify	VBN
10_1101-2021_01_08_425864	745	15	by	by	IN
10_1101-2021_01_08_425864	745	16	peer	peer	NN
10_1101-2021_01_08_425864	745	17	review	review	NN
10_1101-2021_01_08_425864	745	18	)	)	-RRB-
10_1101-2021_01_08_425864	745	19	is	be	VBZ
10_1101-2021_01_08_425864	745	20	the	the	DT
10_1101-2021_01_08_425864	745	21	author	author	NN
10_1101-2021_01_08_425864	745	22	/	/	SYM
10_1101-2021_01_08_425864	745	23	funder	funder	NN
10_1101-2021_01_08_425864	745	24	,	,	,
10_1101-2021_01_08_425864	745	25	who	who	WP
10_1101-2021_01_08_425864	745	26	has	have	VBZ
10_1101-2021_01_08_425864	745	27	granted	grant	VBN
10_1101-2021_01_08_425864	745	28	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	745	29	a	a	DT
10_1101-2021_01_08_425864	745	30	license	license	NN
10_1101-2021_01_08_425864	745	31	to	to	TO
10_1101-2021_01_08_425864	745	32	display	display	VB
10_1101-2021_01_08_425864	745	33	the	the	DT
10_1101-2021_01_08_425864	745	34	preprint	preprint	NN
10_1101-2021_01_08_425864	745	35	in	in	IN
10_1101-2021_01_08_425864	745	36	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	745	37	.	.	.
10_1101-2021_01_08_425864	746	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	746	2	is	be	VBZ
10_1101-2021_01_08_425864	746	3	The	the	DT
10_1101-2021_01_08_425864	746	4	copyright	copyright	NN
10_1101-2021_01_08_425864	746	5	holder	holder	NN
10_1101-2021_01_08_425864	746	6	for	for	IN
10_1101-2021_01_08_425864	746	7	this	this	DT
10_1101-2021_01_08_425864	746	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	746	9	version	version	NN
10_1101-2021_01_08_425864	746	10	posted	post	VBD
10_1101-2021_01_08_425864	746	11	January	January	NNP
10_1101-2021_01_08_425864	746	12	8	8	CD
10_1101-2021_01_08_425864	746	13	,	,	,
10_1101-2021_01_08_425864	746	14	2021	2021	CD
10_1101-2021_01_08_425864	746	15	.	.	.
10_1101-2021_01_08_425864	746	16	;	;	:
10_1101-2021_01_08_425864	746	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	746	18	:	:	:
10_1101-2021_01_08_425864	746	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	746	20	preprint	preprint	NN
10_1101-2021_01_08_425864	746	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	746	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	746	23	838	838	CD
10_1101-2021_01_08_425864	746	24	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	746	25	.	.	.
10_1101-2021_01_08_425864	747	1	10	10	CD
10_1101-2021_01_08_425864	747	2	(	(	-LRB-
10_1101-2021_01_08_425864	747	3	1980	1980	CD
10_1101-2021_01_08_425864	747	4	)	)	-RRB-
10_1101-2021_01_08_425864	747	5	131–135	131–135	CD
10_1101-2021_01_08_425864	747	6	.	.	.
10_1101-2021_01_08_425864	748	1	https://doi.org/10.1016/0020-7519(80)90024-7	https://doi.org/10.1016/0020-7519(80)90024-7	UH
10_1101-2021_01_08_425864	748	2	.	.	.
10_1101-2021_01_08_425864	749	1	839	839	CD
10_1101-2021_01_08_425864	749	2	[	[	-LRB-
10_1101-2021_01_08_425864	749	3	51	51	CD
10_1101-2021_01_08_425864	749	4	]	]	-RRB-
10_1101-2021_01_08_425864	749	5	M.G.	M.G.	NNP
10_1101-2021_01_08_425864	750	1	Pereira	Pereira	NNP
10_1101-2021_01_08_425864	750	2	,	,	,
10_1101-2021_01_08_425864	750	3	G.	G.	NNP
10_1101-2021_01_08_425864	750	4	Visbal	Visbal	NNP
10_1101-2021_01_08_425864	750	5	,	,	,
10_1101-2021_01_08_425864	750	6	T.F.R.	T.F.R.	NNP
10_1101-2021_01_08_425864	751	1	Costa	Costa	NNP
10_1101-2021_01_08_425864	751	2	,	,	,
10_1101-2021_01_08_425864	751	3	S.	S.	NNP
10_1101-2021_01_08_425864	751	4	Frases	Frases	NNP
10_1101-2021_01_08_425864	751	5	,	,	,
10_1101-2021_01_08_425864	751	6	W.	W.	NNP
10_1101-2021_01_08_425864	751	7	de	de	NNP
10_1101-2021_01_08_425864	751	8	Souza	Souza	NNP
10_1101-2021_01_08_425864	751	9	,	,	,
10_1101-2021_01_08_425864	751	10	G.	G.	NNP
10_1101-2021_01_08_425864	751	11	Atella	Atella	NNP
10_1101-2021_01_08_425864	751	12	,	,	,
10_1101-2021_01_08_425864	751	13	N.	N.	NNP
10_1101-2021_01_08_425864	751	14	Cunha	Cunha	NNP
10_1101-2021_01_08_425864	751	15	-	-	HYPH
10_1101-2021_01_08_425864	751	16	e	e	NNP
10_1101-2021_01_08_425864	751	17	-	-	HYPH
10_1101-2021_01_08_425864	751	18	Silva	silva	NN
10_1101-2021_01_08_425864	751	19	,	,	,
10_1101-2021_01_08_425864	751	20	840	840	CD
10_1101-2021_01_08_425864	751	21	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	751	22	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	751	23	epimastigotes	epimastigote	VBZ
10_1101-2021_01_08_425864	751	24	store	store	NN
10_1101-2021_01_08_425864	751	25	cholesteryl	cholesteryl	NN
10_1101-2021_01_08_425864	751	26	esters	ester	NNS
10_1101-2021_01_08_425864	751	27	in	in	IN
10_1101-2021_01_08_425864	751	28	lipid	lipid	NN
10_1101-2021_01_08_425864	751	29	droplets	droplet	NNS
10_1101-2021_01_08_425864	751	30	after	after	IN
10_1101-2021_01_08_425864	751	31	cholesterol	cholesterol	NN
10_1101-2021_01_08_425864	751	32	841	841	CD
10_1101-2021_01_08_425864	751	33	endocytosis	endocytosis	NN
10_1101-2021_01_08_425864	751	34	,	,	,
10_1101-2021_01_08_425864	751	35	Mol	Mol	NNP
10_1101-2021_01_08_425864	751	36	.	.	.
10_1101-2021_01_08_425864	752	1	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	752	2	.	.	.
10_1101-2021_01_08_425864	753	1	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	753	2	.	.	.
10_1101-2021_01_08_425864	754	1	224	224	CD
10_1101-2021_01_08_425864	754	2	(	(	-LRB-
10_1101-2021_01_08_425864	754	3	2018	2018	CD
10_1101-2021_01_08_425864	754	4	)	)	-RRB-
10_1101-2021_01_08_425864	754	5	6–16	6–16	ADD
10_1101-2021_01_08_425864	754	6	.	.	.
10_1101-2021_01_08_425864	755	1	842	842	CD
10_1101-2021_01_08_425864	755	2	https://doi.org/10.1016/J.MOLBIOPARA.2018.07.004	https://doi.org/10.1016/J.MOLBIOPARA.2018.07.004	NNS
10_1101-2021_01_08_425864	755	3	.	.	.
10_1101-2021_01_08_425864	756	1	843	843	CD
10_1101-2021_01_08_425864	756	2	[	[	-LRB-
10_1101-2021_01_08_425864	756	3	52	52	CD
10_1101-2021_01_08_425864	756	4	]	]	-RRB-
10_1101-2021_01_08_425864	756	5	M.G.	M.G.	NNP
10_1101-2021_01_08_425864	757	1	Pereira	Pereira	NNP
10_1101-2021_01_08_425864	757	2	,	,	,
10_1101-2021_01_08_425864	757	3	G.	G.	NNP
10_1101-2021_01_08_425864	757	4	Visbal	Visbal	NNP
10_1101-2021_01_08_425864	757	5	,	,	,
10_1101-2021_01_08_425864	757	6	L.T.	L.T.	NNP
10_1101-2021_01_08_425864	758	1	Salgado	Salgado	NNP
10_1101-2021_01_08_425864	758	2	,	,	,
10_1101-2021_01_08_425864	758	3	J.C.	J.C.	NNP
10_1101-2021_01_08_425864	758	4	Vidal	Vidal	NNP
10_1101-2021_01_08_425864	758	5	,	,	,
10_1101-2021_01_08_425864	758	6	J.L.P.	J.L.P.	NNP
10_1101-2021_01_08_425864	759	1	Godinho	Godinho	NNP
10_1101-2021_01_08_425864	759	2	,	,	,
10_1101-2021_01_08_425864	759	3	N.N.T.	N.N.T.	NNP
10_1101-2021_01_08_425864	760	1	De	De	NNP
10_1101-2021_01_08_425864	760	2	Cicco	Cicco	NNP
10_1101-2021_01_08_425864	760	3	,	,	,
10_1101-2021_01_08_425864	760	4	G.C.	G.C.	NNP
10_1101-2021_01_08_425864	761	1	844	844	CD
10_1101-2021_01_08_425864	761	2	Atella	Atella	NNP
10_1101-2021_01_08_425864	761	3	,	,	,
10_1101-2021_01_08_425864	761	4	W.	W.	NNP
10_1101-2021_01_08_425864	761	5	de	de	NNP
10_1101-2021_01_08_425864	761	6	Souza	Souza	NNP
10_1101-2021_01_08_425864	761	7	,	,	,
10_1101-2021_01_08_425864	761	8	N.	N.	NNP
10_1101-2021_01_08_425864	761	9	Cunha	Cunha	NNP
10_1101-2021_01_08_425864	761	10	-	-	HYPH
10_1101-2021_01_08_425864	761	11	e	e	NNP
10_1101-2021_01_08_425864	761	12	-	-	HYPH
10_1101-2021_01_08_425864	761	13	Silva	Silva	NNP
10_1101-2021_01_08_425864	761	14	,	,	,
10_1101-2021_01_08_425864	761	15	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	761	16	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	761	17	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	761	18	are	be	VBP
10_1101-2021_01_08_425864	761	19	able	able	JJ
10_1101-2021_01_08_425864	761	20	to	to	TO
10_1101-2021_01_08_425864	761	21	manage	manage	VB
10_1101-2021_01_08_425864	761	22	845	845	CD
10_1101-2021_01_08_425864	761	23	internal	internal	JJ
10_1101-2021_01_08_425864	761	24	cholesterol	cholesterol	NN
10_1101-2021_01_08_425864	761	25	levels	level	NNS
10_1101-2021_01_08_425864	761	26	under	under	IN
10_1101-2021_01_08_425864	761	27	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	761	28	lipid	lipid	NN
10_1101-2021_01_08_425864	761	29	stress	stress	NN
10_1101-2021_01_08_425864	761	30	conditions	condition	NNS
10_1101-2021_01_08_425864	761	31	,	,	,
10_1101-2021_01_08_425864	761	32	PLoS	PLoS	NNP
10_1101-2021_01_08_425864	761	33	One	one	CD
10_1101-2021_01_08_425864	761	34	.	.	.
10_1101-2021_01_08_425864	762	1	10	10	CD
10_1101-2021_01_08_425864	762	2	(	(	-LRB-
10_1101-2021_01_08_425864	762	3	2015	2015	CD
10_1101-2021_01_08_425864	762	4	)	)	-RRB-
10_1101-2021_01_08_425864	762	5	846	846	CD
10_1101-2021_01_08_425864	762	6	e0128949	e0128949	CD
10_1101-2021_01_08_425864	762	7	.	.	.
10_1101-2021_01_08_425864	763	1	https://doi.org/10.1371/journal.pone.0128949	https://doi.org/10.1371/journal.pone.0128949	NNP
10_1101-2021_01_08_425864	763	2	.	.	.
10_1101-2021_01_08_425864	764	1	847	847	CD
10_1101-2021_01_08_425864	764	2	[	[	-LRB-
10_1101-2021_01_08_425864	764	3	53	53	CD
10_1101-2021_01_08_425864	764	4	]	]	-RRB-
10_1101-2021_01_08_425864	764	5	S.	S.	NNP
10_1101-2021_01_08_425864	764	6	Allmann	Allmann	NNP
10_1101-2021_01_08_425864	764	7	,	,	,
10_1101-2021_01_08_425864	764	8	M.	M.	NNP
10_1101-2021_01_08_425864	764	9	Mazet	Mazet	NNP
10_1101-2021_01_08_425864	764	10	,	,	,
10_1101-2021_01_08_425864	764	11	N.	N.	NNP
10_1101-2021_01_08_425864	764	12	Ziebart	Ziebart	NNP
10_1101-2021_01_08_425864	764	13	,	,	,
10_1101-2021_01_08_425864	764	14	G.	G.	NNP
10_1101-2021_01_08_425864	764	15	Bouyssou	Bouyssou	NNP
10_1101-2021_01_08_425864	764	16	,	,	,
10_1101-2021_01_08_425864	764	17	L.	L.	NNP
10_1101-2021_01_08_425864	764	18	Fouillen	Fouillen	NNP
10_1101-2021_01_08_425864	764	19	,	,	,
10_1101-2021_01_08_425864	764	20	J.-W.	J.-W.	NNP
10_1101-2021_01_08_425864	764	21	Dupuy	Dupuy	NNP
10_1101-2021_01_08_425864	764	22	,	,	,
10_1101-2021_01_08_425864	764	23	M.	M.	NNP
10_1101-2021_01_08_425864	764	24	Bonneu	Bonneu	NNP
10_1101-2021_01_08_425864	764	25	,	,	,
10_1101-2021_01_08_425864	764	26	P.	P.	NNP
10_1101-2021_01_08_425864	764	27	848	848	CD
10_1101-2021_01_08_425864	764	28	Moreau	Moreau	NNP
10_1101-2021_01_08_425864	764	29	,	,	,
10_1101-2021_01_08_425864	764	30	F.	F.	NNP
10_1101-2021_01_08_425864	764	31	Bringaud	Bringaud	NNP
10_1101-2021_01_08_425864	764	32	,	,	,
10_1101-2021_01_08_425864	764	33	M.	M.	NNP
10_1101-2021_01_08_425864	764	34	Boshart	Boshart	NNP
10_1101-2021_01_08_425864	764	35	,	,	,
10_1101-2021_01_08_425864	764	36	Triacylglycerol	Triacylglycerol	NNP
10_1101-2021_01_08_425864	764	37	storage	storage	NN
10_1101-2021_01_08_425864	764	38	in	in	IN
10_1101-2021_01_08_425864	764	39	lipid	lipid	NN
10_1101-2021_01_08_425864	764	40	droplets	droplet	NNS
10_1101-2021_01_08_425864	764	41	in	in	IN
10_1101-2021_01_08_425864	764	42	procyclic	procyclic	JJ
10_1101-2021_01_08_425864	764	43	849	849	CD
10_1101-2021_01_08_425864	764	44	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	764	45	brucei	brucei	NN
10_1101-2021_01_08_425864	764	46	,	,	,
10_1101-2021_01_08_425864	764	47	PLoS	PLoS	NNP
10_1101-2021_01_08_425864	764	48	One	one	CD
10_1101-2021_01_08_425864	764	49	.	.	.
10_1101-2021_01_08_425864	765	1	9	9	CD
10_1101-2021_01_08_425864	765	2	(	(	-LRB-
10_1101-2021_01_08_425864	765	3	2014	2014	CD
10_1101-2021_01_08_425864	765	4	)	)	-RRB-
10_1101-2021_01_08_425864	765	5	e114628	e114628	NN
10_1101-2021_01_08_425864	765	6	.	.	.
10_1101-2021_01_08_425864	766	1	850	850	CD
10_1101-2021_01_08_425864	766	2	https://doi.org/10.1371/journal.pone.0114628	https://doi.org/10.1371/journal.pone.0114628	IN
10_1101-2021_01_08_425864	766	3	.	.	.
10_1101-2021_01_08_425864	767	1	851	851	CD
10_1101-2021_01_08_425864	767	2	[	[	-LRB-
10_1101-2021_01_08_425864	767	3	54	54	CD
10_1101-2021_01_08_425864	767	4	]	]	-RRB-
10_1101-2021_01_08_425864	767	5	V.E.	V.E.	NNP
10_1101-2021_01_08_425864	768	1	Alvarez	Alvarez	NNP
10_1101-2021_01_08_425864	768	2	,	,	,
10_1101-2021_01_08_425864	768	3	G.	G.	NNP
10_1101-2021_01_08_425864	768	4	Kosec	Kosec	NNP
10_1101-2021_01_08_425864	768	5	,	,	,
10_1101-2021_01_08_425864	768	6	C.	C.	NNP
10_1101-2021_01_08_425864	768	7	Sant’Anna	Sant’Anna	NNP
10_1101-2021_01_08_425864	768	8	,	,	,
10_1101-2021_01_08_425864	768	9	V.	V.	NNP
10_1101-2021_01_08_425864	768	10	Turk	Turk	NNP
10_1101-2021_01_08_425864	768	11	,	,	,
10_1101-2021_01_08_425864	768	12	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	768	13	Cazzulo	Cazzulo	NNP
10_1101-2021_01_08_425864	768	14	,	,	,
10_1101-2021_01_08_425864	768	15	B.	B.	NNP
10_1101-2021_01_08_425864	768	16	Turk	Turk	NNP
10_1101-2021_01_08_425864	768	17	,	,	,
10_1101-2021_01_08_425864	768	18	Autophagy	Autophagy	NNP
10_1101-2021_01_08_425864	768	19	is	be	VBZ
10_1101-2021_01_08_425864	768	20	852	852	CD
10_1101-2021_01_08_425864	768	21	involved	involve	VBN
10_1101-2021_01_08_425864	768	22	in	in	IN
10_1101-2021_01_08_425864	768	23	nutritional	nutritional	JJ
10_1101-2021_01_08_425864	768	24	stress	stress	NN
10_1101-2021_01_08_425864	768	25	response	response	NN
10_1101-2021_01_08_425864	768	26	and	and	CC
10_1101-2021_01_08_425864	768	27	differentiation	differentiation	NN
10_1101-2021_01_08_425864	768	28	in	in	IN
10_1101-2021_01_08_425864	768	29	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	768	30	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	768	31	,	,	,
10_1101-2021_01_08_425864	768	32	J.	J.	NNP
10_1101-2021_01_08_425864	768	33	Biol	Biol	NNP
10_1101-2021_01_08_425864	768	34	.	.	.
10_1101-2021_01_08_425864	769	1	853	853	CD
10_1101-2021_01_08_425864	769	2	Chem	Chem	NNP
10_1101-2021_01_08_425864	769	3	.	.	.
10_1101-2021_01_08_425864	770	1	283	283	CD
10_1101-2021_01_08_425864	770	2	(	(	-LRB-
10_1101-2021_01_08_425864	770	3	2008	2008	CD
10_1101-2021_01_08_425864	770	4	)	)	-RRB-
10_1101-2021_01_08_425864	770	5	3454–3464	3454–3464	ADD
10_1101-2021_01_08_425864	770	6	.	.	.
10_1101-2021_01_08_425864	771	1	https://doi.org/10.1074/jbc.M708474200	https://doi.org/10.1074/jbc.M708474200	NNP
10_1101-2021_01_08_425864	771	2	.	.	.
10_1101-2021_01_08_425864	772	1	854	854	CD
10_1101-2021_01_08_425864	772	2	[	[	-LRB-
10_1101-2021_01_08_425864	772	3	55	55	CD
10_1101-2021_01_08_425864	772	4	]	]	-RRB-
10_1101-2021_01_08_425864	772	5	V.T.	V.T.	NNP
10_1101-2021_01_08_425864	773	1	Contreras	Contreras	NNP
10_1101-2021_01_08_425864	773	2	,	,	,
10_1101-2021_01_08_425864	773	3	J.M.	J.M.	NNP
10_1101-2021_01_08_425864	774	1	Salles	salle	NNS
10_1101-2021_01_08_425864	774	2	,	,	,
10_1101-2021_01_08_425864	774	3	N.	N.	NNP
10_1101-2021_01_08_425864	774	4	Thomas	Thomas	NNP
10_1101-2021_01_08_425864	774	5	,	,	,
10_1101-2021_01_08_425864	774	6	C.M.	C.M.	NNP
10_1101-2021_01_08_425864	775	1	Morel	Morel	NNP
10_1101-2021_01_08_425864	775	2	,	,	,
10_1101-2021_01_08_425864	775	3	S.	S.	NNP
10_1101-2021_01_08_425864	775	4	Goldenberg	Goldenberg	NNP
10_1101-2021_01_08_425864	775	5	,	,	,
10_1101-2021_01_08_425864	775	6	In	in	IN
10_1101-2021_01_08_425864	775	7	vitro	vitro	FW
10_1101-2021_01_08_425864	775	8	differentiation	differentiation	NN
10_1101-2021_01_08_425864	775	9	855	855	CD
10_1101-2021_01_08_425864	775	10	of	of	IN
10_1101-2021_01_08_425864	775	11	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	775	12	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	775	13	under	under	IN
10_1101-2021_01_08_425864	775	14	chemically	chemically	RB
10_1101-2021_01_08_425864	775	15	defined	define	VBN
10_1101-2021_01_08_425864	775	16	conditions	condition	NNS
10_1101-2021_01_08_425864	775	17	,	,	,
10_1101-2021_01_08_425864	775	18	Mol	Mol	NNP
10_1101-2021_01_08_425864	775	19	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	775	20	Parasitol	Parasitol	NNP
10_1101-2021_01_08_425864	775	21	.	.	.
10_1101-2021_01_08_425864	776	1	16	16	CD
10_1101-2021_01_08_425864	776	2	856	856	CD
10_1101-2021_01_08_425864	776	3	(	(	-LRB-
10_1101-2021_01_08_425864	776	4	1985	1985	CD
10_1101-2021_01_08_425864	776	5	)	)	-RRB-
10_1101-2021_01_08_425864	776	6	315–327	315–327	CD
10_1101-2021_01_08_425864	776	7	.	.	.
10_1101-2021_01_08_425864	777	1	https://www.ncbi.nlm.nih.gov/pubmed/3903496	https://www.ncbi.nlm.nih.gov/pubmed/3903496	ADD
10_1101-2021_01_08_425864	777	2	.	.	.
10_1101-2021_01_08_425864	778	1	857	857	CD
10_1101-2021_01_08_425864	778	2	[	[	-LRB-
10_1101-2021_01_08_425864	778	3	56	56	CD
10_1101-2021_01_08_425864	778	4	]	]	-RRB-
10_1101-2021_01_08_425864	778	5	M.J.	M.J.	NNP
10_1101-2021_01_08_425864	778	6	Wainszelbaum	Wainszelbaum	NNP
10_1101-2021_01_08_425864	778	7	,	,	,
10_1101-2021_01_08_425864	778	8	M.L.	M.L.	NNP
10_1101-2021_01_08_425864	779	1	Belaunzarán	Belaunzarán	NNP
10_1101-2021_01_08_425864	779	2	,	,	,
10_1101-2021_01_08_425864	779	3	E.M.	E.M.	NNP
10_1101-2021_01_08_425864	779	4	Lammel	Lammel	NNP
10_1101-2021_01_08_425864	779	5	,	,	,
10_1101-2021_01_08_425864	779	6	M.	M.	NNP
10_1101-2021_01_08_425864	779	7	Florin	Florin	NNP
10_1101-2021_01_08_425864	779	8	-	-	HYPH
10_1101-2021_01_08_425864	779	9	Christensen	Christensen	NNP
10_1101-2021_01_08_425864	779	10	,	,	,
10_1101-2021_01_08_425864	779	11	J.	J.	NNP
10_1101-2021_01_08_425864	779	12	Florin-	Florin-	NNP
10_1101-2021_01_08_425864	779	13	858	858	CD
10_1101-2021_01_08_425864	779	14	Christensen	Christensen	NNP
10_1101-2021_01_08_425864	779	15	,	,	,
10_1101-2021_01_08_425864	779	16	E.L.D.	E.L.D.	NNP
10_1101-2021_01_08_425864	780	1	Isola	Isola	NNP
10_1101-2021_01_08_425864	780	2	,	,	,
10_1101-2021_01_08_425864	780	3	Free	free	JJ
10_1101-2021_01_08_425864	780	4	fatty	fatty	NN
10_1101-2021_01_08_425864	780	5	acids	acid	NNS
10_1101-2021_01_08_425864	780	6	induce	induce	VBP
10_1101-2021_01_08_425864	780	7	cell	cell	NN
10_1101-2021_01_08_425864	780	8	differentiation	differentiation	NN
10_1101-2021_01_08_425864	780	9	to	to	IN
10_1101-2021_01_08_425864	780	10	infective	infective	VB
10_1101-2021_01_08_425864	780	11	forms	form	NNS
10_1101-2021_01_08_425864	780	12	in	in	IN
10_1101-2021_01_08_425864	780	13	859	859	CD
10_1101-2021_01_08_425864	780	14	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	780	15	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	780	16	,	,	,
10_1101-2021_01_08_425864	780	17	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	780	18	.	.	.
10_1101-2021_01_08_425864	781	1	J.	J.	NNP
10_1101-2021_01_08_425864	782	1	375	375	CD
10_1101-2021_01_08_425864	782	2	(	(	-LRB-
10_1101-2021_01_08_425864	782	3	2003	2003	CD
10_1101-2021_01_08_425864	782	4	)	)	-RRB-
10_1101-2021_01_08_425864	782	5	705–12	705–12	CD
10_1101-2021_01_08_425864	782	6	.	.	.
10_1101-2021_01_08_425864	783	1	https://doi.org/10.1042/BJ20021907	https://doi.org/10.1042/bj20021907	UH
10_1101-2021_01_08_425864	783	2	.	.	.
10_1101-2021_01_08_425864	784	1	860	860	CD
10_1101-2021_01_08_425864	784	2	[	[	-LRB-
10_1101-2021_01_08_425864	784	3	57	57	CD
10_1101-2021_01_08_425864	784	4	]	]	-RRB-
10_1101-2021_01_08_425864	784	5	C.C.P.	C.C.P.	NNP
10_1101-2021_01_08_425864	785	1	Aires	aire	NNS
10_1101-2021_01_08_425864	785	2	,	,	,
10_1101-2021_01_08_425864	785	3	L.	L.	NNP
10_1101-2021_01_08_425864	785	4	IJlst	IJlst	NNP
10_1101-2021_01_08_425864	785	5	,	,	,
10_1101-2021_01_08_425864	785	6	F.	F.	NNP
10_1101-2021_01_08_425864	785	7	Stet	Stet	NNP
10_1101-2021_01_08_425864	785	8	,	,	,
10_1101-2021_01_08_425864	785	9	C.	C.	NNP
10_1101-2021_01_08_425864	785	10	Prip	Prip	NNP
10_1101-2021_01_08_425864	785	11	-	-	HYPH
10_1101-2021_01_08_425864	785	12	Buus	Buus	NNP
10_1101-2021_01_08_425864	785	13	,	,	,
10_1101-2021_01_08_425864	785	14	I.T.	I.T.	NNP
10_1101-2021_01_08_425864	786	1	de	de	NNP
10_1101-2021_01_08_425864	786	2	Almeida	Almeida	NNP
10_1101-2021_01_08_425864	786	3	,	,	,
10_1101-2021_01_08_425864	786	4	M.	M.	NNP
10_1101-2021_01_08_425864	786	5	Duran	Duran	NNP
10_1101-2021_01_08_425864	786	6	,	,	,
10_1101-2021_01_08_425864	786	7	R.J.A.	R.J.A.	NNP
10_1101-2021_01_08_425864	787	1	Wanders	wander	NNS
10_1101-2021_01_08_425864	787	2	,	,	,
10_1101-2021_01_08_425864	787	3	861	861	CD
10_1101-2021_01_08_425864	787	4	M.F.B.	M.F.B.	NNP
10_1101-2021_01_08_425864	788	1	Silva	silva	NN
10_1101-2021_01_08_425864	788	2	,	,	,
10_1101-2021_01_08_425864	788	3	Inhibition	inhibition	NN
10_1101-2021_01_08_425864	788	4	of	of	IN
10_1101-2021_01_08_425864	788	5	hepatic	hepatic	JJ
10_1101-2021_01_08_425864	788	6	carnitine	carnitine	NN
10_1101-2021_01_08_425864	788	7	palmitoyl	palmitoyl	NN
10_1101-2021_01_08_425864	788	8	-	-	HYPH
10_1101-2021_01_08_425864	788	9	transferase	transferase	NN
10_1101-2021_01_08_425864	788	10	I	-PRON-	PRP
10_1101-2021_01_08_425864	788	11	(	(	-LRB-
10_1101-2021_01_08_425864	788	12	CPT	CPT	NNP
10_1101-2021_01_08_425864	788	13	IA	IA	NNP
10_1101-2021_01_08_425864	788	14	)	)	-RRB-
10_1101-2021_01_08_425864	788	15	by	by	IN
10_1101-2021_01_08_425864	788	16	valproyl-	valproyl-	NN
10_1101-2021_01_08_425864	788	17	862	862	CD
10_1101-2021_01_08_425864	788	18	CoA	CoA	NNP
10_1101-2021_01_08_425864	788	19	as	as	IN
10_1101-2021_01_08_425864	788	20	a	a	DT
10_1101-2021_01_08_425864	788	21	possible	possible	JJ
10_1101-2021_01_08_425864	788	22	mechanism	mechanism	NN
10_1101-2021_01_08_425864	788	23	of	of	IN
10_1101-2021_01_08_425864	788	24	valproate	valproate	RB
10_1101-2021_01_08_425864	788	25	-	-	HYPH
10_1101-2021_01_08_425864	788	26	induced	induce	VBN
10_1101-2021_01_08_425864	788	27	steatosis	steatosis	NN
10_1101-2021_01_08_425864	788	28	,	,	,
10_1101-2021_01_08_425864	788	29	Biochem	Biochem	NNP
10_1101-2021_01_08_425864	788	30	.	.	.
10_1101-2021_01_08_425864	789	1	Pharmacol	Pharmacol	NNP
10_1101-2021_01_08_425864	789	2	.	.	.
10_1101-2021_01_08_425864	790	1	79	79	CD
10_1101-2021_01_08_425864	790	2	(	(	-LRB-
10_1101-2021_01_08_425864	790	3	2010	2010	CD
10_1101-2021_01_08_425864	790	4	)	)	-RRB-
10_1101-2021_01_08_425864	790	5	863	863	CD
10_1101-2021_01_08_425864	790	6	792–799	792–799	CD
10_1101-2021_01_08_425864	790	7	.	.	.
10_1101-2021_01_08_425864	791	1	https://doi.org/10.1016/j.bcp.2009.10.011	https://doi.org/10.1016/j.bcp.2009.10.011	NNP
10_1101-2021_01_08_425864	791	2	.	.	.
10_1101-2021_01_08_425864	792	1	.CC	.CC	NFP
10_1101-2021_01_08_425864	792	2	-	-	:
10_1101-2021_01_08_425864	792	3	BY	by	IN
10_1101-2021_01_08_425864	792	4	4.0	4.0	CD
10_1101-2021_01_08_425864	792	5	International	international	JJ
10_1101-2021_01_08_425864	792	6	licensemade	licensemade	NN
10_1101-2021_01_08_425864	792	7	available	available	JJ
10_1101-2021_01_08_425864	792	8	under	under	IN
10_1101-2021_01_08_425864	792	9	a	a	DT
10_1101-2021_01_08_425864	792	10	(	(	-LRB-
10_1101-2021_01_08_425864	792	11	which	which	WDT
10_1101-2021_01_08_425864	792	12	was	be	VBD
10_1101-2021_01_08_425864	792	13	not	not	RB
10_1101-2021_01_08_425864	792	14	certified	certify	VBN
10_1101-2021_01_08_425864	792	15	by	by	IN
10_1101-2021_01_08_425864	792	16	peer	peer	NN
10_1101-2021_01_08_425864	792	17	review	review	NN
10_1101-2021_01_08_425864	792	18	)	)	-RRB-
10_1101-2021_01_08_425864	792	19	is	be	VBZ
10_1101-2021_01_08_425864	792	20	the	the	DT
10_1101-2021_01_08_425864	792	21	author	author	NN
10_1101-2021_01_08_425864	792	22	/	/	SYM
10_1101-2021_01_08_425864	792	23	funder	funder	NN
10_1101-2021_01_08_425864	792	24	,	,	,
10_1101-2021_01_08_425864	792	25	who	who	WP
10_1101-2021_01_08_425864	792	26	has	have	VBZ
10_1101-2021_01_08_425864	792	27	granted	grant	VBN
10_1101-2021_01_08_425864	792	28	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	792	29	a	a	DT
10_1101-2021_01_08_425864	792	30	license	license	NN
10_1101-2021_01_08_425864	792	31	to	to	TO
10_1101-2021_01_08_425864	792	32	display	display	VB
10_1101-2021_01_08_425864	792	33	the	the	DT
10_1101-2021_01_08_425864	792	34	preprint	preprint	NN
10_1101-2021_01_08_425864	792	35	in	in	IN
10_1101-2021_01_08_425864	792	36	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	792	37	.	.	.
10_1101-2021_01_08_425864	793	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	793	2	is	be	VBZ
10_1101-2021_01_08_425864	793	3	The	the	DT
10_1101-2021_01_08_425864	793	4	copyright	copyright	NN
10_1101-2021_01_08_425864	793	5	holder	holder	NN
10_1101-2021_01_08_425864	793	6	for	for	IN
10_1101-2021_01_08_425864	793	7	this	this	DT
10_1101-2021_01_08_425864	793	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	793	9	version	version	NN
10_1101-2021_01_08_425864	793	10	posted	post	VBD
10_1101-2021_01_08_425864	793	11	January	January	NNP
10_1101-2021_01_08_425864	793	12	8	8	CD
10_1101-2021_01_08_425864	793	13	,	,	,
10_1101-2021_01_08_425864	793	14	2021	2021	CD
10_1101-2021_01_08_425864	793	15	.	.	.
10_1101-2021_01_08_425864	793	16	;	;	:
10_1101-2021_01_08_425864	793	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	793	18	:	:	:
10_1101-2021_01_08_425864	793	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	793	20	preprint	preprint	NN
10_1101-2021_01_08_425864	793	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	793	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	793	23	864	864	CD
10_1101-2021_01_08_425864	793	24	[	[	-LRB-
10_1101-2021_01_08_425864	793	25	58	58	CD
10_1101-2021_01_08_425864	793	26	]	]	-RRB-
10_1101-2021_01_08_425864	793	27	P.F.	P.F.	NNP
10_1101-2021_01_08_425864	794	1	Kantor	Kantor	NNP
10_1101-2021_01_08_425864	794	2	,	,	,
10_1101-2021_01_08_425864	794	3	A.	a.	NN
10_1101-2021_01_08_425864	794	4	Lucien	Lucien	NNP
10_1101-2021_01_08_425864	794	5	,	,	,
10_1101-2021_01_08_425864	794	6	R.	R.	NNP
10_1101-2021_01_08_425864	794	7	Kozak	Kozak	NNP
10_1101-2021_01_08_425864	794	8	,	,	,
10_1101-2021_01_08_425864	794	9	G.D.	G.D.	NNP
10_1101-2021_01_08_425864	794	10	Lopaschuk	Lopaschuk	NNP
10_1101-2021_01_08_425864	794	11	,	,	,
10_1101-2021_01_08_425864	794	12	The	the	DT
10_1101-2021_01_08_425864	794	13	antianginal	antianginal	JJ
10_1101-2021_01_08_425864	794	14	drug	drug	NN
10_1101-2021_01_08_425864	794	15	trimetazidine	trimetazidine	NN
10_1101-2021_01_08_425864	794	16	shifts	shift	NNS
10_1101-2021_01_08_425864	794	17	865	865	CD
10_1101-2021_01_08_425864	794	18	cardiac	cardiac	JJ
10_1101-2021_01_08_425864	794	19	energy	energy	NN
10_1101-2021_01_08_425864	794	20	metabolism	metabolism	NN
10_1101-2021_01_08_425864	794	21	from	from	IN
10_1101-2021_01_08_425864	794	22	fatty	fatty	NN
10_1101-2021_01_08_425864	794	23	acid	acid	NN
10_1101-2021_01_08_425864	794	24	oxidation	oxidation	NN
10_1101-2021_01_08_425864	794	25	to	to	TO
10_1101-2021_01_08_425864	794	26	glucose	glucose	VB
10_1101-2021_01_08_425864	794	27	oxidation	oxidation	NN
10_1101-2021_01_08_425864	794	28	by	by	IN
10_1101-2021_01_08_425864	794	29	inhibiting	inhibit	VBG
10_1101-2021_01_08_425864	794	30	866	866	CD
10_1101-2021_01_08_425864	794	31	mitochondrial	mitochondrial	JJ
10_1101-2021_01_08_425864	794	32	long	long	JJ
10_1101-2021_01_08_425864	794	33	-	-	HYPH
10_1101-2021_01_08_425864	794	34	chain	chain	NN
10_1101-2021_01_08_425864	794	35	3-ketoacyl	3-ketoacyl	CD
10_1101-2021_01_08_425864	794	36	coenzyme	coenzyme	NNS
10_1101-2021_01_08_425864	794	37	A	a	DT
10_1101-2021_01_08_425864	794	38	thiolase	thiolase	NN
10_1101-2021_01_08_425864	794	39	,	,	,
10_1101-2021_01_08_425864	794	40	Circ	Circ	NNP
10_1101-2021_01_08_425864	794	41	.	.	.
10_1101-2021_01_08_425864	795	1	Res	Res	NNP
10_1101-2021_01_08_425864	795	2	.	.	.
10_1101-2021_01_08_425864	796	1	86	86	CD
10_1101-2021_01_08_425864	796	2	(	(	-LRB-
10_1101-2021_01_08_425864	796	3	2000	2000	CD
10_1101-2021_01_08_425864	796	4	)	)	-RRB-
10_1101-2021_01_08_425864	796	5	580–588	580–588	CD
10_1101-2021_01_08_425864	796	6	.	.	.
10_1101-2021_01_08_425864	797	1	867	867	CD
10_1101-2021_01_08_425864	797	2	https://doi.org/10.1161/01.RES.86.5.580	https://doi.org/10.1161/01.res.86.5.580	NN
10_1101-2021_01_08_425864	797	3	.	.	.
10_1101-2021_01_08_425864	798	1	868	868	CD
10_1101-2021_01_08_425864	798	2	[	[	-LRB-
10_1101-2021_01_08_425864	798	3	59	59	CD
10_1101-2021_01_08_425864	798	4	]	]	-RRB-
10_1101-2021_01_08_425864	798	5	C.D.L.	c.d.l.	NN
10_1101-2021_01_08_425864	799	1	Folmes	Folmes	NNP
10_1101-2021_01_08_425864	799	2	,	,	,
10_1101-2021_01_08_425864	799	3	A.S.	A.S.	NNP
10_1101-2021_01_08_425864	799	4	Clanachan	Clanachan	NNP
10_1101-2021_01_08_425864	799	5	,	,	,
10_1101-2021_01_08_425864	799	6	G.D.	G.D.	NNP
10_1101-2021_01_08_425864	799	7	Lopaschuk	Lopaschuk	NNP
10_1101-2021_01_08_425864	799	8	,	,	,
10_1101-2021_01_08_425864	799	9	Fatty	Fatty	NNP
10_1101-2021_01_08_425864	799	10	acid	acid	NN
10_1101-2021_01_08_425864	799	11	oxidation	oxidation	NN
10_1101-2021_01_08_425864	799	12	inhibitors	inhibitor	NNS
10_1101-2021_01_08_425864	799	13	in	in	IN
10_1101-2021_01_08_425864	799	14	the	the	DT
10_1101-2021_01_08_425864	799	15	869	869	CD
10_1101-2021_01_08_425864	799	16	management	management	NN
10_1101-2021_01_08_425864	799	17	of	of	IN
10_1101-2021_01_08_425864	799	18	chronic	chronic	JJ
10_1101-2021_01_08_425864	799	19	complications	complication	NNS
10_1101-2021_01_08_425864	799	20	of	of	IN
10_1101-2021_01_08_425864	799	21	atherosclerosis	atherosclerosis	NN
10_1101-2021_01_08_425864	799	22	,	,	,
10_1101-2021_01_08_425864	799	23	Curr	curr	UH
10_1101-2021_01_08_425864	799	24	.	.	.
10_1101-2021_01_08_425864	800	1	Atheroscler	Atheroscler	NNP
10_1101-2021_01_08_425864	800	2	.	.	.
10_1101-2021_01_08_425864	801	1	Rep.	Rep.	NNP
10_1101-2021_01_08_425864	801	2	7	7	CD
10_1101-2021_01_08_425864	801	3	(	(	-LRB-
10_1101-2021_01_08_425864	801	4	2005	2005	CD
10_1101-2021_01_08_425864	801	5	)	)	-RRB-
10_1101-2021_01_08_425864	801	6	870	870	CD
10_1101-2021_01_08_425864	801	7	63–70	63–70	CD
10_1101-2021_01_08_425864	801	8	.	.	.
10_1101-2021_01_08_425864	802	1	https://doi.org/10.1007/s11883-005-0077-2	https://doi.org/10.1007/s11883-005-0077-2	CD
10_1101-2021_01_08_425864	802	2	.	.	.
10_1101-2021_01_08_425864	803	1	871	871	CD
10_1101-2021_01_08_425864	803	2	[	[	-LRB-
10_1101-2021_01_08_425864	803	3	60	60	CD
10_1101-2021_01_08_425864	803	4	]	]	-RRB-
10_1101-2021_01_08_425864	803	5	W.C.	W.C.	NNP
10_1101-2021_01_08_425864	803	6	Stanley	Stanley	NNP
10_1101-2021_01_08_425864	803	7	,	,	,
10_1101-2021_01_08_425864	803	8	S.R.	S.R.	NNP
10_1101-2021_01_08_425864	804	1	Meadows	Meadows	NNP
10_1101-2021_01_08_425864	804	2	,	,	,
10_1101-2021_01_08_425864	804	3	K.M.	K.M.	NNP
10_1101-2021_01_08_425864	805	1	Kivilo	Kivilo	NNP
10_1101-2021_01_08_425864	805	2	,	,	,
10_1101-2021_01_08_425864	805	3	B.A.	B.A.	NNP
10_1101-2021_01_08_425864	806	1	Roth	Roth	NNP
10_1101-2021_01_08_425864	806	2	,	,	,
10_1101-2021_01_08_425864	806	3	G.D.	G.D.	NNP
10_1101-2021_01_08_425864	806	4	Lopaschuk	Lopaschuk	NNP
10_1101-2021_01_08_425864	806	5	,	,	,
10_1101-2021_01_08_425864	806	6	β	β	NNP
10_1101-2021_01_08_425864	806	7	-	-	HYPH
10_1101-2021_01_08_425864	806	8	Hydroxybutyrate	Hydroxybutyrate	NNP
10_1101-2021_01_08_425864	806	9	872	872	CD
10_1101-2021_01_08_425864	806	10	inhibits	inhibit	VBZ
10_1101-2021_01_08_425864	806	11	myocardial	myocardial	JJ
10_1101-2021_01_08_425864	806	12	fatty	fatty	NN
10_1101-2021_01_08_425864	806	13	acid	acid	NN
10_1101-2021_01_08_425864	806	14	oxidation	oxidation	NN
10_1101-2021_01_08_425864	806	15	in	in	IN
10_1101-2021_01_08_425864	806	16	vivo	vivo	NNP
10_1101-2021_01_08_425864	806	17	independent	independent	JJ
10_1101-2021_01_08_425864	806	18	of	of	IN
10_1101-2021_01_08_425864	806	19	changes	change	NNS
10_1101-2021_01_08_425864	806	20	in	in	IN
10_1101-2021_01_08_425864	806	21	malonyl	malonyl	NNP
10_1101-2021_01_08_425864	806	22	-	-	HYPH
10_1101-2021_01_08_425864	806	23	CoA	CoA	NNP
10_1101-2021_01_08_425864	806	24	873	873	CD
10_1101-2021_01_08_425864	806	25	content	content	NN
10_1101-2021_01_08_425864	806	26	,	,	,
10_1101-2021_01_08_425864	806	27	Am	Am	NNP
10_1101-2021_01_08_425864	806	28	.	.	.
10_1101-2021_01_08_425864	807	1	J.	J.	NNP
10_1101-2021_01_08_425864	807	2	Physiol	Physiol	NNP
10_1101-2021_01_08_425864	807	3	.	.	.
10_1101-2021_01_08_425864	808	1	Circ	Circ	NNP
10_1101-2021_01_08_425864	808	2	.	.	.
10_1101-2021_01_08_425864	809	1	Physiol	Physiol	NNP
10_1101-2021_01_08_425864	809	2	.	.	.
10_1101-2021_01_08_425864	810	1	285	285	CD
10_1101-2021_01_08_425864	810	2	(	(	-LRB-
10_1101-2021_01_08_425864	810	3	2003	2003	CD
10_1101-2021_01_08_425864	810	4	)	)	-RRB-
10_1101-2021_01_08_425864	810	5	H1626–H1631	h1626–h1631	UH
10_1101-2021_01_08_425864	810	6	.	.	.
10_1101-2021_01_08_425864	811	1	874	874	CD
10_1101-2021_01_08_425864	811	2	https://doi.org/10.1152/ajpheart.00332.2003	https://doi.org/10.1152/ajpheart.00332.2003	NN
10_1101-2021_01_08_425864	811	3	.	.	.
10_1101-2021_01_08_425864	812	1	875	875	CD
10_1101-2021_01_08_425864	812	2	[	[	-LRB-
10_1101-2021_01_08_425864	812	3	61	61	CD
10_1101-2021_01_08_425864	812	4	]	]	-RRB-
10_1101-2021_01_08_425864	812	5	R.S.	R.S.	NNP
10_1101-2021_01_08_425864	813	1	O’Connor	O’Connor	NNP
10_1101-2021_01_08_425864	813	2	,	,	,
10_1101-2021_01_08_425864	813	3	L.	L.	NNP
10_1101-2021_01_08_425864	813	4	Guo	Guo	NNP
10_1101-2021_01_08_425864	813	5	,	,	,
10_1101-2021_01_08_425864	813	6	S.	S.	NNP
10_1101-2021_01_08_425864	813	7	Ghassemi	Ghassemi	NNP
10_1101-2021_01_08_425864	813	8	,	,	,
10_1101-2021_01_08_425864	813	9	N.W.	N.W.	NNP
10_1101-2021_01_08_425864	814	1	Snyder	Snyder	NNP
10_1101-2021_01_08_425864	814	2	,	,	,
10_1101-2021_01_08_425864	814	3	A.J.	A.J.	NNP
10_1101-2021_01_08_425864	815	1	Worth	worth	JJ
10_1101-2021_01_08_425864	815	2	,	,	,
10_1101-2021_01_08_425864	815	3	L.	L.	NNP
10_1101-2021_01_08_425864	815	4	Weng	Weng	NNP
10_1101-2021_01_08_425864	815	5	,	,	,
10_1101-2021_01_08_425864	815	6	Y.	Y.	NNP
10_1101-2021_01_08_425864	815	7	Kam	Kam	NNP
10_1101-2021_01_08_425864	815	8	,	,	,
10_1101-2021_01_08_425864	815	9	B.	B.	NNP
10_1101-2021_01_08_425864	816	1	876	876	CD
10_1101-2021_01_08_425864	816	2	Philipson	Philipson	NNP
10_1101-2021_01_08_425864	816	3	,	,	,
10_1101-2021_01_08_425864	816	4	S.	S.	NNP
10_1101-2021_01_08_425864	816	5	Trefely	trefely	RB
10_1101-2021_01_08_425864	816	6	,	,	,
10_1101-2021_01_08_425864	816	7	S.	S.	NNP
10_1101-2021_01_08_425864	816	8	Nunez	Nunez	NNP
10_1101-2021_01_08_425864	816	9	-	-	HYPH
10_1101-2021_01_08_425864	816	10	Cruz	Cruz	NNP
10_1101-2021_01_08_425864	816	11	,	,	,
10_1101-2021_01_08_425864	816	12	I.A.	I.A.	NNP
10_1101-2021_01_08_425864	817	1	Blair	Blair	NNP
10_1101-2021_01_08_425864	817	2	,	,	,
10_1101-2021_01_08_425864	817	3	C.H.	C.H.	NNP
10_1101-2021_01_08_425864	818	1	June	June	NNP
10_1101-2021_01_08_425864	818	2	,	,	,
10_1101-2021_01_08_425864	818	3	M.C.	M.C.	NNP
10_1101-2021_01_08_425864	819	1	Milone	Milone	NNP
10_1101-2021_01_08_425864	819	2	,	,	,
10_1101-2021_01_08_425864	819	3	The	the	DT
10_1101-2021_01_08_425864	819	4	CPT1a	CPT1a	NNP
10_1101-2021_01_08_425864	819	5	877	877	CD
10_1101-2021_01_08_425864	819	6	inhibitor	inhibitor	NN
10_1101-2021_01_08_425864	819	7	,	,	,
10_1101-2021_01_08_425864	819	8	etomoxir	etomoxir	NNP
10_1101-2021_01_08_425864	819	9	induces	induce	VBZ
10_1101-2021_01_08_425864	819	10	severe	severe	JJ
10_1101-2021_01_08_425864	819	11	oxidative	oxidative	JJ
10_1101-2021_01_08_425864	819	12	stress	stress	NN
10_1101-2021_01_08_425864	819	13	at	at	IN
10_1101-2021_01_08_425864	819	14	commonly	commonly	RB
10_1101-2021_01_08_425864	819	15	used	use	VBN
10_1101-2021_01_08_425864	819	16	concentrations	concentration	NNS
10_1101-2021_01_08_425864	819	17	,	,	,
10_1101-2021_01_08_425864	819	18	Sci	Sci	NNP
10_1101-2021_01_08_425864	819	19	.	.	.
10_1101-2021_01_08_425864	820	1	878	878	CD
10_1101-2021_01_08_425864	820	2	Rep.	Rep.	NNP
10_1101-2021_01_08_425864	820	3	8	8	CD
10_1101-2021_01_08_425864	820	4	(	(	-LRB-
10_1101-2021_01_08_425864	820	5	2018	2018	CD
10_1101-2021_01_08_425864	820	6	)	)	-RRB-
10_1101-2021_01_08_425864	820	7	6289	6289	CD
10_1101-2021_01_08_425864	820	8	.	.	.
10_1101-2021_01_08_425864	820	9	https://doi.org/10.1038/s41598-018-24676-6	https://doi.org/10.1038/s41598-018-24676-6	UH
10_1101-2021_01_08_425864	820	10	.	.	.
10_1101-2021_01_08_425864	821	1	879	879	CD
10_1101-2021_01_08_425864	821	2	[	[	-LRB-
10_1101-2021_01_08_425864	821	3	62	62	CD
10_1101-2021_01_08_425864	821	4	]	]	-RRB-
10_1101-2021_01_08_425864	821	5	C.-H.	C.-H.	NNP
10_1101-2021_01_08_425864	821	6	Yao	Yao	NNP
10_1101-2021_01_08_425864	821	7	,	,	,
10_1101-2021_01_08_425864	821	8	G.-Y.	G.-Y.	NNP
10_1101-2021_01_08_425864	822	1	Liu	Liu	NNP
10_1101-2021_01_08_425864	822	2	,	,	,
10_1101-2021_01_08_425864	822	3	R.	R.	NNP
10_1101-2021_01_08_425864	822	4	Wang	Wang	NNP
10_1101-2021_01_08_425864	822	5	,	,	,
10_1101-2021_01_08_425864	822	6	S.H.	S.H.	NNP
10_1101-2021_01_08_425864	823	1	Moon	Moon	NNP
10_1101-2021_01_08_425864	823	2	,	,	,
10_1101-2021_01_08_425864	823	3	R.W.	R.W.	NNP
10_1101-2021_01_08_425864	824	1	Gross	Gross	NNP
10_1101-2021_01_08_425864	824	2	,	,	,
10_1101-2021_01_08_425864	824	3	G.J.	G.J.	NNP
10_1101-2021_01_08_425864	825	1	Patti	Patti	NNP
10_1101-2021_01_08_425864	825	2	,	,	,
10_1101-2021_01_08_425864	825	3	Identifying	identify	VBG
10_1101-2021_01_08_425864	825	4	off	off	IN
10_1101-2021_01_08_425864	825	5	-	-	HYPH
10_1101-2021_01_08_425864	825	6	target	target	NN
10_1101-2021_01_08_425864	825	7	880	880	CD
10_1101-2021_01_08_425864	825	8	effects	effect	NNS
10_1101-2021_01_08_425864	825	9	of	of	IN
10_1101-2021_01_08_425864	825	10	etomoxir	etomoxir	NNS
10_1101-2021_01_08_425864	825	11	reveals	reveal	VBZ
10_1101-2021_01_08_425864	825	12	that	that	IN
10_1101-2021_01_08_425864	825	13	carnitine	carnitine	NN
10_1101-2021_01_08_425864	825	14	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	825	15	I	-PRON-	PRP
10_1101-2021_01_08_425864	825	16	is	be	VBZ
10_1101-2021_01_08_425864	825	17	essential	essential	JJ
10_1101-2021_01_08_425864	825	18	for	for	IN
10_1101-2021_01_08_425864	825	19	cancer	cancer	NN
10_1101-2021_01_08_425864	825	20	cell	cell	NN
10_1101-2021_01_08_425864	825	21	881	881	CD
10_1101-2021_01_08_425864	825	22	proliferation	proliferation	NN
10_1101-2021_01_08_425864	825	23	independent	independent	JJ
10_1101-2021_01_08_425864	825	24	of	of	IN
10_1101-2021_01_08_425864	825	25	β	β	NN
10_1101-2021_01_08_425864	825	26	-	-	HYPH
10_1101-2021_01_08_425864	825	27	oxidation	oxidation	NN
10_1101-2021_01_08_425864	825	28	,	,	,
10_1101-2021_01_08_425864	825	29	PLOS	PLOS	NNP
10_1101-2021_01_08_425864	825	30	Biol	Biol	NNP
10_1101-2021_01_08_425864	825	31	.	.	.
10_1101-2021_01_08_425864	826	1	16	16	CD
10_1101-2021_01_08_425864	826	2	(	(	-LRB-
10_1101-2021_01_08_425864	826	3	2018	2018	CD
10_1101-2021_01_08_425864	826	4	)	)	-RRB-
10_1101-2021_01_08_425864	826	5	e2003782	e2003782	NN
10_1101-2021_01_08_425864	826	6	.	.	.
10_1101-2021_01_08_425864	827	1	882	882	CD
10_1101-2021_01_08_425864	827	2	https://doi.org/10.1371/journal.pbio.2003782	https://doi.org/10.1371/journal.pbio.2003782	NN
10_1101-2021_01_08_425864	827	3	.	.	.
10_1101-2021_01_08_425864	828	1	883	883	CD
10_1101-2021_01_08_425864	828	2	[	[	-LRB-
10_1101-2021_01_08_425864	828	3	63	63	CD
10_1101-2021_01_08_425864	828	4	]	]	-RRB-
10_1101-2021_01_08_425864	828	5	S.N.	S.N.	NNP
10_1101-2021_01_08_425864	829	1	Rampersad	rampersad	NN
10_1101-2021_01_08_425864	829	2	,	,	,
10_1101-2021_01_08_425864	829	3	Multiple	multiple	JJ
10_1101-2021_01_08_425864	829	4	applications	application	NNS
10_1101-2021_01_08_425864	829	5	of	of	IN
10_1101-2021_01_08_425864	829	6	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	829	7	Blue	Blue	NNP
10_1101-2021_01_08_425864	829	8	as	as	IN
10_1101-2021_01_08_425864	829	9	an	an	DT
10_1101-2021_01_08_425864	829	10	indicator	indicator	NN
10_1101-2021_01_08_425864	829	11	of	of	IN
10_1101-2021_01_08_425864	829	12	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	829	13	function	function	NN
10_1101-2021_01_08_425864	829	14	884	884	CD
10_1101-2021_01_08_425864	829	15	and	and	CC
10_1101-2021_01_08_425864	829	16	cellular	cellular	JJ
10_1101-2021_01_08_425864	829	17	health	health	NN
10_1101-2021_01_08_425864	829	18	in	in	IN
10_1101-2021_01_08_425864	829	19	cell	cell	NN
10_1101-2021_01_08_425864	829	20	viability	viability	NN
10_1101-2021_01_08_425864	829	21	bioassays	bioassay	NNS
10_1101-2021_01_08_425864	829	22	,	,	,
10_1101-2021_01_08_425864	829	23	Sensors	Sensors	NNP
10_1101-2021_01_08_425864	829	24	(	(	-LRB-
10_1101-2021_01_08_425864	829	25	Basel	Basel	NNP
10_1101-2021_01_08_425864	829	26	)	)	-RRB-
10_1101-2021_01_08_425864	829	27	.	.	.
10_1101-2021_01_08_425864	830	1	12	12	CD
10_1101-2021_01_08_425864	830	2	(	(	-LRB-
10_1101-2021_01_08_425864	830	3	2012	2012	CD
10_1101-2021_01_08_425864	830	4	)	)	-RRB-
10_1101-2021_01_08_425864	830	5	12347–60	12347–60	CD
10_1101-2021_01_08_425864	830	6	.	.	.
10_1101-2021_01_08_425864	831	1	885	885	CD
10_1101-2021_01_08_425864	831	2	https://doi.org/10.3390/s120912347	https://doi.org/10.3390/s120912347	NN
10_1101-2021_01_08_425864	831	3	.	.	.
10_1101-2021_01_08_425864	832	1	886	886	CD
10_1101-2021_01_08_425864	832	2	[	[	-LRB-
10_1101-2021_01_08_425864	832	3	64	64	CD
10_1101-2021_01_08_425864	832	4	]	]	-RRB-
10_1101-2021_01_08_425864	832	5	J.J.	J.J.	NNP
10_1101-2021_01_08_425864	832	6	Homsy	Homsy	NNP
10_1101-2021_01_08_425864	832	7	,	,	,
10_1101-2021_01_08_425864	832	8	B.	B.	NNP
10_1101-2021_01_08_425864	832	9	Granger	Granger	NNP
10_1101-2021_01_08_425864	832	10	,	,	,
10_1101-2021_01_08_425864	832	11	S.M.	S.M.	NNP
10_1101-2021_01_08_425864	833	1	Krassner	Krassner	NNP
10_1101-2021_01_08_425864	833	2	,	,	,
10_1101-2021_01_08_425864	833	3	Some	some	DT
10_1101-2021_01_08_425864	833	4	factors	factor	NNS
10_1101-2021_01_08_425864	833	5	inducing	induce	VBG
10_1101-2021_01_08_425864	833	6	formation	formation	NN
10_1101-2021_01_08_425864	833	7	of	of	IN
10_1101-2021_01_08_425864	833	8	metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	833	9	887	887	CD
10_1101-2021_01_08_425864	833	10	stages	stage	NNS
10_1101-2021_01_08_425864	833	11	of	of	IN
10_1101-2021_01_08_425864	833	12	Trypanosoma	Trypanosoma	NNP
10_1101-2021_01_08_425864	833	13	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	833	14	,	,	,
10_1101-2021_01_08_425864	833	15	J.	J.	NNP
10_1101-2021_01_08_425864	833	16	Protozool	Protozool	NNP
10_1101-2021_01_08_425864	833	17	.	.	.
10_1101-2021_01_08_425864	834	1	36	36	CD
10_1101-2021_01_08_425864	834	2	(	(	-LRB-
10_1101-2021_01_08_425864	834	3	1989	1989	CD
10_1101-2021_01_08_425864	834	4	)	)	-RRB-
10_1101-2021_01_08_425864	834	5	150–3	150–3	CD
10_1101-2021_01_08_425864	834	6	.	.	.
10_1101-2021_01_08_425864	835	1	888	888	CD
10_1101-2021_01_08_425864	835	2	http://www.ncbi.nlm.nih.gov/pubmed/2657033	http://www.ncbi.nlm.nih.gov/pubmed/2657033	NNP
10_1101-2021_01_08_425864	835	3	(	(	-LRB-
10_1101-2021_01_08_425864	835	4	accessed	access	VBN
10_1101-2021_01_08_425864	835	5	January	January	NNP
10_1101-2021_01_08_425864	835	6	29	29	CD
10_1101-2021_01_08_425864	835	7	,	,	,
10_1101-2021_01_08_425864	835	8	2019	2019	CD
10_1101-2021_01_08_425864	835	9	)	)	-RRB-
10_1101-2021_01_08_425864	835	10	.	.	.
10_1101-2021_01_08_425864	836	1	889	889	CD
10_1101-2021_01_08_425864	836	2	890	890	CD
10_1101-2021_01_08_425864	836	3	.CC	.CC	:
10_1101-2021_01_08_425864	836	4	-	-	:
10_1101-2021_01_08_425864	836	5	BY	by	IN
10_1101-2021_01_08_425864	836	6	4.0	4.0	CD
10_1101-2021_01_08_425864	836	7	International	international	JJ
10_1101-2021_01_08_425864	836	8	licensemade	licensemade	NN
10_1101-2021_01_08_425864	836	9	available	available	JJ
10_1101-2021_01_08_425864	836	10	under	under	IN
10_1101-2021_01_08_425864	836	11	a	a	DT
10_1101-2021_01_08_425864	836	12	(	(	-LRB-
10_1101-2021_01_08_425864	836	13	which	which	WDT
10_1101-2021_01_08_425864	836	14	was	be	VBD
10_1101-2021_01_08_425864	836	15	not	not	RB
10_1101-2021_01_08_425864	836	16	certified	certify	VBN
10_1101-2021_01_08_425864	836	17	by	by	IN
10_1101-2021_01_08_425864	836	18	peer	peer	NN
10_1101-2021_01_08_425864	836	19	review	review	NN
10_1101-2021_01_08_425864	836	20	)	)	-RRB-
10_1101-2021_01_08_425864	836	21	is	be	VBZ
10_1101-2021_01_08_425864	836	22	the	the	DT
10_1101-2021_01_08_425864	836	23	author	author	NN
10_1101-2021_01_08_425864	836	24	/	/	SYM
10_1101-2021_01_08_425864	836	25	funder	funder	NN
10_1101-2021_01_08_425864	836	26	,	,	,
10_1101-2021_01_08_425864	836	27	who	who	WP
10_1101-2021_01_08_425864	836	28	has	have	VBZ
10_1101-2021_01_08_425864	836	29	granted	grant	VBN
10_1101-2021_01_08_425864	836	30	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	836	31	a	a	DT
10_1101-2021_01_08_425864	836	32	license	license	NN
10_1101-2021_01_08_425864	836	33	to	to	TO
10_1101-2021_01_08_425864	836	34	display	display	VB
10_1101-2021_01_08_425864	836	35	the	the	DT
10_1101-2021_01_08_425864	836	36	preprint	preprint	NN
10_1101-2021_01_08_425864	836	37	in	in	IN
10_1101-2021_01_08_425864	836	38	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	836	39	.	.	.
10_1101-2021_01_08_425864	837	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	837	2	is	be	VBZ
10_1101-2021_01_08_425864	837	3	The	the	DT
10_1101-2021_01_08_425864	837	4	copyright	copyright	NN
10_1101-2021_01_08_425864	837	5	holder	holder	NN
10_1101-2021_01_08_425864	837	6	for	for	IN
10_1101-2021_01_08_425864	837	7	this	this	DT
10_1101-2021_01_08_425864	837	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	837	9	version	version	NN
10_1101-2021_01_08_425864	837	10	posted	post	VBD
10_1101-2021_01_08_425864	837	11	January	January	NNP
10_1101-2021_01_08_425864	837	12	8	8	CD
10_1101-2021_01_08_425864	837	13	,	,	,
10_1101-2021_01_08_425864	837	14	2021	2021	CD
10_1101-2021_01_08_425864	837	15	.	.	.
10_1101-2021_01_08_425864	837	16	;	;	:
10_1101-2021_01_08_425864	837	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	837	18	:	:	:
10_1101-2021_01_08_425864	837	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	837	20	preprint	preprint	NN
10_1101-2021_01_08_425864	837	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	NN
10_1101-2021_01_08_425864	837	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	837	23	891	891	CD
10_1101-2021_01_08_425864	837	24	Supporting	support	VBG
10_1101-2021_01_08_425864	837	25	information	information	NN
10_1101-2021_01_08_425864	837	26	892	892	CD
10_1101-2021_01_08_425864	837	27	S1	s1	NN
10_1101-2021_01_08_425864	837	28	893	893	CD
10_1101-2021_01_08_425864	837	29	S1	S1	NNS
10_1101-2021_01_08_425864	837	30	Fig	fig	NN
10_1101-2021_01_08_425864	837	31	.	.	.
10_1101-2021_01_08_425864	838	1	1H	1h	LS
10_1101-2021_01_08_425864	838	2	-	-	:
10_1101-2021_01_08_425864	838	3	NMR	NMR	NNP
10_1101-2021_01_08_425864	838	4	analysis	analysis	NN
10_1101-2021_01_08_425864	838	5	of	of	IN
10_1101-2021_01_08_425864	838	6	excreted	excreted	JJ
10_1101-2021_01_08_425864	838	7	end	end	NN
10_1101-2021_01_08_425864	838	8	products	product	NNS
10_1101-2021_01_08_425864	838	9	from	from	IN
10_1101-2021_01_08_425864	838	10	glucose	glucose	NN
10_1101-2021_01_08_425864	838	11	and	and	CC
10_1101-2021_01_08_425864	838	12	threonine	threonine	NN
10_1101-2021_01_08_425864	838	13	metabolism	metabolism	NN
10_1101-2021_01_08_425864	838	14	.	.	.
10_1101-2021_01_08_425864	839	1	The	the	DT
10_1101-2021_01_08_425864	839	2	894	894	CD
10_1101-2021_01_08_425864	839	3	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	839	4	end	end	NN
10_1101-2021_01_08_425864	839	5	products	product	NNS
10_1101-2021_01_08_425864	839	6	(	(	-LRB-
10_1101-2021_01_08_425864	839	7	succinate	succinate	NNP
10_1101-2021_01_08_425864	839	8	,	,	,
10_1101-2021_01_08_425864	839	9	acetate	acetate	JJ
10_1101-2021_01_08_425864	839	10	,	,	,
10_1101-2021_01_08_425864	839	11	alanine	alanine	NN
10_1101-2021_01_08_425864	839	12	and	and	CC
10_1101-2021_01_08_425864	839	13	lactate	lactate	NN
10_1101-2021_01_08_425864	839	14	)	)	-RRB-
10_1101-2021_01_08_425864	839	15	excreted	excrete	VBN
10_1101-2021_01_08_425864	839	16	by	by	IN
10_1101-2021_01_08_425864	839	17	the	the	DT
10_1101-2021_01_08_425864	839	18	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	839	19	cells	cell	NNS
10_1101-2021_01_08_425864	839	20	that	that	IN
10_1101-2021_01_08_425864	839	21	895	895	CD
10_1101-2021_01_08_425864	839	22	were	be	VBD
10_1101-2021_01_08_425864	839	23	incubated	incubate	VBN
10_1101-2021_01_08_425864	839	24	after	after	IN
10_1101-2021_01_08_425864	839	25	6	6	CD
10_1101-2021_01_08_425864	839	26	h	h	NN
10_1101-2021_01_08_425864	839	27	in	in	IN
10_1101-2021_01_08_425864	839	28	PBS	PBS	NNP
10_1101-2021_01_08_425864	839	29	(	(	-LRB-
10_1101-2021_01_08_425864	839	30	A	A	NNP
10_1101-2021_01_08_425864	839	31	)	)	-RRB-
10_1101-2021_01_08_425864	839	32	,	,	,
10_1101-2021_01_08_425864	839	33	PBS	PBS	NNP
10_1101-2021_01_08_425864	839	34	after	after	IN
10_1101-2021_01_08_425864	839	35	16	16	CD
10_1101-2021_01_08_425864	839	36	h	h	NN
10_1101-2021_01_08_425864	839	37	of	of	IN
10_1101-2021_01_08_425864	839	38	starvation	starvation	NN
10_1101-2021_01_08_425864	839	39	without	without	IN
10_1101-2021_01_08_425864	839	40	(	(	-LRB-
10_1101-2021_01_08_425864	839	41	B	b	NN
10_1101-2021_01_08_425864	839	42	)	)	-RRB-
10_1101-2021_01_08_425864	839	43	or	or	CC
10_1101-2021_01_08_425864	839	44	with	with	IN
10_1101-2021_01_08_425864	839	45	D-[U-13C]-	D-[U-13C]-	NNP
10_1101-2021_01_08_425864	839	46	896	896	CD
10_1101-2021_01_08_425864	839	47	glucose	glucose	NN
10_1101-2021_01_08_425864	839	48	(	(	-LRB-
10_1101-2021_01_08_425864	839	49	C	c	NN
10_1101-2021_01_08_425864	839	50	)	)	-RRB-
10_1101-2021_01_08_425864	839	51	or	or	CC
10_1101-2021_01_08_425864	839	52	palmitate	palmitate	NN
10_1101-2021_01_08_425864	839	53	(	(	-LRB-
10_1101-2021_01_08_425864	839	54	D	d	NN
10_1101-2021_01_08_425864	839	55	)	)	-RRB-
10_1101-2021_01_08_425864	839	56	were	be	VBD
10_1101-2021_01_08_425864	839	57	determined	determine	VBN
10_1101-2021_01_08_425864	839	58	by	by	IN
10_1101-2021_01_08_425864	839	59	1H	1h	JJ
10_1101-2021_01_08_425864	839	60	-	-	HYPH
10_1101-2021_01_08_425864	839	61	NMR	NMR	NNP
10_1101-2021_01_08_425864	839	62	.	.	.
10_1101-2021_01_08_425864	840	1	Each	each	DT
10_1101-2021_01_08_425864	840	2	spectrum	spectrum	NN
10_1101-2021_01_08_425864	840	3	corresponds	correspond	VBZ
10_1101-2021_01_08_425864	840	4	to	to	IN
10_1101-2021_01_08_425864	840	5	one	one	CD
10_1101-2021_01_08_425864	840	6	897	897	CD
10_1101-2021_01_08_425864	840	7	representative	representative	JJ
10_1101-2021_01_08_425864	840	8	experiment	experiment	NN
10_1101-2021_01_08_425864	840	9	from	from	IN
10_1101-2021_01_08_425864	840	10	a	a	DT
10_1101-2021_01_08_425864	840	11	set	set	NN
10_1101-2021_01_08_425864	840	12	of	of	IN
10_1101-2021_01_08_425864	840	13	at	at	IN
10_1101-2021_01_08_425864	840	14	least	least	JJS
10_1101-2021_01_08_425864	840	15	3	3	CD
10_1101-2021_01_08_425864	840	16	.	.	.
10_1101-2021_01_08_425864	841	1	A	a	DT
10_1101-2021_01_08_425864	841	2	part	part	NN
10_1101-2021_01_08_425864	841	3	of	of	IN
10_1101-2021_01_08_425864	841	4	each	each	DT
10_1101-2021_01_08_425864	841	5	spectrum	spectrum	NN
10_1101-2021_01_08_425864	841	6	ranging	range	VBG
10_1101-2021_01_08_425864	841	7	from	from	IN
10_1101-2021_01_08_425864	841	8	0.5	0.5	CD
10_1101-2021_01_08_425864	841	9	ppm	ppm	NN
10_1101-2021_01_08_425864	841	10	to	to	IN
10_1101-2021_01_08_425864	841	11	898	898	CD
10_1101-2021_01_08_425864	841	12	4	4	CD
10_1101-2021_01_08_425864	841	13	ppm	ppm	NN
10_1101-2021_01_08_425864	841	14	is	be	VBZ
10_1101-2021_01_08_425864	841	15	shown	show	VBN
10_1101-2021_01_08_425864	841	16	.	.	.
10_1101-2021_01_08_425864	842	1	The	the	DT
10_1101-2021_01_08_425864	842	2	resonances	resonance	NNS
10_1101-2021_01_08_425864	842	3	were	be	VBD
10_1101-2021_01_08_425864	842	4	assigned	assign	VBN
10_1101-2021_01_08_425864	842	5	as	as	IN
10_1101-2021_01_08_425864	842	6	indicated	indicate	VBN
10_1101-2021_01_08_425864	842	7	:	:	:
10_1101-2021_01_08_425864	842	8	A12	A12	NNP
10_1101-2021_01_08_425864	842	9	,	,	,
10_1101-2021_01_08_425864	842	10	acetate	acetate	JJ
10_1101-2021_01_08_425864	842	11	;	;	:
10_1101-2021_01_08_425864	842	12	A13	a13	JJ
10_1101-2021_01_08_425864	842	13	,	,	,
10_1101-2021_01_08_425864	842	14	13C	13C	NNP
10_1101-2021_01_08_425864	842	15	-	-	HYPH
10_1101-2021_01_08_425864	842	16	enriched	enrich	VBN
10_1101-2021_01_08_425864	842	17	acetate	acetate	NN
10_1101-2021_01_08_425864	842	18	;	;	:
10_1101-2021_01_08_425864	842	19	899	899	CD
10_1101-2021_01_08_425864	842	20	Al12	Al12	NNP
10_1101-2021_01_08_425864	842	21	,	,	,
10_1101-2021_01_08_425864	842	22	alanine	alanine	NN
10_1101-2021_01_08_425864	842	23	;	;	:
10_1101-2021_01_08_425864	842	24	Al13	Al13	NNP
10_1101-2021_01_08_425864	842	25	,	,	,
10_1101-2021_01_08_425864	842	26	13C	13C	NNP
10_1101-2021_01_08_425864	842	27	-	-	HYPH
10_1101-2021_01_08_425864	842	28	enriched	enrich	VBN
10_1101-2021_01_08_425864	842	29	alanine	alanine	NN
10_1101-2021_01_08_425864	842	30	;	;	:
10_1101-2021_01_08_425864	842	31	G13	G13	NNP
10_1101-2021_01_08_425864	842	32	,	,	,
10_1101-2021_01_08_425864	842	33	13C	13c	CD
10_1101-2021_01_08_425864	842	34	-	-	HYPH
10_1101-2021_01_08_425864	842	35	enriched	enrich	VBN
10_1101-2021_01_08_425864	842	36	glucose	glucose	NN
10_1101-2021_01_08_425864	842	37	;	;	:
10_1101-2021_01_08_425864	842	38	L12	L12	NNP
10_1101-2021_01_08_425864	842	39	,	,	,
10_1101-2021_01_08_425864	842	40	lactate	lactate	NN
10_1101-2021_01_08_425864	842	41	;	;	:
10_1101-2021_01_08_425864	842	42	L13	L13	NNP
10_1101-2021_01_08_425864	842	43	,	,	,
10_1101-2021_01_08_425864	842	44	13C	13C	NNP
10_1101-2021_01_08_425864	842	45	-	-	HYPH
10_1101-2021_01_08_425864	842	46	enriched	enrich	VBN
10_1101-2021_01_08_425864	842	47	900	900	CD
10_1101-2021_01_08_425864	842	48	lactate	lactate	NN
10_1101-2021_01_08_425864	842	49	;	;	:
10_1101-2021_01_08_425864	842	50	P12	P12	NNP
10_1101-2021_01_08_425864	842	51	,	,	,
10_1101-2021_01_08_425864	842	52	palmitate	palmitate	NN
10_1101-2021_01_08_425864	842	53	;	;	:
10_1101-2021_01_08_425864	842	54	S12	S12	NNP
10_1101-2021_01_08_425864	842	55	,	,	,
10_1101-2021_01_08_425864	842	56	succinate	succinate	NN
10_1101-2021_01_08_425864	842	57	;	;	:
10_1101-2021_01_08_425864	842	58	and	and	CC
10_1101-2021_01_08_425864	842	59	S13	S13	NNP
10_1101-2021_01_08_425864	842	60	,	,	,
10_1101-2021_01_08_425864	842	61	13C	13C	NNP
10_1101-2021_01_08_425864	842	62	-	-	HYPH
10_1101-2021_01_08_425864	842	63	enriched	enrich	VBN
10_1101-2021_01_08_425864	842	64	succinate	succinate	NN
10_1101-2021_01_08_425864	842	65	.	.	.
10_1101-2021_01_08_425864	843	1	901	901	CD
10_1101-2021_01_08_425864	843	2	902	902	CD
10_1101-2021_01_08_425864	843	3	S2	s2	NN
10_1101-2021_01_08_425864	843	4	903	903	CD
10_1101-2021_01_08_425864	843	5	904	904	CD
10_1101-2021_01_08_425864	843	6	S2	s2	NN
10_1101-2021_01_08_425864	843	7	Fig	fig	NN
10_1101-2021_01_08_425864	843	8	.	.	.
10_1101-2021_01_08_425864	844	1	Time	time	NN
10_1101-2021_01_08_425864	844	2	course	course	NN
10_1101-2021_01_08_425864	844	3	activities	activity	NNS
10_1101-2021_01_08_425864	844	4	of	of	IN
10_1101-2021_01_08_425864	844	5	enzymes	enzyme	NNS
10_1101-2021_01_08_425864	844	6	measured	measure	VBN
10_1101-2021_01_08_425864	844	7	in	in	IN
10_1101-2021_01_08_425864	844	8	this	this	DT
10_1101-2021_01_08_425864	844	9	work	work	NN
10_1101-2021_01_08_425864	844	10	.	.	.
10_1101-2021_01_08_425864	845	1	A	a	LS
10_1101-2021_01_08_425864	845	2	)	)	-RRB-
10_1101-2021_01_08_425864	845	3	(	(	-LRB-
10_1101-2021_01_08_425864	845	4	ACC	ACC	NNP
10_1101-2021_01_08_425864	845	5	)	)	-RRB-
10_1101-2021_01_08_425864	845	6	acetyl	acetyl	NN
10_1101-2021_01_08_425864	845	7	-	-	HYPH
10_1101-2021_01_08_425864	845	8	CoA	CoA	NNP
10_1101-2021_01_08_425864	845	9	905	905	CD
10_1101-2021_01_08_425864	845	10	carboxylase	carboxylase	NN
10_1101-2021_01_08_425864	845	11	,	,	,
10_1101-2021_01_08_425864	845	12	B	b	NN
10_1101-2021_01_08_425864	845	13	)	)	-RRB-
10_1101-2021_01_08_425864	845	14	(	(	-LRB-
10_1101-2021_01_08_425864	845	15	CPT1	CPT1	NNP
10_1101-2021_01_08_425864	845	16	)	)	-RRB-
10_1101-2021_01_08_425864	845	17	carnitine	carnitine	NN
10_1101-2021_01_08_425864	845	18	-	-	HYPH
10_1101-2021_01_08_425864	845	19	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	845	20	,	,	,
10_1101-2021_01_08_425864	845	21	and	and	CC
10_1101-2021_01_08_425864	845	22	C	C	NNP
10_1101-2021_01_08_425864	845	23	)	)	-RRB-
10_1101-2021_01_08_425864	845	24	(	(	-LRB-
10_1101-2021_01_08_425864	845	25	SPT	SPT	NNP
10_1101-2021_01_08_425864	845	26	)	)	-RRB-
10_1101-2021_01_08_425864	845	27	serine	serine	JJ
10_1101-2021_01_08_425864	845	28	palmitoyltransferase	palmitoyltransferase	NN
10_1101-2021_01_08_425864	845	29	.	.	.
10_1101-2021_01_08_425864	846	1	All	all	DT
10_1101-2021_01_08_425864	846	2	906	906	CD
10_1101-2021_01_08_425864	846	3	the	the	DT
10_1101-2021_01_08_425864	846	4	activities	activity	NNS
10_1101-2021_01_08_425864	846	5	were	be	VBD
10_1101-2021_01_08_425864	846	6	measured	measure	VBN
10_1101-2021_01_08_425864	846	7	in	in	IN
10_1101-2021_01_08_425864	846	8	cell	cell	NN
10_1101-2021_01_08_425864	846	9	-	-	HYPH
10_1101-2021_01_08_425864	846	10	free	free	JJ
10_1101-2021_01_08_425864	846	11	extracts	extract	NNS
10_1101-2021_01_08_425864	846	12	of	of	IN
10_1101-2021_01_08_425864	846	13	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	846	14	forms	form	NNS
10_1101-2021_01_08_425864	846	15	at	at	IN
10_1101-2021_01_08_425864	846	16	different	different	JJ
10_1101-2021_01_08_425864	846	17	moments	moment	NNS
10_1101-2021_01_08_425864	846	18	of	of	IN
10_1101-2021_01_08_425864	846	19	the	the	DT
10_1101-2021_01_08_425864	846	20	907	907	CD
10_1101-2021_01_08_425864	846	21	growth	growth	NN
10_1101-2021_01_08_425864	846	22	curve	curve	NN
10_1101-2021_01_08_425864	846	23	as	as	IN
10_1101-2021_01_08_425864	846	24	indicated	indicate	VBN
10_1101-2021_01_08_425864	846	25	in	in	IN
10_1101-2021_01_08_425864	846	26	the	the	DT
10_1101-2021_01_08_425864	846	27	main	main	JJ
10_1101-2021_01_08_425864	846	28	text	text	NN
10_1101-2021_01_08_425864	846	29	.	.	.
10_1101-2021_01_08_425864	847	1	All	all	PDT
10_1101-2021_01_08_425864	847	2	the	the	DT
10_1101-2021_01_08_425864	847	3	measurements	measurement	NNS
10_1101-2021_01_08_425864	847	4	were	be	VBD
10_1101-2021_01_08_425864	847	5	performed	perform	VBN
10_1101-2021_01_08_425864	847	6	in	in	IN
10_1101-2021_01_08_425864	847	7	triplicates	triplicate	NNS
10_1101-2021_01_08_425864	847	8	.	.	.
10_1101-2021_01_08_425864	848	1	908	908	CD
10_1101-2021_01_08_425864	848	2	S3	S3	NNP
10_1101-2021_01_08_425864	848	3	909	909	CD
10_1101-2021_01_08_425864	848	4	910	910	CD
10_1101-2021_01_08_425864	848	5	To	to	TO
10_1101-2021_01_08_425864	848	6	check	check	VB
10_1101-2021_01_08_425864	848	7	if	if	IN
10_1101-2021_01_08_425864	848	8	other	other	JJ
10_1101-2021_01_08_425864	848	9	well	well	RB
10_1101-2021_01_08_425864	848	10	-	-	HYPH
10_1101-2021_01_08_425864	848	11	known	know	VBN
10_1101-2021_01_08_425864	848	12	FAO	FAO	NNP
10_1101-2021_01_08_425864	848	13	inhibitors	inhibitor	NNS
10_1101-2021_01_08_425864	848	14	have	have	VBP
10_1101-2021_01_08_425864	848	15	the	the	DT
10_1101-2021_01_08_425864	848	16	same	same	JJ
10_1101-2021_01_08_425864	848	17	effect	effect	NN
10_1101-2021_01_08_425864	848	18	on	on	IN
10_1101-2021_01_08_425864	848	19	the	the	DT
10_1101-2021_01_08_425864	848	20	proliferation	proliferation	NN
10_1101-2021_01_08_425864	848	21	of	of	IN
10_1101-2021_01_08_425864	848	22	T.	T.	NNP
10_1101-2021_01_08_425864	848	23	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	848	24	911	911	CD
10_1101-2021_01_08_425864	848	25	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	848	26	,	,	,
10_1101-2021_01_08_425864	848	27	we	-PRON-	PRP
10_1101-2021_01_08_425864	848	28	performed	perform	VBD
10_1101-2021_01_08_425864	848	29	the	the	DT
10_1101-2021_01_08_425864	848	30	same	same	JJ
10_1101-2021_01_08_425864	848	31	assay	assay	NN
10_1101-2021_01_08_425864	848	32	as	as	IN
10_1101-2021_01_08_425864	848	33	described	describe	VBN
10_1101-2021_01_08_425864	848	34	in	in	IN
10_1101-2021_01_08_425864	848	35	Materials	Materials	NNP
10_1101-2021_01_08_425864	848	36	and	and	CC
10_1101-2021_01_08_425864	848	37	Methods	method	NNS
10_1101-2021_01_08_425864	848	38	by	by	IN
10_1101-2021_01_08_425864	848	39	evaluating	evaluate	VBG
10_1101-2021_01_08_425864	848	40	912	912	CD
10_1101-2021_01_08_425864	848	41	different	different	JJ
10_1101-2021_01_08_425864	848	42	concentrations	concentration	NNS
10_1101-2021_01_08_425864	848	43	of	of	IN
10_1101-2021_01_08_425864	848	44	valproic	valproic	JJ
10_1101-2021_01_08_425864	848	45	acid	acid	NN
10_1101-2021_01_08_425864	848	46	(	(	-LRB-
10_1101-2021_01_08_425864	848	47	AV	av	NN
10_1101-2021_01_08_425864	848	48	)	)	-RRB-
10_1101-2021_01_08_425864	848	49	[	[	-LRB-
10_1101-2021_01_08_425864	848	50	57	57	CD
10_1101-2021_01_08_425864	848	51	]	]	-RRB-
10_1101-2021_01_08_425864	848	52	,	,	,
10_1101-2021_01_08_425864	848	53	trimetazidine	trimetazidine	VB
10_1101-2021_01_08_425864	848	54	[	[	-LRB-
10_1101-2021_01_08_425864	848	55	58,59	58,59	CD
10_1101-2021_01_08_425864	848	56	]	]	-RRB-
10_1101-2021_01_08_425864	848	57	and	and	CC
10_1101-2021_01_08_425864	848	58	β	β	NN
10_1101-2021_01_08_425864	848	59	-	-	HYPH
10_1101-2021_01_08_425864	848	60	hydroxybutyrate	hydroxybutyrate	NN
10_1101-2021_01_08_425864	848	61	[	[	-LRB-
10_1101-2021_01_08_425864	848	62	60	60	CD
10_1101-2021_01_08_425864	848	63	]	]	-RRB-
10_1101-2021_01_08_425864	848	64	,	,	,
10_1101-2021_01_08_425864	848	65	913	913	CD
10_1101-2021_01_08_425864	848	66	which	which	WDT
10_1101-2021_01_08_425864	848	67	are	be	VBP
10_1101-2021_01_08_425864	848	68	inhibitors	inhibitor	NNS
10_1101-2021_01_08_425864	848	69	of	of	IN
10_1101-2021_01_08_425864	848	70	3-ketothiolase	3-ketothiolase	CD
10_1101-2021_01_08_425864	848	71	.	.	.
10_1101-2021_01_08_425864	849	1	Because	because	IN
10_1101-2021_01_08_425864	849	2	they	-PRON-	PRP
10_1101-2021_01_08_425864	849	3	did	do	VBD
10_1101-2021_01_08_425864	849	4	not	not	RB
10_1101-2021_01_08_425864	849	5	affect	affect	VB
10_1101-2021_01_08_425864	849	6	the	the	DT
10_1101-2021_01_08_425864	849	7	proliferation	proliferation	NN
10_1101-2021_01_08_425864	849	8	of	of	IN
10_1101-2021_01_08_425864	849	9	the	the	DT
10_1101-2021_01_08_425864	849	10	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	849	11	914	914	CD
10_1101-2021_01_08_425864	849	12	forms	form	NNS
10_1101-2021_01_08_425864	849	13	,	,	,
10_1101-2021_01_08_425864	849	14	we	-PRON-	PRP
10_1101-2021_01_08_425864	849	15	used	use	VBD
10_1101-2021_01_08_425864	849	16	the	the	DT
10_1101-2021_01_08_425864	849	17	higher	high	JJR
10_1101-2021_01_08_425864	849	18	concentration	concentration	NN
10_1101-2021_01_08_425864	849	19	evaluated	evaluate	VBN
10_1101-2021_01_08_425864	849	20	in	in	IN
10_1101-2021_01_08_425864	849	21	these	these	DT
10_1101-2021_01_08_425864	849	22	assays	assay	NNS
10_1101-2021_01_08_425864	849	23	to	to	TO
10_1101-2021_01_08_425864	849	24	know	know	VB
10_1101-2021_01_08_425864	849	25	if	if	IN
10_1101-2021_01_08_425864	849	26	the	the	DT
10_1101-2021_01_08_425864	849	27	compounds	compound	NNS
10_1101-2021_01_08_425864	849	28	inhibit	inhibit	VBP
10_1101-2021_01_08_425864	849	29	915	915	CD
10_1101-2021_01_08_425864	849	30	FAO	FAO	NNP
10_1101-2021_01_08_425864	849	31	by	by	IN
10_1101-2021_01_08_425864	849	32	14CO2	14co2	CD
10_1101-2021_01_08_425864	849	33	trapping	trapping	NN
10_1101-2021_01_08_425864	849	34	by	by	IN
10_1101-2021_01_08_425864	849	35	using	use	VBG
10_1101-2021_01_08_425864	849	36	U-14C	u-14c	NN
10_1101-2021_01_08_425864	849	37	-	-	HYPH
10_1101-2021_01_08_425864	849	38	palmitate	palmitate	NN
10_1101-2021_01_08_425864	849	39	as	as	IN
10_1101-2021_01_08_425864	849	40	a	a	DT
10_1101-2021_01_08_425864	849	41	substrate	substrate	NN
10_1101-2021_01_08_425864	849	42	.	.	.
10_1101-2021_01_08_425864	850	1	As	as	IN
10_1101-2021_01_08_425864	850	2	observed	observe	VBN
10_1101-2021_01_08_425864	850	3	,	,	,
10_1101-2021_01_08_425864	850	4	none	none	NN
10_1101-2021_01_08_425864	850	5	of	of	IN
10_1101-2021_01_08_425864	850	6	these	these	DT
10_1101-2021_01_08_425864	850	7	916	916	CD
10_1101-2021_01_08_425864	850	8	compound	compound	NN
10_1101-2021_01_08_425864	850	9	inhibited	inhibit	VBD
10_1101-2021_01_08_425864	850	10	the	the	DT
10_1101-2021_01_08_425864	850	11	14CO2	14co2	CD
10_1101-2021_01_08_425864	850	12	production	production	NN
10_1101-2021_01_08_425864	850	13	from	from	IN
10_1101-2021_01_08_425864	850	14	palmitate	palmitate	NN
10_1101-2021_01_08_425864	850	15	,	,	,
10_1101-2021_01_08_425864	850	16	confirming	confirm	VBG
10_1101-2021_01_08_425864	850	17	that	that	IN
10_1101-2021_01_08_425864	850	18	they	-PRON-	PRP
10_1101-2021_01_08_425864	850	19	are	be	VBP
10_1101-2021_01_08_425864	850	20	not	not	RB
10_1101-2021_01_08_425864	850	21	inhibiting	inhibit	VBG
10_1101-2021_01_08_425864	850	22	FAO	FAO	NNP
10_1101-2021_01_08_425864	850	23	917	917	CD
10_1101-2021_01_08_425864	850	24	in	in	IN
10_1101-2021_01_08_425864	850	25	T.	t.	NN
10_1101-2021_01_08_425864	850	26	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	850	27	.	.	.
10_1101-2021_01_08_425864	851	1	918	918	CD
10_1101-2021_01_08_425864	851	2	919	919	CD
10_1101-2021_01_08_425864	851	3	S3	S3	NNP
10_1101-2021_01_08_425864	851	4	Fig	Fig	NNP
10_1101-2021_01_08_425864	851	5	.	.	.
10_1101-2021_01_08_425864	852	1	Other	other	JJ
10_1101-2021_01_08_425864	852	2	FAO	FAO	NNP
10_1101-2021_01_08_425864	852	3	inhibitors	inhibitor	NNS
10_1101-2021_01_08_425864	852	4	did	do	VBD
10_1101-2021_01_08_425864	852	5	not	not	RB
10_1101-2021_01_08_425864	852	6	affect	affect	VB
10_1101-2021_01_08_425864	852	7	cell	cell	NN
10_1101-2021_01_08_425864	852	8	proliferation	proliferation	NN
10_1101-2021_01_08_425864	852	9	and	and	CC
10_1101-2021_01_08_425864	852	10	FAO	FAO	NNP
10_1101-2021_01_08_425864	852	11	in	in	IN
10_1101-2021_01_08_425864	852	12	the	the	DT
10_1101-2021_01_08_425864	852	13	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	852	14	920	920	CD
10_1101-2021_01_08_425864	852	15	forms	form	NNS
10_1101-2021_01_08_425864	852	16	.	.	.
10_1101-2021_01_08_425864	853	1	The	the	DT
10_1101-2021_01_08_425864	853	2	compounds	compound	NNS
10_1101-2021_01_08_425864	853	3	were	be	VBD
10_1101-2021_01_08_425864	853	4	evaluated	evaluate	VBN
10_1101-2021_01_08_425864	853	5	at	at	IN
10_1101-2021_01_08_425864	853	6	concentrations	concentration	NNS
10_1101-2021_01_08_425864	853	7	between	between	IN
10_1101-2021_01_08_425864	853	8	0.1	0.1	CD
10_1101-2021_01_08_425864	853	9	and	and	CC
10_1101-2021_01_08_425864	853	10	1000	1000	CD
10_1101-2021_01_08_425864	853	11	µM.	µM.	NNP
10_1101-2021_01_08_425864	854	1	For	for	IN
10_1101-2021_01_08_425864	854	2	positive	positive	JJ
10_1101-2021_01_08_425864	854	3	921	921	CD
10_1101-2021_01_08_425864	854	4	controls	control	NNS
10_1101-2021_01_08_425864	854	5	of	of	IN
10_1101-2021_01_08_425864	854	6	dead	dead	JJ
10_1101-2021_01_08_425864	854	7	cells	cell	NNS
10_1101-2021_01_08_425864	854	8	,	,	,
10_1101-2021_01_08_425864	854	9	a	a	DT
10_1101-2021_01_08_425864	854	10	combination	combination	NN
10_1101-2021_01_08_425864	854	11	of	of	IN
10_1101-2021_01_08_425864	854	12	antimycin	antimycin	NNS
10_1101-2021_01_08_425864	854	13	(	(	-LRB-
10_1101-2021_01_08_425864	854	14	0.5	0.5	CD
10_1101-2021_01_08_425864	854	15	µM	µM	NNP
10_1101-2021_01_08_425864	854	16	)	)	-RRB-
10_1101-2021_01_08_425864	854	17	and	and	CC
10_1101-2021_01_08_425864	854	18	rotenone	rotenone	NN
10_1101-2021_01_08_425864	854	19	(	(	-LRB-
10_1101-2021_01_08_425864	854	20	60	60	CD
10_1101-2021_01_08_425864	854	21	µM	µM	NNP
10_1101-2021_01_08_425864	854	22	)	)	-RRB-
10_1101-2021_01_08_425864	854	23	were	be	VBD
10_1101-2021_01_08_425864	854	24	used	use	VBN
10_1101-2021_01_08_425864	854	25	.	.	.
10_1101-2021_01_08_425864	855	1	The	the	DT
10_1101-2021_01_08_425864	855	2	922	922	CD
10_1101-2021_01_08_425864	855	3	maximum	maximum	JJ
10_1101-2021_01_08_425864	855	4	concentration	concentration	NN
10_1101-2021_01_08_425864	855	5	tested	test	VBN
10_1101-2021_01_08_425864	855	6	for	for	IN
10_1101-2021_01_08_425864	855	7	these	these	DT
10_1101-2021_01_08_425864	855	8	compounds	compound	NNS
10_1101-2021_01_08_425864	855	9	does	do	VBZ
10_1101-2021_01_08_425864	855	10	not	not	RB
10_1101-2021_01_08_425864	855	11	diminish	diminish	VB
10_1101-2021_01_08_425864	855	12	CO2	CO2	NNP
10_1101-2021_01_08_425864	855	13	liberation	liberation	NN
10_1101-2021_01_08_425864	855	14	from	from	IN
10_1101-2021_01_08_425864	855	15	FAO	FAO	NNP
10_1101-2021_01_08_425864	855	16	.	.	.
10_1101-2021_01_08_425864	856	1	A	a	DT
10_1101-2021_01_08_425864	856	2	)	)	-RRB-
10_1101-2021_01_08_425864	856	3	923	923	CD
10_1101-2021_01_08_425864	856	4	Valproic	valproic	JJ
10_1101-2021_01_08_425864	856	5	Acid	acid	NN
10_1101-2021_01_08_425864	856	6	(	(	-LRB-
10_1101-2021_01_08_425864	856	7	AV	av	NN
10_1101-2021_01_08_425864	856	8	)	)	-RRB-
10_1101-2021_01_08_425864	856	9	.	.	.
10_1101-2021_01_08_425864	857	1	B	b	NN
10_1101-2021_01_08_425864	857	2	)	)	-RRB-
10_1101-2021_01_08_425864	857	3	Trimetazidine	Trimetazidine	NNP
10_1101-2021_01_08_425864	857	4	(	(	-LRB-
10_1101-2021_01_08_425864	857	5	TMZ	TMZ	NNP
10_1101-2021_01_08_425864	857	6	)	)	-RRB-
10_1101-2021_01_08_425864	857	7	.	.	.
10_1101-2021_01_08_425864	858	1	C	C	NNP
10_1101-2021_01_08_425864	858	2	)	)	-RRB-
10_1101-2021_01_08_425864	858	3	β	β	NN
10_1101-2021_01_08_425864	858	4	-	-	HYPH
10_1101-2021_01_08_425864	858	5	hydroxybutyrate	hydroxybutyrate	NN
10_1101-2021_01_08_425864	858	6	(	(	-LRB-
10_1101-2021_01_08_425864	858	7	βHOB	βhob	NN
10_1101-2021_01_08_425864	858	8	)	)	-RRB-
10_1101-2021_01_08_425864	858	9	.	.	.
10_1101-2021_01_08_425864	859	1	924	924	CD
10_1101-2021_01_08_425864	859	2	925	925	CD
10_1101-2021_01_08_425864	859	3	S4	s4	NN
10_1101-2021_01_08_425864	859	4	926	926	CD
10_1101-2021_01_08_425864	859	5	927	927	CD
10_1101-2021_01_08_425864	859	6	In	in	IN
10_1101-2021_01_08_425864	859	7	this	this	DT
10_1101-2021_01_08_425864	859	8	study	study	NN
10_1101-2021_01_08_425864	859	9	,	,	,
10_1101-2021_01_08_425864	859	10	we	-PRON-	PRP
10_1101-2021_01_08_425864	859	11	showed	show	VBD
10_1101-2021_01_08_425864	859	12	that	that	IN
10_1101-2021_01_08_425864	859	13	the	the	DT
10_1101-2021_01_08_425864	859	14	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	859	15	forms	form	NNS
10_1101-2021_01_08_425864	859	16	of	of	IN
10_1101-2021_01_08_425864	859	17	T.	T.	NNP
10_1101-2021_01_08_425864	859	18	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	859	19	present	present	JJ
10_1101-2021_01_08_425864	859	20	low	low	JJ
10_1101-2021_01_08_425864	859	21	sensitivity	sensitivity	NN
10_1101-2021_01_08_425864	859	22	in	in	IN
10_1101-2021_01_08_425864	859	23	response	response	NN
10_1101-2021_01_08_425864	859	24	928	928	CD
10_1101-2021_01_08_425864	859	25	to	to	TO
10_1101-2021_01_08_425864	859	26	ETO	eto	VB
10_1101-2021_01_08_425864	859	27	treatment	treatment	NN
10_1101-2021_01_08_425864	859	28	.	.	.
10_1101-2021_01_08_425864	860	1	Recently	recently	RB
10_1101-2021_01_08_425864	860	2	,	,	,
10_1101-2021_01_08_425864	860	3	some	some	DT
10_1101-2021_01_08_425864	860	4	groups	group	NNS
10_1101-2021_01_08_425864	860	5	described	describe	VBD
10_1101-2021_01_08_425864	860	6	off	off	IN
10_1101-2021_01_08_425864	860	7	-	-	HYPH
10_1101-2021_01_08_425864	860	8	target	target	NN
10_1101-2021_01_08_425864	860	9	effects	effect	NNS
10_1101-2021_01_08_425864	860	10	when	when	WRB
10_1101-2021_01_08_425864	860	11	ETO	ETO	NNP
10_1101-2021_01_08_425864	860	12	is	be	VBZ
10_1101-2021_01_08_425864	860	13	used	use	VBN
10_1101-2021_01_08_425864	860	14	at	at	IN
10_1101-2021_01_08_425864	860	15	929	929	CD
10_1101-2021_01_08_425864	860	16	concentrations	concentration	NNS
10_1101-2021_01_08_425864	860	17	of	of	IN
10_1101-2021_01_08_425864	860	18	up	up	IN
10_1101-2021_01_08_425864	860	19	to	to	TO
10_1101-2021_01_08_425864	860	20	200	200	CD
10_1101-2021_01_08_425864	860	21	μM	μM	NNP
10_1101-2021_01_08_425864	860	22	[	[	-LRB-
10_1101-2021_01_08_425864	860	23	61,62	61,62	CD
10_1101-2021_01_08_425864	860	24	]	]	-RRB-
10_1101-2021_01_08_425864	860	25	.	.	.
10_1101-2021_01_08_425864	861	1	To	to	TO
10_1101-2021_01_08_425864	861	2	validate	validate	VB
10_1101-2021_01_08_425864	861	3	ETO	ETO	NNP
10_1101-2021_01_08_425864	861	4	as	as	IN
10_1101-2021_01_08_425864	861	5	an	an	DT
10_1101-2021_01_08_425864	861	6	FAO	FAO	NNP
10_1101-2021_01_08_425864	861	7	inhibitor	inhibitor	NN
10_1101-2021_01_08_425864	861	8	of	of	IN
10_1101-2021_01_08_425864	861	9	T.	T.	NNP
10_1101-2021_01_08_425864	861	10	cruzi	cruzi	NNS
10_1101-2021_01_08_425864	861	11	,	,	,
10_1101-2021_01_08_425864	861	12	the	the	DT
10_1101-2021_01_08_425864	861	13	parasites	parasite	NNS
10_1101-2021_01_08_425864	861	14	930	930	CD
10_1101-2021_01_08_425864	861	15	were	be	VBD
10_1101-2021_01_08_425864	861	16	incubated	incubate	VBN
10_1101-2021_01_08_425864	861	17	for	for	IN
10_1101-2021_01_08_425864	861	18	24	24	CD
10_1101-2021_01_08_425864	861	19	h	h	NN
10_1101-2021_01_08_425864	861	20	in	in	IN
10_1101-2021_01_08_425864	861	21	PBS	PBS	NNP
10_1101-2021_01_08_425864	861	22	(	(	-LRB-
10_1101-2021_01_08_425864	861	23	negative	negative	JJ
10_1101-2021_01_08_425864	861	24	control	control	NN
10_1101-2021_01_08_425864	861	25	)	)	-RRB-
10_1101-2021_01_08_425864	861	26	,	,	,
10_1101-2021_01_08_425864	861	27	0.1	0.1	CD
10_1101-2021_01_08_425864	861	28	mM	mm	NN
10_1101-2021_01_08_425864	861	29	palmitate	palmitate	NN
10_1101-2021_01_08_425864	861	30	supplemented	supplement	VBN
10_1101-2021_01_08_425864	861	31	with	with	IN
10_1101-2021_01_08_425864	861	32	BSA	BSA	NNP
10_1101-2021_01_08_425864	861	33	,	,	,
10_1101-2021_01_08_425864	861	34	5.0	5.0	CD
10_1101-2021_01_08_425864	861	35	.CC	.CC	NFP
10_1101-2021_01_08_425864	861	36	-	-	:
10_1101-2021_01_08_425864	861	37	BY	by	IN
10_1101-2021_01_08_425864	861	38	4.0	4.0	CD
10_1101-2021_01_08_425864	861	39	International	international	JJ
10_1101-2021_01_08_425864	861	40	licensemade	licensemade	NN
10_1101-2021_01_08_425864	861	41	available	available	JJ
10_1101-2021_01_08_425864	861	42	under	under	IN
10_1101-2021_01_08_425864	861	43	a	a	DT
10_1101-2021_01_08_425864	861	44	(	(	-LRB-
10_1101-2021_01_08_425864	861	45	which	which	WDT
10_1101-2021_01_08_425864	861	46	was	be	VBD
10_1101-2021_01_08_425864	861	47	not	not	RB
10_1101-2021_01_08_425864	861	48	certified	certify	VBN
10_1101-2021_01_08_425864	861	49	by	by	IN
10_1101-2021_01_08_425864	861	50	peer	peer	NN
10_1101-2021_01_08_425864	861	51	review	review	NN
10_1101-2021_01_08_425864	861	52	)	)	-RRB-
10_1101-2021_01_08_425864	861	53	is	be	VBZ
10_1101-2021_01_08_425864	861	54	the	the	DT
10_1101-2021_01_08_425864	861	55	author	author	NN
10_1101-2021_01_08_425864	861	56	/	/	SYM
10_1101-2021_01_08_425864	861	57	funder	funder	NN
10_1101-2021_01_08_425864	861	58	,	,	,
10_1101-2021_01_08_425864	861	59	who	who	WP
10_1101-2021_01_08_425864	861	60	has	have	VBZ
10_1101-2021_01_08_425864	861	61	granted	grant	VBN
10_1101-2021_01_08_425864	861	62	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	861	63	a	a	DT
10_1101-2021_01_08_425864	861	64	license	license	NN
10_1101-2021_01_08_425864	861	65	to	to	TO
10_1101-2021_01_08_425864	861	66	display	display	VB
10_1101-2021_01_08_425864	861	67	the	the	DT
10_1101-2021_01_08_425864	861	68	preprint	preprint	NN
10_1101-2021_01_08_425864	861	69	in	in	IN
10_1101-2021_01_08_425864	861	70	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	861	71	.	.	.
10_1101-2021_01_08_425864	862	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	862	2	is	be	VBZ
10_1101-2021_01_08_425864	862	3	The	the	DT
10_1101-2021_01_08_425864	862	4	copyright	copyright	NN
10_1101-2021_01_08_425864	862	5	holder	holder	NN
10_1101-2021_01_08_425864	862	6	for	for	IN
10_1101-2021_01_08_425864	862	7	this	this	DT
10_1101-2021_01_08_425864	862	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	862	9	version	version	NN
10_1101-2021_01_08_425864	862	10	posted	post	VBD
10_1101-2021_01_08_425864	862	11	January	January	NNP
10_1101-2021_01_08_425864	862	12	8	8	CD
10_1101-2021_01_08_425864	862	13	,	,	,
10_1101-2021_01_08_425864	862	14	2021	2021	CD
10_1101-2021_01_08_425864	862	15	.	.	.
10_1101-2021_01_08_425864	862	16	;	;	:
10_1101-2021_01_08_425864	862	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	862	18	:	:	:
10_1101-2021_01_08_425864	862	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	862	20	preprint	preprint	NN
10_1101-2021_01_08_425864	862	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	862	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	862	23	931	931	NNP
10_1101-2021_01_08_425864	862	24	mM	mM	NNP
10_1101-2021_01_08_425864	862	25	histidine	histidine	NN
10_1101-2021_01_08_425864	862	26	,	,	,
10_1101-2021_01_08_425864	862	27	5	5	CD
10_1101-2021_01_08_425864	862	28	mM	mm	NN
10_1101-2021_01_08_425864	862	29	glucose	glucose	NN
10_1101-2021_01_08_425864	862	30	,	,	,
10_1101-2021_01_08_425864	862	31	0.1	0.1	CD
10_1101-2021_01_08_425864	862	32	mM	mm	NN
10_1101-2021_01_08_425864	862	33	carnitine	carnitine	NN
10_1101-2021_01_08_425864	862	34	and	and	CC
10_1101-2021_01_08_425864	862	35	BSA	BSA	NNP
10_1101-2021_01_08_425864	862	36	without	without	IN
10_1101-2021_01_08_425864	862	37	adding	add	VBG
10_1101-2021_01_08_425864	862	38	palmitate	palmitate	NN
10_1101-2021_01_08_425864	862	39	in	in	IN
10_1101-2021_01_08_425864	862	40	the	the	DT
10_1101-2021_01_08_425864	862	41	presence	presence	NN
10_1101-2021_01_08_425864	862	42	932	932	CD
10_1101-2021_01_08_425864	862	43	(	(	-LRB-
10_1101-2021_01_08_425864	862	44	or	or	CC
10_1101-2021_01_08_425864	862	45	not	not	RB
10_1101-2021_01_08_425864	862	46	)	)	-RRB-
10_1101-2021_01_08_425864	862	47	of	of	IN
10_1101-2021_01_08_425864	862	48	500	500	CD
10_1101-2021_01_08_425864	862	49	μM	μM	NNP
10_1101-2021_01_08_425864	862	50	ETO	ETO	NNP
10_1101-2021_01_08_425864	862	51	.	.	.
10_1101-2021_01_08_425864	863	1	The	the	DT
10_1101-2021_01_08_425864	863	2	viability	viability	NN
10_1101-2021_01_08_425864	863	3	of	of	IN
10_1101-2021_01_08_425864	863	4	these	these	DT
10_1101-2021_01_08_425864	863	5	cells	cell	NNS
10_1101-2021_01_08_425864	863	6	was	be	VBD
10_1101-2021_01_08_425864	863	7	inferred	infer	VBN
10_1101-2021_01_08_425864	863	8	from	from	IN
10_1101-2021_01_08_425864	863	9	the	the	DT
10_1101-2021_01_08_425864	863	10	measured	measure	VBN
10_1101-2021_01_08_425864	863	11	total	total	JJ
10_1101-2021_01_08_425864	863	12	reductive	reductive	JJ
10_1101-2021_01_08_425864	863	13	933	933	CD
10_1101-2021_01_08_425864	863	14	activity	activity	NN
10_1101-2021_01_08_425864	863	15	using	use	VBG
10_1101-2021_01_08_425864	863	16	MTT	MTT	NNP
10_1101-2021_01_08_425864	863	17	assays	assays	RB
10_1101-2021_01_08_425864	863	18	(	(	-LRB-
10_1101-2021_01_08_425864	863	19	see	see	VB
10_1101-2021_01_08_425864	863	20	Material	Material	NNP
10_1101-2021_01_08_425864	863	21	and	and	CC
10_1101-2021_01_08_425864	863	22	Methods	Methods	NNP
10_1101-2021_01_08_425864	863	23	section	section	NN
10_1101-2021_01_08_425864	863	24	for	for	IN
10_1101-2021_01_08_425864	863	25	more	more	JJR
10_1101-2021_01_08_425864	863	26	details	detail	NNS
10_1101-2021_01_08_425864	863	27	)	)	-RRB-
10_1101-2021_01_08_425864	863	28	.	.	.
10_1101-2021_01_08_425864	864	1	As	as	IN
10_1101-2021_01_08_425864	864	2	expected	expect	VBN
10_1101-2021_01_08_425864	864	3	,	,	,
10_1101-2021_01_08_425864	864	4	ETO	eto	VB
10_1101-2021_01_08_425864	864	5	934	934	CD
10_1101-2021_01_08_425864	864	6	treatment	treatment	NN
10_1101-2021_01_08_425864	864	7	did	do	VBD
10_1101-2021_01_08_425864	864	8	not	not	RB
10_1101-2021_01_08_425864	864	9	affect	affect	VB
10_1101-2021_01_08_425864	864	10	the	the	DT
10_1101-2021_01_08_425864	864	11	viability	viability	NN
10_1101-2021_01_08_425864	864	12	of	of	IN
10_1101-2021_01_08_425864	864	13	cells	cell	NNS
10_1101-2021_01_08_425864	864	14	incubated	incubate	VBN
10_1101-2021_01_08_425864	864	15	in	in	IN
10_1101-2021_01_08_425864	864	16	glucose	glucose	NN
10_1101-2021_01_08_425864	864	17	or	or	CC
10_1101-2021_01_08_425864	864	18	histidine	histidine	NN
10_1101-2021_01_08_425864	864	19	but	but	CC
10_1101-2021_01_08_425864	864	20	did	do	VBD
10_1101-2021_01_08_425864	864	21	affect	affect	VB
10_1101-2021_01_08_425864	864	22	the	the	DT
10_1101-2021_01_08_425864	864	23	935	935	CD
10_1101-2021_01_08_425864	864	24	viability	viability	NN
10_1101-2021_01_08_425864	864	25	of	of	IN
10_1101-2021_01_08_425864	864	26	the	the	DT
10_1101-2021_01_08_425864	864	27	cells	cell	NNS
10_1101-2021_01_08_425864	864	28	incubated	incubate	VBN
10_1101-2021_01_08_425864	864	29	with	with	IN
10_1101-2021_01_08_425864	864	30	palmitate	palmitate	NN
10_1101-2021_01_08_425864	864	31	or	or	CC
10_1101-2021_01_08_425864	864	32	carnitine	carnitine	NN
10_1101-2021_01_08_425864	864	33	.	.	.
10_1101-2021_01_08_425864	865	1	Surprisingly	surprisingly	RB
10_1101-2021_01_08_425864	865	2	,	,	,
10_1101-2021_01_08_425864	865	3	we	-PRON-	PRP
10_1101-2021_01_08_425864	865	4	also	also	RB
10_1101-2021_01_08_425864	865	5	observed	observe	VBD
10_1101-2021_01_08_425864	865	6	an	an	DT
10_1101-2021_01_08_425864	865	7	ETO	eto	NN
10_1101-2021_01_08_425864	865	8	936	936	CD
10_1101-2021_01_08_425864	865	9	effect	effect	NN
10_1101-2021_01_08_425864	865	10	on	on	IN
10_1101-2021_01_08_425864	865	11	parasites	parasite	NNS
10_1101-2021_01_08_425864	865	12	under	under	IN
10_1101-2021_01_08_425864	865	13	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	865	14	stress	stress	NN
10_1101-2021_01_08_425864	865	15	,	,	,
10_1101-2021_01_08_425864	865	16	such	such	JJ
10_1101-2021_01_08_425864	865	17	as	as	IN
10_1101-2021_01_08_425864	865	18	those	those	DT
10_1101-2021_01_08_425864	865	19	incubated	incubate	VBN
10_1101-2021_01_08_425864	865	20	with	with	IN
10_1101-2021_01_08_425864	865	21	PBS	PBS	NNP
10_1101-2021_01_08_425864	865	22	or	or	CC
10_1101-2021_01_08_425864	865	23	BSA	BSA	NNP
10_1101-2021_01_08_425864	865	24	.	.	.
10_1101-2021_01_08_425864	866	1	This	this	DT
10_1101-2021_01_08_425864	866	2	finding	finding	NN
10_1101-2021_01_08_425864	866	3	937	937	CD
10_1101-2021_01_08_425864	866	4	could	could	MD
10_1101-2021_01_08_425864	866	5	be	be	VB
10_1101-2021_01_08_425864	866	6	explained	explain	VBN
10_1101-2021_01_08_425864	866	7	by	by	IN
10_1101-2021_01_08_425864	866	8	the	the	DT
10_1101-2021_01_08_425864	866	9	fact	fact	NN
10_1101-2021_01_08_425864	866	10	that	that	IN
10_1101-2021_01_08_425864	866	11	under	under	IN
10_1101-2021_01_08_425864	866	12	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	866	13	stress	stress	NN
10_1101-2021_01_08_425864	866	14	,	,	,
10_1101-2021_01_08_425864	866	15	the	the	DT
10_1101-2021_01_08_425864	866	16	parasite	parasite	NN
10_1101-2021_01_08_425864	866	17	mobilizes	mobilize	NNS
10_1101-2021_01_08_425864	866	18	and	and	CC
10_1101-2021_01_08_425864	866	19	consumes	consume	VBZ
10_1101-2021_01_08_425864	866	20	its	-PRON-	PRP$
10_1101-2021_01_08_425864	866	21	938	938	CD
10_1101-2021_01_08_425864	866	22	internal	internal	JJ
10_1101-2021_01_08_425864	866	23	lipids	lipid	NNS
10_1101-2021_01_08_425864	866	24	.	.	.
10_1101-2021_01_08_425864	867	1	939	939	CD
10_1101-2021_01_08_425864	867	2	940	940	CD
10_1101-2021_01_08_425864	867	3	941	941	CD
10_1101-2021_01_08_425864	867	4	S4	s4	NN
10_1101-2021_01_08_425864	867	5	Fig	Fig	NNP
10_1101-2021_01_08_425864	867	6	.	.	.
10_1101-2021_01_08_425864	868	1	ETO	ETO	NNP
10_1101-2021_01_08_425864	868	2	did	do	VBD
10_1101-2021_01_08_425864	868	3	not	not	RB
10_1101-2021_01_08_425864	868	4	affect	affect	VB
10_1101-2021_01_08_425864	868	5	the	the	DT
10_1101-2021_01_08_425864	868	6	viability	viability	NN
10_1101-2021_01_08_425864	868	7	of	of	IN
10_1101-2021_01_08_425864	868	8	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	868	9	forms	form	NNS
10_1101-2021_01_08_425864	868	10	in	in	IN
10_1101-2021_01_08_425864	868	11	the	the	DT
10_1101-2021_01_08_425864	868	12	presence	presence	NN
10_1101-2021_01_08_425864	868	13	of	of	IN
10_1101-2021_01_08_425864	868	14	other	other	JJ
10_1101-2021_01_08_425864	868	15	carbon	carbon	NN
10_1101-2021_01_08_425864	868	16	942	942	CD
10_1101-2021_01_08_425864	868	17	sources	source	NNS
10_1101-2021_01_08_425864	868	18	.	.	.
10_1101-2021_01_08_425864	869	1	The	the	DT
10_1101-2021_01_08_425864	869	2	viability	viability	NN
10_1101-2021_01_08_425864	869	3	of	of	IN
10_1101-2021_01_08_425864	869	4	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	869	5	forms	form	NNS
10_1101-2021_01_08_425864	869	6	after	after	IN
10_1101-2021_01_08_425864	869	7	incubation	incubation	NN
10_1101-2021_01_08_425864	869	8	with	with	IN
10_1101-2021_01_08_425864	869	9	different	different	JJ
10_1101-2021_01_08_425864	869	10	carbon	carbon	NN
10_1101-2021_01_08_425864	869	11	sources	source	NNS
10_1101-2021_01_08_425864	869	12	and	and	CC
10_1101-2021_01_08_425864	869	13	943	943	CD
10_1101-2021_01_08_425864	869	14	palmitate	palmitate	NN
10_1101-2021_01_08_425864	869	15	.	.	.
10_1101-2021_01_08_425864	870	1	The	the	DT
10_1101-2021_01_08_425864	870	2	viability	viability	NN
10_1101-2021_01_08_425864	870	3	was	be	VBD
10_1101-2021_01_08_425864	870	4	assessed	assess	VBN
10_1101-2021_01_08_425864	870	5	after	after	IN
10_1101-2021_01_08_425864	870	6	24	24	CD
10_1101-2021_01_08_425864	870	7	h	h	NN
10_1101-2021_01_08_425864	870	8	using	use	VBG
10_1101-2021_01_08_425864	870	9	MTT	MTT	NNP
10_1101-2021_01_08_425864	870	10	.	.	.
10_1101-2021_01_08_425864	871	1	944	944	CD
10_1101-2021_01_08_425864	871	2	945	945	CD
10_1101-2021_01_08_425864	871	3	S5	s5	NN
10_1101-2021_01_08_425864	871	4	946	946	CD
10_1101-2021_01_08_425864	871	5	947	947	CD
10_1101-2021_01_08_425864	871	6	Because	because	IN
10_1101-2021_01_08_425864	871	7	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	871	8	occurs	occur	VBZ
10_1101-2021_01_08_425864	871	9	in	in	IN
10_1101-2021_01_08_425864	871	10	chemically	chemically	RB
10_1101-2021_01_08_425864	871	11	defined	define	VBN
10_1101-2021_01_08_425864	871	12	conditions	condition	NNS
10_1101-2021_01_08_425864	871	13	,	,	,
10_1101-2021_01_08_425864	871	14	we	-PRON-	PRP
10_1101-2021_01_08_425864	871	15	performed	perform	VBD
10_1101-2021_01_08_425864	871	16	a	a	DT
10_1101-2021_01_08_425864	871	17	viability	viability	NN
10_1101-2021_01_08_425864	871	18	assay	assay	NN
10_1101-2021_01_08_425864	871	19	948	948	CD
10_1101-2021_01_08_425864	871	20	to	to	TO
10_1101-2021_01_08_425864	871	21	define	define	VB
10_1101-2021_01_08_425864	871	22	the	the	DT
10_1101-2021_01_08_425864	871	23	maximum	maximum	NN
10_1101-2021_01_08_425864	871	24	tolerated	tolerated	JJ
10_1101-2021_01_08_425864	871	25	concentration	concentration	NN
10_1101-2021_01_08_425864	871	26	that	that	WDT
10_1101-2021_01_08_425864	871	27	allows	allow	VBZ
10_1101-2021_01_08_425864	871	28	the	the	DT
10_1101-2021_01_08_425864	871	29	parasites	parasite	NNS
10_1101-2021_01_08_425864	871	30	to	to	TO
10_1101-2021_01_08_425864	871	31	survive	survive	VB
10_1101-2021_01_08_425864	871	32	under	under	IN
10_1101-2021_01_08_425864	871	33	ETO	ETO	NNP
10_1101-2021_01_08_425864	871	34	949	949	CD
10_1101-2021_01_08_425864	871	35	treatment	treatment	NN
10_1101-2021_01_08_425864	871	36	.	.	.
10_1101-2021_01_08_425864	872	1	Stationary	stationary	JJ
10_1101-2021_01_08_425864	872	2	epimastigotes	epimastigote	NNS
10_1101-2021_01_08_425864	872	3	in	in	IN
10_1101-2021_01_08_425864	872	4	TAU-3AAG	TAU-3AAG	NNP
10_1101-2021_01_08_425864	872	5	media	medium	NNS
10_1101-2021_01_08_425864	872	6	were	be	VBD
10_1101-2021_01_08_425864	872	7	treated	treat	VBN
10_1101-2021_01_08_425864	872	8	with	with	IN
10_1101-2021_01_08_425864	872	9	different	different	JJ
10_1101-2021_01_08_425864	872	10	concentrations	concentration	NNS
10_1101-2021_01_08_425864	872	11	950	950	CD
10_1101-2021_01_08_425864	872	12	of	of	IN
10_1101-2021_01_08_425864	872	13	ETO	ETO	NNP
10_1101-2021_01_08_425864	872	14	(	(	-LRB-
10_1101-2021_01_08_425864	872	15	range	range	NNP
10_1101-2021_01_08_425864	872	16	5	5	CD
10_1101-2021_01_08_425864	872	17	to	to	IN
10_1101-2021_01_08_425864	872	18	500	500	CD
10_1101-2021_01_08_425864	872	19	μM	μM	NNS
10_1101-2021_01_08_425864	872	20	)	)	-RRB-
10_1101-2021_01_08_425864	872	21	during	during	IN
10_1101-2021_01_08_425864	872	22	24	24	CD
10_1101-2021_01_08_425864	872	23	h.	h.	NNS
10_1101-2021_01_08_425864	872	24	The	the	DT
10_1101-2021_01_08_425864	872	25	viability	viability	NN
10_1101-2021_01_08_425864	872	26	of	of	IN
10_1101-2021_01_08_425864	872	27	these	these	DT
10_1101-2021_01_08_425864	872	28	cells	cell	NNS
10_1101-2021_01_08_425864	872	29	was	be	VBD
10_1101-2021_01_08_425864	872	30	inferred	infer	VBN
10_1101-2021_01_08_425864	872	31	by	by	IN
10_1101-2021_01_08_425864	872	32	measuring	measure	VBG
10_1101-2021_01_08_425864	872	33	the	the	DT
10_1101-2021_01_08_425864	872	34	951	951	CD
10_1101-2021_01_08_425864	872	35	total	total	JJ
10_1101-2021_01_08_425864	872	36	reductive	reductive	JJ
10_1101-2021_01_08_425864	872	37	activity	activity	NN
10_1101-2021_01_08_425864	872	38	using	use	VBG
10_1101-2021_01_08_425864	872	39	an	an	DT
10_1101-2021_01_08_425864	872	40	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	872	41	blue	blue	JJ
10_1101-2021_01_08_425864	872	42	assay	assay	NN
10_1101-2021_01_08_425864	872	43	[	[	-LRB-
10_1101-2021_01_08_425864	872	44	63	63	CD
10_1101-2021_01_08_425864	872	45	]	]	-RRB-
10_1101-2021_01_08_425864	872	46	.	.	.
10_1101-2021_01_08_425864	873	1	Briefly	briefly	RB
10_1101-2021_01_08_425864	873	2	,	,	,
10_1101-2021_01_08_425864	873	3	after	after	IN
10_1101-2021_01_08_425864	873	4	24	24	CD
10_1101-2021_01_08_425864	873	5	h	h	NN
10_1101-2021_01_08_425864	873	6	in	in	IN
10_1101-2021_01_08_425864	873	7	the	the	DT
10_1101-2021_01_08_425864	873	8	presence	presence	NN
10_1101-2021_01_08_425864	873	9	or	or	CC
10_1101-2021_01_08_425864	873	10	absence	absence	NN
10_1101-2021_01_08_425864	873	11	952	952	CD
10_1101-2021_01_08_425864	873	12	of	of	IN
10_1101-2021_01_08_425864	873	13	ETO	ETO	NNP
10_1101-2021_01_08_425864	873	14	,	,	,
10_1101-2021_01_08_425864	873	15	the	the	DT
10_1101-2021_01_08_425864	873	16	cells	cell	NNS
10_1101-2021_01_08_425864	873	17	were	be	VBD
10_1101-2021_01_08_425864	873	18	incubated	incubate	VBN
10_1101-2021_01_08_425864	873	19	with	with	IN
10_1101-2021_01_08_425864	873	20	0,125	0,125	CD
10_1101-2021_01_08_425864	873	21	μg.mL-1	μg.mL-1	NNS
10_1101-2021_01_08_425864	873	22	of	of	IN
10_1101-2021_01_08_425864	873	23	Alamar	Alamar	NNP
10_1101-2021_01_08_425864	873	24	blue	blue	JJ
10_1101-2021_01_08_425864	873	25	reagent	reagent	NN
10_1101-2021_01_08_425864	873	26	in	in	IN
10_1101-2021_01_08_425864	873	27	accordance	accordance	NN
10_1101-2021_01_08_425864	873	28	with	with	IN
10_1101-2021_01_08_425864	873	29	the	the	DT
10_1101-2021_01_08_425864	873	30	953	953	CD
10_1101-2021_01_08_425864	873	31	protocol	protocol	NN
10_1101-2021_01_08_425864	873	32	by	by	IN
10_1101-2021_01_08_425864	873	33	[	[	-LRB-
10_1101-2021_01_08_425864	873	34	17	17	CD
10_1101-2021_01_08_425864	873	35	]	]	-RRB-
10_1101-2021_01_08_425864	873	36	.	.	.
10_1101-2021_01_08_425864	874	1	Under	under	IN
10_1101-2021_01_08_425864	874	2	these	these	DT
10_1101-2021_01_08_425864	874	3	conditions	condition	NNS
10_1101-2021_01_08_425864	874	4	,	,	,
10_1101-2021_01_08_425864	874	5	the	the	DT
10_1101-2021_01_08_425864	874	6	parasites	parasite	NNS
10_1101-2021_01_08_425864	874	7	were	be	VBD
10_1101-2021_01_08_425864	874	8	10	10	CD
10_1101-2021_01_08_425864	874	9	times	time	NNS
10_1101-2021_01_08_425864	874	10	more	more	RBR
10_1101-2021_01_08_425864	874	11	sensitive	sensitive	JJ
10_1101-2021_01_08_425864	874	12	to	to	IN
10_1101-2021_01_08_425864	874	13	ETO	ETO	NNP
10_1101-2021_01_08_425864	874	14	954	954	CD
10_1101-2021_01_08_425864	874	15	treatment	treatment	NN
10_1101-2021_01_08_425864	874	16	,	,	,
10_1101-2021_01_08_425864	874	17	surviving	survive	VBG
10_1101-2021_01_08_425864	874	18	when	when	WRB
10_1101-2021_01_08_425864	874	19	subjected	subject	VBN
10_1101-2021_01_08_425864	874	20	to	to	IN
10_1101-2021_01_08_425864	874	21	ETO	eto	NN
10_1101-2021_01_08_425864	874	22	concentrations	concentration	NNS
10_1101-2021_01_08_425864	874	23	between	between	IN
10_1101-2021_01_08_425864	874	24	5	5	CD
10_1101-2021_01_08_425864	874	25	-	-	SYM
10_1101-2021_01_08_425864	874	26	50	50	CD
10_1101-2021_01_08_425864	874	27	µM	µM	NNP
10_1101-2021_01_08_425864	874	28	(	(	-LRB-
10_1101-2021_01_08_425864	874	29	Fig	Fig	NNP
10_1101-2021_01_08_425864	874	30	.	.	.
10_1101-2021_01_08_425864	875	1	S3	S3	NNP
10_1101-2021_01_08_425864	875	2	A	A	NNP
10_1101-2021_01_08_425864	875	3	)	)	-RRB-
10_1101-2021_01_08_425864	875	4	.	.	.
10_1101-2021_01_08_425864	876	1	This	this	DT
10_1101-2021_01_08_425864	876	2	range	range	NN
10_1101-2021_01_08_425864	876	3	955	955	CD
10_1101-2021_01_08_425864	876	4	of	of	IN
10_1101-2021_01_08_425864	876	5	concentrations	concentration	NNS
10_1101-2021_01_08_425864	876	6	used	use	VBN
10_1101-2021_01_08_425864	876	7	to	to	TO
10_1101-2021_01_08_425864	876	8	treat	treat	VB
10_1101-2021_01_08_425864	876	9	the	the	DT
10_1101-2021_01_08_425864	876	10	parasites	parasite	NNS
10_1101-2021_01_08_425864	876	11	was	be	VBD
10_1101-2021_01_08_425864	876	12	maintained	maintain	VBN
10_1101-2021_01_08_425864	876	13	in	in	IN
10_1101-2021_01_08_425864	876	14	TAU-3AAG	TAU-3AAG	NNP
10_1101-2021_01_08_425864	876	15	medium	medium	NNP
10_1101-2021_01_08_425864	876	16	and	and	CC
10_1101-2021_01_08_425864	876	17	to	to	TO
10_1101-2021_01_08_425864	876	18	follow	follow	VB
10_1101-2021_01_08_425864	876	19	956	956	CD
10_1101-2021_01_08_425864	876	20	the	the	DT
10_1101-2021_01_08_425864	876	21	differentiation	differentiation	NN
10_1101-2021_01_08_425864	876	22	by	by	IN
10_1101-2021_01_08_425864	876	23	daily	daily	JJ
10_1101-2021_01_08_425864	876	24	counts	count	NNS
10_1101-2021_01_08_425864	876	25	,	,	,
10_1101-2021_01_08_425864	876	26	based	base	VBN
10_1101-2021_01_08_425864	876	27	on	on	IN
10_1101-2021_01_08_425864	876	28	the	the	DT
10_1101-2021_01_08_425864	876	29	percentage	percentage	NN
10_1101-2021_01_08_425864	876	30	of	of	IN
10_1101-2021_01_08_425864	876	31	metacyclic	metacyclic	JJ
10_1101-2021_01_08_425864	876	32	trypomastigotes	trypomastigote	NNS
10_1101-2021_01_08_425864	876	33	collected	collect	VBD
10_1101-2021_01_08_425864	876	34	957	957	CD
10_1101-2021_01_08_425864	876	35	in	in	IN
10_1101-2021_01_08_425864	876	36	culture	culture	NN
10_1101-2021_01_08_425864	876	37	supernatant	supernatant	JJ
10_1101-2021_01_08_425864	876	38	.	.	.
10_1101-2021_01_08_425864	877	1	To	to	TO
10_1101-2021_01_08_425864	877	2	confirm	confirm	VB
10_1101-2021_01_08_425864	877	3	that	that	IN
10_1101-2021_01_08_425864	877	4	the	the	DT
10_1101-2021_01_08_425864	877	5	parasites	parasite	NNS
10_1101-2021_01_08_425864	877	6	were	be	VBD
10_1101-2021_01_08_425864	877	7	still	still	RB
10_1101-2021_01_08_425864	877	8	alive	alive	JJ
10_1101-2021_01_08_425864	877	9	after	after	IN
10_1101-2021_01_08_425864	877	10	5	5	CD
10_1101-2021_01_08_425864	877	11	days	day	NNS
10_1101-2021_01_08_425864	877	12	under	under	IN
10_1101-2021_01_08_425864	877	13	differentiation	differentiation	NN
10_1101-2021_01_08_425864	877	14	,	,	,
10_1101-2021_01_08_425864	877	15	958	958	CD
10_1101-2021_01_08_425864	877	16	we	-PRON-	PRP
10_1101-2021_01_08_425864	877	17	checked	check	VBD
10_1101-2021_01_08_425864	877	18	the	the	DT
10_1101-2021_01_08_425864	877	19	viability	viability	NN
10_1101-2021_01_08_425864	877	20	of	of	IN
10_1101-2021_01_08_425864	877	21	cells	cell	NNS
10_1101-2021_01_08_425864	877	22	that	that	WDT
10_1101-2021_01_08_425864	877	23	were	be	VBD
10_1101-2021_01_08_425864	877	24	treated	treat	VBN
10_1101-2021_01_08_425864	877	25	(	(	-LRB-
10_1101-2021_01_08_425864	877	26	or	or	CC
10_1101-2021_01_08_425864	877	27	not	not	RB
10_1101-2021_01_08_425864	877	28	,	,	,
10_1101-2021_01_08_425864	877	29	control	control	NN
10_1101-2021_01_08_425864	877	30	)	)	-RRB-
10_1101-2021_01_08_425864	877	31	using	use	VBG
10_1101-2021_01_08_425864	877	32	the	the	DT
10_1101-2021_01_08_425864	877	33	same	same	JJ
10_1101-2021_01_08_425864	877	34	assay	assay	NN
10_1101-2021_01_08_425864	877	35	.	.	.
10_1101-2021_01_08_425864	878	1	As	as	IN
10_1101-2021_01_08_425864	878	2	shown	show	VBN
10_1101-2021_01_08_425864	878	3	959	959	CD
10_1101-2021_01_08_425864	878	4	above	above	IN
10_1101-2021_01_08_425864	878	5	(	(	-LRB-
10_1101-2021_01_08_425864	878	6	Figure	figure	NN
10_1101-2021_01_08_425864	878	7	S3	S3	NNP
10_1101-2021_01_08_425864	878	8	B	B	NNP
10_1101-2021_01_08_425864	878	9	)	)	-RRB-
10_1101-2021_01_08_425864	878	10	,	,	,
10_1101-2021_01_08_425864	878	11	the	the	DT
10_1101-2021_01_08_425864	878	12	parasites	parasite	NNS
10_1101-2021_01_08_425864	878	13	were	be	VBD
10_1101-2021_01_08_425864	878	14	viable	viable	JJ
10_1101-2021_01_08_425864	878	15	under	under	IN
10_1101-2021_01_08_425864	878	16	all	all	PDT
10_1101-2021_01_08_425864	878	17	the	the	DT
10_1101-2021_01_08_425864	878	18	tested	test	VBN
10_1101-2021_01_08_425864	878	19	conditions	condition	NNS
10_1101-2021_01_08_425864	878	20	.	.	.
10_1101-2021_01_08_425864	879	1	Considering	consider	VBG
10_1101-2021_01_08_425864	879	2	that	that	IN
10_1101-2021_01_08_425864	879	3	TAU-	tau-	NN
10_1101-2021_01_08_425864	879	4	960	960	CD
10_1101-2021_01_08_425864	879	5	3AAG	3aag	NN
10_1101-2021_01_08_425864	879	6	contains	contain	VBZ
10_1101-2021_01_08_425864	879	7	glucose	glucose	NN
10_1101-2021_01_08_425864	879	8	in	in	IN
10_1101-2021_01_08_425864	879	9	its	-PRON-	PRP$
10_1101-2021_01_08_425864	879	10	composition	composition	NN
10_1101-2021_01_08_425864	879	11	,	,	,
10_1101-2021_01_08_425864	879	12	we	-PRON-	PRP
10_1101-2021_01_08_425864	879	13	performed	perform	VBD
10_1101-2021_01_08_425864	879	14	an	an	DT
10_1101-2021_01_08_425864	879	15	in	in	FW
10_1101-2021_01_08_425864	879	16	vitro	vitro	FW
10_1101-2021_01_08_425864	879	17	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	879	18	using	use	VBG
10_1101-2021_01_08_425864	879	19	only	only	RB
10_1101-2021_01_08_425864	879	20	961	961	CD
10_1101-2021_01_08_425864	879	21	proline	proline	NN
10_1101-2021_01_08_425864	879	22	as	as	IN
10_1101-2021_01_08_425864	879	23	a	a	DT
10_1101-2021_01_08_425864	879	24	metabolic	metabolic	JJ
10_1101-2021_01_08_425864	879	25	inducer	inducer	NN
10_1101-2021_01_08_425864	879	26	[	[	-LRB-
10_1101-2021_01_08_425864	879	27	64	64	CD
10_1101-2021_01_08_425864	879	28	]	]	-RRB-
10_1101-2021_01_08_425864	879	29	.	.	.
10_1101-2021_01_08_425864	880	1	As	as	IN
10_1101-2021_01_08_425864	880	2	observed	observe	VBN
10_1101-2021_01_08_425864	880	3	,	,	,
10_1101-2021_01_08_425864	880	4	even	even	RB
10_1101-2021_01_08_425864	880	5	in	in	IN
10_1101-2021_01_08_425864	880	6	the	the	DT
10_1101-2021_01_08_425864	880	7	absence	absence	NN
10_1101-2021_01_08_425864	880	8	of	of	IN
10_1101-2021_01_08_425864	880	9	glucose	glucose	NN
10_1101-2021_01_08_425864	880	10	,	,	,
10_1101-2021_01_08_425864	880	11	ETO	ETO	NNP
10_1101-2021_01_08_425864	880	12	treatment	treatment	NN
10_1101-2021_01_08_425864	880	13	962	962	CD
10_1101-2021_01_08_425864	880	14	affects	affect	NNS
10_1101-2021_01_08_425864	880	15	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	880	16	.	.	.
10_1101-2021_01_08_425864	881	1	963	963	CD
10_1101-2021_01_08_425864	881	2	964	964	CD
10_1101-2021_01_08_425864	881	3	965	965	CD
10_1101-2021_01_08_425864	881	4	966	966	CD
10_1101-2021_01_08_425864	881	5	Fig	Fig	NNP
10_1101-2021_01_08_425864	881	6	S5	s5	NN
10_1101-2021_01_08_425864	881	7	.	.	.
10_1101-2021_01_08_425864	882	1	Viability	viability	NN
10_1101-2021_01_08_425864	882	2	of	of	IN
10_1101-2021_01_08_425864	882	3	epimastigote	epimastigote	JJ
10_1101-2021_01_08_425864	882	4	forms	form	NNS
10_1101-2021_01_08_425864	882	5	subjected	subject	VBN
10_1101-2021_01_08_425864	882	6	to	to	IN
10_1101-2021_01_08_425864	882	7	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	882	8	under	under	IN
10_1101-2021_01_08_425864	882	9	different	different	JJ
10_1101-2021_01_08_425864	882	10	ETO	ETO	NNP
10_1101-2021_01_08_425864	882	11	967	967	CD
10_1101-2021_01_08_425864	882	12	concentrations	concentration	NNS
10_1101-2021_01_08_425864	882	13	.	.	.
10_1101-2021_01_08_425864	883	1	A	a	LS
10_1101-2021_01_08_425864	883	2	)	)	-RRB-
10_1101-2021_01_08_425864	883	3	Cell	cell	NN
10_1101-2021_01_08_425864	883	4	viability	viability	NN
10_1101-2021_01_08_425864	883	5	under	under	IN
10_1101-2021_01_08_425864	883	6	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	883	7	after	after	IN
10_1101-2021_01_08_425864	883	8	24	24	CD
10_1101-2021_01_08_425864	883	9	h	h	NN
10_1101-2021_01_08_425864	883	10	of	of	IN
10_1101-2021_01_08_425864	883	11	treatment	treatment	NN
10_1101-2021_01_08_425864	883	12	with	with	IN
10_1101-2021_01_08_425864	883	13	different	different	JJ
10_1101-2021_01_08_425864	883	14	ETO	ETO	NNP
10_1101-2021_01_08_425864	883	15	968	968	CD
10_1101-2021_01_08_425864	883	16	concentrations	concentration	NNS
10_1101-2021_01_08_425864	883	17	.	.	.
10_1101-2021_01_08_425864	884	1	B	b	NN
10_1101-2021_01_08_425864	884	2	)	)	-RRB-
10_1101-2021_01_08_425864	884	3	Cell	cell	NN
10_1101-2021_01_08_425864	884	4	viability	viability	NN
10_1101-2021_01_08_425864	884	5	under	under	IN
10_1101-2021_01_08_425864	884	6	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	884	7	after	after	IN
10_1101-2021_01_08_425864	884	8	5	5	CD
10_1101-2021_01_08_425864	884	9	days	day	NNS
10_1101-2021_01_08_425864	884	10	in	in	IN
10_1101-2021_01_08_425864	884	11	the	the	DT
10_1101-2021_01_08_425864	884	12	presence	presence	NN
10_1101-2021_01_08_425864	884	13	of	of	IN
10_1101-2021_01_08_425864	884	14	ETO	ETO	NNP
10_1101-2021_01_08_425864	884	15	.	.	.
10_1101-2021_01_08_425864	885	1	C	C	NNP
10_1101-2021_01_08_425864	885	2	)	)	-RRB-
10_1101-2021_01_08_425864	885	3	969	969	CD
10_1101-2021_01_08_425864	885	4	Effect	effect	NN
10_1101-2021_01_08_425864	885	5	of	of	IN
10_1101-2021_01_08_425864	885	6	ETO	ETO	NNP
10_1101-2021_01_08_425864	885	7	on	on	IN
10_1101-2021_01_08_425864	885	8	the	the	DT
10_1101-2021_01_08_425864	885	9	metacyclogenesis	metacyclogenesis	NN
10_1101-2021_01_08_425864	885	10	induced	induce	VBN
10_1101-2021_01_08_425864	885	11	by	by	IN
10_1101-2021_01_08_425864	885	12	proline	proline	NN
10_1101-2021_01_08_425864	885	13	.	.	.
10_1101-2021_01_08_425864	886	1	970	970	CD
10_1101-2021_01_08_425864	886	2	.CC	.CC	:
10_1101-2021_01_08_425864	886	3	-	-	:
10_1101-2021_01_08_425864	886	4	BY	by	IN
10_1101-2021_01_08_425864	886	5	4.0	4.0	CD
10_1101-2021_01_08_425864	886	6	International	international	JJ
10_1101-2021_01_08_425864	886	7	licensemade	licensemade	NN
10_1101-2021_01_08_425864	886	8	available	available	JJ
10_1101-2021_01_08_425864	886	9	under	under	IN
10_1101-2021_01_08_425864	886	10	a	a	DT
10_1101-2021_01_08_425864	886	11	(	(	-LRB-
10_1101-2021_01_08_425864	886	12	which	which	WDT
10_1101-2021_01_08_425864	886	13	was	be	VBD
10_1101-2021_01_08_425864	886	14	not	not	RB
10_1101-2021_01_08_425864	886	15	certified	certify	VBN
10_1101-2021_01_08_425864	886	16	by	by	IN
10_1101-2021_01_08_425864	886	17	peer	peer	NN
10_1101-2021_01_08_425864	886	18	review	review	NN
10_1101-2021_01_08_425864	886	19	)	)	-RRB-
10_1101-2021_01_08_425864	886	20	is	be	VBZ
10_1101-2021_01_08_425864	886	21	the	the	DT
10_1101-2021_01_08_425864	886	22	author	author	NN
10_1101-2021_01_08_425864	886	23	/	/	SYM
10_1101-2021_01_08_425864	886	24	funder	funder	NN
10_1101-2021_01_08_425864	886	25	,	,	,
10_1101-2021_01_08_425864	886	26	who	who	WP
10_1101-2021_01_08_425864	886	27	has	have	VBZ
10_1101-2021_01_08_425864	886	28	granted	grant	VBN
10_1101-2021_01_08_425864	886	29	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	886	30	a	a	DT
10_1101-2021_01_08_425864	886	31	license	license	NN
10_1101-2021_01_08_425864	886	32	to	to	TO
10_1101-2021_01_08_425864	886	33	display	display	VB
10_1101-2021_01_08_425864	886	34	the	the	DT
10_1101-2021_01_08_425864	886	35	preprint	preprint	NN
10_1101-2021_01_08_425864	886	36	in	in	IN
10_1101-2021_01_08_425864	886	37	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	886	38	.	.	.
10_1101-2021_01_08_425864	887	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	887	2	is	be	VBZ
10_1101-2021_01_08_425864	887	3	The	the	DT
10_1101-2021_01_08_425864	887	4	copyright	copyright	NN
10_1101-2021_01_08_425864	887	5	holder	holder	NN
10_1101-2021_01_08_425864	887	6	for	for	IN
10_1101-2021_01_08_425864	887	7	this	this	DT
10_1101-2021_01_08_425864	887	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	887	9	version	version	NN
10_1101-2021_01_08_425864	887	10	posted	post	VBD
10_1101-2021_01_08_425864	887	11	January	January	NNP
10_1101-2021_01_08_425864	887	12	8	8	CD
10_1101-2021_01_08_425864	887	13	,	,	,
10_1101-2021_01_08_425864	887	14	2021	2021	CD
10_1101-2021_01_08_425864	887	15	.	.	.
10_1101-2021_01_08_425864	887	16	;	;	:
10_1101-2021_01_08_425864	887	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	887	18	:	:	:
10_1101-2021_01_08_425864	887	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	887	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	887	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	887	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	887	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	887	24	-	-	:
10_1101-2021_01_08_425864	887	25	BY	by	IN
10_1101-2021_01_08_425864	887	26	4.0	4.0	CD
10_1101-2021_01_08_425864	887	27	International	international	JJ
10_1101-2021_01_08_425864	887	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	887	29	available	available	JJ
10_1101-2021_01_08_425864	887	30	under	under	IN
10_1101-2021_01_08_425864	887	31	a	a	DT
10_1101-2021_01_08_425864	887	32	(	(	-LRB-
10_1101-2021_01_08_425864	887	33	which	which	WDT
10_1101-2021_01_08_425864	887	34	was	be	VBD
10_1101-2021_01_08_425864	887	35	not	not	RB
10_1101-2021_01_08_425864	887	36	certified	certify	VBN
10_1101-2021_01_08_425864	887	37	by	by	IN
10_1101-2021_01_08_425864	887	38	peer	peer	NN
10_1101-2021_01_08_425864	887	39	review	review	NN
10_1101-2021_01_08_425864	887	40	)	)	-RRB-
10_1101-2021_01_08_425864	887	41	is	be	VBZ
10_1101-2021_01_08_425864	887	42	the	the	DT
10_1101-2021_01_08_425864	887	43	author	author	NN
10_1101-2021_01_08_425864	887	44	/	/	SYM
10_1101-2021_01_08_425864	887	45	funder	funder	NN
10_1101-2021_01_08_425864	887	46	,	,	,
10_1101-2021_01_08_425864	887	47	who	who	WP
10_1101-2021_01_08_425864	887	48	has	have	VBZ
10_1101-2021_01_08_425864	887	49	granted	grant	VBN
10_1101-2021_01_08_425864	887	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	887	51	a	a	DT
10_1101-2021_01_08_425864	887	52	license	license	NN
10_1101-2021_01_08_425864	887	53	to	to	TO
10_1101-2021_01_08_425864	887	54	display	display	VB
10_1101-2021_01_08_425864	887	55	the	the	DT
10_1101-2021_01_08_425864	887	56	preprint	preprint	NN
10_1101-2021_01_08_425864	887	57	in	in	IN
10_1101-2021_01_08_425864	887	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	887	59	.	.	.
10_1101-2021_01_08_425864	888	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	888	2	is	be	VBZ
10_1101-2021_01_08_425864	888	3	The	the	DT
10_1101-2021_01_08_425864	888	4	copyright	copyright	NN
10_1101-2021_01_08_425864	888	5	holder	holder	NN
10_1101-2021_01_08_425864	888	6	for	for	IN
10_1101-2021_01_08_425864	888	7	this	this	DT
10_1101-2021_01_08_425864	888	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	888	9	version	version	NN
10_1101-2021_01_08_425864	888	10	posted	post	VBD
10_1101-2021_01_08_425864	888	11	January	January	NNP
10_1101-2021_01_08_425864	888	12	8	8	CD
10_1101-2021_01_08_425864	888	13	,	,	,
10_1101-2021_01_08_425864	888	14	2021	2021	CD
10_1101-2021_01_08_425864	888	15	.	.	.
10_1101-2021_01_08_425864	888	16	;	;	:
10_1101-2021_01_08_425864	888	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	888	18	:	:	:
10_1101-2021_01_08_425864	888	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	888	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	888	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	888	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	888	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	888	24	-	-	:
10_1101-2021_01_08_425864	888	25	BY	by	IN
10_1101-2021_01_08_425864	888	26	4.0	4.0	CD
10_1101-2021_01_08_425864	888	27	International	international	JJ
10_1101-2021_01_08_425864	888	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	888	29	available	available	JJ
10_1101-2021_01_08_425864	888	30	under	under	IN
10_1101-2021_01_08_425864	888	31	a	a	DT
10_1101-2021_01_08_425864	888	32	(	(	-LRB-
10_1101-2021_01_08_425864	888	33	which	which	WDT
10_1101-2021_01_08_425864	888	34	was	be	VBD
10_1101-2021_01_08_425864	888	35	not	not	RB
10_1101-2021_01_08_425864	888	36	certified	certify	VBN
10_1101-2021_01_08_425864	888	37	by	by	IN
10_1101-2021_01_08_425864	888	38	peer	peer	NN
10_1101-2021_01_08_425864	888	39	review	review	NN
10_1101-2021_01_08_425864	888	40	)	)	-RRB-
10_1101-2021_01_08_425864	888	41	is	be	VBZ
10_1101-2021_01_08_425864	888	42	the	the	DT
10_1101-2021_01_08_425864	888	43	author	author	NN
10_1101-2021_01_08_425864	888	44	/	/	SYM
10_1101-2021_01_08_425864	888	45	funder	funder	NN
10_1101-2021_01_08_425864	888	46	,	,	,
10_1101-2021_01_08_425864	888	47	who	who	WP
10_1101-2021_01_08_425864	888	48	has	have	VBZ
10_1101-2021_01_08_425864	888	49	granted	grant	VBN
10_1101-2021_01_08_425864	888	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	888	51	a	a	DT
10_1101-2021_01_08_425864	888	52	license	license	NN
10_1101-2021_01_08_425864	888	53	to	to	TO
10_1101-2021_01_08_425864	888	54	display	display	VB
10_1101-2021_01_08_425864	888	55	the	the	DT
10_1101-2021_01_08_425864	888	56	preprint	preprint	NN
10_1101-2021_01_08_425864	888	57	in	in	IN
10_1101-2021_01_08_425864	888	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	888	59	.	.	.
10_1101-2021_01_08_425864	889	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	889	2	is	be	VBZ
10_1101-2021_01_08_425864	889	3	The	the	DT
10_1101-2021_01_08_425864	889	4	copyright	copyright	NN
10_1101-2021_01_08_425864	889	5	holder	holder	NN
10_1101-2021_01_08_425864	889	6	for	for	IN
10_1101-2021_01_08_425864	889	7	this	this	DT
10_1101-2021_01_08_425864	889	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	889	9	version	version	NN
10_1101-2021_01_08_425864	889	10	posted	post	VBD
10_1101-2021_01_08_425864	889	11	January	January	NNP
10_1101-2021_01_08_425864	889	12	8	8	CD
10_1101-2021_01_08_425864	889	13	,	,	,
10_1101-2021_01_08_425864	889	14	2021	2021	CD
10_1101-2021_01_08_425864	889	15	.	.	.
10_1101-2021_01_08_425864	889	16	;	;	:
10_1101-2021_01_08_425864	889	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	889	18	:	:	:
10_1101-2021_01_08_425864	889	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	889	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	889	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	889	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	889	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	889	24	-	-	:
10_1101-2021_01_08_425864	889	25	BY	by	IN
10_1101-2021_01_08_425864	889	26	4.0	4.0	CD
10_1101-2021_01_08_425864	889	27	International	international	JJ
10_1101-2021_01_08_425864	889	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	889	29	available	available	JJ
10_1101-2021_01_08_425864	889	30	under	under	IN
10_1101-2021_01_08_425864	889	31	a	a	DT
10_1101-2021_01_08_425864	889	32	(	(	-LRB-
10_1101-2021_01_08_425864	889	33	which	which	WDT
10_1101-2021_01_08_425864	889	34	was	be	VBD
10_1101-2021_01_08_425864	889	35	not	not	RB
10_1101-2021_01_08_425864	889	36	certified	certify	VBN
10_1101-2021_01_08_425864	889	37	by	by	IN
10_1101-2021_01_08_425864	889	38	peer	peer	NN
10_1101-2021_01_08_425864	889	39	review	review	NN
10_1101-2021_01_08_425864	889	40	)	)	-RRB-
10_1101-2021_01_08_425864	889	41	is	be	VBZ
10_1101-2021_01_08_425864	889	42	the	the	DT
10_1101-2021_01_08_425864	889	43	author	author	NN
10_1101-2021_01_08_425864	889	44	/	/	SYM
10_1101-2021_01_08_425864	889	45	funder	funder	NN
10_1101-2021_01_08_425864	889	46	,	,	,
10_1101-2021_01_08_425864	889	47	who	who	WP
10_1101-2021_01_08_425864	889	48	has	have	VBZ
10_1101-2021_01_08_425864	889	49	granted	grant	VBN
10_1101-2021_01_08_425864	889	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	889	51	a	a	DT
10_1101-2021_01_08_425864	889	52	license	license	NN
10_1101-2021_01_08_425864	889	53	to	to	TO
10_1101-2021_01_08_425864	889	54	display	display	VB
10_1101-2021_01_08_425864	889	55	the	the	DT
10_1101-2021_01_08_425864	889	56	preprint	preprint	NN
10_1101-2021_01_08_425864	889	57	in	in	IN
10_1101-2021_01_08_425864	889	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	889	59	.	.	.
10_1101-2021_01_08_425864	890	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	890	2	is	be	VBZ
10_1101-2021_01_08_425864	890	3	The	the	DT
10_1101-2021_01_08_425864	890	4	copyright	copyright	NN
10_1101-2021_01_08_425864	890	5	holder	holder	NN
10_1101-2021_01_08_425864	890	6	for	for	IN
10_1101-2021_01_08_425864	890	7	this	this	DT
10_1101-2021_01_08_425864	890	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	890	9	version	version	NN
10_1101-2021_01_08_425864	890	10	posted	post	VBD
10_1101-2021_01_08_425864	890	11	January	January	NNP
10_1101-2021_01_08_425864	890	12	8	8	CD
10_1101-2021_01_08_425864	890	13	,	,	,
10_1101-2021_01_08_425864	890	14	2021	2021	CD
10_1101-2021_01_08_425864	890	15	.	.	.
10_1101-2021_01_08_425864	890	16	;	;	:
10_1101-2021_01_08_425864	890	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	890	18	:	:	:
10_1101-2021_01_08_425864	890	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	890	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	890	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	890	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	890	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	890	24	-	-	:
10_1101-2021_01_08_425864	890	25	BY	by	IN
10_1101-2021_01_08_425864	890	26	4.0	4.0	CD
10_1101-2021_01_08_425864	890	27	International	international	JJ
10_1101-2021_01_08_425864	890	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	890	29	available	available	JJ
10_1101-2021_01_08_425864	890	30	under	under	IN
10_1101-2021_01_08_425864	890	31	a	a	DT
10_1101-2021_01_08_425864	890	32	(	(	-LRB-
10_1101-2021_01_08_425864	890	33	which	which	WDT
10_1101-2021_01_08_425864	890	34	was	be	VBD
10_1101-2021_01_08_425864	890	35	not	not	RB
10_1101-2021_01_08_425864	890	36	certified	certify	VBN
10_1101-2021_01_08_425864	890	37	by	by	IN
10_1101-2021_01_08_425864	890	38	peer	peer	NN
10_1101-2021_01_08_425864	890	39	review	review	NN
10_1101-2021_01_08_425864	890	40	)	)	-RRB-
10_1101-2021_01_08_425864	890	41	is	be	VBZ
10_1101-2021_01_08_425864	890	42	the	the	DT
10_1101-2021_01_08_425864	890	43	author	author	NN
10_1101-2021_01_08_425864	890	44	/	/	SYM
10_1101-2021_01_08_425864	890	45	funder	funder	NN
10_1101-2021_01_08_425864	890	46	,	,	,
10_1101-2021_01_08_425864	890	47	who	who	WP
10_1101-2021_01_08_425864	890	48	has	have	VBZ
10_1101-2021_01_08_425864	890	49	granted	grant	VBN
10_1101-2021_01_08_425864	890	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	890	51	a	a	DT
10_1101-2021_01_08_425864	890	52	license	license	NN
10_1101-2021_01_08_425864	890	53	to	to	TO
10_1101-2021_01_08_425864	890	54	display	display	VB
10_1101-2021_01_08_425864	890	55	the	the	DT
10_1101-2021_01_08_425864	890	56	preprint	preprint	NN
10_1101-2021_01_08_425864	890	57	in	in	IN
10_1101-2021_01_08_425864	890	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	890	59	.	.	.
10_1101-2021_01_08_425864	891	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	891	2	is	be	VBZ
10_1101-2021_01_08_425864	891	3	The	the	DT
10_1101-2021_01_08_425864	891	4	copyright	copyright	NN
10_1101-2021_01_08_425864	891	5	holder	holder	NN
10_1101-2021_01_08_425864	891	6	for	for	IN
10_1101-2021_01_08_425864	891	7	this	this	DT
10_1101-2021_01_08_425864	891	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	891	9	version	version	NN
10_1101-2021_01_08_425864	891	10	posted	post	VBD
10_1101-2021_01_08_425864	891	11	January	January	NNP
10_1101-2021_01_08_425864	891	12	8	8	CD
10_1101-2021_01_08_425864	891	13	,	,	,
10_1101-2021_01_08_425864	891	14	2021	2021	CD
10_1101-2021_01_08_425864	891	15	.	.	.
10_1101-2021_01_08_425864	891	16	;	;	:
10_1101-2021_01_08_425864	891	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	891	18	:	:	:
10_1101-2021_01_08_425864	891	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	891	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	891	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	891	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	891	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	891	24	-	-	:
10_1101-2021_01_08_425864	891	25	BY	by	IN
10_1101-2021_01_08_425864	891	26	4.0	4.0	CD
10_1101-2021_01_08_425864	891	27	International	international	JJ
10_1101-2021_01_08_425864	891	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	891	29	available	available	JJ
10_1101-2021_01_08_425864	891	30	under	under	IN
10_1101-2021_01_08_425864	891	31	a	a	DT
10_1101-2021_01_08_425864	891	32	(	(	-LRB-
10_1101-2021_01_08_425864	891	33	which	which	WDT
10_1101-2021_01_08_425864	891	34	was	be	VBD
10_1101-2021_01_08_425864	891	35	not	not	RB
10_1101-2021_01_08_425864	891	36	certified	certify	VBN
10_1101-2021_01_08_425864	891	37	by	by	IN
10_1101-2021_01_08_425864	891	38	peer	peer	NN
10_1101-2021_01_08_425864	891	39	review	review	NN
10_1101-2021_01_08_425864	891	40	)	)	-RRB-
10_1101-2021_01_08_425864	891	41	is	be	VBZ
10_1101-2021_01_08_425864	891	42	the	the	DT
10_1101-2021_01_08_425864	891	43	author	author	NN
10_1101-2021_01_08_425864	891	44	/	/	SYM
10_1101-2021_01_08_425864	891	45	funder	funder	NN
10_1101-2021_01_08_425864	891	46	,	,	,
10_1101-2021_01_08_425864	891	47	who	who	WP
10_1101-2021_01_08_425864	891	48	has	have	VBZ
10_1101-2021_01_08_425864	891	49	granted	grant	VBN
10_1101-2021_01_08_425864	891	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	891	51	a	a	DT
10_1101-2021_01_08_425864	891	52	license	license	NN
10_1101-2021_01_08_425864	891	53	to	to	TO
10_1101-2021_01_08_425864	891	54	display	display	VB
10_1101-2021_01_08_425864	891	55	the	the	DT
10_1101-2021_01_08_425864	891	56	preprint	preprint	NN
10_1101-2021_01_08_425864	891	57	in	in	IN
10_1101-2021_01_08_425864	891	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	891	59	.	.	.
10_1101-2021_01_08_425864	892	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	892	2	is	be	VBZ
10_1101-2021_01_08_425864	892	3	The	the	DT
10_1101-2021_01_08_425864	892	4	copyright	copyright	NN
10_1101-2021_01_08_425864	892	5	holder	holder	NN
10_1101-2021_01_08_425864	892	6	for	for	IN
10_1101-2021_01_08_425864	892	7	this	this	DT
10_1101-2021_01_08_425864	892	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	892	9	version	version	NN
10_1101-2021_01_08_425864	892	10	posted	post	VBD
10_1101-2021_01_08_425864	892	11	January	January	NNP
10_1101-2021_01_08_425864	892	12	8	8	CD
10_1101-2021_01_08_425864	892	13	,	,	,
10_1101-2021_01_08_425864	892	14	2021	2021	CD
10_1101-2021_01_08_425864	892	15	.	.	.
10_1101-2021_01_08_425864	892	16	;	;	:
10_1101-2021_01_08_425864	892	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	892	18	:	:	:
10_1101-2021_01_08_425864	892	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	892	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	892	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	892	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	892	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	892	24	-	-	:
10_1101-2021_01_08_425864	892	25	BY	by	IN
10_1101-2021_01_08_425864	892	26	4.0	4.0	CD
10_1101-2021_01_08_425864	892	27	International	international	JJ
10_1101-2021_01_08_425864	892	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	892	29	available	available	JJ
10_1101-2021_01_08_425864	892	30	under	under	IN
10_1101-2021_01_08_425864	892	31	a	a	DT
10_1101-2021_01_08_425864	892	32	(	(	-LRB-
10_1101-2021_01_08_425864	892	33	which	which	WDT
10_1101-2021_01_08_425864	892	34	was	be	VBD
10_1101-2021_01_08_425864	892	35	not	not	RB
10_1101-2021_01_08_425864	892	36	certified	certify	VBN
10_1101-2021_01_08_425864	892	37	by	by	IN
10_1101-2021_01_08_425864	892	38	peer	peer	NN
10_1101-2021_01_08_425864	892	39	review	review	NN
10_1101-2021_01_08_425864	892	40	)	)	-RRB-
10_1101-2021_01_08_425864	892	41	is	be	VBZ
10_1101-2021_01_08_425864	892	42	the	the	DT
10_1101-2021_01_08_425864	892	43	author	author	NN
10_1101-2021_01_08_425864	892	44	/	/	SYM
10_1101-2021_01_08_425864	892	45	funder	funder	NN
10_1101-2021_01_08_425864	892	46	,	,	,
10_1101-2021_01_08_425864	892	47	who	who	WP
10_1101-2021_01_08_425864	892	48	has	have	VBZ
10_1101-2021_01_08_425864	892	49	granted	grant	VBN
10_1101-2021_01_08_425864	892	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	892	51	a	a	DT
10_1101-2021_01_08_425864	892	52	license	license	NN
10_1101-2021_01_08_425864	892	53	to	to	TO
10_1101-2021_01_08_425864	892	54	display	display	VB
10_1101-2021_01_08_425864	892	55	the	the	DT
10_1101-2021_01_08_425864	892	56	preprint	preprint	NN
10_1101-2021_01_08_425864	892	57	in	in	IN
10_1101-2021_01_08_425864	892	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	892	59	.	.	.
10_1101-2021_01_08_425864	893	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	893	2	is	be	VBZ
10_1101-2021_01_08_425864	893	3	The	the	DT
10_1101-2021_01_08_425864	893	4	copyright	copyright	NN
10_1101-2021_01_08_425864	893	5	holder	holder	NN
10_1101-2021_01_08_425864	893	6	for	for	IN
10_1101-2021_01_08_425864	893	7	this	this	DT
10_1101-2021_01_08_425864	893	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	893	9	version	version	NN
10_1101-2021_01_08_425864	893	10	posted	post	VBD
10_1101-2021_01_08_425864	893	11	January	January	NNP
10_1101-2021_01_08_425864	893	12	8	8	CD
10_1101-2021_01_08_425864	893	13	,	,	,
10_1101-2021_01_08_425864	893	14	2021	2021	CD
10_1101-2021_01_08_425864	893	15	.	.	.
10_1101-2021_01_08_425864	893	16	;	;	:
10_1101-2021_01_08_425864	893	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	893	18	:	:	:
10_1101-2021_01_08_425864	893	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	893	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	893	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	893	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	893	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	893	24	-	-	:
10_1101-2021_01_08_425864	893	25	BY	by	IN
10_1101-2021_01_08_425864	893	26	4.0	4.0	CD
10_1101-2021_01_08_425864	893	27	International	international	JJ
10_1101-2021_01_08_425864	893	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	893	29	available	available	JJ
10_1101-2021_01_08_425864	893	30	under	under	IN
10_1101-2021_01_08_425864	893	31	a	a	DT
10_1101-2021_01_08_425864	893	32	(	(	-LRB-
10_1101-2021_01_08_425864	893	33	which	which	WDT
10_1101-2021_01_08_425864	893	34	was	be	VBD
10_1101-2021_01_08_425864	893	35	not	not	RB
10_1101-2021_01_08_425864	893	36	certified	certify	VBN
10_1101-2021_01_08_425864	893	37	by	by	IN
10_1101-2021_01_08_425864	893	38	peer	peer	NN
10_1101-2021_01_08_425864	893	39	review	review	NN
10_1101-2021_01_08_425864	893	40	)	)	-RRB-
10_1101-2021_01_08_425864	893	41	is	be	VBZ
10_1101-2021_01_08_425864	893	42	the	the	DT
10_1101-2021_01_08_425864	893	43	author	author	NN
10_1101-2021_01_08_425864	893	44	/	/	SYM
10_1101-2021_01_08_425864	893	45	funder	funder	NN
10_1101-2021_01_08_425864	893	46	,	,	,
10_1101-2021_01_08_425864	893	47	who	who	WP
10_1101-2021_01_08_425864	893	48	has	have	VBZ
10_1101-2021_01_08_425864	893	49	granted	grant	VBN
10_1101-2021_01_08_425864	893	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	893	51	a	a	DT
10_1101-2021_01_08_425864	893	52	license	license	NN
10_1101-2021_01_08_425864	893	53	to	to	TO
10_1101-2021_01_08_425864	893	54	display	display	VB
10_1101-2021_01_08_425864	893	55	the	the	DT
10_1101-2021_01_08_425864	893	56	preprint	preprint	NN
10_1101-2021_01_08_425864	893	57	in	in	IN
10_1101-2021_01_08_425864	893	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	893	59	.	.	.
10_1101-2021_01_08_425864	894	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	894	2	is	be	VBZ
10_1101-2021_01_08_425864	894	3	The	the	DT
10_1101-2021_01_08_425864	894	4	copyright	copyright	NN
10_1101-2021_01_08_425864	894	5	holder	holder	NN
10_1101-2021_01_08_425864	894	6	for	for	IN
10_1101-2021_01_08_425864	894	7	this	this	DT
10_1101-2021_01_08_425864	894	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	894	9	version	version	NN
10_1101-2021_01_08_425864	894	10	posted	post	VBD
10_1101-2021_01_08_425864	894	11	January	January	NNP
10_1101-2021_01_08_425864	894	12	8	8	CD
10_1101-2021_01_08_425864	894	13	,	,	,
10_1101-2021_01_08_425864	894	14	2021	2021	CD
10_1101-2021_01_08_425864	894	15	.	.	.
10_1101-2021_01_08_425864	894	16	;	;	:
10_1101-2021_01_08_425864	894	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	894	18	:	:	:
10_1101-2021_01_08_425864	894	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	894	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	894	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	894	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	894	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	894	24	-	-	:
10_1101-2021_01_08_425864	894	25	BY	by	IN
10_1101-2021_01_08_425864	894	26	4.0	4.0	CD
10_1101-2021_01_08_425864	894	27	International	international	JJ
10_1101-2021_01_08_425864	894	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	894	29	available	available	JJ
10_1101-2021_01_08_425864	894	30	under	under	IN
10_1101-2021_01_08_425864	894	31	a	a	DT
10_1101-2021_01_08_425864	894	32	(	(	-LRB-
10_1101-2021_01_08_425864	894	33	which	which	WDT
10_1101-2021_01_08_425864	894	34	was	be	VBD
10_1101-2021_01_08_425864	894	35	not	not	RB
10_1101-2021_01_08_425864	894	36	certified	certify	VBN
10_1101-2021_01_08_425864	894	37	by	by	IN
10_1101-2021_01_08_425864	894	38	peer	peer	NN
10_1101-2021_01_08_425864	894	39	review	review	NN
10_1101-2021_01_08_425864	894	40	)	)	-RRB-
10_1101-2021_01_08_425864	894	41	is	be	VBZ
10_1101-2021_01_08_425864	894	42	the	the	DT
10_1101-2021_01_08_425864	894	43	author	author	NN
10_1101-2021_01_08_425864	894	44	/	/	SYM
10_1101-2021_01_08_425864	894	45	funder	funder	NN
10_1101-2021_01_08_425864	894	46	,	,	,
10_1101-2021_01_08_425864	894	47	who	who	WP
10_1101-2021_01_08_425864	894	48	has	have	VBZ
10_1101-2021_01_08_425864	894	49	granted	grant	VBN
10_1101-2021_01_08_425864	894	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	894	51	a	a	DT
10_1101-2021_01_08_425864	894	52	license	license	NN
10_1101-2021_01_08_425864	894	53	to	to	TO
10_1101-2021_01_08_425864	894	54	display	display	VB
10_1101-2021_01_08_425864	894	55	the	the	DT
10_1101-2021_01_08_425864	894	56	preprint	preprint	NN
10_1101-2021_01_08_425864	894	57	in	in	IN
10_1101-2021_01_08_425864	894	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	894	59	.	.	.
10_1101-2021_01_08_425864	895	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	895	2	is	be	VBZ
10_1101-2021_01_08_425864	895	3	The	the	DT
10_1101-2021_01_08_425864	895	4	copyright	copyright	NN
10_1101-2021_01_08_425864	895	5	holder	holder	NN
10_1101-2021_01_08_425864	895	6	for	for	IN
10_1101-2021_01_08_425864	895	7	this	this	DT
10_1101-2021_01_08_425864	895	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	895	9	version	version	NN
10_1101-2021_01_08_425864	895	10	posted	post	VBD
10_1101-2021_01_08_425864	895	11	January	January	NNP
10_1101-2021_01_08_425864	895	12	8	8	CD
10_1101-2021_01_08_425864	895	13	,	,	,
10_1101-2021_01_08_425864	895	14	2021	2021	CD
10_1101-2021_01_08_425864	895	15	.	.	.
10_1101-2021_01_08_425864	895	16	;	;	:
10_1101-2021_01_08_425864	895	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	895	18	:	:	:
10_1101-2021_01_08_425864	895	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	895	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	895	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	895	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	895	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	895	24	-	-	:
10_1101-2021_01_08_425864	895	25	BY	by	IN
10_1101-2021_01_08_425864	895	26	4.0	4.0	CD
10_1101-2021_01_08_425864	895	27	International	international	JJ
10_1101-2021_01_08_425864	895	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	895	29	available	available	JJ
10_1101-2021_01_08_425864	895	30	under	under	IN
10_1101-2021_01_08_425864	895	31	a	a	DT
10_1101-2021_01_08_425864	895	32	(	(	-LRB-
10_1101-2021_01_08_425864	895	33	which	which	WDT
10_1101-2021_01_08_425864	895	34	was	be	VBD
10_1101-2021_01_08_425864	895	35	not	not	RB
10_1101-2021_01_08_425864	895	36	certified	certify	VBN
10_1101-2021_01_08_425864	895	37	by	by	IN
10_1101-2021_01_08_425864	895	38	peer	peer	NN
10_1101-2021_01_08_425864	895	39	review	review	NN
10_1101-2021_01_08_425864	895	40	)	)	-RRB-
10_1101-2021_01_08_425864	895	41	is	be	VBZ
10_1101-2021_01_08_425864	895	42	the	the	DT
10_1101-2021_01_08_425864	895	43	author	author	NN
10_1101-2021_01_08_425864	895	44	/	/	SYM
10_1101-2021_01_08_425864	895	45	funder	funder	NN
10_1101-2021_01_08_425864	895	46	,	,	,
10_1101-2021_01_08_425864	895	47	who	who	WP
10_1101-2021_01_08_425864	895	48	has	have	VBZ
10_1101-2021_01_08_425864	895	49	granted	grant	VBN
10_1101-2021_01_08_425864	895	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	895	51	a	a	DT
10_1101-2021_01_08_425864	895	52	license	license	NN
10_1101-2021_01_08_425864	895	53	to	to	TO
10_1101-2021_01_08_425864	895	54	display	display	VB
10_1101-2021_01_08_425864	895	55	the	the	DT
10_1101-2021_01_08_425864	895	56	preprint	preprint	NN
10_1101-2021_01_08_425864	895	57	in	in	IN
10_1101-2021_01_08_425864	895	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	895	59	.	.	.
10_1101-2021_01_08_425864	896	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	896	2	is	be	VBZ
10_1101-2021_01_08_425864	896	3	The	the	DT
10_1101-2021_01_08_425864	896	4	copyright	copyright	NN
10_1101-2021_01_08_425864	896	5	holder	holder	NN
10_1101-2021_01_08_425864	896	6	for	for	IN
10_1101-2021_01_08_425864	896	7	this	this	DT
10_1101-2021_01_08_425864	896	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	896	9	version	version	NN
10_1101-2021_01_08_425864	896	10	posted	post	VBD
10_1101-2021_01_08_425864	896	11	January	January	NNP
10_1101-2021_01_08_425864	896	12	8	8	CD
10_1101-2021_01_08_425864	896	13	,	,	,
10_1101-2021_01_08_425864	896	14	2021	2021	CD
10_1101-2021_01_08_425864	896	15	.	.	.
10_1101-2021_01_08_425864	896	16	;	;	:
10_1101-2021_01_08_425864	896	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	896	18	:	:	:
10_1101-2021_01_08_425864	896	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	896	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	896	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	896	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	896	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	896	24	-	-	:
10_1101-2021_01_08_425864	896	25	BY	by	IN
10_1101-2021_01_08_425864	896	26	4.0	4.0	CD
10_1101-2021_01_08_425864	896	27	International	international	JJ
10_1101-2021_01_08_425864	896	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	896	29	available	available	JJ
10_1101-2021_01_08_425864	896	30	under	under	IN
10_1101-2021_01_08_425864	896	31	a	a	DT
10_1101-2021_01_08_425864	896	32	(	(	-LRB-
10_1101-2021_01_08_425864	896	33	which	which	WDT
10_1101-2021_01_08_425864	896	34	was	be	VBD
10_1101-2021_01_08_425864	896	35	not	not	RB
10_1101-2021_01_08_425864	896	36	certified	certify	VBN
10_1101-2021_01_08_425864	896	37	by	by	IN
10_1101-2021_01_08_425864	896	38	peer	peer	NN
10_1101-2021_01_08_425864	896	39	review	review	NN
10_1101-2021_01_08_425864	896	40	)	)	-RRB-
10_1101-2021_01_08_425864	896	41	is	be	VBZ
10_1101-2021_01_08_425864	896	42	the	the	DT
10_1101-2021_01_08_425864	896	43	author	author	NN
10_1101-2021_01_08_425864	896	44	/	/	SYM
10_1101-2021_01_08_425864	896	45	funder	funder	NN
10_1101-2021_01_08_425864	896	46	,	,	,
10_1101-2021_01_08_425864	896	47	who	who	WP
10_1101-2021_01_08_425864	896	48	has	have	VBZ
10_1101-2021_01_08_425864	896	49	granted	grant	VBN
10_1101-2021_01_08_425864	896	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	896	51	a	a	DT
10_1101-2021_01_08_425864	896	52	license	license	NN
10_1101-2021_01_08_425864	896	53	to	to	TO
10_1101-2021_01_08_425864	896	54	display	display	VB
10_1101-2021_01_08_425864	896	55	the	the	DT
10_1101-2021_01_08_425864	896	56	preprint	preprint	NN
10_1101-2021_01_08_425864	896	57	in	in	IN
10_1101-2021_01_08_425864	896	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	896	59	.	.	.
10_1101-2021_01_08_425864	897	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	897	2	is	be	VBZ
10_1101-2021_01_08_425864	897	3	The	the	DT
10_1101-2021_01_08_425864	897	4	copyright	copyright	NN
10_1101-2021_01_08_425864	897	5	holder	holder	NN
10_1101-2021_01_08_425864	897	6	for	for	IN
10_1101-2021_01_08_425864	897	7	this	this	DT
10_1101-2021_01_08_425864	897	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	897	9	version	version	NN
10_1101-2021_01_08_425864	897	10	posted	post	VBD
10_1101-2021_01_08_425864	897	11	January	January	NNP
10_1101-2021_01_08_425864	897	12	8	8	CD
10_1101-2021_01_08_425864	897	13	,	,	,
10_1101-2021_01_08_425864	897	14	2021	2021	CD
10_1101-2021_01_08_425864	897	15	.	.	.
10_1101-2021_01_08_425864	897	16	;	;	:
10_1101-2021_01_08_425864	897	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	897	18	:	:	:
10_1101-2021_01_08_425864	897	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	897	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	897	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	897	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	897	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	897	24	-	-	:
10_1101-2021_01_08_425864	897	25	BY	by	IN
10_1101-2021_01_08_425864	897	26	4.0	4.0	CD
10_1101-2021_01_08_425864	897	27	International	international	JJ
10_1101-2021_01_08_425864	897	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	897	29	available	available	JJ
10_1101-2021_01_08_425864	897	30	under	under	IN
10_1101-2021_01_08_425864	897	31	a	a	DT
10_1101-2021_01_08_425864	897	32	(	(	-LRB-
10_1101-2021_01_08_425864	897	33	which	which	WDT
10_1101-2021_01_08_425864	897	34	was	be	VBD
10_1101-2021_01_08_425864	897	35	not	not	RB
10_1101-2021_01_08_425864	897	36	certified	certify	VBN
10_1101-2021_01_08_425864	897	37	by	by	IN
10_1101-2021_01_08_425864	897	38	peer	peer	NN
10_1101-2021_01_08_425864	897	39	review	review	NN
10_1101-2021_01_08_425864	897	40	)	)	-RRB-
10_1101-2021_01_08_425864	897	41	is	be	VBZ
10_1101-2021_01_08_425864	897	42	the	the	DT
10_1101-2021_01_08_425864	897	43	author	author	NN
10_1101-2021_01_08_425864	897	44	/	/	SYM
10_1101-2021_01_08_425864	897	45	funder	funder	NN
10_1101-2021_01_08_425864	897	46	,	,	,
10_1101-2021_01_08_425864	897	47	who	who	WP
10_1101-2021_01_08_425864	897	48	has	have	VBZ
10_1101-2021_01_08_425864	897	49	granted	grant	VBN
10_1101-2021_01_08_425864	897	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	897	51	a	a	DT
10_1101-2021_01_08_425864	897	52	license	license	NN
10_1101-2021_01_08_425864	897	53	to	to	TO
10_1101-2021_01_08_425864	897	54	display	display	VB
10_1101-2021_01_08_425864	897	55	the	the	DT
10_1101-2021_01_08_425864	897	56	preprint	preprint	NN
10_1101-2021_01_08_425864	897	57	in	in	IN
10_1101-2021_01_08_425864	897	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	897	59	.	.	.
10_1101-2021_01_08_425864	898	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	898	2	is	be	VBZ
10_1101-2021_01_08_425864	898	3	The	the	DT
10_1101-2021_01_08_425864	898	4	copyright	copyright	NN
10_1101-2021_01_08_425864	898	5	holder	holder	NN
10_1101-2021_01_08_425864	898	6	for	for	IN
10_1101-2021_01_08_425864	898	7	this	this	DT
10_1101-2021_01_08_425864	898	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	898	9	version	version	NN
10_1101-2021_01_08_425864	898	10	posted	post	VBD
10_1101-2021_01_08_425864	898	11	January	January	NNP
10_1101-2021_01_08_425864	898	12	8	8	CD
10_1101-2021_01_08_425864	898	13	,	,	,
10_1101-2021_01_08_425864	898	14	2021	2021	CD
10_1101-2021_01_08_425864	898	15	.	.	.
10_1101-2021_01_08_425864	898	16	;	;	:
10_1101-2021_01_08_425864	898	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	898	18	:	:	:
10_1101-2021_01_08_425864	898	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	898	20	preprint	preprint	JJ
10_1101-2021_01_08_425864	898	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	898	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_08_425864	898	23	.CC	.CC	NFP
10_1101-2021_01_08_425864	898	24	-	-	:
10_1101-2021_01_08_425864	898	25	BY	by	IN
10_1101-2021_01_08_425864	898	26	4.0	4.0	CD
10_1101-2021_01_08_425864	898	27	International	international	JJ
10_1101-2021_01_08_425864	898	28	licensemade	licensemade	NN
10_1101-2021_01_08_425864	898	29	available	available	JJ
10_1101-2021_01_08_425864	898	30	under	under	IN
10_1101-2021_01_08_425864	898	31	a	a	DT
10_1101-2021_01_08_425864	898	32	(	(	-LRB-
10_1101-2021_01_08_425864	898	33	which	which	WDT
10_1101-2021_01_08_425864	898	34	was	be	VBD
10_1101-2021_01_08_425864	898	35	not	not	RB
10_1101-2021_01_08_425864	898	36	certified	certify	VBN
10_1101-2021_01_08_425864	898	37	by	by	IN
10_1101-2021_01_08_425864	898	38	peer	peer	NN
10_1101-2021_01_08_425864	898	39	review	review	NN
10_1101-2021_01_08_425864	898	40	)	)	-RRB-
10_1101-2021_01_08_425864	898	41	is	be	VBZ
10_1101-2021_01_08_425864	898	42	the	the	DT
10_1101-2021_01_08_425864	898	43	author	author	NN
10_1101-2021_01_08_425864	898	44	/	/	SYM
10_1101-2021_01_08_425864	898	45	funder	funder	NN
10_1101-2021_01_08_425864	898	46	,	,	,
10_1101-2021_01_08_425864	898	47	who	who	WP
10_1101-2021_01_08_425864	898	48	has	have	VBZ
10_1101-2021_01_08_425864	898	49	granted	grant	VBN
10_1101-2021_01_08_425864	898	50	bioRxiv	biorxiv	IN
10_1101-2021_01_08_425864	898	51	a	a	DT
10_1101-2021_01_08_425864	898	52	license	license	NN
10_1101-2021_01_08_425864	898	53	to	to	TO
10_1101-2021_01_08_425864	898	54	display	display	VB
10_1101-2021_01_08_425864	898	55	the	the	DT
10_1101-2021_01_08_425864	898	56	preprint	preprint	NN
10_1101-2021_01_08_425864	898	57	in	in	IN
10_1101-2021_01_08_425864	898	58	perpetuity	perpetuity	NN
10_1101-2021_01_08_425864	898	59	.	.	.
10_1101-2021_01_08_425864	899	1	It	-PRON-	PRP
10_1101-2021_01_08_425864	899	2	is	be	VBZ
10_1101-2021_01_08_425864	899	3	The	the	DT
10_1101-2021_01_08_425864	899	4	copyright	copyright	NN
10_1101-2021_01_08_425864	899	5	holder	holder	NN
10_1101-2021_01_08_425864	899	6	for	for	IN
10_1101-2021_01_08_425864	899	7	this	this	DT
10_1101-2021_01_08_425864	899	8	preprintthis	preprintthis	NN
10_1101-2021_01_08_425864	899	9	version	version	NN
10_1101-2021_01_08_425864	899	10	posted	post	VBD
10_1101-2021_01_08_425864	899	11	January	January	NNP
10_1101-2021_01_08_425864	899	12	8	8	CD
10_1101-2021_01_08_425864	899	13	,	,	,
10_1101-2021_01_08_425864	899	14	2021	2021	CD
10_1101-2021_01_08_425864	899	15	.	.	.
10_1101-2021_01_08_425864	899	16	;	;	:
10_1101-2021_01_08_425864	899	17	https://doi.org/10.1101/2021.01.08.425864doi	https://doi.org/10.1101/2021.01.08.425864doi	ADD
10_1101-2021_01_08_425864	899	18	:	:	:
10_1101-2021_01_08_425864	899	19	bioRxiv	biorxiv	VB
10_1101-2021_01_08_425864	899	20	preprint	preprint	NN
10_1101-2021_01_08_425864	899	21	https://doi.org/10.1101/2021.01.08.425864	https://doi.org/10.1101/2021.01.08.425864	ADD
10_1101-2021_01_08_425864	899	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD